Psyllid ID: psy787
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 235 | 2.2.26 [Sep-21-2011] | |||||||
| Q0GGW5 | 440 | Serine/threonine-protein | yes | N/A | 0.953 | 0.509 | 0.727 | 6e-90 | |
| Q15831 | 433 | Serine/threonine-protein | yes | N/A | 0.970 | 0.526 | 0.699 | 2e-88 | |
| Q9WTK7 | 436 | Serine/threonine-protein | yes | N/A | 0.953 | 0.513 | 0.727 | 2e-88 | |
| Q91604 | 432 | Serine/threonine-protein | N/A | N/A | 0.953 | 0.518 | 0.718 | 5e-87 | |
| D4AE59 | 438 | Serine/threonine-protein | yes | N/A | 0.965 | 0.518 | 0.696 | 2e-86 | |
| A8X0C4 | 649 | Serine/threonine-protein | N/A | N/A | 0.885 | 0.320 | 0.497 | 4e-55 | |
| Q9GN62 | 617 | Serine/threonine-protein | yes | N/A | 0.859 | 0.327 | 0.487 | 4e-52 | |
| Q54WJ0 | 586 | Serine/threonine-protein | yes | N/A | 0.902 | 0.361 | 0.427 | 1e-46 | |
| Q54WW7 | 695 | Probable serine/threonine | no | N/A | 0.825 | 0.279 | 0.397 | 3e-32 | |
| Q2QMI0 | 454 | CBL-interacting protein k | yes | N/A | 0.829 | 0.429 | 0.356 | 2e-30 |
| >sp|Q0GGW5|STK11_CHICK Serine/threonine-protein kinase STK11 OS=Gallus gallus GN=STK11 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 330 bits (845), Expect = 6e-90, Method: Compositional matrix adjust.
Identities = 163/224 (72%), Positives = 191/224 (85%)
Query: 12 MISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK 71
M + HR+DS +VIY + + K+IGKY+MGDLLGEGSYGKVKEMLDSETLCRRAVKI K
Sbjct: 22 MDTFIHRIDSTEVIYQPRRKRAKLIGKYLMGDLLGEGSYGKVKEMLDSETLCRRAVKILK 81
Query: 72 KKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD 131
KKKL+RIPNGE NV +EI+LL+ L+H+NVI LVDV N++KQKMY++MEYCV G+Q+MLD
Sbjct: 82 KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD 141
Query: 132 STPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
S P K+FP++QAHGYF QL+DGLEYLHSQGI+HKDIKPGNLLLT +GTLKISD GVAE+L
Sbjct: 142 SVPEKRFPVFQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTNGTLKISDLGVAEAL 201
Query: 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
F DDT TSQGSP FQ PEIANGL SG+KVDIWS+GVTL
Sbjct: 202 HPFAEDDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 245
|
Tumor suppressor serine/threonine-protein kinase that controls the activity of AMP-activated protein kinase (AMPK) family members, thereby playing a role in various processes such as cell metabolism, cell polarity, apoptosis and DNA damage response. Acts by phosphorylating the T-loop of AMPK family proteins, leading to promote their activity. Gallus gallus (taxid: 9031) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q15831|STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 325 bits (832), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 163/233 (69%), Positives = 194/233 (83%), Gaps = 5/233 (2%)
Query: 8 VDGDMISI-----FHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETL 62
+G+++S+ HR+DS +VIY + + K+IGKY+MGDLLGEGSYGKVKE+LDSETL
Sbjct: 13 TEGELMSVGMDTFIHRIDSTEVIYQPRRKRAKLIGKYLMGDLLGEGSYGKVKEVLDSETL 72
Query: 63 CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYC 122
CRRAVKI KKKKL+RIPNGE NV +EI+LL+ L+H+NVI LVDV N++KQKMY++MEYC
Sbjct: 73 CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC 132
Query: 123 VGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKI 182
V G+Q+MLDS P K+FP+ QAHGYF QL+DGLEYLHSQGI+HKDIKPGNLLLT GTLKI
Sbjct: 133 VCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKI 192
Query: 183 SDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
SD GVAE+L F DDT TSQGSP FQ PEIANGL SG+KVDIWS+GVTL
Sbjct: 193 SDLGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 245
|
Tumor suppressor serine/threonine-protein kinase that controls the activity of AMP-activated protein kinase (AMPK) family members, thereby playing a role in various processes such as cell metabolism, cell polarity, apoptosis and DNA damage response. Acts by phosphorylating the T-loop of AMPK family proteins, leading to promote their activity: phosphorylates PRKAA1, PRKAA2, BRSK1, BRSK2, MARK1, MARK2, MARK3, MARK4, NUAK1, NUAK2, SIK1, SIK2, SIK3 and SNRK but not MELK. Also phosphorylates non-AMPK family proteins such as STRADA and possibly p53/TP53. Acts as a key upstream regulator of AMPK by mediating phosphorylation and activation of AMPK catalytic subunits PRKAA1 and PRKAA2: it thereby regulates inhibition of signaling pathways that promote cell growth and proliferation when energy levels are low, glucose homeostasis in liver, activation of autophagy when cells undergo nutrient deprivation, B-cell differentiation in the germinal center in response to DNA damage. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton. Required for cortical neurons polarization by mediating phosphorylation and activation of BRSK1 and BRSK2, leading to axon initiation and specification. Involved in DNA damage response: interacts with p53/TP53 and recruited to the CDKN1A/WAF1 promoter to participate in transcription activation. Able to phosphorylate p53/TP53; the relevance of such result in vivo is however unclear and phosphorylation may be indirect and mediated by downstream STK11/LKB1 kinase NUAK1 Also acts as a mediator p53/TP53-dependent apoptosis via interaction with p53/TP53: translocates to mitochondrion during apoptosis and regulates p53/TP53-dependent apoptosis pathways. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9WTK7|STK11_MOUSE Serine/threonine-protein kinase STK11 OS=Mus musculus GN=Stk11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 325 bits (832), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 163/224 (72%), Positives = 190/224 (84%)
Query: 12 MISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK 71
M + HR+DS +VIY + + K+IGKY+MGDLLGEGSYGKVKE+LDSETLCRRAVKI K
Sbjct: 22 MDTFIHRIDSTEVIYQPRRKRAKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILK 81
Query: 72 KKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD 131
KKKL+RIPNGE NV +EI+LL+ L+HRNVI LVDV N++KQKMY++MEYCV G+Q+MLD
Sbjct: 82 KKKLRRIPNGEANVKKEIQLLRRLRHRNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD 141
Query: 132 STPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
S P K+FP+ QAHGYF QL+DGLEYLHSQGI+HKDIKPGNLLLT +GTLKISD GVAE+L
Sbjct: 142 SVPEKRFPVCQAHGYFRQLIDGLEYLHSQGIVHKDIKPGNLLLTTNGTLKISDLGVAEAL 201
Query: 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
F DDT TSQGSP FQ PEIANGL SG+KVDIWS+GVTL
Sbjct: 202 HPFAVDDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 245
|
Tumor suppressor serine/threonine-protein kinase that controls the activity of AMP-activated protein kinase (AMPK) family members, thereby playing a role in various processes such as cell metabolism, cell polarity, apoptosis and DNA damage response. Acts by phosphorylating the T-loop of AMPK family proteins, leading to promote their activity: phosphorylates PRKAA1, PRKAA2, BRSK1, BRSK2, MARK1, MARK2, MARK3, MARK4, NUAK1, NUAK2, SIK1, SIK2, SIK3 and SNRK but not MELK. Also phosphorylates non-AMPK family proteins such as STRADA and possibly p53/TP53. Acts as a key upstream regulator of AMPK by mediating phosphorylation and activation of AMPK catalytic subunits PRKAA1 and PRKAA2: it thereby regulates inhibition of signaling pathways that promote cell growth and proliferation when energy levels are low, glucose homeostasis in liver, activation of autophagy when cells undergo nutrient deprivation, B-cell differentiation in the germinal center in response to DNA damage. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton. Required for cortical neurons polarization by mediating phosphorylation and activation of BRSK1 and BRSK2, leading to axon initiation and specification. Involved in DNA damage response: interacts with p53/TP53 and recruited to the CDKN1A/WAF1 promoter to participate in transcription activation. Able to phosphorylate p53/TP53; the relevance of such result in vivo is however unclear. Also acts as a mediator p53/TP53-dependent apoptosis via interaction with p53/TP53: translocates to mitochondrion during apoptosis and regulates p53/TP53-dependent apoptosis pathways. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q91604|STK11_XENLA Serine/threonine-protein kinase stk11 OS=Xenopus laevis GN=stk11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (820), Expect = 5e-87, Method: Compositional matrix adjust.
Identities = 161/224 (71%), Positives = 188/224 (83%)
Query: 12 MISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK 71
M + HR+DS +VIY + + K++GKY+MGDLLGEGSYGKVKEMLDS+TLCRRAVKI K
Sbjct: 25 MDTFIHRIDSTEVIYQPRRKRAKLVGKYLMGDLLGEGSYGKVKEMLDSDTLCRRAVKILK 84
Query: 72 KKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD 131
KKKL+RIPNGE NV +EI+LL+ L+HRNVI LVDV N++KQKMY++MEYCV G+Q+MLD
Sbjct: 85 KKKLRRIPNGEANVKKEIQLLRRLRHRNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD 144
Query: 132 STPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
S K FP++QAHGYF QL+DGLEYLHSQGI+HKDIKPGNLLLT DGTLKISD GVAE+L
Sbjct: 145 SVQDKHFPVFQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTDGTLKISDLGVAEAL 204
Query: 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
F DT TSQGSP FQ PEIANGL SG+KVDIWS+GVTL
Sbjct: 205 HPFAEGDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 248
|
Tumor suppressor serine/threonine-protein kinase that controls the activity of AMP-activated protein kinase (AMPK) family members, thereby playing a role in various processes such as cell metabolism, cell polarity, apoptosis and DNA damage response. Acts by phosphorylating the T-loop of AMPK family proteins, leading to promote their activity. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|D4AE59|STK11_RAT Serine/threonine-protein kinase STK11 OS=Rattus norvegicus GN=Stk11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (815), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 163/234 (69%), Positives = 194/234 (82%), Gaps = 7/234 (2%)
Query: 9 DGDMISI-----FHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLC 63
+G+++S+ HR+DS +VIY + + K+IGKY+MGDLLGEGSYGKVKE+LDSETLC
Sbjct: 14 EGELMSVGMDTFIHRIDSTEVIYQPRRKRAKLIGKYLMGDLLGEGSYGKVKEVLDSETLC 73
Query: 64 RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK--MYLIMEY 121
RRAVKI KKKKL+RIPNGE NV +EI+LL+ L+HRNVI LVDV N++KQK Y++MEY
Sbjct: 74 RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHRNVIQLVDVLYNEEKQKRPTYMVMEY 133
Query: 122 CVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLK 181
CV G+Q+MLDS P K+FP+ QAHGYF QL+DGLEYLHSQGI+HKDIKPGNLLLT +GTLK
Sbjct: 134 CVCGMQEMLDSVPEKRFPVCQAHGYFRQLIDGLEYLHSQGIVHKDIKPGNLLLTTNGTLK 193
Query: 182 ISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
ISD GVAE+L F DDT TSQGSP FQ PEIANGL SG+KVDIWS+GVTL
Sbjct: 194 ISDLGVAEALHPFAVDDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 247
|
Tumor suppressor serine/threonine-protein kinase that controls the activity of AMP-activated protein kinase (AMPK) family members, thereby playing a role in various processes such as cell metabolism, cell polarity, apoptosis and DNA damage response. Acts by phosphorylating the T-loop of AMPK family proteins, leading to promote their activity: phosphorylates PRKAA1, PRKAA2, BRSK1, BRSK2, MARK1, MARK2, MARK3, MARK4, NUAK1, NUAK2, SIK1, SIK2, SIK3 and SNRK but not MELK. Also phosphorylates non-AMPK family proteins such as STRADA and possibly p53/TP53. Acts as a key upstream regulator of AMPK by mediating phosphorylation and activation of AMPK catalytic subunits PRKAA1 and PRKAA2: it thereby regulates inhibition of signaling pathways that promote cell growth and proliferation when energy levels are low, glucose homeostasis in liver, activation of autophagy when cells undergo nutrient deprivation, B-cell differentiation in the germinal center in response to DNA damage. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton. Required for cortical neurons polarization by mediating phosphorylation and activation of BRSK1 and BRSK2, leading to axon initiation and specification. Involved in DNA damage response: interacts with p53/TP53 and recruited to the CDKN1A/WAF1 promoter to participate in transcription activation. Able to phosphorylate p53/TP53; the relevance of such result in vivo is however unclear. Also acts as a mediator p53/TP53-dependent apoptosis via interaction with p53/TP53: translocates to mitochondrion during apoptosis and regulates p53/TP53-dependent apoptosis pathways. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A8X0C4|PAR4_CAEBR Serine/threonine-protein kinase par-4 OS=Caenorhabditis briggsae GN=par-4 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 214 bits (545), Expect = 4e-55, Method: Compositional matrix adjust.
Identities = 104/209 (49%), Positives = 145/209 (69%), Gaps = 1/209 (0%)
Query: 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDR 87
NK + K+I Y+ G ++G GSYGKVKE++D T+ RRA KI K +KL++IPNG N+
Sbjct: 186 NKPKEAKIIEGYLWGGIIGTGSYGKVKEVIDIYTITRRAAKIMKYEKLRKIPNGWDNIRS 245
Query: 88 EIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYF 147
E+ +L+ L HRN++ L++VF +K K+Y+I EYC+G +Q+++D P + I ++H F
Sbjct: 246 EMSILRRLNHRNIVKLIEVFNLPEKGKVYMIFEYCIGSVQNLIDMEPAHRLSIGESHAIF 305
Query: 148 LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSP 207
L+L GL YLHS+ + HKDIKPGNLLL++D T+KI DFGVAE + +F D T G+P
Sbjct: 306 LELCHGLNYLHSKRVSHKDIKPGNLLLSIDMTVKICDFGVAEQICLFQSDGRCTKVNGTP 365
Query: 208 VFQAPEIANGLPE-ISGYKVDIWSSGVTL 235
FQ PE G E GYKVD+WS+GVTL
Sbjct: 366 KFQPPECVYGNHEYFDGYKVDMWSAGVTL 394
|
Required for cytoplasmic partitioning and asymmetric cell division in early embryogenesis. Phosphorylates and restricts the asymmetry effectors mex-5 and mex-6 to the anterior cytoplasm of the zygote and maintains these phosphorylations until fertilization. Phosphorylates and regulates aak-2 in response to oxidative stress. May also play a role in motility, behavioral response, regulation of lifespan and dauer formation through this pathway. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9GN62|PAR4_CAEEL Serine/threonine-protein kinase par-4 OS=Caenorhabditis elegans GN=par-4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 204 bits (519), Expect = 4e-52, Method: Compositional matrix adjust.
Identities = 99/203 (48%), Positives = 138/203 (67%), Gaps = 1/203 (0%)
Query: 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLK 93
K+I Y+ G +G GSYGKVKE +D TL RRAVKI K KL++I NG N+ E+ +L+
Sbjct: 178 KIIEGYMWGGQIGTGSYGKVKECIDMYTLTRRAVKIMKYDKLRKITNGWENIRSEMSILR 237
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
+ HRNVI L+++F K K+Y++ EYC+G +Q +LD P ++ I ++H F++L G
Sbjct: 238 RMNHRNVIKLIEIFNIPAKGKVYMVFEYCIGSVQQLLDMEPARRLTIGESHAIFIELCQG 297
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
L YLHS+ + HKDIKPGNLL+++D T+KI DFGVAE +++F D T G+P FQ PE
Sbjct: 298 LNYLHSKRVSHKDIKPGNLLVSIDFTVKICDFGVAEQINLFQRDGRCTKVNGTPKFQPPE 357
Query: 214 IANGLPE-ISGYKVDIWSSGVTL 235
G + GYK D+WS+GVTL
Sbjct: 358 CIYGNHDFFDGYKADMWSAGVTL 380
|
Required for cytoplasmic partitioning and asymmetric cell division in early embryogenesis. Involved in mediating cell polarization via regulation of anillin family scaffold proteins. Phosphorylates and restricts the asymmetry effectors mex-5 and mex-6 to the anterior cytoplasm of the zygote and maintains these phosphorylations until fertilization. Phosphorylates and regulates aak-2 in response to oxidative stress. May also play a role in motility, behavioral response, regulation of lifespan and dauer formation through this pathway. Acts downstream of unc-40 in dendrite outgrowth. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54WJ0|STK11_DICDI Serine/threonine-protein kinase stk11 homolog OS=Dictyostelium discoideum GN=lkb1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 91/213 (42%), Positives = 141/213 (66%), Gaps = 1/213 (0%)
Query: 24 VIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI 83
+ Y ++ K++ Y++G++LGEG+YGKVK+ +DS T R AVKI K+ +L++IP GE
Sbjct: 25 ISYRSRKSTPKLVKHYILGEVLGEGAYGKVKDGMDSFTQKRVAVKILKRARLKKIPGGEA 84
Query: 84 NVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGL-QDMLDSTPYKKFPIWQ 142
+V +EI + K L ++++I L+D F+ ++K K+Y++ EY GG Q++L++ P + P Q
Sbjct: 85 SVLKEINITKKLHNKHIIKLIDHFIIEEKGKLYIVYEYVGGGTSQNILENAPNGRLPPHQ 144
Query: 143 AHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITT 202
+ F QL++ EY+HSQ I+H+DIKP N+L T LK+SDFGVAE + ++
Sbjct: 145 SQFIFRQLIEACEYIHSQKILHRDIKPDNILFTHANVLKLSDFGVAEDSSQLEDFECLSR 204
Query: 203 SQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
S GSP FQ PE+ S +K+DIW+ GVTL
Sbjct: 205 SYGSPAFQPPELTQFQTTFSPFKIDIWAMGVTL 237
|
Serine/threonine-protein kinase that controls the activity of AMP-activated protein kinase (AMPK) family members, thereby playing a role in various processes such as cell metabolism, cell polarity, apoptosis and DNA damage response. Acts by phosphorylating the T-loop of AMPK family proteins, leading to promote their activity. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54WW7|Y0010_DICDI Probable serine/threonine-protein kinase DDB_G0279405 OS=Dictyostelium discoideum GN=DDB_G0279405 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 138 bits (348), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 83/209 (39%), Positives = 124/209 (59%), Gaps = 15/209 (7%)
Query: 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR------IPNGEINVDR 87
KM+ +YV LG+G++GKVK +T A+KIF K +L++ PN +V +
Sbjct: 196 KMVNEYVFVRKLGKGTFGKVKLAYHHDTHHLYAIKIFNKIRLKKQTMGIGRPNAFDDVLK 255
Query: 88 EIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYF 147
EI ++K + H NV+ L +V + +++ +Y++MEY GG + T A YF
Sbjct: 256 EIAIMKKMNHINVVKLYEVINDPQEEYIYIVMEYIEGGSIMSANETSED-----LARKYF 310
Query: 148 LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSP 207
++ GLEYLH Q +IHKD+KP NLL+ +G +KI+DFGV+ +F DD + S+GSP
Sbjct: 311 RDIVFGLEYLHEQKVIHKDLKPENLLVNSEGVVKITDFGVSH---IFDDDDVVRCSRGSP 367
Query: 208 VFQAPEIA-NGLPEISGYKVDIWSSGVTL 235
F APE+ N ISG VD+W+ GV+L
Sbjct: 368 AFLAPELCRNESQPISGKGVDVWALGVSL 396
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QMI0|CIPK4_ORYSJ CBL-interacting protein kinase 4 OS=Oryza sativa subsp. japonica GN=CIPK4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 132 bits (332), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 73/205 (35%), Positives = 114/205 (55%), Gaps = 10/205 (4%)
Query: 35 MIGKYVMGDLLGEGSYGKV---KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRL 91
++GKY +G +LG G++ KV + + E + AVK+ K ++ V RE+
Sbjct: 21 LLGKYELGRMLGRGTFAKVYLARAVAGGEAV---AVKVIDKAEVMGTAGMAPRVLREVAA 77
Query: 92 LKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQL 150
++ L+H +V+ L +V + ++YL+ME GG L L + P ++ P A F+QL
Sbjct: 78 MRRLRHPHVLRLHEVLAT--RARIYLVMELATGGDLLSRLAALPRRRLPESAARRVFVQL 135
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQ 210
+D L Y H++G+ H+D+KP N+LL DG LK+SDFG+A D D + T+ G+P +
Sbjct: 136 VDALSYCHARGVAHRDVKPQNVLLDGDGNLKVSDFGLAALPDTLRDDGRLHTACGTPAYA 195
Query: 211 APEIANGLPEISGYKVDIWSSGVTL 235
APE+ G K D WS GV L
Sbjct: 196 APEVLRRR-AYDGAKADAWSCGVIL 219
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 235 | ||||||
| 332024522 | 431 | Serine/threonine-protein kinase 11 [Acro | 0.982 | 0.535 | 0.741 | 6e-97 | |
| 380029517 | 430 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.537 | 0.754 | 2e-95 | |
| 328780100 | 430 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.537 | 0.754 | 2e-95 | |
| 340722859 | 430 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.537 | 0.754 | 2e-95 | |
| 340722857 | 402 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.574 | 0.754 | 2e-95 | |
| 156555380 | 427 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.540 | 0.768 | 4e-94 | |
| 307177140 | 432 | Serine/threonine-protein kinase 11 [Camp | 0.982 | 0.534 | 0.737 | 4e-94 | |
| 345494998 | 397 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.581 | 0.768 | 6e-94 | |
| 321459539 | 416 | Skb11-like protein [Daphnia pulex] | 1.0 | 0.564 | 0.702 | 5e-93 | |
| 91089965 | 443 | PREDICTED: similar to serine/threonine k | 0.974 | 0.516 | 0.714 | 1e-92 |
| >gi|332024522|gb|EGI64720.1| Serine/threonine-protein kinase 11 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 359 bits (921), Expect = 6e-97, Method: Compositional matrix adjust.
Identities = 172/232 (74%), Positives = 199/232 (85%), Gaps = 1/232 (0%)
Query: 5 DDEVDGDMISIF-HRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLC 63
D D D +++F HRVDSDQ+IY+ K K K IGKYVMGD+LGEGSYGKVKE+LDS+TLC
Sbjct: 32 DPNYDLDEVNMFFHRVDSDQIIYEEKRKKCKFIGKYVMGDVLGEGSYGKVKEVLDSQTLC 91
Query: 64 RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCV 123
RRAVKI KK+KL+RIPNGE NV REI+LL++L+H+NVI LVDV +D+K+KMYL+ME+CV
Sbjct: 92 RRAVKILKKRKLRRIPNGEQNVQREIKLLRILKHKNVINLVDVLYSDEKEKMYLVMEFCV 151
Query: 124 GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKIS 183
GLQDML+STP KK P+WQAH YF QLLDGLEYL+S+GI+HKDIKPGNLLLTLDGTLKIS
Sbjct: 152 CGLQDMLESTPTKKLPLWQAHDYFCQLLDGLEYLYSKGIVHKDIKPGNLLLTLDGTLKIS 211
Query: 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
DFGVAE+LDMF DDT T QGSP FQ PEIANG SG+KVDIWSSGVTL
Sbjct: 212 DFGVAEALDMFSKDDTCTIGQGSPAFQPPEIANGCESFSGFKVDIWSSGVTL 263
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380029517|ref|XP_003698416.1| PREDICTED: serine/threonine-protein kinase STK11-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 354 bits (908), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 175/232 (75%), Positives = 197/232 (84%), Gaps = 1/232 (0%)
Query: 5 DDEVDGDMISIF-HRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLC 63
D D D I++F HRVDSDQ+IY+ K K K IGKYVMGD+LGEGSYGKVKE+LDSETLC
Sbjct: 32 DPTYDLDEINMFFHRVDSDQIIYEEKKKKCKFIGKYVMGDVLGEGSYGKVKEVLDSETLC 91
Query: 64 RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCV 123
RRAVKI K+KKL+RIPNGE+NV REIRLL++L+H+NVI LVDV ND+K+KMYL+ME+CV
Sbjct: 92 RRAVKILKRKKLRRIPNGELNVQREIRLLRILKHKNVINLVDVLYNDEKEKMYLVMEFCV 151
Query: 124 GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKIS 183
GLQDML STP KK PIWQAH YF QLLDGLEYL+S+GI+HKDIKPGNLLL LDGTLKIS
Sbjct: 152 CGLQDMLGSTPLKKLPIWQAHDYFCQLLDGLEYLYSKGIVHKDIKPGNLLLALDGTLKIS 211
Query: 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
DFGVAE+LDMF DDT QGSP FQ PEIANG SG+KVDIWSSGVTL
Sbjct: 212 DFGVAEALDMFSEDDTCKMGQGSPAFQPPEIANGCETFSGFKVDIWSSGVTL 263
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328780100|ref|XP_623596.2| PREDICTED: serine/threonine-protein kinase 11 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 354 bits (908), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 175/232 (75%), Positives = 197/232 (84%), Gaps = 1/232 (0%)
Query: 5 DDEVDGDMISIF-HRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLC 63
D D D I++F HRVDSDQ+IY+ K K K IGKYVMGD+LGEGSYGKVKE+LDSETLC
Sbjct: 32 DPTYDLDEINMFFHRVDSDQIIYEEKKKKCKFIGKYVMGDVLGEGSYGKVKEVLDSETLC 91
Query: 64 RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCV 123
RRAVKI K+KKL+RIPNGE+NV REIRLL++L+H+NVI LVDV ND+K+KMYL+ME+CV
Sbjct: 92 RRAVKILKRKKLRRIPNGELNVQREIRLLRILKHKNVINLVDVLYNDEKEKMYLVMEFCV 151
Query: 124 GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKIS 183
GLQDML STP KK PIWQAH YF QLLDGLEYL+S+GI+HKDIKPGNLLL LDGTLKIS
Sbjct: 152 CGLQDMLGSTPLKKLPIWQAHDYFCQLLDGLEYLYSKGIVHKDIKPGNLLLALDGTLKIS 211
Query: 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
DFGVAE+LDMF DDT QGSP FQ PEIANG SG+KVDIWSSGVTL
Sbjct: 212 DFGVAEALDMFSEDDTCKMGQGSPAFQPPEIANGCETFSGFKVDIWSSGVTL 263
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340722859|ref|XP_003399818.1| PREDICTED: serine/threonine-protein kinase 11-like isoform 2 [Bombus terrestris] gi|350403611|ref|XP_003486853.1| PREDICTED: serine/threonine-protein kinase STK11-like isoform 2 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 353 bits (907), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 175/232 (75%), Positives = 197/232 (84%), Gaps = 1/232 (0%)
Query: 5 DDEVDGDMISIF-HRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLC 63
D D D I++F HRVDSDQ+IY+ K K K IGKYVMGD+LGEGSYGKVKE+LDSETLC
Sbjct: 32 DPNYDLDEINMFFHRVDSDQIIYEEKKKKCKFIGKYVMGDVLGEGSYGKVKEVLDSETLC 91
Query: 64 RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCV 123
RRAVKI K+KKL+RIPNGE+NV REIRLL++L+H+NVI LVDV ND+K+KMYL+ME+CV
Sbjct: 92 RRAVKILKRKKLRRIPNGELNVQREIRLLRILKHKNVINLVDVLYNDEKEKMYLVMEFCV 151
Query: 124 GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKIS 183
GLQDML STP KK PIWQAH YF QLLDGLEYL+S+GI+HKDIKPGNLLL LDGTLKIS
Sbjct: 152 CGLQDMLGSTPLKKLPIWQAHDYFCQLLDGLEYLYSKGIVHKDIKPGNLLLALDGTLKIS 211
Query: 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
DFGVAE+LDMF DDT QGSP FQ PEIANG SG+KVDIWSSGVTL
Sbjct: 212 DFGVAEALDMFSEDDTCKMGQGSPAFQPPEIANGCETFSGFKVDIWSSGVTL 263
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340722857|ref|XP_003399817.1| PREDICTED: serine/threonine-protein kinase 11-like isoform 1 [Bombus terrestris] gi|350403608|ref|XP_003486852.1| PREDICTED: serine/threonine-protein kinase STK11-like isoform 1 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 353 bits (907), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 175/232 (75%), Positives = 197/232 (84%), Gaps = 1/232 (0%)
Query: 5 DDEVDGDMISIF-HRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLC 63
D D D I++F HRVDSDQ+IY+ K K K IGKYVMGD+LGEGSYGKVKE+LDSETLC
Sbjct: 32 DPNYDLDEINMFFHRVDSDQIIYEEKKKKCKFIGKYVMGDVLGEGSYGKVKEVLDSETLC 91
Query: 64 RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCV 123
RRAVKI K+KKL+RIPNGE+NV REIRLL++L+H+NVI LVDV ND+K+KMYL+ME+CV
Sbjct: 92 RRAVKILKRKKLRRIPNGELNVQREIRLLRILKHKNVINLVDVLYNDEKEKMYLVMEFCV 151
Query: 124 GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKIS 183
GLQDML STP KK PIWQAH YF QLLDGLEYL+S+GI+HKDIKPGNLLL LDGTLKIS
Sbjct: 152 CGLQDMLGSTPLKKLPIWQAHDYFCQLLDGLEYLYSKGIVHKDIKPGNLLLALDGTLKIS 211
Query: 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
DFGVAE+LDMF DDT QGSP FQ PEIANG SG+KVDIWSSGVTL
Sbjct: 212 DFGVAEALDMFSEDDTCKMGQGSPAFQPPEIANGCETFSGFKVDIWSSGVTL 263
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|156555380|ref|XP_001605282.1| PREDICTED: serine/threonine-protein kinase 11-like isoform 1 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 350 bits (897), Expect = 4e-94, Method: Compositional matrix adjust.
Identities = 179/233 (76%), Positives = 205/233 (87%), Gaps = 2/233 (0%)
Query: 4 KDDEVD-GDMISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETL 62
++D+ D D+ + FHRVDSDQ+IY+ K K K IGKYVMGDLLGEGSYGKVKEMLDS TL
Sbjct: 27 REDDYDLDDVNTFFHRVDSDQIIYEEKK-KCKYIGKYVMGDLLGEGSYGKVKEMLDSITL 85
Query: 63 CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYC 122
CRRAVKI KKKKL+RIPNGEINV REI+LLK+L+H+NVIGLVDVF N++K+K+Y+IME+C
Sbjct: 86 CRRAVKILKKKKLRRIPNGEINVQREIQLLKVLKHKNVIGLVDVFYNNEKEKLYIIMEFC 145
Query: 123 VGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKI 182
VGGLQDML+STP KKFP+WQAHGYF QLLDGLEYLH + I+HKDIKPGNLLLTLDGTLKI
Sbjct: 146 VGGLQDMLESTPLKKFPVWQAHGYFCQLLDGLEYLHGKSIVHKDIKPGNLLLTLDGTLKI 205
Query: 183 SDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+DFGVAE+LDMF DDT TT QGSP FQ PEIANG +G+KVDIWSSGVTL
Sbjct: 206 TDFGVAEALDMFAKDDTCTTGQGSPAFQPPEIANGCESFAGFKVDIWSSGVTL 258
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307177140|gb|EFN66373.1| Serine/threonine-protein kinase 11 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 349 bits (896), Expect = 4e-94, Method: Compositional matrix adjust.
Identities = 171/232 (73%), Positives = 197/232 (84%), Gaps = 1/232 (0%)
Query: 5 DDEVDGDMISIF-HRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLC 63
D D D I++F HRVDS Q+IY+ K K K IGKYVMGD+LGEGSYGKVKE+LDS+TLC
Sbjct: 32 DPNYDLDEINMFFHRVDSAQIIYEEKKKKCKFIGKYVMGDVLGEGSYGKVKEVLDSQTLC 91
Query: 64 RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCV 123
RRAVKI KK+KL+RIPNGE NV REI+LL++L+H+NVI LVDV +D+K+KMYL+ME+CV
Sbjct: 92 RRAVKILKKRKLRRIPNGEQNVQREIKLLRLLRHKNVINLVDVLYSDEKEKMYLVMEFCV 151
Query: 124 GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKIS 183
GLQDML+S P KK P+WQAH YF QLLDGLEYL+S+GI+HKDIKPGNLLLTLDGTLKIS
Sbjct: 152 CGLQDMLESAPTKKLPLWQAHDYFCQLLDGLEYLYSKGIVHKDIKPGNLLLTLDGTLKIS 211
Query: 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
DFGVAE+LDMF DDT T QGSP FQ PEIANG SG+KVDIWSSGVTL
Sbjct: 212 DFGVAEALDMFSKDDTCTIGQGSPAFQPPEIANGCESFSGFKVDIWSSGVTL 263
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345494998|ref|XP_003427415.1| PREDICTED: serine/threonine-protein kinase 11-like isoform 2 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 349 bits (895), Expect = 6e-94, Method: Compositional matrix adjust.
Identities = 179/233 (76%), Positives = 205/233 (87%), Gaps = 2/233 (0%)
Query: 4 KDDEVD-GDMISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETL 62
++D+ D D+ + FHRVDSDQ+IY+ K K K IGKYVMGDLLGEGSYGKVKEMLDS TL
Sbjct: 27 REDDYDLDDVNTFFHRVDSDQIIYEEKK-KCKYIGKYVMGDLLGEGSYGKVKEMLDSITL 85
Query: 63 CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYC 122
CRRAVKI KKKKL+RIPNGEINV REI+LLK+L+H+NVIGLVDVF N++K+K+Y+IME+C
Sbjct: 86 CRRAVKILKKKKLRRIPNGEINVQREIQLLKVLKHKNVIGLVDVFYNNEKEKLYIIMEFC 145
Query: 123 VGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKI 182
VGGLQDML+STP KKFP+WQAHGYF QLLDGLEYLH + I+HKDIKPGNLLLTLDGTLKI
Sbjct: 146 VGGLQDMLESTPLKKFPVWQAHGYFCQLLDGLEYLHGKSIVHKDIKPGNLLLTLDGTLKI 205
Query: 183 SDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+DFGVAE+LDMF DDT TT QGSP FQ PEIANG +G+KVDIWSSGVTL
Sbjct: 206 TDFGVAEALDMFAKDDTCTTGQGSPAFQPPEIANGCESFAGFKVDIWSSGVTL 258
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|321459539|gb|EFX70591.1| Skb11-like protein [Daphnia pulex] | Back alignment and taxonomy information |
|---|
Score = 346 bits (887), Expect = 5e-93, Method: Compositional matrix adjust.
Identities = 165/235 (70%), Positives = 193/235 (82%)
Query: 1 MGDKDDEVDGDMISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSE 60
M D + D ++ HR+ S+Q+IY +K + K IGKYVMGDLLGEGSYGKVKE+LD+E
Sbjct: 1 MDDPFNLEDDGLMPFIHRISSEQIIYKSKKNQCKFIGKYVMGDLLGEGSYGKVKEVLDTE 60
Query: 61 TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIME 120
TLCR+AVKI K++KL+RIPNGE NV+REI+LL+ML H+NVI L +V N++KQKMYLI E
Sbjct: 61 TLCRKAVKILKRRKLRRIPNGEQNVEREIKLLQMLNHKNVIRLYEVMHNEEKQKMYLIFE 120
Query: 121 YCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTL 180
YCV GLQ+++DSTP KKFPIWQAHGYF QL+DGLEYLHSQGIIHKDIKP NLLLT DG L
Sbjct: 121 YCVSGLQELIDSTPLKKFPIWQAHGYFCQLIDGLEYLHSQGIIHKDIKPSNLLLTTDGML 180
Query: 181 KISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
KISD GVAE+LDMF DD TSQGSP FQ PEIANGL G+KVD+WSSGVTL
Sbjct: 181 KISDLGVAEALDMFAVDDLCQTSQGSPAFQPPEIANGLDSFPGFKVDVWSSGVTL 235
|
Source: Daphnia pulex Species: Daphnia pulex Genus: Daphnia Family: Daphniidae Order: Diplostraca Class: Branchiopoda Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|91089965|ref|XP_973678.1| PREDICTED: similar to serine/threonine kinase 11 [Tribolium castaneum] gi|270014272|gb|EFA10720.1| polarization-related protein LKB1 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 344 bits (883), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 165/231 (71%), Positives = 198/231 (85%), Gaps = 2/231 (0%)
Query: 6 DEVD-GDMISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCR 64
D++D G++ + FHRV S+QVIY K ++KMIGKYVMGDLLGEGSYGKVKEMLDS+TLCR
Sbjct: 54 DDLDVGNISNFFHRVSSEQVIYQAKK-RLKMIGKYVMGDLLGEGSYGKVKEMLDSDTLCR 112
Query: 65 RAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVG 124
RAVKI K++KL+RIPNG NV+REI+LLK L+H+NVI LVDV N++KQKMYLIME+CVG
Sbjct: 113 RAVKILKQRKLRRIPNGVQNVEREIKLLKSLKHKNVISLVDVLFNEEKQKMYLIMEFCVG 172
Query: 125 GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISD 184
LQ ML+STPYKKFP++QAHGYF+QL+DGLEYLHS+ ++HKDIKPGNLLLTL+G LKISD
Sbjct: 173 SLQGMLESTPYKKFPLYQAHGYFIQLIDGLEYLHSKRVVHKDIKPGNLLLTLEGELKISD 232
Query: 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
GVAE++D F DDT QGSP FQ PEIANGL G+KVD+WSSGV+L
Sbjct: 233 LGVAETIDFFAIDDTCVQGQGSPAFQPPEIANGLDSFPGFKVDVWSSGVSL 283
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 235 | ||||||
| ZFIN|ZDB-GENE-050417-383 | 440 | stk11 "serine/threonine kinase | 0.978 | 0.522 | 0.718 | 2.3e-87 | |
| UNIPROTKB|F1NG57 | 441 | STK11 "Serine/threonine-protei | 0.953 | 0.507 | 0.727 | 3.7e-87 | |
| UNIPROTKB|Q0GGW5 | 440 | STK11 "Serine/threonine-protei | 0.953 | 0.509 | 0.727 | 3.7e-87 | |
| MGI|MGI:1341870 | 436 | Stk11 "serine/threonine kinase | 0.953 | 0.513 | 0.727 | 2.6e-86 | |
| UNIPROTKB|Q15831 | 433 | STK11 "Serine/threonine-protei | 0.953 | 0.517 | 0.723 | 5.4e-86 | |
| UNIPROTKB|Q91604 | 432 | stk11 "Serine/threonine-protei | 0.953 | 0.518 | 0.718 | 1.4e-85 | |
| RGD|1308653 | 438 | Stk11 "serine/threonine kinase | 0.953 | 0.511 | 0.716 | 1.7e-84 | |
| UNIPROTKB|E2R6D1 | 441 | STK11 "Uncharacterized protein | 0.953 | 0.507 | 0.712 | 2.1e-84 | |
| FB|FBgn0038167 | 567 | lkb1 "lkb1" [Drosophila melano | 0.978 | 0.405 | 0.688 | 1e-82 | |
| UNIPROTKB|F6XGD4 | 512 | STK11 "Uncharacterized protein | 0.868 | 0.398 | 0.754 | 7.4e-82 |
| ZFIN|ZDB-GENE-050417-383 stk11 "serine/threonine kinase 11" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 873 (312.4 bits), Expect = 2.3e-87, P = 2.3e-87
Identities = 166/231 (71%), Positives = 194/231 (83%)
Query: 5 DDEVDGDMISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCR 64
++E+ G M + HR+DS +VIY + + K+IGKY+MGDLLGEGSYGKVKEMLD ETLCR
Sbjct: 15 ENELMG-MDTFIHRIDSTEVIYQPRRKRAKLIGKYLMGDLLGEGSYGKVKEMLDPETLCR 73
Query: 65 RAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVG 124
RAVKI KKKKL+RIPNGE NV +EI+LL+ LQH+NVI LVDV N++KQKMY++MEYCV
Sbjct: 74 RAVKILKKKKLRRIPNGEANVKKEIQLLRRLQHKNVIQLVDVLYNEEKQKMYMVMEYCVC 133
Query: 125 GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISD 184
G+Q+MLDS P K+FP++QAHGYF QLLDGLEYLHSQGI+HKDIKPGNLLLT DG LKISD
Sbjct: 134 GMQEMLDSVPGKRFPVFQAHGYFCQLLDGLEYLHSQGIVHKDIKPGNLLLTTDGALKISD 193
Query: 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
GVAE+L F DDT TSQGSP FQ PEIANGL SG+KVDIWS+GVTL
Sbjct: 194 LGVAEALHPFAKDDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 244
|
|
| UNIPROTKB|F1NG57 STK11 "Serine/threonine-protein kinase STK11" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 871 (311.7 bits), Expect = 3.7e-87, P = 3.7e-87
Identities = 163/224 (72%), Positives = 191/224 (85%)
Query: 12 MISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK 71
M + HR+DS +VIY + + K+IGKY+MGDLLGEGSYGKVKEMLDSETLCRRAVKI K
Sbjct: 24 MDTFIHRIDSTEVIYQPRRKRAKLIGKYLMGDLLGEGSYGKVKEMLDSETLCRRAVKILK 83
Query: 72 KKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD 131
KKKL+RIPNGE NV +EI+LL+ L+H+NVI LVDV N++KQKMY++MEYCV G+Q+MLD
Sbjct: 84 KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD 143
Query: 132 STPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
S P K+FP++QAHGYF QL+DGLEYLHSQGI+HKDIKPGNLLLT +GTLKISD GVAE+L
Sbjct: 144 SVPEKRFPVFQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTNGTLKISDLGVAEAL 203
Query: 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
F DDT TSQGSP FQ PEIANGL SG+KVDIWS+GVTL
Sbjct: 204 HPFAEDDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 247
|
|
| UNIPROTKB|Q0GGW5 STK11 "Serine/threonine-protein kinase STK11" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 871 (311.7 bits), Expect = 3.7e-87, P = 3.7e-87
Identities = 163/224 (72%), Positives = 191/224 (85%)
Query: 12 MISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK 71
M + HR+DS +VIY + + K+IGKY+MGDLLGEGSYGKVKEMLDSETLCRRAVKI K
Sbjct: 22 MDTFIHRIDSTEVIYQPRRKRAKLIGKYLMGDLLGEGSYGKVKEMLDSETLCRRAVKILK 81
Query: 72 KKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD 131
KKKL+RIPNGE NV +EI+LL+ L+H+NVI LVDV N++KQKMY++MEYCV G+Q+MLD
Sbjct: 82 KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD 141
Query: 132 STPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
S P K+FP++QAHGYF QL+DGLEYLHSQGI+HKDIKPGNLLLT +GTLKISD GVAE+L
Sbjct: 142 SVPEKRFPVFQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTNGTLKISDLGVAEAL 201
Query: 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
F DDT TSQGSP FQ PEIANGL SG+KVDIWS+GVTL
Sbjct: 202 HPFAEDDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 245
|
|
| MGI|MGI:1341870 Stk11 "serine/threonine kinase 11" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 863 (308.9 bits), Expect = 2.6e-86, P = 2.6e-86
Identities = 163/224 (72%), Positives = 190/224 (84%)
Query: 12 MISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK 71
M + HR+DS +VIY + + K+IGKY+MGDLLGEGSYGKVKE+LDSETLCRRAVKI K
Sbjct: 22 MDTFIHRIDSTEVIYQPRRKRAKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILK 81
Query: 72 KKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD 131
KKKL+RIPNGE NV +EI+LL+ L+HRNVI LVDV N++KQKMY++MEYCV G+Q+MLD
Sbjct: 82 KKKLRRIPNGEANVKKEIQLLRRLRHRNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD 141
Query: 132 STPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
S P K+FP+ QAHGYF QL+DGLEYLHSQGI+HKDIKPGNLLLT +GTLKISD GVAE+L
Sbjct: 142 SVPEKRFPVCQAHGYFRQLIDGLEYLHSQGIVHKDIKPGNLLLTTNGTLKISDLGVAEAL 201
Query: 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
F DDT TSQGSP FQ PEIANGL SG+KVDIWS+GVTL
Sbjct: 202 HPFAVDDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 245
|
|
| UNIPROTKB|Q15831 STK11 "Serine/threonine-protein kinase STK11" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 860 (307.8 bits), Expect = 5.4e-86, P = 5.4e-86
Identities = 162/224 (72%), Positives = 189/224 (84%)
Query: 12 MISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK 71
M + HR+DS +VIY + + K+IGKY+MGDLLGEGSYGKVKE+LDSETLCRRAVKI K
Sbjct: 22 MDTFIHRIDSTEVIYQPRRKRAKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILK 81
Query: 72 KKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD 131
KKKL+RIPNGE NV +EI+LL+ L+H+NVI LVDV N++KQKMY++MEYCV G+Q+MLD
Sbjct: 82 KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD 141
Query: 132 STPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
S P K+FP+ QAHGYF QL+DGLEYLHSQGI+HKDIKPGNLLLT GTLKISD GVAE+L
Sbjct: 142 SVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISDLGVAEAL 201
Query: 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
F DDT TSQGSP FQ PEIANGL SG+KVDIWS+GVTL
Sbjct: 202 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 245
|
|
| UNIPROTKB|Q91604 stk11 "Serine/threonine-protein kinase stk11" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.4e-85, P = 1.4e-85
Identities = 161/224 (71%), Positives = 188/224 (83%)
Query: 12 MISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK 71
M + HR+DS +VIY + + K++GKY+MGDLLGEGSYGKVKEMLDS+TLCRRAVKI K
Sbjct: 25 MDTFIHRIDSTEVIYQPRRKRAKLVGKYLMGDLLGEGSYGKVKEMLDSDTLCRRAVKILK 84
Query: 72 KKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD 131
KKKL+RIPNGE NV +EI+LL+ L+HRNVI LVDV N++KQKMY++MEYCV G+Q+MLD
Sbjct: 85 KKKLRRIPNGEANVKKEIQLLRRLRHRNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD 144
Query: 132 STPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
S K FP++QAHGYF QL+DGLEYLHSQGI+HKDIKPGNLLLT DGTLKISD GVAE+L
Sbjct: 145 SVQDKHFPVFQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTDGTLKISDLGVAEAL 204
Query: 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
F DT TSQGSP FQ PEIANGL SG+KVDIWS+GVTL
Sbjct: 205 HPFAEGDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 248
|
|
| RGD|1308653 Stk11 "serine/threonine kinase 11" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
Identities = 162/226 (71%), Positives = 189/226 (83%)
Query: 12 MISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK 71
M + HR+DS +VIY + + K+IGKY+MGDLLGEGSYGKVKE+LDSETLCRRAVKI K
Sbjct: 22 MDTFIHRIDSTEVIYQPRRKRAKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILK 81
Query: 72 KKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM--YLIMEYCVGGLQDM 129
KKKL+RIPNGE NV +EI+LL+ L+HRNVI LVDV N++KQK Y++MEYCV G+Q+M
Sbjct: 82 KKKLRRIPNGEANVKKEIQLLRRLRHRNVIQLVDVLYNEEKQKRPTYMVMEYCVCGMQEM 141
Query: 130 LDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189
LDS P K+FP+ QAHGYF QL+DGLEYLHSQGI+HKDIKPGNLLLT +GTLKISD GVAE
Sbjct: 142 LDSVPEKRFPVCQAHGYFRQLIDGLEYLHSQGIVHKDIKPGNLLLTTNGTLKISDLGVAE 201
Query: 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+L F DDT TSQGSP FQ PEIANGL SG+KVDIWS+GVTL
Sbjct: 202 ALHPFAVDDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 247
|
|
| UNIPROTKB|E2R6D1 STK11 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 845 (302.5 bits), Expect = 2.1e-84, P = 2.1e-84
Identities = 161/226 (71%), Positives = 188/226 (83%)
Query: 12 MISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK 71
M + HR+DS +VIY + + K+IGKY+MGDLLGEGSYGKVKE+LDSETLCRRAVKI K
Sbjct: 22 MDTFIHRIDSTEVIYQPRRKRAKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILK 81
Query: 72 KKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK--MYLIMEYCVGGLQDM 129
KKKL+RIPNGE NV +EI+LL+ L+H+NVI LVDV N++KQK Y++MEYCV G+Q+M
Sbjct: 82 KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKHRTYMVMEYCVCGMQEM 141
Query: 130 LDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189
LDS P K+FP+ QAHGYF QL+DGLEYLHSQGI+HKDIKPGNLLLT GTLKISD GVAE
Sbjct: 142 LDSVPEKRFPVCQAHGYFCQLVDGLEYLHSQGIVHKDIKPGNLLLTTSGTLKISDLGVAE 201
Query: 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+L F DDT TSQGSP FQ PEIANGL SG+KVDIWS+GVTL
Sbjct: 202 ALHPFAEDDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 247
|
|
| FB|FBgn0038167 lkb1 "lkb1" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 829 (296.9 bits), Expect = 1.0e-82, P = 1.0e-82
Identities = 159/231 (68%), Positives = 188/231 (81%)
Query: 6 DEVDGDMISIF-HRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCR 64
D V DM ++F +RVDS +IY K +KM+GKY+MGD+LGEGSYGKVKE ++SE LCR
Sbjct: 138 DRVTLDMGNMFFNRVDSQDIIYQQKKKSIKMVGKYIMGDVLGEGSYGKVKEAMNSENLCR 197
Query: 65 RAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVG 124
AVKI K+KL+RIPNGE NV REI LLK L+HR+V+ LVDV N++KQKMYL+MEYCVG
Sbjct: 198 LAVKILTKRKLRRIPNGEQNVTREIALLKQLKHRHVVELVDVLYNEEKQKMYLVMEYCVG 257
Query: 125 GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISD 184
GLQ+M+D P K+ P++QAHGYF QL+DGLEYLHS +IHKDIKPGNLLL+LD TLKISD
Sbjct: 258 GLQEMIDYQPDKRMPLFQAHGYFKQLVDGLEYLHSCRVIHKDIKPGNLLLSLDQTLKISD 317
Query: 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
FGVAE LD+F DDT TT QGSP FQ PEIANG +G+KVDIWSSGVTL
Sbjct: 318 FGVAEQLDLFAPDDTCTTGQGSPAFQPPEIANGHETFAGFKVDIWSSGVTL 368
|
|
| UNIPROTKB|F6XGD4 STK11 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 821 (294.1 bits), Expect = 7.4e-82, P = 7.4e-82
Identities = 154/204 (75%), Positives = 177/204 (86%)
Query: 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRL 91
+ K+IGKY+MGDLLGEGSYGKVKE+LDSETLCRRAVKI KKKKL+RIPNGE NV +EI+L
Sbjct: 115 RAKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL 174
Query: 92 LKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLL 151
L+ L+H+NVI LVDV N++KQKMY++MEYCV G+Q+MLDS P K+FP+ QAHGYF QL+
Sbjct: 175 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLV 234
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQA 211
DGLEYLHSQGI+HKDIKPGNLLLT GTLKISD GVAE+L F DDT TSQGSP FQ
Sbjct: 235 DGLEYLHSQGIVHKDIKPGNLLLTTSGTLKISDLGVAEALHPFAEDDTCRTSQGSPAFQP 294
Query: 212 PEIANGLPEISGYKVDIWSSGVTL 235
PEIANGL SG+KVDIWS+GVTL
Sbjct: 295 PEIANGLDTFSGFKVDIWSAGVTL 318
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9WTK7 | STK11_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7276 | 0.9531 | 0.5137 | yes | N/A |
| D4AE59 | STK11_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.6965 | 0.9659 | 0.5182 | yes | N/A |
| Q0GGW5 | STK11_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7276 | 0.9531 | 0.5090 | yes | N/A |
| Q15831 | STK11_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6995 | 0.9702 | 0.5265 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 235 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-64 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-51 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-41 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-40 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-39 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-38 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-38 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-33 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-32 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-31 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-31 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-30 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-29 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-29 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-29 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-29 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-29 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-29 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-28 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-28 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-27 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-27 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-27 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-27 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-27 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-27 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-26 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-26 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-25 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-25 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-25 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-24 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-24 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-24 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-24 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-23 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-23 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-23 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-23 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-23 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-23 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-23 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-22 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-22 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-22 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-21 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-21 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-20 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-20 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-20 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-20 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-19 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-18 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-18 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-18 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-18 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-17 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-17 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-17 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-16 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-15 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-15 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-13 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-12 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-12 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-12 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-07 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 7e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.001 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.003 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.003 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.004 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 5e-64
Identities = 86/198 (43%), Positives = 123/198 (62%), Gaps = 13/198 (6%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
Y + + LGEGS+GKV D +T A+K+ KKKK+++ + REI++LK L+H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRE---RILREIKILKKLKHP 57
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
N++ L DVF ++ K +YL+MEYC GG L D+L + +A Y Q+L LEYL
Sbjct: 58 NIVRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKK--RGRLSEDEARFYLRQILSALEYL 113
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG 217
HS+GI+H+D+KP N+LL DG +K++DFG+A LD + +TT G+P + APE+ G
Sbjct: 114 HSKGIVHRDLKPENILLDEDGHVKLADFGLARQLD---PGEKLTTFVGTPEYMAPEVLLG 170
Query: 218 LPEISGYKVDIWSSGVTL 235
G VDIWS GV L
Sbjct: 171 KG--YGKAVDIWSLGVIL 186
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 2e-53
Identities = 78/193 (40%), Positives = 111/193 (57%), Gaps = 11/193 (5%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LGEG +G V D +T + A+KI KK+ + + REI +LK L H N++ L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE---ELLREIEILKKLNHPNIVKLY 57
Query: 105 DVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
VF ++ +YL+MEYC GG L+D+L K + LQ+L+GLEYLHS GII
Sbjct: 58 GVFEDENH--LYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 164 HKDIKPGNLLLT-LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS 222
H+D+KP N+LL +G +K++DFG+++ L + T G+P + APE+ G S
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 223 GYKVDIWSSGVTL 235
K DIWS GV L
Sbjct: 173 -EKSDIWSLGVIL 184
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 3e-53
Identities = 83/198 (41%), Positives = 112/198 (56%), Gaps = 10/198 (5%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
Y + LG GS+G V + T AVKI KK+ + REIR+L+ L H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHP 58
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
N++ L+D F + K +YL+MEYC GG L D L +A LQ+L GLEYL
Sbjct: 59 NIVRLIDAFED--KDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYL 114
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG 217
HS GIIH+D+KP N+LL +G +KI+DFG+A+ L ++TT G+P + APE+ G
Sbjct: 115 HSNGIIHRDLKPENILLDENGVVKIADFGLAKKLL--KSSSSLTTFVGTPWYMAPEVLLG 172
Query: 218 LPEISGYKVDIWSSGVTL 235
G KVD+WS GV L
Sbjct: 173 GNGY-GPKVDVWSLGVIL 189
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 5e-51
Identities = 73/199 (36%), Positives = 109/199 (54%), Gaps = 9/199 (4%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VDREIRLLKMLQ 96
++ G+LLG GS+G V LD +T AVK +L E+ ++REIR+L LQ
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVK---SVELSGDSEEELEALEREIRILSSLQ 57
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H N++ +++K + + +EY GG L +L + K P Y Q+L+GL
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLA 115
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
YLHS GI+H+DIK N+L+ DG +K++DFG A+ L + + +G+P + APE+
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 216 NGLPEISGYKVDIWSSGVT 234
G E G DIWS G T
Sbjct: 176 RG--EEYGRAADIWSLGCT 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-41
Identities = 73/202 (36%), Positives = 111/202 (54%), Gaps = 17/202 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VDREIRLLKMLQ 96
Y +GDL+G G++G V + L+ ET V I K+ L++I + + +EI LLK L+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLET--GDFVAI-KQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H N++ + + +Y+I+EY G L+ ++ + FP Y Q+L GL
Sbjct: 58 HPNIVKYIGSI--ETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAVYVYQVLQGLA 113
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
YLH QG+IH+DIK N+L T DG +K++DFGVA L+ + G+P + APE+
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLND--VSKDDASVVGTPYWMAPEVI 171
Query: 216 NGLPEISGY--KVDIWSSGVTL 235
E+SG DIWS G T+
Sbjct: 172 ----EMSGASTASDIWSLGCTV 189
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-40
Identities = 81/206 (39%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGE--INVD--REIRLLK 93
+Y G LGEG+Y V + D ET R V I KK KL + IN REI+LL+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKET--GRIVAI-KKIKLGERKEAKDGINFTALREIKLLQ 57
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAH--GYFLQLL 151
L+H N+IGL+DVF K + L+ E+ L+ ++ K + A Y L L
Sbjct: 58 ELKHPNIIGLLDVFG--HKSNINLVFEFMETDLEKVIKD---KSIVLTPADIKSYMLMTL 112
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF-- 209
GLEYLHS I+H+D+KP NLL+ DG LK++DFG+A S F + T Q V
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS---FGSPNRKMTHQ---VVTR 166
Query: 210 --QAPEIANGLPEISGYKVDIWSSGV 233
+APE+ G G VD+WS G
Sbjct: 167 WYRAPELLFG-ARHYGVGVDMWSVGC 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 7e-40
Identities = 74/200 (37%), Positives = 104/200 (52%), Gaps = 20/200 (10%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGE----INVDREIRLLKM 94
Y + LGEG+YG V + D +T +I KK+ R+ N E REI LLK
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKT-----GEIVALKKI-RLDNEEEGIPSTALREISLLKE 54
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
L+H N++ L+DV ++K +YL+ EYC L+ LD P QLL GL
Sbjct: 55 LKHPNIVKLLDVIHTERK--LYLVFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGL 111
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE--SLDMFLHDDTITTSQGSPVFQAP 212
Y HS I+H+D+KP N+L+ DG LK++DFG+A + + + + T ++AP
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVT----LWYRAP 167
Query: 213 EIANGLPEISGYKVDIWSSG 232
EI G S VDIWS G
Sbjct: 168 EILLGSKHYS-TAVDIWSVG 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 8e-40
Identities = 71/192 (36%), Positives = 111/192 (57%), Gaps = 13/192 (6%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
+G+G +G+V + T A+K+ K + ++ + EI++LK +H N++
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEK----IINEIQILKKCKHPNIVKYY 63
Query: 105 DVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
++ KK +++++ME+C GG L+D+L ST + Q +LL GLEYLHS GII
Sbjct: 64 GSYL--KKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGII 120
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISG 223
H+DIK N+LLT DG +K+ DFG++ L +T+ G+P + APE+ NG P
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKP--YD 175
Query: 224 YKVDIWSSGVTL 235
YK DIWS G+T
Sbjct: 176 YKADIWSLGITA 187
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-39
Identities = 68/207 (32%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 38 KYVMGDLLGEGSYGK---VKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
KY + +G+GS+GK V+ D + + + + + +R + E+++LK
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE-----DALNEVKILKK 55
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDST--PYKKFP---IWQAHGYFL 148
L H N+I + F +K K+ ++MEY GG L + K FP I +F+
Sbjct: 56 LNHPNIIKYYESFE--EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD---WFV 110
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV 208
QL L+YLHS+ I+H+DIKP N+ LT +G +K+ DFG+++ L D T G+P
Sbjct: 111 QLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPY 168
Query: 209 FQAPEIANGLPEISGYKVDIWSSGVTL 235
+ +PE+ P YK DIWS G L
Sbjct: 169 YLSPELCQNKP--YNYKSDIWSLGCVL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-38
Identities = 70/198 (35%), Positives = 107/198 (54%), Gaps = 25/198 (12%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNG-EINVDREIRLLKMLQHRNVIGL 103
+GEG+YG+V + + +T A+K K +++ G I REI+LL+ L+H N++ L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALK---KIRMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 104 VDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
++ + K +Y++ EY L +LDS P KF Q Y QLL+GL+YLHS GI+
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDS-PEVKFTESQIKCYMKQLLEGLQYLHSNGIL 122
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF---------QAPEI 214
H+DIK N+L+ DG LK++DFG+A T + S + + PE+
Sbjct: 123 HRDIKGSNILINNDGVLKLADFGLARPY----------TKRNSADYTNRVITLWYRPPEL 172
Query: 215 ANGLPEISGYKVDIWSSG 232
G G +VD+WS G
Sbjct: 173 LLGA-TRYGPEVDMWSVG 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-38
Identities = 66/197 (33%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK-IFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+Y + +GEG++G V + D ET A+K + ++ IPN REI+ L+ Q
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN---QALREIKALQACQ 57
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
H V+ L+DVF + L+MEY L ++L + P Q Y LL G+ Y
Sbjct: 58 HPYVVKLLDVFPHG--SGFVLVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAY 114
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ-GSPVFQAPEIA 215
+H+ GI+H+D+KP NLL++ DG LKI+DFG+A + + + Q + ++APE+
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSE--EEPRLYSHQVATRWYRAPELL 172
Query: 216 NGLPEISGYKVDIWSSG 232
G + VD+W+ G
Sbjct: 173 YGARKYDP-GVDLWAVG 188
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-35
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 35/221 (15%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN-GEINVDREIRLLKMLQH 97
+ G ++GEGS+ V + ET A+KI K++L + + +++E+ L ++ H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLNGH 61
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEY 156
+I L F ++ + +Y ++EY G ++L Y Y ++L LEY
Sbjct: 62 PGIIKLYYTFQDE--ENLYFVLEYAPNG--ELLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ------------ 204
LHS+GIIH+D+KP N+LL D +KI+DFG A L ++ S
Sbjct: 118 LHSKGIIHRDLKPENILLDKDMHIKITDFGTA----KVLDPNSSPESNKGDATNIDSQIE 173
Query: 205 ----------GSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
G+ + +PE+ N + +G D+W+ G +
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCII 212
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-33
Identities = 77/207 (37%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
Y + LGEGS+G+V D + + A+K+ KK + REI++L L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLV---ALKVLAKKL-ESKSKEVERFLREIQILASLNH 56
Query: 98 -RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYK-KFPIWQAHGYFLQLLDGL 154
N++ L D F ++ +YL+MEY GG L+D+L K +A Q+L L
Sbjct: 57 PPNIVKLYDFFQDEGS--LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGT-LKISDFGVA----ESLDMFLHDDTITTSQGSPVF 209
EYLHS+GIIH+DIKP N+LL DG +K+ DFG+A + +TS G+P +
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 210 QAPEIANGLPEIS-GYKVDIWSSGVTL 235
APE+ GL DIWS G+TL
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITL 201
|
Length = 384 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 68/193 (35%), Positives = 101/193 (52%), Gaps = 18/193 (9%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR-IPNGEINVDREIRLLKMLQHRNVIGL 103
+GEG+YG V + D T A+K K + IP + REI+LLK L H N+I L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL---REIKLLKELNHPNIIKL 63
Query: 104 VDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAH--GYFLQLLDGLEYLHSQG 161
+DVF K +YL+ E+ L ++ + ++ Y QLL GL + HS G
Sbjct: 64 LDVF--RHKGDLYLVFEFMDTDLYKLIKDRQR---GLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESL--DMFLHDDTITTSQGSPVFQAPEIANGLP 219
I+H+D+KP NLL+ +G LK++DFG+A S + + + T ++APE+ G
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW----YRAPELLLGD- 173
Query: 220 EISGYKVDIWSSG 232
+ VDIWS G
Sbjct: 174 KGYSTPVDIWSVG 186
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-32
Identities = 66/197 (33%), Positives = 97/197 (49%), Gaps = 22/197 (11%)
Query: 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIG 102
+ LGEGSYG V + + ET A+K+ + + +EI +LK ++
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVV------PVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 103 LVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG 161
+ K ++++MEYC G + D++ T K + Q L GLEYLHS
Sbjct: 63 YYGSYF--KNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESLD--MFLHDDTITTSQGSPVFQAPEIANGLP 219
IH+DIK GN+LL +G K++DFGV+ L M + I G+P + APE+
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI----GTPFWMAPEVIQE-- 173
Query: 220 EISGY--KVDIWSSGVT 234
GY K DIWS G+T
Sbjct: 174 --IGYNNKADIWSLGIT 188
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-32
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 40 VMGDLLGEGSYGKVKE----MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+G LGEG++G+V + AVK K+ RE R+++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA---SEQQIEEFLREARIMRKL 58
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
H N++ L+ V +++ + ++MEY GG L D L K+ + + LQ+ G+
Sbjct: 59 DHPNIVKLLGVCT--EEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG-SPVF-QAP 212
EYL S+ IH+D+ N L+ + +KISDFG++ L DD G P+ AP
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY---DDDYYKVKGGKLPIRWMAP 173
Query: 213 E-IANGLPEISGYKVDIWSSGVTL 235
E + G K D+WS GV L
Sbjct: 174 ESLKEG---KFTSKSDVWSFGVLL 194
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-32
Identities = 67/202 (33%), Positives = 108/202 (53%), Gaps = 24/202 (11%)
Query: 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVI 101
G+ +G G++GKV ++ +T AVK + + P + E+++L++L+H N++
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLV 62
Query: 102 GLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ 160
V V+ +K+Y+ MEYC GG L+++L+ + + Y LQLL+GL YLHS
Sbjct: 63 KYYGVEVHR--EKVYIFMEYCSGGTLEELLEHGRILDEHVIRV--YTLQLLEGLAYLHSH 118
Query: 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAESL--------DMFLHDDTITTSQGSPVFQAP 212
GI+H+DIKP N+ L +G +K+ DFG A L + G+P + AP
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS------LAGTPAYMAP 172
Query: 213 EIANGLPEISGY--KVDIWSSG 232
E+ G + G+ DIWS G
Sbjct: 173 EVITG-GKGKGHGRAADIWSLG 193
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-32
Identities = 71/196 (36%), Positives = 106/196 (54%), Gaps = 18/196 (9%)
Query: 45 LGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV 100
LG+GS+GKV +L D+ L A+K+ KKKK+ + + E +L + H +
Sbjct: 1 LGKGSFGKV--LLVRKKDTGKL--YAMKVLKKKKIIK-RKEVEHTLTERNILSRINHPFI 55
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159
+ L F ++K +YL++EY GG L L +F +A Y +++ LEYLHS
Sbjct: 56 VKLHYAFQTEEK--LYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAEIVLALEYLHS 111
Query: 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLP 219
GII++D+KP N+LL DG +K++DFG+A+ L T G+P + APE+ G
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSS--EGSRTNTFCGTPEYLAPEVLLGKG 169
Query: 220 EISGYKVDIWSSGVTL 235
G VD WS GV L
Sbjct: 170 Y--GKAVDWWSLGVLL 183
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-31
Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 41/214 (19%)
Query: 39 YVMGDLLGEGSYGKV---KEMLDSETLCRRAVKIFKKKKLQRIPNGE----INVDREIRL 91
Y +GEG+YG V +++ + KK+ R+P E ++ REI L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTG--------RFVALKKV-RVPLSEEGIPLSTLREIAL 51
Query: 92 LKMLQ---HRNVIGLVDVFVN---DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG 145
LK L+ H N++ L+DV D++ K+ L+ E+ L L P P
Sbjct: 52 LKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD 111
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE--SLDMFLHDDTITTS 203
QLL G+++LHS I+H+D+KP N+L+T DG +KI+DFG+A S +M L
Sbjct: 112 LMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL-------- 163
Query: 204 QGSPV-----FQAPEIANGLPEISGYKVDIWSSG 232
+ V ++APE+ + VD+WS G
Sbjct: 164 --TSVVVTLWYRAPEVLLQSSYAT--PVDMWSVG 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-31
Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 31/208 (14%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK--IFKKKKLQRIPNGEINVDREIRLLKML 95
Y + +GEG+ G+V + D T A+K +K+ + I N EI ++K
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-------EILIMKDC 72
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
+H N++ D ++ + ++++MEY GG L D++ + Q ++L GL
Sbjct: 73 KHPNIVDYYDSYLVGDE--LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGL 129
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ-------GSP 207
EYLHSQ +IH+DIK N+LL+ DG++K++DFG A L T + G+P
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL---------TKEKSKRNSVVGTP 180
Query: 208 VFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ APE+ G KVDIWS G+
Sbjct: 181 YWMAPEVIKRKD--YGPKVDIWSLGIMC 206
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 41/216 (18%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK--------KKKLQRIPNGEINVDRE 88
KY + ++GEG+YG V + + T A+K FK KK R E
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR----------E 50
Query: 89 IRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL 148
+++L+ L+H N++ L + F +K ++YL+ EY L ++L+++P P Y
Sbjct: 51 VKVLRQLRHENIVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGG-LPPDAVRSYIW 107
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV 208
QLL + Y HS IIH+DIKP N+L++ G LK+ DFG A +L ++ +
Sbjct: 108 QLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARAL----------RARPASP 157
Query: 209 ---------FQAPEIANGLPEISGYKVDIWSSGVTL 235
++APE+ G G VD+W+ G +
Sbjct: 158 LTDYVATRWYRAPELLVGDTNY-GKPVDVWAIGCIM 192
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-31
Identities = 69/192 (35%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNG-EINVDREIRLLKMLQHRNVIGL 103
+GEG+YG V D+ + + KK ++ +G I+ REI LL L+H N++ L
Sbjct: 15 IGEGTYGIVYRARDTTS---GEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVEL 71
Query: 104 VDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
+V V ++L+MEYC L +LD+ P F Q LQLL GL+YLH II
Sbjct: 72 KEVVVGKHLDSIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFII 130
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISG 223
H+D+K NLLLT G LKI+DFG+A + + T + ++APE+ G +
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGCTTYT- 187
Query: 224 YKVDIWSSGVTL 235
+D+W+ G L
Sbjct: 188 TAIDMWAVGCIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-30
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 40 VMGDLLGEGSYGKVKE----MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+G LGEG++G+V + + AVK K+ RE R+++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA---SEQQIEEFLREARIMRKL 58
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
H NV+ L+ V +++ +Y++MEY GG L L K + + LQ+ G+
Sbjct: 59 DHPNVVKLLGVCT--EEEPLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGM 115
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG--SPVF-QA 211
EYL S+ IH+D+ N L+ + +KISDFG++ L+DD +G P+ A
Sbjct: 116 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMA 171
Query: 212 PE-IANGLPEISGYKVDIWSSGVTL 235
PE + G K D+WS GV L
Sbjct: 172 PESLKEG---KFTSKSDVWSFGVLL 193
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-30
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 43 DLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLLKMLQHRN 99
LGEG++G+V K L + V + K L+ + E D +E R++K L H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAV---KTLKEDASEEERKDFLKEARVMKKLGHPN 57
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML-------DSTPYKKFPIWQAHGYFLQLL 151
V+ L+ V +++ +YL++EY GG L D L S + + +Q+
Sbjct: 58 VVRLLGVCT--EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG-SPVF- 209
G+EYL S+ +H+D+ N L+ D +KISDFG++ D++ D + G P+
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR--DVYDDDYYRKKTGGKLPIRW 173
Query: 210 QAPE-IANGLPEISGYKVDIWSSGVTL 235
APE + +G I K D+WS GV L
Sbjct: 174 MAPESLKDG---IFTSKSDVWSFGVLL 197
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-30
Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 29/206 (14%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN---VDREIRLLKMLQHRNV 100
+G G+YG V +D R V I KK+ + + I+ + REI+LL+ L+H N+
Sbjct: 7 PIGSGAYGVVCSAVD--KRTGRKVAI---KKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 101 IGLVDVFVNDKKQKM---YLIMEYCVGGLQDMLDSTPYKKFPIWQAHG-YFL-QLLDGLE 155
IGL+D+ + Y++ E ++ L P+ H YFL Q+L GL+
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTEL----METDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQ----A 211
YLHS +IH+D+KP N+L+ + LKI DFG+A +D D+ V A
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVD---PDEDEKGFLTEYVVTRWYRA 174
Query: 212 PEIANGLPEISGYK--VDIWSSGVTL 235
PE+ L S Y +DIWS G
Sbjct: 175 PEL---LLSSSRYTKAIDIWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 38 KYVMGDLLGEGSYG---KVKEMLDSETLCRRAVK--IFKKKKLQRIPNGEINVDREIRLL 92
Y + + +G+GS+G KV+ D + L + + +K+ Q++ + E+ +L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-------EVNIL 53
Query: 93 KMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDST--PYKKFP---IWQAHGY 146
+ L+H N++ D ++ Q +Y++MEYC GG L ++ K IW+
Sbjct: 54 RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRI--- 110
Query: 147 FLQLLDGLEYLH-----SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT 201
QLL L H ++H+D+KP N+ L + +K+ DFG+A+ L HD +
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG---HDSSFA 167
Query: 202 TSQ-GSPVFQAPEIANGLPEISGY--KVDIWSSG 232
+ G+P + +PE N + Y K DIWS G
Sbjct: 168 KTYVGTPYYMSPEQLNHMS----YDEKSDIWSLG 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-29
Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 33/206 (16%)
Query: 43 DLLGEGSYG---KVKEMLDSETLCRRAVKIFKKKKLQRIPNGE----INVDREIRLLKML 95
LG+GSYG KVK + D++ K+ L + E +N EIR+L +
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYA------LKEVDLGSMSQKEREDAVN---EIRILASV 56
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG------LQDMLDSTPYKKFPIWQAHGYFLQ 149
H N+I + F++ K + ++MEY G + + IW+ F+Q
Sbjct: 57 NHPNIISYKEAFLDGNK--LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR---IFIQ 111
Query: 150 LLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF 209
LL GL+ LH Q I+H+D+K N+LL + +KI D G+++ L + T G+P +
Sbjct: 112 LLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHY 167
Query: 210 QAPEIANGLPEISGYKVDIWSSGVTL 235
APE+ G P YK DIWS G L
Sbjct: 168 MAPEVWKGRP--YSYKSDIWSLGCLL 191
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-29
Identities = 72/201 (35%), Positives = 103/201 (51%), Gaps = 31/201 (15%)
Query: 43 DLLGEGSYGKVKEMLDSETLCRR-------AVKIFKKKKLQRIPNGEINVDREIRLLKML 95
LG GS+G+V L R A+KI K K+ ++ E +V E R+L+ +
Sbjct: 7 KTLGTGSFGRVM-------LVRHKGSGKYYALKILSKAKIVKLKQVE-HVLNEKRILQSI 58
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
+H ++ L F +D +YL+MEY GG L L +FP A Y Q++ L
Sbjct: 59 RHPFLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLAL 114
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEI 214
EYLHS I+++D+KP NLLL DG +KI+DFG A+ + T T G+P + APEI
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK----GRTYTLC-GTPEYLAPEI 169
Query: 215 ANGLPEISGY--KVDIWSSGV 233
GY VD W+ G+
Sbjct: 170 ILS----KGYGKAVDWWALGI 186
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-29
Identities = 66/197 (33%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VDREIRLLKMLQHRNV 100
G LLG+G++G+V D +T AVK E+N ++ EI+LLK LQH +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159
+ +D + + + MEY GG ++D L + Y Y Q+L+G+EYLHS
Sbjct: 67 VQYYGCLRDD--ETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHS 122
Query: 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF-LHDDTITTSQGSPVFQAPEIANGL 218
I+H+DIK N+L G +K+ DFG ++ L + + G+P + +PE+ +G
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG- 181
Query: 219 PEISGYKVDIWSSGVTL 235
E G K D+WS G T+
Sbjct: 182 -EGYGRKADVWSVGCTV 197
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-29
Identities = 67/189 (35%), Positives = 105/189 (55%), Gaps = 9/189 (4%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVK-IFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGL 103
+GEG+YG V + + T A+K I + + +P+ I REI LLK L H N++ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI---REISLLKELNHPNIVKL 64
Query: 104 VDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
+DV + K +YL+ E+ L+ +D++P P+ Y QLL GL + HS ++
Sbjct: 65 LDVIHTENK--LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISG 223
H+D+KP NLL+ +G +K++DFG+A + + + T T + ++APEI G S
Sbjct: 123 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYST 180
Query: 224 YKVDIWSSG 232
VDIWS G
Sbjct: 181 -AVDIWSLG 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-29
Identities = 72/200 (36%), Positives = 110/200 (55%), Gaps = 25/200 (12%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VDREIRLLKMLQHRNVIGL 103
+G G+YG V + D T A+K+ K L+ P + + +EI +LK +H N++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIK---LE--PGDDFEIIQQEISMLKECRHPNIVAY 65
Query: 104 VDVFVNDKKQKMYLIMEYCVGG-LQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQ 160
++ ++ K++++MEYC GG LQD+ T P + I A+ + L GL YLH
Sbjct: 66 FGSYL--RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQI--AYVCR-ETLKGLAYLHET 120
Query: 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI---TTSQGSPVFQAPEIANG 217
G IH+DIK N+LLT DG +K++DFGV+ L TI + G+P + APE+A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQL-----TATIAKRKSFIGTPYWMAPEVAAV 175
Query: 218 LPEISGY--KVDIWSSGVTL 235
+ GY K DIW+ G+T
Sbjct: 176 ERK-GGYDGKCDIWALGITA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-29
Identities = 67/197 (34%), Positives = 108/197 (54%), Gaps = 17/197 (8%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LG+G++GKV + ET A KI + + + + + + EI +L +H N++GL
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV----EIDILSECKHPNIVGLY 68
Query: 105 DVFVNDKKQKMYLIMEYCVGGLQD--MLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
+ + + K+++++E+C GG D ML+ P + Q+L+ L +LHS +
Sbjct: 69 EAYFYE--NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCR--QMLEALNFLHSHKV 124
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGV-AESLDMFLHDDTITTSQGSPVFQAPEIANGLPEI 221
IH+D+K GN+LLTLDG +K++DFGV A++ DT G+P + APE+
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACETFK 181
Query: 222 SG---YKVDIWSSGVTL 235
YK DIWS G+TL
Sbjct: 182 DNPYDYKADIWSLGITL 198
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 6e-29
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 38 KYVMGDLLGEGSYGKVKE--MLDSETLCR-RAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
++ G+LLG GS+G V E LD + V + + + ++ +EI LL
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE--QEIALLSK 58
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
LQH N++ + + +Y+ +E GG L +L Y FP Y Q+L G
Sbjct: 59 LQHPNIVQYLGTEREE--DNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLG 114
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
LEYLH + +H+DIK N+L+ +G +K++DFG+A+ + F + +GSP + APE
Sbjct: 115 LEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SFAKSFKGSPYWMAPE 171
Query: 214 IANGLPEISGYKVDIWSSGVT 234
+ G DIWS G T
Sbjct: 172 VIAQ-QGGYGLAADIWSLGCT 191
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 27/201 (13%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD------REIRLLKMLQHR 98
+G G+YG V +D+ + + A+K +IP+ RE+++L+ +H
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK--------KIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 99 NVIGLVDVF---VNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAH-GYFL-QLLDG 153
N+I + D+ D K +Y++M+ L ++ + P+ + H YFL QLL G
Sbjct: 65 NIIAIRDILRPPGADFKD-VYVVMDLMESDLHHII----HSDQPLTEEHIRYFLYQLLRG 119
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF--LHDDTITTSQGSPVFQA 211
L+Y+HS +IH+D+KP NLL+ D L+I DFG+A L H +T + ++A
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 212 PEIANGLPEISGYKVDIWSSG 232
PE+ LPE + +D+WS G
Sbjct: 180 PELLLSLPEYT-TAIDMWSVG 199
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-28
Identities = 68/215 (31%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAV---KIFKKKKLQRIPNGEINVDREIRLL 92
+ Y + LGEG++G+V + +T R V KI + P I REI++L
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKT--GRVVALKKILMHNEKDGFP---ITALREIKIL 61
Query: 93 KMLQHRNVIGLVDVFV------NDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGY 146
K L+H NV+ L+D+ V K+ +Y++ Y L +L++ P K Q Y
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-PSVKLTESQIKCY 120
Query: 147 FLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD----MFLHDDTITT 202
LQLL+G+ YLH I+H+DIK N+L+ G LKI+DFG+A D T
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
Query: 203 SQGSPV-----FQAPEIANGLPEISGYKVDIWSSG 232
+ + + ++ PE+ G + VDIW G
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTT-AVDIWGIG 214
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 4e-28
Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 17/195 (8%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LG+GS G V ++ T A+K + + RE++ L+ + V+
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIH---VDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 105 DVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GI 162
F K+ ++ +++EY GG L D+L K P Q+L GL+YLH++ I
Sbjct: 66 GAF--YKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLD--MFLHDDTITTSQGSPVFQAPEIANGLPE 220
IH+DIKP NLL+ G +KI+DFG+++ L+ + + T G+ + +PE G E
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN----TFVGTVTYMSPERIQG--E 175
Query: 221 ISGYKVDIWSSGVTL 235
Y DIWS G+TL
Sbjct: 176 SYSYAADIWSLGLTL 190
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-28
Identities = 71/203 (34%), Positives = 104/203 (51%), Gaps = 37/203 (18%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR----IPNGEINVDREIRLLKMLQHRNV 100
+GEG+YG V + D T V + KK +L+ +P+ I REI LLK L H N+
Sbjct: 7 IGEGTYGVVYKARDKLT--GEIVAL-KKIRLETEDEGVPSTAI---REISLLKELNHPNI 60
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ 160
+ L+DV ++ K +YL+ E+ L+ +DS+P Y QLL G+ Y HS
Sbjct: 61 VRLLDVVHSENK--LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV-----------F 209
++H+D+KP NLL+ +G LK++DFG+A + G PV +
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAF-------------GVPVRTYTHEVVTLWY 165
Query: 210 QAPEIANGLPEISGYKVDIWSSG 232
+APEI G + S VDIWS G
Sbjct: 166 RAPEILLGSRQYS-TPVDIWSIG 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-28
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 40 VMGDLLGEGSYGKVKE----MLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLL 92
+G LGEG++G+V + T + AVK K+ E + E ++
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG------ASEEEREEFLEEASIM 55
Query: 93 KMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLL 151
K L H N++ L+ V + + +Y++ EY GG L D L +K + LQ+
Sbjct: 56 KKLSHPNIVRLLGVCT--QGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIA 112
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PVF 209
G+EYL S+ +H+D+ N L+T + +KISDFG++ + DD G P+
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIY---EDDYYRKRGGGKLPIK 169
Query: 210 -QAPE-IANGLPEISGYKVDIWSSGVTL 235
APE + +G + + K D+WS GV L
Sbjct: 170 WMAPESLKDG--KFT-SKSDVWSFGVLL 194
|
Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-27
Identities = 62/179 (34%), Positives = 90/179 (50%), Gaps = 27/179 (15%)
Query: 78 IPNGE------INVD----------REIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEY 121
+PN E I+++ +E++ + H NV+ FV +++L+M Y
Sbjct: 23 LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV--VGDELWLVMPY 80
Query: 122 CVGG--LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT 179
GG L M S P ++L GLEYLHS G IH+DIK GN+LL DG+
Sbjct: 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS 140
Query: 180 LKISDFGVAESL--DMFLHDDTITTSQGSPVFQAPEIANGLPEISGY--KVDIWSSGVT 234
+KI+DFGV+ SL T G+P + APE+ + ++ GY K DIWS G+T
Sbjct: 141 VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV---MEQVHGYDFKADIWSFGIT 196
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-27
Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 20/200 (10%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGE--INVDREIR-LLKML 95
Y + LG+G++G V + ET A+K KKK + E +N+ RE++ L K+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK----FYSWEECMNL-REVKSLRKLN 55
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
+H N++ L +VF + ++Y + EY G L ++ K F Q+L GL
Sbjct: 56 EHPNIVKLKEVFR--ENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTITTSQGSPVFQAPEI 214
++H G H+D+KP NLL++ +KI+DFG+A E + D ++T ++APEI
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRW----YRAPEI 169
Query: 215 ANGLPEISGY--KVDIWSSG 232
L + Y VDIW+ G
Sbjct: 170 ---LLRSTSYSSPVDIWALG 186
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-27
Identities = 78/227 (34%), Positives = 117/227 (51%), Gaps = 34/227 (14%)
Query: 16 FHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKL 75
F+R + ++ +++ + +Y +G G+YG+V D++T R V I KKL
Sbjct: 1 FYRQELNKTVWE-------VPDRYQNLSPVGSGAYGQVCSAFDTKT--GRKVAI---KKL 48
Query: 76 QRIPNGEINVD---REIRLLKMLQHRNVIGLVDVFV----NDKKQKMYLIMEYCVGGLQD 128
R I+ RE+RLLK + H NVIGL+DVF + Q +YL+ L +
Sbjct: 49 SRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNN 108
Query: 129 MLDSTPYKKFPIWQAHGYFL--QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186
++ K + H FL Q+L GL+Y+HS GIIH+D+KP N+ + D LKI DFG
Sbjct: 109 IV-----KCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG 163
Query: 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYK-VDIWSSG 232
+A DD +T + ++APEI L + + VDIWS G
Sbjct: 164 LARHT-----DDEMTGYVATRWYRAPEIM--LNWMHYNQTVDIWSVG 203
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-27
Identities = 65/197 (32%), Positives = 99/197 (50%), Gaps = 26/197 (13%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIF---------KKKKLQRIPNGEINVDREIRLLKML 95
+GEGSYG V + + ET A+K F KK L REIR+LK L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL-----------REIRMLKQL 57
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
+H N++ L++VF +K+K++L+ EYC + + L+ P + P Q L +
Sbjct: 58 KHPNLVNLIEVF--RRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVN 114
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
+ H IH+D+KP N+L+T G +K+ DFG A L D T + ++APE+
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG--PGDDYTDYVATRWYRAPELL 172
Query: 216 NGLPEISGYKVDIWSSG 232
G + G VD+W+ G
Sbjct: 173 VGDTQY-GPPVDVWAIG 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML- 95
G + + +++GEG+YGKV + +T A+KI + I + E + E +L+
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKI-----MDIIEDEEEEIKEEYNILRKYS 60
Query: 96 QHRNVIGLVDVFVNDKKQ----KMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAH-GYFLQ 149
H N+ F+ +++L+ME C GG + D++ K + + Y L+
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 150 -LLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV 208
L GL YLH +IH+DIK N+LLT + +K+ DFGV+ LD L T G+P
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR--NTFIGTPY 178
Query: 209 FQAPEI--ANGLPEIS-GYKVDIWSSGVT 234
+ APE+ + P+ S + D+WS G+T
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGIT 207
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-27
Identities = 76/203 (37%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI---NVDREIRLLKM 94
+Y +G G+YG V +D T + A+K KL R EI RE+ LLK
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIK-----KLSRPFQSEIFAKRAYRELTLLKH 70
Query: 95 LQHRNVIGLVDVFVN----DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQL 150
+QH NVIGL+DVF + D+ Q YL+M Y LQ ++ + Q+
Sbjct: 71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQM 126
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQ 210
L GL+Y+HS GIIH+D+KPGNL + D LKI DFG+A D + +T ++
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YR 181
Query: 211 APE-IANGLPEISGYKVDIWSSG 232
APE I N + VDIWS G
Sbjct: 182 APEVILNWMH--YNQTVDIWSVG 202
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 6e-27
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 30/203 (14%)
Query: 48 GSYGKVKEMLDSETLCRR-------AVKIFKKKKLQR-IPNGEINVDREIRLLKMLQHRN 99
G+YG+V L ++ A+K+ KK + R ++ +R+I L Q
Sbjct: 4 GAYGRV-------FLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPY 54
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
V+ L F K +YL+MEY GG L +L++ A Y +++ LEYLH
Sbjct: 55 VVKLYYSFQGKKN--LYLVMEYLPGGDLASLLEN--VGSLDEDVARIYIAEIVLALEYLH 110
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFG------VAESLDMFLHDDTITTSQGSPVFQAP 212
S GIIH+D+KP N+L+ +G LK++DFG V +++ + G+P + AP
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 213 EIANGLPEISGYKVDIWSSGVTL 235
E+ G VD WS G L
Sbjct: 171 EVILGQG--HSKTVDWWSLGCIL 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-27
Identities = 70/205 (34%), Positives = 108/205 (52%), Gaps = 28/205 (13%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN--VDREIRLLKML 95
KY L+GEGSYG V + ET A+K F L+ + + REIR+LK L
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQL 57
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG--------YF 147
+H N++ L++VF +K+++YL+ E+ + D L+ P +G Y
Sbjct: 58 RHENLVNLIEVF--RRKKRLYLVFEFVDHTVLDDLEKYP---------NGLDESRVRKYL 106
Query: 148 LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSP 207
Q+L G+E+ HS IIH+DIKP N+L++ G +K+ DFG A +L + T +
Sbjct: 107 FQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--PGEVYTDYVATR 164
Query: 208 VFQAPEIANGLPEISGYKVDIWSSG 232
++APE+ G + G VDIW+ G
Sbjct: 165 WYRAPELLVGDTKY-GRAVDIWAVG 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-27
Identities = 70/218 (32%), Positives = 101/218 (46%), Gaps = 44/218 (20%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI--NVDREIRLLKM 94
K V LGEG+ G V + + IF K + PN ++ + RE+ + K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRL-----KNTGMIFALKTITTDPNPDLQKQILRELEINKS 55
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKF----------PIWQ-A 143
+ ++ F+++ + + MEYC GG LDS YKK + + A
Sbjct: 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGG---SLDSI-YKKVKKRGGRIGEKVLGKIA 111
Query: 144 HGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA----ESLDMFLHDDT 199
+L GL YLHS+ IIH+DIKP N+LLT G +K+ DFGV+ SL
Sbjct: 112 ES----VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG------ 161
Query: 200 ITTSQGSPVFQAPEIANGLPEISGYKV--DIWSSGVTL 235
T G+ + APE G P Y + D+WS G+TL
Sbjct: 162 --TFTGTSFYMAPERIQGKP----YSITSDVWSLGLTL 193
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 70/199 (35%), Positives = 109/199 (54%), Gaps = 21/199 (10%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LG+G++GKV + + ET A K+ + K + + + + EI +L H ++ L+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV----EIEILATCNHPYIVKLL 75
Query: 105 DVFVNDKKQKMYLIMEYCVGGLQD--MLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
F D K +++++E+C GG D ML+ P Q Q+L+ L+YLHS I
Sbjct: 76 GAFYWDGK--LWIMIEFCPGGAVDAIMLELDRGLTEP--QIQVICRQMLEALQYLHSMKI 131
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGV-AESLDMFLHDDTITTSQGSPVFQAPEIA-----N 216
IH+D+K GN+LLTLDG +K++DFGV A+++ D+ G+P + APE+
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI---GTPYWMAPEVVMCETMK 188
Query: 217 GLPEISGYKVDIWSSGVTL 235
P YK DIWS G+TL
Sbjct: 189 DTP--YDYKADIWSLGITL 205
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-26
Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 9/201 (4%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK------KKKLQRIPNGEINVDREIRL 91
K+V G+L+G+G+YG+V L+ T AVK + + R + + EI
Sbjct: 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61
Query: 92 LKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLL 151
LK L H N++ + ++ + + +EY GG T Y +F + Q+L
Sbjct: 62 LKDLDHLNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRT-YGRFEEQLVRFFTEQVL 118
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQA 211
+GL YLHS+GI+H+D+K NLL+ DG KISDFG+++ D +D + QGS + A
Sbjct: 119 EGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 212 PEIANGLPEISGYKVDIWSSG 232
PE+ + + KVDIWS G
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 69/196 (35%), Positives = 105/196 (53%), Gaps = 14/196 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+YV +G G++G V D L + V I K K P RE++LLK L+H
Sbjct: 11 RYVDLQPVGMGAFGLVCSARD--QLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL-QLLDGLEY 156
N+I L D+F++ + +Y + E L +L S P +K Q YFL Q+L GL+Y
Sbjct: 69 ENIISLSDIFIS-PLEDIYFVTELLGTDLHRLLTSRPLEK----QFIQYFLYQILRGLKY 123
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIAN 216
+HS G++H+D+KP N+L+ + LKI DFG+A + D +T + ++APEI
Sbjct: 124 VHSAGVVHRDLKPSNILINENCDLKICDFGLAR-----IQDPQMTGYVSTRYYRAPEIML 178
Query: 217 GLPEISGYKVDIWSSG 232
+ +VDIWS+G
Sbjct: 179 TWQKY-DVEVDIWSAG 193
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-26
Identities = 65/195 (33%), Positives = 101/195 (51%), Gaps = 21/195 (10%)
Query: 46 GEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI-NVDREIRLLKMLQHRNVIGLV 104
G+G++GKV + +T A+K K+K + G + NV E R+L+ L H ++ L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKC--VEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 105 DVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159
F ++ + MYL+++ +GG L KF Q + +++ LEYLHS
Sbjct: 67 YSFQDE--ENMYLVVDLLLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHS 118
Query: 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLP 219
+GIIH+DIKP N+LL G + I+DF +A D T++ G+P + APE+
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLC--R 173
Query: 220 EISGYKVDIWSSGVT 234
+ VD WS GVT
Sbjct: 174 QGYSVAVDWWSLGVT 188
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 17/197 (8%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LG+G++GKV + + ET A K+ K + + + + +D +L H N++ L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEID----ILASCDHPNIVKLL 68
Query: 105 DVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIH 164
D F + +++++E+C GG D + + Q Q L+ L YLH IIH
Sbjct: 69 DAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 165 KDIKPGNLLLTLDGTLKISDFGV-AESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS- 222
+D+K GN+L TLDG +K++DFGV A++ D+ G+P + APE+ + E S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI---GTPYWMAPEVV--MCETSK 181
Query: 223 ----GYKVDIWSSGVTL 235
YK D+WS G+TL
Sbjct: 182 DRPYDYKADVWSLGITL 198
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-26
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 28/211 (13%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD----------- 86
K++ G L+G GS+G V +++ + AVK + +P+ +
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVE------LPSVSASSKDRKRSMLDALA 54
Query: 87 REIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHG 145
REI LLK LQH N++ + ++ ++L EY GG + +L++ Y F
Sbjct: 55 REIALLKELQHENIVQYLGSSLDADHLNIFL--EYVPGGSVAALLNN--YGAFEETLVRN 110
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS-- 203
+ Q+L GL YLH++GIIH+DIK N+L+ G +KISDFG+++ L+ +
Sbjct: 111 FVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 204 --QGSPVFQAPEIANGLPEISGYKVDIWSSG 232
QGS + APE+ K DIWS G
Sbjct: 171 SLQGSVFWMAPEVVK--QTSYTRKADIWSLG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-26
Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 24/204 (11%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ----HRNV 100
LG+G+YG V ++ET V I KK+ + + +I R +R LK+L+ H+N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAI---KKITNVFSKKILAKRALRELKLLRHFRGHKNI 64
Query: 101 IGLVD---VFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAH-GYFL-QLLDGLE 155
L D VF ++YL E L ++ S P+ AH F+ Q+L GL+
Sbjct: 65 TCLYDMDIVF-PGNFNELYLYEELMEADLHQIIRSGQ----PLTDAHFQSFIYQILCGLK 119
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE--SLDMFLHDDTITTSQGSPVFQAPE 213
Y+HS ++H+D+KPGNLL+ D LKI DFG+A S + + +T + ++APE
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 214 IANGLPEISGYK--VDIWSSGVTL 235
I + Y +D+WS G L
Sbjct: 180 I---MLSFQSYTKAIDVWSVGCIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-26
Identities = 68/202 (33%), Positives = 99/202 (49%), Gaps = 33/202 (16%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFK--------KKKLQRIPNGEINVDREIRLLKMLQ 96
+G GS+G V D T V I K +K Q I +E+R L+ L+
Sbjct: 23 IGHGSFGAVYFARDVRT--NEVVAIKKMSYSGKQSNEKWQDII-------KEVRFLQQLR 73
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD--STPYKKFPIWQAHGYFLQLLDGL 154
H N I ++ ++ +L+MEYC+G D+L+ P ++ I L GL
Sbjct: 74 HPNTIEYKGCYL--REHTAWLVMEYCLGSASDILEVHKKPLQEVEI---AAICHGALQGL 128
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEI 214
YLHS IH+DIK GN+LLT GT+K++DFG A + + G+P + APE+
Sbjct: 129 AYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV------SPANSFVGTPYWMAPEV 182
Query: 215 ANGLPEISGY--KVDIWSSGVT 234
+ E Y KVD+WS G+T
Sbjct: 183 ILAMDE-GQYDGKVDVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-25
Identities = 60/198 (30%), Positives = 101/198 (51%), Gaps = 21/198 (10%)
Query: 45 LGEGSYGKVKEMLDSETLCRRA----VKIFKKKKLQRI-PNGEINVDREIRLLKMLQHRN 99
LG+G++G TL RR + ++K+ L R+ + EI +L +LQH N
Sbjct: 8 LGKGAFG-------EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
+I + F++D + + MEY GG L D + + F Y Q++ + Y+H
Sbjct: 61 IIAYYNHFMDD--NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL-DMFLHDDTITTSQGSPVFQAPEIANG 217
GI+H+DIK N+ LT G +K+ DFG+++ L + +T+ G+P + +PE+ G
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV---GTPYYMSPELCQG 175
Query: 218 LPEISGYKVDIWSSGVTL 235
+ +K DIW+ G L
Sbjct: 176 VK--YNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 70/195 (35%), Positives = 101/195 (51%), Gaps = 21/195 (10%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI---NVDREIRLLKMLQHRNVI 101
+G G+YG V LD T + A+K KL R E+ RE+RLLK ++H NVI
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLKHMKHENVI 77
Query: 102 GLVDVFVND----KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
GL+DVF D + YL+M + L ++ ++K + Q+L GL+Y+
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYI 134
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG 217
H+ GIIH+D+KPGNL + D LKI DFG+A D + +T ++APE+
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRW-----YRAPEVILN 189
Query: 218 LPEISGYKVDIWSSG 232
+ VDIWS G
Sbjct: 190 WMHYT-QTVDIWSVG 203
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-25
Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 44/213 (20%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKL----QRIPNGEINVDREIRLLK 93
KY + +GEG+YG V + + ET + K+ +L + +P+ + REI LLK
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRVRLDDDDEGVPSSAL---REICLLK 54
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLD 152
L+H+N++ L DV +DKK + L+ EYC L+ DS I ++ + QLL
Sbjct: 55 ELKHKNIVRLYDVLHSDKK--LTLVFEYCDQDLKKYFDSCNGDIDPEIVKS--FMFQLLK 110
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV---- 208
GL + HS ++H+D+KP NLL+ +G LK++DFG+A + G PV
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF-------------GIPVRCYS 157
Query: 209 -------FQAPEIANGLPEISGY--KVDIWSSG 232
++ P++ G Y +D+WS+G
Sbjct: 158 AEVVTLWYRPPDVLFG---AKLYSTSIDMWSAG 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 5e-25
Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 41/212 (19%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD----------R 87
+ + + +G+GS+G+V + +D T A+K+ I+++ +
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV-------------IDLEEAEDEIEDIQQ 48
Query: 88 EIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGY 146
EI+ L + + F+ K+++IMEYC GG D+L + I +
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKG--SKLWIIMEYCGGGSCLDLLKPGKLDETYI----AF 102
Query: 147 FL-QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL-DMFLHDDTITTSQ 204
L ++L GLEYLH +G IH+DIK N+LL+ +G +K++DFGV+ L +T
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV--- 159
Query: 205 GSPVFQAPEIANGLPEISGY--KVDIWSSGVT 234
G+P + APE+ SGY K DIWS G+T
Sbjct: 160 GTPFWMAPEVIKQ----SGYDEKADIWSLGIT 187
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 8e-25
Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 38/204 (18%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR----IPNGEINVDREIRLLKMLQHRNV 100
+GEG+YG V + + +T + KK +L+ +P+ I REI LLK LQH N+
Sbjct: 8 IGEGTYGVVYKGRNKKT---GQIVAMKKIRLESEEEGVPSTAI---REISLLKELQHPNI 61
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKF-PIWQAHGYFLQLLDGLEYLHS 159
+ L DV + + ++YLI E+ L+ LDS P ++ Y Q+L G+ + HS
Sbjct: 62 VCLQDVLMQE--SRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV----------- 208
+ ++H+D+KP NLL+ G +K++DFG+A + G PV
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-------------GIPVRVYTHEVVTLW 166
Query: 209 FQAPEIANGLPEISGYKVDIWSSG 232
++APE+ G P S VDIWS G
Sbjct: 167 YRAPEVLLGSPRYS-TPVDIWSIG 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-24
Identities = 64/202 (31%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 38 KYVMGDLLGEGSYGK---VKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
KYV +GEGS+GK VK D + + + I K +R + +E+ +L
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES-----RKEVAVLSN 55
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
++H N++ + F ++ +Y++M+YC GG L +++ FP Q +F+Q+
Sbjct: 56 MKHPNIVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA 113
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
L+++H + I+H+DIK N+ LT DGT+K+ DFG+A L+ + + T G+P + +PE
Sbjct: 114 LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--ELARTCIGTPYYLSPE 171
Query: 214 IANGLPEISGYKVDIWSSGVTL 235
I P K DIW+ G L
Sbjct: 172 ICENRP--YNNKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-24
Identities = 65/198 (32%), Positives = 106/198 (53%), Gaps = 7/198 (3%)
Query: 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VDREIRLLKMLQHRN 99
+G LLG+G++G+V D++T AVK + + E+N ++ EI+LLK L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
++ + ++ + + ME+ GG ++D L S Y Y Q+L+G+ YLH
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLH 123
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF-LHDDTITTSQGSPVFQAPEIANG 217
S I+H+DIK N+L G +K+ DFG ++ L L + + G+P + +PE+ +G
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 218 LPEISGYKVDIWSSGVTL 235
E G K DIWS G T+
Sbjct: 184 --EGYGRKADIWSVGCTV 199
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-24
Identities = 68/199 (34%), Positives = 111/199 (55%), Gaps = 14/199 (7%)
Query: 38 KYVMGDLLGEGSYG---KVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
+Y + +GEG+YG K ++ + +ET+ + KI +++ + +P+ I REI LLK
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALK--KIRLEQEDEGVPSTAI---REISLLKE 57
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
+QH N++ L DV ++K+ +YL+ EY L+ +DS+P Y Q+L G+
Sbjct: 58 MQHGNIVRLQDVVHSEKR--LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 155 EYLHSQGIIHKDIKPGNLLLTL-DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
Y HS ++H+D+KP NLL+ LK++DFG+A + + + T T + ++APE
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPE 173
Query: 214 IANGLPEISGYKVDIWSSG 232
I G S VDIWS G
Sbjct: 174 ILLGSRHYST-PVDIWSVG 191
|
Length = 294 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-24
Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNG-EINVDREIRLLKMLQ 96
K+ + +GEG+YG+V + D +T + KK +L G I REI++L+ L
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDT---GELVALKKVRLDNEKEGFPITAIREIKILRQLN 64
Query: 97 HRNVIGLVDVFVND------KKQK--MYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL 148
HRN++ L ++ + KK K YL+ EY L +L+S F +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDHIKSFMK 123
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA---ESLDMFLHDDTITTSQG 205
QLL+GL Y H + +H+DIK N+LL G +K++DFG+A S + + + + T
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183
Query: 206 SPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
P PE+ G E G +D+WS G L
Sbjct: 184 RP----PELLLG-EERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 3e-24
Identities = 73/200 (36%), Positives = 103/200 (51%), Gaps = 25/200 (12%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDR---EIRLLKMLQHRNVI 101
+G G+YG V D++T R AVK KL R I+ R E+RLLK ++H NVI
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVK-----KLSRPFQSIIHAKRTYRELRLLKHMKHENVI 79
Query: 102 GLVDVFVNDKKQK----MYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL--QLLDGLE 155
GL+DVF + + +YL+ L +++ K + H FL Q+L GL+
Sbjct: 80 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-----KCQKLTDDHVQFLIYQILRGLK 134
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
Y+HS IIH+D+KP NL + D LKI DFG+A DD +T + ++APEI
Sbjct: 135 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEIM 189
Query: 216 NGLPEISGYKVDIWSSGVTL 235
+ VDIWS G +
Sbjct: 190 LNWMHYN-QTVDIWSVGCIM 208
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-24
Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 7/197 (3%)
Query: 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VDREIRLLKMLQHRNV 100
G LLG+G++G+V D +T A K + + E++ ++ EI+LLK LQH +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159
+ + ++ + + MEY GG ++D L + Y Y Q+L+G+ YLHS
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHS 124
Query: 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT-ITTSQGSPVFQAPEIANGL 218
I+H+DIK N+L G +K+ DFG ++ L T I + G+P + +PE+ +G
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG- 183
Query: 219 PEISGYKVDIWSSGVTL 235
E G K D+WS G T+
Sbjct: 184 -EGYGRKADVWSLGCTV 199
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 6e-24
Identities = 71/197 (36%), Positives = 101/197 (51%), Gaps = 25/197 (12%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDR---EIRLLKMLQHRNVI 101
+G G+YG V D+ + AVK KL R I+ R E+RLLK ++H NVI
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVK-----KLSRPFQSLIHARRTYRELRLLKHMKHENVI 77
Query: 102 GLVDVFVN----DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL--QLLDGLE 155
GL+DVF + ++YL+ L +++ K + H FL QLL GL+
Sbjct: 78 GLLDVFTPATSIENFNEVYLVTNLMGADLNNIV-----KCQKLSDEHVQFLIYQLLRGLK 132
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
Y+HS GIIH+D+KP N+ + D L+I DFG+A DD +T + ++APEI
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA-----DDEMTGYVATRWYRAPEIM 187
Query: 216 NGLPEISGYKVDIWSSG 232
+ VDIWS G
Sbjct: 188 LNWMHYN-QTVDIWSVG 203
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 9e-24
Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 23/199 (11%)
Query: 45 LGEGSYG---KVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVI 101
+G+GS+G KV D + + + K + +R I+ E R+L L +I
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRER--EEAID---EARVLAKLDSSYII 62
Query: 102 GLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFP---IWQAHGYFLQLLDGLEYL 157
+ F++ K K+ ++MEY G L +L + P +W+ +F+Q+L GL +L
Sbjct: 63 RYYESFLD--KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR---FFIQILLGLAHL 117
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL-DMFLHDDTITTSQGSPVFQAPEIAN 216
HS+ I+H+DIK NL L +KI D GVA+ L D +TI G+P + +PE+
Sbjct: 118 HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV---GTPYYLSPELCE 174
Query: 217 GLPEISGYKVDIWSSGVTL 235
P K D+W+ GV L
Sbjct: 175 DKP--YNEKSDVWALGVVL 191
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-23
Identities = 66/193 (34%), Positives = 95/193 (49%), Gaps = 20/193 (10%)
Query: 47 EGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGE---INVDREIRLLKMLQHRNVIGL 103
EG+YG V D +T +I KKL+ E I REI +L LQH N++ +
Sbjct: 15 EGTYGVVYRARDKKT-----GEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 104 VDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
+V V K+Y++MEY L+ ++++ F + LQLL G+ +LH I+
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQP-FLQSEVKCLMLQLLSGVAHLHDNWIL 128
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV----FQAPEIANGLP 219
H+D+K NLLL G LKI DFG+A L T V ++APE+ G
Sbjct: 129 HRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT------QLVVTLWYRAPELLLGAK 182
Query: 220 EISGYKVDIWSSG 232
E S +D+WS G
Sbjct: 183 EYST-AIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-23
Identities = 63/198 (31%), Positives = 106/198 (53%), Gaps = 7/198 (3%)
Query: 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VDREIRLLKMLQHRN 99
+G LLG G++G+V D++T AVK + + E+N ++ EI+LLK L+H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
++ + +++K+ + +EY GG ++D L + Y Y Q+L G+ YLH
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLH 123
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT-ITTSQGSPVFQAPEIANG 217
S I+H+DIK N+L G +K+ DFG ++ + T I + G+P + +PE+ +G
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 218 LPEISGYKVDIWSSGVTL 235
E G K D+WS T+
Sbjct: 184 --EGYGRKADVWSVACTV 199
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-23
Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 27/203 (13%)
Query: 41 MGDLLGEGSYGKVKEMLDSETLCRR-------AVKIFKKKKLQRIPNGEINVDREIRLLK 93
MG+ LG GS+G+V+ + + A+K KK+++ ++ + +V +E +L
Sbjct: 22 MGETLGTGSFGRVR-------IAKHKGTGEYYAIKCLKKREILKMKQVQ-HVAQEKSILM 73
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLD 152
L H ++ ++ F ++ + +Y ++E+ VGG L L +FP A Y +L+
Sbjct: 74 ELSHPFIVNMMCSFQDENR--VYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVL 129
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAP 212
EYLHS+ II++D+KP NLLL G +K++DFG A+ + D T T G+P + AP
Sbjct: 130 AFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP----DRTFTLC-GTPEYLAP 184
Query: 213 EIANGLPEISGYKVDIWSSGVTL 235
E+ + G VD W+ GV L
Sbjct: 185 EVIQS--KGHGKAVDWWTMGVLL 205
|
Length = 329 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-23
Identities = 62/200 (31%), Positives = 105/200 (52%), Gaps = 12/200 (6%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLLKML 95
K+ + ++GEG+YG V + ET A+K FK + N E+ RE+++L+ L
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE----ENEEVKETTLRELKMLRTL 57
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
+ N++ L + F ++ K+YL+ EY + ++L+ P P + Y QL+ +
Sbjct: 58 KQENIVELKEAF--RRRGKLYLVFEYVEKNMLELLEEMPNGVPPE-KVRSYIYQLIKAIH 114
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
+ H I+H+DIKP NLL++ + LK+ DFG A +L + T + +++PE+
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANYTEYVATRWYRSPELL 173
Query: 216 NGLPEISGYKVDIWSSGVTL 235
G P G VD+WS G L
Sbjct: 174 LGAP--YGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 3e-23
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 48/215 (22%)
Query: 46 GEGSYGKVKEMLDSETLCRR--AVKIFKKKKLQR--IPNGEINVDREIRLLKMLQHRNVI 101
G G+YG+V + + A+K FK K Q I REI LL+ L+H NV+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC---REIALLRELKHENVV 65
Query: 102 GLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPI-WQAHGYFL-----QLLDGLE 155
LV+VF+ + +YL+ +Y D+ + + + Q+L+G+
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAE---HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 156 YLHSQGIIHKDIKPGNLLLTLD----GTLKISDFGVA----ESLDMFLHDDTITTSQGSP 207
YLHS ++H+D+KP N+L+ + G +KI D G+A L D P
Sbjct: 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD--------P 174
Query: 208 V-----FQAPEIANGLPEISGYK-----VDIWSSG 232
V ++APE+ + G + +DIW+ G
Sbjct: 175 VVVTIWYRAPEL------LLGARHYTKAIDIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-23
Identities = 63/175 (36%), Positives = 94/175 (53%), Gaps = 21/175 (12%)
Query: 71 KKKKLQRIPNGEIN------VDREIRLLKMLQHRNVIGLVDVF---VNDKKQKMYLIMEY 121
K+ L+++PN N V RE+++L +H NV+ +D+ D +++Y++ E
Sbjct: 26 KRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTEL 85
Query: 122 CVGGLQDMLDSTPYKKFPIWQAH-GYFL-QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT 179
L ++ S P+ H FL Q+L GL+YLHS GI+H+DIKPGNLL+ +
Sbjct: 86 MQSDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV 141
Query: 180 LKISDFGVA--ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSG 232
LKI DFG+A E D H +T + ++APEI G + VDIWS G
Sbjct: 142 LKICDFGLARVEEPDESKH---MTQEVVTQYYRAPEILMGSRHYTS-AVDIWSVG 192
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-23
Identities = 76/213 (35%), Positives = 109/213 (51%), Gaps = 43/213 (20%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD------REIRL 91
+Y +G G+ G V D+ T A+K KL R P NV RE+ L
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK-----KLSR-PF--QNVTHAKRAYRELVL 68
Query: 92 LKMLQHRNVIGLVDVFVNDKK----QKMYLIMEYCVGGL----QDMLDSTPYKKFPIWQA 143
+K++ H+N+IGL++VF K Q +YL+ME L Q LD +
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH---------ER 119
Query: 144 HGYFL-QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL-DMFLHDDTIT 201
Y L Q+L G+++LHS GIIH+D+KP N+++ D TLKI DFG+A + F+ +
Sbjct: 120 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 179
Query: 202 TSQGSPVFQAPEIANGLPEISGYK--VDIWSSG 232
T ++APE+ G+ GYK VDIWS G
Sbjct: 180 TR----YYRAPEVILGM----GYKENVDIWSVG 204
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-23
Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 25/200 (12%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGE----INVDREIRLLKMLQ---H 97
+G G+YG V + D + F K R+ E ++ RE+ LLK L+ H
Sbjct: 8 IGVGAYGTVYKARDPHS------GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 98 RNVIGLVDVFVN---DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
N++ L+DV D++ K+ L+ E+ L+ LD P P Q L GL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE--SLDMFLHDDTITTSQGSPVFQAP 212
++LH+ I+H+D+KP N+L+T G +K++DFG+A S M L +T ++AP
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW-----YRAP 176
Query: 213 EIANGLPEISGYKVDIWSSG 232
E+ L VD+WS G
Sbjct: 177 EVL--LQSTYATPVDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 6e-23
Identities = 69/201 (34%), Positives = 112/201 (55%), Gaps = 30/201 (14%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VDREIRLLKMLQHRNVIGL 103
+G G+YG V + + T AVKI K + P + + + +EI ++K +H N++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE-----PGDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 104 VDVFVNDKKQKMYLIMEYCVGG-LQDMLDST-PYKKFPIWQAHGYFL-QLLDGLEYLHSQ 160
+++ ++K+++ MEYC GG LQD+ T P + I Y + L GL YLHS+
Sbjct: 72 FGSYLS--REKLWICMEYCGGGSLQDIYHVTGPLSELQI----AYVCRETLQGLAYLHSK 125
Query: 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ-----GSPVFQAPEIA 215
G +H+DIK N+LLT +G +K++DFGVA + T T ++ G+P + APE+A
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKI-------TATIAKRKSFIGTPYWMAPEVA 178
Query: 216 NGLPEISGYK--VDIWSSGVT 234
+ + GY DIW+ G+T
Sbjct: 179 -AVEKNGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 7e-23
Identities = 60/213 (28%), Positives = 108/213 (50%), Gaps = 20/213 (9%)
Query: 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGE----INVDR 87
+ KY +G+G++G+V + ++ +I KK+ + N + I R
Sbjct: 7 FCDEVSKYEKLAKIGQGTFGEVFK-----ARHKKTKQIVALKKV-LMENEKEGFPITALR 60
Query: 88 EIRLLKMLQHRNVIGLVDV------FVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIW 141
EI++L++L+H NV+ L+++ N K YL+ E+C L +L S KF +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLL-SNKNVKFTLS 119
Query: 142 QAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT-- 199
+ LL+GL Y+H I+H+D+K N+L+T DG LK++DFG+A + + +
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 200 ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSG 232
T + ++ PE+ G + G +D+W +G
Sbjct: 180 YTNRVVTLWYRPPELLLGERDY-GPPIDMWGAG 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 8e-23
Identities = 69/231 (29%), Positives = 112/231 (48%), Gaps = 33/231 (14%)
Query: 9 DGDMISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVK 68
D ++ +F + D +++ D + I G GS+G V D T A+K
Sbjct: 11 DPEIAELFFKEDPEKLFTDLREI--------------GHGSFGAVYFARDVRTNEVVAIK 56
Query: 69 IFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQD 128
Q + ++ +E++ L+ ++H N I ++ ++ +L+MEYC+G D
Sbjct: 57 KMSYSGKQSNEKWQ-DIIKEVKFLQRIKHPNSIEYKGCYL--REHTAWLVMEYCLGSASD 113
Query: 129 MLD--STPYKKFPIWQ-AHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDF 185
+L+ P ++ I HG L GL YLHS +IH+DIK GN+LLT G +K++DF
Sbjct: 114 LLEVHKKPLQEVEIAAITHG----ALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 169
Query: 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGY--KVDIWSSGVT 234
G A + G+P + APE+ + E Y KVD+WS G+T
Sbjct: 170 GSASIA------SPANSFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGIT 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-22
Identities = 62/197 (31%), Positives = 107/197 (54%), Gaps = 14/197 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
KY + +G+G+ G V +D T A+K + LQ+ P E+ ++ EI +++ +H
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIK---QMNLQQQPKKELIIN-EILVMRENKH 75
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
N++ +D ++ +++++MEY GG L D++ T + Q + L LE+
Sbjct: 76 PNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALEF 130
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIAN 216
LHS +IH+DIK N+LL +DG++K++DFG + +T G+P + APE+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVT 188
Query: 217 GLPEISGYKVDIWSSGV 233
+ G KVDIWS G+
Sbjct: 189 --RKAYGPKVDIWSLGI 203
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-22
Identities = 67/195 (34%), Positives = 101/195 (51%), Gaps = 19/195 (9%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
+G GS+G V +S T AVK Q + ++ +E++ L+ L+H N I
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQ-DIIKEVKFLQQLKHPNTIEYK 87
Query: 105 DVFVNDKKQKMYLIMEYCVGGLQDMLD--STPYKKFPIWQ-AHGYFLQLLDGLEYLHSQG 161
++ K+ +L+MEYC+G D+L+ P ++ I HG L GL YLHS
Sbjct: 88 GCYL--KEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHG----ALQGLAYLHSHN 141
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEI 221
+IH+DIK GN+LLT G +K++DFG A + G+P + APE+ + E
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKS------SPANSFVGTPYWMAPEVILAMDE- 194
Query: 222 SGY--KVDIWSSGVT 234
Y KVD+WS G+T
Sbjct: 195 GQYDGKVDVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-22
Identities = 60/196 (30%), Positives = 90/196 (45%), Gaps = 20/196 (10%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN--VDREIRLLKMLQHRNVIG 102
LG G+ G V ++L R KI K ++ N I + RE+ +L ++G
Sbjct: 9 LGAGNSGVVSKVLH-----RPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-G 161
F N+ + + MEY GG D + + P + +L GL YLH +
Sbjct: 64 FYGAFYNNGD--ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEI 221
IIH+D+KP N+L+ G +K+ DFGV+ L + T G+ + APE G
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV----NSLAKTFVGTSSYMAPERIQGN--- 174
Query: 222 SGYKV--DIWSSGVTL 235
Y V DIWS G++L
Sbjct: 175 -DYSVKSDIWSLGLSL 189
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-22
Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 33/216 (15%)
Query: 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNG----EINVD---------RE 88
G LGEG+YGKV++ D TL + V I KK K+ I N V RE
Sbjct: 14 GAHLGEGTYGKVEKAYD--TLTGKIVAI-KKVKIIEISNDVTKDRQLVGMCGIHFTTLRE 70
Query: 89 IRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL 148
++++ ++H N++GLVDV+V + + L+M+ L+ ++D + Q L
Sbjct: 71 LKIMNEIKHENIMGLVDVYV--EGDFINLVMDIMASDLKKVVDRK--IRLTESQVKCILL 126
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG--- 205
Q+L+GL LH +H+D+ P N+ + G KI+DFG+A + DT++ +
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 206 -----SPV----FQAPEIANGLPEISGYKVDIWSSG 232
S V ++APE+ G E + VD+WS G
Sbjct: 187 REEMTSKVVTLWYRAPELLMG-AEKYHFAVDMWSVG 221
|
Length = 335 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 2e-22
Identities = 71/208 (34%), Positives = 107/208 (51%), Gaps = 30/208 (14%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VD-----REIRL 91
KYV +G G+YG V +SET + A+K +I N N +D REI+L
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIK--------KIANAFDNRIDAKRTLREIKL 57
Query: 92 LKMLQHRNVIGLVDVFVNDKKQK---MYLIMEYCVGGLQDMLDSTPYKKFPIWQAH-GYF 147
L+ L H NVI + D+ ++ +Y++ E L ++ S+ + H YF
Sbjct: 58 LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQ----TLSDDHCQYF 113
Query: 148 L-QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS 206
L QLL GL+Y+HS ++H+D+KP NLLL + LKI DFG+A + D +T +
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--KGDFMTEYVVT 171
Query: 207 PVFQAPEIANGLPEISGY--KVDIWSSG 232
++APE+ L S Y +D+WS G
Sbjct: 172 RWYRAPEL---LLNCSEYTTAIDVWSVG 196
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 2e-22
Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKI---FKKKKL-QRIPNGEINVDREIRLLKM 94
Y +GEG+YG V T + A+K F+ + QR REI++L+
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR-------TLREIKILRR 59
Query: 95 LQHRNVIGLVDVFVNDKKQKM---YLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL-QL 150
+H N+IG++D+ + Y++ E L ++ + I YFL Q+
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHI----QYFLYQI 115
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT--ITTSQGSPV 208
L GL+Y+HS ++H+D+KP NLLL + LKI DFG+A D HD T +T +
Sbjct: 116 LRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP-EHDHTGFLTEYVATRW 174
Query: 209 FQAPEIANGLPEISGYK--VDIWSSGVTL 235
++APEI + GY +DIWS G L
Sbjct: 175 YRAPEI---MLNSKGYTKAIDIWSVGCIL 200
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-22
Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 28/208 (13%)
Query: 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR-------LLKM 94
G++LG+G+YG V L ++ ++ K+++ + + ++E LLK
Sbjct: 5 GEVLGKGAYGTVYCGLTNQG------QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS 58
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
L+H N++ + ++D ++ ME+ GG + +L+ + P Y Q+LDG
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIF--MEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDG 114
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF----LHDDTITTSQGSPVF 209
+ YLH+ ++H+DIK N++L +G +K+ DFG A L H + + + G+P +
Sbjct: 115 VAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 210 QAPEIANGLPEISGY--KVDIWSSGVTL 235
APE+ N SGY K DIWS G T+
Sbjct: 175 MAPEVINE----SGYGRKSDIWSIGCTV 198
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-22
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRR----AVKIFKKKKLQRIPNGEIN-VDREIRLL 92
KY ++G G++G V LCRR + I K+ ++++ E E ++L
Sbjct: 1 KYEKIRVVGRGAFGIVH-------LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVL 53
Query: 93 KMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLL 151
K+L H N+I + F+ DK + ++MEY GG L + + +F+Q+L
Sbjct: 54 KLLSHPNIIEYYENFLEDKA--LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGT-LKISDFGVAESLDMFLHDDTITTSQGSPVFQ 210
L ++H++ I+H+D+K N+LL +KI DFG+++ L T G+P +
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYI 168
Query: 211 APEIANGLPEISGYKVDIWSSGVTL 235
+PE+ G P K DIW+ G L
Sbjct: 169 SPELCEGKP--YNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 6e-22
Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 18/197 (9%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNG-EINVDREIRLLKMLQ---HRNV 100
+GEG+YGKV + D + R K+ ++Q G ++ RE+ +L+ L+ H NV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 101 IGLVDVFV---NDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
+ L DV D++ K+ L+ E+ L LD P P QLL GL++L
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE--SLDMFLHDDTITTSQGSPVFQAPEIA 215
HS ++H+D+KP N+L+T G +K++DFG+A S M L +T ++APE+
Sbjct: 127 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW-----YRAPEVL 181
Query: 216 NGLPEISGYKVDIWSSG 232
L VD+WS G
Sbjct: 182 --LQSSYATPVDLWSVG 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-22
Identities = 64/209 (30%), Positives = 111/209 (53%), Gaps = 28/209 (13%)
Query: 38 KYVMGDLLGEGSYGKV---KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDR-EIRLLK 93
+Y + +GEGS+GK+ K DSE C + K+ L ++P E + E+ LL
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEH-C-----VIKEIDLTKMPVKEKEASKKEVILLA 54
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKK---FPIWQAHGYFLQL 150
++H N++ F + +++++MEYC GG D++ ++ F Q +F+Q+
Sbjct: 55 KMKHPNIVTFFASF--QENGRLFIVMEYCDGG--DLMKRINRQRGVLFSEDQILSWFVQI 110
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTL-KISDFGVAESLDMFLHDDTITTSQ---GS 206
GL+++H + I+H+DIK N+ L+ +G + K+ DFG+A L +D++ + G+
Sbjct: 111 SLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-----NDSMELAYTCVGT 165
Query: 207 PVFQAPEIANGLPEISGYKVDIWSSGVTL 235
P + +PEI P K DIWS G L
Sbjct: 166 PYYLSPEICQNRP--YNNKTDIWSLGCVL 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 8e-22
Identities = 65/195 (33%), Positives = 105/195 (53%), Gaps = 20/195 (10%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
+GEGS G V D T + AVK +K QR E+ + E+ +++ QH N++ +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR---RELLFN-EVVIMRDYQHPNIVEMY 82
Query: 105 DVF-VNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
+ V D+ ++++ME+ GG L D++ T + Q L +L L +LH+QG+
Sbjct: 83 SSYLVGDE---LWVVMEFLEGGALTDIVTHTRMNE---EQIATVCLAVLKALSFLHAQGV 136
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--GSPVFQAPEIANGLPE 220
IH+DIK ++LLT DG +K+SDFG + + G+P + APE+ + LP
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVS----KEVPRRKSLVGTPYWMAPEVISRLP- 191
Query: 221 ISGYKVDIWSSGVTL 235
G +VDIWS G+ +
Sbjct: 192 -YGTEVDIWSLGIMV 205
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-21
Identities = 67/196 (34%), Positives = 108/196 (55%), Gaps = 19/196 (9%)
Query: 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIG 102
+ +G+GS+G+V + +D+ T A+KI L+ + ++ +EI +L V
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQ-DMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG 161
++ K K+++IMEY GG D+L + P+ +F Q ++L GL+YLHS+
Sbjct: 67 YYGSYL--KGTKLWIIMEYLGGGSALDLLRAGPFDEF---QIATMLKEILKGLDYLHSEK 121
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESL-DMFLHDDTITTSQGSPVFQAPEIANGLPE 220
IH+DIK N+LL+ G +K++DFGVA L D + +T G+P + APE+ +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPEVI----Q 174
Query: 221 ISGY--KVDIWSSGVT 234
S Y K DIWS G+T
Sbjct: 175 QSAYDSKADIWSLGIT 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-21
Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 36/216 (16%)
Query: 36 IGKYVMGDLLGEGSYGKV---KEMLDSETLCRRAVKIFK---KKKLQRIPNGEINVDREI 89
+G + + +G+G + V +LD + + V+IF+ K Q +EI
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCL-------KEI 53
Query: 90 RLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYC-VGGLQDMLDSTPYKKFPI-----WQA 143
LLK L H NVI + F+ + ++ +++E G L M+ +K I W+
Sbjct: 54 DLLKQLDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK- 110
Query: 144 HGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS 203
YF+QL LE++HS+ I+H+DIKP N+ +T G +K+ D G L F T
Sbjct: 111 --YFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLG----LGRFFSSKTTAAH 164
Query: 204 Q--GSPVFQAPEIANGLPEISGY--KVDIWSSGVTL 235
G+P + +PE + +GY K DIWS G L
Sbjct: 165 SLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-21
Identities = 63/194 (32%), Positives = 98/194 (50%), Gaps = 15/194 (7%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LG G +G+V+ + A+K KK+ + + ++ E +L+ H ++ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET-GQQEHIFSEKEILEECNHPFIVKLY 59
Query: 105 DVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
F + K +Y++MEYC+GG L +L F + A Y ++ EYLH++GII
Sbjct: 60 RTFKDKKY--IYMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGII 115
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISG 223
++D+KP NLLL +G +K+ DFG A+ L T G+P + APEI G
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---GTPEYVAPEIILN----KG 168
Query: 224 YK--VDIWSSGVTL 235
Y VD WS G+ L
Sbjct: 169 YDFSVDYWSLGILL 182
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-21
Identities = 62/196 (31%), Positives = 109/196 (55%), Gaps = 20/196 (10%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINV-DREIRLLKMLQHRNVIGL 103
+G G+YG V + + T A+K+ K + P + V +EI ++K +H N++
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLE-----PGEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 104 VDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFL--QLLDGLEYLHSQ 160
++ ++ K+++ ME+C GG LQD+ T P+ ++ ++ + L GL YLHS+
Sbjct: 72 FGSYL--RRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK 125
Query: 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPE 220
G +H+DIK N+LLT +G +K++DFGV+ + + + G+P + APE+A +
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAPEVA-AVER 182
Query: 221 ISGYK--VDIWSSGVT 234
GY DIW+ G+T
Sbjct: 183 KGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-21
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 29/204 (14%)
Query: 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI-NVDREIRLLKMLQH---R 98
+L+G G+YG V T A+KI P+ ++ ++ RE+ LL L+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPP 62
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL--QLLDGLEY 156
N+ ++ + +++IMEY GG L K PI + + + ++L L+Y
Sbjct: 63 NITKYYGSYLKGPR--LWIIMEYAEGGSVRTL----MKAGPIAEKYISVIIREVLVALKY 116
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ-----GSPVFQA 211
+H G+IH+DIK N+L+T G +K+ DFGVA L +S+ G+P + A
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL-------NQNSSKRSTFVGTPYWMA 169
Query: 212 PEIANGLPEISGYKVDIWSSGVTL 235
PE+ K DIWS G+T+
Sbjct: 170 PEVITEGKYYD-TKADIWSLGITI 192
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-21
Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+ + LGEG+Y V + + T A+K + P+ I REI L+K L+H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI---REISLMKELKHE 58
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEYL 157
N++ L DV + K+ L+ EY L+ +D+ + QLL G+ +
Sbjct: 59 NIVRLHDVI--HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG 217
H ++H+D+KP NLL+ G LK++DFG+A + + + +T + + ++AP++ G
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--NTFSNEVVTLWYRAPDVLLG 174
Query: 218 LPEISGYKVDIWSSG 232
S +DIWS G
Sbjct: 175 SRTYST-SIDIWSVG 188
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 4e-21
Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 54/221 (24%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAV---KIF----KKKKLQRIPNGEINVDREIR 90
KY + LG+G+YG V + +D T + V KIF QR REI
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRT--KEVVALKKIFDAFRNATDAQR-------TFREIM 58
Query: 91 LLKML-QHRNVIGLVDVFVNDKKQKMYLIMEYC---------VGGLQDMLDSTPYKKFPI 140
L+ L H N++ L++V + + +YL+ EY L+D+ +K++ +
Sbjct: 59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV-----HKRYIM 113
Query: 141 WQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200
+Q LL L+Y+HS +IH+D+KP N+LL D +K++DFG+A SL +
Sbjct: 114 YQ-------LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL------SEL 160
Query: 201 TTSQGSPV---------FQAPEIANGLPEISGYKVDIWSSG 232
+ +PV ++APEI G + VD+WS G
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKG-VDMWSVG 200
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 7e-21
Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI-PNGEINVDREIRLLKMLQHRNVIG 102
+LG+G+YG V D T R A+K ++ + + P E EI L L+HRN++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE-----EIALHSYLKHRNIVQ 69
Query: 103 LVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHG----YFLQLLDGLEYL 157
+ + K++ ME GG L +L S K P+ Y Q+L+GL+YL
Sbjct: 70 YLGSDSENGFFKIF--MEQVPGGSLSALLRS---KWGPLKDNEQTIIFYTKQILEGLKYL 124
Query: 158 HSQGIIHKDIKPGNLLL-TLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIAN 216
H I+H+DIK N+L+ T G +KISDFG ++ L + T G+ + APE+ +
Sbjct: 125 HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVID 182
Query: 217 GLPEISGYKVDIWSSGVTL 235
P G DIWS G T+
Sbjct: 183 KGPRGYGAPADIWSLGCTI 201
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 7e-21
Identities = 62/198 (31%), Positives = 105/198 (53%), Gaps = 25/198 (12%)
Query: 45 LGEGSYGKV---KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVI 101
+G GS+G V +++ +SE + + + K+ ++ + + +E+R L+ L+H N I
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD----IIKEVRFLQKLRHPNTI 78
Query: 102 GLVDVFVNDKKQKMYLIMEYCVGGLQDMLD--STPYKKFPIWQ-AHGYFLQLLDGLEYLH 158
++ ++ +L+MEYC+G D+L+ P ++ I HG L GL YLH
Sbjct: 79 QYRGCYL--REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG----ALQGLAYLH 132
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGL 218
S +IH+D+K GN+LL+ G +K+ DFG A + G+P + APE+ +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAM 186
Query: 219 PEISGY--KVDIWSSGVT 234
E Y KVD+WS G+T
Sbjct: 187 DE-GQYDGKVDVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 8e-21
Identities = 70/205 (34%), Positives = 109/205 (53%), Gaps = 35/205 (17%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDR---EIRLLKMLQHRNVI 101
+G G+ G V D+ + R V I KKL R + + R E+ L+K + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDA--ILERNVAI---KKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 102 GLVDVFVNDKK----QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAH---GYFL-QLLDG 153
GL++VF K Q +Y++ME ++D+ + + H Y L Q+L G
Sbjct: 87 GLLNVFTPQKSLEEFQDVYIVME--------LMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM-FLHDDTITTSQGSPVFQAP 212
+++LHS GIIH+D+KP N+++ D TLKI DFG+A + F+ + T ++AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR----YYRAP 194
Query: 213 EIANGLPEISGYK--VDIWSSGVTL 235
E+ G+ GYK VDIWS G +
Sbjct: 195 EVILGM----GYKENVDIWSVGCIM 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 8e-21
Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 10/196 (5%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINV-DREIRLLKMLQH 97
Y ++G+GSYG+V ++ T ++ V KK L+ E ++E +LL L+H
Sbjct: 2 YCFVRVVGKGSYGEVS-LVRHRTDGKQYV--IKKLNLRNASRRERKAAEQEAQLLSQLKH 58
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
N++ + + + +Y++M +C GG L L K P Q +F+Q+ L+Y
Sbjct: 59 PNIVAYRESWEGEDGL-LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIAN 216
LH + I+H+D+K N+ LT +K+ D G+A L+ D +T G+P + +PE+ +
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELFS 175
Query: 217 GLPEISGYKVDIWSSG 232
P YK D+W+ G
Sbjct: 176 NKP--YNYKSDVWALG 189
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-20
Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 43 DLLGEGSYGKVKEMLDSETLCRR---AVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN 99
LG+GS+G V+ S + + AVK K KL I + + +E ++ L H N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL---KEAAIMHSLDHEN 57
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
+I L V + + ++ E G L D L F I Y +Q+ +G+ YL
Sbjct: 58 LIRLYGVVLT---HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV---FQAPEIA 215
S+ IH+D+ N+LL D +KI DFG+ +L ++D + V + APE
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALP--QNEDHYVMEEHLKVPFAWCAPESL 172
Query: 216 NGLPEISGYKVDIWSSGVTL 235
+ D+W GVTL
Sbjct: 173 RTRT--FSHASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-20
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI-PNGEINVDREIRLLKMLQ 96
+Y++ LG+GS+G V + D + + +K+ K+ + + PN + ++E +LL L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVG-GLQDMLDSTPY--KKFPIWQAHGYFLQLLDG 153
H ++ F+ ++ +I EYC G L L+ + K Q +F+QLL G
Sbjct: 61 HPAIVKFHASFL--ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
+ Y+H + I+H+D+K N+ L + LKI DFGV+ L D TT G+P + +PE
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLL--MGSCDLATTFTGTPYYMSPE 175
Query: 214 IANGLPEISGY--KVDIWSSGVTL 235
GY K DIWS G L
Sbjct: 176 ALKH----QGYDSKSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 1e-20
Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 16/198 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
KY + +G+G+ G V +D T A+K + LQ+ P E+ ++ EI +++ ++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIK---QMNLQQQPKKELIIN-EILVMRENKN 75
Query: 98 RNVIGLVDVF-VNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
N++ +D + V D+ ++++MEY GG L D++ T + Q + L L+
Sbjct: 76 PNIVNYLDSYLVGDE---LWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALD 129
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
+LHS +IH+DIK N+LL +DG++K++DFG + +T G+P + APE+
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVV 187
Query: 216 NGLPEISGYKVDIWSSGV 233
+ G KVDIWS G+
Sbjct: 188 T--RKAYGPKVDIWSLGI 203
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-20
Identities = 63/196 (32%), Positives = 96/196 (48%), Gaps = 20/196 (10%)
Query: 45 LGEGSYGKV--KEMLDSETLCRRAVKIFKKKKLQRIPNGEI-NVDREIRLLKML---QHR 98
LG G +GKV E + L A+K KK + I E+ ++ E R+ + +H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELY--AIKALKKGDI--IARDEVESLMCEKRIFETANSERHP 62
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
++ L F + + +MEY GG D++ F +A Y ++ GL+YLH
Sbjct: 63 FLVNLFACF--QTEDHVCFVMEYAAGG--DLMMHIHTDVFSEPRAVFYAACVVLGLQYLH 118
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGL 218
I+++D+K NLLL +G +KI+DFG+ + M D +T G+P F APE+ L
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMG-FGDRTSTFCGTPEFLAPEV---L 173
Query: 219 PEIS-GYKVDIWSSGV 233
E S VD W GV
Sbjct: 174 TETSYTRAVDWWGLGV 189
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 3e-20
Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 25/201 (12%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREI-------RLLKML- 95
+LG+GS+GKV T AVK+ KK I D ++ R+L +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKK--------DVILQDDDVECTMTEKRVLALAG 53
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQD-MLDSTPYKKFPIWQAHGYFLQLLDGL 154
+H + L F K +++ +MEY GG D M +F +A Y +++ GL
Sbjct: 54 KHPFLTQLHSCF--QTKDRLFFVMEYVNGG--DLMFHIQRSGRFDEPRARFYAAEIVLGL 109
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEI 214
++LH +GII++D+K N+LL +G +KI+DFG+ + + L T +T G+P + APEI
Sbjct: 110 QFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEI 167
Query: 215 ANGLPEISGYKVDIWSSGVTL 235
+ P G VD W+ GV L
Sbjct: 168 LSYQP--YGPAVDWWALGVLL 186
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-20
Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 26/207 (12%)
Query: 38 KYVMGDLLGEGSYGK---VKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRL 91
+Y + ++GEGS+G+ V+ + + + + R+P V+ +E L
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI---------RLPKSSSAVEDSRKEAVL 51
Query: 92 LKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKK---FPIWQAHGYFL 148
L ++H N++ + F D +Y++MEYC GG D++ ++ FP +F+
Sbjct: 52 LAKMKHPNIVAFKESFEADGH--LYIVMEYCDGG--DLMQKIKLQRGKLFPEDTILQWFV 107
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV 208
Q+ G++++H + ++H+DIK N+ LT +G +K+ DFG A L T G+P
Sbjct: 108 QMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AYACTYVGTPY 165
Query: 209 FQAPEIANGLPEISGYKVDIWSSGVTL 235
+ PEI +P K DIWS G L
Sbjct: 166 YVPPEIWENMP--YNNKSDIWSLGCIL 190
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-20
Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 25/202 (12%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR----IPNGEINVDREIRLLKMLQHRN- 99
+GEG+YGKV + D T + V + KK +L+ IP + REI LL+ML
Sbjct: 9 IGEGTYGKVYKARDKNT--GKLVAL-KKTRLEMDEEGIPPTAL---REISLLQMLSESIY 62
Query: 100 VIGLVDVF---VNDKKQKMYLIMEYCVGGLQDMLDST---PYKKFPIWQAHGYFLQLLDG 153
++ L+DV + K +YL+ EY L+ +DS P + P + QLL G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLD-GTLKISDFGVAESLDMFLHDDT--ITTSQGSPVFQ 210
+ + H G++H+D+KP NLL+ G LKI+D G+ + + + T I T ++
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW----YR 178
Query: 211 APEIANGLPEISGYKVDIWSSG 232
APE+ G S VDIWS G
Sbjct: 179 APEVLLGSTHYST-PVDIWSVG 199
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 4e-20
Identities = 65/198 (32%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
KY + +G+G+ G V +D T A+K + LQ+ P E+ ++ EI ++K L++
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIK---QINLQKQPKKELIIN-EILVMKELKN 75
Query: 98 RNVIGLVDVF-VNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
N++ +D F V D+ ++++MEY GG L D++ T + Q + L LE
Sbjct: 76 PNIVNFLDSFLVGDE---LFVVMEYLAGGSLTDVVTETCMDEA---QIAAVCRECLQALE 129
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
+LH+ +IH+DIK N+LL +DG++K++DFG + +T G+P + APE+
Sbjct: 130 FLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVV 187
Query: 216 NGLPEISGYKVDIWSSGV 233
+ G KVDIWS G+
Sbjct: 188 T--RKAYGPKVDIWSLGI 203
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-20
Identities = 70/205 (34%), Positives = 106/205 (51%), Gaps = 35/205 (17%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDR---EIRLLKMLQHRNVI 101
+G G+ G V D+ AVK KL R + + R E+ LLK + H+N+I
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVK-----KLSRPFQNQTHAKRAYRELVLLKCVNHKNII 83
Query: 102 GLVDVFVNDKK----QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAH---GYFL-QLLDG 153
L++VF K Q +YL+ME ++D+ + + H Y L Q+L G
Sbjct: 84 SLLNVFTPQKSLEEFQDVYLVME--------LMDANLCQVIHMELDHERMSYLLYQMLCG 135
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM-FLHDDTITTSQGSPVFQAP 212
+++LHS GIIH+D+KP N+++ D TLKI DFG+A + F+ + T ++AP
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTR----YYRAP 191
Query: 213 EIANGLPEISGYK--VDIWSSGVTL 235
E+ G+ GYK VDIWS G +
Sbjct: 192 EVILGM----GYKENVDIWSVGCIM 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 9e-20
Identities = 63/192 (32%), Positives = 103/192 (53%), Gaps = 14/192 (7%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
+GEGS G V + T + AVK +K QR E+ + E+ +++ H NV+ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR---RELLFN-EVVIMRDYHHENVVDMY 85
Query: 105 DVF-VNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
+ + V D+ ++++ME+ GG + D + + Q L +L L YLH+QG+I
Sbjct: 86 NSYLVGDE---LWVVMEFLEGGA--LTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVI 140
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISG 223
H+DIK ++LLT DG +K+SDFG + + G+P + APE+ + LP G
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV--GTPYWMAPEVISRLP--YG 196
Query: 224 YKVDIWSSGVTL 235
+VDIWS G+ +
Sbjct: 197 TEVDIWSLGIMV 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 1e-19
Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 16/198 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
KY + +G+G+ G V +D T A++ + LQ+ P E+ ++ EI +++ ++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIR---QMNLQQQPKKELIIN-EILVMRENKN 76
Query: 98 RNVIGLVDVF-VNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
N++ +D + V D+ ++++MEY GG L D++ T + Q + L LE
Sbjct: 77 PNIVNYLDSYLVGDE---LWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALE 130
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
+LHS +IH+DIK N+LL +DG++K++DFG + +T G+P + APE+
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVV 188
Query: 216 NGLPEISGYKVDIWSSGV 233
+ G KVDIWS G+
Sbjct: 189 T--RKAYGPKVDIWSLGI 204
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-19
Identities = 64/190 (33%), Positives = 105/190 (55%), Gaps = 14/190 (7%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
+GEGS G V + + + AVK+ +K QR E+ + E+ +++ QH+NV+ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---RELLFN-EVVIMRDYQHQNVVEMY 84
Query: 105 DVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
++ ++++++ME+ GG L D++ T + I LQ L YLHSQG+I
Sbjct: 85 KSYL--VGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQ---ALCYLHSQGVI 139
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISG 223
H+DIK ++LLTLDG +K+SDFG + + G+P + APE+ + P G
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV--GTPYWMAPEVISRTP--YG 195
Query: 224 YKVDIWSSGV 233
+VDIWS G+
Sbjct: 196 TEVDIWSLGI 205
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-19
Identities = 69/198 (34%), Positives = 99/198 (50%), Gaps = 16/198 (8%)
Query: 45 LGEGSYGKVK----EMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV 100
LGEG +GKV + + T AVK K++ Q+ +G +EI +LK L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWK---KEINILKTLYHENI 68
Query: 101 IGLVDVFVNDKKQKMYLIMEYC-VGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159
+ + + LIMEY +G L+D L P K + Q + Q+ +G+ YLHS
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF-QAPEIANGL 218
Q IH+D+ N+LL D +KI DFG+A+++ + SPVF A E L
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC---L 182
Query: 219 PEIS-GYKVDIWSSGVTL 235
E Y D+WS GVTL
Sbjct: 183 KENKFSYASDVWSFGVTL 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-19
Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 30/204 (14%)
Query: 45 LGEGSYGKVKE---MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVI 101
+G G + +V +LD + + + V+IF+ + + +EI LLK L H NVI
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK----ARQDCVKEIDLLKQLNHPNVI 65
Query: 102 GLVDVFVNDKKQKMYLIMEYC-VGGLQDMLDSTPYKK--FP---IWQAHGYFLQLLDGLE 155
+D F+ D ++ +++E G L M+ +K P +W+ YF+QL +E
Sbjct: 66 KYLDSFIED--NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK---YFVQLCSAVE 120
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--GSPVFQAPE 213
++HS+ ++H+DIKP N+ +T G +K+ D G L F T G+P + +PE
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLG----LGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 214 I--ANGLPEISGYKVDIWSSGVTL 235
NG +K DIWS G L
Sbjct: 177 RIHENGY----NFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-19
Identities = 70/205 (34%), Positives = 108/205 (52%), Gaps = 35/205 (17%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDR---EIRLLKMLQHRNVI 101
+G G+ G V D+ + R V I KKL R + + R E+ L+K + H+N+I
Sbjct: 25 IGSGAQGIVCAAYDA--VLDRNVAI---KKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 102 GLVDVFVNDKK----QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAH---GYFL-QLLDG 153
L++VF K Q +YL+ME ++D+ + + H Y L Q+L G
Sbjct: 80 SLLNVFTPQKSLEEFQDVYLVME--------LMDANLCQVIQMELDHERMSYLLYQMLCG 131
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM-FLHDDTITTSQGSPVFQAP 212
+++LHS GIIH+D+KP N+++ D TLKI DFG+A + F+ + T ++AP
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR----YYRAP 187
Query: 213 EIANGLPEISGYK--VDIWSSGVTL 235
E+ G+ GYK VDIWS G +
Sbjct: 188 EVILGM----GYKENVDIWSVGCIM 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-19
Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
Y+ + LGEGSY V + + A+K+ K + +P I RE LLK L+H
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI---REASLLKGLKHA 63
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
N++ L D+ K+ + + EY L + P P + + QLL GL Y+H
Sbjct: 64 NIVLLHDII--HTKETLTFVFEYMHTDLAQYMIQHPGGLHP-YNVRLFMFQLLRGLAYIH 120
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGL 218
Q I+H+D+KP NLL++ G LK++DFG+A + + T ++ + ++ P++ G
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARAKS--IPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 219 PEISGYKVDIWSSG 232
+ S +DIW +G
Sbjct: 179 TDYSS-ALDIWGAG 191
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 3e-19
Identities = 66/195 (33%), Positives = 103/195 (52%), Gaps = 21/195 (10%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
+G+GS+G+V + +D+ T A+KI L+ + ++ +EI +L V
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIID---LEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 105 DVFVNDKKQKMYLIMEYCVGGLQ-DMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
++ D K +++IMEY GG D+L+ P + Q ++L GL+YLHS+ I
Sbjct: 69 GSYLKDTK--LWIIMEYLGGGSALDLLEPGPLDET---QIATILREILKGLDYLHSEKKI 123
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--GSPVFQAPEIANGLPEI 221
H+DIK N+LL+ G +K++DFGVA L D I + G+P + APE+
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQIKRNTFVGTPFWMAPEVIKQ---- 175
Query: 222 SGY--KVDIWSSGVT 234
S Y K DIWS G+T
Sbjct: 176 SAYDSKADIWSLGIT 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 3e-19
Identities = 63/194 (32%), Positives = 104/194 (53%), Gaps = 15/194 (7%)
Query: 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIG 102
+ +G+GS+G+V + +D+ T A+KI L+ + ++ +EI +L +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIID---LEEAEDEIEDIQQEITVLSQCDSPYITR 66
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQ-DMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG 161
++ K K+++IMEY GG D+L P ++ I ++L GL+YLHS+
Sbjct: 67 YYGSYL--KGTKLWIIMEYLGGGSALDLLKPGPLEETYIATI---LREILKGLDYLHSER 121
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESL-DMFLHDDTITTSQGSPVFQAPEIANGLPE 220
IH+DIK N+LL+ G +K++DFGVA L D + +T G+P + APE+
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPEVIK--QS 176
Query: 221 ISGYKVDIWSSGVT 234
+K DIWS G+T
Sbjct: 177 AYDFKADIWSLGIT 190
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-19
Identities = 62/208 (29%), Positives = 109/208 (52%), Gaps = 18/208 (8%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML- 95
G + + +++G G+YG+V + +T A+K+ + + E + EI +LK
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKV-----MDVTEDEEEEIKLEINMLKKYS 70
Query: 96 QHRNVIGLVDVFVND----KKQKMYLIMEYC-VGGLQDMLDSTPYKKFP-IWQAHGYFLQ 149
HRN+ F+ +++L+ME+C G + D++ +T W A+ +
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICRE 129
Query: 150 LLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF 209
+L GL +LH+ +IH+DIK N+LLT + +K+ DFGV+ LD + T G+P +
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYW 187
Query: 210 QAPEI--ANGLPEIS-GYKVDIWSSGVT 234
APE+ + P+ + Y+ DIWS G+T
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGIT 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 6e-19
Identities = 62/208 (29%), Positives = 109/208 (52%), Gaps = 18/208 (8%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML- 95
G + + +L+G G+YG+V + +T A+K+ + + E + +EI +LK
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV-----MDVTGDEEEEIKQEINMLKKYS 60
Query: 96 QHRNVIGLVDVFVNDK----KQKMYLIMEYC-VGGLQDMLDSTPYKKFPI-WQAHGYFLQ 149
HRN+ F+ +++L+ME+C G + D++ +T W A+ +
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICRE 119
Query: 150 LLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF 209
+L GL +LH +IH+DIK N+LLT + +K+ DFGV+ LD + T G+P +
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYW 177
Query: 210 QAPEI--ANGLPEIS-GYKVDIWSSGVT 234
APE+ + P+ + +K D+WS G+T
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGIT 205
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 7e-19
Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 23/205 (11%)
Query: 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVI 101
+ +G+G+YGKV ++L+ + + AVKI L I + + ++ E +LK L H NV+
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKI-----LDPIHDIDEEIEAEYNILKALSDHPNVV 78
Query: 102 GLVDVFVN-DKKQ--KMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFL-QLLD 152
++ D K +++L++E C GG ++ L + PI Y L + L
Sbjct: 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII---AYILHEALM 135
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAP 212
GL++LH IH+D+K N+LLT +G +K+ DFGV+ L TS G+P + AP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAP 193
Query: 213 EI---ANGLPEISGYKVDIWSSGVT 234
E+ L + D+WS G+T
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGIT 218
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 9e-19
Identities = 52/153 (33%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
Y D LGEGSY V + T A+K + + + P I RE LLK L+H
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI---REASLLKDLKHA 63
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG---YFLQLLDGLE 155
N++ L D+ K + L+ EY L+ +D H + QLL GL
Sbjct: 64 NIVTLHDIIHTKKT--LTLVFEYLDTDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLA 117
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188
Y H + ++H+D+KP NLL++ G LK++DFG+A
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 55/159 (34%), Positives = 84/159 (52%), Gaps = 26/159 (16%)
Query: 87 REIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGY 146
REI +L+ + H NV+ D+F D ++ +++E+ GG L+ T I
Sbjct: 121 REIEILRDVNHPNVVKCHDMF--DHNGEIQVLLEFMDGG---SLEGTH-----IADEQ-- 168
Query: 147 FL-----QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT 201
FL Q+L G+ YLH + I+H+DIKP NLL+ +KI+DFGV+ L + D
Sbjct: 169 FLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCN 226
Query: 202 TSQGSPVFQAPEIAN-----GLPEISGYKVDIWSSGVTL 235
+S G+ + +PE N G + GY DIWS GV++
Sbjct: 227 SSVGTIAYMSPERINTDLNHGAYD--GYAGDIWSLGVSI 263
|
Length = 353 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-18
Identities = 66/193 (34%), Positives = 102/193 (52%), Gaps = 9/193 (4%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIG 102
+LG+GS+GKV T A+K KK + + E + E R+L + +H +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTM-VEKRVLSLAWEHPFLTH 60
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
L F K+ ++ +MEY GG M KF + +A Y +++ GL++LHS+GI
Sbjct: 61 LYCTF--QTKENLFFVMEYLNGG-DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS 222
+++D+K N+LL DG +KI+DFG+ + + L D T G+P + APEI G +
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLG--QKY 173
Query: 223 GYKVDIWSSGVTL 235
VD WS GV L
Sbjct: 174 NTSVDWWSFGVLL 186
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 1e-18
Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNG--EINVDREIRL 91
K++GK +GEG++ +V + R+ K + K +++ ++N REI+
Sbjct: 2 KILGK------IGEGTFSEVLKAQ-----SRKTGKYYAIKCMKKHFKSLEQVNNLREIQA 50
Query: 92 LKMLQ-HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDM--LDSTPYKKFPIWQAH--GY 146
L+ L H N++ L++V + K ++ L+ E L DM + +K P+ + Y
Sbjct: 51 LRRLSPHPNILRLIEVLFDRKTGRLALVFE-----LMDMNLYELIKGRKRPLPEKRVKSY 105
Query: 147 FLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL-HDDTITTSQG 205
QLL L+++H GI H+DIKP N+L+ D LK++DFG + + + I+T
Sbjct: 106 MYQLLKSLDHMHRNGIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEYISTRW- 163
Query: 206 SPVFQAPE--IANGLPEISGYKVDIWSSG 232
++APE + +G G K+DIW+ G
Sbjct: 164 ---YRAPECLLTDGY---YGPKMDIWAVG 186
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-18
Identities = 59/176 (33%), Positives = 84/176 (47%), Gaps = 23/176 (13%)
Query: 66 AVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR--NVIGLVDVFVNDKKQKMYLIMEYCV 123
A+K+ KK + N NV E ++ M+Q V L F K +YL+MEY
Sbjct: 25 AIKVLKKSDMIAK-NQVTNVKAERAIM-MIQGESPYVAKLYYSF--QSKDYLYLVMEYLN 80
Query: 124 GG----LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT 179
GG L L P W A Y +++ G+E LH +GIIH+DIKP NLL+ G
Sbjct: 81 GGDCASLIKTLGGLPED----W-AKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH 135
Query: 180 LKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
LK++DFG++ L + G+P + APE G+ + D WS G +
Sbjct: 136 LKLTDFGLSR---NGLENKKFV---GTPDYLAPETILGVGDDK--MSDWWSLGCVI 183
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-18
Identities = 64/204 (31%), Positives = 92/204 (45%), Gaps = 26/204 (12%)
Query: 45 LGEGSYGKVK----EMLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLLKMLQHR 98
LGEG +GKV+ + L T + AVK L + D REI +L+ L H
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVK-----SLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYC-VGGLQDMLDSTPYKKFPIWQAHG----YFLQLLDG 153
N++ V + + LIMEY G L+D L + + Q+ G
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-----INLKRLLLFSSQICKG 121
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF-QAP 212
++YL SQ IH+D+ N+L+ + +KISDFG+A+ L + SP+F AP
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 213 EIANGLPE-ISGYKVDIWSSGVTL 235
E L D+WS GVTL
Sbjct: 182 E---CLRTSKFSSASDVWSFGVTL 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-18
Identities = 63/211 (29%), Positives = 110/211 (52%), Gaps = 31/211 (14%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVK-IFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIG 102
L+ G+YG V + ET R A+K I K+ + R ++ V+R+I L ++ V+
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI--LTFAENPFVVS 65
Query: 103 LVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
+ F + K+ + ++MEY GG L+++ P+ A YF + + LEYL
Sbjct: 66 MFCSF--ETKRHLCMVMEYVEGGDCATLLKNI------GALPVDMARMYFAETVLALEYL 117
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE------SLDMFLHDDTITTSQ------- 204
H+ GI+H+D+KP NLL+T G +K++DFG+++ + +++ T +
Sbjct: 118 HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 205 GSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
G+P + APE+ L + G VD W+ G+ L
Sbjct: 178 GTPEYIAPEVI--LRQGYGKPVDWWAMGIIL 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-18
Identities = 64/196 (32%), Positives = 102/196 (52%), Gaps = 15/196 (7%)
Query: 44 LLGEGSYGKV---KEMLDSETLCRRAVKIFKKKK-LQRIPNGEINVDREIRLLKMLQHRN 99
++G+GS+GKV K LD + AVK+ +KK L R I +R + LLK ++H
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCY---AVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPF 57
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159
++GL F +K+Y ++++ GG + + FP +A Y ++ L YLHS
Sbjct: 58 LVGLHYSF--QTTEKLYFVLDFVNGG-ELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLP 219
I+++D+KP N+LL G + ++DFG+ + + DT TT G+P + APE+ P
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 220 EISGYKVDIWSSGVTL 235
VD W G L
Sbjct: 173 --YDNTVDWWCLGAVL 186
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-18
Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 53/234 (22%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRR-------AVKIFKKKKLQRIPNGEINVDREIRL 91
+ + ++G G++G+V L R A+K+ +K + I +I R R
Sbjct: 3 FEVIKVIGRGAFGEVW-------LVRDKDTGQVYAMKVLRKSDM--IKRNQIAHVRAERD 53
Query: 92 LKMLQHRN--VIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFL 148
+ + + ++ L F +++ +YL+MEY GG D+++ FP A Y
Sbjct: 54 I-LADADSPWIVKLYYSFQDEEH--LYLVMEYMPGG--DLMNLLIRKDVFPEETARFYIA 108
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL-----DMFLHDDTITTS 203
+L+ L+ +H G IH+DIKP N+L+ DG +K++DFG+ + + + +D+
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 204 Q----------------------GSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
G+P + APE+ G P G + D WS GV L
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP--YGLECDWWSLGVIL 220
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-18
Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 25/200 (12%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKK-LQRIPNGEINVDREIRLLKMLQHRNVIGL 103
+G+GS+GKV AVK+ +KK L++ I +R + LLK ++H ++GL
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGL 61
Query: 104 VDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
F K+Y +++Y GG LQ + FP +A Y ++ L YLH
Sbjct: 62 HYSFQT--ADKLYFVLDYVNGGELFFHLQRE------RSFPEPRARFYAAEIASALGYLH 113
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTITTSQGSPVFQAPEIANG 217
S II++D+KP N+LL G + ++DFG+ E ++ H T +T G+P + APE+
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE---HSKTTSTFCGTPEYLAPEVLRK 170
Query: 218 LPEISGY--KVDIWSSGVTL 235
P Y VD W G L
Sbjct: 171 QP----YDRTVDWWCLGAVL 186
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-18
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LG GS G V +DS+ C + V + KK + P + REI++++ L H N++ +
Sbjct: 13 LGCGSNGLVFSAVDSD--CDKRVAV--KKIVLTDPQSVKHALREIKIIRRLDHDNIVKVY 68
Query: 105 DVFVNDKKQ------------KMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLD 152
+V +Y++ EY L ++L+ P A + QLL
Sbjct: 69 EVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP---LSEEHARLFMYQLLR 125
Query: 153 GLEYLHSQGIIHKDIKPGNLLL-TLDGTLKISDFGVAESLDM-FLHDDTITTSQGSPVFQ 210
GL+Y+HS ++H+D+KP N+ + T D LKI DFG+A +D + H ++ + ++
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 211 APEIANGLPEISGYK--VDIWSSGVTL 235
+P + L + Y +D+W++G
Sbjct: 186 SPRL---LLSPNNYTKAIDMWAAGCIF 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 3e-18
Identities = 60/188 (31%), Positives = 96/188 (51%), Gaps = 9/188 (4%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LGEGSY V + A+K+ + ++ + P I RE LLK L+H N++ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI---REASLLKGLKHANIVLLH 69
Query: 105 DVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIH 164
D+ K+ + L+ EY L +D P P + QLL GL Y+H + I+H
Sbjct: 70 DII--HTKETLTLVFEYVHTDLCQYMDKHPGGLHPE-NVKLFLFQLLRGLSYIHQRYILH 126
Query: 165 KDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGY 224
+D+KP NLL++ G LK++DFG+A + + H T + + ++ P++ G E S
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 225 KVDIWSSG 232
+D+W G
Sbjct: 185 -LDMWGVG 191
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-18
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 45 LGEGSYGKVKEMLDSETLCR------RAVKIFKKKKLQRIPNGE--INVDREIRLLKMLQ 96
LGEG +GKV+ LCR + K L+ G ++ +EI +L+ L
Sbjct: 12 LGEGHFGKVE-------LCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYC-VGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H N++ + D + LIME+ G L++ L K + Q Y +Q+ G++
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMD 123
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF-QAPEI 214
YL S+ +H+D+ N+L+ + +KI DFG+ ++++ T+ SPVF APE
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 215 ANGLPEISGYKV-DIWSSGVTL 235
L + Y D+WS GVTL
Sbjct: 184 ---LIQSKFYIASDVWSFGVTL 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-18
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
YV D LGEG+Y V + T A+K + + + P I RE+ LLK L+H
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI---REVSLLKNLKHA 63
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
N++ L D+ ++ + L+ EY L+ LD+ + + QLL GL Y H
Sbjct: 64 NIVTLHDIIHTERC--LTLVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH 120
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGV--AESLDMFLHDDTITTSQGSPVFQAPEIAN 216
+ I+H+D+KP NLL+ G LK++DFG+ A+S+ + + + T P P++
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRP----PDVLL 176
Query: 217 GLPEISGYKVDIWSSGVTL 235
G E S +D+W G L
Sbjct: 177 GSTEYST-PIDMWGVGCIL 194
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 9e-18
Identities = 62/190 (32%), Positives = 100/190 (52%), Gaps = 14/190 (7%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
+GEGS G V + AVK +K QR E+ + E+ +++ QH NV+ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR---RELLFN-EVVIMRDYQHENVVEMY 83
Query: 105 DVF-VNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
+ + V D+ ++++ME+ GG + D + + Q L +L L LH+QG+I
Sbjct: 84 NSYLVGDE---LWVVMEFLEGGA--LTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVI 138
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISG 223
H+DIK ++LLT DG +K+SDFG + + G+P + APE+ + LP G
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPELISRLP--YG 194
Query: 224 YKVDIWSSGV 233
+VDIWS G+
Sbjct: 195 PEVDIWSLGI 204
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-17
Identities = 60/192 (31%), Positives = 104/192 (54%), Gaps = 15/192 (7%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGL 103
+G G++G+V + D + A+K+ ++ R+ + +V E R+LK + H +I L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ-HVHNEKRVLKEVSHPFIIRL 66
Query: 104 VDVFVNDKKQK-MYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG 161
F + Q+ +Y++MEY GG L L ++ +F Y +++ LEYLHS+
Sbjct: 67 ---FWTEHDQRFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKE 121
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEI 221
I+++D+KP N+LL +G +K++DFG A+ L D T T G+P + APE+ +
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKK----LRDRTWTLC-GTPEYLAPEVIQS--KG 174
Query: 222 SGYKVDIWSSGV 233
VD W+ G+
Sbjct: 175 HNKAVDWWALGI 186
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-17
Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 17/197 (8%)
Query: 44 LLGEGSYGKV---KEMLDSETLCRRAVKIFKKKK-LQRIPNGEINVDREIRLLKMLQHRN 99
++G+GS+GKV K D AVK+ +KK L++ I +R + LLK L+H
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFY---AVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPF 57
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159
++GL F +K+Y +++Y GG + + F +A Y ++ + YLHS
Sbjct: 58 LVGLHYSF--QTAEKLYFVLDYVNGG-ELFFHLQRERCFLEPRARFYAAEVASAIGYLHS 114
Query: 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTITTSQGSPVFQAPEIANGL 218
II++D+KP N+LL G + ++DFG+ E ++ ++T +T G+P + APE+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE---PEETTSTFCGTPEYLAPEVLRKE 171
Query: 219 PEISGYKVDIWSSGVTL 235
P VD W G L
Sbjct: 172 P--YDRTVDWWCLGAVL 186
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-17
Identities = 64/202 (31%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-----VDREIRLLKMLQ 96
G LG G++ + D +T AVK + R + E + +EIRL+ L
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVK---QVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
H ++I ++ D +++ E+ GG L S Y F Y QLL GL Y
Sbjct: 62 HPHIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSY 118
Query: 157 LHSQGIIHKDIKPGNLLLTLDGT-LKISDFGVAESLDMFLHDDTITTSQ--GSPVFQAPE 213
LH IIH+D+K NLL+ G L+I+DFG A L Q G+ F APE
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 214 IANGLPEISGYKVDIWSSGVTL 235
+ G E G D+WS G +
Sbjct: 179 VLRG--EQYGRSCDVWSVGCVI 198
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-17
Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
Y+ D LGEG+Y V + T A+K + + + P I RE+ LLK L+H
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI---REVSLLKDLKHA 64
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
N++ L D+ +K + L+ EY L+ LD + + QLL GL Y H
Sbjct: 65 NIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCH 121
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGV--AESLDMFLHDDTITTSQGSPVFQAPEIAN 216
+ ++H+D+KP NLL+ G LK++DFG+ A+S+ + + + T P P+I
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRP----PDILL 177
Query: 217 GLPEISGYKVDIWSSG 232
G + S ++D+W G
Sbjct: 178 GSTDYST-QIDMWGVG 192
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-17
Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 13/195 (6%)
Query: 44 LLGEGSYGKV--KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN-V 100
+LG+GS+GKV E ++ L A+KI KK + + + E + E R+L + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDEL--YAIKILKKDVIIQDDDVECTM-VEKRVLALPGKPPFL 63
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ 160
L F ++Y +MEY GG M KF A Y ++ GL +LHS+
Sbjct: 64 TQLHSCF--QTMDRLYFVMEYVNGG-DLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPE 220
GII++D+K N++L +G +KI+DFG+ + ++F T T G+P + APEI P
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIF-GGKTTRTFCGTPDYIAPEIIAYQP- 177
Query: 221 ISGYKVDIWSSGVTL 235
G VD W+ GV L
Sbjct: 178 -YGKSVDWWAFGVLL 191
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-17
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 36/205 (17%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
+G+GS+GKV ++ +T A+K +K + + E+ L R V+ V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI--VSRSEVT--------HTLAERTVLAQV 50
Query: 105 DV-------FVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLLD 152
+ F +K+YL++ + GG LQ +F + +A Y +LL
Sbjct: 51 NCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE------GRFDLSRARFYTAELLC 104
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAP 212
LE LH +I++D+KP N+LL G + + DFG+ + L+M DD T G+P + AP
Sbjct: 105 ALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCK-LNM-KDDDKTNTFCGTPEYLAP 162
Query: 213 EIANGLPEISGYK--VDIWSSGVTL 235
E+ G GY VD W+ GV L
Sbjct: 163 ELLLGH----GYTKAVDWWTLGVLL 183
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-17
Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 42/208 (20%)
Query: 44 LLGEGSYGKV---KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV 100
+LG+G YGKV +++ ++T A+K+ KK + R + E +L+ ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGG------------LQDMLDSTPYKKFPIWQAHGYFL 148
+ L+ F K +YLI+EY GG ++D A Y
Sbjct: 63 VDLIYAFQTGGK--LYLILEYLSGGELFMHLEREGIFMEDT-------------ACFYLS 107
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTIT-TSQGS 206
++ LE+LH QGII++D+KP N+LL G +K++DFG+ ES +H+ T+T T G+
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKES----IHEGTVTHTFCGT 163
Query: 207 PVFQAPEIANGLPEISGY--KVDIWSSG 232
+ APEI SG+ VD WS G
Sbjct: 164 IEYMAPEILMR----SGHGKAVDWWSLG 187
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 3e-17
Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKK------KLQRIPNGEINVDREIRLLKMLQH 97
LLG+G G+V + T A+K+ KK K++R V E +L L H
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKR-------VLTEQEILATLDH 60
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
+ L F + + L+M+YC GG L +L P K A Y ++L LEY
Sbjct: 61 PFLPTLYASFQTETY--LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD----------------MFLHDDTI 200
LH GI+++D+KP N+LL G + +SDF +++ D ++
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 201 TTSQGSPVFQ-----------APEIANGLPEISGYKVDIWSSGVTL 235
T P F+ APE+ +G S VD W+ G+ L
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA--VDWWTLGILL 222
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-17
Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VDREIRLLKMLQHRNVIG 102
+LG+GS+GKV T A+K KK + + E V+R + L +H +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTH 60
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
L F K+ ++ +MEY GG M +F +A Y +++ GL++LH +GI
Sbjct: 61 LFCTF--QTKEHLFFVMEYLNGG-DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS 222
I++D+K N+LL DG +KI+DFG+ + +M + +T G+P + APEI G +
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNG-EGKASTFCGTPDYIAPEILKG--QKY 173
Query: 223 GYKVDIWSSGVTL 235
VD WS GV L
Sbjct: 174 NESVDWWSFGVLL 186
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-17
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
Y+ + LGEG+Y V + T A+K + + + P I RE+ LLK L+H
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI---REVSLLKDLKHA 64
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
N++ L D+ DK + L+ EY L+ +D + + Q+L GL Y H
Sbjct: 65 NIVTLHDIVHTDKS--LTLVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH 121
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGV--AESLDMFLHDDTITTSQGSPVFQAPEIAN 216
+ ++H+D+KP NLL+ G LK++DFG+ A+S+ + + + T P P++
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP----PDVLL 177
Query: 217 GLPEISGYKVDIWSSG 232
G E S ++D+W G
Sbjct: 178 GSSEYST-QIDMWGVG 192
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-17
Identities = 60/192 (31%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LG+G +G+V T A K KK+L++ GE E ++L+ + R ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-RKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 105 DVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
F + K + L+M GG L+ + + FP +A Y Q++ GLE+LH + I+
Sbjct: 60 YAF--ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISG 223
++D+KP N+LL G ++ISD G+A I G+P + APE+ G E+
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVE---LKGGKKIKGRAGTPGYMAPEVLQG--EVYD 172
Query: 224 YKVDIWSSGVTL 235
+ VD ++ G TL
Sbjct: 173 FSVDWFALGCTL 184
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 7e-17
Identities = 55/192 (28%), Positives = 99/192 (51%), Gaps = 19/192 (9%)
Query: 45 LGEGSYGKV--KEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VDREIRLLKMLQHRNVI 101
+G+G YG+V + D+ + A+K KK L ++ E+ V E +L + ++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIV--ALKRMKKSLLFKL--NEVRHVLTERDILTTTKSEWLV 64
Query: 102 GLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ 160
L+ F +D + +YL MEY GG + +L++ A Y ++ + ++ LH
Sbjct: 65 KLLYAFQDD--EYLYLAMEYVPGGDFRTLLNNLGVLSED--HARFYMAEMFEAVDALHEL 120
Query: 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPE 220
G IH+D+KP N L+ G +K++DFG+++ + + + + GSP + APE+ G +
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN-----SVVGSPDYMAPEVLRG--K 173
Query: 221 ISGYKVDIWSSG 232
+ VD WS G
Sbjct: 174 GYDFTVDYWSLG 185
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 7e-17
Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 33/216 (15%)
Query: 39 YVMGDLLGEGSYG---KVKEMLDSETLCRRAVK-------IFKKKKLQRIPNGEINVDRE 88
Y + + LG G++G KV++ + + L A+K F K K +R + ++ E
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLL--ALKEINVHNPAFGKDKRERDKSIG-DIVSE 58
Query: 89 IRLLK-MLQHRNVIGLVDVFV-NDKKQKMYLIMEYCVGG-LQDMLDSTPYKK--FP---I 140
+ ++K L+H N++ F+ ND+ +Y++M+ G L + +S KK F I
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDR---LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI 115
Query: 141 WQAHGYFLQLLDGLEYLHSQG-IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT 199
W F+Q++ L YLH + I+H+D+ P N++L D + I+DFG+A+ +
Sbjct: 116 WNI---FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ---PESK 169
Query: 200 ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+T+ G+ ++ PEI P G K D+W+ G L
Sbjct: 170 LTSVVGTILYSCPEIVKNEP--YGEKADVWAFGCIL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-17
Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 32/211 (15%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI---PNGEINVDREIRLLKM 94
+Y + +++G+GSYG V +D+ T + A+K K+ + + + REI+LL++
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK-----KINDVFEHVSDATRILREIKLLRL 55
Query: 95 LQHRNVIGLVDVFVNDKK---QKMYLIMEYCVGGLQDML----DSTPYKKFPIWQAHGYF 147
L+H +++ + + + + + +Y++ E L ++ D TP + H +F
Sbjct: 56 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTP-------EHHQFF 108
Query: 148 L-QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI---TTS 203
L QLL L+Y+H+ + H+D+KP N+L D LKI DFG+A F T T
Sbjct: 109 LYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--AFNDTPTAIFWTDY 166
Query: 204 QGSPVFQAPEIANGLPEISGYK--VDIWSSG 232
+ ++APE+ S Y +DIWS G
Sbjct: 167 VATRWYRAPELCGSF--FSKYTPAIDIWSIG 195
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-16
Identities = 46/125 (36%), Positives = 78/125 (62%), Gaps = 7/125 (5%)
Query: 112 KQKMYLIMEYCVGGLQDMLDSTPYK-KFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPG 170
K+ ++ +ME+ GG D++ K +F +++A Y +++ GL++LHS+GII++D+K
Sbjct: 68 KEHLFFVMEFLNGG--DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLD 125
Query: 171 NLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWS 230
N++L DG +KI+DFG+ + + D+ +T G+P + APEI GL + VD WS
Sbjct: 126 NVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLK--YTFSVDWWS 181
Query: 231 SGVTL 235
GV L
Sbjct: 182 FGVLL 186
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-16
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 45 LGEGSYGKVKE---MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVI 101
+G G + +V +LD + + V+IF + + +EI LLK L H NVI
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK----ARADCIKEIDLLKQLNHPNVI 65
Query: 102 GLVDVFVNDKKQKMYLIMEYC-VGGLQDMLDSTPYKK--FPIWQAHGYFLQLLDGLEYLH 158
F+ D ++ +++E G L M+ +K P YF+QL LE++H
Sbjct: 66 KYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--GSPVFQAPEI-- 214
S+ ++H+DIKP N+ +T G +K+ D G L F T G+P + +PE
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLG----LGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 215 ANGLPEISGYKVDIWSSGVTL 235
NG +K DIWS G L
Sbjct: 180 ENGY----NFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-16
Identities = 66/198 (33%), Positives = 100/198 (50%), Gaps = 18/198 (9%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LG+G +G+V T A K KK+L++ G E R+L + R ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK-RKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 105 DVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159
F K + L+M GG + ++ + P FP +A Y Q++ GLE+LH
Sbjct: 60 YAF--QTKTDLCLVMTIMNGGDLRYHIYNVDEENP--GFPEPRACFYTAQIISGLEHLHQ 115
Query: 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS--QGSPVFQAPEIANG 217
+ II++D+KP N+LL DG ++ISD G+A + L D T G+P F APE+ G
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLA----VELKDGQSKTKGYAGTPGFMAPELLQG 171
Query: 218 LPEISGYKVDIWSSGVTL 235
E + VD ++ GVTL
Sbjct: 172 --EEYDFSVDYFALGVTL 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-16
Identities = 60/193 (31%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI-NVDREIRLLKMLQHRNVIG 102
LLG+G++GKV + + T A+KI +K+ + I E+ + E R+L+ +H +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
L F ++ +MEY GG + + + F +A Y +++ LEYLHS+ +
Sbjct: 60 LKYAF--QTHDRLCFVMEYANGG-ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 116
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS 222
+++DIK NL+L DG +KI+DFG+ + + T+ T G+P + APE+
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED--NDY 172
Query: 223 GYKVDIWSSGVTL 235
G VD W GV +
Sbjct: 173 GRAVDWWGLGVVM 185
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-16
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 26/199 (13%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLLKMLQHRNVI 101
LG G +G+V + T + AVK K G ++ + +E +++K L+H ++
Sbjct: 14 LGAGQFGEVWMGTWNGTT-KVAVKTLKP--------GTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 102 GLVDVFVNDKKQKMYLIMEY-CVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ 160
L V +++ +Y++ EY G L D L S KK + Q Q+ +G+ YL S+
Sbjct: 65 QLYAVC--SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQAPEIAN- 216
IH+D+ N+L+ + KI+DFG+A + DD T +G+ P+ + APE AN
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLAR----LIEDDEYTAREGAKFPIKWTAPEAANY 178
Query: 217 GLPEISGYKVDIWSSGVTL 235
G I K D+WS G+ L
Sbjct: 179 GRFTI---KSDVWSFGILL 194
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-16
Identities = 60/191 (31%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM-LQHRNVIG 102
+LG+GS+GKV T A+K+ KK + + + + + E R+L + +H +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMT-EKRILALAAKHPFLTA 60
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
L F K +++ +MEY GG M +KF ++ Y ++ L +LH G+
Sbjct: 61 LHCCF--QTKDRLFFVMEYVNGG-DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGV 117
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS 222
I++D+K N+LL +G K++DFG+ + + L+ T TT G+P + APEI L
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELE--Y 173
Query: 223 GYKVDIWSSGV 233
G VD W+ GV
Sbjct: 174 GPSVDWWALGV 184
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-16
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI-NVDREIRLLKMLQHRNVIG 102
LG+G++G V E+ + L ++ KKLQ + + +REI +LK LQH N++
Sbjct: 11 QLGKGNFGSV-ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 103 LVDVFVNDKKQKMYLIMEYC-VGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG 161
V + ++ + L+MEY G L+D L + Y Q+ G+EYL S+
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL-YASQICKGMEYLGSKR 128
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF-QAPEIANGLPE 220
+H+D+ N+L+ + +KI DFG+ + L + SP+F APE L E
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE---SLTE 185
Query: 221 ISGYKV--DIWSSGVTL 235
S + V D+WS GV L
Sbjct: 186 -SKFSVASDVWSFGVVL 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-16
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 25/206 (12%)
Query: 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVI 101
+ +G+G+YGKV ++ + + AVKI L I + + ++ E +L+ L H NV+
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKI-----LDPISDVDEEIEAEYNILQSLPNHPNVV 82
Query: 102 GLVDVFVNDKK---QKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFL-QLLD 152
+F K +++L++E C GG ++ +L + Y L L
Sbjct: 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI---SYILYGALL 139
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL-DMFLHDDTITTSQGSPVFQA 211
GL++LH+ IIH+D+K N+LLT +G +K+ DFGV+ L L + TS G+P + A
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN---TSVGTPFWMA 196
Query: 212 PE-IANGLPEISGY--KVDIWSSGVT 234
PE IA Y + D+WS G+T
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGIT 222
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-16
Identities = 59/193 (30%), Positives = 99/193 (51%), Gaps = 9/193 (4%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKK-LQRIPNGEINVDREIRLLKMLQHRNVIG 102
++G+GS+GKV AVK+ +KK L++ I +R + LLK ++H ++G
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVG 60
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
L F K+Y +++Y GG + + F +A Y ++ L YLHS I
Sbjct: 61 LHFSF--QTADKLYFVLDYINGG-ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 117
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS 222
+++D+KP N+LL G + ++DFG+ + + H+ T +T G+P + APE+ + P
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP--Y 173
Query: 223 GYKVDIWSSGVTL 235
VD W G L
Sbjct: 174 DRTVDWWCLGAVL 186
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-15
Identities = 50/183 (27%), Positives = 85/183 (46%), Gaps = 26/183 (14%)
Query: 66 AVKIFK-----KKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIME 120
AVK K+ L+ + EI + LQH N++ V F+ D ++Y++
Sbjct: 29 AVKKINLDSCSKEDLKLLQQ-------EIITSRQLQHPNILPYVTSFIVD--SELYVVSP 79
Query: 121 Y-CVGGLQDMLDSTPYKKFPIWQAHGYFLQ-LLDGLEYLHSQGIIHKDIKPGNLLLTLDG 178
G +D+L + + P A + L+ +L+ L+Y+HS+G IH+ +K ++LL+ DG
Sbjct: 80 LMAYGSCEDLLKTHFPEGLP-ELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG 138
Query: 179 TLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEI-----SGY--KVDIWSS 231
+ +S G+ S+ M H P + PE+ GY K DI+S
Sbjct: 139 KVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV 196
Query: 232 GVT 234
G+T
Sbjct: 197 GIT 199
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-15
Identities = 59/193 (30%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI-NVDREIRLLKMLQHRNVIG 102
LLG+G++GKV + + T A+KI KK+ + I E+ + E R+L+ +H +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
L F ++ +MEY GG + + + F +A Y +++ L YLHS +
Sbjct: 60 LKYSF--QTHDRLCFVMEYANGG-ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS 222
+++D+K NL+L DG +KI+DFG+ + + T+ T G+P + APE+
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED--NDY 172
Query: 223 GYKVDIWSSGVTL 235
G VD W GV +
Sbjct: 173 GRAVDWWGLGVVM 185
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-15
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 36/207 (17%)
Query: 43 DLLGEGSYGKV-KEMLDSETL-----CRRA-VKIFKKKKLQRIPNGEINVDREIRLLKML 95
+ +G+G++G V K +L T CR K+K LQ E +LK
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQ-----------EAEILKQY 49
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD--STPYKKFPIWQAHGYFLQLLDG 153
H N++ L+ V V +KQ +Y++ME GG +L + + + L G
Sbjct: 50 DHPNIVKLIGVCV--QKQPIYIVMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDAAAG 105
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS----PV- 208
+EYL S+ IH+D+ N L+ + LKISDFG++ + I T P+
Sbjct: 106 MEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRE-----EEGGIYTVSDGLKQIPIK 160
Query: 209 FQAPEIANGLPEISGYKVDIWSSGVTL 235
+ APE N S + D+WS G+ L
Sbjct: 161 WTAPEALNYGRYTS--ESDVWSYGILL 185
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-15
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 29/206 (14%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLLKMLQHRNVIG 102
+G G+YG V + R+ K K+ L++I I++ REI LL+ L+H NVI
Sbjct: 9 VGRGTYGHVYKAK------RKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA 62
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLD----STPYKK---FPIWQAHGYFLQLLDGLE 155
L VF++ +K++L+ +Y L ++ S KK P Q+LDG+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGT----LKISDFGVAESLDMFLH-----DDTITTSQGS 206
YLH+ ++H+D+KP N+L+ +G +KI+D G A + L D + T
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW-- 180
Query: 207 PVFQAPEIANGLPEISGYKVDIWSSG 232
++APE+ G + +DIW+ G
Sbjct: 181 --YRAPELLLGARHYTK-AIDIWAIG 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 60/203 (29%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
Y +G+++G GS+G V E + +T + A+K K+ + P + +RE+ ++K L H
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIK-----KVLQDPQYK---NRELLIMKNLNHI 119
Query: 99 NVIGLVDVFV------NDKKQKMYLIMEYCVGGLQDMLD--STPYKKFPIWQAHGYFLQL 150
N+I L D + N+K + ++ME+ + + + P++ Y QL
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDG-TLKISDFGVAESLDMFLHDDTITTSQGSPVF 209
L Y+HS+ I H+D+KP NLL+ + TLK+ DFG A++L L + S +
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL---LAGQRSVSYICSRFY 236
Query: 210 QAPEIANGLPEISGYKVDIWSSG 232
+APE+ G + + +D+WS G
Sbjct: 237 RAPELMLGATNYTTH-IDLWSLG 258
|
Length = 440 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-15
Identities = 58/194 (29%), Positives = 93/194 (47%), Gaps = 16/194 (8%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LG G +G+V E L + R A+KI K L + + +E++ LK L+H+++I L
Sbjct: 14 LGSGYFGEVWEGLWKNRV-RVAIKILKSDDLLKQQD----FQKEVQALKRLRHKHLISLF 68
Query: 105 DVFVNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
V + +Y+I E G L L S + P+ Q+ +G+ YL Q I
Sbjct: 69 AVCSVG--EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSI 126
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS-PV-FQAPEIANGLPEI 221
H+D+ N+L+ D K++DFG+A + +D +S P + APE A+
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLAR----LIKEDVYLSSDKKIPYKWTAPEAAS--HGT 180
Query: 222 SGYKVDIWSSGVTL 235
K D+WS G+ L
Sbjct: 181 FSTKSDVWSFGILL 194
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-15
Identities = 59/193 (30%), Positives = 99/193 (51%), Gaps = 9/193 (4%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIG 102
+LG+GS+GKV E+ AVK+ KK + + + E + E R+L + H +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMT-EKRILSLARNHPFLTQ 60
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
L F +++ +ME+ GG M ++F +A Y ++ L +LH +GI
Sbjct: 61 LYCCF--QTPDRLFFVMEFVNGG-DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGI 117
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS 222
I++D+K N+LL +G K++DFG+ + + + T +T G+P + APEI +
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQ--EMLY 173
Query: 223 GYKVDIWSSGVTL 235
G VD W+ GV L
Sbjct: 174 GPSVDWWAMGVLL 186
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-15
Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 23/200 (11%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH------ 97
++G GSY KV + + A+K+ KK+ ++ D +I ++ +H
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL--------VHDDEDIDWVQTEKHVFEQAS 53
Query: 98 --RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
++GL F +++L++EY GG M +K P A Y ++ L
Sbjct: 54 SNPFLVGLHSCF--QTTSRLFLVIEYVNGG-DLMFHMQRQRKLPEEHARFYAAEICIALN 110
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
+LH +GII++D+K N+LL DG +K++D+G+ + + DT +T G+P + APEI
Sbjct: 111 FLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 216 NGLPEISGYKVDIWSSGVTL 235
G E G+ VD W+ GV +
Sbjct: 169 RG--EEYGFSVDWWALGVLM 186
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 3e-15
Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 48/223 (21%)
Query: 45 LGEGSYGKV---KEMLDSETLCRRAVK---IFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+G G +G+V K E C +A+ + +++K Q + E+NV RE L+H+
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI--EVNVMRE------LKHK 72
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYF---LQLLDGLE 155
N++ +D F+N QK+Y++ME+C G YK F + H QLL L
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 156 YLHS-------QGIIHKDIKPGNLLLT---------------LDG--TLKISDFGVAESL 191
Y H+ + ++H+D+KP N+ L+ L+G KI DFG+++++
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGY--KVDIWSSG 232
+ + + G+P + +PE+ L E Y K D+W+ G
Sbjct: 193 GI---ESMAHSCVGTPYYWSPELL--LHETKSYDDKSDMWALG 230
|
Length = 1021 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-15
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 23/200 (11%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH------ 97
++G GSY KV + +T A+K+ KK+ +N D +I ++ +H
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKEL--------VNDDEDIDWVQTEKHVFEQAS 53
Query: 98 --RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
++GL F + +++ ++EY GG M +K P A Y ++ L
Sbjct: 54 NHPFLVGLHSCF--QTESRLFFVIEYVNGG-DLMFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
YLH +GII++D+K N+LL +G +K++D+G+ + + DT +T G+P + APEI
Sbjct: 111 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 216 NGLPEISGYKVDIWSSGVTL 235
G E G+ VD W+ GV +
Sbjct: 169 RG--EDYGFSVDWWALGVLM 186
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-15
Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 20/197 (10%)
Query: 44 LLGEGSYGKV---KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV 100
+LG+GS+GKV +++ + A+K+ KK L+ ++R+I L + H +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDI--LAEVNHPFI 60
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKK---FPIWQAHGYFLQLLDGLEYL 157
+ L F + K+YLI+++ GG D+ T K F Y +L L++L
Sbjct: 61 VKLHYAF--QTEGKLYLILDFLRGG--DLF--TRLSKEVMFTEEDVKFYLAELALALDHL 114
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTITTSQGSPVFQAPEIAN 216
HS GII++D+KP N+LL +G +K++DFG++ ES+D H+ + G+ + APE+ N
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID---HEKKAYSFCGTVEYMAPEVVN 171
Query: 217 GLPEISGYKVDIWSSGV 233
D WS GV
Sbjct: 172 --RRGHTQSADWWSFGV 186
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-15
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 29/206 (14%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLLKMLQHRNVIG 102
+G G+YG V + R+ K + L++I I++ REI LL+ L+H NVI
Sbjct: 9 VGRGTYGHVYKAK------RKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVIS 62
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLD---STPYKKFPIWQAHGY----FLQLLDGLE 155
L VF++ +K++L+ +Y L ++ ++ K P+ G Q+LDG+
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGT----LKISDFGVAESLDMFLH-----DDTITTSQGS 206
YLH+ ++H+D+KP N+L+ +G +KI+D G A + L D + T
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW-- 180
Query: 207 PVFQAPEIANGLPEISGYKVDIWSSG 232
++APE+ G + +DIW+ G
Sbjct: 181 --YRAPELLLGARHYTK-AIDIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 6e-15
Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 88 EIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGY 146
E +++ L H N++ L V K++ ++++ EY G L + L K
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCT--KQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDM 105
Query: 147 FLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS 206
+ + +EYL S G IH+D+ N L+ D +K+SDFG+A ++ DD T+SQG+
Sbjct: 106 CSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR----YVLDDQYTSSQGT 161
Query: 207 --PVFQAPEIANGLPEISGY-----KVDIWSSGVTL 235
PV AP PE+ Y K D+WS GV +
Sbjct: 162 KFPVKWAP------PEVFDYSRFSSKSDVWSFGVLM 191
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-15
Identities = 60/190 (31%), Positives = 98/190 (51%), Gaps = 12/190 (6%)
Query: 45 LGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGL 103
LG GS+G+V +E A+K F+K K+ + + +V E ++L + H + L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD-HVFSERKILNYINHPFCVNL 96
Query: 104 VDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
F ++ +YL++E+ +GG + K+FP Y Q++ EYL S I+
Sbjct: 97 YGSFKDE--SYLYLVLEFVIGG-EFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISG 223
++D+KP NLLL DG +K++DFG A+ +D + T G+P + APEI L G
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY-----TLCGTPEYIAPEIL--LNVGHG 206
Query: 224 YKVDIWSSGV 233
D W+ G+
Sbjct: 207 KAADWWTLGI 216
|
Length = 340 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-15
Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 23/200 (11%)
Query: 44 LLGEGSYGKV--KEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VDREIRLLK-----ML 95
+LG+GS+GKV E ++ L A+KI KK + + + E V++ + L+ +
Sbjct: 7 VLGKGSFGKVMLAERKGTDEL--YAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
Q + VD ++Y +MEY GG M KF QA Y ++ GL
Sbjct: 65 QLHSCFQTVD--------RLYFVMEYVNGG-DLMYHIQQVGKFKEPQAVFYAAEISVGLF 115
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
+LH +GII++D+K N++L +G +KI+DFG+ + + + T T G+P + APEI
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEII 173
Query: 216 NGLPEISGYKVDIWSSGVTL 235
P G VD W+ GV L
Sbjct: 174 AYQP--YGKSVDWWAYGVLL 191
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-15
Identities = 67/201 (33%), Positives = 99/201 (49%), Gaps = 25/201 (12%)
Query: 43 DLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVI 101
+LLG+G++G+V K L +T AVK K+ Q + +I E R+LK H N++
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPV--AVKTCKEDLPQEL---KIKFLSEARILKQYDHPNIV 55
Query: 102 GLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKK--FPIWQAHGYFLQLLDGLEYLHS 159
L+ V ++Q +Y++ME GG D L KK Q + L G+ YL S
Sbjct: 56 KLIGVCT--QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES 111
Query: 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLP 219
+ IH+D+ N L+ + LKISDFG++ DD I +S G + Q P I P
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQ-----EDDGIYSSSG--LKQIP-IKWTAP 163
Query: 220 EISGY-----KVDIWSSGVTL 235
E Y + D+WS G+ L
Sbjct: 164 EALNYGRYSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-15
Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 14/202 (6%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKK-KKLQRIPNGEINVDREIRLLKMLQH 97
Y + ++G G++G+V+ + + A+K+ K + ++R + +R+I +
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDI--MAFANS 102
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
V+ L F +DK +Y++MEY GG D+++ P A Y +++ L+ +
Sbjct: 103 PWVVQLFCAFQDDKY--LYMVMEYMPGG--DLVNLMSNYDVPEKWAKFYTAEVVLALDAI 158
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM--FLHDDTITTSQGSPVFQAPEI- 214
HS G+IH+D+KP N+LL G LK++DFG +D + D T+ G+P + +PE+
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD---TAVGTPDYISPEVL 215
Query: 215 -ANGLPEISGYKVDIWSSGVTL 235
+ G G + D WS GV L
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFL 237
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-14
Identities = 59/200 (29%), Positives = 103/200 (51%), Gaps = 23/200 (11%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH-----R 98
++G GSY KV + +T A+K+ KK+ +N D +I ++ +H
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKEL--------VNDDEDIDWVQTEKHVFETAS 53
Query: 99 N---VIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
N ++GL F + +++ ++E+ GG M +K P A Y ++ L
Sbjct: 54 NHPFLVGLHSCF--QTESRLFFVIEFVSGG-DLMFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
+LH +GII++D+K N+LL +G +K++D+G+ + + DT +T G+P + APEI
Sbjct: 111 FLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 216 NGLPEISGYKVDIWSSGVTL 235
G E G+ VD W+ GV +
Sbjct: 169 RG--EDYGFSVDWWALGVLM 186
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-14
Identities = 60/193 (31%), Positives = 100/193 (51%), Gaps = 10/193 (5%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI-NVDREIRLLKMLQHRNVIG 102
LLG+G++GKV + + + A+KI KK+ + I E+ + E R+LK +H +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
L F K ++ +MEY GG + + + F + Y +++ L+YLHS I
Sbjct: 60 LKYSF--QTKDRLCFVMEYVNGG-ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS 222
+++D+K NL+L DG +KI+DFG+ + + T+ T G+P + APE+
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLED--NDY 172
Query: 223 GYKVDIWSSGVTL 235
G VD W GV +
Sbjct: 173 GRAVDWWGLGVVM 185
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-14
Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 38 KYVMGDLLGEGSYGKVKEM----LDSET---LCRRAVKIFKKKKLQRIPNGEINVDREIR 90
+ V+G LGEG +G+V LD E + + AVK+ K ++ + I+ E+
Sbjct: 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLIS---EME 75
Query: 91 LLKML-QHRNVIGLVDVFVNDKKQKMYLIMEYCV-GGLQDML--------------DSTP 134
++KM+ +H+N+I L+ D +Y+I+EY G L++ L P
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 135 YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194
++ Q+ G+EYL S+ IH+D+ N+L+T D +KI+DFG+A +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193
Query: 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ T + + APE I ++ D+WS GV L
Sbjct: 194 DYYKKTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-14
Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 28/203 (13%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN-----GEINVDREIRLLKMLQHRN 99
+G+G++G+V ++ +T A+K+ KK++ GE N+ + + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNI---LVRTLLDESPF 57
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
++GL F D +YL+ +Y GG LQ +F +A Y +L+ L
Sbjct: 58 IVGLKFSFQTD--SDLYLVTDYMSGGELFWHLQKE------GRFSEDRAKFYIAELVLAL 109
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEI 214
E+LH I+++D+KP N+LL G + + DFG++++ + T T G+ + APE+
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA--NLTDNKTTNTFCGTTEYLAPEV 167
Query: 215 ANGLPEISGY--KVDIWSSGVTL 235
L + GY VD WS GV +
Sbjct: 168 ---LLDEKGYTKHVDFWSLGVLV 187
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 61/215 (28%), Positives = 111/215 (51%), Gaps = 17/215 (7%)
Query: 28 NKTIKVKMIGK-YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKK-KKLQRIPNGEINV 85
NK ++M + Y + ++G G++G+V+ + T A+K+ K + ++R +
Sbjct: 33 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 86 DREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG 145
+R+I + V+ L F +D+ +Y++MEY GG D+++ P A
Sbjct: 93 ERDI--MAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGG--DLVNLMSNYDVPEKWARF 146
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT---T 202
Y +++ L+ +HS G IH+D+KP N+LL G LK++DFG M ++ + + T
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC----MKMNKEGMVRCDT 202
Query: 203 SQGSPVFQAPEI--ANGLPEISGYKVDIWSSGVTL 235
+ G+P + +PE+ + G G + D WS GV L
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-14
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 23/201 (11%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRR-AVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
K +G+++GEG +G V L E ++ AVK K + E V + L
Sbjct: 7 KLTLGEIIGEGEFGAV---LQGEYTGQKVAVKNIKCDVTAQAFLEETAV------MTKLH 57
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H+N++ L+ V ++ +Y++ME G L + L + + Q + L + +G+E
Sbjct: 58 HKNLVRLLGVILH---NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV-FQAPEI 214
YL S+ ++H+D+ N+L++ DG K+SDFG+A M + + + PV + APE
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL------PVKWTAPEA 168
Query: 215 ANGLPEISGYKVDIWSSGVTL 235
S K D+WS GV L
Sbjct: 169 LKHKKFSS--KSDVWSYGVLL 187
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-14
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 32/221 (14%)
Query: 38 KYVMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLL 92
+ +G LGEG++G+V + + AVK+ K ++ ++ E+ ++
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK---DLSDLVSEMEMM 69
Query: 93 KML-QHRNVIGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDST----PYKKFPIWQAHGY 146
KM+ +H+N+I L+ V + +Y+++EY G L+D L + Y +
Sbjct: 70 KMIGKHKNIINLLGVCTQEGP--LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 147 FLQLLD----------GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196
L D G+E+L S+ IH+D+ N+L+T D +KI+DFG+A D+
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHI 185
Query: 197 DDTITTSQGS-PV-FQAPEIANGLPEISGYKVDIWSSGVTL 235
D T+ G PV + APE + ++ D+WS GV L
Sbjct: 186 DYYRKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLL 224
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-14
Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 20/200 (10%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKK-KKLQRIPNGEINVDREIRLLKMLQHRN--- 99
++G G++G+V+ + + A+K+ K + ++R + +R+I + H N
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI-----MAHANSEW 104
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159
++ L F +DK +Y++MEY GG D+++ P A Y +++ L+ +HS
Sbjct: 105 IVQLHYAFQDDKY--LYMVMEYMPGG--DLVNLMSNYDIPEKWARFYTAEVVLALDAIHS 160
Query: 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM--FLHDDTITTSQGSPVFQAPEI--A 215
G IH+D+KP N+LL G LK++DFG +D + D T+ G+P + +PE+ +
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD---TAVGTPDYISPEVLKS 217
Query: 216 NGLPEISGYKVDIWSSGVTL 235
G G + D WS GV L
Sbjct: 218 QGGDGYYGRECDWWSVGVFL 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-13
Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 21/199 (10%)
Query: 40 VMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN 99
+G +G+G +G V + V + K L+ E ++ L+H N
Sbjct: 9 KLGATIGKGEFGDVML----GDYRGQKVAV---KCLKDDSTAAQAFLAEASVMTTLRHPN 61
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
++ L+ V + +Y++ EY G L D L S + Q G+ L + +G+EYL
Sbjct: 62 LVQLLGVVLQG--NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV-FQAPE-IAN 216
+ +H+D+ N+L++ D K+SDFG+A+ S PV + APE +
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ------DSGKLPVKWTAPEALRE 173
Query: 217 GLPEISGYKVDIWSSGVTL 235
K D+WS G+ L
Sbjct: 174 K---KFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-13
Identities = 47/153 (30%), Positives = 78/153 (50%), Gaps = 15/153 (9%)
Query: 88 EIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGY 146
E L+K LQH ++ L V ++ +Y+I EY G L D L + K I +
Sbjct: 51 EANLMKQLQHPRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDM 107
Query: 147 FLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS 206
Q+ +G+ ++ + IH+D++ N+L++ KI+DFG+A + D+ T +G+
Sbjct: 108 AAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR----LIEDNEYTAREGA 163
Query: 207 --PV-FQAPEIAN-GLPEISGYKVDIWSSGVTL 235
P+ + APE N G I K D+WS G+ L
Sbjct: 164 KFPIKWTAPEAINYGTFTI---KSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 56/177 (31%), Positives = 84/177 (47%), Gaps = 12/177 (6%)
Query: 62 LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEY 121
+C + +KK + + G REI +LK + HR +I L+ + K + ++M
Sbjct: 110 VCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRW--KSTVCMVMPK 167
Query: 122 CVGGLQDMLD-STPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTL 180
L +D S P P+ QA +LL+ L YLH +GIIH+D+K N+ L
Sbjct: 168 YKCDLFTYVDRSGP---LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENA 224
Query: 181 KISDFGVAESLDMFLHDDTITTS--QGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ DFG A LD H DT G+ +PE+ P + K DIWS+G+ L
Sbjct: 225 VLGDFGAACKLDA--HPDTPQCYGWSGTLETNSPELLALDPYCA--KTDIWSAGLVL 277
|
Length = 392 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 49/145 (33%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKK-LQRIPNGEINVDREIRLLKMLQHRNVIGL 103
LG G++G+V +T A+K +KK L R + +R+I L + V+ L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDI--LAEADNEWVVKL 66
Query: 104 VDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
F + K +Y +M+Y GG DM+ + FP A Y +L +E +H G
Sbjct: 67 YYSFQD--KDNLYFVMDYIPGG--DMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGV 187
IH+DIKP N+L+ LDG +K++DFG+
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-13
Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKK---KLQRIPNGEINVDREIR-LLKMLQHRN 99
++G G++G+V + + A K+F K K + + E RE R +L ++
Sbjct: 8 VIGRGAFGEV-----AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159
+ L F ++ +YL+M+Y VGG L S + P A Y +++ ++ +H
Sbjct: 63 ITTLHYAFQDE--NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS--QGSPVFQAPEIANG 217
+H+DIKP N+L+ ++G ++++DFG L + D T+ +S G+P + +PEI
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL---MEDGTVQSSVAVGTPDYISPEILQA 177
Query: 218 LPEISGY---KVDIWSSGVTL 235
+ + G + D WS GV +
Sbjct: 178 MEDGKGKYGPECDWWSLGVCM 198
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-13
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 40 VMGDLLGEGSYGKVKE-----MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
G LG G++GKV E + S+ + + AVK+ K E + E++++
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMS-ELKIMSH 94
Query: 95 L-QHRNVIGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLD 152
L H N++ L+ + +I EYC G L + L + + Q+
Sbjct: 95 LGNHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS---PV- 208
G+ +L S+ IH+D+ N+LLT +KI DFG+A + ++D +G+ PV
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI---MNDSNY-VVKGNARLPVK 208
Query: 209 FQAPE-IANGLPEISGYKVDIWSSGVTL 235
+ APE I N + + D+WS G+ L
Sbjct: 209 WMAPESIFNCVYTF---ESDVWSYGILL 233
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-13
Identities = 58/194 (29%), Positives = 101/194 (52%), Gaps = 11/194 (5%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI-NVDREIRLLKMLQHRNVIG 102
LLG+G++GKV + + T A+KI KK+ + + E+ + E R+L+ +H +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-G 161
L F ++ +MEY GG + + + F +A Y +++ L+YLHS+
Sbjct: 60 LKYSF--QTHDRLCFVMEYANGG-ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEI 221
++++D+K NL+L DG +KI+DFG+ + + T+ T G+P + APE+
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLED--ND 172
Query: 222 SGYKVDIWSSGVTL 235
G VD W GV +
Sbjct: 173 YGRAVDWWGLGVVM 186
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-13
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 32/211 (15%)
Query: 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REI 89
+K++ K LG G +G+V M + AVK K G ++V E
Sbjct: 8 IKLVKK------LGAGQFGEV-WMGYYNNSTKVAVKTLKP--------GTMSVQAFLEEA 52
Query: 90 RLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFL 148
L+K LQH ++ L V K++ +Y+I EY G L D L S K + + +
Sbjct: 53 NLMKTLQHDKLVRLYAVVT--KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS-- 206
Q+ +G+ Y+ + IH+D++ N+L++ KI+DFG+A ++ D+ T +G+
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE----DNEYTAREGAKF 166
Query: 207 PV-FQAPEIAN-GLPEISGYKVDIWSSGVTL 235
P+ + APE N G I K D+WS G+ L
Sbjct: 167 PIKWTAPEAINFGSFTI---KSDVWSFGILL 194
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-13
Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 34/223 (15%)
Query: 38 KYVMGDLLGEGSYGKVK-------EMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR 90
+ V+G LGEG +G+V + + AVK+ K + I+ E+
Sbjct: 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS---EME 69
Query: 91 LLKML-QHRNVIGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDS----TPYKKFPIWQAH 144
L+K++ +H+N+I L+ V + +Y+I+EY G L++ L + P F I +
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGP--LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 145 GYFL----------QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194
L Q+ G+EYL S+ IH+D+ N+L+T D +KI+DFG+A +
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187
Query: 195 LHDDTITTSQGS-PV-FQAPEIANGLPEISGYKVDIWSSGVTL 235
D TS G PV + APE + ++ D+WS G+ +
Sbjct: 188 --DYYKKTSNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGILM 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-13
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 37/220 (16%)
Query: 40 VMGDLLGEGSYGK---------VKEMLDSETLCRRAVKIFKKKKL--QRIPNGE---INV 85
V+ DL G++GK +E + K ++L +R+ G I +
Sbjct: 152 VIDDLP-AGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQL 210
Query: 86 DREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDST-PYKKFP-IWQA 143
+ EI L L H N++ + ++ ++ M + +Y M D +K P + Q
Sbjct: 211 ENEILALGRLNHENILKIEEILRSEANTYM-ITQKYDFDLYSFMYDEAFDWKDRPLLKQT 269
Query: 144 HGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM------FLHD 197
QLL +EY+H + +IH+DIK N+ L DG + + DFG A + +
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV 329
Query: 198 DTITTSQGSPVFQAPEI--ANGLPEISGYKVDIWSSGVTL 235
T+ T+ +PEI +G EI+ DIWS G+ L
Sbjct: 330 GTVATN-------SPEILAGDGYCEIT----DIWSCGLIL 358
|
Length = 501 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-13
Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 10/146 (6%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKK-LQRIPNGEINVDREIRLLKMLQHRNVIGL 103
+G G++G+V + +T A+K +K L R + +R+I L + V+ L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDI--LAEADNEWVVKL 66
Query: 104 VDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKK--FPIWQAHGYFLQLLDGLEYLHSQG 161
F + K +Y +M+Y GG DM+ S + F A Y +L +E +H G
Sbjct: 67 YYSFQD--KDNLYFVMDYIPGG--DMM-SLLIRLGIFEEDLARFYIAELTCAIESVHKMG 121
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGV 187
IH+DIKP N+L+ DG +K++DFG+
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-13
Identities = 53/190 (27%), Positives = 93/190 (48%), Gaps = 9/190 (4%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGL 103
+LG+G +G+V T A K +KK++++ GE E ++L+ + R V+ L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSL 65
Query: 104 VDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
+ + K + L++ GG L+ + + F +A Y ++ GLE LH + I
Sbjct: 66 A--YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS 222
+++D+KP N+LL G ++ISD G+A + +TI G+ + APE+ E
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIP---EGETIRGRVGTVGYMAPEVVKN--ERY 178
Query: 223 GYKVDIWSSG 232
+ D W G
Sbjct: 179 TFSPDWWGLG 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-13
Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 23/200 (11%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VDREIRLLK-----MLQH 97
+LG+GS+GKV T A+KI KK + + + E V++ + L + Q
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
+ +D ++Y +MEY GG M +F A Y ++ GL +L
Sbjct: 67 HSCFQTMD--------RLYFVMEYVNGG-DLMYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--GSPVFQAPEIA 215
HS+GII++D+K N++L +G +KI+DFG+ + +M+ D +TT G+P + APEI
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMW---DGVTTKTFCGTPDYIAPEII 173
Query: 216 NGLPEISGYKVDIWSSGVTL 235
P G VD W+ GV L
Sbjct: 174 AYQP--YGKSVDWWAFGVLL 191
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-13
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 25/204 (12%)
Query: 40 VMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLLKMLQ 96
M LG G YG+V E + + AVK K+ ++ V+ +E ++K ++
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--------VEEFLKEAAVMKEIK 60
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEY-CVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H N++ L+ V ++ Y+I E+ G L D L ++ Q+ +E
Sbjct: 61 HPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQAP 212
YL + IH+D+ N L+ + +K++DFG++ + DT T G+ P+ + AP
Sbjct: 119 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR----LMTGDTYTAHAGAKFPIKWTAP 174
Query: 213 EIANGLPEIS-GYKVDIWSSGVTL 235
E L K D+W+ GV L
Sbjct: 175 E---SLAYNKFSIKSDVWAFGVLL 195
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-13
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGL 103
L+G G +G+V+ + + T A+K+ KK L + E +L + + L
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA-QETVSFFEEERDILSISNSPWIPQL 66
Query: 104 VDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
F + K +YL+MEY GG L + +F A Y +L+ + +H G +
Sbjct: 67 QYAFQD--KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYV 124
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI--TTSQGSPVFQAPEI---ANGL 218
H+DIKP N+L+ G +K++DFG A L + + G+P + APE+ NG
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAARLTA---NKMVNSKLPVGTPDYIAPEVLTTMNGD 181
Query: 219 PEIS-GYKVDIWSSGV 233
+ + G + D WS GV
Sbjct: 182 GKGTYGVECDWWSLGV 197
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-13
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 27/199 (13%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLLKMLQHRNVI 101
LG G +G+V M + AVK K G ++V+ E ++K LQH ++
Sbjct: 14 LGAGQFGEV-WMATYNKHTKVAVKTMKP--------GSMSVEAFLAEANVMKTLQHDKLV 64
Query: 102 GLVDVFVNDKKQKMYLIMEYC-VGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ 160
L V K+ +Y+I E+ G L D L S K P+ + + Q+ +G+ ++ +
Sbjct: 65 KLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQAPEIAN- 216
IH+D++ N+L++ KI+DFG+A + D+ T +G+ P+ + APE N
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLAR----VIEDNEYTAREGAKFPIKWTAPEAINF 177
Query: 217 GLPEISGYKVDIWSSGVTL 235
G I K D+WS G+ L
Sbjct: 178 GSFTI---KSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 17/156 (10%)
Query: 88 EIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG------LQDMLDSTPYKKFPIW 141
E+ L H ++ D F +D K+ LIMEY GG Q + + P++++
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSD--DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEY--- 169
Query: 142 QAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT 201
+ F Q++ L+ +HS+ ++H+D+K N+ L G +K+ DFG ++ + D +
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 202 TSQGSPVFQAPEIANGLPEISGY--KVDIWSSGVTL 235
+ G+P + APE L E Y K D+WS GV L
Sbjct: 230 SFCGTPYYLAPE----LWERKRYSKKADMWSLGVIL 261
|
Length = 478 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-12
Identities = 51/190 (26%), Positives = 93/190 (48%), Gaps = 9/190 (4%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGL 103
+LG+G +G+V T A K +KK++++ GE E ++L+ + + V+ L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-RKGESMALNEKQILEKVNSQFVVNL 65
Query: 104 VDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
+ + K + L++ GG L+ + + F +A Y ++L GLE LH +
Sbjct: 66 A--YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS 222
+++D+KP N+LL G ++ISD G+A + ++I G+ + APE+ N +
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIP---EGESIRGRVGTVGYMAPEVLNN--QRY 178
Query: 223 GYKVDIWSSG 232
D W G
Sbjct: 179 TLSPDYWGLG 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-12
Identities = 52/160 (32%), Positives = 79/160 (49%), Gaps = 26/160 (16%)
Query: 87 REIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDST-PYKKFPIWQAH 144
+E R+LK H N++ L+ V +KQ +Y++ME GG L + P K
Sbjct: 42 QEARILKQYSHPNIVRLIGVCT--QKQPIYIVMELVQGGDFLTFLRTEGPRLKVK----- 94
Query: 145 GYFLQLLD----GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200
+Q+++ G+EYL S+ IH+D+ N L+T LKISDFG++ +D +
Sbjct: 95 -ELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSRE-----EEDGV 148
Query: 201 TTSQGS----PV-FQAPEIANGLPEISGYKVDIWSSGVTL 235
S G PV + APE N S + D+WS G+ L
Sbjct: 149 YASTGGMKQIPVKWTAPEALNYGRYSS--ESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-12
Identities = 34/74 (45%), Positives = 46/74 (62%), Gaps = 3/74 (4%)
Query: 120 EYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT 179
E+ + G + + D+ P K I G Q+L GL LH GI+H+DIKP NLL+T+DG
Sbjct: 289 EFMMAG-KKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ 347
Query: 180 LKISDFGVAESLDM 193
+KI DFG A +DM
Sbjct: 348 VKIIDFGAA--VDM 359
|
Length = 507 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-12
Identities = 47/151 (31%), Positives = 82/151 (54%), Gaps = 10/151 (6%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKK-LQRIPNGEINVDREIRLLKMLQHRNVIG 102
++G G++G+V+ + +T A+KI +K L++ G I +R+I L + +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI-----LVEADSLW 62
Query: 103 LVDVFVN-DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL-QLLDGLEYLHSQ 160
+V +F + K +YLIME+ GG DM+ K + +++ + + ++ +H
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
G IH+DIKP NLLL G +K+SDFG+ L
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-12
Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKK-KKLQRIPNGEINVDREIRLLKMLQHRNVIG 102
++G G++G+V + T A+KI K + L+R +R + + Q +
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW--ITT 65
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
L F ++ +YL+M+Y VGG L S + P A Y +++ + +H
Sbjct: 66 LHYAFQDE--NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY 123
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS--QGSPVFQAPEIANGLPE 220
+H+DIKP N+LL ++G ++++DFG L M D T+ +S G+P + +PEI + +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG--SCLKM-NQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 221 ISGY---KVDIWSSGVTL 235
G + D WS GV +
Sbjct: 181 GMGKYGPECDWWSLGVCM 198
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-12
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 28/203 (13%)
Query: 45 LGEGSYGKVKEMLDSETLCRR----------AVKIFKKKK-LQRIPNGEINVDREIRLLK 93
LG G+YGKV L R+ A+K+ KK +Q+ E L
Sbjct: 8 LGTGAYGKV-------FLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLD 152
+ + ++ L F D K++LI++Y GG L L + F + Y +++
Sbjct: 61 VRRCPFLVTLHYAFQTD--TKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVL 116
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--GSPVFQ 210
L++LH GII++DIK N+LL +G + ++DFG+++ FL ++ G+ +
Sbjct: 117 ALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK---EFLAEEEERAYSFCGTIEYM 173
Query: 211 APEIANGLPEISGYKVDIWSSGV 233
APE+ G VD WS GV
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGV 196
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-12
Identities = 35/96 (36%), Positives = 58/96 (60%), Gaps = 11/96 (11%)
Query: 114 KMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNL 172
+YL+MEY +GG ++ +L Y F A Y ++ L+YLH GIIH+D+KP N+
Sbjct: 78 NVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNM 135
Query: 173 LLTLDGTLKISDFGVAE-----SLDMFLHDDTITTS 203
L++ +G +K++DFG+++ L+M D +TT
Sbjct: 136 LISNEGHIKLTDFGLSKVTLNRELNMM---DILTTP 168
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-12
Identities = 34/89 (38%), Positives = 53/89 (59%), Gaps = 2/89 (2%)
Query: 147 FLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS 206
F+Q+L + ++HS+ +IH+DIK N+LL +G +K+ DFG ++ + DD T G+
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGT 208
Query: 207 PVFQAPEIANGLPEISGYKVDIWSSGVTL 235
P + APEI P K D++S GV L
Sbjct: 209 PYYVAPEIWRRKP--YSKKADMFSLGVLL 235
|
Length = 496 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-12
Identities = 48/145 (33%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKK-LQRIPNGEINVDREIRLLKMLQHRNVIGL 103
LG G++G+V +T A+K +KK L R + +R+I L + V+ L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDI--LAEADNEWVVRL 66
Query: 104 VDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
F + K +Y +M+Y GG DM+ FP A Y +L +E +H G
Sbjct: 67 YYSFQD--KDNLYFVMDYIPGG--DMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGV 187
IH+DIKP N+L+ DG +K++DFG+
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-12
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 43/219 (19%)
Query: 45 LGEGSYGKVKE---MLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLLKMLQHRN 99
LGEG++GKV + +E L +V I K L+ ++ + +E L+ LQH N
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAI---KTLKENAEPKVQQEFRQEAELMSDLQHPN 69
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCV-GGLQDML------------DSTPYKKFPIWQAHGY 146
++ L+ V K+Q ++ EY G L + L K +
Sbjct: 70 IVCLLGVCT--KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD--CSD 125
Query: 147 FL----QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITT 202
FL Q+ G+EYL S +H+D+ N L+ T+KISDFG++ D++ D
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR--DIYSADYYRVQ 183
Query: 203 SQGS-PV-FQAPEIANGLPEISGYKV----DIWSSGVTL 235
S+ PV + PE I K DIWS GV L
Sbjct: 184 SKSLLPVRWMPPE------AILYGKFTTESDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-12
Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 9/193 (4%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGL 103
+LG+G +G+V T A K +KK++++ GE E ++L+ + R V+ L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMALNEKQILEKVNSRFVVSL 65
Query: 104 VDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
+ + K + L++ GG L+ + F +A Y ++ GLE LH + I
Sbjct: 66 A--YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS 222
+++D+KP N+LL G ++ISD G+A + TI G+ + APE+ E
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTVGYMAPEVVKN--ERY 178
Query: 223 GYKVDIWSSGVTL 235
+ D W+ G L
Sbjct: 179 TFSPDWWALGCLL 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 5e-12
Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 25/201 (12%)
Query: 45 LGEGSYGKVKEMLDSETLCRR---AVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVI 101
LG G++G V + + + AVK K++ I G+ RE ++ L H ++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH---IAAGKKEFLREASVMAQLDHPCIV 59
Query: 102 GLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHG---YFLQLLDGLEYL 157
L+ V + + L+ME G L L KK Q+ G+ YL
Sbjct: 60 RLIGVCKGEP---LMLVMELAPLGPLLKYL-----KKRREIPVSDLKELAHQVAMGMAYL 111
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQAPEI 214
S+ +H+D+ N+LL KISDFG++ +L D + P+ + APE
Sbjct: 112 ESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTAGRWPLKWYAPEC 169
Query: 215 ANGLPEISGYKVDIWSSGVTL 235
N + S K D+WS GVTL
Sbjct: 170 IN-YGKFS-SKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-12
Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 148 LQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ-G 205
+ ++ LEYLHS+ +IH+D+KP N+L+ +G +K+ DFG++ +L D T G
Sbjct: 110 VSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG----YLVDSVAKTIDAG 165
Query: 206 SPVFQAPEIANGLPEISGYKV--DIWSSGVTL 235
+ APE N GY V D+WS G+T+
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITM 197
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-12
Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 9/192 (4%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LG+G +G+V + T A K KK+L++ +GE E +L+ + ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 105 DVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
F + K + L+M GG L+ + + + + + Y Q+ G+ +LHS I+
Sbjct: 60 YAF--ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISG 223
++D+KP N+LL G ++SD G+A L TIT G+ + APEI E
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELK---DGKTITQRAGTNGYMAPEIL--KEEPYS 172
Query: 224 YKVDIWSSGVTL 235
Y VD ++ G ++
Sbjct: 173 YPVDWFAMGCSI 184
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 9e-12
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 31/217 (14%)
Query: 38 KYVMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLL 92
K + LG+GS+G V K ++ E R A+K + R I E ++
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR---ERIEFLNEASVM 63
Query: 93 KMLQHRNVIGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDST--------PYKKFPIWQA 143
K +V+ L+ V Q ++ME G L+ L S + +
Sbjct: 64 KEFNCHHVVRLLGVV--STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 144 HGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS 203
++ DG+ YL ++ +H+D+ N ++ D T+KI DFG+ D++ D
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGG 179
Query: 204 QGS-PV-FQAPEIANGLPEISGY---KVDIWSSGVTL 235
+G PV + APE G K D+WS GV L
Sbjct: 180 KGLLPVRWMAPESLK-----DGVFTTKSDVWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 27/203 (13%)
Query: 44 LLGEGSYGKVK--EMLDSETLCRRAVKIFKK-KKLQRIPNGEINVDREIR-LLKMLQHRN 99
++G G++G+V +M ++ + A+KI K + L+R E RE R +L R
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQV--YAMKILNKWEMLKR---AETACFREERDVLVNGDRRW 62
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKF----PIWQAHGYFLQLLDGLE 155
+ L F ++ +YL+M+Y VGG D+L T KF P A Y +++ ++
Sbjct: 63 ITNLHYAFQDENN--LYLVMDYYVGG--DLL--TLLSKFEDRLPEDMARFYLAEMVLAID 116
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS--QGSPVFQAPE 213
+H G +H+DIKP N+LL +G ++++DFG S L D T+ ++ G+P + +PE
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFG---SCLRLLADGTVQSNVAVGTPDYISPE 173
Query: 214 IANGLPEISGY---KVDIWSSGV 233
I + + G + D WS GV
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGV 196
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 38 KYVMGDLLGEGSYGKV---------KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDRE 88
+ +G LGEG +G+V K+ + AVK+ K + + ++ E
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTV--AVKMLKDDATDKDLSDLVS---E 67
Query: 89 IRLLKML-QHRNVIGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDS-------------- 132
+ ++KM+ +H+N+I L+ D +Y+++EY G L++ L +
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGP--LYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 133 TPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192
P ++ Q+ G+EYL SQ IH+D+ N+L+T D +KI+DFG+A +
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ T + + APE + ++ D+WS GV L
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLL 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-11
Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 30/221 (13%)
Query: 38 KYVMGDLLGEGSYGKV--KEML-----DSETLCRRAVKIFKKKKLQRIPNGEINVDREIR 90
K +G LGEG +G+V E L + AVK+ K ++ + ++ E+
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS---EME 72
Query: 91 LLKML-QHRNVIGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDS--------------TP 134
++KM+ +H+N+I L+ D +Y+I+EY G L++ L + P
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 135 YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194
++ Q+ G+EYL SQ IH+D+ N+L+T + +KI+DFG+A ++
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI 190
Query: 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ T + + APE + ++ D+WS GV +
Sbjct: 191 DYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLM 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-11
Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 29/200 (14%)
Query: 45 LGEGSYG---KVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVI 101
LG G+ G KVK + + ++ V I K +++ + RE++++ + ++
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK------QILRELQIMHECRSPYIV 66
Query: 102 GLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKF-PI-WQAHGYF-LQLLDGLEYLH 158
F+N+ M ME+ G D + YKK PI + G + +++GL YL+
Sbjct: 67 SFYGAFLNENNICM--CMEFMDCGSLDRI----YKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 159 S-QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG 217
+ I+H+DIKP N+L+ G +K+ DFGV+ L + D + TS + +PE G
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTS----TYMSPERIQG 176
Query: 218 LPEISGYKV--DIWSSGVTL 235
Y V D+WS G+++
Sbjct: 177 ----GKYTVKSDVWSLGISI 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-11
Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 16/193 (8%)
Query: 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIG 102
++LG G+ G V + T AVK+ L + + E+ +L +IG
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIP---LDITVELQKQIMSELEILYKCDSPYIIG 63
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
F + ++ + E+ GG D+ Y+K P + ++ GL YL S I
Sbjct: 64 FYGAFFVE--NRISICTEFMDGGSLDV-----YRKIPEHVLGRIAVAVVKGLTYLWSLKI 116
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS 222
+H+D+KP N+L+ G +K+ DFGV+ L + T G+ + APE +G E
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQ----LVNSIAKTYVGTNAYMAPERISG--EQY 170
Query: 223 GYKVDIWSSGVTL 235
G D+WS G++
Sbjct: 171 GIHSDVWSLGISF 183
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-11
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 44 LLGEGSYGKV---KEMLDSETLCRRAVKIFKKKKL-QRIPNGE-INVDREIRLLKMLQHR 98
+LG G+YGKV +++ ++ A+K+ KK + Q+ E +R++ L + Q
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV-LEHIRQSP 65
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
++ L F D K ++LI++Y GG + + ++F + Y +++ LE+LH
Sbjct: 66 FLVTLHYAFQTDTK--LHLILDYINGG-ELFTHLSQRERFKEQEVQIYSGEIVLALEHLH 122
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--GSPVFQAPEIAN 216
GII++DIK N+LL +G + ++DFG+++ F D+ G+ + AP+I
Sbjct: 123 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE---FHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 217 GLPEISGYKVDIWSSGVTL 235
G VD WS GV +
Sbjct: 180 GGDGGHDKAVDWWSMGVLM 198
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-11
Identities = 50/175 (28%), Positives = 73/175 (41%), Gaps = 59/175 (33%)
Query: 88 EIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGY- 146
E RLL+ L H V+ L+DV V VGGL ++ P +++ Y
Sbjct: 210 EARLLRRLSHPAVLALLDVRV--------------VGGLTCLV-------LPKYRSDLYT 248
Query: 147 FL-----------------QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189
+L QLL ++Y+H +GIIH+DIK N+L+ + + DFG A
Sbjct: 249 YLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA- 307
Query: 190 SLDMFLHDDTITTSQGSPVF---------QAPEIANGLPEISGYKVDIWSSGVTL 235
F S +P APE+ G P VDIWS+G+ +
Sbjct: 308 ---CF-----ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTP--SVDIWSAGLVI 352
|
Length = 461 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-11
Identities = 47/151 (31%), Positives = 82/151 (54%), Gaps = 10/151 (6%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKK-LQRIPNGEINVDREIRLLKMLQHRNVIG 102
++G G++G+V+ + +T A+KI +K L++ I +R+I L +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI-----LVEADGAW 62
Query: 103 LVDVFVN-DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL-QLLDGLEYLHSQ 160
+V +F + K+ +YLIME+ GG DM+ K +A +++ + + ++ +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
G IH+DIKP NLLL G +K+SDFG+ L
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 6e-11
Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 35/171 (20%)
Query: 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRR-------AVKIFKKKK-LQRIPNGEIN 84
+K+IG+ G++G+V+ L ++ A+K +K + L++ +
Sbjct: 6 IKVIGR---------GAFGEVR-------LVQKKDTGHIYAMKKLRKSEMLEKEQVAHVR 49
Query: 85 VDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIW--- 141
+R+I L + V+ L F + + +YLIMEY GG DM+ T K +
Sbjct: 50 AERDI--LAEADNPWVVKLYYSFQD--ENYLYLIMEYLPGG--DMM--TLLMKKDTFTEE 101
Query: 142 QAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192
+ Y + + ++ +H G IH+DIKP NLLL G +K+SDFG+ L
Sbjct: 102 ETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-11
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 38/205 (18%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLLKMLQHRNVI 101
LG G +G+V E L + T AVK K G ++ E +++K L+H +I
Sbjct: 14 LGAGQFGEVWEGLWNNT-TPVAVKTLKP--------GTMDPKDFLAEAQIMKKLRHPKLI 64
Query: 102 GLVDVFVNDKKQKMYLI---MEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
L V ++ +Y++ M+Y G L + L + + Q Q+ G+ YL
Sbjct: 65 QLYAVCT--LEEPIYIVTELMKY--GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQAPEIA 215
+Q IH+D+ N+L+ + K++DFG+A + +D +G+ P+ + APE A
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLARVIK----EDIYEAREGAKFPIKWTAPEAA 176
Query: 216 NGLPEISGY-----KVDIWSSGVTL 235
Y K D+WS G+ L
Sbjct: 177 L-------YNRFSIKSDVWSFGILL 194
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-11
Identities = 66/235 (28%), Positives = 107/235 (45%), Gaps = 49/235 (20%)
Query: 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK-KKKLQRIPNGEINVDREIRLLKM 94
+ +Y + L+G+G G+V L + +C R V + K ++ L P + RE ++
Sbjct: 1 MQRYDIIRLIGKGGMGEV--YLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAAD 58
Query: 95 LQHRNVIGLVDVF-VNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAH-------- 144
L H G+V V+ + +Y M Y G L+ +L S WQ
Sbjct: 59 LIHP---GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSV-------WQKESLSKELAE 108
Query: 145 ----GYFLQLLD----GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-------- 188
G FL + +EY+HS+G++H+D+KP N+LL L G + I D+G A
Sbjct: 109 KTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE 168
Query: 189 ESLDMFLHDDTITTSQ--------GSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ LD+ + + I S G+P + APE G+P + DI++ GV L
Sbjct: 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP--ASESTDIYALGVIL 221
|
Length = 932 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-10
Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 88 EIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGY 146
E +++ L H ++ L V K++ +Y++ EY G L + L K+F Q
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCT--KQRPIYIVTEYMSNGCLLNYLREH-GKRFQPSQLLEM 105
Query: 147 FLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS 206
+ +G+ YL S+ IH+D+ N L+ G +K+SDFG L ++ DD T+S GS
Sbjct: 106 CKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFG----LSRYVLDDEYTSSVGS 161
Query: 207 --PVFQAPEIANGLPEISGY-----KVDIWSSGVTL 235
PV +P PE+ Y K D+W+ GV +
Sbjct: 162 KFPVRWSP------PEVLLYSKFSSKSDVWAFGVLM 191
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-10
Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 39/228 (17%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRR-----AVKIFKKKKLQRIPNGEINVDREIRLL 92
V+G LGEG +GKV + R AVK+ K+ + ++ E LL
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLL 57
Query: 93 KMLQHRNVIGLVDVFVNDKKQKMYLIMEYC-VGGLQDML--------------------- 130
K + H +VI L D + LI+EY G L+ L
Sbjct: 58 KQVNHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 131 -DSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189
D+ + + + Q+ G++YL ++H+D+ N+L+ +KISDFG+
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGL-- 173
Query: 190 SLDMFLHDDTITTSQGS-PV-FQAPEIANGLPEISGYKVDIWSSGVTL 235
S D++ D + S+G PV + A E + I + D+WS GV L
Sbjct: 174 SRDVYEEDSYVKRSKGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLL 219
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-10
Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 9/190 (4%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGL 103
+LG+G +G+V T A K +KK++++ GE E R+L+ + R V+ L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSL 65
Query: 104 VDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
+ + K + L++ GG L+ + + F +A Y +L GLE L + I
Sbjct: 66 A--YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS 222
+++D+KP N+LL G ++ISD G+A + +T+ G+ + APE+ N E
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIP---EGETVRGRVGTVGYMAPEVINN--EKY 178
Query: 223 GYKVDIWSSG 232
+ D W G
Sbjct: 179 TFSPDWWGLG 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-10
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 44 LLGEGSYGKV----------KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLK 93
+LG G+YGKV L + + ++A + +K K E NV +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAA-LVQKAKTVEHTRTERNVLEHVR--- 62
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKK--FPIWQAHGYFLQLL 151
Q ++ L F + K ++LI++Y GG + + Y++ F + Y +++
Sbjct: 63 --QSPFLVTLHYAFQTEAK--LHLILDYVSGG---EMFTHLYQRDNFSEDEVRFYSGEII 115
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--GSPVF 209
LE+LH GI+++DIK N+LL +G + ++DFG+++ FL ++ T G+ +
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKE---FLSEEKERTYSFCGTIEY 172
Query: 210 QAPEIANGLPEISGYKVDIWSSGVTL 235
APEI G G VD WS G+ +
Sbjct: 173 MAPEIIRGKGG-HGKAVDWWSLGILI 197
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-10
Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 87 REIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHG 145
RE L L H N++ L+D ++ + EY G L+++L + P +
Sbjct: 27 RETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYVPGRTLREVLAAD--GALPAGETGR 83
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT---LKISDFGVAESLDMFLHDD--TI 200
LQ+LD L H+QGI+H+D+KP N++++ G K+ DFG+ L D T+
Sbjct: 84 LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL 143
Query: 201 TTSQ---GSPVFQAPEIANGLP 219
T + G+P + APE G P
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEP 165
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-10
Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 19/195 (9%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LG+G +G+V M + A+K K + +P + +E +++K L+H ++ L
Sbjct: 14 LGQGCFGEV-WMGTWNGTTKVAIKTLKPGTM--MPEAFL---QEAQIMKKLRHDKLVPLY 67
Query: 105 DVFVNDKKQKMYLIMEYC-VGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
V ++ +Y++ E+ G L D L K + Q Q+ DG+ Y+ I
Sbjct: 68 AVV---SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQAPEIANGLPE 220
H+D++ N+L+ + KI+DFG+A + D+ T QG+ P+ + APE A L
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLAR----LIEDNEYTARQGAKFPIKWTAPEAA--LYG 178
Query: 221 ISGYKVDIWSSGVTL 235
K D+WS G+ L
Sbjct: 179 RFTIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 154 LEYL-HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL-DMFLHDDTITTSQGSPVFQA 211
L YL G+IH+D+KP N+LL G +K+ DFG++ L D T S G + A
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK----TRSAGCAAYMA 182
Query: 212 PEIANGLPEISGYKV--DIWSSGVTL 235
PE + Y + D+WS G++L
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISL 208
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-10
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIG 102
D LG+G+YG V ++L T A+K R+ E ++ I L +L
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI------RLELDESKFNQIIMELDILHKAVSPY 60
Query: 103 LVDVF-VNDKKQKMYLIMEYCVGGLQDML--DSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159
+VD + + +Y+ MEY G D L + P ++ GL++L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 160 Q-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE-IANG 217
+ IIH+D+KP N+L+ +G +K+ DFGV+ +L L I G + APE I +G
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSG 176
Query: 218 LPEISG-YKV--DIWSSGVTL 235
P + Y V D+WS G+++
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSI 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-10
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 19/195 (9%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LG+G +G+V + T R A+K K + P + +E +++K L+H ++ L
Sbjct: 14 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--PEAFL---QEAQVMKKLRHEKLVQLY 67
Query: 105 DVFVNDKKQKMYLIMEYC-VGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
V ++ +Y++ EY G L D L K + Q Q+ G+ Y+ +
Sbjct: 68 AVV---SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQAPEIANGLPE 220
H+D++ N+L+ + K++DFG+A + D+ T QG+ P+ + APE A L
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEAA--LYG 178
Query: 221 ISGYKVDIWSSGVTL 235
K D+WS G+ L
Sbjct: 179 RFTIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-10
Identities = 55/165 (33%), Positives = 81/165 (49%), Gaps = 21/165 (12%)
Query: 27 DNKTIKVKMIGKYVMGD--LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN 84
D T+KV IGK G+ L+ + GK+ M +TL ++FKK +L +
Sbjct: 2 DFHTVKV--IGKGAFGEVRLVQKKDTGKIYAM---KTL--LKSEMFKKDQLA-------H 47
Query: 85 VDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQA 143
V E +L V+ L F + Q +YLIME+ GG L ML Y F
Sbjct: 48 VKAERDVLAESDSPWVVSLYYSFQD--AQYLYLIMEFLPGGDLMTML--IKYDTFSEDVT 103
Query: 144 HGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188
Y + + +E +H G IH+DIKP N+L+ G +K+SDFG++
Sbjct: 104 RFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-10
Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 17/192 (8%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
+G+G +G V ML + AVK K + E +V + L+H N++ L+
Sbjct: 14 IGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQAFLAEASV------MTQLRHSNLVQLL 65
Query: 105 DVFVNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGII 163
V V +K +Y++ EY G L D L S + L + + +EYL + +
Sbjct: 66 GVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124
Query: 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISG 223
H+D+ N+L++ D K+SDFG+ + T T + + APE +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALR--EKKFS 177
Query: 224 YKVDIWSSGVTL 235
K D+WS G+ L
Sbjct: 178 TKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-10
Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 37/215 (17%)
Query: 45 LGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN 99
LGEG++GKV + AVK K+ + + +RE LL QH N
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS---NDARKDFEREAELLTNFQHEN 69
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDS------------TPYKKFPIWQAHGY 146
++ V + ++ EY G L L S +P + + Q
Sbjct: 70 IVKFYGVCT--EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 147 FLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD-DTITTSQG 205
+Q+ G+ YL SQ +H+D+ N L+ D +KI DFG+ S D++ D +
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM--SRDVYTTDYYRVGGHTM 185
Query: 206 SPVFQAPEIANGLPEISGYK-----VDIWSSGVTL 235
P+ P PE Y+ D+WS GV L
Sbjct: 186 LPIRWMP------PESIMYRKFTTESDVWSFGVVL 214
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-10
Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 17/152 (11%)
Query: 88 EIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGY 146
E +++ L H ++ L V ++ + L+ E+ G L D L KF G
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCT--ERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGM 105
Query: 147 FLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS 206
L + +G+ YL S +IH+D+ N L+ + +K+SDFG+ F+ DD T+S G+
Sbjct: 106 CLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTR----FVLDDQYTSSTGT 161
Query: 207 --PV-FQAPEIANGLPEISGY--KVDIWSSGV 233
PV + +PE+ + S Y K D+WS GV
Sbjct: 162 KFPVKWSSPEVFS----FSKYSSKSDVWSFGV 189
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 32/89 (35%), Positives = 49/89 (55%), Gaps = 11/89 (12%)
Query: 150 LLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV 208
+L GL YL + I+H+D+KP N+L+ G +K+ DFGV+ L D + G+
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRS 163
Query: 209 FQAPEIANGLPEISGYKV--DIWSSGVTL 235
+ +PE G + Y V DIWS G++L
Sbjct: 164 YMSPERLQG----THYTVQSDIWSLGLSL 188
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 48/209 (22%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 44 LLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
LG G +G+V K + + VK +K K + N + RE+ + + L H+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE---NLQSEFRRELDMFRKLSHK 68
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYC-VGGLQDMLDST-----PYKKFPIWQAHGYFL--QL 150
NV+ L+ + + + Y+I+EY +G L+ L +T K P+ L Q+
Sbjct: 69 NVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE---SLDMFLHDDTITTSQGSP 207
G+++L + +H+D+ N L++ +K+S +++ + + + + + P
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-----P 181
Query: 208 V-FQAPEIANGLPEISGYKVDIWSSGVTL 235
+ + APE + K D+WS GV +
Sbjct: 182 LRWLAPEAV--QEDDFSTKSDVWSFGVLM 208
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-09
Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 88 EIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYF 147
E LL+ + H +VI + D V +++ + L L + + PI QA
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV--SGAITCMVLPHYSSDLYTYL-TKRSRPLPIDQALIIE 163
Query: 148 LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG-----VAESLDMFLHDDTITT 202
Q+L+GL YLH+Q IIH+D+K N+ + + I D G V + L T+ T
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA-GTVET 222
Query: 203 SQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ APE+ S K DIWS+G+ L
Sbjct: 223 N-------APEVLARDKYNS--KADIWSAGIVL 246
|
Length = 357 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 14/152 (9%)
Query: 87 REIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGY 146
RE+++L ++G F +D + + + ME+ GG D + K+ P
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKEA-KRIPEEILGKV 108
Query: 147 FLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG 205
+ +L GL YL + I+H+D+KP N+L+ G +K+ DFGV+ L D + G
Sbjct: 109 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVG 164
Query: 206 SPVFQAPEIANGLPEISGYKV--DIWSSGVTL 235
+ + +PE G + Y V DIWS G++L
Sbjct: 165 TRSYMSPERLQG----THYSVQSDIWSMGLSL 192
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-09
Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 17/89 (19%)
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PVF 209
+G+EYL IH+D+ N L++ G +K+SDFG+ ++ DD T+S G+ PV
Sbjct: 111 EGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTR----YVLDDEYTSSSGAKFPVK 166
Query: 210 QAPEIANGLPEISGY-----KVDIWSSGV 233
+P PE+ + K D+WS GV
Sbjct: 167 WSP------PEVFNFSKYSSKSDVWSFGV 189
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-09
Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 45 LGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGL 103
LG G +G+V + T + AVK K + P + E +++K L+H ++ L
Sbjct: 14 LGNGQFGEVWMGTWNGNT--KVAVKTLKPGTMS--PESFLE---EAQIMKKLRHDKLVQL 66
Query: 104 VDVFVNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
V ++ +Y++ EY G L D L + + Q+ G+ Y+
Sbjct: 67 YAVV---SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQAPEIANGLP 219
IH+D++ N+L+ KI+DFG+A + D+ T QG+ P+ + APE A L
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLAR----LIEDNEYTARQGAKFPIKWTAPEAA--LY 177
Query: 220 EISGYKVDIWSSGVTL 235
K D+WS G+ L
Sbjct: 178 GRFTIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 43/197 (21%), Positives = 81/197 (41%), Gaps = 44/197 (22%)
Query: 40 VMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNG----EINVDREIR----- 90
+G +GEG +G V + ++ + ++I + +R
Sbjct: 9 TLGRCIGEGQFGDVYQ------------GVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ 56
Query: 91 ---LLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQ 142
+++ H +++ L+ V + ++++ME G LQ S +
Sbjct: 57 EAYIMRQFDHPHIVKLIGVITENP---VWIVMELAPLGELRSYLQVNKYSLDLASLIL-- 111
Query: 143 AHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI-T 201
Y QL L YL S+ +H+DI N+L++ +K+ DFG L +L D++
Sbjct: 112 ---YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFG----LSRYLEDESYYK 164
Query: 202 TSQGS-PV-FQAPEIAN 216
S+G P+ + APE N
Sbjct: 165 ASKGKLPIKWMAPESIN 181
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 7e-09
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIG 102
D +G G +GKV + ++ +A + K+ + P+ ++ +E++ + L H NV+
Sbjct: 1 DEIGNGWFGKVL-LGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 103 LVDVFVNDKKQKMYLIMEYC-VGGLQDMLDST-------PYKKFPIWQAHGYFLQLLDGL 154
+ + + L++E+C +G L++ L S K A ++ GL
Sbjct: 60 CLGQCI--ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMAC----EVASGL 113
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS-PV-FQAP 212
+LH IH D+ N LT D ++KI D+G+A L+ + D IT + P+ + AP
Sbjct: 114 LWLHQADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLRWLAP 171
Query: 213 EI-----ANGLPEISGYKVDIWSSGVTL 235
E+ + LP+ K +IWS GVT+
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTM 199
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 42/170 (24%), Positives = 69/170 (40%), Gaps = 25/170 (14%)
Query: 45 LGEGSYGKV--KEMLDSETLCRRAVKIFKKKKLQRI-------PNGEINV----DREIRL 91
LGEG +G+V E + +A + P+ N +E+++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 92 LKMLQHRNVIGLVDVFVNDKKQKMYLIMEY-CVGGLQDML--------DSTPYKKFPIWQ 142
L L N+ L+ V D + +IMEY G L L K +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPP--LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 143 AHGYF-LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
Y Q+ G+ YL S +H+D+ N L+ + T+KI+DFG++ +L
Sbjct: 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 21/196 (10%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104
LG G+ G V ++ + A K+ L+ P + RE+++L ++G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 105 DVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYK--KFPIWQAHGYFLQLLDGLEYLHSQ-G 161
F +D + + + ME+ GG LD K + P + ++ GL YL +
Sbjct: 70 GAFYSDGE--ISICMEHMDGG---SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEI 221
I+H+D+KP N+L+ G +K+ DFGV+ L D + G+ + +PE G
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG---- 176
Query: 222 SGYKV--DIWSSGVTL 235
+ Y V DIWS G++L
Sbjct: 177 THYSVQSDIWSMGLSL 192
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 34/214 (15%)
Query: 43 DLLGEGSYGKV-KEMLDSETLCRRA----VKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
D++GEG++G+V + M+ + L A +K F + R GE+ V L K+ H
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV-----LCKLGHH 62
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYC-VGGLQDML-DSTPYKKFPIW-QAHG--------- 145
N+I L+ N + +Y+ +EY G L D L S + P + + HG
Sbjct: 63 PNIINLLGACEN--RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 146 ---YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITT 202
+ + G++YL + IH+D+ N+L+ + KI+DFG++ ++++ T
Sbjct: 121 LLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK----KT 176
Query: 203 SQGSPV-FQAPEIANGLPEISGYKVDIWSSGVTL 235
PV + A E N + K D+WS GV L
Sbjct: 177 MGRLPVRWMAIESLN--YSVYTTKSDVWSFGVLL 208
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-08
Identities = 41/173 (23%), Positives = 80/173 (46%), Gaps = 30/173 (17%)
Query: 39 YVMGDLLGEGSYGKVKEM---LDSETLCRRAVKIFKKKKLQRIPNGEINVD-------RE 88
+ +G +LG+G +G V+E + + + AVK+ K +I RE
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK---------ADIFSSSDIEEFLRE 51
Query: 89 IRLLKMLQHRNVIGLVDVFVNDK-KQKM---YLIMEYCVGG------LQDMLDSTPYKKF 138
+K H NVI L+ V + + K ++ +I+ + G L + P+
Sbjct: 52 AACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT-L 110
Query: 139 PIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
P+ + + + G+EYL S+ IH+D+ N +L + T+ ++DFG+++ +
Sbjct: 111 PLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI 163
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-08
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 34/214 (15%)
Query: 43 DLLGEGSYGKV-KEMLDSETL-CRRAVKIFKK---KKLQRIPNGEINVDREIRLLKMLQH 97
D++GEG++G+V K + + L A+K K+ K R GE+ V L K+ H
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-----LCKLGHH 55
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYC-VGGLQDML-DSTPYKKFPIW-QAHGYF-----LQ 149
N+I L+ + + +YL +EY G L D L S + P + A+ Q
Sbjct: 56 PNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 150 LL-------DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITT 202
LL G++YL + IH+D+ N+L+ + KI+DFG++ ++++ T
Sbjct: 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK----KT 169
Query: 203 SQGSPV-FQAPEIANGLPEISGYKVDIWSSGVTL 235
PV + A E N + D+WS GV L
Sbjct: 170 MGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLL 201
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-08
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 47/208 (22%)
Query: 39 YVMGDLLGEGSYGKV-KEMLDSETLCRR------------AVKIFKKKKLQR-IPN---- 80
+V+G LGEG++G V K L ++ + AV+I+ ++++R PN
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193
Query: 81 ------GEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTP 134
++ +E + ++ L D+ + K+ Y + Y +G +QD L
Sbjct: 194 FVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQS--KEFPYNVEPYLLGKVQD-LPKGL 250
Query: 135 YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT-LDGTLKISDFGVAESLDM 193
++ I Q Q+L L+ LHS GI+H+D+KP N++ + G+ KI D G A L +
Sbjct: 251 ERENKIIQT--IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRV 308
Query: 194 --------FLHDDTITTSQGSPVFQAPE 213
FL D P + APE
Sbjct: 309 GINYIPKEFLLD---------PRYAAPE 327
|
Length = 566 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 7e-08
Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 13/91 (14%)
Query: 151 LDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--GSP 207
+ L YL + IIH+D+KP N+LL +G +K+ DFG++ L D+I ++ G
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-----VDSIAKTRDAGCR 171
Query: 208 VFQAPE-IANGLPEISGYKV--DIWSSGVTL 235
+ APE I + GY V D+WS G+TL
Sbjct: 172 PYMAPERIDPSARD--GYDVRSDVWSLGITL 200
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-08
Identities = 51/211 (24%), Positives = 102/211 (48%), Gaps = 36/211 (17%)
Query: 41 MGDLLGEGSYGKVKEML---DSETLC-RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+LG G++G V + + + E + A+K+ +++ N EI E ++ +
Sbjct: 11 KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEIL--DEAYVMASVD 67
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYC-VGGL-------QDMLDSTPYKKFPIWQAHGYFL 148
H +V+ L+ + ++ ++ LI + +G L +D + S + +
Sbjct: 68 HPHVVRLLGICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGS--------QYLLNWCV 116
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV 208
Q+ G+ YL + ++H+D+ N+L+ +KI+DFG+A+ LD+ D+ ++G V
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV---DEKEYHAEGGKV 173
Query: 209 ---FQAPE-IANGLPEISGYKVDIWSSGVTL 235
+ A E I + I +K D+WS GVT+
Sbjct: 174 PIKWMALESILHR---IYTHKSDVWSYGVTV 201
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 17/199 (8%)
Query: 44 LLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIG 102
++G G +G+V + +L AV I K K + E ++ H N+I
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAI-KTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162
L V K + +I EY G D +F +Q G + G++YL
Sbjct: 71 LEGVV--TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY 128
Query: 163 IHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS-PV-FQAPEIANGLPE 220
+H+D+ N+L+ + K+SDFG++ L+ + T TTS G P+ + APE
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDD-PEGTYTTSGGKIPIRWTAPE------A 181
Query: 221 ISGYKV----DIWSSGVTL 235
I+ K D+WS G+ +
Sbjct: 182 IAYRKFTSASDVWSFGIVM 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-07
Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKK----LQRIPNGEINVDR-----EIRLLK 93
+++G G +G+V CR +K+ K++ ++ + +G R E ++
Sbjct: 10 EVIGAGEFGEV---------CRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG 60
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
H N+I L V K + + +I E+ G D +F + Q G + G
Sbjct: 61 QFDHPNIIHLEGVVT--KSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAG 118
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
++YL +H+D+ N+L+ + K+SDFG++ L+ D T T+S G +
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI----P 174
Query: 214 IANGLPEISGYK-----VDIWSSGVTL 235
I PE Y+ D+WS G+ +
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVM 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 44/157 (28%), Positives = 63/157 (40%), Gaps = 25/157 (15%)
Query: 88 EIRLLKMLQHRNVIGLVDVFVNDKKQKM----YLIMEYCVGGLQDMLDSTPYKKFPIWQA 143
E +L+ + H ++I L F +K + Y YC L + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCY--LAAK------RNIAICDI 184
Query: 144 HGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS 203
+L ++YLH IIH+DIK N+ + G + + DFG A F D
Sbjct: 185 LAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA----CFPVDINANKY 240
Query: 204 QGSPVFQAPEIANGLPEI-----SGYKVDIWSSGVTL 235
G A IA PE+ G VDIWS+G+ L
Sbjct: 241 YG----WAGTIATNAPELLARDPYGPAVDIWSAGIVL 273
|
Length = 391 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 41 MGDLLGEGSYGKVKE-MLDSETLCRRAVKIFKKKKLQRIPNGEINVDR---EIRLLKMLQ 96
+ DLL EG++G++ +L E + K K EI V E LL L
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLS 66
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG------YFLQL 150
H+N++ ++ V + D + L G L+ L + QA +Q+
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD-DTITTSQGSPV- 208
G+ YLH +G+IHKDI N ++ + +KI+D A S D+F D + ++ PV
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD--NALSRDLFPMDYHCLGDNENRPVK 184
Query: 209 FQAPE-IANGLPEISGYKVDIWSSGVTL 235
+ A E + N + D+WS GV L
Sbjct: 185 WMALESLVNKEYSSAS---DVWSFGVLL 209
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-07
Identities = 34/88 (38%), Positives = 40/88 (45%), Gaps = 17/88 (19%)
Query: 148 LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSP 207
LQ L L LH Q K GN+LLT DG LK LD + T S+ P
Sbjct: 24 LQCLGALRELHRQA------KSGNILLTWDGLLK---------LDGSVAFKTPEQSRPDP 68
Query: 208 VFQAPEIANGLPEISGYKVDIWSSGVTL 235
F APE+ G K DI+S G+TL
Sbjct: 69 YFMAPEVIQGQSY--TEKADIYSLGITL 94
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-07
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 44 LLGEGSYGKVKE------MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
LG G++G+V E + R AVK +K + +E L+ H
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNH 58
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL-QLLD---- 152
N++ L+ V + ++ Q Y+IME GG D+L + + L +LLD
Sbjct: 59 PNIVKLLGVCLLNEPQ--YIIMELMEGG--DLLSYLRDARVERFGPPLLTLKELLDICLD 114
Query: 153 ---GLEYLHSQGIIHKDIKPGNLLLTLDG-----TLKISDFGVAESLDMFLHDDTITTSQ 204
G YL IH+D+ N L++ G +KI DFG+A D++ D +
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYYRKEGE 172
Query: 205 GS-PV-FQAPE-IANGLPEISGYKVDIWSSGV 233
G PV + APE + +G D+WS GV
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQS---DVWSFGV 201
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-07
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 34/206 (16%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKK---------KLQRIPNGEINVDREIRLLKML 95
+G G +G+V CR +K+ KK K ++ E ++
Sbjct: 12 IGGGEFGEV---------CRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF 62
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H N+I L V K + + +I EY G D KF + Q G + G++
Sbjct: 63 DHPNIIRLEGVVT--KSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG-SPV-FQAPE 213
YL +H+D+ N+L+ + K+SDFG++ L+ + T TT G P+ + APE
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS--EATYTTKGGKIPIRWTAPE 178
Query: 214 IANGLPEISGYKV----DIWSSGVTL 235
I+ K D+WS G+ +
Sbjct: 179 ------AIAYRKFTSASDVWSFGIVM 198
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-07
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR--IPNGEINVDREIRLLKMLQHRNVIG 102
LGEG++GKV + + LC KI K + N + RE LL LQH +++
Sbjct: 13 LGEGAFGKVF-LAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQD------------MLDSTPYKKFPIWQAHGYFLQL 150
V V + + ++ EY G + M + + Q Q+
Sbjct: 72 FYGVCV--EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD-DTITTSQGSPVF 209
G+ YL SQ +H+D+ N L+ + +KI DFG+ S D++ D + P+
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGM--SRDVYSTDYYRVGGHTMLPIR 187
Query: 210 QAPEIANGLPEISGYK-----VDIWSSGVTL 235
P PE Y+ D+WS GV L
Sbjct: 188 WMP------PESIMYRKFTTESDVWSLGVVL 212
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-07
Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 45/223 (20%)
Query: 45 LGEGSYGKVKE-----MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN 99
+G+G++G+V + +L E AVK+ K++ + + RE L+ H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA---DFQREAALMAEFDHPN 69
Query: 100 VIGLVDVFVNDKKQKMYLIMEY-CVGGLQDML-DSTPY-----------------KKFPI 140
++ L+ V K M L+ EY G L + L +P P+
Sbjct: 70 IVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 141 WQAH--GYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDD 198
Q+ G+ YL + +H+D+ N L+ + +KI+DFG+ S +++ D
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL--SRNIYSADY 185
Query: 199 -TITTSQGSPVFQAPEIANGLPEISGY-----KVDIWSSGVTL 235
+ + P+ P PE Y + D+W+ GV L
Sbjct: 186 YKASENDAIPIRWMP------PESIFYNRYTTESDVWAYGVVL 222
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-07
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 38 KYVMGDLLGEGSYGKVKE-----MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLL 92
K M LG+GS+G V E ++ E R A+K + R I E ++
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR---ERIEFLNEASVM 63
Query: 93 KMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG--------LQDMLDSTPYKKFP----I 140
K +V+ L+ V + Q +IME G L+ +++ P + P +
Sbjct: 64 KEFNCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 141 WQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200
Q G ++ DG+ YL++ +H+D+ N ++ D T+KI DFG+ D++ D
Sbjct: 122 IQMAG---EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR 176
Query: 201 TTSQG-SPV-FQAPE-IANGLPEISGYKVDIWSSGVTL 235
+G PV + +PE + +G+ D+WS GV L
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 40/217 (18%)
Query: 43 DLLGEGSYGKV------KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
D++GEG++G+V K+ L + +R +K + K R GE+ V L K+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEV-----LCKLGH 66
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCV-GGLQD------MLDSTPYKKFPIWQAHGYFL- 148
H N+I L+ + + +YL +EY G L D +L++ P F I + L
Sbjct: 67 HPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP--AFAIANSTASTLS 122
Query: 149 --QLLD-------GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT 199
QLL G++YL + IH+D+ N+L+ + KI+DFG++ ++++
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--- 179
Query: 200 ITTSQGSPV-FQAPEIANGLPEISGYKVDIWSSGVTL 235
T PV + A E N + D+WS GV L
Sbjct: 180 -KTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLL 213
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 18/165 (10%)
Query: 41 MGDLLGEGSYGKVKE---MLDSETLCRRAVKIFKKKKLQRIPNGEI-NVDREIRLLKMLQ 96
+G +LGEG +G V E D + + AVK K L EI E +K
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK---LDIHTYSEIEEFLSEAACMKDFD 59
Query: 97 HRNVIGLVDV-FVNDKKQKM---YLIMEYCVGG------LQDMLDSTPYKKFPIWQAHGY 146
H NV+ L+ V F QK+ +I+ + G L L P +K P+ +
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP-EKLPLQTLLKF 118
Query: 147 FLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
+ + G+EYL ++ IH+D+ N +L D T+ ++DFG+++ +
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI 163
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-06
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 13/154 (8%)
Query: 87 REIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGY 146
E ++ H N+I L V K + + ++ EY G D +F + Q G
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVT--KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGM 111
Query: 147 FLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDD---TITTS 203
+ G++YL G +H+D+ N+L+ + K+SDFG L L DD TT
Sbjct: 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFG----LSRVLEDDPEAAYTTR 167
Query: 204 QGS-PV-FQAPEIANGLPEISGYKVDIWSSGVTL 235
G P+ + APE A + + D+WS G+ +
Sbjct: 168 GGKIPIRWTAPE-AIAYRKFTSAS-DVWSYGIVM 199
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 88 EIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYF 147
E+ + K+ H N++ F+ D +++++ + G L T + A Y
Sbjct: 49 ELHVSKLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYI 106
Query: 148 LQ-LLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS 206
LQ +L L+Y+H G +H+ +K ++L+++DG + +S G+ +L M H +
Sbjct: 107 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDF 164
Query: 207 PVFQAPEIANGLPEI-----SGY--KVDIWSSGVT 234
P + + PE+ GY K DI+S G+T
Sbjct: 165 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 199
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 33/215 (15%)
Query: 41 MGDLLGEGSYGKVKE--MLDSETLCRRAVKIFKKKKLQRIPNGEI-NVDREIRLLKMLQH 97
+G LGEG +G V E + +++ + AVK K R E+ + E +K H
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR---SEMEDFLSEAVCMKEFDH 59
Query: 98 RNVIGLVDVFVNDKKQKMY----LIMEYCVGG------LQDMLDSTPYKKFPIWQAHGYF 147
NV+ L+ V + + + Y +I+ + G L L P + P +
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP-QYLPTQMLVKFM 118
Query: 148 LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL---DMFLHDDTITTSQ 204
+ G+EYL S+ IH+D+ N +L + + ++DFG+++ + D + Q
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY--------RQ 170
Query: 205 GSPVFQAP----EIANGLPEISGYKVDIWSSGVTL 235
G + + P I + + K D+WS GVT+
Sbjct: 171 GR-IAKMPVKWIAIESLADRVYTTKSDVWSFGVTM 204
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-06
Identities = 42/153 (27%), Positives = 79/153 (51%), Gaps = 17/153 (11%)
Query: 44 LLGEGSYGKV--KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLLKMLQHR 98
++G+G +G V ++DS+ + + K L RI + E V+ +E ++K H
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQ-KIHCAV---KSLNRITDLE-EVEQFLKEGIIMKDFSHP 56
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS---TPYKKFPIWQAHGYFLQLLDGLE 155
NV+ L+ + + + + ++ G L++ + S P K I G+ LQ+ G+E
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI----GFGLQVAKGME 112
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188
YL S+ +H+D+ N +L T+K++DFG+A
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKVADFGLA 145
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG 205
Y Q+ G+E+L S+ IH+D+ N+LL+ + +KI DFG+A D++ D +
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGDA 235
Query: 206 S-PV-FQAPEIANGLPEISGYKVDIWSSGVTL 235
P+ + APE + ++ + D+WS GV L
Sbjct: 236 RLPLKWMAPE--SIFDKVYTTQSDVWSFGVLL 265
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG 205
Y Q+ G+E+L S+ IH+D+ N+LL+ + +KI DFG+A D++ D +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGSA 236
Query: 206 S-PV-FQAPEIANGLPEISGYKVDIWSSGVTL 235
P+ + APE + ++ + D+WS GV L
Sbjct: 237 RLPLKWMAPE--SIFDKVYTTQSDVWSFGVLL 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 27/171 (15%)
Query: 45 LGEGSYGKV------------KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIR 90
LGEG +G+V + + + V + K L+ N D +EI+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPV-LVAVKMLREDANKNARNDFLKEIK 71
Query: 91 LLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL-- 148
++ L+ N+I L+ V + M I EY G + S + +A +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCM--ITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 149 --------QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
Q+ G++YL S +H+D+ N L+ + T+KI+DFG++ +L
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 48/198 (24%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 45 LGEGSYGKVKE---MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVI 101
LG G++G VK+ + + + A+K+ K + + + + + RE ++ L + ++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQI-DVAIKVLKNENEKSVRD---EMMREAEIMHQLDNPYIV 58
Query: 102 GLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG 161
++ V + + + L+ME GG + S + + Q+ G++YL +
Sbjct: 59 RMIGVC---EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS---PV-FQAPEIANG 217
+H+D+ N+LL KISDFG++++L DD+ ++ + P+ + APE N
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINF 172
Query: 218 LPEISGYKVDIWSSGVTL 235
S + D+WS G+T+
Sbjct: 173 RKFSS--RSDVWSYGITM 188
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 35/206 (16%)
Query: 45 LGEGSYGKVK----EMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV 100
LG G++G VK +M SE AVKI K N D +R ++Q +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTV--AVKILKNDN-----NDPALKDELLREANVMQQLDN 55
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAH-------GYFLQLLDG 153
+V + + + L+ME + + P KF H Q+ G
Sbjct: 56 PYIVRMIGICEAESWMLVME--------LAELGPLNKFLQKNKHVTEKNITELVHQVSMG 107
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS---PV-F 209
++YL +H+D+ N+LL KISDFG++++L D+ ++ PV +
Sbjct: 108 MKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALG---ADENYYKAKTHGKWPVKW 164
Query: 210 QAPEIANGLPEISGYKVDIWSSGVTL 235
APE N S K D+WS GV +
Sbjct: 165 YAPECMNYYKFSS--KSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 40/169 (23%), Positives = 71/169 (42%), Gaps = 24/169 (14%)
Query: 45 LGEGSYGKVK-----------EMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLK 93
LGEG +G+V E + + K + + +EI+++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTP--YKKFPI--------WQA 143
L++ N+I L+ V V+D + +I EY G + S F
Sbjct: 73 RLKNPNIIRLLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 144 HGYF-LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
Y +Q+ G++YL S +H+D+ N L+ T+KI+DFG++ +L
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG 205
Y Q+ G+E+L S+ IH+D+ N+LL+ + +KI DFG+A D++ D +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGDA 241
Query: 206 S-PV-FQAPEIANGLPEISGYKVDIWSSGVTL 235
P+ + APE + + D+WS GV L
Sbjct: 242 RLPLKWMAPETI--FDRVYTIQSDVWSFGVLL 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-06
Identities = 38/147 (25%), Positives = 78/147 (53%), Gaps = 5/147 (3%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGL 103
++G G +G+V ++T A+K KK++ ++ GE E +L ++ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 104 VDV-FVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG 161
V + + K+ I++ GG L L + + F + Y +++ GLE++H++
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVA 188
++++D+KP N+LL G ++ISD G+A
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-06
Identities = 17/43 (39%), Positives = 33/43 (76%)
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188
Y +++ GLE++H++ ++++D+KP N+LL G ++ISD G+A
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-06
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 35/212 (16%)
Query: 45 LGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN 99
LG+GS+G V ++++ E R AVK + R I E ++K +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR---ERIEFLNEASVMKGFTCHH 70
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDS------------TPYKKFPIWQAHGY 146
V+ L+ V K Q ++ME G L+ L S P + I A
Sbjct: 71 VVRLLGVV--SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA-- 126
Query: 147 FLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG- 205
++ DG+ YL+++ +H+D+ N ++ D T+KI DFG+ D++ D +G
Sbjct: 127 --EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGL 182
Query: 206 SPV-FQAPE-IANGLPEISGYKVDIWSSGVTL 235
PV + APE + +G+ + D+WS GV L
Sbjct: 183 LPVRWMAPESLKDGV--FTTSS-DMWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-06
Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 39/216 (18%)
Query: 45 LGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN 99
LGEG++GKV +L + AVK K+ + + RE LL +LQH++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----ESARQDFQREAELLTVLQHQH 68
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDS-------------TPYKKFPIWQAHG 145
++ V + + ++ EY G L L S + + Q
Sbjct: 69 IVRFYGVCTEG--RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD-DTITTSQ 204
Q+ G+ YL S +H+D+ N L+ +KI DFG+ S D++ D +
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGM--SRDIYSTDYYRVGGRT 184
Query: 205 GSPVFQAPEIANGLPEISGYK-----VDIWSSGVTL 235
P+ P PE Y+ DIWS GV L
Sbjct: 185 MLPIRWMP------PESILYRKFTTESDIWSFGVVL 214
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-05
Identities = 57/216 (26%), Positives = 84/216 (38%), Gaps = 37/216 (17%)
Query: 45 LGEGSYGKVKE-----MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM----L 95
LGE +GKV + E A+K K K E + E + M L
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-------AEGPLREEFKHEAMMRSRL 65
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYC-VGGLQDML--------------DSTPYKKFPI 140
QH N++ L+ V K+Q + +I YC L + L D T
Sbjct: 66 QHPNIVCLLGVVT--KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123
Query: 141 WQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200
Q+ G+E+L S ++HKD+ N+L+ +KISD G+ + + +
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 201 TTSQGSPVFQAPE-IANGLPEISGYKVDIWSSGVTL 235
S + +PE I G I DIWS GV L
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDS---DIWSYGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 14/93 (15%)
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS-- 206
Q+ G+E+L S+ +H+D+ N+LL +KI DFG+A + +HD S+GS
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI---MHDSNY-VSKGSTF 300
Query: 207 -PV-FQAPE--IANGLPEISGYKVDIWSSGVTL 235
PV + APE N +S D+WS G+ L
Sbjct: 301 LPVKWMAPESIFDNLYTTLS----DVWSYGILL 329
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-05
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 31/209 (14%)
Query: 45 LGEGSYGKV--KEMLDSETLCRRAVKIFK-----KKKLQRIPNGEINVDREIRLLKMLQH 97
+G G +GKV E+ + R VK K K++ + + G+ ++LQH
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDP--------YRILQH 54
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYC-VGGLQDMLDSTP--YKKFPIWQAHGYFLQLLDGL 154
N++ + V + L+ EYC +G L+ L + + ++ G+
Sbjct: 55 PNILQCLGQCV--EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV---FQA 211
++H +H D+ N LT D T+K+ D+G+ S +D I T V + A
Sbjct: 113 THMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSR---YKEDYIETEDDKCVPLRWLA 169
Query: 212 PEIA----NGLPEISGYKV-DIWSSGVTL 235
PE+ GL K ++W+ GVTL
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTL 198
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 16/98 (16%)
Query: 145 GYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ 204
G+ Q+ +G+E+L S+ +H+D+ N+L+ +KI DFG+A + + D S+
Sbjct: 243 GFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDI---MRDSNY-ISK 298
Query: 205 GS---PV-FQAPE-IANGLPEISGYKV--DIWSSGVTL 235
GS P+ + APE I N L Y D+WS G+ L
Sbjct: 299 GSTFLPLKWMAPESIFNNL-----YTTLSDVWSFGILL 331
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-05
Identities = 32/142 (22%), Positives = 64/142 (45%), Gaps = 20/142 (14%)
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
N++ L V++ ++L++++ GG L + + P + +++ L+ L
Sbjct: 46 NMVCLHKYIVSE--DSVFLVLQHAEGGKLWSHISK--FLNIPEECVKRWAAEMVVALDAL 101
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFG----VAESLDMFLHDDTITTSQGSPVFQAPE 213
H +GI+ +D+ P N+LL G ++++ F V +S D + + ++ APE
Sbjct: 102 HREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD----GEAV-----ENMYCAPE 152
Query: 214 IANGLPEISGYKVDIWSSGVTL 235
+ E D WS G L
Sbjct: 153 VGGISEETEA--CDWWSLGAIL 172
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-05
Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 25/161 (15%)
Query: 45 LGEGSYGKVKEML------DSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLLKMLQ 96
LG G++G+V E L D+ L V + K L + + D E ++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVEL---QVAV---KTLPESCSEQDESDFLMEALIMSKFN 67
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML-DSTPYKKFPIWQAHGYFLQL-LD- 152
H+N++ L+ V ++ ++++E GG L+ L ++ P + P L D
Sbjct: 68 HQNIVRLIGVSF--ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 153 --GLEYLHSQGIIHKDIKPGNLLLTLDG---TLKISDFGVA 188
G +YL IH+DI N LLT G KI+DFG+A
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 7e-05
Identities = 33/132 (25%), Positives = 59/132 (44%), Gaps = 23/132 (17%)
Query: 69 IFK--KKKLQRIP--NGEINVDREIRLLKMLQHRNVIG-----LVDVFVNDKKQKMYLIM 119
+ K K R P + I +R R +++ G + V ++M
Sbjct: 23 VIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE----NFIIVM 78
Query: 120 EYCVGG--LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD 177
EY + G L+D+++S ++ + + G + L HS GIIH D+ N++L+
Sbjct: 79 EY-IEGEPLKDLINSNGMEELELSREIGRLVGKL------HSAGIIHGDLTTSNMILS-G 130
Query: 178 GTLKISDFGVAE 189
G + + DFG+AE
Sbjct: 131 GKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-05
Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 34/214 (15%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLLKMLQHRNVIG 102
LGEG++GKV + + L K+ K + P D RE LL LQH +++
Sbjct: 13 LGEGAFGKVF-LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 103 LVDVFVNDKKQKMYLIMEYCVGGLQD------------MLDSTPYK---KFPIWQAHGYF 147
V + + ++ EY G + ++D P + + + Q
Sbjct: 72 FYGVCGDG--DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 148 LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD-DTITTSQGS 206
Q+ G+ YL SQ +H+D+ N L+ + +KI DFG+ S D++ D +
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM--SRDVYSTDYYRVGGHTML 187
Query: 207 PVFQAPEIANGLPEISGYK-----VDIWSSGVTL 235
P+ P PE Y+ D+WS GV L
Sbjct: 188 PIRWMP------PESIMYRKFTTESDVWSFGVIL 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-05
Identities = 27/89 (30%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 148 LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSP 207
+Q+ G+ YL ++H+D+ N+L+ +KI+DFG+A LD+ D+T + G
Sbjct: 116 VQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI---DETEYHADGGK 172
Query: 208 V-FQAPEIANGLPEISGYKVDIWSSGVTL 235
V + + + L ++ D+WS GVT+
Sbjct: 173 VPIKWMALESILHRRFTHQSDVWSYGVTV 201
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 9e-05
Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 39/181 (21%)
Query: 45 LGEGSYGKVK--EMLDSETL--------CRR------AVKIFKKKKLQRIPNGEINVDRE 88
LGEG +G+V E+++ + L R+ AVKI + + N + +E
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK---NARNDFLKE 69
Query: 89 IRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-------LQDMLDSTPYKKFPIW 141
+++L L+ N+I L+ V V++ + +I EY G + D +
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 142 QAH-----------GYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190
AH LQ+ G++YL S +H+D+ N L+ + T+KI+DFG++ +
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 191 L 191
L
Sbjct: 188 L 188
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 12/92 (13%)
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS-- 206
Q+ G+ +L S+ IH+D+ N+LLT KI DFG+A + +D+ +G+
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD----IRNDSNYVVKGNAR 277
Query: 207 -PV-FQAPE-IANGLPEISGYKVDIWSSGVTL 235
PV + APE I N + ++ D+WS G+ L
Sbjct: 278 LPVKWMAPESIFNC---VYTFESDVWSYGILL 306
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 59/220 (26%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 45 LGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGL 103
LGE ++GK+ K L + + K K P +E L+ L H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 104 VDVFVNDKKQKMYLIMEYCV-GGLQDML---------------DSTPYKKFPIWQAHGYF 147
+ V ++Q + ++ EY G L + L D T HG F
Sbjct: 73 LGVVT--QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD----HGDF 126
Query: 148 L----QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE---SLDMFLHDDTI 200
L Q+ G+EYL S +HKD+ N+L+ +KISD G++ S D + +
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY----RV 182
Query: 201 TTSQGSPVFQAPEIANGLPEISGY-----KVDIWSSGVTL 235
P+ P PE Y DIWS GV L
Sbjct: 183 QPKSLLPIRWMP------PEAIMYGKFSSDSDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 43/137 (31%), Positives = 66/137 (48%), Gaps = 27/137 (19%)
Query: 117 LIMEYC-VGGLQDMLDS-------TPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIK 168
L+ME+C +G L+ L S TP Q + L GL +LH IH D+
Sbjct: 72 LVMEFCPLGDLKGYLRSCRKAELMTP--DPTTLQRMACEIAL--GLLHLHKNNFIHSDLA 127
Query: 169 PGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ-GSPV-FQAPEIANGLPEISGYKV 226
N LLT D T+KI D+G++ + + D +T Q P+ + APE+ + E+ G +
Sbjct: 128 LRNCLLTADLTVKIGDYGLSHN--KYKEDYYVTPDQLWVPLRWIAPEL---VDEVHGNLL 182
Query: 227 --------DIWSSGVTL 235
++WS GVT+
Sbjct: 183 VVDQTKESNVWSLGVTI 199
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 47/199 (23%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 44 LLGEGSYGKVKEML---DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV 100
+LG G++G V + L + E + + V I K+ + P + E ++ + + +V
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKV-KIPVAI-KELREATSPKANKEILDEAYVMASVDNPHV 71
Query: 101 IGLVDVFVNDKKQKMYLIMEY-CVGGLQDMLDSTPYKKFPIWQAH--GYFLQLLDGLEYL 157
L+ + + Q + +M + C +LD K I + + +Q+ G+ YL
Sbjct: 72 CRLLGICLTSTVQLITQLMPFGC------LLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV-FQAPEIAN 216
+ ++H+D+ N+L+ +KI+DFG+A+ L D+ ++G V + + +
Sbjct: 126 EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---DEKEYHAEGGKVPIKWMALES 182
Query: 217 GLPEISGYKVDIWSSGVTL 235
L I ++ D+WS GVT+
Sbjct: 183 ILHRIYTHQSDVWSYGVTV 201
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 2e-04
Identities = 26/89 (29%), Positives = 34/89 (38%), Gaps = 21/89 (23%)
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYF------ 147
M + N I L K LIM+Y G D+ F + + G
Sbjct: 65 MKDNPNFIKLYYSVTTLKGH--VLIMDYIKDG--DL--------FDLLKKEGKLSEAEVK 112
Query: 148 ---LQLLDGLEYLHSQGIIHKDIKPGNLL 173
QL++ L LH IIH DIK N+L
Sbjct: 113 KIIRQLVEALNDLHKHNIIHNDIKLENVL 141
|
Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 25/88 (28%), Positives = 47/88 (53%), Gaps = 2/88 (2%)
Query: 148 LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSP 207
+Q+ G+ YL ++H+++ N+LL D ++I+DFGVA+ L + D S+
Sbjct: 116 VQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL--YPDDKKYFYSEHKT 173
Query: 208 VFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ + + L ++ D+WS GVT+
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTV 201
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 13/93 (13%)
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQ 210
L GL YLH G IH++IK ++L++ DG + +S G++ + + P F
Sbjct: 111 LRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFS 168
Query: 211 -------APEIANGLPEISGYKV--DIWSSGVT 234
+PE+ ++ GY V DI+S G+T
Sbjct: 169 TSVLPWLSPELLR--QDLYGYNVKSDIYSVGIT 199
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 3e-04
Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 16/118 (13%)
Query: 125 GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISD 184
+D D+ + + Q+ G+++L S+ IH+D+ N+LLT KI D
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICD 255
Query: 185 FGVAESLDMFLHDDTITTSQGS---PV-FQAPE-IANGLPEISGYKV--DIWSSGVTL 235
FG+A + +D+ +G+ PV + APE I + + Y V D+WS G+ L
Sbjct: 256 FGLARD----IMNDSNYVVKGNARLPVKWMAPESIFDCV-----YTVQSDVWSYGILL 304
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 5e-04
Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 40/220 (18%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKK-KKLQRIPNGEINVDREIRLLKML 95
++ + LLGEG++GKV E D + AVKI + K R EI ++R
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPA 188
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLL---- 151
++ + F N+ ++ +Y L ++ P+ +H + Q++
Sbjct: 189 DRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPF-------SHRHLAQIIFQTG 241
Query: 152 DGLEYLHSQ-GIIHKDIKPGNLLLTLDGT----------------LKISDFG--VAESLD 192
L+Y H++ ++H D+KP N+L+ T ++I D G E
Sbjct: 242 VALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-- 299
Query: 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSG 232
H T S + +++PE+ GL + Y D+WS G
Sbjct: 300 ---HSRTAIVS--TRHYRSPEVVLGLGWM--YSTDMWSMG 332
|
Length = 467 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 56/225 (24%), Positives = 86/225 (38%), Gaps = 45/225 (20%)
Query: 27 DNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKL----QRIPNGE 82
DNK+IK++ I LG G +G++ CR +K+ K++L + G
Sbjct: 3 DNKSIKIERI--------LGTGRFGEL---------CRGCLKLPSKRELPVAIHTLRAGC 45
Query: 83 INVDR-----EIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKK 137
+ R E L H N++ L V + M ++ EY G D +
Sbjct: 46 SDKQRRGFLAEALTLGQFDHSNIVRLEGVIT--RGNTMMIVTEYMSNGALDSFLRKHEGQ 103
Query: 138 FPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197
Q G L G++YL G +HK + +L+ D KIS F +
Sbjct: 104 LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS---- 159
Query: 198 DTITTSQG--SPVFQAPEIANGLPEISGY-----KVDIWSSGVTL 235
+ I T+ SPV A PE Y D+WS G+ +
Sbjct: 160 EAIYTTMSGKSPVLWAA------PEAIQYHHFSSASDVWSFGIVM 198
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.003
Identities = 40/175 (22%), Positives = 79/175 (45%), Gaps = 17/175 (9%)
Query: 28 NKTIKVKMIGK-YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR--------I 78
+ + GK + + L+G G +G V E + C + K + L+ +
Sbjct: 2 EGIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLV 61
Query: 79 PNGEINVDREIRLLKMLQHRNVIGLVDVFV--NDKKQKMY---LIMEYCVGGLQDMLDST 133
N ++D+ I L K + + + +G+ + + K+ +MY +++E V +++
Sbjct: 62 YNNIYDIDK-IALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI 120
Query: 134 PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188
K + + +L LEY+H GI H DIKP N+++ + I D+G+A
Sbjct: 121 KCKNKKLIKN--IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 36.9 bits (86), Expect = 0.003
Identities = 30/139 (21%), Positives = 55/139 (39%), Gaps = 32/139 (23%)
Query: 64 RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIG-----------LVDVFVNDKK 112
AV + K R P +D ++R + + ++ + DV +
Sbjct: 20 LPAVVKERIPKRYRHPE----LDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD--- 72
Query: 113 QKMYLIMEYCVGG--LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPG 170
++MEY + G L+D L+ + + G + L H GI+H D+
Sbjct: 73 -NGLIVMEY-IEGELLKDALEEARP---DLLREVGRLVGKL------HKAGIVHGDLTTS 121
Query: 171 NLLLTLDGTLKISDFGVAE 189
N++L+ G + DFG+ E
Sbjct: 122 NIILS-GGRIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 37/165 (22%), Positives = 62/165 (37%), Gaps = 34/165 (20%)
Query: 87 REIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYC-VGGLQDMLDSTPYKKFPIWQAHG 145
L+ L H++++ L V V D+ ++ EY G L L +
Sbjct: 50 ETASLMSQLSHKHLVKLYGVCVRDENI---MVEEYVKFGPLDVFLHREKN---NVSLH-- 101
Query: 146 YFL----QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT-------LKISDFGVAESLDMF 194
+ L QL L YL + ++H ++ N+L+ G +K+SD G+ ++
Sbjct: 102 WKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV--- 158
Query: 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDI----WSSGVTL 235
S+ V + P IA + I WS G TL
Sbjct: 159 -------LSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTL 196
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 36.6 bits (85), Expect = 0.004
Identities = 28/117 (23%), Positives = 48/117 (41%), Gaps = 13/117 (11%)
Query: 75 LQRIPNGEINVDR--EIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS 132
L+ P+ E DR E+ +L++L + + + + YL+ME+ G D +
Sbjct: 26 LKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSE 85
Query: 133 TPYKKFPIWQAHGYFLQLLDGLEYLHSQ---GIIHKDIKPGNLLLTLDGTLKISDFG 186
+ QL + L LH + H D+ PGN+L+ L I D+
Sbjct: 86 EEKEDI--------AEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 235 | |||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| KOG2345|consensus | 302 | 100.0 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG1152|consensus | 772 | 100.0 | ||
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| KOG0662|consensus | 292 | 99.98 | ||
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| KOG0579|consensus | 1187 | 99.98 | ||
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG0668|consensus | 338 | 99.98 | ||
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.98 | |
| KOG0612|consensus | 1317 | 99.98 | ||
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| KOG4279|consensus | 1226 | 99.97 | ||
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0607|consensus | 463 | 99.97 | ||
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG1006|consensus | 361 | 99.97 | ||
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1026|consensus | 774 | 99.97 | ||
| KOG4645|consensus | 1509 | 99.97 | ||
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1094|consensus | 807 | 99.97 | ||
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0574|consensus | 502 | 99.97 | ||
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| KOG1095|consensus | 1025 | 99.97 | ||
| KOG2052|consensus | 513 | 99.97 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| KOG0690|consensus | 516 | 99.97 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| KOG0984|consensus | 282 | 99.97 | ||
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| KOG0669|consensus | 376 | 99.97 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| KOG1035|consensus | 1351 | 99.97 | ||
| KOG0196|consensus | 996 | 99.97 | ||
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0983|consensus | 391 | 99.97 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1151|consensus | 775 | 99.97 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG1290|consensus | 590 | 99.97 | ||
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG3653|consensus | 534 | 99.96 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0614|consensus | 732 | 99.96 | ||
| KOG0696|consensus | 683 | 99.96 | ||
| KOG0587|consensus | 953 | 99.96 | ||
| KOG0664|consensus | 449 | 99.96 | ||
| KOG0695|consensus | 593 | 99.96 | ||
| KOG0608|consensus | 1034 | 99.96 | ||
| KOG4278|consensus | 1157 | 99.96 | ||
| KOG0603|consensus | 612 | 99.96 | ||
| KOG4257|consensus | 974 | 99.95 | ||
| KOG1027|consensus | 903 | 99.95 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0670|consensus | 752 | 99.95 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665|consensus | 369 | 99.95 | ||
| KOG1345|consensus | 378 | 99.95 | ||
| KOG0199|consensus | 1039 | 99.95 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1163|consensus | 341 | 99.94 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG1025|consensus | 1177 | 99.94 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| KOG1167|consensus | 418 | 99.93 | ||
| KOG0576|consensus | 829 | 99.93 | ||
| KOG0200|consensus | 609 | 99.93 | ||
| KOG1164|consensus | 322 | 99.92 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG1165|consensus | 449 | 99.91 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1024|consensus | 563 | 99.84 | ||
| KOG1166|consensus | 974 | 99.84 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0590|consensus | 601 | 99.81 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| KOG1240|consensus | 1431 | 99.77 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| KOG0195|consensus | 448 | 99.72 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG4158|consensus | 598 | 99.69 | ||
| KOG0603|consensus | 612 | 99.67 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.59 | |
| KOG3087|consensus | 229 | 99.58 | ||
| KOG0606|consensus | 1205 | 99.58 | ||
| KOG1033|consensus | 516 | 99.57 | ||
| KOG0590|consensus | 601 | 99.54 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| KOG1023|consensus | 484 | 99.53 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.48 | |
| KOG1243|consensus | 690 | 99.35 | ||
| KOG1266|consensus | 458 | 99.34 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.33 | |
| KOG0601|consensus | 524 | 99.32 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.18 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.15 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.11 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 99.08 | |
| KOG3741|consensus | 655 | 99.07 | ||
| KOG0601|consensus | 524 | 98.98 | ||
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.96 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.81 | |
| KOG2137|consensus | 700 | 98.77 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.65 | |
| KOG1235|consensus | 538 | 98.64 | ||
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.63 | |
| KOG0606|consensus | 1205 | 98.6 | ||
| KOG2270|consensus | 520 | 98.43 | ||
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.38 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.37 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.36 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.31 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.28 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.24 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.13 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.07 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.04 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.03 | |
| KOG2268|consensus | 465 | 98.02 | ||
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.92 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.76 | |
| KOG0576|consensus | 829 | 97.74 | ||
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.73 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.72 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.65 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.6 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.51 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.41 | |
| PLN02236 | 344 | choline kinase | 97.21 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.19 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.18 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.12 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.03 | |
| KOG1035|consensus | 1351 | 96.99 | ||
| PTZ00384 | 383 | choline kinase; Provisional | 96.97 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.89 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.82 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.52 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.43 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.56 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.48 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.36 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.08 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.71 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.19 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.99 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.53 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.47 |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=280.98 Aligned_cols=201 Identities=36% Similarity=0.547 Sum_probs=172.1
Q ss_pred CCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC---CccccHHHHHHHHHhcCCCCcceee
Q psy787 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP---NGEINVDREIRLLKMLQHRNVIGLV 104 (235)
Q Consensus 28 ~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~ 104 (235)
++.......+.|.+.+.||+|+||.|-+|..+++++.||+|++.++...... .....+.+|+.+|+++.||+|+++.
T Consensus 163 ~~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~ 242 (475)
T KOG0615|consen 163 SKVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIK 242 (475)
T ss_pred ccCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEe
Confidence 3455556778899999999999999999999999999999999887766532 2334578999999999999999999
Q ss_pred eEEEcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC---CcE
Q psy787 105 DVFVNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD---GTL 180 (235)
Q Consensus 105 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~---~~~ 180 (235)
++| +.....|+||||++| .|.+.+..+ +.+.+..-..+++||+.|+.|||++||+||||||+||++..+ ..+
T Consensus 243 d~f--~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~ll 318 (475)
T KOG0615|consen 243 DFF--EVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLL 318 (475)
T ss_pred eee--ecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEE
Confidence 999 666788999999976 599999887 667777889999999999999999999999999999999876 679
Q ss_pred EEeeeccccccCccccCCcccccCCCCcccCccccCCCCC-CCCCcccEEEeeeeC
Q psy787 181 KISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPE-ISGYKVDIWSSGVTL 235 (235)
Q Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~~Di~slG~~l 235 (235)
||+|||+|+..+ ......+.+||+.|.|||++.+..- .+..+.|+|||||+|
T Consensus 319 KItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvL 371 (475)
T KOG0615|consen 319 KITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVL 371 (475)
T ss_pred Eecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceE
Confidence 999999999664 4567788999999999999976322 233488999999986
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=287.40 Aligned_cols=192 Identities=35% Similarity=0.597 Sum_probs=172.6
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
....+.|.+.++||+|+|++||+++++.++..||+|.+.+.... .+.++.+..|+.+|+.++|+||+.+++++ +..
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~--~k~~e~L~~Ei~iLkel~H~nIV~l~d~~--~~~ 81 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN--KKLVELLLSEIKILKELKHPNIVRLLDCI--EDD 81 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC--HHHHHHHHHHHHHHHhcCCcceeeEEEEE--ecC
Confidence 34568999999999999999999999999999999999877653 46667789999999999999999999999 677
Q ss_pred ceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC------CcEEEeee
Q psy787 113 QKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD------GTLKISDF 185 (235)
Q Consensus 113 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~------~~~~l~df 185 (235)
+++|+|||||. |+|.++++.. +.+++..++.++.||+.||++||+++|+||||||+||++... -.+||+||
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 79999999997 5799999987 689999999999999999999999999999999999999875 35899999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+++.+. +..-..+.+|++.|||||++.. .+|+-++|+||+|++|
T Consensus 160 GfAR~L~---~~~~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Il 204 (429)
T KOG0595|consen 160 GFARFLQ---PGSMAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTIL 204 (429)
T ss_pred chhhhCC---chhHHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHH
Confidence 9999776 4556677889999999999987 6799999999999875
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=284.88 Aligned_cols=190 Identities=35% Similarity=0.632 Sum_probs=172.7
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
.+|...+.||.|||+++|.+++..+|+.||+|++.+..... ....+.+.+|+.+.+.|.|||||+++++| ++..++|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k-~~~reKv~~EIeIHr~L~HpnIV~f~~~F--EDs~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK-PKQREKVLNEIEIHRSLKHPNIVQFYHFF--EDSNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC-cchHHHHHHHHHHHHhcCCCcEEeeeeEe--ecCCceE
Confidence 58999999999999999999999999999999998877665 46667899999999999999999999999 8888999
Q ss_pred EEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+|.|.|. ++|-.++... +++++.+++.+++||+.||.|||+++|+|||||..|+|++.+.++||+|||+|..+..
T Consensus 95 ivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~-- 170 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY-- 170 (592)
T ss_pred EEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--
Confidence 9999997 5677766644 8899999999999999999999999999999999999999999999999999998753
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...+..+.+|||.|.|||++... .-++.+||||+||+|
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvm 208 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVM 208 (592)
T ss_pred cccccceecCCCcccChhHhccC--CCCCchhhhhhhhHH
Confidence 44677889999999999999874 478899999999985
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=272.67 Aligned_cols=194 Identities=32% Similarity=0.508 Sum_probs=172.9
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
..-.+.|++++.||.|+||+|++++...+++.+|+|++++..+.. .+......+|..+|..++||+|+++...| ++.
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-~~e~~~~~~Er~IL~~v~hPFiv~l~ysF--Qt~ 97 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-KKEVRHTKAERNILSKIKHPFIVKLIYSF--QTE 97 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-hhhHHHHHHHHHHHHhCCCCcEeeeEEec--ccC
Confidence 445678999999999999999999999999999999999998886 35666788999999999999999999999 778
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+|+|++|+.| .|...++.. +.+++..+.-++..|+.||.|||++||+||||||+|||++.+|+++|+|||+++..
T Consensus 98 ~kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 899999999976 599888876 78999999999999999999999999999999999999999999999999999844
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
-. ........+||+.|+|||.+.+. .++.++|+||||+++
T Consensus 176 ~~--~~~~t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGill 215 (357)
T KOG0598|consen 176 LK--DGDATRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILL 215 (357)
T ss_pred cc--CCCccccccCCccccChHHHhcC--CCCcccchHhHHHHH
Confidence 21 22334457899999999999984 599999999999874
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=273.11 Aligned_cols=195 Identities=28% Similarity=0.463 Sum_probs=169.4
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
.-..|+|.++||+|+||+||++++..+|+.+|.|.++..... .+..+....|+.+|++++||||+++++.-+.+++..
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md--~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD--AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc--HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 345799999999999999999999999999999998855544 466778899999999999999999999665566666
Q ss_pred EEEEEeccc-CCHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHh--CC--cccCCCCCCCeEEccCCcEEEeeecc
Q psy787 115 MYLIMEYCV-GGLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHS--QG--IIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 115 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~--~~--i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
++|+||+|+ |+|...+... ....+++..+|+++.|++.||..+|+ .. +.||||||.||+++.+|.+||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 899999996 5688777643 33679999999999999999999999 34 89999999999999999999999999
Q ss_pred ccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++.+.+ ......+.+|||.||+||.+.+++ |++++|||||||+|
T Consensus 175 ~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~--Y~~kSDiWslGCll 218 (375)
T KOG0591|consen 175 GRFLSS--KTTFAHSLVGTPYYMSPERIHESG--YNFKSDIWSLGCLL 218 (375)
T ss_pred HhHhcc--hhHHHHhhcCCCcccCHHHHhcCC--CCcchhHHHHHHHH
Confidence 997753 344556788999999999999955 99999999999975
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=263.60 Aligned_cols=187 Identities=32% Similarity=0.480 Sum_probs=163.1
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
...+.++.||+|..|+||+++|+.+++.+|+|++... .....+..+.+|+.+++..+||+|+.+++.|+.+.. .+.
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~is 154 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EIS 154 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEE
Confidence 3677788999999999999999999999999999322 224556678999999999999999999999975544 699
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
|+||||++ +|.+.+... +.+++..+.+++.++++||.|||. .+|+||||||+|+++...|.+||+|||.+..+..
T Consensus 155 I~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn- 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN- 231 (364)
T ss_pred eehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh-
Confidence 99999975 688777766 789999999999999999999995 8999999999999999999999999999986642
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.-..+..||..|||||++.+ ..|+.++||||||+.|
T Consensus 232 ---S~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsl 267 (364)
T KOG0581|consen 232 ---SIANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSL 267 (364)
T ss_pred ---hhcccccccccccChhhhcC--CcCCcccceecccHHH
Confidence 24456779999999999999 5699999999999864
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=257.84 Aligned_cols=190 Identities=32% Similarity=0.512 Sum_probs=171.7
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
-..++|++++.||.|+||+|.+++++.+|..+|+|++++..... -+..+-..+|..+|+.+.||+++++++.+ .+..
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk-lKQveH~~nEk~vL~~v~~PFlv~l~~t~--~d~~ 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK-LKQVEHTHNEKRVLKAVSHPFLVKLYGTF--KDNS 117 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH-HHHHHHHhhHHHHHhhccCceeEEEEEee--ccCC
Confidence 45568999999999999999999999999999999999888775 34455678999999999999999999999 5677
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
++++||||.+| .|.+++++. +++++..++-++.+++.|++|||+++|++|||||+|||++.+|.++|+|||+|+...
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 89999999976 499999887 789999999999999999999999999999999999999999999999999998653
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+..+.+|||.|+|||.+.+.+ ++.++|+||||+++
T Consensus 196 -----~rT~TlCGTPeYLAPEii~sk~--ynkavDWWalGVLI 231 (355)
T KOG0616|consen 196 -----GRTWTLCGTPEYLAPEIIQSKG--YNKAVDWWALGVLI 231 (355)
T ss_pred -----CcEEEecCCccccChHHhhcCC--CCcchhHHHHHHHH
Confidence 3466789999999999998844 89999999999874
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=270.15 Aligned_cols=197 Identities=34% Similarity=0.507 Sum_probs=170.3
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...+.|+.+++||+|.||.||+|++..+|+.||+|.+...... ........+||.+|++|.||||+++.++..+...+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~--~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK--EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC--CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 4456788999999999999999999999999999998776533 24455678999999999999999999999877678
Q ss_pred eEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 114 KMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 114 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.+|+|+|||+-+|.-++... .-.+++.++..+++||++||+|||++|++|||||.+||||+.+|.+||+|||+|+.+..
T Consensus 192 siYlVFeYMdhDL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 192 SIYLVFEYMDHDLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred eEEEEEecccchhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99999999999988877653 36799999999999999999999999999999999999999999999999999997653
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. .....+..+-|.=|.|||.+.|. ..|+.+.|+||.||||
T Consensus 271 ~-~~~~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl 310 (560)
T KOG0600|consen 271 S-GSAPYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCIL 310 (560)
T ss_pred C-CCcccccceEEeeccChHHhcCC-cccccceeehhhhHHH
Confidence 2 22234555567779999999984 4699999999999985
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=269.31 Aligned_cols=198 Identities=40% Similarity=0.668 Sum_probs=171.0
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC-CccccHHHHHHHHHhcC-CCCcceeeeEEEc
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP-NGEINVDREIRLLKMLQ-HRNVIGLVDVFVN 109 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 109 (235)
.....++|.+.+.||+|+||+|+++.+..++..+|+|++......... .....+.+|+.+++.++ ||||++++.++
T Consensus 12 ~~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~-- 89 (370)
T KOG0583|consen 12 LQLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF-- 89 (370)
T ss_pred cccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE--
Confidence 346678999999999999999999999999999999988776443222 34445678999999998 99999999999
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC-CcEEEeeecc
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD-GTLKISDFGV 187 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~ 187 (235)
.....+++||||+.| .|.+++... +++.+.++..+++|+++|++|||+.||+||||||+|++++.+ +++||+|||+
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 555669999999976 799999884 889999999999999999999999999999999999999999 9999999999
Q ss_pred ccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+...+ .........+|++.|+|||++.+...+-+.++||||+|++|
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViL 213 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVIL 213 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHH
Confidence 98663 23456677889999999999988433556899999999975
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=257.23 Aligned_cols=200 Identities=31% Similarity=0.445 Sum_probs=175.8
Q ss_pred ceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 30 TIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 30 ~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
-..|..++.|+.+..|+.|+||.||+|+++++++.||+|.++..... .-....-.+|+++|...+||||+.+-.+.+.
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek--~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK--EGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc--CCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 56788899999999999999999999999999999999999876622 2344556799999999999999999999987
Q ss_pred CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 110 DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
.+-..+|+|||||+.+|.+++.... .+++..++..++.|+++|++|||.+.|+||||||+|+++...|.+||+|||+|+
T Consensus 147 ~~~d~iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred cccceeeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhh
Confidence 7777899999999999999998775 689999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+..+ ....+...-|.=|.|||.+.+. ..|+.+.||||+||++
T Consensus 226 ~ygsp--~k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~ 268 (419)
T KOG0663|consen 226 EYGSP--LKPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIF 268 (419)
T ss_pred hhcCC--cccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHH
Confidence 87643 2233444566779999999984 3689999999999985
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=246.57 Aligned_cols=191 Identities=35% Similarity=0.530 Sum_probs=167.2
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
.+|...+++|+|.||.||+|++.++|+.||+|.++.....+ .......+|++.|+.++|+||+.+.++| .....+-
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--Gi~~talREIK~Lqel~h~nIi~LiD~F--~~~~~l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--GINRTALREIKLLQELKHPNIIELIDVF--PHKSNLS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc--CccHHHHHHHHHHHHccCcchhhhhhhc--cCCCceE
Confidence 47888999999999999999999999999999998885442 3345678999999999999999999999 7777899
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+|+||++.+|...+.... ..++..++..++.++++|++|||++.|+||||||.|++++.+|.+||+|||+++.+..+.
T Consensus 78 lVfEfm~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~- 155 (318)
T KOG0659|consen 78 LVFEFMPTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN- 155 (318)
T ss_pred EEEEeccccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC-
Confidence 999999999999988764 789999999999999999999999999999999999999999999999999999775322
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......+.|.=|.|||.+.|+ ..|+...||||.||++
T Consensus 156 -~~~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~ 192 (318)
T KOG0659|consen 156 -RIQTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIF 192 (318)
T ss_pred -cccccceeeeeccChHHhccc-hhcCCcchhhhHHHHH
Confidence 222223566669999999885 4689999999999975
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=268.86 Aligned_cols=196 Identities=34% Similarity=0.555 Sum_probs=171.9
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDK 111 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 111 (235)
-+-...|..++.||.|+|++|++|.+..+++.+|+||..++.+.. ++....+..|-.+|.+| .||+|++++..| .+
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TF--QD 145 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTF--QD 145 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEe--ec
Confidence 345668999999999999999999999999999999999888776 45566788899999999 899999999999 66
Q ss_pred CceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...+|+|+||.+ |+|.+++... +.+++...+.++.+|+.||+|||++||+||||||+|||++.+++++|+|||.|+.
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence 678999999997 5699999887 8899999999999999999999999999999999999999999999999999998
Q ss_pred cCccccC---------Ccc--cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHD---------DTI--TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~---------~~~--~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++..... ... ...+||-.|.+||++... ..++++|+|+|||+|
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCil 277 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCIL 277 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHH
Confidence 7432222 111 346788999999999984 489999999999985
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=253.38 Aligned_cols=191 Identities=35% Similarity=0.564 Sum_probs=165.0
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
+.|+.+.++|.|++|+||+++++.+|+.||+|.+....... ....-..+|+++|++++|+|+|.+.++| .-++.++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~--~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrklh 77 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP--VVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKLH 77 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH--HHHHHHHHHHHHHHhcccchHHHHHHHH--HhcceeE
Confidence 46888999999999999999999999999999887654221 2223457999999999999999999999 6677899
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+|+|||+-++.+.+...+ .+++...+.++++|++.|+.|+|+++++||||||+||+|...|.+||||||+|+.+.. +
T Consensus 78 LVFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--p 154 (396)
T KOG0593|consen 78 LVFEYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--P 154 (396)
T ss_pred EEeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--C
Confidence 999999999888887765 6789999999999999999999999999999999999999999999999999997753 3
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...-+..+.|.=|.|||.+.|. .+|+.+.||||+||++
T Consensus 155 gd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~ 192 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVF 192 (396)
T ss_pred cchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHH
Confidence 3344455667779999999883 4699999999999974
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=268.23 Aligned_cols=193 Identities=27% Similarity=0.473 Sum_probs=169.4
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKK 112 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 112 (235)
...++|.++++||.|.||.||+|+...+++.||+|.++...... .+..=.+|+..|+++. ||||+++.+++.+..+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~---ee~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH---HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 45679999999999999999999999999999999988776542 2223468999999997 9999999999986554
Q ss_pred ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 113 QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 113 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++|||||+..|..++..+ ...+++..+..|++||+.||+|+|.+|+.|||+||+||++.....+||+|||+|+...
T Consensus 84 -~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 84 -ILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred -eEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 89999999999999999887 5899999999999999999999999999999999999999999999999999999665
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.....+..+.|.=|.|||++..+ ..|+.+.||||+||++
T Consensus 162 ---SkpPYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~ 200 (538)
T KOG0661|consen 162 ---SKPPYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIM 200 (538)
T ss_pred ---cCCCcchhhhcccccchHHhhhc-cccCCchHHHHHHHHH
Confidence 33445556677779999998763 6799999999999974
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=269.08 Aligned_cols=189 Identities=33% Similarity=0.629 Sum_probs=171.7
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|.+.+.||+|+||+||+++.+.+.+.||+|++.+.... .+....+.+|+++++.++||||+.++++| +....+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~--~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN--EKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc--hHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEE
Confidence 5789999999999999999999999999999999877654 35666789999999999999999999999 8889999
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+|.||+.|+|..++... +.+++..+..+++++++||.|||+.+|+|+|+||.||++..++.+|++|||+++.... +
T Consensus 78 vVte~a~g~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~ 153 (808)
T KOG0597|consen 78 VVTEYAVGDLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N 153 (808)
T ss_pred EEehhhhhhHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence 99999999999988876 7899999999999999999999999999999999999999999999999999986642 3
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..-.....|||.|||||.+.+.+ ++..+|+|||||++
T Consensus 154 t~vltsikGtPlYmAPElv~e~p--yd~~sDlWslGcil 190 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQP--YDHTSDLWSLGCIL 190 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCC--ccchhhHHHHHHHH
Confidence 44455667999999999999844 99999999999985
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=255.93 Aligned_cols=196 Identities=30% Similarity=0.465 Sum_probs=161.5
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhh-eeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCR-RAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~-~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
.........+.+.||+|+||+||++... |+. +|+|++......... ...|.+|+.++.+++||||++|+|++.
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~--~~~f~~E~~il~~l~HpNIV~f~G~~~-- 109 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES--RKAFRREASLLSRLRHPNIVQFYGACT-- 109 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH--HHHHHHHHHHHHhCCCCCeeeEEEEEc--
Confidence 3333455666677999999999998874 455 999999877655422 668999999999999999999999995
Q ss_pred CCc-eEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCC-cccCCCCCCCeEEccCC-cEEEeeec
Q psy787 111 KKQ-KMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG-IIHKDIKPGNLLLTLDG-TLKISDFG 186 (235)
Q Consensus 111 ~~~-~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~-i~H~dl~p~nili~~~~-~~~l~dfg 186 (235)
... .+++||||++ |+|..++.......++...++.++.+++.||+|||+++ |+||||||+|++++.+. ++||+|||
T Consensus 110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCc
Confidence 333 6899999997 56888888755588999999999999999999999999 99999999999999997 99999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+++...... .......||+.|||||++.+....++.++||||||++|
T Consensus 190 lsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvl 236 (362)
T KOG0192|consen 190 LSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVL 236 (362)
T ss_pred cceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHH
Confidence 998553211 23333568999999999984313599999999999975
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=245.03 Aligned_cols=194 Identities=36% Similarity=0.583 Sum_probs=161.2
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
..+|...+.||+|+||.||++.+.++|...|+|.+....... .+.+.+|+.+|..++|||||+++|.........+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT----SESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh----HHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 457889999999999999999999889999999887663221 4568899999999999999999997421222368
Q ss_pred EEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc-CCcEEEeeeccccccCc
Q psy787 116 YLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL-DGTLKISDFGVAESLDM 193 (235)
Q Consensus 116 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~~ 193 (235)
+++|||++ |+|.+++..... .+++..+..+.+|+++||.|||++|++|+||||+||+++. ++.+||+|||.+.....
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999996 479999988754 7999999999999999999999999999999999999999 69999999999987653
Q ss_pred -cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 -FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 -~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...........+++.|+|||.+.. .....+++|||||||++
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtV 212 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTV 212 (313)
T ss_pred ccccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEE
Confidence 111233445679999999999984 12344699999999975
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=253.08 Aligned_cols=190 Identities=33% Similarity=0.551 Sum_probs=162.4
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...+.|++.+.||.|+||.||++++..+++.+|+|++....... ......+.+|+.++..++||||+++++.+ ....
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~ 91 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK-MKQVQHVAQEKSILMELSHPFIVNMMCSF--QDEN 91 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHhCCCCCCCcEEEEE--EcCC
Confidence 34578999999999999999999999999999999997654332 23345678999999999999999999999 4566
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.++++|||+.+ +|.+.+... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 89999999965 688888765 568889999999999999999999999999999999999999999999999997553
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 170 ~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 205 (329)
T PTZ00263 170 D-----RTFTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLL 205 (329)
T ss_pred C-----CcceecCChhhcCHHHHcC--CCCCCcceeechHHHH
Confidence 2 2223468889999999987 4478999999999974
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=255.35 Aligned_cols=194 Identities=30% Similarity=0.474 Sum_probs=165.7
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..+.|.+++.||+|+||.||+|+.+.+|..+|+|++++..... .....-+.+|-.+|....++.+|+++..| .+..+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~-~~Qv~hV~aERdiL~~~ds~~vVKLyYsF--QD~~~ 215 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK-KNQVEHVRAERDILAEVDSPWVVKLYYSF--QDKEY 215 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh-hhhHHHHHHHHHHhhhcCCCcEEEEEEEe--cCCCe
Confidence 5678999999999999999999999999999999999887665 34445678899999999999999999999 77889
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+||||||++| +...++... ..+++..+..++.+++.|++-+|+.|++||||||+|+||+..|++||+|||++.-+..
T Consensus 216 LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred eEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999976 477777766 7899999999999999999999999999999999999999999999999999863311
Q ss_pred c-------------------ccC--C-----cc-------------------cccCCCCcccCccccCCCCCCCCCcccE
Q psy787 194 F-------------------LHD--D-----TI-------------------TTSQGSPVFQAPEIANGLPEISGYKVDI 228 (235)
Q Consensus 194 ~-------------------~~~--~-----~~-------------------~~~~~~~~~~aPE~~~~~~~~~~~~~Di 228 (235)
. .+. . .. ...+|||.|+|||++.+. .|+..+|+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDw 371 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDW 371 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccH
Confidence 0 000 0 00 023489999999999984 49999999
Q ss_pred EEeeeeC
Q psy787 229 WSSGVTL 235 (235)
Q Consensus 229 ~slG~~l 235 (235)
|||||++
T Consensus 372 WSLG~Im 378 (550)
T KOG0605|consen 372 WSLGCIM 378 (550)
T ss_pred HHHHHHH
Confidence 9999985
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=246.98 Aligned_cols=198 Identities=32% Similarity=0.508 Sum_probs=163.4
Q ss_pred ecCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeee
Q psy787 26 YDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVD 105 (235)
Q Consensus 26 ~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 105 (235)
+.+...+....=.|+-.+.+|+|+||.||.+....+++.+|+|..-+.... =.+|+.+++.++||||+++.-
T Consensus 13 ~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~--------knrEl~im~~l~HpNIV~L~~ 84 (364)
T KOG0658|consen 13 AEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY--------KNRELQIMRKLDHPNIVRLLY 84 (364)
T ss_pred eecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc--------CcHHHHHHHhcCCcCeeeEEE
Confidence 344444444555789999999999999999999999999999976444322 247999999999999999999
Q ss_pred EEEcCCCc---eEEEEEecccCCHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC-Cc
Q psy787 106 VFVNDKKQ---KMYLIMEYCVGGLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD-GT 179 (235)
Q Consensus 106 ~~~~~~~~---~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~-~~ 179 (235)
.|...... +..+||||++.+|...+... .+..++.-.++-+.+||++||+|||+.||+||||||.|++++.+ |.
T Consensus 85 ~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~ 164 (364)
T KOG0658|consen 85 FFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGV 164 (364)
T ss_pred EEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCe
Confidence 88654333 55689999999999888742 23678888999999999999999999999999999999999977 88
Q ss_pred EEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 180 LKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+||+|||.|+.+. ......+...+..|.|||.+.|.. .|+.+.||||.||++
T Consensus 165 LKicDFGSAK~L~---~~epniSYicSRyYRaPELifga~-~Yt~~IDiWSaGCV~ 216 (364)
T KOG0658|consen 165 LKICDFGSAKVLV---KGEPNISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVM 216 (364)
T ss_pred EEeccCCcceeec---cCCCceeEEEeccccCHHHHcCcc-ccCceeEEhhhhHHH
Confidence 9999999999775 233345666788899999998853 588999999999975
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=254.60 Aligned_cols=192 Identities=28% Similarity=0.425 Sum_probs=158.5
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
+.|+++++||+|+||+||++++..+++.+|+|++....... ......+.+|+.++..++|+||+++++.+ ...+.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~--~~~~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM-RNQAAHVKAERDILAEADNEWVVKLYYSF--QDKDNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHh-hhhHHHHHHHHHHHHhCCCCCcceEEEEE--EcCCEEE
Confidence 46999999999999999999999999999999987654322 22334577899999999999999999999 5567899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++..+....
T Consensus 78 lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999965 688888765 568888999999999999999999999999999999999999999999999975331000
Q ss_pred c-----------------------------------------CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeee
Q psy787 196 H-----------------------------------------DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 196 ~-----------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 234 (235)
. ........+++.|+|||++.+ ..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 000112358889999999987 448899999999998
Q ss_pred C
Q psy787 235 L 235 (235)
Q Consensus 235 l 235 (235)
|
T Consensus 234 l 234 (376)
T cd05598 234 L 234 (376)
T ss_pred e
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=251.04 Aligned_cols=187 Identities=29% Similarity=0.489 Sum_probs=160.9
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||+|+||.||+|++..+++.+|+|+++...... ......+.+|+.++..++|+||+++++.+ .....++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~--~~~~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK-LNEVRHVLTERDILTTTKSEWLVKLLYAF--QDDEYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhCCCCCCccEEEEE--EcCCEEE
Confidence 47999999999999999999999899999999998664332 22334578899999999999999999998 5566899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++|||+++ +|.+++... ..+++..+..++.|++.||.+||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 99999965 698888765 5689999999999999999999999999999999999999999999999999975432
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......+++.|+|||.+.+ ..++.++||||||++|
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il 188 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCML 188 (333)
T ss_pred ---ccCCcccCccccChhHhcC--CCCCCccceecchHHH
Confidence 2234558889999999987 4589999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=255.28 Aligned_cols=192 Identities=28% Similarity=0.441 Sum_probs=158.4
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|.++++||.|+||+||++.+..+++.+|+|++....... ......+.+|+.++..++||||+++++.+ .+...+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~iv~~~~~~--~~~~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK-KDQLAHVKAERDVLAESDSPWVVSLYYSF--QDAQYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hHHHHHHHHHHHHHHhCCCCCcceEEEEE--EcCCeeE
Confidence 47899999999999999999999999999999987654322 23334678899999999999999999999 5566899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..+....
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999964 688888765 678899999999999999999999999999999999999999999999999986331100
Q ss_pred cC-----------C----------------------------------cccccCCCCcccCccccCCCCCCCCCcccEEE
Q psy787 196 HD-----------D----------------------------------TITTSQGSPVFQAPEIANGLPEISGYKVDIWS 230 (235)
Q Consensus 196 ~~-----------~----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 230 (235)
.. . ......+++.|+|||.+.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 0 0012358889999999977 45899999999
Q ss_pred eeeeC
Q psy787 231 SGVTL 235 (235)
Q Consensus 231 lG~~l 235 (235)
|||+|
T Consensus 234 lGvil 238 (377)
T cd05629 234 LGAIM 238 (377)
T ss_pred cchhh
Confidence 99985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=255.73 Aligned_cols=192 Identities=27% Similarity=0.430 Sum_probs=160.2
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||+|+||+||++.+..+++.+|+|++....... ......+..|+.++..++|++|+++++.+ .....++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~~~iv~~~~~~--~~~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE-KEQVGHIRAERDILVEADSLWVVKMFYSF--QDKLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHhCCCCCcceEEEEE--ecCCeEE
Confidence 36899999999999999999999999999999997654322 23334577899999999999999999999 5566899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..+....
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 99999975 688888765 678999999999999999999999999999999999999999999999999987543110
Q ss_pred cC---------------------------------CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HD---------------------------------DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~---------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .......|++.|+|||.+.+ ..++.++||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil 226 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIM 226 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHH
Confidence 00 00123458899999999987 4588999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=253.15 Aligned_cols=188 Identities=29% Similarity=0.393 Sum_probs=156.6
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
..++.++.||+|.||.||++....+ ..+++|.++..... ...|.+|+++++.|+|++|+++++++. ..+.++
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~-----~~~f~~Ea~iMk~L~H~~lV~l~gV~~--~~~piy 277 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS-----PEAFLREAQIMKKLRHEKLVKLYGVCT--KQEPIY 277 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC-----hhHHHHHHHHHHhCcccCeEEEEEEEe--cCCceE
Confidence 3456678999999999999988533 58999999876432 235889999999999999999999994 444799
Q ss_pred EEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
|||||++ |+|.++++......++....+.++.|||+||+||+++++|||||..+|||+++++.+||+|||+++......
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999996 789999998666889999999999999999999999999999999999999999999999999999443211
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
-..+ ....-+..|+|||.+.. ..++.+|||||||++|
T Consensus 358 Y~~~-~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL 394 (468)
T KOG0197|consen 358 YTAS-EGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLL 394 (468)
T ss_pred eeec-CCCCCCceecCHHHHhh--CCcccccceeehhhhH
Confidence 1111 11123445999999988 6699999999999986
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=249.67 Aligned_cols=204 Identities=43% Similarity=0.674 Sum_probs=165.0
Q ss_pred ceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCC----------ccccHHHHHHHHHhcCCCC
Q psy787 30 TIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN----------GEINVDREIRLLKMLQHRN 99 (235)
Q Consensus 30 ~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~ 99 (235)
.-..+..++|++.+.||+|.+|.|-+|++..+++.||+|++.+........ ..+.+.+|+.+++++.|+|
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 345567789999999999999999999999999999999997755433211 1246889999999999999
Q ss_pred cceeeeEEEcCCCceEEEEEecccCCHHHHhhcCCCCC-CCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC
Q psy787 100 VIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKK-FPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG 178 (235)
Q Consensus 100 i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~ 178 (235)
+|+++++.-+.....+|+|+|||..+-..+.. ..++ +++..+++++++++.||+|||.+||+||||||+|+|++.+|
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 99999999666667899999999755222222 2255 89999999999999999999999999999999999999999
Q ss_pred cEEEeeeccccccCccc---cCCcccccCCCCcccCccccCCCC--CCCCCcccEEEeeeeC
Q psy787 179 TLKISDFGVAESLDMFL---HDDTITTSQGSPVFQAPEIANGLP--EISGYKVDIWSSGVTL 235 (235)
Q Consensus 179 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~~Di~slG~~l 235 (235)
++||+|||.+..+..-. .........|||+|+|||...+.. -..+.+.||||||++|
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTL 309 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTL 309 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhH
Confidence 99999999987652111 112233466999999999876522 1356899999999975
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=254.35 Aligned_cols=192 Identities=28% Similarity=0.452 Sum_probs=159.5
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||.|+||+||++++..+++.+|+|++....... ......+.+|+.++..++|+||+++++.+ .....++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~--~~~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE-KEQVAHVRAERDILAEADNPWVVKLYYSF--QDENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEE--EcCCeEE
Confidence 47999999999999999999999999999999997654322 22334577899999999999999999999 5667899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..+....
T Consensus 78 lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 99999975 588888765 568999999999999999999999999999999999999999999999999986442111
Q ss_pred cCC------------------------------------cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDD------------------------------------TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... ......|++.|+|||++.+ ..++.++|||||||++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il 229 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIM 229 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHH
Confidence 000 0012358899999999877 4588999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=255.70 Aligned_cols=191 Identities=31% Similarity=0.516 Sum_probs=165.1
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-C-----CCcceee
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-H-----RNVIGLV 104 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~ 104 (235)
+.+.+..+|.|.+.||+|+||.|-+|++.++++.||+|+++...... .....|+.+|..++ | -|+++++
T Consensus 180 ~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~-----~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 180 VNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFL-----RQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred ecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHH-----HHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 34444559999999999999999999999999999999998776432 23567889998886 3 4899999
Q ss_pred eEEEcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC--cEEE
Q psy787 105 DVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG--TLKI 182 (235)
Q Consensus 105 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~--~~~l 182 (235)
++| .-++++|||+|.++.+|.+++..+...+++...++.++.|++.||.+||+.+|+|+||||+|||+.+.+ .+||
T Consensus 255 d~F--~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 255 DYF--YFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred ecc--ccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeE
Confidence 999 567899999999999999999999999999999999999999999999999999999999999997654 5999
Q ss_pred eeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 183 SDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|||.+.... ........+..|.|||++.|.+ |+.+.|||||||++
T Consensus 333 IDFGSSc~~~-----q~vytYiQSRfYRAPEVILGlp--Y~~~IDmWSLGCIl 378 (586)
T KOG0667|consen 333 IDFGSSCFES-----QRVYTYIQSRFYRAPEVILGLP--YDTAIDMWSLGCIL 378 (586)
T ss_pred EecccccccC-----CcceeeeeccccccchhhccCC--CCCccceeehhhhH
Confidence 9999997443 2222555677799999999944 99999999999985
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=254.14 Aligned_cols=191 Identities=30% Similarity=0.473 Sum_probs=158.4
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
.|++++.||+|+||+||++.+..+++.+|+|++....... ......+.+|+.++..++|+||+++++.+ .....+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~--~~~~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN-RNQVAHVKAERDILAEADNEWVVKLYYSF--QDKDNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhcCCCCeeeeEEEE--ecCCEEEE
Confidence 6899999999999999999999999999999997654332 23344678999999999999999999999 45668999
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
||||+++ +|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++..+.....
T Consensus 79 v~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 79 VMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999965 688888765 5688999999999999999999999999999999999999999999999998753311000
Q ss_pred C---------------------------------------------CcccccCCCCcccCccccCCCCCCCCCcccEEEe
Q psy787 197 D---------------------------------------------DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSS 231 (235)
Q Consensus 197 ~---------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 231 (235)
. .......++..|+|||.+.+ ..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSl 234 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceeeh
Confidence 0 00112358889999999977 448899999999
Q ss_pred eeeC
Q psy787 232 GVTL 235 (235)
Q Consensus 232 G~~l 235 (235)
||+|
T Consensus 235 G~il 238 (381)
T cd05626 235 GVIL 238 (381)
T ss_pred hhHH
Confidence 9975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=258.62 Aligned_cols=194 Identities=30% Similarity=0.482 Sum_probs=170.4
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDK 111 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 111 (235)
..-.++|.+.+.||+|+||+|+++..+.+++.+|+|++++..+.. .++.+....|.+++... +||+++.++..| ..
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT 440 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCF--QT 440 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeeccccc--cc
Confidence 445678999999999999999999999999999999999999887 45566677888888876 699999999999 78
Q ss_pred CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 112 KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 112 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
+.++|+||||+.|+. +..-+....+++..+.-++..++.||.|||++||++||||.+||+++.+|.+||+|||+++.-
T Consensus 441 ~~~l~fvmey~~Ggd--m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGD--LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred CCeEEEEEEecCCCc--EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc
Confidence 889999999998764 333344478999999999999999999999999999999999999999999999999999843
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
- .......+.+||+.|+|||.+.+ ..|+.+.|+|||||+|
T Consensus 519 m--~~g~~TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLl 558 (694)
T KOG0694|consen 519 M--GQGDRTSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLL 558 (694)
T ss_pred C--CCCCccccccCChhhcChhhhcc--CcccchhhHHHHHHHH
Confidence 2 23446667889999999999998 5699999999999975
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=251.09 Aligned_cols=197 Identities=30% Similarity=0.456 Sum_probs=163.8
Q ss_pred cCCceeEeeeceEEeeeeeccccceEEEEeeccchh-hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeee
Q psy787 27 DNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETL-CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVD 105 (235)
Q Consensus 27 ~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 105 (235)
.+........++|++.+.||.|+||.||+|.+..++ ..+|+|++....... ......+.+|+.++..++||||+++++
T Consensus 20 ~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~ 98 (340)
T PTZ00426 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK-QKQVDHVFSERKILNYINHPFCVNLYG 98 (340)
T ss_pred ccccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCCcceEE
Confidence 344445556778999999999999999999865544 689999887654332 233456788999999999999999999
Q ss_pred EEEcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEee
Q psy787 106 VFVNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISD 184 (235)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~d 184 (235)
.+ .....++++|||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|
T Consensus 99 ~~--~~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 99 SF--KDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred EE--EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEec
Confidence 99 456689999999965 688888765 5789999999999999999999999999999999999999999999999
Q ss_pred eccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||++..... ......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 175 FG~a~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil 218 (340)
T PTZ00426 175 FGFAKVVDT-----RTYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFI 218 (340)
T ss_pred CCCCeecCC-----CcceecCChhhcCHHHHhC--CCCCccccccchhhHH
Confidence 999975531 2234468889999999977 4478999999999975
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=240.92 Aligned_cols=195 Identities=35% Similarity=0.522 Sum_probs=164.0
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC-cceeeeEEEcCC---
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN-VIGLVDVFVNDK--- 111 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~--- 111 (235)
...|..+++||.|.+|+||+|+...+|+.||+|.+...... +-......+|+.+++.++|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence 55688899999999999999999999999999998766542 234456789999999999999 999999996332
Q ss_pred -CceEEEEEecccCCHHHHhhcCCC--CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 112 -KQKMYLIMEYCVGGLQDMLDSTPY--KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 112 -~~~~~lv~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
...+++|+||..-+|..++..... ..++...+..+++||+.||+|||+.+|+||||||+|++|+..|.+||+|||+|
T Consensus 88 ~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred ccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 237899999999999999988754 36777899999999999999999999999999999999999999999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.+.-+ ......-..|.-|.|||++.++. .|+...||||+||++
T Consensus 168 ra~~ip--~~~yt~evvTlWYRaPEvLlGs~-~Ys~~vDiWs~GcIf 211 (323)
T KOG0594|consen 168 RAFSIP--MRTYTPEVVTLWYRAPEVLLGST-SYSTSVDIWSLGCIF 211 (323)
T ss_pred HHhcCC--cccccccEEEeeccCHHHhcCCC-cCCCCcchHhHHHHH
Confidence 855422 12233334556699999999864 489999999999974
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=250.04 Aligned_cols=187 Identities=30% Similarity=0.473 Sum_probs=159.6
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||+|+||+||++.+..+++.+|+|++....... .+....+.+|+.++..++||||+++++.+ .+...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR-LKQEQHVHNEKRVLKEVSHPFIIRLFWTE--HDQRFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-hHHHHHHHHHHHHHHhCCCCcHhhhHhhh--ccCCeEE
Confidence 47899999999999999999999899999999987654322 22344578899999999999999999988 5567899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++|||+++ +|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-- 153 (291)
T cd05612 78 MLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-- 153 (291)
T ss_pred EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC--
Confidence 99999975 688888765 5789999999999999999999999999999999999999999999999999875431
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il 188 (291)
T cd05612 154 ---RTWTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILI 188 (291)
T ss_pred ---CcccccCChhhcCHHHHcC--CCCCchhhHHHHHHHH
Confidence 1223458889999999987 4478999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=253.71 Aligned_cols=192 Identities=30% Similarity=0.440 Sum_probs=158.1
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
.+|++++.||+|+||+||++++..+++.+|+|++....... ......+.+|+.++..+.|+||+++++.+ .....++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~il~~~~h~~iv~~~~~~--~~~~~~~ 77 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLL-RNQVAHVKAERDILAEADNEWVVRLYYSF--QDKDNLY 77 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhh-HHHHHHHHHHHHHHHhCCCCcCCeEEEEE--EeCCEEE
Confidence 36899999999999999999999999999999987654322 23344678899999999999999999999 4566899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..+....
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999975 688888665 568899999999999999999999999999999999999999999999999975321000
Q ss_pred c---------------------------------------------CCcccccCCCCcccCccccCCCCCCCCCcccEEE
Q psy787 196 H---------------------------------------------DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWS 230 (235)
Q Consensus 196 ~---------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 230 (235)
. ........+++.|+|||.+.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEe
Confidence 0 000112357889999999987 44889999999
Q ss_pred eeeeC
Q psy787 231 SGVTL 235 (235)
Q Consensus 231 lG~~l 235 (235)
|||+|
T Consensus 234 lGvil 238 (382)
T cd05625 234 VGVIL 238 (382)
T ss_pred chHHH
Confidence 99975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=243.47 Aligned_cols=190 Identities=28% Similarity=0.419 Sum_probs=159.1
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
.|++.+.||+|+||+||++.+..+++.+|+|.+....... ......+.+|+.++..+.|++++++.+.+ .....+++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~iv~~~~~~--~~~~~~~l 77 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLAYAY--ETKDALCL 77 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCcEEEEEEEE--ccCCeEEE
Confidence 4788999999999999999999999999999987654332 22334577899999999999999999998 45568999
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+||++++ +|.+.+.......+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~--- 154 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--- 154 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---
Confidence 9999975 577777654445789999999999999999999999999999999999999999999999999875431
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+ ..++.++||||||++|
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil 191 (285)
T cd05631 155 GETVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLI 191 (285)
T ss_pred CCeecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHH
Confidence 112234458899999999987 4589999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=243.95 Aligned_cols=195 Identities=28% Similarity=0.440 Sum_probs=167.6
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
-.+.|++.+.||.|..++||+|+...+++.||+|++....... ....+.+|+..+..+.||||++++..|. ....
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~---~ld~l~kE~~~msl~~HPNIv~~~~sFv--v~~~ 98 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN---DLDALRKEVQTMSLIDHPNIVTYHCSFV--VDSE 98 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh---hHHHHHHHHHHhhhcCCCCcceEEEEEE--ecce
Confidence 3468999999999999999999999999999999998776654 2456889999999999999999999995 4568
Q ss_pred EEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+|+||+|+. |++.+.+...-..++++..+..+++++++||.|||++|.+|||||+.||+|+.+|.++|+|||.+-.+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999996 5788888877667899999999999999999999999999999999999999999999999997765532
Q ss_pred cccC--CcccccCCCCcccCccccCCCCCCCCCcccEEEeeee
Q psy787 194 FLHD--DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 194 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 234 (235)
.... .+.....+++.|+|||++...-+.|++++||||||++
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGIT 221 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGIT 221 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHH
Confidence 2211 1113447999999999977666779999999999975
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=248.59 Aligned_cols=194 Identities=32% Similarity=0.630 Sum_probs=173.6
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
-.+.-+|++.+.||.|.+|+|-+|.....|+.||+|.+++..+.+ +++.-.+.+|+.++..+.||||..++.+| +++
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkd-eqDlvhIRREIeIMSsLNHPhII~IyEVF--ENk 125 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKD-EQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENK 125 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhccc-HHHHHHHHHHHHHHhhcCCCceeehhhhh--cCC
Confidence 345568999999999999999999999999999999999888765 44555678999999999999999999999 777
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
.-+.|||||..+ .|.+++.+. +.+++.++..+++||++|+.|+|+++++|||||.+||+++.+++++|.|||++..+
T Consensus 126 dKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh
Confidence 789999999965 699999988 88999999999999999999999999999999999999999999999999999766
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ......+.+|.+.|.+||.++|.| +-++..|-||||++|
T Consensus 204 ~---~~kfLqTFCGSPLYASPEIvNG~P-Y~GPEVDsWsLGvLL 243 (668)
T KOG0611|consen 204 A---DKKFLQTFCGSPLYASPEIVNGTP-YKGPEVDSWSLGVLL 243 (668)
T ss_pred c---cccHHHHhcCCcccCCccccCCCC-CCCCccchhhHHHHH
Confidence 4 345567888999999999999954 557899999999975
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=249.74 Aligned_cols=192 Identities=27% Similarity=0.442 Sum_probs=159.9
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
+.|++++.||+|+||+||++++..+++.+|+|++....... ......+.+|+.++..++|++++++++.+ .....++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~--~~~~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE-KEQVAHIRAERDILVEADGAWVVKMFYSF--QDKRNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHhCCCCCEeeEEEEE--EcCCEEE
Confidence 36899999999999999999999999999999997654322 23345678899999999999999999998 5667899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..+....
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 99999975 688888765 568999999999999999999999999999999999999999999999999986442110
Q ss_pred cC---------------------------------CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HD---------------------------------DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~---------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .......+++.|+|||++.+ ..++.++|||||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil 226 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIM 226 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceecccccee
Confidence 00 00112358889999999987 4488999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=250.20 Aligned_cols=192 Identities=30% Similarity=0.533 Sum_probs=162.6
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|.+++.||+|+||+||+|.+..+++.+|+|+++...... ......+..|+.++..+.|+|++++++.+ .....++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQIAHVRAERDILADADSPWIVKLYYSF--QDEEHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhcCCCCccchhhhe--ecCCeEE
Confidence 47999999999999999999999999999999998664432 23345678899999999999999999998 5566899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 99999965 688888766 678999999999999999999999999999999999999999999999999987554221
Q ss_pred ---------------------------cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 ---------------------------HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ---------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........+++.|+|||.+.+ ..++.++|||||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il 220 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVIL 220 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhh
Confidence 0011223458889999999988 4589999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=245.94 Aligned_cols=191 Identities=29% Similarity=0.459 Sum_probs=159.5
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++.++||.|+||+||++.+..+++.+|+|++..... ......+.+|+.+++.++|+||+++++++ ......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDII--HTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEE--ecCCeE
Confidence 4689999999999999999999998999999999865432 22234567899999999999999999999 456689
Q ss_pred EEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 116 YLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 116 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++||||++++|.+.+.... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 79 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~- 156 (303)
T cd07869 79 TLVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP- 156 (303)
T ss_pred EEEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC-
Confidence 9999999999888887543 56889999999999999999999999999999999999999999999999998744321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il 194 (303)
T cd07869 157 -SHTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIF 194 (303)
T ss_pred -CccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHH
Confidence 1122334578889999988652 2477899999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=250.10 Aligned_cols=195 Identities=27% Similarity=0.450 Sum_probs=160.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|+||.||++.+..+++.+|+|++.+..... ......+..|+.++..+.||||+++++.+ ....
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--~~~~ 116 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFCAF--QDDK 116 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCEeeEEEEE--EcCC
Confidence 34578999999999999999999999999999999987644322 22334577899999999999999999999 5567
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++||||+++ +|.+++.. ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 89999999965 68887754 357888999999999999999999999999999999999999999999999997653
Q ss_pred ccccCCcccccCCCCcccCccccCCCC--CCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLP--EISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~~Di~slG~~l 235 (235)
.. .........+++.|+|||.+.+.+ ..++.++|+||||++|
T Consensus 194 ~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~il 237 (370)
T cd05621 194 ET-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237 (370)
T ss_pred cC-CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHH
Confidence 21 111223456899999999986532 2378899999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=246.44 Aligned_cols=184 Identities=32% Similarity=0.469 Sum_probs=154.1
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecc
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYC 122 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 122 (235)
+.||+|+||.||++.+..+++.+|+|+++...... ......+.+|+.++..++||||+++.+.+ .....+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~--~~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA-KDEVAHTLTESRVLQNTRHPFLTALKYSF--QTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCCEEEEE--EcCCEEEEEEeCC
Confidence 46899999999999999999999999997654322 23334567899999999999999999998 5566899999999
Q ss_pred cC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccc
Q psy787 123 VG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT 201 (235)
Q Consensus 123 ~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 201 (235)
++ +|.+.+... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..... ......
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~ 153 (323)
T cd05571 78 NGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMK 153 (323)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCccc
Confidence 75 688877665 6789999999999999999999999999999999999999999999999999874321 112233
Q ss_pred ccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 202 TSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 202 ~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...+++.|+|||.+.+ ..++.++|||||||++
T Consensus 154 ~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il 185 (323)
T cd05571 154 TFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVM 185 (323)
T ss_pred ceecCccccChhhhcC--CCCCccccCcccchhh
Confidence 4558899999999987 4489999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=243.47 Aligned_cols=191 Identities=30% Similarity=0.490 Sum_probs=159.2
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++.++||.|+||.||++++..+++.+|+|+++.... ......+.+|+.+++.++|+||+++++.+ ......
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDII--HTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEE--cCCCeE
Confidence 4579999999999999999999999999999999865432 22334577999999999999999999998 456688
Q ss_pred EEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 116 YLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 116 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+++||+++++|.+++.... ..++...+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 79 ~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~- 156 (288)
T cd07871 79 TLVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP- 156 (288)
T ss_pred EEEEeCCCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC-
Confidence 9999999999988886543 45788899999999999999999999999999999999999999999999998754321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l 194 (288)
T cd07871 157 -TKTYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCIL 194 (288)
T ss_pred -CccccCceecccccChHHhcCC-cccCcHHHHHHHHHHH
Confidence 1122234567889999988652 3478899999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=253.41 Aligned_cols=195 Identities=39% Similarity=0.660 Sum_probs=172.8
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
.....+.|++++-||.|+.|.|-+|.+..||+..|+|++.+..... ......+..|+-+++.+.|||++.+++++ ++
T Consensus 7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s-~s~~~~IerEIviMkLi~HpnVl~LydVw--e~ 83 (786)
T KOG0588|consen 7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS-SSQPAGIEREIVIMKLIEHPNVLRLYDVW--EN 83 (786)
T ss_pred ccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccc-cccccchhhhhHHHHHhcCCCeeeeeeee--cc
Confidence 3455789999999999999999999999999999999998774332 45566789999999999999999999999 77
Q ss_pred CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
+..+|+|.||++| .|.+++... +++++.++.++++||+.|+.|+|..+|+||||||+|++++..+++||+|||+|..
T Consensus 84 ~~~lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred CceEEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeec
Confidence 8899999999975 599999887 8899999999999999999999999999999999999999999999999999973
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
=. +..-..+.+|.+.|.+||.+.|.+ +-+.++||||+|++|
T Consensus 162 e~---~gklLeTSCGSPHYA~PEIV~G~p-YdG~~sDVWSCGVIL 202 (786)
T KOG0588|consen 162 EV---PGKLLETSCGSPHYAAPEIVSGRP-YDGRPSDVWSCGVIL 202 (786)
T ss_pred cc---CCccccccCCCcccCCchhhcCCC-CCCCccccchhHHHH
Confidence 32 345566788999999999999843 567899999999985
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=248.60 Aligned_cols=194 Identities=26% Similarity=0.470 Sum_probs=159.3
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC---ce
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK---QK 114 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~ 114 (235)
+|++.+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++..... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH--VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc--chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 689999999999999999999999999999988643221 1233457899999999999999999998853322 35
Q ss_pred EEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 115 MYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 115 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++++||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 79 ~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 79 IYVVFELMESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEEecCCCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 8999999999999888765 56899999999999999999999999999999999999999999999999999754221
Q ss_pred cc-CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LH-DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........+++.|+|||.+.+....++.++||||||+++
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl 198 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 198 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHH
Confidence 11 111233458889999999865334588999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=250.27 Aligned_cols=193 Identities=30% Similarity=0.516 Sum_probs=170.8
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|..++++|+|+||.+++++++...+.+++|.+....... ..++...+|..++.+++||||+.+.+.|.+ ++..+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~--~~r~~A~~E~~lis~~~hP~iv~y~ds~~~-~~~~l 79 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE--PERRSAIQEMDLLSKLLHPNIVEYKDSFEE-DGQLL 79 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc--hhhHHHHHHHHHHHhccCCCeeeeccchhc-CCceE
Confidence 468999999999999999999999999999999988776554 445578999999999999999999999963 33348
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+|+|+||+| ++.+.+..+....+++..+..|+.|++.|+.|||++.|+|||||+.|||+..++.++|+|||+++.+...
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999976 5888888887778999999999999999999999999999999999999999999999999999988632
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.....+..||+.|+.||.+.+-+ |..++|||||||++
T Consensus 160 --~~~a~tvvGTp~YmcPEil~d~p--Yn~KSDiWsLGC~~ 196 (426)
T KOG0589|consen 160 --DSLASTVVGTPYYMCPEILSDIP--YNEKSDIWSLGCCL 196 (426)
T ss_pred --hhhhheecCCCcccCHHHhCCCC--CCccCcchhhcchH
Confidence 23556677999999999999855 99999999999985
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=251.46 Aligned_cols=184 Identities=24% Similarity=0.350 Sum_probs=157.1
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++++.||.|+||.||++.+..+++.+|+|.... ..+.+|+.+++.++||||+++++.+ .....
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~ 157 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTF--TYNKF 157 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEE--EECCe
Confidence 34679999999999999999999999999999996431 2367899999999999999999998 44567
Q ss_pred EEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 115 MYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 115 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
.++++|++.++|..++... ..++...++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 158 ~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 158 TCLILPRYKTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred eEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 8999999999988888765 56889999999999999999999999999999999999999999999999998643211
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........+++.|+|||++.+ ..+++++||||||++|
T Consensus 236 -~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil 273 (391)
T PHA03212 236 -NANKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVL 273 (391)
T ss_pred -cccccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHH
Confidence 1122334568999999999987 4589999999999874
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=248.21 Aligned_cols=196 Identities=27% Similarity=0.438 Sum_probs=160.8
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
....++|++++.||+|+||.||++++..+++.+|+|++....... ......+..|+.++..++||||+++++.+ ...
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--~~~ 115 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAF--QDD 115 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EcC
Confidence 344579999999999999999999999999999999987644322 22334567899999999999999999999 456
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+++||||+++ +|.+++.. ..++...+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 789999999975 68887754 45788899999999999999999999999999999999999999999999999755
Q ss_pred CccccCCcccccCCCCcccCccccCCCC--CCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLP--EISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~~Di~slG~~l 235 (235)
... .........+++.|+|||++.+.. ..++.++||||||++|
T Consensus 193 ~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvil 237 (371)
T cd05622 193 NKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237 (371)
T ss_pred CcC-CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHH
Confidence 321 111223455889999999986532 2378899999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=241.24 Aligned_cols=191 Identities=31% Similarity=0.564 Sum_probs=159.7
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||+|++|+||++++..+++.+++|++...... ......+.+|+.+++.++|+||+++++.+ .....++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~ 76 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELKEAF--RRRGKLY 76 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhhHHHHHHHHHhCCCccccchhhhE--ecCCEEE
Confidence 4799999999999999999999999999999998765332 23345678999999999999999999998 5566899
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+||||+++++.+.+.... ..+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 154 (287)
T cd07848 77 LVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS- 154 (287)
T ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-
Confidence 999999988666665432 568999999999999999999999999999999999999999999999999997653211
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+ ..++.++|+||||+++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil 191 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCIL 191 (287)
T ss_pred cccccccccccccCCcHHHcC--CCCCCchhHHhHHHHH
Confidence 112223457888999999977 4488999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=243.67 Aligned_cols=194 Identities=28% Similarity=0.445 Sum_probs=160.3
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|.+.+.||+|+||+||++.+..+++.+|+|+++...... ......+..|+.++..+.|+||+++++.+ .....++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~i~~~~~~~~i~~~~~~~--~~~~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA-QETVSFFEEERDILSISNSPWIPQLQYAF--QDKDNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceeeEE--ecCCeEE
Confidence 47999999999999999999999999999999998654322 23345678899999999999999999998 4566899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++.... ..+++..+..++.|++.||++||+.+++||||||+||+++.++.++|+|||++..+....
T Consensus 78 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred EEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 99999965 6888887653 568999999999999999999999999999999999999999999999999997553211
Q ss_pred cCCcccccCCCCcccCccccCCC----CCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGL----PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+... ...++.++||||||+++
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 199 (330)
T cd05601 157 -MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIA 199 (330)
T ss_pred -ceeeecccCCccccCHHHhccccccccCCCCCcceeeccccee
Confidence 1122234578899999998631 23478899999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=243.20 Aligned_cols=184 Identities=32% Similarity=0.479 Sum_probs=154.0
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecc
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYC 122 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 122 (235)
+.||+|+||.||++++..+++.+|+|++....... ......+.+|+.+++.+.||||+++.+.+ .....+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA-KDEVAHTLTESRVLKNTRHPFLTSLKYSF--QTKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEE--EcCCEEEEEEeCC
Confidence 46899999999999999999999999997654332 23345677899999999999999999998 5566899999999
Q ss_pred cC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccc
Q psy787 123 VG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT 201 (235)
Q Consensus 123 ~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 201 (235)
++ +|...+... ..+++..+..++.||+.||+|||+.+++||||||+||+++.++.++|+|||++..... ......
T Consensus 78 ~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~ 153 (328)
T cd05593 78 NGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMK 153 (328)
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccc
Confidence 75 587777654 5789999999999999999999999999999999999999999999999999874321 112223
Q ss_pred ccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 202 TSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 202 ~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...+++.|+|||.+.+ ..++.++||||||++|
T Consensus 154 ~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil 185 (328)
T cd05593 154 TFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVM 185 (328)
T ss_pred cccCCcCccChhhhcC--CCCCccCCccccchHH
Confidence 4458899999999977 4588999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=243.09 Aligned_cols=192 Identities=28% Similarity=0.404 Sum_probs=157.3
Q ss_pred eEEeeeeeccccceEEEEeecc---chhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCc
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDS---ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (235)
+|++++.||+|+||+||++++. .+++.+|+|++.+............+..|+.++..+ .|++|+++++.+ ....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF--QTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE--ecCC
Confidence 4899999999999999998763 468899999997655443334445677899999999 589999999988 5566
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.++++|||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+.
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 88999999975 688888665 568999999999999999999999999999999999999999999999999987542
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .........++..|+|||.+.+. ..++.++||||||++|
T Consensus 157 ~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il 197 (332)
T cd05614 157 SE-EKERTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILI 197 (332)
T ss_pred cc-CCCccccccCCccccCHHHhcCC-CCCCCccccccchhhh
Confidence 11 11122234588999999998752 2367899999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=246.40 Aligned_cols=195 Identities=26% Similarity=0.431 Sum_probs=159.7
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|+||.||++++..+++.+|+|++....... ......+..|+.++..++||||+++++.+ ....
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~h~~iv~~~~~~--~~~~ 116 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK-RSDSAFFWEERDIMAHANSEWIVQLHYAF--QDDK 116 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCcceEEEEE--ecCC
Confidence 34578999999999999999999999999999999987543322 22233467899999999999999999988 5567
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++||||+++ +|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 89999999965 68877754 457888999999999999999999999999999999999999999999999987553
Q ss_pred ccccCCcccccCCCCcccCccccCCCC--CCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLP--EISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~~Di~slG~~l 235 (235)
... ........+++.|+|||.+.+.. ..++.++||||||++|
T Consensus 194 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvil 237 (370)
T cd05596 194 ANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237 (370)
T ss_pred CCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHH
Confidence 211 11222345889999999986532 2478899999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=238.71 Aligned_cols=192 Identities=31% Similarity=0.497 Sum_probs=155.7
Q ss_pred ceEEeeeeeccccceEEEEeeccc-hhhheeeeeeeeccccCCCCccccHHHHHHHHHhc---CCCCcceeeeEEEc---
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSE-TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML---QHRNVIGLVDVFVN--- 109 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~--- 109 (235)
++|++++.||+|+||+||++++.. +++.+|+|.++...... .....+.+|+..++.+ .||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC--CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 479999999999999999998854 46789999886544322 2223455677776665 69999999998842
Q ss_pred CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 110 DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
.....++++||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 79 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 79 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 23456899999999999999887665678999999999999999999999999999999999999999999999999987
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ........++..|+|||.+.+ ..++.++||||||+++
T Consensus 159 ~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il 199 (290)
T cd07862 159 IYSF---QMALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIF 199 (290)
T ss_pred eccC---CcccccccccccccChHHHhC--CCCCCccchHHHHHHH
Confidence 5432 122233457888999999977 4488999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=241.46 Aligned_cols=184 Identities=32% Similarity=0.481 Sum_probs=152.9
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecc
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYC 122 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 122 (235)
+.||+|+||+||++.+..+++.+|+|+++...... ......+..|+.++..++|+||+++.+.+ .....+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~~~hp~i~~~~~~~--~~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCCceEEEE--EcCCEEEEEEeCC
Confidence 46899999999999999999999999998654332 23334567899999999999999999988 5566899999999
Q ss_pred cC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 123 VG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 123 ~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
++ +|...+... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~ 153 (325)
T cd05594 78 NGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATM 153 (325)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCccc
Confidence 75 577777654 578999999999999999999997 7999999999999999999999999999864321 11222
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....++..|+|||++.+ ..++.++||||||++|
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 186 (325)
T cd05594 154 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVM 186 (325)
T ss_pred ccccCCcccCCHHHHcc--CCCCCcccccccccee
Confidence 33458899999999977 4588999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=241.61 Aligned_cols=194 Identities=25% Similarity=0.430 Sum_probs=158.8
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||+|+||+||++++..+++.+|+|++.+..... ......+.+|+.++..+.|++|+.+++.+ ...+..|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~l~~~~--~~~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLK-RAETACFREERNVLVNGDCQWITTLHYAF--QDENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHh-hHHHHHHHHHHHHHHhCCCCCEeeEEEEE--EcCCEEE
Confidence 47999999999999999999999999999999987643222 22334577888999999999999999999 5567899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999965 6888887532 568899999999999999999999999999999999999999999999999987553211
Q ss_pred cCCcccccCCCCcccCccccCCCC---CCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLP---EISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+.. ..++.++||||||++|
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil 198 (331)
T cd05624 157 -TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCM 198 (331)
T ss_pred -ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhh
Confidence 11122345889999999886421 2467899999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=243.47 Aligned_cols=184 Identities=32% Similarity=0.491 Sum_probs=153.2
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecc
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYC 122 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 122 (235)
+.||+|+||.||++++..+|+.+|+|+++...... ......+..|+.++..++||||+++++.+ .....+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~i~~~~~~~--~~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAF--QTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCcceeeEE--ecCCEEEEEEeCC
Confidence 46899999999999999999999999997654332 23334567899999999999999999998 4556899999999
Q ss_pred cC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccc
Q psy787 123 VG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT 201 (235)
Q Consensus 123 ~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 201 (235)
++ +|...+... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ......
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~ 153 (323)
T cd05595 78 NGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMK 153 (323)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccc
Confidence 75 587777654 5789999999999999999999999999999999999999999999999998864321 112223
Q ss_pred ccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 202 TSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 202 ~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...+++.|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil 185 (323)
T cd05595 154 TFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVM 185 (323)
T ss_pred cccCCcCcCCcccccC--CCCCchhchhhhHHHH
Confidence 4558899999999977 4588999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=242.87 Aligned_cols=191 Identities=31% Similarity=0.406 Sum_probs=157.3
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|.-...||+|+||.||++.... +..+|+|.+....... ..+|.+|+.++.+++|||+++++|+|.+.+. .
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~ 146 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-H 146 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-e
Confidence 34677777899999999999998753 4889999665544321 3349999999999999999999999964433 6
Q ss_pred EEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCC---cccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 115 MYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG---IIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 115 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
.++|+||++ |+|.+.+......+++|..+.+|+.+++.||+|||... |+||||||+||++|.+.+.||+|||++..
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 899999997 68999998765338899999999999999999999864 99999999999999999999999999964
Q ss_pred cCccccCCccccc-CCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTS-QGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+.. ....... .++.+|+|||+... +..+.++||||||++|
T Consensus 227 ~~~~--~~~~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvl 268 (361)
T KOG1187|consen 227 GPEG--DTSVSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVL 268 (361)
T ss_pred CCcc--ccceeeecCCCCccCChhhhcc--CCcCcccccccchHHH
Confidence 4310 2222222 79999999999977 6789999999999874
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=240.96 Aligned_cols=182 Identities=30% Similarity=0.469 Sum_probs=152.7
Q ss_pred eccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecccC
Q psy787 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVG 124 (235)
Q Consensus 45 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 124 (235)
||+|+||+||++++..+++.+|+|+++...... ......+..|+.++..++||||+++++.+ ......+++|||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS-RSEVTHTLAERTVLAQVNCPFIVPLKFSF--QSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCcEeceeeEE--ecCCeEEEEEcCCCC
Confidence 689999999999999899999999987654322 23344577899999999999999999998 456689999999975
Q ss_pred -CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccccc
Q psy787 125 -GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS 203 (235)
Q Consensus 125 -~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 203 (235)
+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..... ........
T Consensus 78 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~ 153 (312)
T cd05585 78 GELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTF 153 (312)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccc
Confidence 688888764 5689999999999999999999999999999999999999999999999999874321 11222344
Q ss_pred CCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 204 QGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 204 ~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+++.|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~gt~~y~aPE~~~~--~~~~~~~DvwslGvil 183 (312)
T cd05585 154 CGTPEYLAPELLLG--HGYTKAVDWWTLGVLL 183 (312)
T ss_pred cCCcccCCHHHHcC--CCCCCccceechhHHH
Confidence 58899999999987 4589999999999974
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=246.81 Aligned_cols=186 Identities=32% Similarity=0.560 Sum_probs=162.6
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
..|...++||+|..|.||.|....+++.||+|.+....-. ..+.+.+|+.+++..+|+||+.+++.|+.. ..+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~----~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLW 346 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP----KKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELW 346 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC----chhhhHHHHHHHHhccchHHHHHHHHhccc--ceeE
Confidence 4688889999999999999999999999999998776532 234578999999999999999999999643 5799
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||++| +|.+.+.. ..+++.++..+++.++.||+|||.+||+|||||.+||++..+|++||+|||++..+..
T Consensus 347 VVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~-- 421 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE-- 421 (550)
T ss_pred EEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc--
Confidence 99999975 58888876 4589999999999999999999999999999999999999999999999999987652
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....-...+||+.|||||.+.. ..|+++.||||||+++
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMa 459 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMA 459 (550)
T ss_pred ccCccccccCCCCccchhhhhh--cccCccccchhhhhHH
Confidence 2234556789999999999988 4499999999999863
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=242.09 Aligned_cols=194 Identities=26% Similarity=0.448 Sum_probs=158.1
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||+|+||+||++++..+++.+|+|++.+..... ......+..|+.++..++|+||+++++.+ ....+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK-RAETACFREERDVLVNGDRRWITNLHYAF--QDENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHhCCCCCCCceEEEE--ecCCeEE
Confidence 47999999999999999999999999999999987543322 22334577899999999999999999999 5567899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++..+...
T Consensus 78 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~- 155 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD- 155 (331)
T ss_pred EEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC-
Confidence 99999965 6888886532 56899999999999999999999999999999999999999999999999998654311
Q ss_pred cCCcccccCCCCcccCccccCCC---CCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~l 235 (235)
.........+++.|+|||++.+. ...++.++||||||+++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l 198 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCM 198 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHH
Confidence 11112223588899999998631 23467899999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=238.96 Aligned_cols=197 Identities=30% Similarity=0.468 Sum_probs=169.1
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
.-.+.|++++.||+|.-|+||+++...++..+|+|++.+..... .+...+++.|-.+|..++||+++.+|..| +...
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~ 150 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLYASF--ETDK 150 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhhhee--eccc
Confidence 34567899999999999999999999999999999999888776 45556788999999999999999999999 8888
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
+.|++||||+| +|..+.+.++.+.+++..++-++..++-||+|||-+||++|||||+||||.++|++.|+||.++....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999976 59999999999999999999999999999999999999999999999999999999999999875431
Q ss_pred c---cc---------------------------------------------------cCCcccccCCCCcccCccccCCC
Q psy787 193 M---FL---------------------------------------------------HDDTITTSQGSPVFQAPEIANGL 218 (235)
Q Consensus 193 ~---~~---------------------------------------------------~~~~~~~~~~~~~~~aPE~~~~~ 218 (235)
. .. ...+....+||..|.|||++.|
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G- 309 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG- 309 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence 1 00 0011112347888999999998
Q ss_pred CCCCCCcccEEEeeeeC
Q psy787 219 PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 219 ~~~~~~~~Di~slG~~l 235 (235)
..-+.+.|+|+||++|
T Consensus 310 -~GHgsAVDWWtfGIfl 325 (459)
T KOG0610|consen 310 -EGHGSAVDWWTFGIFL 325 (459)
T ss_pred -CCCCchhhHHHHHHHH
Confidence 4467799999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=244.33 Aligned_cols=194 Identities=26% Similarity=0.420 Sum_probs=152.6
Q ss_pred eceEEeeeeeccccceEEEEeec-----cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEc
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLD-----SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVN 109 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (235)
.++|++.++||.|+||.||+|.+ ..+++.||+|+++.... ......+.+|+.++..+ +||||+++++.+..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT---ASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc---hHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 36899999999999999999974 34557899998864321 12334688999999999 89999999998853
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCC------------------------------------------------------
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTP------------------------------------------------------ 134 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~------------------------------------------------------ 134 (235)
....++++|||+++ +|.+++....
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 34468999999975 6888876431
Q ss_pred ------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCc
Q psy787 135 ------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV 208 (235)
Q Consensus 135 ------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 208 (235)
..++++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++................++..
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 12477788899999999999999999999999999999999999999999999975432111111122334567
Q ss_pred ccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 209 FQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 209 ~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+|||.+.+ ..++.++||||||++|
T Consensus 242 y~aPE~~~~--~~~~~~sDiwslG~il 266 (338)
T cd05102 242 WMAPESIFD--KVYTTQSDVWSFGVLL 266 (338)
T ss_pred ccCcHHhhc--CCCCcccCHHHHHHHH
Confidence 999999977 4589999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=246.55 Aligned_cols=183 Identities=28% Similarity=0.343 Sum_probs=155.1
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
....|++++.||+|+||.||++.+..+++.+++|+.... ....|+.++..++|+||+++++.+. ....
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~ 131 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLV--SGAI 131 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEE--eCCe
Confidence 345799999999999999999999888899999974322 2356999999999999999999994 4567
Q ss_pred EEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 115 MYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 115 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
.+++++++.++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 132 ~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~-- 208 (357)
T PHA03209 132 TCMVLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV-- 208 (357)
T ss_pred eEEEEEccCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccc--
Confidence 89999999999888886543 578999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........++..|+|||.+.+ ..++.++||||||+++
T Consensus 209 -~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl 246 (357)
T PHA03209 209 -VAPAFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVL 246 (357)
T ss_pred -cCcccccccccccccCCeecCC--CCCCchhhHHHHHHHH
Confidence 1122233457889999999987 4589999999999874
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=236.35 Aligned_cols=191 Identities=30% Similarity=0.482 Sum_probs=156.2
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc---CCCCcceeeeEEEcC---C
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML---QHRNVIGLVDVFVND---K 111 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~---~ 111 (235)
+|++++.||+|++|+||++++..+++.+++|.++...... .....+.+|+..+..+ .|+||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 5899999999999999999999999999999887643221 2223455677666655 699999999988532 2
Q ss_pred CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 112 KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 112 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
...+++++|+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 79 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 79 ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred CceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 34689999999999998887765566899999999999999999999999999999999999999999999999998755
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........++..|+|||.+.+ ..++.++||||||+++
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l 197 (288)
T cd07863 159 SC---QMALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIF 197 (288)
T ss_pred cC---cccCCCccccccccCchHhhC--CCCCCcchhhhHHHHH
Confidence 31 112223456788999999977 4589999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=236.40 Aligned_cols=190 Identities=27% Similarity=0.412 Sum_probs=158.6
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|++.+.||.|++|+||++.+..+++.+|+|++....... ......+.+|+.+++.++|+||+++++.+ .....+++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAY--ETKDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh-hhhHHHHHHHHHHHHhcCCCCEeeeeeee--cCCCeEEE
Confidence 5889999999999999999998899999999987654332 22234567899999999999999999998 55668999
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+|||+++ +|.+.+.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~--- 154 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--- 154 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---
Confidence 9999975 687777655445689999999999999999999999999999999999999999999999999875431
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l 191 (285)
T cd05605 155 GETIRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLI 191 (285)
T ss_pred CCccccccCCCCccCcHHhcC--CCCCccccchhHHHHH
Confidence 112223457889999999977 4488999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=244.09 Aligned_cols=191 Identities=32% Similarity=0.466 Sum_probs=158.8
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC--
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK-- 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (235)
...++|++.+.||+|+||.||++.+..+++.+|+|++...... ......+.+|+.++..++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN--QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc--hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 4578999999999999999999999999999999998654322 233446778999999999999999999885322
Q ss_pred --CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 112 --KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 112 --~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
...++++||++++++...+.. .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 96 EEFQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred cccceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 135799999999988777643 47888999999999999999999999999999999999999999999999987
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ........++..|+|||.+.+ ..++.++||||||+++
T Consensus 172 ~~~~---~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il 212 (359)
T cd07876 172 TACT---NFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIM 212 (359)
T ss_pred cccc---CccCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHH
Confidence 4421 122233457888999999987 4588999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=235.37 Aligned_cols=197 Identities=35% Similarity=0.557 Sum_probs=165.7
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc---C
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN---D 110 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 110 (235)
....+|...+.||.|++|.|+.|.++.+|+.||+|.+..... ..-...+..+|++.|+.++|+||+.+.+++.. +
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~--~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFE--NQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhh--chHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 344566668999999999999999999999999998762221 12334567899999999999999999999854 2
Q ss_pred CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 111 KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 111 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
.-+.+|+|+|+++.+|...+.++ ..+++.++..+++|++.||.|+|+.+++||||||+|++++.++.+||+|||+|+.
T Consensus 97 ~f~DvYiV~elMetDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 97 KFNDVYLVFELMETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred ccceeEEehhHHhhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence 34568999999999999999886 5599999999999999999999999999999999999999999999999999997
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+........+....|.-|.|||.+.. ...||.+.||||+||+|
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~ 218 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCIL 218 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHH
Confidence 754423344456667788999998854 35699999999999985
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=240.73 Aligned_cols=189 Identities=32% Similarity=0.444 Sum_probs=155.6
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCC-CcceeeeEEEcCCCceEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR-NVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~~ 116 (235)
+|++.+.||+|+||.||++.+..+++.+|+|++.+..... ......+..|..++..+.|+ +++.+++.+ .....+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTMDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhcCCCCceeeeEEEE--EcCCEEE
Confidence 4889999999999999999999899999999998654332 23345577888888888765 577888887 4556899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 78 lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~-- 153 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF-- 153 (324)
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--
Confidence 99999965 688887665 5688999999999999999999999999999999999999999999999999864321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil 191 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLL 191 (324)
T ss_pred CCCceeeecCCccccChhhhcC--CCCCcccchhhhHHHH
Confidence 1222334558899999999987 4488999999999874
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=240.64 Aligned_cols=184 Identities=32% Similarity=0.509 Sum_probs=149.4
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHH-HHHhcCCCCcceeeeEEEcCCCceEEEEEec
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR-LLKMLQHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.||+|+||+||++.+..+++.+|+|++........ .....+..|.. .++.++||||+++++.+ .....+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~~~~~l~hp~iv~~~~~~--~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK-KEQKHIMAERNVLLKNVKHPFLVGLHYSF--QTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-hHHHHHHHHHHHHHhhCCCCCCCCeeEEE--EeCCEEEEEEcC
Confidence 468999999999999999999999999976543321 22233444544 45678999999999998 456688999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+++ +|..++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (323)
T cd05575 78 VNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTT 153 (323)
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCcc
Confidence 975 688877664 5789999999999999999999999999999999999999999999999999864321 12222
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....+++.|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il 186 (323)
T cd05575 154 STFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVL 186 (323)
T ss_pred ccccCChhhcChhhhcC--CCCCccccccccchhh
Confidence 33458889999999987 4488999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=241.24 Aligned_cols=187 Identities=29% Similarity=0.420 Sum_probs=153.0
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHH---HhcCCCCcceeeeEEEcCCCceE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLL---KMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
|++++.||+|++|.||++.+..+++.+|+|+++...... ......+..|+.++ ..++||||+++++.+ .....+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~--~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-RDEVESLMCEKRIFETANSERHPFLVNLFACF--QTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccccCCCChhceeeEE--EcCCEE
Confidence 688999999999999999999999999999998654332 22334566666554 456799999999998 556789
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
|+||||+++ +|...+.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 78 ~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~- 153 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG- 153 (324)
T ss_pred EEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC-
Confidence 999999976 57666543 5689999999999999999999999999999999999999999999999998864321
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 154 -~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il 191 (324)
T cd05589 154 -FGDRTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLI 191 (324)
T ss_pred -CCCcccccccCccccCHhHhcC--CCCCcccchhhHHHHH
Confidence 1122234558889999999987 4588999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=240.94 Aligned_cols=191 Identities=28% Similarity=0.478 Sum_probs=169.1
Q ss_pred eceEEee--eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 36 IGKYVMG--DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 36 ~~~y~i~--~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
..-|+|. +.||+|-||+||-+.++++|+.||+|++.+-.... +.+..+.+|+.+|+.+.||+|+.+...| +...
T Consensus 561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~--kqesqlR~EVaILq~l~HPGiV~le~M~--ET~e 636 (888)
T KOG4236|consen 561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT--KQESQLRNEVAILQNLHHPGIVNLECMF--ETPE 636 (888)
T ss_pred HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCC--chHHHHHHHHHHHHhcCCCCeeEEEEee--cCCc
Confidence 3346665 68999999999999999999999999998877665 4456788999999999999999999999 8888
Q ss_pred eEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC---CcEEEeeeccccc
Q psy787 114 KMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD---GTLKISDFGVAES 190 (235)
Q Consensus 114 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~---~~~~l~dfg~~~~ 190 (235)
.+++|||.+.|+..+.+.+...+++++..-..++.||+.||+|||-++|+|+||||+||++... ..+||+|||+|+.
T Consensus 637 rvFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred eEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 9999999999999999998888999999999999999999999999999999999999999754 4699999999997
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++. ...-+...||++|+|||++.. ..|..+.|+||.|+++
T Consensus 717 IgE---ksFRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIi 756 (888)
T KOG4236|consen 717 IGE---KSFRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVII 756 (888)
T ss_pred cch---hhhhhhhcCCccccCHHHHhh--ccccccccceeeeEEE
Confidence 752 233445679999999999987 4599999999999985
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=239.86 Aligned_cols=186 Identities=33% Similarity=0.469 Sum_probs=152.7
Q ss_pred eeeeccccceEEEEeecc---chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 42 GDLLGEGSYGKVKEMLDS---ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
++.||+|+||.||++++. .+++.+|+|+++.............+.+|+.++..++||||+++++.+ ..++.++++
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~--~~~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF--QTGGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE--ecCCeEEEE
Confidence 367999999999999763 468899999998755433333344577899999999999999999998 455689999
Q ss_pred EecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC
Q psy787 119 MEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 119 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 197 (235)
|||+++ +|.+.+... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ..
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 154 (323)
T cd05584 79 LEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EG 154 (323)
T ss_pred EeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CC
Confidence 999975 688887665 5678889999999999999999999999999999999999999999999999864321 11
Q ss_pred CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 198 DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......+++.|+|||++.+ ..++.++||||||++|
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 190 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALM 190 (323)
T ss_pred CcccccCCCccccChhhccC--CCCCCcceecccHHHH
Confidence 22233458899999999987 4478899999999874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=239.67 Aligned_cols=184 Identities=32% Similarity=0.497 Sum_probs=149.8
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHH-HHHhcCCCCcceeeeEEEcCCCceEEEEEec
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR-LLKMLQHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.||.|+||+||++.+..+|+.+|+|++....... ......+..|.. +++.++||||+++++.+ .....++++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~--~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQKHIMAERNVLLKNVKHPFLVGLHYSF--QTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHHhCCCCCCccEEEEE--ecCCEEEEEEcC
Confidence 46899999999999999999999999997654332 222334455554 46678999999999998 556689999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+++ +|...+... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~ 153 (325)
T cd05604 78 VNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTT 153 (325)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCc
Confidence 975 587777654 6789999999999999999999999999999999999999999999999999864321 12223
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....++..|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il 186 (325)
T cd05604 154 TTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVL 186 (325)
T ss_pred ccccCChhhCCHHHHcC--CCCCCcCcccccccee
Confidence 34458889999999987 4588999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=239.50 Aligned_cols=189 Identities=32% Similarity=0.436 Sum_probs=155.1
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCceEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 116 (235)
+|.+.+.||+|+||+||++++..+++.+|+|++.+..... ......+..|..++..+ .|++++.+.+.+ .....++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALSGKPPFLTQLHSCF--QTMDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCeEeeEEEEE--ecCCEEE
Confidence 4889999999999999999999899999999998654332 22333456677777776 578888899888 5566899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+.+... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 78 lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~-- 153 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-- 153 (323)
T ss_pred EEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--
Confidence 99999964 688877665 5689999999999999999999999999999999999999999999999999874321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil 191 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLL 191 (323)
T ss_pred CCCccccCCCChhhcCHHHhcC--CCCCCccchhchhHHH
Confidence 1122234457889999999987 4489999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=248.62 Aligned_cols=197 Identities=24% Similarity=0.403 Sum_probs=166.8
Q ss_pred ceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 30 TIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 30 ~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
.-++...+...+.+.||+|+||+||++++. ..||||++....... +..+.|.+|+.+++.-+|.||+-|.|++.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~--~qlqaFKnEVa~lkkTRH~NIlLFMG~~~- 458 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTP--EQLQAFKNEVAVLKKTRHENILLFMGACM- 458 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCH--HHHHHHHHHHHHHhhcchhhheeeehhhc-
Confidence 344556677888999999999999999874 368999998777654 35677999999999999999999999994
Q ss_pred CCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
.. .++||+.||+|+ |..++.... ..+.....+.|++|++.||.|||.++|+|+|||..|||+.++++++|+|||++
T Consensus 459 -~p-~~AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 459 -NP-PLAIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -CC-ceeeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccce
Confidence 33 349999999985 888887654 67888999999999999999999999999999999999999999999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCC-CCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLP-EISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~slG~~l 235 (235)
................+...|+|||+++... ..+++.+||||||+++
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~ 583 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVW 583 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHH
Confidence 8776555556666677888899999986432 2489999999999974
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=239.67 Aligned_cols=184 Identities=32% Similarity=0.497 Sum_probs=148.7
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHH-HHHhcCCCCcceeeeEEEcCCCceEEEEEec
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR-LLKMLQHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.||+|+||+||++++..+++.+|+|++........ .....+..|.. +++.++|+||+++++.+ .....++++|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~--~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSF--QTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEE--EcCCeEEEEEeC
Confidence 468999999999999998999999999976543321 22223444443 46778999999999998 456688999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+++ +|.+.+... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~ 153 (325)
T cd05602 78 INGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTT 153 (325)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCc
Confidence 976 688877654 5688889999999999999999999999999999999999999999999999874321 12223
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....+++.|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 186 (325)
T cd05602 154 STFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVL 186 (325)
T ss_pred ccccCCccccCHHHHcC--CCCCCccccccccHHH
Confidence 34458899999999987 4588999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=240.15 Aligned_cols=194 Identities=36% Similarity=0.643 Sum_probs=170.8
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEc
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVN 109 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 109 (235)
........|++.+.||.|.||.||++++..+|+.+|+|++.+...... .....+.+|+.+++++. ||||+.+.+.|
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~-~~~~~v~~Ev~il~~l~~hpniv~l~~~~-- 105 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK-EDREDVRREVAILQQLSGHPNIVQLKDAF-- 105 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc-ccHHHHHHHHHHHHhccCCCCEEEEEEEE--
Confidence 455667789999999999999999999999999999999988876652 34567899999999998 99999999999
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC----CcEEEee
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD----GTLKISD 184 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~----~~~~l~d 184 (235)
+....+++|||++.| .|.+.+... .+++.++..++.|++.+++|||+.|++|||+||+|+++... +.++++|
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEee
Confidence 777799999999975 599999877 39999999999999999999999999999999999999654 3699999
Q ss_pred eccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||++..... ........|++.|+|||.+.+ ..++..+||||+|+++
T Consensus 183 FGla~~~~~---~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~ 228 (382)
T KOG0032|consen 183 FGLAKFIKP---GERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVIL 228 (382)
T ss_pred CCCceEccC---CceEeeecCCccccCchhhcC--CCCCcccchhHHHHHH
Confidence 999986652 445667789999999999987 4499999999999863
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=239.30 Aligned_cols=184 Identities=30% Similarity=0.509 Sum_probs=153.3
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCceEEEEEec
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.||+|+||.||++.+..+++.+|+|++++..... ......+..|..++..+ +||||+++++.+ .....+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~--~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND-DEDIDWVQTEKHVFETASNHPFLVGLHSCF--QTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCCCCceEEEE--EcCCEEEEEEeC
Confidence 46899999999999999999999999998654332 23334577889988888 799999999998 556689999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+++ +|..++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~ 153 (329)
T cd05588 78 VSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTT 153 (329)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCcc
Confidence 975 687777654 6799999999999999999999999999999999999999999999999999863211 12223
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....++..|+|||.+.+ ..++.++|+||||+++
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l 186 (329)
T cd05588 154 STFCGTPNYIAPEILRG--EDYGFSVDWWALGVLM 186 (329)
T ss_pred ccccCCccccCHHHHcC--CCCCCccceechHHHH
Confidence 34568899999999987 4588999999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=238.85 Aligned_cols=184 Identities=32% Similarity=0.494 Sum_probs=149.3
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHH-HHHhcCCCCcceeeeEEEcCCCceEEEEEec
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR-LLKMLQHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.||.|+||+||++++..+++.+++|++.+..... ......+..|.. +++.++|+||+++++.+ .....+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~--~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSF--QTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEE--EcCCEEEEEEcC
Confidence 46899999999999999999999999987654332 222334555554 56788999999999988 556689999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+++ +|...+... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (321)
T cd05603 78 VNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETT 153 (321)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCcc
Confidence 975 577776654 5688999999999999999999999999999999999999999999999999864321 11222
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....+++.|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 186 (321)
T cd05603 154 STFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVL 186 (321)
T ss_pred ccccCCcccCCHHHhcC--CCCCCcCcccccchhh
Confidence 33457889999999977 4588999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=238.19 Aligned_cols=184 Identities=32% Similarity=0.512 Sum_probs=152.0
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCceEEEEEec
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.||+|+||+||++++..+++.+|+|++++..... ......+..|+.++..+ +||||+++++.+ .....+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~--~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCF--QTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc-hhHHHHHHHHHHHHHhcCCCCcCCceeeEE--EeCCEEEEEEeC
Confidence 46899999999999999999999999998764332 23334567888888776 799999999998 456689999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+++ +|...+... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~ 153 (329)
T cd05618 78 VNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTT 153 (329)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCcc
Confidence 975 587777654 5789999999999999999999999999999999999999999999999999864321 11222
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....++..|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 186 (329)
T cd05618 154 STFCGTPNYIAPEILRG--EDYGFSVDWWALGVLM 186 (329)
T ss_pred ccccCCccccCHHHHcC--CCCCCccceecccHHH
Confidence 34458889999999987 4588999999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=238.27 Aligned_cols=194 Identities=24% Similarity=0.429 Sum_probs=157.7
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.++||+|+||+||++++..+++.+|+|++.+..... ......+..|+.++..++|++++++.+.+ .....++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDNQWITTLHYAF--QDENNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHH-hhHHHHHHHHHHHHhhCCCCCEeeEEEEE--ecCCEEE
Confidence 47999999999999999999999899999999986543322 22233477888899999999999999998 5566899
Q ss_pred EEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+. |+|.+++.... ..+++..+..++.|++.||.+||+.+++||||||+||+++.++.++|+|||++..+...
T Consensus 78 lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~- 155 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED- 155 (332)
T ss_pred EEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-
Confidence 9999996 56888887532 56889999999999999999999999999999999999999999999999998754211
Q ss_pred cCCcccccCCCCcccCccccCCC---CCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~l 235 (235)
.........+++.|+|||++.+. ...++.++||||||++|
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil 198 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCM 198 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHH
Confidence 11122234588999999988531 23478899999999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=238.21 Aligned_cols=184 Identities=34% Similarity=0.488 Sum_probs=149.8
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHh-cCCCCcceeeeEEEcCCCceEEEEEec
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM-LQHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.||+|+||+||++.+..+++.||+|+++...... ......+..|..++.. ..||||+++++.+ .....+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~--~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-DDDVECTMVERRVLALAWEHPFLTHLFCTF--QTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhccCCCCccceeeEE--EcCCEEEEEEcC
Confidence 46899999999999999899999999998654332 2223334556666654 4899999999998 556689999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+++ +|...+... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~ 153 (316)
T cd05592 78 LNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKA 153 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCcc
Confidence 965 688877655 5689999999999999999999999999999999999999999999999999874321 11223
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....+++.|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il 186 (316)
T cd05592 154 STFCGTPDYIAPEILKG--QKYNESVDWWSFGVLL 186 (316)
T ss_pred ccccCCccccCHHHHcC--CCCCCcccchhHHHHH
Confidence 34458899999999987 4488999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=236.90 Aligned_cols=184 Identities=31% Similarity=0.458 Sum_probs=151.5
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCceEEEEEec
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.||+|+||.||++.+..+++.+|+|+++...... ......+..|..++..+ +||||+++++.+ ...+.+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~hp~i~~~~~~~--~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ-DDDVDCTMTEKRILALAAKHPFLTALHCCF--QTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhccCCCCccceeeEE--EcCCeEEEEEeC
Confidence 46899999999999998899999999997654332 23334566788888765 799999999999 556689999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+++ +|...+... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 153 (321)
T cd05591 78 VNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTT 153 (321)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCccc
Confidence 975 688777655 5688999999999999999999999999999999999999999999999999874321 11222
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....++..|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il 186 (321)
T cd05591 154 TTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLM 186 (321)
T ss_pred cccccCccccCHHHHcC--CCCCCccceechhHHH
Confidence 33457889999999977 4488999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=242.64 Aligned_cols=188 Identities=30% Similarity=0.404 Sum_probs=157.1
Q ss_pred EeeeceEEeeeeeccccceEEEEeecc--chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDS--ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
.....+|.+++.||.|++|.||++... .+++.+++|.+.... ...+|+.++..++|+||+++++.+ .
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---------~~~~E~~il~~l~h~~iv~~~~~~--~ 156 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---------TPGREIDILKTISHRAIINLIHAY--R 156 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---------cHHHHHHHHHhcCCCCccceeeeE--e
Confidence 334567999999999999999998643 456778888764321 356899999999999999999998 4
Q ss_pred CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 111 KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 111 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
....++++|+++.++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 157 ~~~~~~lv~e~~~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 157 WKSTVCMVMPKYKCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred eCCEEEEEehhcCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 55688999999999998888543 6789999999999999999999999999999999999999999999999999976
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.............++..|+|||++.+ ..++.++|||||||+|
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil 277 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVL 277 (392)
T ss_pred cCcccccccccccccccCccCHhHhcC--CCCCchhhHHHHHHHH
Confidence 543322233334568999999999987 4488999999999975
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=246.46 Aligned_cols=185 Identities=29% Similarity=0.329 Sum_probs=156.5
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
...|.+.+.||.|+||.||++.+..+++.|++|.... ..+.+|+.++++++|+||+++++++. ..+..
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~--~~~~~ 235 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRV--VGGLT 235 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEE--ECCEE
Confidence 4579999999999999999999999999999984321 23678999999999999999999984 45578
Q ss_pred EEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 116 YLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 116 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+++|+++.++|.+++.... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 236 ~lv~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 236 CLVLPKYRSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEEccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9999999989888876543 468999999999999999999999999999999999999999999999999997653221
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........++..|+|||++.+ ..++.++|||||||+|
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL 352 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVI 352 (461)
T ss_pred ccccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHH
Confidence 2222223458899999999987 4589999999999975
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=245.85 Aligned_cols=190 Identities=29% Similarity=0.476 Sum_probs=154.3
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC---
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND--- 110 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 110 (235)
...++|++++.||+|+||+||+|.+..+++.+|+|.+.... ....+|+.+++.++|+||+++.+++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 34568999999999999999999998899999999774321 2345799999999999999998876421
Q ss_pred ---CCceEEEEEecccCCHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-cEEEee
Q psy787 111 ---KKQKMYLIMEYCVGGLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-TLKISD 184 (235)
Q Consensus 111 ---~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-~~~l~d 184 (235)
...+++++|||+++++.+++... ....+++..++.++.|++.||+|||+.+++||||||+||+++.++ .++|+|
T Consensus 135 ~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred cCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 22357799999999987776532 236789999999999999999999999999999999999999665 699999
Q ss_pred eccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||++..+.. ........+++.|+|||.+.+. ..++.++|||||||+|
T Consensus 215 FGla~~~~~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil 261 (440)
T PTZ00036 215 FGSAKNLLA---GQRSVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCII 261 (440)
T ss_pred cccchhccC---CCCcccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHH
Confidence 999985532 2223344578889999988652 3478999999999975
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=234.99 Aligned_cols=184 Identities=30% Similarity=0.470 Sum_probs=152.1
Q ss_pred eeeeccccceEEEEeec---cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 42 GDLLGEGSYGKVKEMLD---SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~---~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
++.||+|+||.||++++ ..+|+.+|+|++....... .....+..|+.++.+++||||+++++.+ ...+.+|+|
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~~lv 76 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV--RDRVRTKMERDILAEVNHPFIVKLHYAF--QTEGKLYLI 76 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHhCCCCCcccEEEEE--EcCCEEEEE
Confidence 36799999999999875 3578999999997654322 2334567899999999999999999999 556689999
Q ss_pred Eeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC
Q psy787 119 MEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 119 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 197 (235)
|||++ ++|.+.+... ..+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..... ..
T Consensus 77 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~ 152 (318)
T cd05582 77 LDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HE 152 (318)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CC
Confidence 99996 4688887654 5689999999999999999999999999999999999999999999999999875431 11
Q ss_pred CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 198 DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+ ..++.++||||||+++
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il 188 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLM 188 (318)
T ss_pred CceecccCChhhcCHHHHcC--CCCCCccceeccceEe
Confidence 22234457889999999987 4478899999999985
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=241.91 Aligned_cols=191 Identities=31% Similarity=0.459 Sum_probs=158.3
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC--
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK-- 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (235)
...++|++++.||+|+||.||++.+..+++.+|+|.+...... ......+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC--hHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 3567999999999999999999999989999999988654322 223345678999999999999999999885322
Q ss_pred --CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 112 --KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 112 --~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
...++++||++++++...+.. .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 92 ~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 92 EEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred cccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 235799999999988877653 47888999999999999999999999999999999999999999999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ........++..|+|||.+.+ ..++.++||||||+++
T Consensus 168 ~~~~---~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il 208 (355)
T cd07874 168 TAGT---SFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIM 208 (355)
T ss_pred cCCC---ccccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHH
Confidence 5432 122233457889999999987 4488999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=235.32 Aligned_cols=191 Identities=27% Similarity=0.477 Sum_probs=158.6
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++.++||.|+||+||++.+..+++.+|+|.++..... .....+.+|+..++.++|+|++++++.+ ...+..
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIV--HTDKSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC---CcchhHHHHHHHHHhCCCCCcceEEEEE--eeCCeE
Confidence 46799999999999999999999889999999988754422 2334567899999999999999999999 455688
Q ss_pred EEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 116 YLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 116 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+++|||++++|.+++.... ..++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 80 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~- 157 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP- 157 (309)
T ss_pred EEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC-
Confidence 9999999999888876543 45788999999999999999999999999999999999999999999999998754321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+. ..++.++||||||+++
T Consensus 158 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il 195 (309)
T cd07872 158 -TKTYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIF 195 (309)
T ss_pred -ccccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHH
Confidence 1122233467889999988652 3478899999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=236.78 Aligned_cols=184 Identities=31% Similarity=0.484 Sum_probs=151.7
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCceEEEEEec
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.||+|+||+||++++..+++.+|+|++.+..... ......+..|..++..+ .|||++++++.+ .....+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~--~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLYCCF--QTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhccCCCchhceeeEE--EcCCEEEEEEcC
Confidence 36899999999999999999999999987654332 23334566788887766 699999999999 556789999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+++ +|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~ 153 (320)
T cd05590 78 VNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTT 153 (320)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCcc
Confidence 975 688777665 5789999999999999999999999999999999999999999999999999864321 11222
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....+++.|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 186 (320)
T cd05590 154 STFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLL 186 (320)
T ss_pred cccccCccccCHHHHcC--CCCCCccchhhhHHHH
Confidence 34458899999999987 4588999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=240.96 Aligned_cols=191 Identities=30% Similarity=0.465 Sum_probs=158.8
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC---
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND--- 110 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 110 (235)
...++|++.+.||+|+||.||++.+..+++.+|+|++...... ......+.+|+.+++.++|+||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC--chhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 4568999999999999999999999989999999988654322 23334577899999999999999999987422
Q ss_pred -CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 111 -KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 111 -~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
....+++|||++++++...+.. .++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 99 ~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 99 EEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred cccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 2246799999999998887753 47888999999999999999999999999999999999999999999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ........++..|+|||.+.+ ..++.++||||||++|
T Consensus 175 ~~~~---~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il 215 (364)
T cd07875 175 TAGT---SFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIM 215 (364)
T ss_pred ccCC---CCcccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHH
Confidence 5532 122233457889999999987 4588999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=223.02 Aligned_cols=198 Identities=33% Similarity=0.529 Sum_probs=174.8
Q ss_pred CCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 28 ~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
......-..++|.+.+.||.|-||.||+|+..+++..+|+|++.+.++.. ......+.+|+.+-..++||||++++++|
T Consensus 13 ~~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 13 SRATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-TQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-hcchhhhhheeEeecccCCccHHhhhhhe
Confidence 34445556678999999999999999999999999999999999888665 45566788999999999999999999999
Q ss_pred EcCCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeec
Q psy787 108 VNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
. +...+|+++||.+ |++...+......++++...+.+++|++.|+.|+|..+++|||+||.|++++..+.++++|||
T Consensus 92 h--d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 92 H--DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred e--ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCC
Confidence 4 5668999999986 679999998887899999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeee
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 234 (235)
.+... +...-.+.+||..|.|||++.+ ...+...|+|++|++
T Consensus 170 wsV~~----p~~kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl 211 (281)
T KOG0580|consen 170 WSVHA----PSNKRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVL 211 (281)
T ss_pred ceeec----CCCCceeeecccccCCHhhcCC--CCccchhhHHHHHHH
Confidence 88743 2445567789999999999988 448889999999975
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=236.63 Aligned_cols=189 Identities=32% Similarity=0.442 Sum_probs=154.2
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCCceEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 116 (235)
+|+..+.||+|+||+||+|++..+++.||+|++....... ......+..|..++..+. |++++++.+.+ .....++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~ 77 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALQDKPPFLTQLHSCF--QTVDRLY 77 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCchhheeeEE--ecCCEEE
Confidence 4788899999999999999999999999999987654322 233345667888888775 46777888887 4556899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 78 lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~-- 153 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-- 153 (323)
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--
Confidence 99999975 688887665 5689999999999999999999999999999999999999999999999999874321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil 191 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLL 191 (323)
T ss_pred CCccccCccCCccccCHHHHcC--CCCCCccchhhhHHHH
Confidence 1122233458899999999987 4488999999999874
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=236.21 Aligned_cols=184 Identities=31% Similarity=0.500 Sum_probs=152.9
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCceEEEEEec
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.||+|+||+||++.+..+++.+|+|+++...... ......+..|+.++..+ .|++++.+++.+ .....+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD-DEDIDWVQTEKHVFEQASSNPFLVGLHSCF--QTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhhcCCCCEeeEEEEE--EeCCEEEEEEeC
Confidence 46999999999999999999999999998654332 23344577888888887 699999999998 556689999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+++ +|...+... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (327)
T cd05617 78 VNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTT 153 (327)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCce
Confidence 975 687777654 5789999999999999999999999999999999999999999999999998864211 11223
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....+++.|+|||.+.+ ..++.++||||||++|
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil 186 (327)
T cd05617 154 STFCGTPNYIAPEILRG--EEYGFSVDWWALGVLM 186 (327)
T ss_pred ecccCCcccCCHHHHCC--CCCCchheeehhHHHH
Confidence 34568899999999987 4588999999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=234.60 Aligned_cols=193 Identities=26% Similarity=0.331 Sum_probs=151.5
Q ss_pred eceEEeeeeeccccceEEEEeeccc----------------hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSE----------------TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN 99 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~----------------~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 99 (235)
.++|++.++||+|+||.||++.+.. ++..+|+|++..... ......+.+|+.++..++|||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN---KNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC---HHHHHHHHHHHHHHhhcCCCC
Confidence 3689999999999999999997532 334689998765421 223446889999999999999
Q ss_pred cceeeeEEEcCCCceEEEEEecccC-CHHHHhhcCC-----------------CCCCCHHhHHHHHHHHHHHHHHHHhCC
Q psy787 100 VIGLVDVFVNDKKQKMYLIMEYCVG-GLQDMLDSTP-----------------YKKFPIWQAHGYFLQLLDGLEYLHSQG 161 (235)
Q Consensus 100 i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-----------------~~~~~~~~~~~~~~ql~~~l~~lH~~~ 161 (235)
|+++++.+. .....+++|||+++ +|.+++.... ...+++..++.++.|++.||.|||+.|
T Consensus 81 iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 81 IIRLLGVCV--DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred eeEEEEEEe--cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999995 44578999999965 6888775431 123677789999999999999999999
Q ss_pred cccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 162 i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++|+||||+||+++.++.++|+|||++................++..|+|||.+.+ ..++.++||||||+++
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l 230 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTL 230 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHH
Confidence 99999999999999999999999999875432111111122234678999999877 4589999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=242.24 Aligned_cols=192 Identities=30% Similarity=0.466 Sum_probs=156.1
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC---Cce
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK---KQK 114 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~ 114 (235)
.|++.++||+|+||.||++.+..+++.+|+|.+...... ......+.+|+.++..++|+||+++++++.... ...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN--LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc--hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 378899999999999999999889999999987543211 122345789999999999999999999984322 126
Q ss_pred EEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 115 MYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 115 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++++||+.++|.+.+... ..++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 79 ~~lv~e~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 79 IYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEEeeccccCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 8999999999988888665 67899999999999999999999999999999999999999999999999998754321
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........++..|+|||.+.+. ..++.++||||||+++
T Consensus 157 -~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il 195 (372)
T cd07853 157 -ESKHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIF 195 (372)
T ss_pred -ccccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHH
Confidence 11122233467889999998763 3478899999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=235.05 Aligned_cols=184 Identities=33% Similarity=0.495 Sum_probs=151.0
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCceEEEEEec
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.||+|+||.||++++..+++.+|+|+++...... ......+..|..++... +|++++++++.+ ...+.+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-DDDVECTMVEKRVLALAWENPFLTHLYCTF--QTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCCccCeeEEE--EeCCEEEEEECC
Confidence 46899999999999999999999999998754322 12333456677777654 899999999999 556789999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+.+ +|...+... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (316)
T cd05620 78 LNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRA 153 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCce
Confidence 975 688777664 5689999999999999999999999999999999999999999999999998863321 12223
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....++..|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil 186 (316)
T cd05620 154 STFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLL 186 (316)
T ss_pred eccCCCcCccCHHHHcC--CCCCcccchhhhHHHH
Confidence 34568899999999987 4588999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=238.48 Aligned_cols=194 Identities=36% Similarity=0.584 Sum_probs=174.3
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
....++.|.+.+.||+|.|++|.++.+.-++..||+|++.+..... ...+.+.+|+.++..+.||||++++.+. +.
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~--~~~~k~~rev~imk~l~HPnIvkl~~v~--~t 126 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP--SKRQKLGREVDIMKSLNHPNIVKLFSVI--ET 126 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh--HHHHHHHHHHHHHHhcCCcceeeeeeee--ee
Confidence 3456788999999999999999999999999999999999887664 4445588999999999999999999999 67
Q ss_pred CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...+|+||||..+ .+.+++... +.+.+..+..++.|+++|++|||+++|+|||||+.|++++.+.+++|+|||++..
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeecccccee
Confidence 7899999999965 599999887 6778899999999999999999999999999999999999999999999999987
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++ ......++++++.|.|||+..+.. +.++.+|+||||++|
T Consensus 205 ~~---~~~~lqt~cgsppyAaPEl~~g~~-y~gpe~D~Wslgvvl 245 (596)
T KOG0586|consen 205 FD---YGLMLQTFCGSPPYAAPELFNGKK-YDGPEVDIWSLGVVL 245 (596)
T ss_pred ec---ccccccccCCCCCccChHhhcCcc-cCCcceehhhhhhhh
Confidence 76 456677889999999999998843 678999999999975
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=254.58 Aligned_cols=195 Identities=27% Similarity=0.391 Sum_probs=157.7
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
+++|+++++||+|+||.||+|.+..+++.||+|++...... ......++.+|+.++..++|||++++++.+ ...+..
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~-~e~~~~rflrEi~ILs~L~HPNIVkl~~v~--~d~~~l 77 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSE-NPLLKKRFLREAKIAADLIHPGIVPVYSIC--SDGDPV 77 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccccc-CHHHHHHHHHHHHHHHhCCCcCcCeEEEEE--eeCCEE
Confidence 37899999999999999999999999999999998654322 123345688999999999999999999998 456688
Q ss_pred EEEEecccC-CHHHHhhcCC---------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeee
Q psy787 116 YLIMEYCVG-GLQDMLDSTP---------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDF 185 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~---------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~df 185 (235)
+++|||++| +|.+++.... ....+...++.++.|++.||+|||+.|++||||||+||+++.++.++|+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEec
Confidence 999999975 6888775321 134566778899999999999999999999999999999999999999999
Q ss_pred ccccccCcccc----------------CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLH----------------DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~----------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|++........ ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVIL 221 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVIL 221 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHH
Confidence 99975521000 001112358899999999987 4489999999999974
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=228.69 Aligned_cols=190 Identities=26% Similarity=0.398 Sum_probs=157.7
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
.|++.+.||.|+||+||++.+..+++.+|+|.+....... ......+.+|+.++..++|++++.+.+.+ ..+...++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~--~~~~~~~l 77 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-RKGESMALNEKQILEKVNSQFVVNLAYAY--ETKDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHHcCCcCceeEEEEE--ecCCEEEE
Confidence 4788899999999999999999999999999987654332 22234567899999999999999999988 45568999
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+||++.+ +|.+.+.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~--- 154 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--- 154 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---
Confidence 9999975 577777654445799999999999999999999999999999999999999999999999998864421
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 ~~~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l 191 (285)
T cd05632 155 GESIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLI 191 (285)
T ss_pred CCcccCCCCCcCccChHHhcC--CCCCcccchHHHHHHH
Confidence 112233457889999999977 4588999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=246.52 Aligned_cols=201 Identities=26% Similarity=0.375 Sum_probs=162.9
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
......++|++.+.||+|+||+||++++..+++.+|+|++...... ......+.+|+..+..++|+|++++...+...
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS--EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC--HHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 3344557999999999999999999999999999999998765432 23345678899999999999999998777432
Q ss_pred CC------ceEEEEEeccc-CCHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEE
Q psy787 111 KK------QKMYLIMEYCV-GGLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLK 181 (235)
Q Consensus 111 ~~------~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~ 181 (235)
.. ..++++|||++ |+|.+.+... ....+++..++.++.|++.||.|||+.+++||||||+||+++.++.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence 21 14689999997 4688887643 235689999999999999999999999999999999999999999999
Q ss_pred EeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 182 ISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+|||++..+.............+++.|+|||.+.+ ..++.++||||||++|
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvil 235 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLL 235 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHH
Confidence 999999876542222222334568899999999987 4589999999999874
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=228.69 Aligned_cols=190 Identities=28% Similarity=0.412 Sum_probs=158.0
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
.|++.+.||.|+||.||++.+..+++.+++|.+....... ......+.+|+.+++.++|++++.+.+.+ .....+++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~--~~~~~~~l 77 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMALNEKQILEKVNSRFVVSLAYAY--ETKDALCL 77 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc-hHHHHHHHHHHHHHHhCCCCCeeeeeEEE--ecCCEEEE
Confidence 4778899999999999999999999999999887654332 12233467899999999999999999998 45568999
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+|||+++ +|.+.+.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~--- 154 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--- 154 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---
Confidence 9999965 688887655445789999999999999999999999999999999999999999999999998864421
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l 191 (285)
T cd05630 155 GQTIKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLL 191 (285)
T ss_pred CccccCCCCCccccChHHHcC--CCCCCccccHHHHHHH
Confidence 112223457889999999977 4589999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=228.43 Aligned_cols=183 Identities=30% Similarity=0.431 Sum_probs=151.5
Q ss_pred eccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecccC
Q psy787 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVG 124 (235)
Q Consensus 45 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 124 (235)
||+|+||.||+++...+|+.+++|.+....... ......+..|+.++..++||||+++.+.+ .....++++|||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~--~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAF--ESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEE--ecCCeEEEEEecCCC
Confidence 689999999999999999999999987544322 11223456799999999999999999998 556789999999965
Q ss_pred -CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccccc
Q psy787 125 -GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS 203 (235)
Q Consensus 125 -~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 203 (235)
+|.+.+.......++...+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++..... .......
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---Cceeecc
Confidence 687777665556688999999999999999999999999999999999999999999999999875532 1222334
Q ss_pred CCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 204 QGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 204 ~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 ~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l 184 (277)
T cd05607 155 AGTNGYMAPEILKE--EPYSYPVDWFAMGCSI 184 (277)
T ss_pred CCCCCccCHHHHcc--CCCCCchhHHHHHHHH
Confidence 57889999999977 3489999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=234.47 Aligned_cols=187 Identities=26% Similarity=0.418 Sum_probs=158.7
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++++.||+|++|.||++++..++..+++|++..... ......+.+|+.++..++|+|++++++.+. ..+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC---HHHHHHHHHHHHHHHHCCCCCCCeEEEEEE--ECCEE
Confidence 4689999999999999999999999999999998875421 123446889999999999999999999984 45688
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+++|||+++ +|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..+..
T Consensus 79 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 999999975 688888765 5688999999999999999999986 699999999999999999999999999875432
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+ ..++.++||||||+++
T Consensus 157 ----~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il 192 (331)
T cd06649 157 ----SMANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSL 192 (331)
T ss_pred ----cccccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHH
Confidence 12233457889999999987 4589999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=232.76 Aligned_cols=183 Identities=28% Similarity=0.433 Sum_probs=147.0
Q ss_pred eccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc---CCCCcceeeeEEEcCCCceEEEEEec
Q psy787 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML---QHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 45 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
||+|+||+||++++..+++.+|+|++....... ......+..|..++... .||+|+.++..+ .....+++||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~--~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSF--QTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEE--ecCCeEEEEEcC
Confidence 689999999999999999999999987654332 12222344566666554 699999999999 556689999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+++ +|...+... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~ 153 (330)
T cd05586 78 MSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTT 153 (330)
T ss_pred CCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCc
Confidence 975 687777654 6789999999999999999999999999999999999999999999999999874321 11222
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....++..|+|||.+.+. ..++.++||||||+++
T Consensus 154 ~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil 187 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLV 187 (330)
T ss_pred cCccCCccccCHHHHcCC-CCCCCccceeccccEE
Confidence 345588899999998652 2378899999999985
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=234.00 Aligned_cols=184 Identities=33% Similarity=0.487 Sum_probs=151.5
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCceEEEEEec
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.||.|+||+||++.+..+++.+|+|++++..... ......+..|..++..+ +||||+++++.+ ...+.+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~h~~i~~~~~~~--~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-DDDVECTMTEKRVLALAGKHPFLTQLHSCF--QTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhccCCCCccceeeEE--EcCCEEEEEEcC
Confidence 46899999999999999899999999998664332 22334466788888777 799999999998 556689999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+++ +|...+... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (318)
T cd05570 78 VNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTT 153 (318)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcc
Confidence 975 687777665 5789999999999999999999999999999999999999999999999998864211 11222
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....++..|+|||.+.+ ..++.++|+||||+++
T Consensus 154 ~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil 186 (318)
T cd05570 154 STFCGTPDYIAPEILSY--QPYGPAVDWWALGVLL 186 (318)
T ss_pred cceecCccccCHHHhcC--CCCCcchhhhhHHHHH
Confidence 33457889999999987 4589999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=237.55 Aligned_cols=191 Identities=34% Similarity=0.509 Sum_probs=157.5
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC--
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK-- 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (235)
...++|++++.||.|+||+||++.+..+++.+|+|.+...... ......+.+|+.+++.++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh--hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3457899999999999999999999999999999988654321 122345678999999999999999998874221
Q ss_pred --CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 112 --KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 112 --~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
....++++++++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 90 ENFNEVYLVTNLMGADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred cccCcEEEEeecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccce
Confidence 235789999998888877754 568999999999999999999999999999999999999999999999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ......+++.|+|||.+.+. ..++.++||||||+++
T Consensus 167 ~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 206 (343)
T cd07878 167 QADD-----EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIM 206 (343)
T ss_pred ecCC-----CcCCccccccccCchHhcCC-ccCCchhhhHhHHHHH
Confidence 5532 22334578889999998652 3478899999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=245.09 Aligned_cols=191 Identities=25% Similarity=0.397 Sum_probs=156.0
Q ss_pred ceEEeeeeeccccceEEEEeeccch-hhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSET-LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
..|.+.+.||+|++|.||+|.+..+ ++.+++|.+.... ......+..|+..+..++||||+++++.+ ...+.+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~--~~~~~~ 140 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND----ERQAAYARSELHCLAACDHFGIVKHFDDF--KSDDKL 140 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC----HHHHHHHHHHHHHHHhCCCCCEeEEEEEE--EECCEE
Confidence 3499999999999999999988777 7788888653322 22234577899999999999999999999 456689
Q ss_pred EEEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 116 YLIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
++||||+++ +|.+.+... ...++++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..+.
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999964 687776432 23568899999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
............+++.|+|||.+.+ ..++.++||||||+++
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l 261 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVIL 261 (478)
T ss_pred CccccccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHH
Confidence 3222222334558899999999987 4589999999999874
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=254.85 Aligned_cols=199 Identities=24% Similarity=0.464 Sum_probs=163.0
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
.+...++|++++.||.|+||+||++.+..++..+++|++....... .....+..|+.++..+.||||+++++.|....
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e--~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE--REKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH--HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 4456679999999999999999999999999999999987654322 33456889999999999999999999997666
Q ss_pred CceEEEEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhC-------CcccCCCCCCCeEEccC----
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQ-------GIIHKDIKPGNLLLTLD---- 177 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~-------~i~H~dl~p~nili~~~---- 177 (235)
...+|+||||+++ +|.+++... ....+++..++.++.||+.||.|||+. +|+|+||||+|||+...
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 6789999999975 788888643 225689999999999999999999985 49999999999999642
Q ss_pred -------------CcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 178 -------------GTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 178 -------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.++|+|||++..+.. ........+++.|+|||++.+....++.++|||||||+|
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~IL 233 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHH
Confidence 3489999999975532 112233458899999999876445588999999999975
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=229.03 Aligned_cols=184 Identities=34% Similarity=0.494 Sum_probs=151.1
Q ss_pred eccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecccC
Q psy787 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVG 124 (235)
Q Consensus 45 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 124 (235)
||+|+||+||++.+..+++.+|+|.+....... ......+..|+.+++.+.|+|++++.+.+ .....++++|||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~--~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK-RKGYEGAMVEKRILAKVHSRFIVSLAYAF--QTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh-hHHHHHHHHHHHHHHhCCCCcEeeeeEEE--cCCCeEEEEEeCCCC
Confidence 689999999999999999999999987654332 22334567899999999999999999988 556689999999975
Q ss_pred -CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccc
Q psy787 125 -GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT 201 (235)
Q Consensus 125 -~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 201 (235)
+|...+... ....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+... .....
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~ 155 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTK 155 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--Ccccc
Confidence 577666432 2356899999999999999999999999999999999999999999999999998755321 11222
Q ss_pred ccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 202 TSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 202 ~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...+++.|+|||.+.+ ..++.++|+||||+++
T Consensus 156 ~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il 187 (280)
T cd05608 156 GYAGTPGFMAPELLQG--EEYDFSVDYFALGVTL 187 (280)
T ss_pred ccCCCcCccCHHHhcC--CCCCccccHHHHHHHH
Confidence 3457889999999987 4588999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=232.67 Aligned_cols=184 Identities=35% Similarity=0.498 Sum_probs=150.0
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHh-cCCCCcceeeeEEEcCCCceEEEEEec
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM-LQHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.||+|+||+||++++..+++.+|+|+++...... ......+..|..++.. +.||||+++++.+ .....+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~--~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHLYCTF--QTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCcCcceEEEE--EeCCEEEEEEeC
Confidence 46899999999999999999999999998764322 1223345567777765 4899999999999 456689999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+++ +|.+.+... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..... .....
T Consensus 78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (316)
T cd05619 78 LNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKT 153 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCce
Confidence 965 688888764 5688999999999999999999999999999999999999999999999999864311 11222
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....++..|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il 186 (316)
T cd05619 154 CTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLL 186 (316)
T ss_pred eeecCCccccCHHHHcC--CCCCchhhhhhHHHHH
Confidence 34457889999999987 4489999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=228.08 Aligned_cols=191 Identities=32% Similarity=0.510 Sum_probs=157.5
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
.|++++.||.|++|.||++.+..+++.+++|.++..... ......+.+|+.++..++|+|++++++.+. ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE--EGVPSTAIREISLLKELQHPNIVCLQDVLM--QESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc--CCchHHHHHHHHHHHhcCCCCEeeeEEEEe--eCCeEEE
Confidence 488999999999999999999889999999988654322 223345788999999999999999999994 4568899
Q ss_pred EEecccCCHHHHhhcCCC-CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVGGLQDMLDSTPY-KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
||||++++|.+++..... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 77 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 154 (285)
T cd07861 77 IFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-- 154 (285)
T ss_pred EEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence 999999888888765432 56899999999999999999999999999999999999999999999999998755321
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+. ..++.++|+||||+++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il 192 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIF 192 (285)
T ss_pred cccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHH
Confidence 1112223457789999988652 2368899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=229.57 Aligned_cols=192 Identities=29% Similarity=0.489 Sum_probs=159.0
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++++.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..+..++|+||+++++.+ .....
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~nI~~~~~~~--~~~~~ 78 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDII--HTEKS 78 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc---CchhHHHHHHHHHHhcCCCCcceEEEEE--ecCCe
Confidence 456899999999999999999999889999999988654322 2234567899999999999999999999 45668
Q ss_pred EEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 115 MYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 115 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++++|||++++|.+++.... ..++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 79 LTLVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred EEEEEeccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 99999999999888887543 46888999999999999999999999999999999999999999999999998754321
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 158 --~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l 195 (301)
T cd07873 158 --TKTYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIF 195 (301)
T ss_pred --CCcccccceeecccCcHHHhCC-CCCccHHHHHHHHHHH
Confidence 1112233467889999987652 2467899999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=229.34 Aligned_cols=187 Identities=36% Similarity=0.655 Sum_probs=158.8
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
|+++++||+|+||+||++.+..+++.+|+|++....... ........|+..+..++|+||+++.+++. .....+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE--EEREENIREIKILRRLRHPNIVQILDVFQ--DDNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH--HHHHHHHHHHHHHHHHTBTTBCHEEEEEE--ESSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc--cccchhhhhhhcccccccccccccccccc--cccccccc
Confidence 889999999999999999999999999999998775443 22223345899999999999999999994 46688999
Q ss_pred EecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC
Q psy787 119 MEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 119 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 197 (235)
||++.+ +|.+++... ..++...+..++.|++.||.+||+.+++|+||||+||+++.++.++|+|||.+.... ...
T Consensus 77 ~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp EEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred cccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccc
Confidence 999987 798888833 678999999999999999999999999999999999999999999999999987531 122
Q ss_pred CcccccCCCCcccCccccC-CCCCCCCCcccEEEeeeeC
Q psy787 198 DTITTSQGSPVFQAPEIAN-GLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~~~~~~~~~~aPE~~~-~~~~~~~~~~Di~slG~~l 235 (235)
.......+++.|.|||.+. + ..++.++|+||||+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il 189 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIIL 189 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHH
T ss_pred ccccccccccccccccccccc--cccccccccccccccc
Confidence 3444556788899999987 5 4589999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=229.29 Aligned_cols=190 Identities=31% Similarity=0.541 Sum_probs=158.3
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|++.+.||.|++|.||++.+..+|+.+++|.++..... ......+.+|+..++.++|+|++++++.+ .+...+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~--~~~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLYDVL--HSDKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc--ccCccchhHHHHHHHhcCCCCeeeHHHHh--ccCCceEE
Confidence 589999999999999999999999999999988654322 23334577899999999999999999999 45668899
Q ss_pred EEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC
Q psy787 118 IMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 118 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 197 (235)
++||++++|.+.+.... ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++..+... .
T Consensus 77 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~ 153 (284)
T cd07839 77 VFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--V 153 (284)
T ss_pred EEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--C
Confidence 99999999888876543 56899999999999999999999999999999999999999999999999998755321 1
Q ss_pred CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 198 DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+. ..++.++||||||+++
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il 190 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIF 190 (284)
T ss_pred CCcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHH
Confidence 122233467789999988662 2368899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=227.52 Aligned_cols=187 Identities=35% Similarity=0.521 Sum_probs=159.5
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|++|.||++.+..+++.+++|++....... ......+.+|+.+++++.||||+++++.+ .....++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK-LKQVEHVLNEKRILQSIRHPFLVNLYGSF--QDDSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCccceeeEE--EcCCeEE
Confidence 47999999999999999999998899999999987654322 23345678899999999999999999999 4556889
Q ss_pred EEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++||+++ ++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999994 6798888776 67899999999999999999999999999999999999999999999999998755321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.....+++.|+|||.+.+ ...+.++|+||||+++
T Consensus 155 ----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 188 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILI 188 (290)
T ss_pred ----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHH
Confidence 223457788999999876 3478899999999874
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=223.58 Aligned_cols=192 Identities=31% Similarity=0.544 Sum_probs=164.6
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
..+.++|++-+.||+|.|+.|+++.+..+|+.+++|++....... ..-+.+.+|+++-+.++||||+++.+.+ ++.
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti--~~~ 82 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSI--QEE 82 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhh--ccc
Confidence 345678999999999999999999999999999999998776654 3566788999999999999999999999 667
Q ss_pred ceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc---EEEeeeccc
Q psy787 113 QKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT---LKISDFGVA 188 (235)
Q Consensus 113 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~ 188 (235)
.+.|+|+|++.|+ |..-+-.. -.+++..+...++||++||.|+|.++|+|||+||.|+++....+ +||+|||++
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred ceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceE
Confidence 7899999999875 54444333 45788999999999999999999999999999999999975543 899999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..+. .........|+|.|+|||++.. +.++.++|||+.|++|
T Consensus 161 i~l~---~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViL 202 (355)
T KOG0033|consen 161 IEVN---DGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVIL 202 (355)
T ss_pred EEeC---CccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHH
Confidence 8765 3445556779999999999988 4499999999999975
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=230.64 Aligned_cols=187 Identities=29% Similarity=0.493 Sum_probs=149.6
Q ss_pred eeeeccccceEEEEeecc--chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEE
Q psy787 42 GDLLGEGSYGKVKEMLDS--ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIM 119 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 119 (235)
.++||+|+||+||+|++. .+++.+|+|.+.... ....+.+|+.+++.++||||+++.+.+.......+++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 367999999999999854 467889999875432 123467899999999999999999999766667889999
Q ss_pred ecccCCHHHHhhcCC-------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE----ccCCcEEEeeeccc
Q psy787 120 EYCVGGLQDMLDSTP-------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL----TLDGTLKISDFGVA 188 (235)
Q Consensus 120 e~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili----~~~~~~~l~dfg~~ 188 (235)
|+++++|.+++.... ...++...+..++.|++.||.|||+.|++||||||+||++ ...+.++|+|||++
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 999999888775321 2358889999999999999999999999999999999999 45578999999999
Q ss_pred cccCccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......... .......+++.|+|||.+.+. ..++.++||||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 206 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIF 206 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHH
Confidence 765432111 122234578889999998762 2478899999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=236.75 Aligned_cols=193 Identities=26% Similarity=0.393 Sum_probs=152.3
Q ss_pred eceEEeeeeeccccceEEEEeec-----cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEc
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLD-----SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVN 109 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (235)
.++|++.+.||.|+||+||++.+ ..++..+|+|+++.... ......+.+|+.++..+ +||||+++++.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-- 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH---LTEREALMSELKVLSYLGNHINIVNLLGAC-- 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC---cHHHHHHHHHHHHHHHhcCCcceeeeeeee--
Confidence 34799999999999999999863 34567899998864432 12334678999999999 899999999999
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCC------------------------------------------------------
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTP------------------------------------------------------ 134 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~------------------------------------------------------ 134 (235)
......+++|||+++ +|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 555678999999975 6887775431
Q ss_pred -------------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 135 -------------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 135 -------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
...+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 1246788899999999999999999999999999999999999999999999997553211
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..........+..|+|||.+.+ ..++.++||||||++|
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l 306 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILL 306 (375)
T ss_pred cccccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHH
Confidence 1111112224557999999987 4589999999999974
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=240.68 Aligned_cols=188 Identities=31% Similarity=0.484 Sum_probs=161.4
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
..|.-++.||.|+||.||-|++..+.+.||+|.+.-.-....++ -+.+..|+..|++++|||++.+-++|+.+. +.|
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EK-WqDIlKEVrFL~~l~HPntieYkgCyLre~--TaW 102 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK-WQDILKEVRFLRQLRHPNTIEYKGCYLREH--TAW 102 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHH-HHHHHHHHHHHHhccCCCcccccceeeccc--hHH
Confidence 35777889999999999999999999999999886655444222 245889999999999999999999997544 569
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+|||||-|+..+++.... +++.+-.+..|+.+.+.||+|||+.+.+|||||..||++.+.|.+||+|||.+....
T Consensus 103 LVMEYClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---- 177 (948)
T KOG0577|consen 103 LVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---- 177 (948)
T ss_pred HHHHHHhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC----
Confidence 999999998777776554 789999999999999999999999999999999999999999999999999997543
Q ss_pred CCcccccCCCCcccCccccC-CCCCCCCCcccEEEeeee
Q psy787 197 DDTITTSQGSPVFQAPEIAN-GLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~-~~~~~~~~~~Di~slG~~ 234 (235)
...+..|||.|||||++. -..++|+-++||||||++
T Consensus 178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGIT 214 (948)
T KOG0577|consen 178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 214 (948)
T ss_pred --chhcccCCccccchhHheeccccccCCccceeeccch
Confidence 445678999999999863 334679999999999984
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=236.81 Aligned_cols=194 Identities=26% Similarity=0.392 Sum_probs=151.9
Q ss_pred eeceEEeeeeeccccceEEEEeeccc-----hhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEE
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSE-----TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFV 108 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 108 (235)
..++|++++.||+|+||.||++++.. ++..||+|+++..... .....+.+|+.+++.+ +|+||+++++.+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~il~~l~~h~nIv~~~~~~- 111 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT---DEREALMSELKILSHLGQHKNIVNLLGAC- 111 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH---HHHHHHHHHHHHHHhhccCCceeeEeeEe-
Confidence 34579999999999999999988543 3357999988654321 2234578999999999 899999999999
Q ss_pred cCCCceEEEEEecccC-CHHHHhhcCC-----------------------------------------------------
Q psy787 109 NDKKQKMYLIMEYCVG-GLQDMLDSTP----------------------------------------------------- 134 (235)
Q Consensus 109 ~~~~~~~~lv~e~~~~-~l~~~~~~~~----------------------------------------------------- 134 (235)
...+.++++|||+++ +|.+++....
T Consensus 112 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 112 -THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred -cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 455688999999964 6887775321
Q ss_pred ---------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCc
Q psy787 135 ---------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT 199 (235)
Q Consensus 135 ---------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 199 (235)
..++++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...........
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 12477788999999999999999999999999999999999999999999999875532111111
Q ss_pred ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 200 ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 200 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.....++..|+|||.+.+ ..++.++||||||+++
T Consensus 271 ~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil 304 (374)
T cd05106 271 KGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILL 304 (374)
T ss_pred ccCCCCccceeCHHHhcC--CCCCccccHHHHHHHH
Confidence 112224557999999876 4489999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=246.63 Aligned_cols=197 Identities=26% Similarity=0.435 Sum_probs=158.3
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeee-EEEc---
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVD-VFVN--- 109 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~-~~~~--- 109 (235)
-.-+.+|.+.|.+|||+.||+|++...+..+|+|.+-... +...+.+.+|+.+++.|. |+|||.+++ ....
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d----e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND----EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC----HHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3447889999999999999999998888999999775442 455566889999999995 999999999 3321
Q ss_pred CC-CceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeEEccCCcEEEeee
Q psy787 110 DK-KQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLTLDGTLKISDF 185 (235)
Q Consensus 110 ~~-~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~nili~~~~~~~l~df 185 (235)
+. ...+.|+||||. |+|.+++..+....+++.++++|++++|+|+..||... |+|||||-+||||..+|++|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 11 245789999998 58999998776677999999999999999999999997 999999999999999999999999
Q ss_pred ccccccCccccCCcc-------cccCCCCcccCccccCCCC-CCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTI-------TTSQGSPVFQAPEIANGLP-EISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~-------~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~slG~~l 235 (235)
|.+...-........ -....|+-|.|||++.-.. ..++.++|||+|||+|
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclL 248 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLL 248 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHH
Confidence 999744211111110 0223678899999985322 2388999999999985
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=232.85 Aligned_cols=187 Identities=25% Similarity=0.405 Sum_probs=157.4
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++.++||.|+||.||++.+..++..+++|++..... ......+.+|++++..++|+||+++++.+. ..+.+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC---HHHHHHHHHHHHHHHHCCCCcccceeEEEE--ECCEE
Confidence 4689999999999999999999998999999998765421 123345889999999999999999999994 45689
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+++|||+.+ +|.+++... ..++...+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..+..
T Consensus 79 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999965 798888765 5688889999999999999999985 799999999999999999999999999875431
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 157 ----~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il 192 (333)
T cd06650 157 ----SMANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSL 192 (333)
T ss_pred ----hccccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHH
Confidence 11223457888999999977 4588999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=220.91 Aligned_cols=190 Identities=30% Similarity=0.472 Sum_probs=160.4
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
.|.+.+.||+|++|.||++.+..+++.+++|.+...... ......+.+|+..++.++|+|++++++.+. ..+.+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN--RREREEAIDEARVLAKLDSSYIIRYYESFL--DKGKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC--HHHHHHHHHHHHHHHhcCCCCeehheeeec--cCCEEEE
Confidence 478899999999999999999889999999988654433 244556889999999999999999999994 5568899
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+|||+++ +|.+++.......++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..+...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~-- 154 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN-- 154 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--
Confidence 9999965 7999888765567899999999999999999999999999999999999999999999999998765421
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||...+ ..++.++|+||||+++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 191 (256)
T cd08529 155 TNFANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVL 191 (256)
T ss_pred cchhhccccCccccCHHHhcC--CCCCCccchHHHHHHH
Confidence 112223457788999999987 4488999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=234.47 Aligned_cols=187 Identities=33% Similarity=0.552 Sum_probs=162.1
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
..|+..++||+|+||.||+|.+..+++.||+|++..... ......++.|+..+.+++++||.++++.++. +..++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~---~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA---EDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc---chhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHH
Confidence 467788999999999999999999999999999965543 4556678999999999999999999999964 44789
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++||||.| ++.+.+... ..+.+..+..+++.+..|+.|||..+.+|||||+.||++...|.++++|||.+-.+...
T Consensus 88 iiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~- 164 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT- 164 (467)
T ss_pred HHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech-
Confidence 99999975 588888765 44588888999999999999999999999999999999999999999999999876532
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeee
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 234 (235)
........||+.|||||++.+ ..|+.++||||||++
T Consensus 165 -~~rr~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGIT 200 (467)
T KOG0201|consen 165 -VKRRKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGIT 200 (467)
T ss_pred -hhccccccccccccchhhhcc--ccccchhhhhhhhHH
Confidence 223367789999999999987 459999999999975
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=219.38 Aligned_cols=189 Identities=30% Similarity=0.507 Sum_probs=158.6
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|++.+.||.|++|.||++.+..+++.+++|.++.... ......+.+|+..++.++|+|++++.+.+ .....+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS---SSAVEDSRKEAVLLAKMKHPNIVAFKESF--EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc---hHHHHHHHHHHHHHHhCCCCCcceEEEEE--EECCEEEE
Confidence 58899999999999999999999999999998864432 22334677899999999999999999998 56678999
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++||+++ ++.+++.......++...++.++.|++.||.+||+.|++|+||+|+||++++++.++++|||.+......
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 153 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-- 153 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--
Confidence 9999975 6888877655567899999999999999999999999999999999999999999999999998755321
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~ 190 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCIL 190 (255)
T ss_pred ccccccccCCccccCHHHHcc--CCcCchhhhhhhchhh
Confidence 111223457788999999877 4488999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=224.04 Aligned_cols=191 Identities=29% Similarity=0.474 Sum_probs=157.7
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+.+++.++|+||+++.+++ ......
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDII--HTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEE--ecCCeE
Confidence 47899999999999999999999888999999988754322 2223467899999999999999999998 456689
Q ss_pred EEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 116 YLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 116 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++||||++++|.+++.... ..+++..+..++.|+++||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 79 TLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9999999999988887653 468899999999999999999999999999999999999999999999999986442111
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+. ..++.++||||||+++
T Consensus 158 --~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il 194 (291)
T cd07844 158 --KTYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIF 194 (291)
T ss_pred --ccccccccccccCCcHHhhcC-cccCcHHHHHHHHHHH
Confidence 111222356789999988652 2368899999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=230.00 Aligned_cols=194 Identities=27% Similarity=0.416 Sum_probs=168.4
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
.-.+.|+.-+.||+|+||.|+-++-..+|+-+|+|.+.+..+.. .+......+|..+|.++..++||.+-..| +.+.
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd 258 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAF--ETKD 258 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCC
Confidence 34456777788999999999999999999999999998777665 45566778999999999999999999998 8888
Q ss_pred eEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+|+|+..|.|+ |.-.+-...+..+++..++-++.+|+.+|++||..+||+|||||.||++|+.|+++|+|+|+|..+.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999765 6555555555689999999999999999999999999999999999999999999999999998664
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........||.+|||||++.. ..|+.+.|+|||||+|
T Consensus 339 ---~g~~~~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCll 376 (591)
T KOG0986|consen 339 ---EGKPIRGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLL 376 (591)
T ss_pred ---CCCccccccCcccccCHHHHcC--CcccCCccHHHHHhHH
Confidence 3344555689999999999988 6699999999999975
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=211.00 Aligned_cols=205 Identities=28% Similarity=0.340 Sum_probs=167.1
Q ss_pred cCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeE
Q psy787 27 DNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDV 106 (235)
Q Consensus 27 ~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 106 (235)
....+...-.+||+|.+.+|.|||+.||+++...++..+|+|.+.... .+.++...+|+...++++|||++++++.
T Consensus 11 c~~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh 86 (302)
T KOG2345|consen 11 CRRGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDH 86 (302)
T ss_pred eCCCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHH
Confidence 334555666789999999999999999999999999999999987665 3556678899999999999999999987
Q ss_pred EEc---CCCceEEEEEeccc-CCHHHHhhcCC--CCCCCHHhHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeEEccCC
Q psy787 107 FVN---DKKQKMYLIMEYCV-GGLQDMLDSTP--YKKFPIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLTLDG 178 (235)
Q Consensus 107 ~~~---~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~nili~~~~ 178 (235)
.+. +.+...|++.+|+. |+|.+.+.... ...+++.+++.|+.++++||++||... +.|+||||.||++.+.+
T Consensus 87 ~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~ 166 (302)
T KOG2345|consen 87 QLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG 166 (302)
T ss_pred HHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC
Confidence 753 23457899999995 78999887653 246999999999999999999999998 99999999999999999
Q ss_pred cEEEeeeccccccCccccCCcc-------cccCCCCcccCccccCCC-CCCCCCcccEEEeeeeC
Q psy787 179 TLKISDFGVAESLDMFLHDDTI-------TTSQGSPVFQAPEIANGL-PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~-------~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 235 (235)
.+++.|||.+..........+. .....+..|.|||.++=. ....+.++|||||||+|
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtL 231 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTL 231 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHH
Confidence 9999999999865322211111 122367889999987422 23488999999999975
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=239.68 Aligned_cols=186 Identities=24% Similarity=0.376 Sum_probs=150.8
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCC------CCcceeeeEEE
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH------RNVIGLVDVFV 108 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~ 108 (235)
..++|++++.||.|+||+||++.+..+++.||+|+++... .....+..|+..+..++| .+++.+.+++.
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3578999999999999999999999899999999986432 112234567777766654 45778888775
Q ss_pred cCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEccCC---------
Q psy787 109 NDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTLDG--------- 178 (235)
Q Consensus 109 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~~~--------- 178 (235)
.....+|++|++++++|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++
T Consensus 202 -~~~~~~~iv~~~~g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 202 -NETGHMCIVMPKYGPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred -cCCceEEEEEeccCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 334578999999999999888765 678999999999999999999998 5999999999999998765
Q ss_pred -------cEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 179 -------TLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 179 -------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++|+|||.+.... .......+++.|+|||++.+ ..++.++|||||||+|
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil 335 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCII 335 (467)
T ss_pred ccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhc--CCCCcHHHHHHHHHHH
Confidence 49999999875321 22334568899999999987 4589999999999975
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=222.58 Aligned_cols=191 Identities=29% Similarity=0.481 Sum_probs=156.2
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.+.|++++.||+|++|.||++.+..+++.+++|++...... .....+.+|+..++.++|+|++++.+.+ ......
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~--~~~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE---GVPFTAIREASLLKGLKHANIVLLHDII--HTKETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC---CCcHHHHHHHHHHHhcCCCCEeEEEEEE--ecCCeE
Confidence 36899999999999999999999888999999988654321 2233567899999999999999999998 455688
Q ss_pred EEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 116 YLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 116 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++++|++.+++.+.+.... ..+++..+..++.|++.||.+||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred EEEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9999999988887776543 457888889999999999999999999999999999999999999999999987543211
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l 194 (291)
T cd07870 158 --QTYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIF 194 (291)
T ss_pred --CCCCCccccccccCCceeecC-CCCCcHHHHHHHHHHH
Confidence 112223467789999998652 2367899999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=233.64 Aligned_cols=195 Identities=26% Similarity=0.411 Sum_probs=153.1
Q ss_pred eeeceEEeeeeeccccceEEEEeeccch-----hhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEE
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSET-----LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVF 107 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 107 (235)
...++|++++.||.|+||.||++.+... +..||+|+++.... ....+.+.+|+.++..+. ||||+++++++
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR---SSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 3456788999999999999999875432 34689998865432 233456889999999995 99999999999
Q ss_pred EcCCCceEEEEEecccC-CHHHHhhcCC----------------------------------------------------
Q psy787 108 VNDKKQKMYLIMEYCVG-GLQDMLDSTP---------------------------------------------------- 134 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------------------------------------------- 134 (235)
......++||||+++ +|.+++..+.
T Consensus 111 --~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 111 --TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred --ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 556688999999964 6877765421
Q ss_pred ------------------------------------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCe
Q psy787 135 ------------------------------------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNL 172 (235)
Q Consensus 135 ------------------------------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~ni 172 (235)
...++...+..++.|++.||.|||+.+++|+||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 12467778899999999999999999999999999999
Q ss_pred EEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 173 LLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 173 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+++.++.++|+|||++................++..|+|||.+.+ ..++.++||||||++|
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil 329 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILL 329 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHH
Confidence 999999999999999875432111112222345677999999877 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=224.67 Aligned_cols=191 Identities=20% Similarity=0.280 Sum_probs=152.5
Q ss_pred eceEEeeeeeccccceEEEEeecc---chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDS---ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
.++|++.+.||+|+||.||++... ..+..+++|.++.... ......+.+|+..+..++|||++++++.+. .+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS---DKQRRGFLAEALTLGQFDHSNIVRLEGVIT--RG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEe--cC
Confidence 467999999999999999998754 4567888888765422 233346889999999999999999999984 55
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+++||||+++ +|.+++.... ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++++|||.+...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 678999999976 5777776542 57899999999999999999999999999999999999999999999999987643
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... .........++..|+|||.+.+ ..++.++||||||+++
T Consensus 158 ~~~-~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 198 (266)
T cd05064 158 KSE-AIYTTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVM 198 (266)
T ss_pred ccc-chhcccCCCCceeecCHHHHhh--CCccchhHHHHHHHHH
Confidence 211 1111112224567999999877 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=233.77 Aligned_cols=188 Identities=30% Similarity=0.469 Sum_probs=151.9
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..+.|+++++||.|+||+||++.+..+++.|++|++..... ......+.+|+.+++.++|+||+++++.+ ...+.
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~ 146 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE---DTVRRQICREIEILRDVNHPNVVKCHDMF--DHNGE 146 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc---HHHHHHHHHHHHHHHhCCCCCcceeeeEe--ccCCe
Confidence 35678999999999999999999988999999999854321 23345688999999999999999999998 56678
Q ss_pred EEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
++++|||+.++ |.+. ...++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+..
T Consensus 147 ~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred EEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99999999764 5431 2346678889999999999999999999999999999999999999999999875532
Q ss_pred cccCCcccccCCCCcccCccccCCC---CCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~l 235 (235)
. ........++..|+|||.+... ....+.++||||||++|
T Consensus 221 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil 263 (353)
T PLN00034 221 T--MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSI 263 (353)
T ss_pred c--cccccccccCccccCccccccccccCcCCCcchhHHHHHHHH
Confidence 1 1112234588899999987431 12355789999999974
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=217.78 Aligned_cols=194 Identities=30% Similarity=0.485 Sum_probs=166.9
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCcc----ccHHHHHHHHHhc-CCCCcceeeeEEEc
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGE----INVDREIRLLKML-QHRNVIGLVDVFVN 109 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (235)
....|.-.+.+|.|..++|-++.+..+++.+++|++.-.......+.. +.-..|+.+|+++ .||+|.++.+.|
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-- 92 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-- 92 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--
Confidence 445666778899999999999999999999999999776655444432 2345788999988 799999999999
Q ss_pred CCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
+++.++++|++.++ |.|.+++.+. -.++++...++++|+++++.|||.++|+||||||+||+++++.+++|+|||++
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecccee
Confidence 78889999999996 6799999987 67999999999999999999999999999999999999999999999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccC----CCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIAN----GLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~~Di~slG~~l 235 (235)
..+. ........+|||+|+|||.+. .....|+...|+|++|+++
T Consensus 171 ~~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVIm 218 (411)
T KOG0599|consen 171 CQLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIM 218 (411)
T ss_pred eccC---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHH
Confidence 9775 566778889999999999773 1123488899999999974
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=230.69 Aligned_cols=196 Identities=31% Similarity=0.436 Sum_probs=155.8
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhh---h-eeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLC---R-RAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~---~-~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
++....+-.+.++||+|.||.||.+.....+. . ||+|..+..... ..+.+.++.+|.++++.++||||++++|+.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~-~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL-TKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccc-cHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34445555666899999999999997654322 2 677776642212 245567899999999999999999999999
Q ss_pred EcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeec
Q psy787 108 VNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
. ....+++|||+|.| +|.+++.... ..++..+...++.+.+.||+|||+++++||||..+|++++.++.+||+|||
T Consensus 231 ~--~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 231 V--LEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred c--CCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccc
Confidence 5 44568999999975 6999999875 369999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++..-.... .......-+..|+|||.+.. ..+++++||||||+++
T Consensus 308 Ls~~~~~~~--~~~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~ 352 (474)
T KOG0194|consen 308 LSRAGSQYV--MKKFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLL 352 (474)
T ss_pred cccCCccee--eccccccCcceecChhhhcc--CccccccchhheeeeE
Confidence 987432110 01101124567999999987 5799999999999974
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=238.03 Aligned_cols=199 Identities=32% Similarity=0.492 Sum_probs=166.4
Q ss_pred ceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 30 TIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 30 ~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
.+.......|..-+.||.|+||.||+++++.+|+.+|+|.+++... .........|+.+++++.|+|||+++++--.
T Consensus 6 ~l~~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~---~r~~e~~~~EieilkKLnh~NIVk~f~iee~ 82 (732)
T KOG4250|consen 6 VLTSGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS---LRPRERWCREIEILKKLNHPNIVKLFDIEET 82 (732)
T ss_pred ccccCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcc---cchHHHHHHHHHHHHHcCchhhhhhcccCCc
Confidence 3444455678888999999999999999999999999999887652 3555677899999999999999999988632
Q ss_pred CC----CceEEEEEeccc-CCHHHHhhcCC-CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC----c
Q psy787 110 DK----KQKMYLIMEYCV-GGLQDMLDSTP-YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG----T 179 (235)
Q Consensus 110 ~~----~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~----~ 179 (235)
.. .....++||||. |+|...+.+.. ..++++..++.++..++.||+|||.+||+||||||.||++.... .
T Consensus 83 ~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 83 KFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred cccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceE
Confidence 22 335689999996 56998888653 36799999999999999999999999999999999999997543 3
Q ss_pred EEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 180 LKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.||+|||.|+.++ ......+..||..|++||..-. ...++...|.|||||++
T Consensus 163 yKLtDfG~Arel~---d~s~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~Gvtl 214 (732)
T KOG4250|consen 163 YKLTDFGAARELD---DNSLFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTL 214 (732)
T ss_pred EeeecccccccCC---CCCeeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHH
Confidence 7999999999776 3446778889999999999864 25689999999999974
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=220.32 Aligned_cols=193 Identities=32% Similarity=0.530 Sum_probs=158.3
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC-CCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI-PNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
++|.+.+.||.|++|.||.+.+..+++.+++|.+........ ......+.+|+.++++++|||++++++.+ .....+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL--RDDETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE--ccCCeE
Confidence 468999999999999999999988999999998876543221 11234578899999999999999999999 455689
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++++|++++ +|.+.+... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999975 688887765 56888999999999999999999999999999999999999999999999998755321
Q ss_pred ccCCc-ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDT-ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... .....++..|+|||.+.+ ..++.++||||||+++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 197 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTV 197 (263)
T ss_pred ccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHH
Confidence 11111 123346678999999987 4488999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=224.86 Aligned_cols=196 Identities=35% Similarity=0.541 Sum_probs=161.1
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||.|++|.||++.+..+|+.+++|.++...... .....+.+|+.+++.++|+|++++++.+.+....
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD--GIPISSLREITLLLNLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC--CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence 35678999999999999999999999999999999987554321 2233456899999999999999999998755556
Q ss_pred eEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 114 KMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 114 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.++++||+++++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 789999999999888887543 5689999999999999999999999999999999999999999999999999976542
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........+..|+|||.+.+. ..++.++|+||||+++
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il 199 (309)
T cd07845 161 PA--KPMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCIL 199 (309)
T ss_pred cc--CCCCcccccccccChhhhcCC-CCcCchHHHHHHHHHH
Confidence 11 111222346679999988652 2368899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=227.46 Aligned_cols=191 Identities=21% Similarity=0.321 Sum_probs=152.2
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhh----eeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCR----RAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~----~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
..+|++.+.||+|+||+||++.+..+++. +++|+++... .......+..|+..+..+.|+||+++++.+..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-- 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--
Confidence 45799999999999999999987655554 7888775322 12334568889999999999999999999853
Q ss_pred CceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...+++++++. |+|.+.+.... ..++...++.++.|++.||+|||+.+++||||||+||+++.++.++|+|||++..
T Consensus 81 -~~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 81 -STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred -CCceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 24678999986 56888887653 4578889999999999999999999999999999999999999999999999986
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...............+..|+|||.+.+ ..++.++||||||++|
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l 201 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTV 201 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhcc--CCCCchhhhHHHHHHH
Confidence 542222111222234567999999877 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=220.01 Aligned_cols=195 Identities=31% Similarity=0.501 Sum_probs=158.4
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC-CCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI-PNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.+|++.+.||.|++|.||.+.+..+++.+++|.+........ ......+.+|+.++..+.|+|++++++.+.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478999999999999999999988999999998864432211 1223467889999999999999999998854445678
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++||++++ +|.+++... ..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 899999975 688888765 45788899999999999999999999999999999999999999999999998754321
Q ss_pred cc-CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LH-DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il 199 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTV 199 (265)
T ss_pred cccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHH
Confidence 11 111223447788999999876 4478999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=221.03 Aligned_cols=190 Identities=25% Similarity=0.336 Sum_probs=156.5
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
...|.+.+.||.|++|.||++.+..+++.+++|.+.... .....+.+|+..++.++|+|++++++.+ .....+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~ 77 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPF 77 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-----hHHHHHHHHHHHHHhCCCCChhheEEEE--cCCCCc
Confidence 346899999999999999999998889999999875332 2234578999999999999999999998 455678
Q ss_pred EEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++|||++ ++|.+++.......++...++.++.|++.+|++||+.+++|+||+|+||++++++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999996 56888887665567899999999999999999999999999999999999999999999999998755321
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... .......+..|+|||.+.+ ..++.++||||||+++
T Consensus 158 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il 195 (263)
T cd05052 158 TYT-AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLL 195 (263)
T ss_pred eee-ccCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHH
Confidence 111 1111223457999999877 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=218.28 Aligned_cols=191 Identities=27% Similarity=0.518 Sum_probs=158.0
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
.|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|+..+++++|+|++++.+.+. .....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS--RRERKAAEQEAQLLSQLKHPNIVAYRESWE-GEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC--HHHHHHHHHHHHHHHhCCCCCeeeeeeeec-CCCCEEEE
Confidence 489999999999999999999888999999988654322 123345788999999999999999998873 23456899
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++|++++ +|.+.+.......+++..++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~-- 155 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-- 155 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc--
Confidence 9999975 6888887655567899999999999999999999999999999999999999999999999998755321
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||...+ ..++.++|+||||+++
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il 192 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCV 192 (257)
T ss_pred CCccccccCCcCccChhHhcC--CCCCchhhhHHHHHHH
Confidence 122233457788999999877 4588899999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=230.27 Aligned_cols=194 Identities=26% Similarity=0.398 Sum_probs=152.3
Q ss_pred eceEEeeeeeccccceEEEEeeccc-----hhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEc
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSE-----TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVN 109 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (235)
.++|++++.||.|+||.||+|++.. +++.+++|+++.... ......+..|+..+.++ .|+||+++++.+..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT---ASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC---HHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 3589999999999999999997433 457899998864321 12234567899999999 79999999998863
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCC-----------------------------------------------------
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPY----------------------------------------------------- 135 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------------------------------------- 135 (235)
....+++++||+++ +|.+++.....
T Consensus 83 -~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 83 -PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred -CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 34578899999975 68777754321
Q ss_pred ------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcc
Q psy787 136 ------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF 209 (235)
Q Consensus 136 ------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 209 (235)
.++++..+..++.|++.||+|||+++++||||||.||+++.++.++|+|||++..+.............++..|
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 25788899999999999999999999999999999999999999999999999865322111122223345679
Q ss_pred cCccccCCCCCCCCCcccEEEeeeeC
Q psy787 210 QAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 210 ~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|||.+.+ ..++.++|||||||+|
T Consensus 242 ~aPE~~~~--~~~~~~~Di~SlGv~l 265 (337)
T cd05054 242 MAPESIFD--KVYTTQSDVWSFGVLL 265 (337)
T ss_pred cCcHHhcC--CCCCccccHHHHHHHH
Confidence 99999977 4489999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=229.77 Aligned_cols=191 Identities=32% Similarity=0.472 Sum_probs=157.4
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC--
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK-- 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (235)
...++|++++.||+|++|.||++.+..+++.+++|.+...... ......+.+|+.++.+++|+|++++++.+....
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN--VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC--hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 3568899999999999999999999999999999987543221 122335678999999999999999999885322
Q ss_pred --CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 112 --KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 112 --~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
....++|||++.++|.+.+... ++...+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 91 ~~~~~~~lv~e~~~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 91 EEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred cccCcEEEEEeccCCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 2357999999999988877543 7888999999999999999999999999999999999999999999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 167 ~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l 207 (353)
T cd07850 167 TAGTS---FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIM 207 (353)
T ss_pred eCCCC---CCCCCCcccccccCHHHHhC--CCCCCchhhHhHHHHH
Confidence 65421 12223346788999999977 4488999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=220.34 Aligned_cols=188 Identities=34% Similarity=0.534 Sum_probs=159.6
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|++.+.||.|++|.||++.+..+++.+++|++....... ......+.+|+..+++++|||++++++.+ .....+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-KGSVRNVLNERRILQELNHPFLVNLWYSF--QDEENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc-hhHHHHHHHHHHHHHhCCCCChHHHHHhh--cCCCeEEE
Confidence 5899999999999999999998899999999997654332 23345688999999999999999999998 56678999
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++|++.+ +|.+.+... .++++..+..++.|+++||.+||+++++|+||+|+||+++.++.++|+|||.+.....
T Consensus 78 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~--- 152 (258)
T cd05578 78 VVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP--- 152 (258)
T ss_pred EEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC---
Confidence 9999965 688887765 5789999999999999999999999999999999999999999999999999875532
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l 189 (258)
T cd05578 153 DTLTTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTA 189 (258)
T ss_pred CccccccCCChhhcCHHHHcc--cCCCCcccchhhHHHH
Confidence 112233457778999999977 4488999999999874
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=221.64 Aligned_cols=191 Identities=33% Similarity=0.527 Sum_probs=159.7
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|++.+.||.|++|.||+|.+..+++.+++|++....... .....+.+|+..+++++|+|++++++.+ .....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG--GIPNQALREIKALQACQHPYVVKLLDVF--PHGSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc--hhhHHHHHHHHHHHhCCCCCCcceeeEE--ecCCeeEE
Confidence 5899999999999999999998889999999987654322 3345688999999999999999999999 45668899
Q ss_pred EEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC
Q psy787 118 IMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 118 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 197 (235)
|+|+++++|.+++.... ..+++..++.++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 77 v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 77 VMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 99999778998886543 6789999999999999999999999999999999999999999999999999886542211
Q ss_pred CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 198 DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+. ..++.++||||||+++
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l 191 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIF 191 (286)
T ss_pred CccccccCcccccCceeeecc-ccCCchhHHHHHHHHH
Confidence 112234577889999988652 3368899999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=225.13 Aligned_cols=186 Identities=28% Similarity=0.490 Sum_probs=148.3
Q ss_pred eeeccccceEEEEeecc--chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEe
Q psy787 43 DLLGEGSYGKVKEMLDS--ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 120 (235)
.+||.|+||+||+|.+. .++..+++|.+.... ....+.+|+.+++.++|||++++++++.......+++++|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 57999999999999854 356788999775432 1235778999999999999999999987666678899999
Q ss_pred cccCCHHHHhhcC-------CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE----ccCCcEEEeeecccc
Q psy787 121 YCVGGLQDMLDST-------PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL----TLDGTLKISDFGVAE 189 (235)
Q Consensus 121 ~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili----~~~~~~~l~dfg~~~ 189 (235)
+++++|.+++... ....+++..++.++.|++.||.|||+.+++|+||||+||++ ..++.++|+|||++.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 81 YAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 9999988877532 12357888999999999999999999999999999999999 456789999999998
Q ss_pred ccCccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........ .......++..|+|||.+.+. ..++.++||||||+++
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il 206 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIF 206 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHH
Confidence 65422111 122234568889999998652 3478899999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=229.60 Aligned_cols=201 Identities=29% Similarity=0.446 Sum_probs=173.2
Q ss_pred ecCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCcc----ccHHHHHHHHHhcC---CC
Q psy787 26 YDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGE----INVDREIRLLKMLQ---HR 98 (235)
Q Consensus 26 ~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~----~~~~~e~~~l~~l~---h~ 98 (235)
-.++....+.+..|...+.+|.|+||.|++|.++++...|++|.+.+..+...-..+ =.+-.|+++|..+. |+
T Consensus 550 ~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~ 629 (772)
T KOG1152|consen 550 NIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHE 629 (772)
T ss_pred cccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCcc
Confidence 446677778888999999999999999999999999999999999877654321111 12557999999997 99
Q ss_pred CcceeeeEEEcCCCceEEEEEecccC--CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc
Q psy787 99 NVIGLVDVFVNDKKQKMYLIMEYCVG--GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL 176 (235)
Q Consensus 99 ~i~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~ 176 (235)
||+++.+.| ++.+++|++||..+. +|.+++... ..+++.++..+++|++.|+++||++||+|||||-+|++++.
T Consensus 630 NIlKlLdfF--Eddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~ 705 (772)
T KOG1152|consen 630 NILKLLDFF--EDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDS 705 (772)
T ss_pred chhhhhhee--ecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEec
Confidence 999999999 888899999999865 499999877 77999999999999999999999999999999999999999
Q ss_pred CCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 177 DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|-++|+|||.+... .+.......||-.|.|||++.|. .+.+..-|||+||++|
T Consensus 706 ~g~~klidfgsaa~~----ksgpfd~f~gtv~~aapevl~g~-~y~gk~qdiwalgill 759 (772)
T KOG1152|consen 706 NGFVKLIDFGSAAYT----KSGPFDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILL 759 (772)
T ss_pred CCeEEEeeccchhhh----cCCCcceeeeeccccchhhhCCC-ccCCCcchhhhhhhee
Confidence 999999999998633 34555677799999999999884 3567889999999986
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=224.03 Aligned_cols=193 Identities=32% Similarity=0.512 Sum_probs=156.1
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...+.|++++.||.|++|.||++.+..+++.+++|++.... ......+.+|+.++..+.|+|++++++.+. ..+
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~ 82 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYMVEIEILATCNHPYIVKLLGAFY--WDG 82 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCcEeeeEEEEE--eCC
Confidence 34467999999999999999999999899999999886432 233456788999999999999999999984 456
Q ss_pred eEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.++++|||++++ |...+.... ..+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 889999999865 655554432 568999999999999999999999999999999999999999999999999886432
Q ss_pred ccccCCcccccCCCCcccCccccCCC---CCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~l 235 (235)
. .........++..|+|||.+.+. ...++.++|+||||+++
T Consensus 162 ~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il 205 (292)
T cd06644 162 K--TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 205 (292)
T ss_pred c--cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHH
Confidence 1 11222334577889999988531 13367899999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=223.06 Aligned_cols=191 Identities=26% Similarity=0.398 Sum_probs=150.0
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhhe--eeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCC
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRR--AVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDK 111 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~--~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 111 (235)
..++|++.+.||.|+||.||+|.+..++..+ ++|.++... .......+.+|+.++.++ +|+|++++++.+ ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~--~~ 79 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EH 79 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC---CHHHHHHHHHHHHHHHHhcCCCCcceEEEEE--CC
Confidence 3568999999999999999999987777655 444433211 123344677899999999 899999999998 55
Q ss_pred CceEEEEEeccc-CCHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc
Q psy787 112 KQKMYLIMEYCV-GGLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL 176 (235)
Q Consensus 112 ~~~~~lv~e~~~-~~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~ 176 (235)
.+.++++|||++ ++|.+++.... ...++...++.++.|++.|+++||+.|++||||||+||+++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 668899999997 46888886442 135788899999999999999999999999999999999999
Q ss_pred CCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 177 DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++.++|+|||++..... .........+..|+|||...+ ..++.++||||||+++
T Consensus 160 ~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 213 (303)
T cd05088 160 NYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLL 213 (303)
T ss_pred CCcEEeCccccCcccch---hhhcccCCCcccccCHHHHhc--cCCcccccchhhhhHH
Confidence 99999999999863221 111111223557999998876 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=220.59 Aligned_cols=193 Identities=27% Similarity=0.380 Sum_probs=155.3
Q ss_pred ceEEeeeeeccccceEEEEee----ccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 37 GKYVMGDLLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
..|++++.||+|+||.||++. ...++..+++|.++.... ......+.+|+.+++.+.|+|++++.+.+...+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc---HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 357999999999999999986 345788899998764421 2334468899999999999999999999865445
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..++++|||+++ +|.+++.... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 678999999964 6888876543 45889999999999999999999999999999999999999999999999999865
Q ss_pred CccccCC-cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDD-TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....... ......++..|+|||.+.+ ..++.++||||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il 202 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTL 202 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhh
Confidence 3211111 1122335567999999876 4488999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=222.17 Aligned_cols=192 Identities=28% Similarity=0.411 Sum_probs=154.2
Q ss_pred ceEEeeeeeccccceEEEEee----ccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 37 GKYVMGDLLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
.+|++++.||+|+||.||++. +..++..+++|.+.... ......+.+|+.++..++|+|++++.+.+...+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST----AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 479999999999999999986 45578889999876432 2233467899999999999999999998865555
Q ss_pred ceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+++++||++ ++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 67899999996 57988886542 45889999999999999999999999999999999999999999999999999865
Q ss_pred CccccCCc-ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDT-ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........ ......+..|+|||.+.+ ..++.++|+||||+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 201 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVL 201 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHH
Confidence 32111100 111123345999999877 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=220.20 Aligned_cols=191 Identities=34% Similarity=0.531 Sum_probs=156.1
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||+|++|.||++.+..+++.+++|.+...... ......+.+|+.++.+++|+|++++++.+ .....++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~~ 76 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD--PVIKKIALREIRMLKQLKHPNLVNLIEVF--RRKRKLH 76 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC--ccccHHHHHHHHHHHhCCCCCEeeeeeEE--eeCCEEE
Confidence 4799999999999999999999888999999988654322 22334578999999999999999999999 4566889
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++|||+++++.+.+.... ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07847 77 LVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG- 154 (286)
T ss_pred EEEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc-
Confidence 999999887555444332 468999999999999999999999999999999999999999999999999998654211
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 155 -~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~ 191 (286)
T cd07847 155 -DDYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVF 191 (286)
T ss_pred -ccccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHH
Confidence 112233466789999998652 3478899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=222.53 Aligned_cols=191 Identities=33% Similarity=0.564 Sum_probs=158.9
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|++++.||.|++|.||++.+..+++.+++|.+...... ......+.+|+..+.+++|+|++++++.+ .+....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~~ 76 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVI--HTENKLYL 76 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc--cccchHHHHHHHHHHhcCCCCCcchhhhc--ccCCcEEE
Confidence 488999999999999999999889999999987654322 23334688999999999999999999998 45668899
Q ss_pred EEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC
Q psy787 118 IMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 118 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 197 (235)
+|||+.++|.+++.......+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 77 VFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred EeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence 999998889888877665778999999999999999999999999999999999999999999999999987553211
Q ss_pred CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 198 DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il 191 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIF 191 (284)
T ss_pred cccccccccccccCCeEEecC-CCCCcHHHHHHHHHHH
Confidence 112223356789999988652 2367899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=222.15 Aligned_cols=190 Identities=31% Similarity=0.481 Sum_probs=157.3
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++.+.||.|++|.||++.+..+++.+++|+++.... .....+.+|+.+++.++|||++++++.+. ....+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~~~~l~h~~ii~~~~~~~--~~~~~ 81 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG----EDFAVVQQEIIMMKDCKHSNIVAYFGSYL--RRDKL 81 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCeeeEEEEEE--eCCEE
Confidence 3589999999999999999999988999999998865432 22235678999999999999999999984 45688
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++++||+++ +|.+++... +.+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 999999975 688887655 57899999999999999999999999999999999999999999999999998755321
Q ss_pred ccCCcccccCCCCcccCccccCCC-CCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGL-PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+... ...++.++|+||||+++
T Consensus 160 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il 199 (267)
T cd06645 160 --IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITA 199 (267)
T ss_pred --ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHH
Confidence 1222344578889999987421 23478899999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=218.73 Aligned_cols=189 Identities=28% Similarity=0.378 Sum_probs=154.9
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|+++++||+|++|.||++... .++.+++|.+.... .....+.+|+.+++.++|+|++++++.+ ......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~ 76 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVV--TKEEPI 76 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEE--cCCCCc
Confidence 468999999999999999999864 45678888765432 2234688999999999999999999998 556678
Q ss_pred EEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++++|+++ ++|.+++.......++...+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999996 57988887665567888999999999999999999999999999999999999999999999999765421
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .......++..|+|||...+ ..+++++|+||||+++
T Consensus 157 ~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 194 (261)
T cd05072 157 EY-TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILL 194 (261)
T ss_pred ce-eccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHH
Confidence 11 11112234567999999877 4588899999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=221.28 Aligned_cols=192 Identities=26% Similarity=0.462 Sum_probs=157.8
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|++|.||++.+..+++.+++|.+....... ......+.+|+..++.++|||++++++.+. ..+..+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD-AKARQDCVKEIDLLKQLNHPNVIKYLDSFI--EDNELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC-HHHHHHHHHHHHHHHhCCCcceeeeeeeEE--ECCeEE
Confidence 58999999999999999999998899999999876543322 233456788999999999999999999984 456789
Q ss_pred EEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 117 LIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+++|++++ +|.+++... ....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999975 687777532 224578899999999999999999999999999999999999999999999999875532
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 159 ~--~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l 196 (267)
T cd08228 159 K--TTAAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLL 196 (267)
T ss_pred h--hHHHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHH
Confidence 1 111223457788999999877 4478899999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=225.02 Aligned_cols=194 Identities=31% Similarity=0.438 Sum_probs=159.8
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|++|.||++.+..+++.+++|.+....... ......+..|+..+..+.|+||+++++.+ ......+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPFLPTLYASF--QTETYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCCchhheeee--ecCCEEE
Confidence 47999999999999999999998889999999987654332 12344678899999999999999999998 5566899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++||++.+ +|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999965 78888876655678999999999999999999999999999999999999999999999999886442111
Q ss_pred cC---------------------------CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HD---------------------------DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll 222 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILL 222 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHH
Confidence 00 00112246778999999987 4478999999999874
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=223.42 Aligned_cols=193 Identities=27% Similarity=0.339 Sum_probs=153.0
Q ss_pred eceEEeeeeeccccceEEEEeeccchh-----hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETL-----CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
.++|++.+.||.|++|.||++.....+ ..+++|.++.... ......+.+|+..+..++|+|++++++.+ .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~~~~~~--~ 78 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE---PKVQQEFRQEAELMSDLQHPNIVCLLGVC--T 78 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC---HHHHHHHHHHHHHHHhcCCcccceEEEEE--c
Confidence 357999999999999999999865444 5688887754321 22344688999999999999999999998 4
Q ss_pred CCceEEEEEecccC-CHHHHhhcCCC--------------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDSTPY--------------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT 175 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~ 175 (235)
.....+++|||+++ +|.+++..... ..++...++.++.|++.||.|||+.+++|+||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 45678999999974 68888865421 4578889999999999999999999999999999999999
Q ss_pred cCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 176 LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 176 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++.++|+|||++................++..|+|||.+.+ ..++.++||||||+++
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il 216 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVL 216 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHH
Confidence 999999999999875422111111222335677999999876 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=234.21 Aligned_cols=191 Identities=30% Similarity=0.444 Sum_probs=161.9
Q ss_pred ceeecCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcce
Q psy787 23 QVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIG 102 (235)
Q Consensus 23 ~~~~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 102 (235)
++...+..+++.-+....-++=||+|+.|.||+++. .++.||||.++.-. ..+|+-|++|+|+||+.
T Consensus 110 e~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~elk-----------ETdIKHLRkLkH~NII~ 176 (904)
T KOG4721|consen 110 EHKQQQEELWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK-----------ETDIKHLRKLKHPNIIT 176 (904)
T ss_pred ehhhhhhhhccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhhh-----------hhhHHHHHhccCcceee
Confidence 344445555566666666778899999999999987 46789998664322 35888999999999999
Q ss_pred eeeEEEcCCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEE
Q psy787 103 LVDVFVNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLK 181 (235)
Q Consensus 103 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~ 181 (235)
|.|+| .....+|||||||. |-|...+... ..++......|.++|+.+|+|||...|+|||||.-||+|..+..+|
T Consensus 177 FkGVC--tqsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 177 FKGVC--TQSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred Eeeee--cCCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEE
Confidence 99999 67789999999997 5699999887 7899999999999999999999999999999999999999999999
Q ss_pred EeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 182 ISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+|||.++.... ........||-.|||||++...| .+.+.|||||||+|
T Consensus 253 IsDFGTS~e~~~---~STkMSFaGTVaWMAPEvIrneP--csEKVDIwSfGVVL 301 (904)
T KOG4721|consen 253 ISDFGTSKELSD---KSTKMSFAGTVAWMAPEVIRNEP--CSEKVDIWSFGVVL 301 (904)
T ss_pred eccccchHhhhh---hhhhhhhhhhHhhhCHHHhhcCC--cccccceehhHHHH
Confidence 999999875542 24455677999999999999855 89999999999985
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=220.06 Aligned_cols=191 Identities=31% Similarity=0.416 Sum_probs=152.6
Q ss_pred ceE-EeeeeeccccceEEEEee----ccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 37 GKY-VMGDLLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 37 ~~y-~i~~~ig~g~~~~v~~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
++| ++++.||.|+||+||++. ...+++.+++|+++.... ......+.+|+..++.++|||++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG---QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 456 999999999999998754 335678899998865432 123346788999999999999999999886555
Q ss_pred CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...++++||++++ +|.+++.. ..+++..++.++.|++.||.+||+.+++|+||||+||+++.++.++|+|||++..
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 5678999999975 68887765 4589999999999999999999999999999999999999999999999999876
Q ss_pred cCccccCCc-ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDT-ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......... .....++..|+|||...+ ..++.++||||||+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l 200 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTL 200 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHH
Confidence 542111111 112234556999999876 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=216.58 Aligned_cols=190 Identities=29% Similarity=0.501 Sum_probs=160.1
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|++++.||.|++|.||.+++..+++.+++|.+....... .....+.+|+.++++++|+|++++++.+. ....+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE--KERRDALNEIVILSLLQHPNIIAYYNHFM--DDNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch--hHHHHHHHHHHHHHhCCCCCeeEEEeEEe--cCCeEEE
Confidence 5899999999999999999999999999999886554332 33446789999999999999999999994 4568899
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+||++++ +|.+.+.......++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~- 155 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY- 155 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc-
Confidence 9999975 79888877655678999999999999999999999999999999999999999999999999987553221
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......+++.|.|||.+.+ ..++.++|+||||+++
T Consensus 156 -~~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~ 191 (256)
T cd08221 156 -SMAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVL 191 (256)
T ss_pred -ccccccCCCccccCHhhcCC--CCCCCcchhHHHHHHH
Confidence 12233457888999999877 3478899999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=220.26 Aligned_cols=193 Identities=28% Similarity=0.496 Sum_probs=152.8
Q ss_pred eceEEeeeeeccccceEEEEeeccch-----hhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEc
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSET-----LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVN 109 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (235)
.++|++.+.||+|++|.||++..... ...+++|.+..... .+....+.+|+..+..+ +|+|++++++.+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-- 85 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIINLLGVC-- 85 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC---HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--
Confidence 35799999999999999999986533 36788887764321 22334578899999999 799999999998
Q ss_pred CCCceEEEEEeccc-CCHHHHhhcC--------------CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE
Q psy787 110 DKKQKMYLIMEYCV-GGLQDMLDST--------------PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL 174 (235)
Q Consensus 110 ~~~~~~~lv~e~~~-~~l~~~~~~~--------------~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili 174 (235)
...+.++++|||++ ++|.+++... ....+++..++.++.|++.||+|||+.+++|+||+|+||++
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 45567899999996 4688887542 23568889999999999999999999999999999999999
Q ss_pred ccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 175 TLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 175 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.++.++|+|||.+.................+..|+|||.+.+ ..++.++||||||+++
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 224 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLL 224 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc--CCcCcccceeehhhHH
Confidence 9999999999999985532111111122234567999999876 4588999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=223.14 Aligned_cols=194 Identities=32% Similarity=0.482 Sum_probs=160.6
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++.+.||.|++|.||+|.+..+++.+++|.++..... ......+.+|+..+..++|||++++.+.+.......+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 46899999999999999999999888999999998755433 2223346789999999999999999999865544789
Q ss_pred EEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 116 YLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 116 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++++|+++++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 82 YMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999999999888887653 468999999999999999999999999999999999999999999999999988654321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l 197 (293)
T cd07843 161 --KPYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIF 197 (293)
T ss_pred --cccccccccccccCchhhcCC-ccccchhhHHHHHHHH
Confidence 112233467789999988653 2368899999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=235.18 Aligned_cols=199 Identities=29% Similarity=0.488 Sum_probs=172.9
Q ss_pred CCceeEeeeceEEee-eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeE
Q psy787 28 NKTIKVKMIGKYVMG-DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDV 106 (235)
Q Consensus 28 ~~~~~~~~~~~y~i~-~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 106 (235)
...++....++|.-. +.||+|+|.+||+|.|..+|-.||.--++...........++|..|+.+|+.|+|+||++++..
T Consensus 30 ~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~S 109 (632)
T KOG0584|consen 30 SEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDS 109 (632)
T ss_pred ccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeh
Confidence 344555556666444 6899999999999999999999998888777777766777899999999999999999999999
Q ss_pred EEcCCCceEEEEEecc-cCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC--CcccCCCCCCCeEEccC-CcEEE
Q psy787 107 FVNDKKQKMYLIMEYC-VGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ--GIIHKDIKPGNLLLTLD-GTLKI 182 (235)
Q Consensus 107 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--~i~H~dl~p~nili~~~-~~~~l 182 (235)
+.+..+.++.+|+|.+ +|+|..++.+. +.++...+..|++||++||.|||++ .|+|||||-+||||.-+ |.+||
T Consensus 110 W~d~~n~~in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKI 187 (632)
T KOG0584|consen 110 WVDTDNKTINFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKI 187 (632)
T ss_pred eecCCCceeeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceee
Confidence 9887778899999999 57899999988 7789999999999999999999998 49999999999999855 89999
Q ss_pred eeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 183 SDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|+|+|.... ..+...-.|||.|||||+.- ..|+...||||||+|+
T Consensus 188 GDLGLAtl~r----~s~aksvIGTPEFMAPEmYE---E~YnE~VDVYaFGMCm 233 (632)
T KOG0584|consen 188 GDLGLATLLR----KSHAKSVIGTPEFMAPEMYE---ENYNELVDVYAFGMCM 233 (632)
T ss_pred cchhHHHHhh----ccccceeccCccccChHHHh---hhcchhhhhhhhhHHH
Confidence 9999998664 34455567999999999986 3489999999999975
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=223.96 Aligned_cols=196 Identities=30% Similarity=0.514 Sum_probs=158.3
Q ss_pred eEEeeeeeccccceEEEEeeccc--hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSE--TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
+|.+.++||+|++|.||++.+.. +++.+|+|.+...... .......+.+|+.++..++|||++++++.+.......+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-YTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 48899999999999999999987 7899999998765421 12334457789999999999999999999975545789
Q ss_pred EEEEecccCCHHHHhhcCC---CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc----CCcEEEeeeccc
Q psy787 116 YLIMEYCVGGLQDMLDSTP---YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL----DGTLKISDFGVA 188 (235)
Q Consensus 116 ~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~----~~~~~l~dfg~~ 188 (235)
++|||++++++.+.+.... ...+++..++.++.|++.||+|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999999988877765332 236889999999999999999999999999999999999999 889999999998
Q ss_pred cccCccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......... .......++..|+|||.+.+. ..++.++||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l 206 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIF 206 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHH
Confidence 865422111 111223457789999987652 3478899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=217.33 Aligned_cols=195 Identities=30% Similarity=0.511 Sum_probs=159.5
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccC-CCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR-IPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.+|++.+.||+|++|.||++.+..+++.+++|.+....... .......+.+|+.+++.++|+|++++++.+.......+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 37999999999999999999999899999999875432211 12233467889999999999999999999865555678
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++++|++++ +|.+.+... ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 999999975 688888765 45888999999999999999999999999999999999999999999999999765321
Q ss_pred ccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... .......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 199 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTV 199 (264)
T ss_pred cccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHH
Confidence 111 11223457788999999977 4588999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=219.18 Aligned_cols=192 Identities=32% Similarity=0.484 Sum_probs=157.1
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+..+..++|+|++++++.+. ...
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~~e~~~l~~~~h~~ii~~~~~~~--~~~ 79 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG----DDFSLIQQEIFMVKECKHCNIVAYFGSYL--SRE 79 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc----chHHHHHHHHHHHHhcCCCCeeeeeEEEE--eCC
Confidence 345689999999999999999999988999999998864432 22335778999999999999999999984 456
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..+++|||+++ +|.+++... ..+++..+..++.|++.||.|||+.+++|+|++|+||+++.++.++|+|||++....
T Consensus 80 ~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 88999999975 688877654 568999999999999999999999999999999999999999999999999997553
Q ss_pred ccccCCcccccCCCCcccCccccCCC-CCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGL-PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 235 (235)
.. ........++..|+|||.+.+. ...++.++|+||||+++
T Consensus 158 ~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il 199 (267)
T cd06646 158 AT--IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITA 199 (267)
T ss_pred cc--ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHH
Confidence 21 1112233477889999987431 13367899999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=220.42 Aligned_cols=192 Identities=33% Similarity=0.582 Sum_probs=159.0
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|++|.||++.+..+++.+++|.++..... ......+.+|+++++.+.|+|++++.+.+. ..+..+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~ 76 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNLKEAFR--RKGRLY 76 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc--ccchhHHHHHHHHHHhcCCCCeeehhheEE--ECCEEE
Confidence 4799999999999999999999888999999988755432 233456889999999999999999999994 466889
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++|||+++++...+.... ..++...++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 77 iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 77 LVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 999999988665554433 5589999999999999999999999999999999999999999999999999886543211
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l 192 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIM 192 (288)
T ss_pred -ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHH
Confidence 122234467789999999773 1588999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=216.28 Aligned_cols=190 Identities=32% Similarity=0.578 Sum_probs=159.1
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|++++.||+|++|.+|++.+..+++.+++|.+...... ......+.+|+.+++.++|+|++++.+.+ ...+..++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS--PKEREESRKEVAVLSNMKHPNIVQYQESF--EENGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC--hHHHHHHHHHHHHHHhCCCCCeeeeEeee--cCCCeEEE
Confidence 589999999999999999999889999999988654332 23334688999999999999999999998 56678999
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++|++.+ +|.+.+.......+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++++|||++.......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 9999965 68888876554568899999999999999999999999999999999999999999999999987553211
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||...+ ..++.++|+||||+++
T Consensus 156 -~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~ 191 (256)
T cd08218 156 -ELARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVL 191 (256)
T ss_pred -hhhhhccCCccccCHHHhCC--CCCCCccchhHHHHHH
Confidence 11223346778999999877 4588899999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=227.67 Aligned_cols=193 Identities=34% Similarity=0.548 Sum_probs=168.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
++.+-|-+-+-||+|.|+.|-+|++.-+|++||+|++.+....+... -.+.+|++.++.++||||+++|++. ....
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st--~hlfqEVRCMKLVQHpNiVRLYEVi--DTQT 90 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLST--GHLFQEVRCMKLVQHPNIVRLYEVI--DTQT 90 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhh--hHHHHHHHHHHHhcCcCeeeeeehh--cccc
Confidence 45677899999999999999999999999999999999887665322 2456899999999999999999999 6666
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC-CcEEEeeecccccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD-GTLKISDFGVAESL 191 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~ 191 (235)
-+|+|.|.-.+ +|.+++.... .++.+..+.+++.||+.|+.|+|+..+|||||||+|+.+.+. |.+||.|||++..+
T Consensus 91 KlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 78999999865 7999999876 679999999999999999999999999999999999988755 88999999999765
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. +.......+|...|-|||.+.|. .+..++.||||||++|
T Consensus 170 ~---PG~kL~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVIL 209 (864)
T KOG4717|consen 170 Q---PGKKLTTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVIL 209 (864)
T ss_pred C---CcchhhcccchhhccCchhhhcC-ccCCcchhhhHHHHHH
Confidence 4 66777888999999999999882 3456899999999985
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=217.45 Aligned_cols=192 Identities=27% Similarity=0.467 Sum_probs=159.5
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|++|.||++.+..+++.+++|.++...... ......+.+|+.++++++|++++++++.+. ..+..+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~--~~~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-AKARQDCLKEIDLLKQLDHPNVIKYLASFI--ENNELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCeeeeeeeee--cCCeEE
Confidence 58999999999999999999998899999999887644332 233456889999999999999999999995 456789
Q ss_pred EEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 117 LIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
++|||+++ +|.+++... ....++...++.++.+++.||.+||+.|++|+||+|+||+++.++.++++|||++..+..
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999975 688877643 234588999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ........++..|.|||.+.+ ..++.++|+||||+++
T Consensus 159 ~--~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il 196 (267)
T cd08224 159 K--TTAAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLL 196 (267)
T ss_pred C--CcccceecCCccccCHHHhcc--CCCCchhcHHHHHHHH
Confidence 1 112223457788999999877 4588999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=218.09 Aligned_cols=185 Identities=28% Similarity=0.393 Sum_probs=148.4
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecc
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYC 122 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 122 (235)
+.||+|++|.||++.+..+++.+++|.+..... .+....+.+|+.+++.+.|+||+++++.+ .....++++|||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP---PDLKAKFLQEARILKQYSHPNIVRLIGVC--TQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEE--cCCCCeEEEEeec
Confidence 468999999999999988999999998754321 22334688999999999999999999998 4556789999999
Q ss_pred cC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccc
Q psy787 123 VG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT 201 (235)
Q Consensus 123 ~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 201 (235)
++ +|.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.............
T Consensus 76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 65 6888876542 468899999999999999999999999999999999999999999999999987543211111111
Q ss_pred ccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 202 TSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 202 ~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....+..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 ~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il 186 (252)
T cd05084 155 MKQIPVKWTAPEALNY--GRYSSESDVWSFGILL 186 (252)
T ss_pred CCCCceeecCchhhcC--CCCChHHHHHHHHHHH
Confidence 1123456999999877 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=216.97 Aligned_cols=191 Identities=23% Similarity=0.351 Sum_probs=154.3
Q ss_pred ceEEeeeeeccccceEEEEeeccch---hhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSET---LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
++|++.+.||+|+||+||+|..... ...+++|.++.... ......+.+|+..+..++|+|++++++.+ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS---DKQRLDFLTEASIMGQFDHPNIIRLEGVV--TKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC---hHHHHHHHHHHHHHHhCCCCCcceEeEEE--ecCC
Confidence 5799999999999999999987543 35678887754321 23345678899999999999999999998 4556
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..+++||++++ +|.+++.... ..++...++.++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||++..+.
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 78999999975 6888887653 478999999999999999999999999999999999999999999999999998664
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.............+..|+|||.+.+ ..++.++|+||||+++
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l 198 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVM 198 (266)
T ss_pred ccccceeccCCCCCccccChhhhcc--CCCccccchHHHHHHH
Confidence 2111111222334567999999877 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=217.33 Aligned_cols=195 Identities=31% Similarity=0.509 Sum_probs=159.2
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC-CCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI-PNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.+|++.+.||.|++|.||++.+..++..+++|.+........ .+....+.+|+.+++.++|+|++++++.+.......+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368999999999999999999988999999998865543221 1223457889999999999999999998865556788
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++++|++++ +|.+.+... ..++....+.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 999999975 688888765 45888999999999999999999999999999999999999999999999998754321
Q ss_pred cc-CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LH-DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~ 199 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTV 199 (266)
T ss_pred cccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHH
Confidence 11 112223447788999999977 4588999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=220.09 Aligned_cols=192 Identities=33% Similarity=0.505 Sum_probs=156.7
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|++|+||++.+..+++.+++|.+...... ......+.+|+..++.++|+|++++++.+ .....++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED--EGVPSTAIREISLLKEMQHGNIVRLQDVV--HSEKRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc--ccchHHHHHHHHHHHhccCCCEeeEEEEE--ecCCeEE
Confidence 5799999999999999999999889999999987654322 22334577899999999999999999999 4556899
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc-CCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL-DGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++++.+.+.......++...++.++.|++.||++||+++++|+||+|+||+++. ++.++|+|||++......
T Consensus 78 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 78 LVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred EEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 999999988888887665455788889999999999999999999999999999999985 457999999998754321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+. ..++.++|+||||+++
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~ 194 (294)
T PLN00009 157 -VRTFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIF 194 (294)
T ss_pred -ccccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHH
Confidence 1112233457789999988652 3478899999999874
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=215.93 Aligned_cols=190 Identities=34% Similarity=0.513 Sum_probs=157.6
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|++|.||++.+..+++.+++|++..... .....+.+|+.++..++|+|++++++.+ .....++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~~ 76 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG----DDFEIIQQEISMLKECRHPNIVAYFGSY--LRRDKLW 76 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch----hhHHHHHHHHHHHHhCCCCChhceEEEE--EeCCEEE
Confidence 579999999999999999999988889999999875432 2345688999999999999999999998 4566899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++||++++ +|.+++.... ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+..+...
T Consensus 77 l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~- 154 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT- 154 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh-
Confidence 99999976 5777766542 56889999999999999999999999999999999999999999999999998755321
Q ss_pred cCCcccccCCCCcccCccccCCCC-CCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLP-EISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+.. ..++.++|+||||+++
T Consensus 155 -~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l 194 (262)
T cd06613 155 -IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITA 194 (262)
T ss_pred -hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHH
Confidence 11222344677899999986631 1478899999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=220.02 Aligned_cols=183 Identities=28% Similarity=0.457 Sum_probs=152.0
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||+|++|.||++.+..+++.+++|++..... ......+.+|+.++.++.|||++++++.+. ..+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT---VELQKQIMSELEILYKCDSPYIIGFYGAFF--VENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC---hHHHHHHHHHHHHHHhCCCCCeeeEEEEEE--ECCEEE
Confidence 368889999999999999999999999999998864421 233346889999999999999999999994 456789
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++|||++++..+.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+..
T Consensus 76 lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~--- 147 (279)
T cd06619 76 ICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN--- 147 (279)
T ss_pred EEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc---
Confidence 99999987533322 3467888999999999999999999999999999999999999999999999875431
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 148 -~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l 183 (279)
T cd06619 148 -SIAKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISF 183 (279)
T ss_pred -ccccCCCCChhhcCceeecC--CCCCCcchHHHHHHHH
Confidence 12233457889999999987 4488999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=216.62 Aligned_cols=189 Identities=26% Similarity=0.354 Sum_probs=154.1
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++.+.||+|++|.||++.+. .++.+++|.++... .....+.+|+..+++++|+|++++++.+ ...+.+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~ 76 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-----MDPKDFLAEAQIMKKLRHPKLIQLYAVC--TLEEPI 76 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-----ccHHHHHHHHHHHHHCCCCCccceeEEE--ecCCCe
Confidence 457999999999999999999875 44678999876433 2234578899999999999999999988 455678
Q ss_pred EEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++||+++ ++|.+++.......++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999995 67999887765457899999999999999999999999999999999999999999999999998765421
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........+..|+|||...+ ..++.++|+||||+++
T Consensus 157 ~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 194 (261)
T cd05068 157 IY-EAREGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILL 194 (261)
T ss_pred cc-cccCCCcCceeccCcccccc--CCCCchhhHHHHHHHH
Confidence 11 11111122356999999877 4589999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=222.24 Aligned_cols=193 Identities=24% Similarity=0.292 Sum_probs=150.9
Q ss_pred eceEEeeeeeccccceEEEEeeccchh--------------hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcc
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETL--------------CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVI 101 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~--------------~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 101 (235)
.++|++.+.||+|+||.||++++..++ ..+++|.++.... ......+.+|+..+.+++|+|++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT---KTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhCCCCCcC
Confidence 358999999999999999999875432 2478887764321 22334688999999999999999
Q ss_pred eeeeEEEcCCCceEEEEEecccC-CHHHHhhcCC----------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q psy787 102 GLVDVFVNDKKQKMYLIMEYCVG-GLQDMLDSTP----------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPG 170 (235)
Q Consensus 102 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~ 170 (235)
++++.+ ......+++|||+++ +|.+++.... ...+++..++.++.|++.||.|||+.+++|+||||+
T Consensus 81 ~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 81 RLLGVC--VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred eEEEEE--cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 999999 455678999999975 6888775431 123677889999999999999999999999999999
Q ss_pred CeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 171 NLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 171 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||+++.++.++|+|||++................++..|+|||...+ ..++.++|+||||+++
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l 221 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTL 221 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHH
Confidence 99999999999999999875432111111112234567999999877 4589999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=220.83 Aligned_cols=194 Identities=25% Similarity=0.309 Sum_probs=151.6
Q ss_pred eeceEEeeeeeccccceEEEEeecc-----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDS-----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
..++|++.+.||.|++|.||++.+. ..+..+++|++..... ......+.+|+..+..++|+|++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS---MRERIEFLNEASVMKEFNCHHVVRLLGVV-- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEE--
Confidence 4568999999999999999998754 2346788887753321 12234578899999999999999999998
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCC--------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcE
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPY--------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTL 180 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~ 180 (235)
..+...+++||++++ +|.+++..... ..++...+..++.|++.||.|||+.+++|+||||+||+++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 555678999999975 68888765321 235677889999999999999999999999999999999999999
Q ss_pred EEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 181 KISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|+|||++................++..|+|||.+.+ ..++.++||||||+++
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 211 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVL 211 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHH
Confidence 9999999875432111111112234567999999877 4489999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=220.44 Aligned_cols=192 Identities=24% Similarity=0.287 Sum_probs=151.5
Q ss_pred ceEEeeeeeccccceEEEEeec----cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLD----SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~----~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
..|++.+.||+|+||+||++.. ...+..+++|.+..... ......+.+|+..++.++|+|++++++.+. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN---PQQWGEFQQEASLMAELHHPNIVCLLGVVT--QE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC---HHHHHHHHHHHHHHhhCCCCCeeeEEEEEe--cC
Confidence 5789999999999999999874 34557788887764321 122346788999999999999999999984 45
Q ss_pred ceEEEEEecccC-CHHHHhhcCC---------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTP---------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL 176 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~ 176 (235)
...+++|||+++ +|.+++.... ...++...+..++.|++.||.|||+++++|+||+|+||+++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 578999999975 6888875321 134778889999999999999999999999999999999999
Q ss_pred CCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 177 DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++.++|+|||++................++..|+|||.+.+ ..++.++|+||||++|
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il 216 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVL 216 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhcc--CCCCchhhhHHHHHHH
Confidence 99999999999975532111112223334567999999876 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=220.09 Aligned_cols=198 Identities=29% Similarity=0.525 Sum_probs=158.0
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC--
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK-- 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (235)
...++|++.++||.|++|.||++.+..+++.+++|.+...... ......+.+|+.++++++|||++++++.+....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc--CCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 3456899999999999999999999989999999988654322 122234568999999999999999999875322
Q ss_pred ----CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 112 ----KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 112 ----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
....+++||++++++.+.+.... ..+++..++.++.|+++||+|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 24579999999999888776543 4689999999999999999999999999999999999999999999999999
Q ss_pred ccccCccccC--CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHD--DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+......... .......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l 214 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIM 214 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHH
Confidence 9755322111 111223456779999988652 2367899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=220.63 Aligned_cols=188 Identities=29% Similarity=0.491 Sum_probs=156.9
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
...+|++++.||+|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.+.|+|++++.+.+. ....
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~--~~~~ 91 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYL--VGDE 91 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEE--eCCE
Confidence 44689999999999999999999888899999998865442 22345788999999999999999999984 4568
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.++||||+++ +|.+++.. ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred EEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 8999999975 68887754 4578889999999999999999999999999999999999999999999998875431
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ........+++.|+|||.+.+ ..++.++|+||||+++
T Consensus 169 ~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil 206 (296)
T cd06654 169 E--QSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMA 206 (296)
T ss_pred c--ccccCcccCCccccCHHHHcC--CCCCccchHHHHHHHH
Confidence 1 111223457788999999877 4478999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=221.66 Aligned_cols=192 Identities=36% Similarity=0.567 Sum_probs=158.0
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC-CCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI-PNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
+|.+.+.||.|++|.||++.+..+++.+++|.+........ ......+..|+..+..++|+|++++++.+. .....+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG--HKSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee--cCCEEE
Confidence 58889999999999999999988899999999876654321 122334678999999999999999999994 466889
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+|||++.++|.+++.... ..+++..++.++.|+++||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 156 (298)
T cd07841 79 LVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN- 156 (298)
T ss_pred EEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-
Confidence 999999778999887653 478999999999999999999999999999999999999999999999999997654211
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|.|||.+.+. ..++.++|+||||+++
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il 193 (298)
T cd07841 157 -RKMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIF 193 (298)
T ss_pred -ccccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHH
Confidence 122223456779999988542 3478899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=238.42 Aligned_cols=196 Identities=24% Similarity=0.373 Sum_probs=148.2
Q ss_pred eeeceEEeeeeeccccceEEEEeeccch-hhheeeee--------------eeeccccCCCCccccHHHHHHHHHhcCCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSET-LCRRAVKI--------------FKKKKLQRIPNGEINVDREIRLLKMLQHR 98 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~-~~~~~~K~--------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 98 (235)
...++|+++++||+|+||+||++..... +...+.|. +.+. ..........+.+|+.++..++|+
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~-~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKR-VKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHH-hhcchHHHHHHHHHHHHHHhCCCC
Confidence 3457899999999999999999865332 22222221 1100 001112234578999999999999
Q ss_pred CcceeeeEEEcCCCceEEEEEecccCCHHHHhhcCC---CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc
Q psy787 99 NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTP---YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT 175 (235)
Q Consensus 99 ~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~ 175 (235)
||+++++++ ......+++++++.+++.+++.... ........+..++.|++.||.|||++||+||||||+||+++
T Consensus 224 nIv~l~~~~--~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 224 NILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcCcEeEEE--EECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999999999 4556789999999988887765432 12234567788999999999999999999999999999999
Q ss_pred cCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 176 LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 176 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++.++|+|||++..+... .........++..|+|||++.+ ..++.++|||||||+|
T Consensus 302 ~~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil 358 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLIL 358 (501)
T ss_pred CCCCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHH
Confidence 9999999999999765421 1112223568899999999987 4589999999999975
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=221.27 Aligned_cols=193 Identities=25% Similarity=0.304 Sum_probs=153.3
Q ss_pred eceEEeeeeeccccceEEEEeeccchh----------------hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETL----------------CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN 99 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~----------------~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 99 (235)
.++|++++.||+|+||.||++.+...+ ..+++|.+...... .....+.+|+.++..++|+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD---NAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH---HHHHHHHHHHHHHHhcCCCC
Confidence 358999999999999999998876543 34688876644321 23446788999999999999
Q ss_pred cceeeeEEEcCCCceEEEEEecccC-CHHHHhhcCC---------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCC
Q psy787 100 VIGLVDVFVNDKKQKMYLIMEYCVG-GLQDMLDSTP---------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKP 169 (235)
Q Consensus 100 i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p 169 (235)
++++++.+. ....+++++|++.+ +|.+++.... ...+++..++.++.|++.||.+||+.+++|+||||
T Consensus 81 i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 81 IARLLGVCT--VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred EeEEEEEEe--cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 999999984 44678999999965 6888876542 12688999999999999999999999999999999
Q ss_pred CCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 170 GNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 170 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+||+++.++.++|+|||++................++..|+|||.+.+ ..++.++||||||+++
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l 222 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTL 222 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHH
Confidence 999999999999999999875432111111223335668999999876 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=220.83 Aligned_cols=189 Identities=29% Similarity=0.477 Sum_probs=157.5
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++++.||.|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.++|+|++++++.+ ....
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~ 89 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSY--LVGD 89 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCCCCCEeeEEEEE--ecCC
Confidence 345789999999999999999999988999999998864432 2234578899999999999999999999 4566
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.++++|||+++ +|.+++.. ..++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred EEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 88999999965 68887754 457888999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........+++.|+|||.+.+ ..++.++|+||||+++
T Consensus 167 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil 205 (297)
T cd06656 167 PE--QSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMA 205 (297)
T ss_pred CC--ccCcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHH
Confidence 21 111223457778999999977 4478999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=221.27 Aligned_cols=195 Identities=28% Similarity=0.457 Sum_probs=152.8
Q ss_pred eeeceEEeeeeeccccceEEEEeeccc-------hhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeee
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSE-------TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVD 105 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 105 (235)
...++|.+.+.||+|+||.||++.+.. +...+++|.++.... ......+..|+.++..+ +|+|++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC---hHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 334689999999999999999997643 234688888764321 23334577899999999 7999999999
Q ss_pred EEEcCCCceEEEEEecccC-CHHHHhhcCCC--------------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q psy787 106 VFVNDKKQKMYLIMEYCVG-GLQDMLDSTPY--------------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPG 170 (235)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~ 170 (235)
.+ ......+++||++++ +|.+++..... ..++...++.++.|++.||+|||+.|++|+||||+
T Consensus 92 ~~--~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 92 AC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EE--ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 99 455678999999974 79988876421 34788899999999999999999999999999999
Q ss_pred CeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 171 NLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 171 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||+++.++.++|+|||.+.................+..|+|||.+.+ ..++.++|+||||+++
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l 232 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLL 232 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHH
Confidence 99999999999999999875432111111112223467999999877 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=214.46 Aligned_cols=187 Identities=23% Similarity=0.349 Sum_probs=150.8
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
+.|++.+.||+|+||.||++... .+..+++|.+.... .....+.+|+..++.++|||++++++.+ .....++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~ 75 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPKLVQLYGVC--TQQKPLY 75 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCCceeEEEEE--ccCCCEE
Confidence 46899999999999999999764 45678888765332 2234688899999999999999999998 5566789
Q ss_pred EEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++|||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++++|||.+.......
T Consensus 76 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 9999997 46888876543 468889999999999999999999999999999999999999999999999887442111
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. .......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l 191 (256)
T cd05114 155 Y-TSSSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLM 191 (256)
T ss_pred e-eccCCCCCchhhCChhhccc--CccchhhhhHHHHHHH
Confidence 1 11112224457999999876 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=220.82 Aligned_cols=193 Identities=26% Similarity=0.314 Sum_probs=154.0
Q ss_pred eceEEeeeeeccccceEEEEeecc-----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDS-----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
.++|.+.+.||.|++|.||++.+. .+++.+++|.++.... .+....+.+|+.++..++|+|++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-- 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS---NDARKDFEREAELLTNFQHENIVKFYGVCT-- 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC---HHHHHHHHHHHHHHHhcCCCCchheeeEEe--
Confidence 357899999999999999999764 3457899998764432 223457889999999999999999999994
Q ss_pred CCceEEEEEecccC-CHHHHhhcCC------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDSTP------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD 177 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~ 177 (235)
.....+++|||+++ +|.+++.... ...+++..+..++.|++.|+.+||++|++|+||+|+||+++.+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence 45678999999965 6888886542 2347888999999999999999999999999999999999999
Q ss_pred CcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 178 GTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.++|+|||++.................+..|+|||.+.+ ..++.++||||||+++
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 214 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVL 214 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHH
Confidence 9999999999874421111111122234577999999987 4589999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=225.41 Aligned_cols=191 Identities=17% Similarity=0.238 Sum_probs=151.5
Q ss_pred eeeeeccc--cceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 41 MGDLLGEG--SYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 41 i~~~ig~g--~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
+++.||+| ++++||++.+..+|+.+|+|.+....... .....+.+|+.+++.++||||+++++.+. ..+..++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN--EMVTFLQGELHVSKLFNHPNIVPYRATFI--ADNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH--HHHHHHHHHHHHHHhcCCCCeeeEEEEEE--ECCEEEEE
Confidence 56789999 78999999999999999999886554321 23345778999999999999999999994 45678999
Q ss_pred EecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC
Q psy787 119 MEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 119 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 197 (235)
|||+++ +|.+++.......+++..++.++.|++.||.|||+++++|+||||+||+++.++.+++.||+...........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999975 6888886654456899999999999999999999999999999999999999999999999865433211110
Q ss_pred C-----cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 198 D-----TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ......++..|+|||.+.+....++.++||||||+++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il 200 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 200 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHH
Confidence 0 1112235567999999876333478999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=217.99 Aligned_cols=195 Identities=32% Similarity=0.514 Sum_probs=160.1
Q ss_pred ceEEeeeeeccccceEEEEeeccchh----hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETL----CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
..|++++.||+|.+|.||+|....++ +.+|+|.++.....+ .......+|+..++.++|+|++.+..+++.. .
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t--GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d 100 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT--GISMSACREIALLRELKHPNVISLVKVFLSH-D 100 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC--CcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-C
Confidence 47999999999999999999654432 368999887664322 3445688999999999999999999999844 6
Q ss_pred ceEEEEEecccCCHHHHhhcC---CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC----CcEEEeee
Q psy787 113 QKMYLIMEYCVGGLQDMLDST---PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD----GTLKISDF 185 (235)
Q Consensus 113 ~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~----~~~~l~df 185 (235)
..++++++|.+-+|+..+... ....++...+..+++||+.++.|||++-++||||||.||++..+ |++||+|+
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 789999999999998888644 23578899999999999999999999999999999999999877 89999999
Q ss_pred ccccccCccccCC-cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDD-TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+++.+..+...- .....+-|.=|.|||.+.|. ..||++.|||+.||++
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIf 230 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIF 230 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHH
Confidence 9999886543332 22222345569999999984 4699999999999974
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=216.16 Aligned_cols=188 Identities=24% Similarity=0.343 Sum_probs=152.5
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++.++||.|++|.||++.+..+ ..+++|.++.... ....+.+|+..+..++|+|++++++.+ .. ...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~--~~-~~~ 75 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVV--SE-EPI 75 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEE--CC-CCc
Confidence 46899999999999999999987655 4589998764322 234578999999999999999999887 32 357
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++||++++ +|.+++.......+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+..+...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 899999975 7988887654456889999999999999999999999999999999999999999999999998755421
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... ......++..|+|||...+ ..++.++|+||||+++
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l 193 (262)
T cd05071 156 EYT-ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILL 193 (262)
T ss_pred ccc-cccCCcccceecCHhHhcc--CCCCchhhHHHHHHHH
Confidence 111 1112235567999998876 4489999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=221.31 Aligned_cols=186 Identities=26% Similarity=0.428 Sum_probs=155.9
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|+||.||++.+..++..+++|.+..... ......+.+|+.++.+++||||+++++.+. ..+.++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK---PAIRNQIIRELKVLHECNSPYIVGFYGAFY--SDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--eCCEEE
Confidence 369999999999999999999988999999998764321 123345788999999999999999999994 556899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++|||+++ +|.+++... ..+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~- 152 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 152 (308)
T ss_pred EEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc-
Confidence 99999975 688888765 668899999999999999999997 5999999999999999999999999998864421
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 153 ---~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l 188 (308)
T cd06615 153 ---SMANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSL 188 (308)
T ss_pred ---cccccCCCCcCccChhHhcC--CCCCccchHHHHHHHH
Confidence 11223457788999999876 4488999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=217.72 Aligned_cols=194 Identities=25% Similarity=0.321 Sum_probs=153.4
Q ss_pred eeceEEeeeeeccccceEEEEeeccch-----hhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSET-----LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
..++|++.+.||.|++|.||++.+... +..+++|.+..... ......+.+|+..+..+.|+|++++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-- 78 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS---MRERIEFLNEASVMKEFNCHHVVRLLGVV-- 78 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC---HHHHHHHHHHHHHHHhCCCCceeEEEEEE--
Confidence 346899999999999999999887543 37889998753321 12234577899999999999999999998
Q ss_pred CCCceEEEEEeccc-CCHHHHhhcCC--------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcE
Q psy787 110 DKKQKMYLIMEYCV-GGLQDMLDSTP--------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTL 180 (235)
Q Consensus 110 ~~~~~~~lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~ 180 (235)
......+++||+++ ++|.+++.... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 45567899999996 57888886532 1246778899999999999999999999999999999999999999
Q ss_pred EEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 181 KISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|+|||++................++..|+|||.+.+ ..++.++||||||+++
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 211 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVL 211 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHH
Confidence 9999999875432111111222335677999999876 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=217.43 Aligned_cols=193 Identities=30% Similarity=0.509 Sum_probs=158.2
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCC---
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDK--- 111 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~--- 111 (235)
.+.|++.+.||.|++|.||++....+++.+++|++.... .....+..|+..+..+ +|+|++++.+.+....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 467999999999999999999998899999999886432 2334578899999988 7999999999986432
Q ss_pred -CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 112 -KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 112 -~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
...++++||++++ +|.+++.......+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 2468999999975 68888876555678999999999999999999999999999999999999999999999999987
Q ss_pred ccCccccCCcccccCCCCcccCccccCCC---CCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~l 235 (235)
..... ........++..|+|||.+.+. ...++.++|+||||+++
T Consensus 160 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l 206 (272)
T cd06637 160 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 206 (272)
T ss_pred ecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHH
Confidence 55321 1223344578889999988532 23478899999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=220.62 Aligned_cols=199 Identities=32% Similarity=0.484 Sum_probs=159.6
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC-
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK- 111 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 111 (235)
+...++|++.++||.|++|.||++.+..+++.+++|.+....... .....+.+|+..++.++|+||+++++.+.+..
T Consensus 4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--CcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 345789999999999999999999998899999999887654322 22335678999999999999999998875432
Q ss_pred -----CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeec
Q psy787 112 -----KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 112 -----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
...++++++|+.+++...+.... ..+++..+..++.|+++||.|||++|++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred cccccCceEEEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 23579999999988887776542 569999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCCc---------ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDT---------ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++........... .....+++.|+|||.+.+. ..++.++||||||+++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il 217 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVF 217 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHH
Confidence 9875532211111 1112346779999987652 3478899999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=220.48 Aligned_cols=191 Identities=36% Similarity=0.584 Sum_probs=155.3
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||+|++|.||++.+..+++.+++|.+....... .....+.+|+.++..++|+|++++++.+ ......+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~ 76 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK--MVKKIAMREIRMLKQLRHENLVNLIEVF--RRKKRLY 76 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc--hhhHHHHHHHHHHHhcCCcchhhHHHhc--ccCCeEE
Confidence 47999999999999999999998889999999876543321 2344577899999999999999999999 5667899
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+++||+++++.+.+.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~-- 153 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 153 (286)
T ss_pred EEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--
Confidence 999999876444443322 45899999999999999999999999999999999999999999999999998755321
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+. ..++.++||||||+++
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l 191 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLV 191 (286)
T ss_pred ccccCcccceeeccCcHHhccc-cccCchHhHHHHHHHH
Confidence 1122233467789999988652 3467899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=219.26 Aligned_cols=189 Identities=29% Similarity=0.419 Sum_probs=157.5
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
-..|+++++||.|++|.||++.+.. ++.+++|++..... .....+.+|+..++.++|+|++++++.+ .....+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~ 77 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL----LKQQDFQKEVQALKRLRHKHLISLFAVC--SVGEPV 77 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch----hhHHHHHHHHHHHhcCCCcchhheeeeE--ecCCCe
Confidence 3469999999999999999999876 78999998765432 2334578999999999999999999998 455678
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++|||+++ +|.+++.......++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999975 7999998766567899999999999999999999999999999999999999999999999998755321
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. .......++..|+|||...+ ..++.++|+||||+++
T Consensus 158 ~--~~~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l 194 (261)
T cd05148 158 V--YLSSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILL 194 (261)
T ss_pred c--ccccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHH
Confidence 1 11123335567999999876 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=216.87 Aligned_cols=191 Identities=24% Similarity=0.377 Sum_probs=152.6
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHH-HHhcCCCCcceeeeEEEcCCCceE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRL-LKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
++|++++.||+|+||.||++.+..+|+.+|+|.++..... .....+..|+.. ++...|+|++++++.+. ....+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~--~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS---QEQKRLLMDLDISMRSVDCPYTVTFYGALF--REGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc---HHHHHHHHHHHHHHHHcCCCCeeeeeEEEe--cCCcE
Confidence 4799999999999999999999999999999988654321 223345556654 55568999999999994 45578
Q ss_pred EEEEecccCCHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 116 YLIMEYCVGGLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 116 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
+++||+++++|.+++... ....+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..+.
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999888777543 225689999999999999999999997 99999999999999999999999999987543
Q ss_pred ccccCCcccccCCCCcccCccccCCCC--CCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLP--EISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~~Di~slG~~l 235 (235)
. ........++..|+|||.+.+.. ..++.++|+||||+++
T Consensus 156 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l 197 (283)
T cd06617 156 D---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197 (283)
T ss_pred c---ccccccccCCccccChhhcCCcccccccCccccchhhHHHH
Confidence 1 11112234677899999886421 2367899999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=218.73 Aligned_cols=192 Identities=20% Similarity=0.302 Sum_probs=152.6
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhh----eeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCR----RAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~----~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
...+|+++++||.|++|+||++.+..+++. |++|+++.... ......+.+|+..+..+.|+|++++++.+..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS---PKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC---HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 345799999999999999999987666654 68887754322 2234467889999999999999999999852
Q ss_pred CCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 111 KKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 111 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
...++++++++ |+|.+.+.... ..+++..++.++.|++.||+|||+.+++|+||||+||++..++.++|+|||++.
T Consensus 81 --~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 81 --STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred --CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 34678999996 56888876543 568999999999999999999999999999999999999999999999999998
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
................+..|+|||...+ ..++.++||||||++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l 201 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTV 201 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHH
Confidence 6542211111222234567999999877 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=225.75 Aligned_cols=194 Identities=27% Similarity=0.406 Sum_probs=151.1
Q ss_pred eceEEeeeeeccccceEEEEeec-----cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEc
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLD-----SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVN 109 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (235)
.++|++.+.||.|+||+||+|.+ ..+++.+|+|+++.... ......+.+|+.++.++ +|+|++++++.+..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC---hHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 46899999999999999999974 34678899998864321 12234577899999999 68999999998853
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCC------------------------------------------------------
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTP------------------------------------------------------ 134 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~------------------------------------------------------ 134 (235)
....++++|||+++ +|.+++....
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 34467899999975 6888876431
Q ss_pred -----------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccccc
Q psy787 135 -----------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS 203 (235)
Q Consensus 135 -----------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 203 (235)
...++...+..++.|+++||+|||+.+++|+||||+||+++.++.++|+|||++...............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 123677788899999999999999999999999999999999999999999998754321111111122
Q ss_pred CCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 204 QGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 204 ~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++..|+|||.+.+ ..++.++||||||+++
T Consensus 242 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 271 (343)
T cd05103 242 RLPLKWMAPETIFD--RVYTIQSDVWSFGVLL 271 (343)
T ss_pred CCCcceECcHHhcC--CCCCchhhHHHHHHHH
Confidence 34567999999876 4588999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=213.90 Aligned_cols=189 Identities=26% Similarity=0.461 Sum_probs=158.2
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|+..+++++|+|++++++.+ ...+..++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT--KDERLAAQNECQVLKLLSHPNIIEYYENF--LEDKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc--cHHHHHHHHHHHHHhhCCCCchhheeeeE--ecCCEEEE
Confidence 589999999999999999999889999999998755432 23345688999999999999999999988 45568899
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-cEEEeeeccccccCccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-TLKISDFGVAESLDMFL 195 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~ 195 (235)
++|++++ +|.+++.......+++..+..++.+++.+|++||+++++|+||+|+||+++.++ .++++|||.+......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~- 155 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK- 155 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC-
Confidence 9999975 699988776556689999999999999999999999999999999999998654 5799999999765421
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l 191 (256)
T cd08220 156 --SKAYTVVGTPCYISPELCEG--KPYNQKSDIWALGCVL 191 (256)
T ss_pred --ccccccccCCcccCchhccC--CCCCcccchHHHHHHH
Confidence 12223457788999999977 4488999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=219.08 Aligned_cols=192 Identities=27% Similarity=0.451 Sum_probs=157.7
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|++|.||++.+..+++.+++|.+....... ......+.+|+.+++.+.|+|++++++.+. ..+.++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD-AKARADCIKEIDLLKQLNHPNVIKYYASFI--EDNELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh-HHHHHHHHHHHHHHHHccCCchhhhhheeE--eCCeEE
Confidence 57899999999999999999998899999999876543222 233456789999999999999999999985 455789
Q ss_pred EEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 117 LIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
++||++++ +|.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999975 688877632 225688999999999999999999999999999999999999999999999998875532
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 159 ~--~~~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il 196 (267)
T cd08229 159 K--TTAAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLL 196 (267)
T ss_pred C--CcccccccCCcCccCHHHhcC--CCccchhhHHHHHHHH
Confidence 1 111223457788999999977 4488899999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=221.09 Aligned_cols=196 Identities=27% Similarity=0.435 Sum_probs=154.2
Q ss_pred EeeeceEEeeeeeccccceEEEEeecc-------chhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceee
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDS-------ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLV 104 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 104 (235)
.....+|.+.+.||.|+||.||+++.. ..+..+++|....... ......+.+|+..+..+ +|+||++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc---hHHHHHHHHHHHHHHhhccCCCchhee
Confidence 345678999999999999999999642 2345688887754321 23345688999999999 899999999
Q ss_pred eEEEcCCCceEEEEEecccC-CHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCC
Q psy787 105 DVFVNDKKQKMYLIMEYCVG-GLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKP 169 (235)
Q Consensus 105 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p 169 (235)
+.+ .....++++|||+++ +|.+++.... ...++...+..++.|++.||.|||+.|++|+||||
T Consensus 88 ~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 88 GAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred EEE--ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 998 455678999999965 7888886542 13477788999999999999999999999999999
Q ss_pred CCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 170 GNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 170 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+||+++.++.++|+|||.+................++..|+|||.+.+ ..++.++||||||++|
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 229 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLM 229 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHH
Confidence 999999999999999999986542222222222334567999999877 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=218.09 Aligned_cols=186 Identities=31% Similarity=0.526 Sum_probs=155.5
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
.+|++++.||.|++|.||++.+..+++.+++|.+..... .....+.+|+..++.++|+|++++++.+. ....++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~ 92 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKELIINEILVMKELKNPNIVNFLDSFL--VGDELF 92 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHHHHHHHHHHHHhcCCCceeeeeeeEe--cCceEE
Confidence 579999999999999999999988999999998864322 22346788999999999999999999984 456889
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+++||+.+ +|..++.. ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~- 168 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE- 168 (296)
T ss_pred EEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc-
Confidence 99999975 57776654 45899999999999999999999999999999999999999999999999988754321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil 205 (296)
T cd06655 169 -QSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMA 205 (296)
T ss_pred -cccCCCcCCCccccCcchhcC--CCCCchhhHHHHHHHH
Confidence 111223457788999999877 4488999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=217.57 Aligned_cols=190 Identities=21% Similarity=0.280 Sum_probs=148.0
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhh----eeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCR----RAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~----~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
+.|++.+.||.|+||+||++....+++. +++|.+.... .......+..|+..+..+.|+||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAYIVRLLGICP--G- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc---chHHHHHHHHHHHHHhcCCCCCcceEEEEEC--C-
Confidence 5788999999999999999988766664 4555443211 1122245677788888999999999999873 2
Q ss_pred ceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
...++++|+++ ++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||.+...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 35678899986 57988886543 56899999999999999999999999999999999999999999999999999755
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.............++..|+|||...+ ..++.++||||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il 201 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTV 201 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHH
Confidence 32111111222335667999999877 4589999999999874
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=219.50 Aligned_cols=191 Identities=26% Similarity=0.319 Sum_probs=151.3
Q ss_pred ceEEeeeeeccccceEEEEeec-----cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLD-----SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
..|.+.+.||.|+||+||++.+ ..++..+++|.+.... ......+.+|+.++..++|+|++++++.+ ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~ 78 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS----DNARKDFHREAELLTNLQHEHIVKFYGVC--VE 78 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC----HHHHHHHHHHHHHHHhCCCCCcceEEEEE--ec
Confidence 4689999999999999999874 2345567788765332 22334588999999999999999999998 45
Q ss_pred CceEEEEEeccc-CCHHHHhhcCC-----------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc
Q psy787 112 KQKMYLIMEYCV-GGLQDMLDSTP-----------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT 179 (235)
Q Consensus 112 ~~~~~lv~e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~ 179 (235)
...+++++||++ ++|.+++.... ...+++..++.++.|++.||++||+.|++||||||+||+++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 567899999997 56888886432 134899999999999999999999999999999999999999999
Q ss_pred EEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 180 LKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++|+|||++................++..|+|||.+.+ ..++.++|+||||+++
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il 212 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVL 212 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHH
Confidence 99999999875432111111112224567999999977 5588999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=219.35 Aligned_cols=192 Identities=32% Similarity=0.484 Sum_probs=156.0
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|++|.||++.+..+++.+++|.+....... ......+.+|+.+++.++|+|++++++.+ ..+..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~ 77 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLIL-RNQIQQVFVERDILTFAENPFVVSMFCSF--ETKRHLC 77 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhh-HHHHHHHHHHHHHHHhCCCCCeeeeEEEE--ecCCEEE
Confidence 36899999999999999999999999999999887654321 12334577899999999999999999998 5566899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++||++++ +|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++++|||++.......
T Consensus 78 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 78 MVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 99999975 688888665 568999999999999999999999999999999999999999999999999876321000
Q ss_pred c-------------CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 H-------------DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~-------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl 206 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIIL 206 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHH
Confidence 0 001112345678999999876 4588999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=217.98 Aligned_cols=189 Identities=32% Similarity=0.534 Sum_probs=152.6
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
-|++.+.||.|++|.||++.+..++..+++|.+.... ......+.+|+.+++.++|+|++++++.+. .....++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~--~~~~~~~ 79 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFY--YENNLWI 79 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC----HHHHHHHHHHHHHHHHCCCCCeeeEEEEEe--eCCEEEE
Confidence 3788899999999999999998888888998875432 223345788999999999999999999985 4567899
Q ss_pred EEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++||++++ |...+... ..++++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-- 156 (282)
T cd06643 80 LIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-- 156 (282)
T ss_pred EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--
Confidence 99999764 66655442 257899999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccCCCCcccCccccCCC---CCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+... ...++.++|+||||+++
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil 198 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 198 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHH
Confidence 1122334578889999987421 13467899999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=214.20 Aligned_cols=186 Identities=30% Similarity=0.432 Sum_probs=154.3
Q ss_pred eeeccccceEEEEeeccch---hhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEE
Q psy787 43 DLLGEGSYGKVKEMLDSET---LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIM 119 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 119 (235)
+.||.|+||.||++.+... +..+++|++....... ....+.+|+..+..++|+|++++++++. ....++++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE---ERKDFLKEARVMKKLGHPNVVRLLGVCT--EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh---HHHHHHHHHHHHhhcCCCChheeeeeec--CCCceEEEE
Confidence 4689999999999998765 8899999886554321 3456889999999999999999999994 467889999
Q ss_pred eccc-CCHHHHhhcCC-------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 120 EYCV-GGLQDMLDSTP-------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 120 e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
|+++ ++|.+++.... ...+++..++.++.|++.||.+||+++++|+||+|+||+++.++.++|+|||.+...
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccc
Confidence 9994 67998887652 367899999999999999999999999999999999999999999999999999866
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.............++..|+|||...+ ..++.++||||||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 197 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLL 197 (262)
T ss_pred ccccccccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHH
Confidence 43221122333446778999999877 4589999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=218.24 Aligned_cols=183 Identities=21% Similarity=0.241 Sum_probs=150.0
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc--CCCceEEEEEe
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN--DKKQKMYLIME 120 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~~lv~e 120 (235)
..|+.|+++.||++.. +|+.||+|.++...... ......+.+|+.++.+++||||+++++++.+ +....++++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGH-KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccccccc-HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 4689999999999987 67899999887543221 1223567799999999999999999999865 44557899999
Q ss_pred cccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEccCCcEEEeeeccccccCccccCC
Q psy787 121 YCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDD 198 (235)
Q Consensus 121 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 198 (235)
|+++ +|.+++... ..+++.....++.+++.||.+||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 103 y~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~----- 175 (283)
T PHA02988 103 YCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS----- 175 (283)
T ss_pred eCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-----
Confidence 9975 698888765 5688899999999999999999984 899999999999999999999999999875432
Q ss_pred cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 199 TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 199 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+.+....++.++||||||+++
T Consensus 176 ~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil 212 (283)
T PHA02988 176 PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVL 212 (283)
T ss_pred ccccccCcccccCHHHhhhccccccchhhhhHHHHHH
Confidence 1123447788999999875334589999999999874
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=215.01 Aligned_cols=192 Identities=23% Similarity=0.344 Sum_probs=153.0
Q ss_pred eceEEeeeeeccccceEEEEeeccchhh---heeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLC---RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
.+.|++.+.||+|++|.||++.+..+++ .+++|+++.... ......+..|+..++.+.|||++++.+.+ ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~--~~~ 77 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT---EKQRRDFLSEASIMGQFDHPNIIHLEGVV--TKS 77 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCcCcceEEEEE--CCC
Confidence 3578999999999999999998876654 589998764321 23345688999999999999999999998 455
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..++++||++++ +|.+++.... ..++...++.++.|++.|+++||++|++|+||+|+||+++.++.++++|||.+...
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 678999999975 6887776543 56899999999999999999999999999999999999999999999999988754
Q ss_pred CccccCCcccccC---CCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQ---GSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~---~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
............. .+..|+|||.+.+ ..++.++||||||+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l 201 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVM 201 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHH
Confidence 3211111111111 1346999999876 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=215.01 Aligned_cols=194 Identities=30% Similarity=0.489 Sum_probs=158.5
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCC--
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDK-- 111 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-- 111 (235)
..++|++.+.||.|++|.||++.+..+++.+++|++..... ....+.+|+.++.++ .|+|++++++.+....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 45799999999999999999999988889999998865432 334688999999998 6999999999986433
Q ss_pred --CceEEEEEecccC-CHHHHhhcCC--CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeec
Q psy787 112 --KQKMYLIMEYCVG-GLQDMLDSTP--YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 112 --~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
...++++||++++ +|.+++.... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 4568999999976 6887776533 3678999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCC---CCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~l 235 (235)
.+..... .........++..|+|||.+... ...++.++||||||++|
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il 208 (275)
T cd06608 159 VSAQLDS--TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITA 208 (275)
T ss_pred cceeccc--chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHH
Confidence 9875432 11222334577889999987532 23467899999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=221.14 Aligned_cols=189 Identities=31% Similarity=0.484 Sum_probs=149.9
Q ss_pred EeeeeeccccceEEEEeecc----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 40 VMGDLLGEGSYGKVKEMLDS----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 40 ~i~~~ig~g~~~~v~~~~~~----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.+.+.||.|.||.||+|... ..+..|++|.++... .......+.+|++.+..++||||+++++++. .....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~--~~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS---SEEEEEEFLNEIQILRKLRHPNIVKLYGFCI--ENEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS---SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE--SSSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc---ccccceeeeeccccccccccccccccccccc--ccccc
Confidence 46789999999999999776 456788898884422 1233567899999999999999999999996 34458
Q ss_pred EEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++|+||++ |+|.+++.......+++..++.++.|++.||.|||+.+++|++|+++||+++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999997 57999999875678999999999999999999999999999999999999999999999999999865211
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..............|+|||.+.. ..++.++||||||+++
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l 195 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLL 195 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccc--cccccccccccccccc
Confidence 11122223335667999999877 4489999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=211.24 Aligned_cols=191 Identities=29% Similarity=0.484 Sum_probs=159.4
Q ss_pred eeEeeeceEEee-eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHH-HHhcCCCCcceeeeEEE
Q psy787 31 IKVKMIGKYVMG-DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRL-LKMLQHRNVIGLVDVFV 108 (235)
Q Consensus 31 ~~~~~~~~y~i~-~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~ 108 (235)
.+..+.+.|+|. ++||-|-.|+|-.+.++++|+++|+|++.-.. ...+|+.. +..-.|+|||.++++|-
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~---------KARrEVeLHw~~s~h~~iV~IidVye 125 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP---------KARREVELHWMASGHPHIVSIIDVYE 125 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH---------HHHhHhhhhhhhcCCCceEEeehhhh
Confidence 344566677776 48999999999999999999999999875443 24466654 33458999999999984
Q ss_pred c--CCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC---CcEEE
Q psy787 109 N--DKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD---GTLKI 182 (235)
Q Consensus 109 ~--~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~---~~~~l 182 (235)
+ ....++.+|||.++|+ |.+.++.+....+++.++..+++||+.|+.|||+.+|.||||||+|++.... .-+||
T Consensus 126 Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 126 NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEe
Confidence 3 3456788999999765 9999999988889999999999999999999999999999999999999754 35899
Q ss_pred eeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 183 SDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|||+|+... ......+.+.|+.|.|||++.. .+++.+.|+||||+++
T Consensus 206 tDfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVim 253 (400)
T KOG0604|consen 206 TDFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIM 253 (400)
T ss_pred cccccccccC---CCccccCCcccccccCHHHhCc--hhcCCCCCccchhHHH
Confidence 9999998654 2456677889999999999976 6699999999999874
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=219.37 Aligned_cols=191 Identities=32% Similarity=0.494 Sum_probs=157.3
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
...+|++.+.||+|++|+||++.+..+++.+++|.+....... ......+.+|+..++.++|+|++++.+.+. ....
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~--~~~~ 89 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQQLRHPNTIEYKGCYL--REHT 89 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCc-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEE--eCCe
Confidence 3457999999999999999999998889999999886543222 223345789999999999999999999995 4557
Q ss_pred EEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 115 MYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 115 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
.++++|++.+++.+.+.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 90 ~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~- 167 (307)
T cd06607 90 AWLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP- 167 (307)
T ss_pred EEEEHHhhCCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-
Confidence 89999999999888776433 5689999999999999999999999999999999999999999999999998864421
Q ss_pred ccCCcccccCCCCcccCccccCCC-CCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGL-PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 235 (235)
.....++..|+|||.+.+. ...++.++||||||+++
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il 204 (307)
T cd06607 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204 (307)
T ss_pred -----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHH
Confidence 1233467789999987431 24478899999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=217.02 Aligned_cols=190 Identities=28% Similarity=0.478 Sum_probs=157.1
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|+++++||.|++|.||++.+..+++.+++|.++..... .....+.+|+.+++.++|+|++++++.+. ..+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE---GTPSTAIREISLMKELKHENIVRLHDVIH--TENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc---cchHHHHHHHHHHHhhcCCCEeeeeeeEe--eCCcEEE
Confidence 589999999999999999999889999999988755422 23345678999999999999999999994 4567899
Q ss_pred EEecccCCHHHHhhcCC-CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVGGLQDMLDSTP-YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+||+++++|.+++.... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||++.......
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 76 VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred EEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 99999999888876543 2468999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l 191 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIM 191 (284)
T ss_pred -cccccccccccccChHHhcCC-CCCCcHHHHHHHHHHH
Confidence 111223457789999988653 2368899999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=222.84 Aligned_cols=194 Identities=29% Similarity=0.456 Sum_probs=156.7
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC---C
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND---K 111 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 111 (235)
..++|++.+.||.|++|.||++.+..+++.|++|.+..... ......+..|+.++..++|+|++++++.+... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH---QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc---chhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 34789999999999999999999999999999998864221 23334577899999999999999999887432 2
Q ss_pred CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 112 KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 112 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
...+++++|++++++.+.+.. ..+++..++.++.|++.||++||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 80 FNDVYIVQELMETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred cceEEEEehhcccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 235799999999988877754 56899999999999999999999999999999999999999999999999998754
Q ss_pred Ccccc-CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLH-DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... ........++..|+|||.+.+. ..++.++||||||+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil 200 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCIL 200 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHH
Confidence 32111 1112234567889999986541 3478899999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=213.80 Aligned_cols=189 Identities=26% Similarity=0.361 Sum_probs=154.1
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|+++++||+|++|.||+|... +++.+++|.+.... .....+.+|+.++++++|+|++++++.+. ...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~ 74 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-----MSPEAFLAEANLMKQLQHPRLVRLYAVVT---QEP 74 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCC
Confidence 4568999999999999999999864 56789999876433 22346889999999999999999998872 345
Q ss_pred EEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
++++||++. ++|.+.+.......++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 799999996 5798888766556789999999999999999999999999999999999999999999999999875531
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 ~~-~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l 193 (260)
T cd05067 155 NE-YTAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILL 193 (260)
T ss_pred CC-cccccCCcccccccCHHHhcc--CCcCcccchHHHHHHH
Confidence 11 111112234567999999877 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=213.96 Aligned_cols=194 Identities=34% Similarity=0.509 Sum_probs=157.7
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC------CccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP------NGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
+|.+.+.||.|++|.||++.+..+++.+++|.++........ .....+..|+..++.++|+|++++++.+ ..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~ 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE--TT 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe--cc
Confidence 688999999999999999998888999999988653322111 1123567899999999999999999988 55
Q ss_pred CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
....+++||++.+ +|.+++... ..++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++++|||++..
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 6788999999965 688888765 5788899999999999999999999999999999999999999999999999875
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..............++..|+|||........++.++|+||||+++
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l 202 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVV 202 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHH
Confidence 542222222333457788999999866333478899999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=224.34 Aligned_cols=196 Identities=31% Similarity=0.498 Sum_probs=159.4
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (235)
...++|++.+.||+|++|.||++.+..+++.+++|.+...... ......+..|+.++.++ +|+||+++++++.....
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN--ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc--chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 4567899999999999999999999888999999987543221 12334567899999999 99999999999865555
Q ss_pred ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 113 QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 113 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..+++|||+++++|.+++... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred ceEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 678999999999998887653 67888889999999999999999999999999999999999999999999987553
Q ss_pred ccccC---CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHD---DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... .......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l 203 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCIL 203 (337)
T ss_pred cccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHH
Confidence 22111 122233467889999987542 3477899999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=224.75 Aligned_cols=198 Identities=28% Similarity=0.395 Sum_probs=161.3
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEc
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVN 109 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (235)
.-......|+++++||+||.++||++..... +.+++|.+...... ......+.+|+..|.++ .|.+|+.++++-+
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D--~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv- 430 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEAD--NQTLDGYRNEIALLNKLKGHDKIIQLYDYEV- 430 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcC--HHHHHHHHHHHHHHHHhcCCceEEEEeeeec-
Confidence 3344556799999999999999999987644 45555544333222 34556789999999999 5899999999985
Q ss_pred CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 110 DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
..+++|+|||+=+.+|...+.... .......++.+++||+.|+.++|+.||||.||||.|+++- .|.+||+|||+|.
T Consensus 431 -~d~~lYmvmE~Gd~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 431 -TDGYLYMVMECGDIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIAN 507 (677)
T ss_pred -cCceEEEEeecccccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhc
Confidence 466899999998888998887653 3344458889999999999999999999999999999998 8999999999999
Q ss_pred ccCccccCCcccccCCCCcccCccccCCC---------CCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGL---------PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---------~~~~~~~~Di~slG~~l 235 (235)
.+..+..........||..||+||.+... +-+.++++|||||||+|
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCIL 562 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCIL 562 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHH
Confidence 88777677777788999999999988421 22367899999999986
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=218.48 Aligned_cols=193 Identities=24% Similarity=0.305 Sum_probs=150.0
Q ss_pred eceEEeeeeeccccceEEEEeecc----------------chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDS----------------ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN 99 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~----------------~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 99 (235)
.++|++.++||.|+||.||++.+. .++..+++|++..... ......+.+|+..+..++|+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN---KNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCC
Confidence 357999999999999999998543 2344678887754321 233456889999999999999
Q ss_pred cceeeeEEEcCCCceEEEEEeccc-CCHHHHhhcCCC---------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCC
Q psy787 100 VIGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDSTPY---------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKP 169 (235)
Q Consensus 100 i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p 169 (235)
++++++.+. .....+++||+++ ++|.+++..... ..++...+..++.|++.||++||+.|++|+||||
T Consensus 81 i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 81 IIRLLAVCI--TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred cceEEEEEe--cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 999999984 4557899999996 478888765421 2366778999999999999999999999999999
Q ss_pred CCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 170 GNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 170 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+||+++.++.++|+|||++..+..............+..|+|||...+ +.++.++|+||||+++
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l 222 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTL 222 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHH
Confidence 999999999999999999875432111111112223567999998876 4589999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=215.28 Aligned_cols=191 Identities=30% Similarity=0.453 Sum_probs=161.0
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-C-C----Ccceee
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-H-R----NVIGLV 104 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~i~~~~ 104 (235)
+++.+.++|.|++.+|+|.||+|-.+++..++..+|+|+++.-... .+...-|+.+|.++. + | -++...
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-----reAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-----REAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-----hhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 4566788999999999999999999999999999999999765533 233567888999883 2 2 255565
Q ss_pred eEEEcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC-------
Q psy787 105 DVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD------- 177 (235)
Q Consensus 105 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~------- 177 (235)
++| +-.++.|||+|.++-++.+++..++..+++...+..+++||++++++||+.+++|.||||+||++...
T Consensus 158 ~wF--dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 158 DWF--DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred hhh--hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 667 77889999999999999999999999999999999999999999999999999999999999998432
Q ss_pred -------------CcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 178 -------------GTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 178 -------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..++++|||.|..-. ......+.|..|.|||++.+. .++.++||||+||+|
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL 299 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGL--GWSQPCDVWSIGCIL 299 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheecc--CcCCccCceeeeeEE
Confidence 238999999997432 233455678889999999994 499999999999986
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=214.89 Aligned_cols=192 Identities=32% Similarity=0.519 Sum_probs=156.5
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCC-----ccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN-----GEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
+|++.+.||.|++|.||+|.+..+++.+++|.+.......... ....+.+|+.++.+++|+|++++++.+. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL--DA 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--eC
Confidence 5788999999999999999998888999999886654432211 1235778999999999999999999984 45
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
...++++|++++ +|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 678999999965 688888765 56888999999999999999999999999999999999999999999999998766
Q ss_pred CccccC----CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHD----DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...... .......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il 202 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLV 202 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHH
Confidence 421111 11112346778999999877 4578899999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=225.44 Aligned_cols=197 Identities=26% Similarity=0.429 Sum_probs=155.1
Q ss_pred eEeeeceEEeeeeeccccceEEEEeec-----cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeee
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLD-----SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVD 105 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~ 105 (235)
.....++|.+.+.||.|+||.||++.+ ...++.||+|+++..... .....+.+|+.++.++. |+||+++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS---SEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh---hHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 566677899999999999999999984 335568999998654321 22346789999999996 999999999
Q ss_pred EEEcCCCceEEEEEeccc-CCHHHHhhcCCC-------------------------------------------------
Q psy787 106 VFVNDKKQKMYLIMEYCV-GGLQDMLDSTPY------------------------------------------------- 135 (235)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------------------------------------------- 135 (235)
.+ ......++||||++ |+|.+++.....
T Consensus 109 ~~--~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 109 AC--TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EE--ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 99 44567899999997 468888754311
Q ss_pred -----------------------------------------------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCC
Q psy787 136 -----------------------------------------------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIK 168 (235)
Q Consensus 136 -----------------------------------------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~ 168 (235)
..+++..++.++.|++.||.|||+.+++|+|||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk 266 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA 266 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence 235667788899999999999999999999999
Q ss_pred CCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 169 PGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 169 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+||+++.++.++|+|||++................++..|+|||.+.+ ..++.++||||||++|
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil 331 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILL 331 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHH
Confidence 9999999999999999999875432111111122335678999999977 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=213.14 Aligned_cols=184 Identities=26% Similarity=0.379 Sum_probs=151.5
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
..+|++.+.||+|++|.||++.. .+..+++|.++.. .....+.+|+.++++++|++++++++.+.. .....
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 75 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGL 75 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEc-CCCce
Confidence 35789999999999999999876 4678899987432 223467899999999999999999998753 34568
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++++|++++ +|.+++.......+++..++.++.|++.||++||++|++|+||+|+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999975 7999887765456888999999999999999999999999999999999999999999999998744311
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......+..|+|||...+ ..++.++||||||+++
T Consensus 156 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~ 189 (256)
T cd05082 156 -----QDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILL 189 (256)
T ss_pred -----CCCCccceeecCHHHHcc--CCCCchhhhHHHHHHH
Confidence 112224457999999877 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=217.08 Aligned_cols=194 Identities=31% Similarity=0.485 Sum_probs=155.1
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCC---C
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDK---K 112 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~---~ 112 (235)
++|++.+.||.|++|.||++.+..+++.+++|.++..... ......+.+|+.++..+. |+|++++++.+.... .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE--EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc--cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 4799999999999999999999989999999987654322 223345778999999995 699999999885322 2
Q ss_pred ceEEEEEecccCCHHHHhhcCC---CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc-CCcEEEeeeccc
Q psy787 113 QKMYLIMEYCVGGLQDMLDSTP---YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL-DGTLKISDFGVA 188 (235)
Q Consensus 113 ~~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~-~~~~~l~dfg~~ 188 (235)
...+++|||+++++.+++.... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 79 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 79 PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred ceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 2479999999999888876542 246899999999999999999999999999999999999998 789999999998
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..+.... .......+++.|+|||.+.+. ..++.++|+||||+++
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l 202 (295)
T cd07837 159 RAFSIPV--KSYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIF 202 (295)
T ss_pred eecCCCc--cccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHH
Confidence 7553211 112223456779999988652 2368899999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=213.27 Aligned_cols=193 Identities=32% Similarity=0.473 Sum_probs=158.3
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|++|+||++....++..+++|++...... .....+.+|+..++.++|+|++++++.+ .....++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ---TSVDELRKEVQAMSQCNHPNVVKYYTSF--VVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc---hHHHHHHHHHHHHHhcCCCCEEEEEEEE--eeCCEEE
Confidence 4799999999999999999998888899999988644322 2345688999999999999999999988 4566889
Q ss_pred EEEecccC-CHHHHhhcCCC-CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 117 LIMEYCVG-GLQDMLDSTPY-KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++|++++ +|.+++..... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++..+...
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 99999975 68888876433 56899999999999999999999999999999999999999999999999998755422
Q ss_pred ccCC--cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDD--TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ......++..|+|||.+... ..++.++|+||||+++
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~ 197 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITA 197 (267)
T ss_pred ccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHH
Confidence 1111 11233477889999998763 2578999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=215.53 Aligned_cols=188 Identities=29% Similarity=0.471 Sum_probs=153.2
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCCceEEE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~l 117 (235)
|+++++||.|++|.||++.+..+++.+++|.++..... ........|+..+.++. |+|++++++.+.+...+.+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS---LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC---chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 67899999999999999999889999999988654322 12223457888888885 999999999996554478999
Q ss_pred EEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC
Q psy787 118 IMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 118 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 197 (235)
++|++++++.+.+.... ..+++..++.++.|++.||++||+.+++|+||+|+||+++. +.++|+|||++......
T Consensus 78 v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--- 152 (282)
T cd07831 78 VFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--- 152 (282)
T ss_pred EEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---
Confidence 99999999888877643 56899999999999999999999999999999999999999 99999999999755321
Q ss_pred CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 198 DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+... ..++.++|+||||+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l 189 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVF 189 (282)
T ss_pred CCcCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHH
Confidence 112223467889999976542 3478899999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=222.03 Aligned_cols=194 Identities=31% Similarity=0.479 Sum_probs=158.6
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC--
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK-- 112 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 112 (235)
..++|.+.+.||.|++|+||++.+..+++.+++|.++..... ......+.+|+.++..++|+|++++.+.+.....
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN--RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc--cchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 346899999999999999999999999999999988654321 2333456789999999999999999998743221
Q ss_pred -ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 -QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 -~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
...++++|+++++|.+++... ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 81 FNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred cCcEEEEEeCCCCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 357999999999998888765 67899999999999999999999999999999999999999999999999998755
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... ........++..|+|||.+... ..++.++|+||||+++
T Consensus 159 ~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il 199 (337)
T cd07858 159 SEK--GDFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIF 199 (337)
T ss_pred CCC--cccccccccccCccChHHHhcC-CCCCCcccHHHHHHHH
Confidence 321 1122233467789999987642 2378899999999874
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=213.91 Aligned_cols=189 Identities=24% Similarity=0.320 Sum_probs=153.0
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|+++++||.|++|.||++.+. .+..+++|.+..... ....+.+|+.++++++|++++++++.+ .. ..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~--~~-~~ 74 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVV--SE-EP 74 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEE--CC-CC
Confidence 3468999999999999999999765 556789998765432 234688999999999999999999887 32 35
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.+++||++++ +|.+++.......+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+..+..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 7899999975 798888765556689999999999999999999999999999999999999999999999999975532
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... .......++..|+|||...+ ..++.++|+||||+++
T Consensus 155 ~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 193 (260)
T cd05070 155 NEY-TARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILL 193 (260)
T ss_pred ccc-ccccCCCCCccccChHHHhc--CCCcchhhhHHHHHHH
Confidence 111 11112224457999999876 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=221.36 Aligned_cols=196 Identities=27% Similarity=0.431 Sum_probs=152.1
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccch-------hhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceee
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSET-------LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLV 104 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 104 (235)
+....+|++++.||+|+||.||++++... +..+++|+++... .......+.+|+.++.++ +|+||++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---TDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 34445899999999999999999975322 2357888765332 122334678899999999 799999999
Q ss_pred eEEEcCCCceEEEEEecccC-CHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCC
Q psy787 105 DVFVNDKKQKMYLIMEYCVG-GLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKP 169 (235)
Q Consensus 105 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p 169 (235)
+.+ .....+++++||+++ +|.+++.... ...++...+..++.|++.||.|||++|++|+||+|
T Consensus 85 ~~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 85 GAC--TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred EEE--ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 999 455678999999965 7888886532 23477788899999999999999999999999999
Q ss_pred CCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 170 GNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 170 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+||+++.++.++|+|||+++................+..|+|||.+.+ ..++.++||||||++|
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 226 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLL 226 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHH
Confidence 999999999999999999875532111111122223456999999977 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=213.52 Aligned_cols=190 Identities=27% Similarity=0.362 Sum_probs=155.4
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++.++||.|++|.||++.+. .++.+++|.+..... ....+.+|+..++.++|+|++++++.+ .....
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 75 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVC--SEEEP 75 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeee--ecCCc
Confidence 3468999999999999999999875 457789998764332 234688999999999999999999998 45567
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.+++||++++ +|.+++.......++...+..++.+++.|+.+||+++++|+||+|+||+++.++.++++|||.+..+..
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 8999999965 799888776556789999999999999999999999999999999999999999999999999875532
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .........+..|+|||.+.+ ..++.++|+||||+++
T Consensus 156 ~~-~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il 194 (261)
T cd05034 156 DE-YTAREGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILL 194 (261)
T ss_pred hh-hhhhhccCCCccccCHHHhcc--CCcCchhHHHHHHHHH
Confidence 11 111112223457999999987 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=219.16 Aligned_cols=196 Identities=26% Similarity=0.416 Sum_probs=155.6
Q ss_pred EeeeceEEeeeeeccccceEEEEeec-----cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeE
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLD-----SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDV 106 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 106 (235)
....++|.+.+.||.|+||.||++.+ ..++..+++|.++.... ......+.+|+.+++++ +|+||+++++.
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH---SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC---hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 34556899999999999999999864 23455788887764421 12234678999999999 79999999999
Q ss_pred EEcCCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeee
Q psy787 107 FVNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDF 185 (235)
Q Consensus 107 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~df 185 (235)
+ ...+..+++|||+. ++|.+++.......++...+..++.|++.||.|||+++++|+||+|+||+++.++.++++||
T Consensus 108 ~--~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 108 C--TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred E--ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCC
Confidence 8 45567899999996 57988887654445899999999999999999999999999999999999999999999999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|++..+.............++..|+|||.+.+ ..++.++||||||+++
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil 233 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILL 233 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHH
Confidence 99875532111111112234567999999877 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=216.15 Aligned_cols=192 Identities=35% Similarity=0.550 Sum_probs=158.3
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
|+++++||.|++|.||++.+..+++.+++|.+.... ........+.+|+.+++.++|+|++++.+.+........+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 678999999999999999998889999999998664 112334467889999999999999999999954323689999
Q ss_pred EecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCC
Q psy787 119 MEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDD 198 (235)
Q Consensus 119 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 198 (235)
+||++++|.+++.... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 79 ~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (287)
T cd07840 79 FEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-A 156 (287)
T ss_pred eccccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-c
Confidence 9999988888876543 5789999999999999999999999999999999999999999999999999986543211 1
Q ss_pred cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 199 TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 199 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......+..|+|||.+.+. ..++.++||||||+++
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l 192 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCIL 192 (287)
T ss_pred cccccccccccCCceeeEcc-ccCChHHHHHHHHHHH
Confidence 12233456779999987652 3478899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=216.21 Aligned_cols=193 Identities=27% Similarity=0.399 Sum_probs=156.7
Q ss_pred eEEeeeeeccccceEEEEeecc---chhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCc
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDS---ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (235)
.|++.+.||.|++|.||++.+. .+|+.+++|++..............+..|+.++..+ .|++|+++.+.+ ....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF--QTDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe--ecCC
Confidence 4889999999999999999864 478899999987654433333445678899999999 589999999888 5566
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++++|++++ +|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..+.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 88999999975 688888765 568889999999999999999999999999999999999999999999999987553
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... ........++..|+|||.+.+....++.++|+||||+++
T Consensus 157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l 198 (290)
T cd05613 157 EDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLM 198 (290)
T ss_pred ccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHH
Confidence 211 112223447788999999875334467899999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=216.03 Aligned_cols=190 Identities=35% Similarity=0.538 Sum_probs=157.0
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
|++.+.||.|++|.||++.+..+|+.+++|++...... ......+.+|+..++.++|+|++++++.+ ......+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~iv~~~~~~--~~~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED--EGVPSTAIREISLLKELNHPNIVRLLDVV--HSENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc--ccchhHHHHHHHHHHhcCCCCccCHhhee--ccCCeEEEE
Confidence 67889999999999999999889999999988654322 22334577899999999999999999998 455688999
Q ss_pred EecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCC
Q psy787 119 MEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDD 198 (235)
Q Consensus 119 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 198 (235)
+|+++++|.+++.......+++..++.++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~ 154 (283)
T cd07835 77 FEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--R 154 (283)
T ss_pred EeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--c
Confidence 99998889998877654578999999999999999999999999999999999999999999999999987543211 1
Q ss_pred cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 199 TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 199 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l 190 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIF 190 (283)
T ss_pred ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHH
Confidence 11222357789999987652 2368899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=215.42 Aligned_cols=183 Identities=33% Similarity=0.503 Sum_probs=152.4
Q ss_pred eccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecccC
Q psy787 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVG 124 (235)
Q Consensus 45 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 124 (235)
||.|+||+||++.+..+++.+++|.+....... ......+..|+.+++.++|||++++.+.+ ...+.+|++|||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-RKGEQMALNEKKILEKVSSRFIVSLAYAF--ETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-hhhhHHHHHHHHHHHhCCCCCEeeeeeEE--ecCCeEEEEEecCCC
Confidence 689999999999998899999999987654332 23344567899999999999999999998 556688999999975
Q ss_pred -CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccccc
Q psy787 125 -GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS 203 (235)
Q Consensus 125 -~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 203 (235)
+|.+.+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..... .......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence 688888766545789999999999999999999999999999999999999999999999998875432 1222234
Q ss_pred CCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 204 QGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 204 ~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++..|+|||...+ ..++.++|+||||+++
T Consensus 155 ~~~~~y~~PE~~~~--~~~~~~~Di~slG~il 184 (277)
T cd05577 155 AGTPGYMAPEVLQG--EVYDFSVDWFALGCTL 184 (277)
T ss_pred cCCCCcCCHHHhcC--CCCCchhhhHHHHHHH
Confidence 46778999999877 4488999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=215.57 Aligned_cols=191 Identities=23% Similarity=0.347 Sum_probs=151.9
Q ss_pred eceEEeeeeeccccceEEEEeeccchhh----heeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLC----RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
.++|++++.||+|+||+||++....+++ .+++|....... ......+.+|+..+..++|+|++++++.+..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS---PKANKEILDEAYVMASVDHPHVVRLLGICLS-- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 4689999999999999999998766554 467776644322 2233467889999999999999999999853
Q ss_pred CceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...++++|+++ ++|.+++.... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 57899999996 46888887643 4589999999999999999999999999999999999999999999999999986
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...............+..|+|||.... ..++.++|+||||+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l 201 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTV 201 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHH
Confidence 542111111111223457999998866 4588999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=216.10 Aligned_cols=187 Identities=32% Similarity=0.542 Sum_probs=157.7
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|++|.||++.+..+++.+++|++..... ......+.+|+.+++.++|+|++++.+.+. ....++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA---EDEIEDIQQEIQFLSQCRSPYITKYYGSFL--KGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc---chHHHHHHHHHHHHHHcCCCCeeeeeEEEE--ECCeEE
Confidence 478999999999999999999988999999998865431 223345788999999999999999999985 346889
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+++|++++ +|.+++... .+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 99999975 688887653 78999999999999999999999999999999999999999999999999997664321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il 188 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITA 188 (274)
T ss_pred --cccccccCCccccChhhhcc--CCCCchhhHHHHHHHH
Confidence 22233456778999999987 4489999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=213.40 Aligned_cols=187 Identities=24% Similarity=0.346 Sum_probs=150.7
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
.+|++.+.||.|++|.||++.+. ++..+++|++..... ....+.+|+.+++.++|+|++++++.+ ......+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~ 75 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVC--TKQRPIF 75 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEE--cCCCceE
Confidence 35889999999999999999875 456889998754332 223578899999999999999999998 5556789
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++||++++ +|.+++.... ..+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 76 IVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 99999965 6888887543 468899999999999999999999999999999999999999999999999887442111
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ........+..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 ~-~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il 191 (256)
T cd05059 155 Y-TSSQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLM 191 (256)
T ss_pred c-cccCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHH
Confidence 0 11111123346999999877 4588999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=216.94 Aligned_cols=192 Identities=26% Similarity=0.310 Sum_probs=151.4
Q ss_pred eceEEeeeeeccccceEEEEeecc-----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDS-----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
.++|.+.+.||.|++|.||++.+. .++..+++|.+.... ......+.+|+..+..++|+|++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~ 77 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT----LAARKDFQREAELLTNLQHEHIVKFYGVC--G 77 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc----HHHHHHHHHHHHHHhcCCCCCcceEEEEE--c
Confidence 457999999999999999999743 234556777654332 12234578999999999999999999999 4
Q ss_pred CCceEEEEEeccc-CCHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc
Q psy787 111 KKQKMYLIMEYCV-GGLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT 175 (235)
Q Consensus 111 ~~~~~~lv~e~~~-~~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~ 175 (235)
.....+++|||++ ++|.+++.... ...+++..++.++.|++.|+++||+++++|+||||+||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 5567899999996 57888886542 13478889999999999999999999999999999999999
Q ss_pred cCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 176 LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 176 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++.++|+|||++................++..|+|||.+.+ ..++.++||||||+++
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 215 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVIL 215 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHH
Confidence 999999999999875432111111222335677999999877 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=218.69 Aligned_cols=191 Identities=32% Similarity=0.533 Sum_probs=155.9
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++++.||.|++|.||++.+..+++.+++|++.... ......+..|+.+++.++|+|++++++.+. ....+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 77 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES----EEELEDFMVEIDILSECKHPNIVGLYEAYF--YENKL 77 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC----HHHHHHHHHHHHHHHhCCCCceeEEEEEEe--cCCeE
Confidence 357999999999999999999998889999999986442 223345788999999999999999999994 56688
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++|||+++ +|.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 78 WILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 999999976 5777766542 56899999999999999999999999999999999999999999999999987644211
Q ss_pred ccCCcccccCCCCcccCccccCCC---CCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+... ...++.++|+||||+++
T Consensus 157 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il 198 (280)
T cd06611 157 --LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITL 198 (280)
T ss_pred --ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHH
Confidence 1122234577889999987421 12367899999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=212.80 Aligned_cols=187 Identities=25% Similarity=0.353 Sum_probs=150.8
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
+.|++.+.||.|++|+||++... .+..+++|.++.... ....+.+|+..+..++||||+++++.+ .....++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~ 75 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVC--TKQRPIY 75 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEE--ccCCCcE
Confidence 46899999999999999999764 345689998764332 234588999999999999999999998 4455789
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++||++.+ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 99999965 6888887643 368999999999999999999999999999999999999999999999999887543211
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||...+ ..++.++|+||||+++
T Consensus 155 -~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l 191 (256)
T cd05113 155 -YTSSVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLM 191 (256)
T ss_pred -eeecCCCccChhhCCHHHHhc--CcccchhHHHHHHHHH
Confidence 111112224567999999977 4488899999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=218.38 Aligned_cols=195 Identities=27% Similarity=0.474 Sum_probs=151.5
Q ss_pred eeeceEEeeeeeccccceEEEEeecc-------chhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeee
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDS-------ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVD 105 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 105 (235)
...++|.+.+.||+|++|.||++.+. .....+++|.++.... ......+.+|+..++.+ +|+||+++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT---DKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC---hHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 34468999999999999999999753 2345678887754321 12234577899999999 6999999999
Q ss_pred EEEcCCCceEEEEEeccc-CCHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q psy787 106 VFVNDKKQKMYLIMEYCV-GGLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPG 170 (235)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~ 170 (235)
.+ .....+++++||++ ++|.+++.... ...++...+..++.|++.||.|||+.|++|+||||+
T Consensus 86 ~~--~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 86 VC--TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EE--ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 98 45567899999996 47888886532 235788899999999999999999999999999999
Q ss_pred CeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 171 NLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 171 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||+++.++.++|+|||.+.................+..|+|||.+.+ ..++.++||||||+++
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l 226 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILM 226 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc--CCcCccchhhHHHHHH
Confidence 99999999999999999975532111111111223456999999877 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=213.65 Aligned_cols=192 Identities=27% Similarity=0.448 Sum_probs=160.0
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|++.+.||.|++|.||++.+..+++.+++|.+...... ......+..|+..++.++|+|++++++.+.......+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT--EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC--HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 488999999999999999999999999999988654432 233456788999999999999999999887666678899
Q ss_pred EEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHH-----hCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 118 IMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLH-----SQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH-----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
+||++++ +|.+++... ....+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence 9999965 688887653 2356899999999999999999999 8899999999999999999999999999998
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...... .......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il 200 (265)
T cd08217 159 ILGHDS--SFAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLI 200 (265)
T ss_pred cccCCc--ccccccccCCCccChhhhcC--CCCCchhHHHHHHHHH
Confidence 664221 11223457888999999877 4588999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=221.09 Aligned_cols=195 Identities=28% Similarity=0.475 Sum_probs=158.8
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC--CCc
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND--KKQ 113 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 113 (235)
.++|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|+.+++.+.|+||+++.+++... ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc--ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 46899999999999999999999999999999988654322 23344577899999999999999999877422 335
Q ss_pred eEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 114 KMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 114 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.+++++||++++|.+.+... ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 82 DVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred eEEEEEehhhhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 78999999998888888665 5589999999999999999999999999999999999999999999999999875432
Q ss_pred cccC--CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHD--DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... .......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l 202 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIF 202 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHH
Confidence 1111 111234577789999987552 3478899999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=216.67 Aligned_cols=204 Identities=18% Similarity=0.221 Sum_probs=147.6
Q ss_pred CCceeEeeeceEEeeeeeccccceEEEEeeccch---hhheeeeeeeeccccCCCCc-------cccHHHHHHHHHhcCC
Q psy787 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSET---LCRRAVKIFKKKKLQRIPNG-------EINVDREIRLLKMLQH 97 (235)
Q Consensus 28 ~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~-------~~~~~~e~~~l~~l~h 97 (235)
+.++.+...++|++.+.||+|+||+||++.+..+ +..+++|+..........+. ......+...+..+.|
T Consensus 3 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h 82 (294)
T PHA02882 3 GIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDH 82 (294)
T ss_pred CeeeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCC
Confidence 4556667778999999999999999999988766 55666665432221100000 0011223334455689
Q ss_pred CCcceeeeEEEcCCC--ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc
Q psy787 98 RNVIGLVDVFVNDKK--QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT 175 (235)
Q Consensus 98 ~~i~~~~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~ 175 (235)
++++++++.+..... ...+++++.+..++.+.+... ...++..+..++.|++.||.|||+.+++||||||+||+++
T Consensus 83 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~ 160 (294)
T PHA02882 83 LGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD 160 (294)
T ss_pred CCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 999999987643222 234778888877777666543 3457788899999999999999999999999999999999
Q ss_pred cCCcEEEeeeccccccCcccc-----CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 176 LDGTLKISDFGVAESLDMFLH-----DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 176 ~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++.++|+|||+++.+..... ........+++.|+|||...+ ..++.++||||||++|
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l 223 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCM 223 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHH
Confidence 999999999999976531111 111122358899999999887 4589999999999974
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=212.47 Aligned_cols=188 Identities=25% Similarity=0.327 Sum_probs=151.8
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|.+.++||.|++|.||++.+..+ ..+++|.+.... .....+.+|+.+++.++|+|++++++.+ . ....
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~-~~~~ 75 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVV--S-EEPI 75 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEE--c-CCCc
Confidence 36799999999999999999987554 458888765432 2234678999999999999999999887 3 3457
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++||++++ +|.+++.......++...+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 899999975 7999887655456889999999999999999999999999999999999999999999999999755321
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .......++..|+|||...+ ..++.++|+||||+++
T Consensus 156 ~~-~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l 193 (260)
T cd05069 156 EY-TARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILL 193 (260)
T ss_pred cc-cccCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHH
Confidence 11 11112234567999998876 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=214.39 Aligned_cols=192 Identities=30% Similarity=0.465 Sum_probs=156.0
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC--CccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP--NGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
+|++.+.||.|++|.||++.+..+++.+++|++......... +....+.+|+..+++++|+|++++++.+ ...+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT--CEDSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee--ccCCeE
Confidence 478889999999999999999899999999998754422211 1235688999999999999999999999 566788
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-cEEEeeeccccccCc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-TLKISDFGVAESLDM 193 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~ 193 (235)
++++|++.+ +|.+++... .++++..++.++.|++.||++||++|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 79 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999975 688887654 5788999999999999999999999999999999999998776 599999999875542
Q ss_pred cccC--CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHD--DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... .......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l 198 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVI 198 (268)
T ss_pred ccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHH
Confidence 2111 11112346778999999876 4478999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=216.01 Aligned_cols=189 Identities=26% Similarity=0.430 Sum_probs=148.7
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhh--eeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCc
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCR--RAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~--~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (235)
++|++.+.||.|+||.||++....++.. +++|.++... .....+.+.+|+.++.++ .||||+++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA---SENDHRDFAGELEVLCKLGHHPNIINLLGAC--ENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC---CHHHHHHHHHHHHHHHhhcCCCchhheEEEE--ccCC
Confidence 5799999999999999999988766543 5666654321 122344678899999999 799999999998 4556
Q ss_pred eEEEEEeccc-CCHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC
Q psy787 114 KMYLIMEYCV-GGLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG 178 (235)
Q Consensus 114 ~~~lv~e~~~-~~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~ 178 (235)
.+++++|+++ ++|.+++.... ...++...++.++.|++.||++||+.|++|+||||+||+++.++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence 7899999996 57888886532 13478889999999999999999999999999999999999999
Q ss_pred cEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 179 TLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++|+|||++...... ........+..|+|||...+ ..++.++||||||+++
T Consensus 157 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il 208 (297)
T cd05089 157 ASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLL 208 (297)
T ss_pred eEEECCcCCCccccce---eccCCCCcCccccCchhhcc--CCCCchhhHHHHHHHH
Confidence 9999999998633211 11111223456999999877 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=216.55 Aligned_cols=193 Identities=25% Similarity=0.324 Sum_probs=151.3
Q ss_pred eceEEeeeeeccccceEEEEeeccc-----hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSE-----TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
.++|.+.+.||+|++|.||++.+.. ++..+++|.+..... ......+.+|+..++.++|+|++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-- 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS---EQDESDFLMEALIMSKFNHQNIVRLIGVSF-- 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--
Confidence 4679999999999999999998876 667788887643321 122345788999999999999999999884
Q ss_pred CCceEEEEEeccc-CCHHHHhhcCCC-----CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC---cEE
Q psy787 111 KKQKMYLIMEYCV-GGLQDMLDSTPY-----KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG---TLK 181 (235)
Q Consensus 111 ~~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~---~~~ 181 (235)
.....+++||++. ++|.+++..... ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++ .++
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 4456799999996 578888865432 2588899999999999999999999999999999999998765 589
Q ss_pred EeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 182 ISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+|||++.................+..|+|||.+.+ ..++.++||||||+++
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il 211 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLL 211 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHH
Confidence 999999875532111111112223457999999876 4589999999999874
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=217.28 Aligned_cols=197 Identities=31% Similarity=0.520 Sum_probs=159.1
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC--
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK-- 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (235)
...++|++.+.||.|++|.||++.+..+++.+++|.++..... ......+.+|+.++++++|||++++++.+....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 3467899999999999999999999888999999988755422 233345678999999999999999999885322
Q ss_pred ------CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeee
Q psy787 112 ------KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDF 185 (235)
Q Consensus 112 ------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~df 185 (235)
...+++++|++++++...+... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 3378999999999888777654 356899999999999999999999999999999999999999999999999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|.+........ ........+..|+|||.+.+. ...+.++||||||+++
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~ 208 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCIL 208 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCC-CCCCchhHHHHHHHHH
Confidence 99875532111 111122346679999988652 2468899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=213.35 Aligned_cols=194 Identities=28% Similarity=0.491 Sum_probs=155.2
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEc---C
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVN---D 110 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~ 110 (235)
..++|++.+.||+|++|.||++.+..+++.+++|++.... .....+.+|+.++..+ +|+|++++++.+.. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 4568999999999999999999999899999999875432 1223577899999998 69999999998853 2
Q ss_pred CCceEEEEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
....++++|||+++ +|.+++... ....+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 34578999999975 687776532 225678889999999999999999999999999999999999999999999999
Q ss_pred ccccCccccCCcccccCCCCcccCccccCCC---CCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~l 235 (235)
+...... ........++..|+|||.+... ...++.++||||||+++
T Consensus 171 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~ 219 (286)
T cd06638 171 SAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITA 219 (286)
T ss_pred eeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHH
Confidence 8754321 1122234578889999987531 13478899999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=216.27 Aligned_cols=194 Identities=26% Similarity=0.316 Sum_probs=149.6
Q ss_pred eeceEEeeeeeccccceEEEEeecc-----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDS-----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
-.++|++.+.||+|++|.||++... ..+..+++|.+..... ......+.+|+..++.++|+|++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-- 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS---LRERIEFLNEASVMKGFTCHHVVRLLGVV-- 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEE--
Confidence 3468999999999999999998643 2345788887653321 12233577899999999999999999998
Q ss_pred CCCceEEEEEeccc-CCHHHHhhcCC--------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcE
Q psy787 110 DKKQKMYLIMEYCV-GGLQDMLDSTP--------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTL 180 (235)
Q Consensus 110 ~~~~~~~lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~ 180 (235)
......+++|||++ ++|.+++.... ....+...+..++.|++.||.|||+.+++|+||||+||+++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 44557899999996 57888886432 1234667888999999999999999999999999999999999999
Q ss_pred EEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 181 KISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|+|||++................++..|+|||.+.+ ..++.++|+||||+++
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l 211 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVL 211 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHH
Confidence 9999999875432111111112234567999999877 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=213.07 Aligned_cols=193 Identities=25% Similarity=0.337 Sum_probs=149.1
Q ss_pred EEeeeeeccccceEEEEeeccc---hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC---
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSE---TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK--- 112 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 112 (235)
|.+++.||+|+||.||.+.... .+..+++|.++..... ......+.+|+..++.+.|+|++++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT--YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 5688999999999999998654 3478999987643322 1223457889999999999999999998853222
Q ss_pred -ceEEEEEecccC-CHHHHhhcC----CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeec
Q psy787 113 -QKMYLIMEYCVG-GLQDMLDST----PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 113 -~~~~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
...++++||+++ +|..++... ....+++..+..++.|++.||.|||+.+++|+||||+||++++++.++|+|||
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCcc
Confidence 347999999974 677776433 22468889999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++.................+..|+|||.+.+ ..++.++||||||+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il 205 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTM 205 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc--CCCCcccchHHHHHHH
Confidence 9875532111111111224567999999876 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=214.19 Aligned_cols=190 Identities=31% Similarity=0.450 Sum_probs=157.6
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|.+.+.||.|++|.||++.+..+++.+++|.+..... ......+.+|+..++.++|+||+++++.+.......++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN---PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc---hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 478999999999999999999988999999998865422 13345688999999999999999999998766666889
Q ss_pred EEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 117 LIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
++|||+++ +|.+++... ....++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999975 687765432 235688899999999999999999999999999999999999999999999999864431
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 158 ----~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il 193 (287)
T cd06621 158 ----SLAGTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTL 193 (287)
T ss_pred ----cccccccCCccccCHHHhcC--CCCCchhhHHHHHHHH
Confidence 11123346778999999877 4588999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-33 Score=195.84 Aligned_cols=190 Identities=31% Similarity=0.543 Sum_probs=162.3
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
.|.-.++||.|.+|+||+++...+++.||+|.++..... +....+..+|+-+++.++|+||++++++. .+.+-+.+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd--egvpssalreicllkelkhknivrl~dvl--hsdkkltl 78 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKLTL 78 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC--CCCcHHHHHHHHHHHHhhhcceeehhhhh--ccCceeEE
Confidence 455668999999999999999999999999988765432 34456788999999999999999999998 56677899
Q ss_pred EEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC
Q psy787 118 IMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 118 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 197 (235)
|+|||...|..++.+.+ +.++.+....++.|++.++.++|+.+++|||+||+|.+|..+|.+++.|||+++.++-+.
T Consensus 79 vfe~cdqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-- 155 (292)
T KOG0662|consen 79 VFEFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-- 155 (292)
T ss_pred eHHHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence 99999999999998876 678999999999999999999999999999999999999999999999999998775321
Q ss_pred CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 198 DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.....-.-|.-|.||.++.|. .-|+.+.|+||-||++
T Consensus 156 rcysaevvtlwyrppdvlfga-kly~tsidmwsagcif 192 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIF 192 (292)
T ss_pred EeeeceeeeeeccCcceeeee-ehhccchHhhhcchHH
Confidence 122233356669999999883 2488999999999974
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=214.22 Aligned_cols=194 Identities=30% Similarity=0.498 Sum_probs=157.2
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcC---
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVND--- 110 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--- 110 (235)
..+.|++.+.||.|+||.||++.+..+++.+++|++.... .....+..|+.++.++ .|+|++++++.+...
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 3468999999999999999999998899999999875432 2233577888888888 699999999998532
Q ss_pred -CCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 111 -KKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 111 -~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
....++++|||+++ +|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 24578999999975 6888887655566888889999999999999999999999999999999999999999999998
Q ss_pred cccCccccCCcccccCCCCcccCccccCCC---CCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~l 235 (235)
...... ........++..|+|||.+... ...++.++|+||||+++
T Consensus 169 ~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l 216 (282)
T cd06636 169 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITA 216 (282)
T ss_pred hhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHH
Confidence 754321 1122334578889999987521 23477899999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=212.96 Aligned_cols=190 Identities=33% Similarity=0.472 Sum_probs=154.0
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc---CCCCcceeeeEEEcCCC---
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML---QHRNVIGLVDVFVNDKK--- 112 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~--- 112 (235)
|++.+.||.|++|.||++.+..+++.+++|.++..... ......+.+|+.++.++ .|+|++++++.+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE--EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc--chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 67899999999999999999888999999998755432 12223455777776666 59999999999954322
Q ss_pred ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 113 QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 113 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..++++||++.++|.+++.......+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 ~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 79 LKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred ceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 23899999999899888876554568999999999999999999999999999999999999999999999999987653
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l 196 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIF 196 (287)
T ss_pred CC---cccccccccccccChHHhcc--CCCCCcchhhhHHHHH
Confidence 21 11122336778999999977 4488999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=213.21 Aligned_cols=192 Identities=22% Similarity=0.337 Sum_probs=152.5
Q ss_pred eceEEeeeeeccccceEEEEeeccchhh---heeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLC---RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
.++|++.+.||+|+||.||++.+..++. .+++|.++.... ......+.+|+..+.+++|||++++++.+ ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT---EKQRRDFLSEASIMGQFDHPNIIHLEGVV--TKS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEE--ecC
Confidence 3579999999999999999998754443 578887654321 22345688999999999999999999998 455
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..++++||++++ +|.+++.... ..++...+..++.|++.|+++||+.+++|+||+|+||+++.++.++++|||++...
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 678999999975 6888887653 56899999999999999999999999999999999999999999999999998755
Q ss_pred CccccCC-cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDD-TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....... .......+..|+|||.+.+ ..++.++|+||||+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l 199 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVM 199 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHH
Confidence 3211111 0111122457999999977 4589999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=215.72 Aligned_cols=192 Identities=26% Similarity=0.309 Sum_probs=150.2
Q ss_pred eceEEeeeeeccccceEEEEeec-----cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLD-----SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
..+|.+.++||.|+||.||++.. ..++..+++|.+.... ......+.+|+..+..++|+||+++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~ 77 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----ESARQDFQREAELLTVLQHQHIVRFYGVC--T 77 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC----HHHHHHHHHHHHHHhcCCCCCCceEEEEE--e
Confidence 35788899999999999999863 2345677777665332 23344688999999999999999999988 4
Q ss_pred CCceEEEEEecccC-CHHHHhhcCCC-------------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDSTPY-------------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL 176 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~ 176 (235)
.....++++|++++ +|.+++..... ..++...++.++.|++.|++|||+.|++|+||+|+||++++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 45678999999964 68888765421 34788899999999999999999999999999999999999
Q ss_pred CCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 177 DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++.++|+|||++................++..|+|||.+.+ ..++.++||||||+++
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 214 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVL 214 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHH
Confidence 99999999999864421111011112224567999999877 4589999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-33 Score=218.14 Aligned_cols=192 Identities=26% Similarity=0.291 Sum_probs=150.5
Q ss_pred ceEEeeeeeccccceEEEEeeccc-----hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSE-----TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
..|.++++||.|+||.||++.+.. .++.+++|+++.... ......+.+|+.++..++|+||+++++.+ ..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h~~iv~~~~~~--~~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE---GPLREEFKHEAMMRSRLQHPNIVCLLGVV--TK 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC---HHHHHHHHHHHHHHhcCCCCCcCeEEEEE--cC
Confidence 468889999999999999997643 357889998764321 12234578899999999999999999998 45
Q ss_pred CceEEEEEecccC-CHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL 176 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~ 176 (235)
....+++++++.+ +|.+++.... ...++...+..++.|++.||.|||+.|++||||||+||++.+
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 5678999999964 5777774221 134788889999999999999999999999999999999999
Q ss_pred CCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 177 DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++.++|+|||++................+++.|+|||.+.+ ..++.++||||||+++
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l 216 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVL 216 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHH
Confidence 99999999999875532111111222334667999999876 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=210.37 Aligned_cols=192 Identities=34% Similarity=0.622 Sum_probs=158.9
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|++.+.||+|+++.||++.+..+++.+++|+++..... ......+..|+.+++.++|+||+++++.+ .....+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~--~~~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVE--VHREKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeE--ecCCEEEE
Confidence 689999999999999999998888999999998765432 23456788999999999999999999988 45668899
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++||+++ +|.+++... ..+++..+..++.+++.||.+||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 77 FMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999975 688888764 4578889999999999999999999999999999999999999999999999886542211
Q ss_pred CCc--ccccCCCCcccCccccCCCC-CCCCCcccEEEeeeeC
Q psy787 197 DDT--ITTSQGSPVFQAPEIANGLP-EISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~--~~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~slG~~l 235 (235)
... .....++..|+|||.+.+.. ..++.++||||||+++
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il 196 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVV 196 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHH
Confidence 111 11345677899999987632 2378899999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-33 Score=215.80 Aligned_cols=187 Identities=30% Similarity=0.459 Sum_probs=158.0
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..++.+.|+|++++++.+. ....++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE---AIQKQILRELDILHKCNSPYIVGFYGAFY--NNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh---HHHHHHHHHHHHHHHCCCCchhhhheeee--cCCEEE
Confidence 4688899999999999999999989999999988665322 34456789999999999999999999984 457899
Q ss_pred EEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 117 LIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 117 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++|+++ ++|.+++.... ..+++..+..++.|++.||++||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999998 57888887653 678899999999999999999999 99999999999999999999999999988754311
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 ----~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l 189 (265)
T cd06605 155 ----LAKTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSL 189 (265)
T ss_pred ----HhhcccCChhccCHHHHcC--CCCCchhhHHHHHHHH
Confidence 1112557788999999977 4589999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=211.51 Aligned_cols=188 Identities=33% Similarity=0.484 Sum_probs=159.5
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..+..++|+|++++++.+. ..+.++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---EFRKQLLRELKTLRSCESPYVVKCYGAFY--KEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEc--cCCeEE
Confidence 3689999999999999999999989999999988655321 33456889999999999999999999994 457889
Q ss_pred EEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 117 LIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 117 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++|+++ ++|.+++... ..+++..++.++.|++.|+.+||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred EEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999998 5799888765 678999999999999999999999 99999999999999999999999999998755321
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 154 --~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il 190 (264)
T cd06623 154 --LDQCNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTL 190 (264)
T ss_pred --CCcccceeecccccCHhhhCC--CCCCchhhHHHHHHHH
Confidence 111123446788999999877 4588999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-34 Score=233.21 Aligned_cols=191 Identities=32% Similarity=0.542 Sum_probs=157.0
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
+-|.|+..||.|+||+||+|....++-..|-|++.... .+....+.-|+.+|...+||+|+++++.|+-+ +.+|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks----eEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLw 105 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS----EEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLW 105 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc----hhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceE
Confidence 45889999999999999999998888888888886554 34445688899999999999999999877533 4689
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++.|||+|+.-+.+.-.-...+++..+.-+++|++.||+|||++.|+|||||..||++..+|.++|.|||.+-.... .
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 99999999865555544457899999999999999999999999999999999999999999999999998864321 1
Q ss_pred CCcccccCCCCcccCccccCC---CCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANG---LPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~~Di~slG~~l 235 (235)
...-....|||+|||||++.- ....|+.++||||||+.|
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITL 225 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITL 225 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHH
Confidence 222335669999999998731 112388999999999865
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=210.76 Aligned_cols=190 Identities=33% Similarity=0.526 Sum_probs=157.0
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC-CCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI-PNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
+|+..+.||+|++|+||++....+++.+++|.+........ .+....+.+|+.+++.++|+|++++++.+ .....++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE--REEDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE--ecCCeEE
Confidence 57788999999999999999988899999998876543221 22345688999999999999999999988 4556889
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+++||+++ +|.+++... ..++...+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 79 IFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999975 688888765 568899999999999999999999999999999999999999999999999987553211
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+... ..++.++|+||||+++
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l 192 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTV 192 (258)
T ss_pred ---cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHH
Confidence 22344577889999988652 2378999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=212.62 Aligned_cols=193 Identities=29% Similarity=0.395 Sum_probs=155.7
Q ss_pred ceEEeeeeeccccceEEEEeecc----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDS----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
..|++.+.||+|++|.||++... .+++.+++|++...... .....+.+|+..++.+.|+|++++++++.....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 46888899999999999999854 34788999988654322 234568899999999999999999998865556
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
...+++|||+++ +|.+++.... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 688999999964 7888887653 35899999999999999999999999999999999999999999999999999865
Q ss_pred CccccCCc-ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDT-ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........ ......+..|+|||...+ ..++.++|+||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l 202 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTL 202 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhh
Confidence 42111111 112234456999999877 4588999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=214.32 Aligned_cols=192 Identities=24% Similarity=0.319 Sum_probs=148.3
Q ss_pred EeeeeeccccceEEEEeeccchhh--heeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC----Cc
Q psy787 40 VMGDLLGEGSYGKVKEMLDSETLC--RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK----KQ 113 (235)
Q Consensus 40 ~i~~~ig~g~~~~v~~~~~~~~~~--~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~ 113 (235)
.+.+.||+|++|.||+++...++. .+++|.++..... ......+..|+..++.++|+|++++++.+.... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT--RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 567899999999999998876654 5788877654221 233456788999999999999999999875321 23
Q ss_pred eEEEEEeccc-CCHHHHhhcC----CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 114 KMYLIMEYCV-GGLQDMLDST----PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 114 ~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
..++++||++ ++|.+++... ....++...+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 5689999997 4677766422 2245789999999999999999999999999999999999999999999999998
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.................++.|+|||...+ ..++.++||||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il 204 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTM 204 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHH
Confidence 86532111111122235567999999987 4589999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=209.10 Aligned_cols=189 Identities=26% Similarity=0.381 Sum_probs=153.1
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++.++||+|++|.||++.+. .+..+++|.+.... .....+.+|+.+++.++|+|++++.+.+. . ..
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~-~~ 74 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT--K-EP 74 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-----hHHHHHHHHHHHHHhcCCCCcceEEEEEc--C-CC
Confidence 4578999999999999999999754 44668888775432 22345788999999999999999999984 3 56
Q ss_pred EEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
++++||+++ ++|.+++.......++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..+..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 799999996 5799998876556688889999999999999999999999999999999999999999999999875532
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 ~~-~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l 193 (260)
T cd05073 155 NE-YTAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILL 193 (260)
T ss_pred CC-cccccCCcccccccCHhHhcc--CCcCccccchHHHHHH
Confidence 11 111112234566999999876 4588899999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=212.78 Aligned_cols=191 Identities=31% Similarity=0.521 Sum_probs=154.0
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC--CCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI--PNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
+|++.+.||.|+||+||++.. .+++.+++|.+........ ......+.+|+..++.++|+|++++.+.+ .....+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC--LDDNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe--ecCCeE
Confidence 478899999999999999976 4778899998765432211 11224578899999999999999999999 455789
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++++||+++ +|.+++... ..++...+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 78 SIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 999999975 688888665 56788999999999999999999999999999999999999999999999988754211
Q ss_pred c----cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 L----HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. .........++..|+|||...+ ..++.++|+||||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~ 198 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTV 198 (265)
T ss_pred cccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHH
Confidence 1 1111223457788999999977 4478999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=216.88 Aligned_cols=190 Identities=33% Similarity=0.517 Sum_probs=156.5
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++++.||.|++|.||++.+..+++.+++|.+.+.... ......+..|+.++..++|||++++.+.+.. ...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 83 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST--PVLAKRTYRELKLLKHLRHENIISLSDIFIS-PLE 83 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc--cchhHHHHHHHHHHHhcCCCCeeeEeeeEec-CCC
Confidence 3567899999999999999999999999999999987654321 2334567789999999999999999998853 344
Q ss_pred eEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 114 KMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 114 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.+++++|+++++|...+.. ..++...+..++.|+++||.+||+.+++|+||+|+||+++.++.++|+|||.+...+.
T Consensus 84 ~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 84 DIYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred cEEEEeehhccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 6889999998888877754 4578888889999999999999999999999999999999999999999999874431
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+.+ ...++.++|+||||+++
T Consensus 161 -----~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il 196 (328)
T cd07856 161 -----QMTGYVSTRYYRAPEIMLT-WQKYDVEVDIWSAGCIF 196 (328)
T ss_pred -----CcCCCcccccccCceeeec-cCCcCcHHHHHHHHHHH
Confidence 1223346778999998754 13478999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=219.64 Aligned_cols=198 Identities=29% Similarity=0.509 Sum_probs=157.9
Q ss_pred EeeeceEEee-eeeccccceEEEEeeccchhhheeeeeeeeccccCCCC----------ccccHHHHHHHHHhcCCCCcc
Q psy787 33 VKMIGKYVMG-DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN----------GEINVDREIRLLKMLQHRNVI 101 (235)
Q Consensus 33 ~~~~~~y~i~-~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~ 101 (235)
....++|..+ +.||.|++|+||++.+..+++.+++|.++......... ....+.+|+.++..++|+|++
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 3456788754 67999999999999998899999999987654332110 011467899999999999999
Q ss_pred eeeeEEEcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEE
Q psy787 102 GLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLK 181 (235)
Q Consensus 102 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~ 181 (235)
++.+++. .....+++||+++++|.+++... ..+++.....++.|++.||++||+.|++|+||+|+||+++.++.++
T Consensus 84 ~~~~~~~--~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 84 GLVDVYV--EGDFINLVMDIMASDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred eeeEEEe--cCCcEEEEEeccccCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEE
Confidence 9999984 55688999999999999888764 5689999999999999999999999999999999999999999999
Q ss_pred EeeeccccccCccc------------cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 182 ISDFGVAESLDMFL------------HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 182 l~dfg~~~~~~~~~------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+|||.+....... .........++..|+|||.+.+. ..++.++|+||||+++
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l 224 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIF 224 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHH
Confidence 99999887543110 01111122356779999998652 3468899999999874
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-34 Score=207.99 Aligned_cols=194 Identities=28% Similarity=0.478 Sum_probs=162.9
Q ss_pred cCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeee
Q psy787 27 DNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVD 105 (235)
Q Consensus 27 ~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~ 105 (235)
+...+.....+.|++++++|+|-++.||.+....+++++++|++++-... .+.+|+.+|..+. ||||+++.+
T Consensus 28 E~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkk-------KIkREikIL~nL~gg~NIi~L~D 100 (338)
T KOG0668|consen 28 ESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKK-------KIKREIKILQNLRGGPNIIKLLD 100 (338)
T ss_pred hheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHH-------HHHHHHHHHHhccCCCCeeehhh
Confidence 44566677788999999999999999999999889999999999876643 3789999999996 999999999
Q ss_pred EEEcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-cEEEee
Q psy787 106 VFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-TLKISD 184 (235)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-~~~l~d 184 (235)
+..+.....+.+++|+....-...+- ..++..++..+++++++||.|+|++||.|||+||.|++|+... .++|+|
T Consensus 101 iV~Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlID 176 (338)
T KOG0668|consen 101 IVKDPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLID 176 (338)
T ss_pred hhcCccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeee
Confidence 99888888999999999875332221 4578889999999999999999999999999999999999765 599999
Q ss_pred eccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|+|.... +...-.....+..|--||.+... ..+..+.|+|||||+|
T Consensus 177 WGLAEFYH---p~~eYnVRVASRyfKGPELLVdy-~~YDYSLD~WS~Gcml 223 (338)
T KOG0668|consen 177 WGLAEFYH---PGKEYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCML 223 (338)
T ss_pred cchHhhcC---CCceeeeeeehhhcCCchheeec-hhccccHHHHHHHHHH
Confidence 99998553 23333445567779999998763 4588999999999975
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=210.52 Aligned_cols=181 Identities=33% Similarity=0.545 Sum_probs=152.1
Q ss_pred eccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecccC
Q psy787 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVG 124 (235)
Q Consensus 45 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 124 (235)
||.|++|.||++.+..+++.+++|++....... ......+.+|+.+++.++|+|++++++.+ .....+++++||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-TGQQEHIFSEKEILEECNHPFIVKLYRTF--KDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-hhHHHHHHHHHHHHHhCCCCCEeeeeeeE--EcCCccEEEEecCCC
Confidence 689999999999998889999999987654332 23345688999999999999999999988 455678999999964
Q ss_pred -CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccccc
Q psy787 125 -GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS 203 (235)
Q Consensus 125 -~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 203 (235)
+|.+++... ..++...+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+...... ......
T Consensus 78 ~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~---~~~~~~ 152 (262)
T cd05572 78 GELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---QKTWTF 152 (262)
T ss_pred CcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc---cccccc
Confidence 688888765 55889999999999999999999999999999999999999999999999999865421 122334
Q ss_pred CCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 204 QGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 204 ~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++..|+|||.+.+ ..++.++|+||||+++
T Consensus 153 ~~~~~~~~PE~~~~--~~~~~~~Di~slG~il 182 (262)
T cd05572 153 CGTPEYVAPEIILN--KGYDFSVDYWSLGILL 182 (262)
T ss_pred cCCcCccChhHhcC--CCCCChhhhhhhHHHH
Confidence 57788999999876 4488999999999874
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=211.20 Aligned_cols=186 Identities=33% Similarity=0.525 Sum_probs=157.2
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++.+.||.|++|.||++....+++.+++|.+..... ...+.+|+..++.++|+|++++++.+. ....++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~ 74 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED------LQEIIKEISILKQCDSPYIVKYYGSYF--KNTDLW 74 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH------HHHHHHHHHHHHhCCCCcEeeeeeeee--cCCcEE
Confidence 579999999999999999999888889999998865432 456889999999999999999999994 456889
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+++|++++ +|.+++.... ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 75 l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~- 152 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT- 152 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC-
Confidence 99999975 6888876543 57899999999999999999999999999999999999999999999999998865321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+ ..++.++||||||+++
T Consensus 153 -~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il 189 (256)
T cd06612 153 -MAKRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITA 189 (256)
T ss_pred -ccccccccCCccccCHHHHhc--CCCCchhhHHHHHHHH
Confidence 112223346778999999877 3588999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-33 Score=241.77 Aligned_cols=194 Identities=26% Similarity=0.437 Sum_probs=160.6
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
...|.|++.||+|+||.|.+++++.+++.+|.|++.+..-..... ..-|..|-.++..-..+=|+.+...| .+..++
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~-tA~F~EERDimv~~ns~Wiv~LhyAF--QD~~~L 150 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAE-TACFREERDIMVFGNSEWIVQLHYAF--QDERYL 150 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchh-HHHHHHHhHHHHcCCcHHHHHHHHHh--cCccce
Confidence 457999999999999999999999999999999987743332111 12355666677666677788888888 778899
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
|+||+|++| +|..++... ..+++.+++.++..|+.||.-+|+.|+|||||||+||+++..|+++|+|||.+-.++..
T Consensus 151 YlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 999999976 588888776 47999999999999999999999999999999999999999999999999998877633
Q ss_pred ccCCcccccCCCCcccCccccCC---CCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANG---LPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~~Di~slG~~l 235 (235)
..-+....+|||.|.+||++.. ..+.|++.+|+||||+++
T Consensus 229 -G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~ 271 (1317)
T KOG0612|consen 229 -GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFM 271 (1317)
T ss_pred -CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHH
Confidence 3344556679999999998842 135689999999999974
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=219.06 Aligned_cols=192 Identities=35% Similarity=0.524 Sum_probs=156.9
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
+...++|++++.||.|++|.||++.+..++..+++|.+..... .......+.+|+.+++.++|+||+++.+.+.....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 3467789999999999999999999998999999998754321 12233457789999999999999999998853221
Q ss_pred ----ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 113 ----QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 113 ----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
..++++|++++++|.+++.. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||++
T Consensus 89 ~~~~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 89 LDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccceEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 24689999998888877754 46899999999999999999999999999999999999999999999999998
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... ......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 166 ~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll 206 (343)
T cd07880 166 RQTDS-----EMTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIM 206 (343)
T ss_pred ccccc-----CccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHH
Confidence 75431 12233467789999988652 2478899999999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=215.29 Aligned_cols=190 Identities=25% Similarity=0.393 Sum_probs=154.1
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||.|++|.||++.+..+++.+++|.++.... ......+.+|+..+.+++|+|++++++.+. ..+.++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD---ESKFNQIIMELDILHKAVSPYIVDFYGAFF--IEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC---HHHHHHHHHHHHHHHhcCCCcHHhhhhhee--cCCeEE
Confidence 368999999999999999999988999999998864321 122346788999999999999999999884 566899
Q ss_pred EEEecccC-CHHHHhhcCC-CCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 117 LIMEYCVG-GLQDMLDSTP-YKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
++|||+++ +|..++.... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+..+..
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 99999976 5776665431 2478999999999999999999997 5999999999999999999999999999875431
Q ss_pred cccCCcccccCCCCcccCccccCCCC----CCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLP----EISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+.. ..++.++|+||||+++
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 197 (286)
T cd06622 156 ----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSI 197 (286)
T ss_pred ----CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHH
Confidence 1222334677899999885422 1357899999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=215.08 Aligned_cols=192 Identities=32% Similarity=0.533 Sum_probs=159.6
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCCceE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 115 (235)
++|.+.+.||+|++|.||++.+..+++.+++|++....... ......+..|+.++.++. |+|++++++.+ ......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~--~~~~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-EKKVKYVKIEKEVLTRLNGHPGIIKLYYTF--QDEENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc-hHHHHHHHHHHHHHHhcccCCCchhHHHHh--cCCceE
Confidence 47999999999999999999998899999999987654332 233356788999999998 99999999998 556688
Q ss_pred EEEEecc-cCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYC-VGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++||++ .++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.+++++++|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999 56799888765 47999999999999999999999999999999999999999999999999998765422
Q ss_pred ccC------------------CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHD------------------DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... .......++..|+|||...+ ..++.++|+||||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l 212 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCII 212 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHH
Confidence 211 11122345678999999877 4488899999999864
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=218.00 Aligned_cols=190 Identities=35% Similarity=0.511 Sum_probs=154.9
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC----
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND---- 110 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 110 (235)
..++|++.+.||+|+||.||++.+..+++.+|+|.+...... ......+.+|+.++.+++|+||+++.+.+...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh--hHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 447899999999999999999999889999999988653221 12234577899999999999999999987422
Q ss_pred CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 111 KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 111 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
....+++++++++++|.+.+.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccccEEEEehhcccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 1235789999998888877764 4589999999999999999999999999999999999999999999999999874
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... ......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 170 ~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il 208 (345)
T cd07877 170 TDD-----EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIM 208 (345)
T ss_pred ccc-----cccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHH
Confidence 431 12234567789999987551 2478899999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=213.41 Aligned_cols=187 Identities=33% Similarity=0.525 Sum_probs=155.5
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
..|+..+.||.|++|.||.+.+..+++.+++|++...... .....+.+|+..+..+.|+|++++++.+. ....++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYL--KGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCEEE
Confidence 4688889999999999999999888999999988654321 22346788999999999999999999994 556899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++||++++ +|.+++.. .+++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++++|||++......
T Consensus 79 lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 154 (277)
T cd06640 79 IIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT- 154 (277)
T ss_pred EEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC-
Confidence 99999975 68887764 46788899999999999999999999999999999999999999999999999755321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 -~~~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il 191 (277)
T cd06640 155 -QIKRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITA 191 (277)
T ss_pred -ccccccccCcccccCHhHhcc--CCCccHHHHHHHHHHH
Confidence 111222346778999999877 4488999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=209.12 Aligned_cols=184 Identities=27% Similarity=0.443 Sum_probs=154.3
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.+.|++.+.||.|++|.||++.. .++.+++|.++.... ....+.+|+.++..++|+|++++++.+. .....
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~ 75 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-----AAQAFLAEASVMTTLRHPNLVQLLGVVL--QGNPL 75 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-----HHHHHHHHHHHHHhcCCcceeeeEEEEc--CCCCe
Confidence 45789999999999999999986 478899998864432 3456889999999999999999999984 45678
Q ss_pred EEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++||+++ ++|.+++.......+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~- 154 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ- 154 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc-
Confidence 99999997 5799988776545789999999999999999999999999999999999999999999999999875421
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......+..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 ----~~~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il 189 (256)
T cd05039 155 ----GQDSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILL 189 (256)
T ss_pred ----ccccCCCcccccCchhhcC--CcCCcHHHHHHHHHHH
Confidence 1112234567999999876 4588899999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=210.37 Aligned_cols=183 Identities=26% Similarity=0.369 Sum_probs=145.5
Q ss_pred eeccccceEEEEeec--cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEec
Q psy787 44 LLGEGSYGKVKEMLD--SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 44 ~ig~g~~~~v~~~~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
.||+|+||.||++.. ..+++.+++|+++..... ......+..|+.++..+.|+||+++++.+ . ...++++||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~-~~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIVRMIGIC--E-AESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc--HHHHHHHHHHHHHHHhCCCCCcceEEEEE--c-CCCcEEEEec
Confidence 589999999999853 456788999987644321 23345678899999999999999999987 3 3457899999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCC-c
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDD-T 199 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-~ 199 (235)
+++ +|.+++... ..+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||++.......... .
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 975 588888654 568999999999999999999999999999999999999999999999999997553221111 1
Q ss_pred ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 200 ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 200 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.....++..|+|||.+.. ..++.++|+||||+++
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 188 (257)
T cd05116 155 KTHGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLM 188 (257)
T ss_pred cCCCCCCccccCHhHhcc--CCcCchhHHHHHHHHH
Confidence 112223467999999876 4488899999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=209.94 Aligned_cols=185 Identities=30% Similarity=0.407 Sum_probs=149.8
Q ss_pred eeeccccceEEEEeeccc-hhh--heeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEE
Q psy787 43 DLLGEGSYGKVKEMLDSE-TLC--RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIM 119 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~-~~~--~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 119 (235)
+.||+|++|.||++.+.. .++ .+++|.+...... .....+.+|+..+.+++|+|++++++.+.. ..+++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence 468999999999998755 332 5888888665432 344568899999999999999999999853 6789999
Q ss_pred eccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCC
Q psy787 120 EYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDD 198 (235)
Q Consensus 120 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 198 (235)
|+++ ++|.+.+.......+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++..+.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 9996 579988877643568999999999999999999999999999999999999999999999999998664211111
Q ss_pred -cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 199 -TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 199 -~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+.+ ..++.++||||||+++
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l 190 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTL 190 (257)
T ss_pred ecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHH
Confidence 1112345678999999877 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=224.31 Aligned_cols=183 Identities=33% Similarity=0.523 Sum_probs=157.2
Q ss_pred eeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEeccc
Q psy787 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCV 123 (235)
Q Consensus 44 ~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 123 (235)
.||.|.+|+||-+++..+....|+|-+..+. ....+-+..|+..-++++|.||+++.|.+ ..++++-|.||..+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD----SREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQVP 655 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc----chhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecCC
Confidence 5899999999999999998888888765443 34556688999999999999999999998 67779999999997
Q ss_pred C-CHHHHhhcCCCCCC--CHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc-CCcEEEeeeccccccCccccCCc
Q psy787 124 G-GLQDMLDSTPYKKF--PIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL-DGTLKISDFGVAESLDMFLHDDT 199 (235)
Q Consensus 124 ~-~l~~~~~~~~~~~~--~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~~~~~~~~ 199 (235)
| +|.+++++. .+++ ++..+..+.+||++||.|||.+.|||||||-+|++|.- .|.+||+|||.++.+.+ .++.
T Consensus 656 GGSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~ 732 (1226)
T KOG4279|consen 656 GGSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPC 732 (1226)
T ss_pred CCcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcc
Confidence 6 577777643 4666 77788889999999999999999999999999999974 48899999999997753 3455
Q ss_pred ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 200 ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 200 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..+..||.-|||||++...+..|+.++|||||||.+
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~ 768 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTM 768 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhcccee
Confidence 667779999999999988788899999999999974
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=210.13 Aligned_cols=194 Identities=28% Similarity=0.471 Sum_probs=155.6
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCC--
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDK-- 111 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-- 111 (235)
..++|.+.+.||+|++|.||++.+..+++.+++|++.... .....+.+|+.++.++ +|+|++++++.+....
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 4678999999999999999999998899999999886432 2233567899999988 7999999999986432
Q ss_pred -CceEEEEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 112 -KQKMYLIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 112 -~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
...+++++||+++ +|.+++... ....+++..++.++.|++.||++||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 2468999999965 687776532 235688999999999999999999999999999999999999999999999999
Q ss_pred ccccCccccCCcccccCCCCcccCccccCCCC---CCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGLP---EISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~~Di~slG~~l 235 (235)
+....... .......++..|+|||.+.... ..++.++|+||||+++
T Consensus 175 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~ 223 (291)
T cd06639 175 SAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITA 223 (291)
T ss_pred chhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHH
Confidence 87553211 1122334678899999875422 1267899999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=214.25 Aligned_cols=187 Identities=24% Similarity=0.391 Sum_probs=156.5
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++++.||+|++|+||++.+..+++.+++|++..... ......+.+|+.++..++|+|++++++.+. ....+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK---SSVRKQILRELQIMHECRSPYIVSFYGAFL--NENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc---chHHHHHHHHHHHHHHcCCCCcceEeeeEe--cCCEE
Confidence 3579999999999999999999988899999998765421 233456889999999999999999999994 45688
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+++|||+++ +|.+++... +.++...+..++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999976 577777654 568999999999999999999997 5899999999999999999999999998864421
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 157 ----~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l 192 (284)
T cd06620 157 ----SIADTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISI 192 (284)
T ss_pred ----hccCccccCcccCCHHHHcc--CCCCccchHHHHHHHH
Confidence 11223457888999999876 4588999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=213.40 Aligned_cols=188 Identities=34% Similarity=0.513 Sum_probs=154.5
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
.|...++||.|++|+||++.+..+++.+++|.+....... ......+.+|+..++.++|+|++++.+.+. .....++
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~l 98 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT-NEKWQDIIKEVKFLQQLKHPNTIEYKGCYL--KEHTAWL 98 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHHhCCCCCCccEEEEEE--eCCEEEE
Confidence 3677788999999999999998899999999886543322 223345778999999999999999999994 4567899
Q ss_pred EEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC
Q psy787 118 IMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 118 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 197 (235)
+|||+.+++.+.+.... .++++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 99 v~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----- 172 (313)
T cd06633 99 VMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----- 172 (313)
T ss_pred EEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----
Confidence 99999988888776543 568899999999999999999999999999999999999999999999999886321
Q ss_pred CcccccCCCCcccCccccCC-CCCCCCCcccEEEeeeeC
Q psy787 198 DTITTSQGSPVFQAPEIANG-LPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+.. ....++.++|+||||+++
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil 210 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 210 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHH
Confidence 1223457788999999742 124578899999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=218.62 Aligned_cols=192 Identities=28% Similarity=0.471 Sum_probs=153.9
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC---
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK--- 112 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 112 (235)
.++|++.+.||.|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.++|+|++++++.+.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 4799999999999999999999999999999998865542 333457889999999999999999987643221
Q ss_pred ---------ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc-CCcEEE
Q psy787 113 ---------QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL-DGTLKI 182 (235)
Q Consensus 113 ---------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~-~~~~~l 182 (235)
...++++||++++|.+.+.. ..+++..++.++.|+++||.|||+.|++|+||+|+||+++. ++.+++
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccccceEEEEeecccccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 35789999999888877754 46889999999999999999999999999999999999975 457899
Q ss_pred eeeccccccCccccCC-cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 183 SDFGVAESLDMFLHDD-TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 183 ~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|||.+..+....... ......++..|.|||.+.+ +..++.++||||||+++
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwSlGvil 209 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIF 209 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhC-ccccCchhhHHHHHHHH
Confidence 9999987553211111 1112246778999998754 23478899999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=214.64 Aligned_cols=193 Identities=22% Similarity=0.318 Sum_probs=152.0
Q ss_pred eceEEeeeeeccccceEEEEeecc-----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDS-----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
.++|++.+.||.|+||.||++.+. .++..+++|++..... ......+.+|+..+..+.|+|++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~ei~~l~~l~h~~iv~~~~~~--~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEFDHPNIVKLLGVC--A 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC---HHHHHHHHHHHHHHHhcCCCchheEEEEE--c
Confidence 457999999999999999999864 3567889998764321 12334588899999999999999999998 4
Q ss_pred CCceEEEEEecccC-CHHHHhhcCC--------------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCC
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDSTP--------------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKP 169 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~~--------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p 169 (235)
.....++++|++++ +|.+++.... ...++...++.++.|++.||.+||+.+++|+||+|
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 55578999999975 6888886431 12467788899999999999999999999999999
Q ss_pred CCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 170 GNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 170 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+||+++.++.++|+|||++.................+..|+|||...+ ..++.++|+||||+++
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il 222 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVL 222 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHH
Confidence 999999999999999999875432111111112224556999999877 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=208.57 Aligned_cols=184 Identities=27% Similarity=0.384 Sum_probs=148.1
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecc
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYC 122 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 122 (235)
++||.|++|.||++.+.. ++.+++|.+...... +....+.+|+.+++.+.|+||+++++.+ ......++++|++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPNIVKLIGVC--VQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeEEEEEEE--ecCCCeEEEEEcC
Confidence 468999999999999877 899999987654332 2344688999999999999999999998 4556789999999
Q ss_pred cC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccc
Q psy787 123 VG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT 201 (235)
Q Consensus 123 ~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 201 (235)
++ +|.+++.... ..++...+..++.+++.++.+||+++++|+||+|+||+++.++.++|+|||.+.............
T Consensus 75 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 75 PGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 65 6888876543 467888999999999999999999999999999999999999999999999987543211111111
Q ss_pred ccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 202 TSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 202 ~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....+..|+|||.+.+ ..++.++|+||||+++
T Consensus 154 ~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~ 185 (251)
T cd05041 154 LKQIPIKWTAPEALNY--GRYTSESDVWSYGILL 185 (251)
T ss_pred cCcceeccCChHhhcc--CCCCcchhHHHHHHHH
Confidence 2223456999999877 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=209.31 Aligned_cols=183 Identities=24% Similarity=0.391 Sum_probs=144.0
Q ss_pred eeccccceEEEEeecc--chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEec
Q psy787 44 LLGEGSYGKVKEMLDS--ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 44 ~ig~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
.||.|+||.||++... ..+..+++|+...... ......+.+|+.++++++|+||+++++.+ + ...++++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~~E~~~l~~l~h~~ii~~~~~~--~-~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIVRMIGVC--E-AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC---hHHHHHHHHHHHHHHhcCCCCeEEEEEEE--c-CCCeEEEEEe
Confidence 3899999999998654 3455688988764421 23345688999999999999999999987 3 3467999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCc-
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT- 199 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~- 199 (235)
+++ +|.+++.... ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++...........
T Consensus 76 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 76 ASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 975 6888776432 5789999999999999999999999999999999999999999999999999875532211111
Q ss_pred ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 200 ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 200 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......+..|+|||.+.+ ..++.++||||||+++
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 188 (257)
T cd05115 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITM 188 (257)
T ss_pred cCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHH
Confidence 111223467999999876 4488899999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=209.23 Aligned_cols=189 Identities=30% Similarity=0.418 Sum_probs=153.6
Q ss_pred EEeeeeeccccceEEEEeeccchh----hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETL----CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
+++.+.||.|+||.||++.+...+ ..+++|+++..... .....+..|+..+..+.|+|++++++.+. ....
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE---QQIEEFLREARIMRKLDHPNIVKLLGVCT--EEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh---HHHHHHHHHHHHHHhcCCCchheEEEEEc--CCCe
Confidence 357789999999999999987765 88999988544321 14456889999999999999999999994 4468
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.+++||++++ +|.+++.......+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 8999999975 788888765433389999999999999999999999999999999999999999999999999875532
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... .......++..|+|||...+ ..++.++|+||||+++
T Consensus 156 ~~~-~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~ 194 (258)
T smart00219 156 DDY-YKKKGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLL 194 (258)
T ss_pred ccc-cccccCCCcccccChHHhcc--CCCCcchhHHHHHHHH
Confidence 211 11112235678999999866 5589999999999874
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=211.17 Aligned_cols=188 Identities=31% Similarity=0.491 Sum_probs=155.1
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCCceEEE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~l 117 (235)
|++.+.||.|++|+||+|....+++.+++|.+...... .......+|+..+.+++ |+|++++++.+ ......++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVKLKEVF--RENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCCchhHHHHh--hcCCcEEE
Confidence 67889999999999999999888899999987654321 12223457888899998 99999999998 44678899
Q ss_pred EEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC
Q psy787 118 IMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 118 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 197 (235)
+||+++++|.+.+.......+++..+..++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||.+..... .
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~---~ 152 (283)
T cd07830 76 VFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---R 152 (283)
T ss_pred EEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC---C
Confidence 9999988898888776545789999999999999999999999999999999999999999999999999875532 1
Q ss_pred CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 198 DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l 189 (283)
T cd07830 153 PPYTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIM 189 (283)
T ss_pred CCcCCCCCcccccCceeeecC-cCcCCccchhhHHHHH
Confidence 122234467789999987542 3478899999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=207.17 Aligned_cols=192 Identities=36% Similarity=0.594 Sum_probs=160.9
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|.+.+.||+|++|.||++.+..+++.+++|++...... ......+.+|+..++++.|+|++++++.+.......+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 478889999999999999999889999999998765432 234557889999999999999999999995443368899
Q ss_pred EEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++|+++ ++|.+++... ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 79 FLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999995 5788888765 3789999999999999999999999999999999999999999999999999986643221
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|.|||...+ ..++.++|+||||+++
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il 193 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTV 193 (260)
T ss_pred cccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHH
Confidence 111334557788999999977 3488999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=214.18 Aligned_cols=189 Identities=31% Similarity=0.491 Sum_probs=155.0
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
..|...+.||+|+||.||++.+..++..+++|.+....... .+....+.+|+..++.++|+|++++.+.+. .....+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~ 101 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS-NEKWQDIIKEVKFLQRIKHPNSIEYKGCYL--REHTAW 101 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc-hHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--eCCeEE
Confidence 34788899999999999999998889999999876543222 233346788999999999999999999984 455789
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++|||+.+++.+.+.... .++++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus 102 lv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~---- 176 (317)
T cd06635 102 LVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS---- 176 (317)
T ss_pred EEEeCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC----
Confidence 999999988877765432 568999999999999999999999999999999999999999999999999886432
Q ss_pred CCcccccCCCCcccCccccCC-CCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANG-LPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+.. .....+.++|+||||+++
T Consensus 177 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil 214 (317)
T cd06635 177 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 214 (317)
T ss_pred --CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHH
Confidence 1223347778999998742 124578899999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=215.11 Aligned_cols=191 Identities=21% Similarity=0.324 Sum_probs=149.9
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhh----eeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCR----RAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~----~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
.++|++.+.||+|++|.||++.+..++.. +++|.+..... ......+.+|+.++..+.|+|++++++.+..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG---PKANVEFMDEALIMASMDHPHLVRLLGVCLS-- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--
Confidence 35788999999999999999988777664 46666543221 1223357789999999999999999999842
Q ss_pred CceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...++++++++ |+|.+++.... ..++...++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++..
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 24578999997 56888876542 4688889999999999999999999999999999999999999999999999986
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+..............+..|+|||.+.+ ..++.++||||||+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l 201 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTI 201 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHH
Confidence 542211111222334567999999877 4488999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=212.64 Aligned_cols=188 Identities=30% Similarity=0.503 Sum_probs=155.3
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|.+++.||+|++|.||++.+..+++.+++|.+.... ......+.+|+..++.++|||++++++.+. ....
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~ 90 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYL--VGDE 90 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheee--eCCc
Confidence 3579999999999999999999988888999999875332 223346788999999999999999999984 4567
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.++|+||+++ +|.+++.. ..++...+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 8999999975 68887765 3578889999999999999999999999999999999999999999999998864432
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 168 ~--~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll 205 (293)
T cd06647 168 E--QSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMA 205 (293)
T ss_pred c--ccccccccCChhhcCchhhcc--CCCCchhhHHHHHHHH
Confidence 1 112223347778999999876 4478899999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=211.29 Aligned_cols=194 Identities=24% Similarity=0.299 Sum_probs=152.9
Q ss_pred eceEEeeeeeccccceEEEEeeccc----hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSE----TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
.++|++.+.||+|+||.||.+.+.. .+..+++|.+.... .......+.+|+..++.+.|+|++++++.+...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA---SEIQVTLLLQESCLLYGLSHQNILPILHVCIED- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-
Confidence 4689999999999999999998765 25778888765321 123345578899999999999999999988643
Q ss_pred CceEEEEEeccc-CCHHHHhhcCCC------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEee
Q psy787 112 KQKMYLIMEYCV-GGLQDMLDSTPY------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISD 184 (235)
Q Consensus 112 ~~~~~lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~d 184 (235)
....++++++++ ++|.+++..... ..++...++.++.|++.||+|||+.+++|+||+|+||+++.++.++++|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 456789999986 578888765422 4588999999999999999999999999999999999999999999999
Q ss_pred eccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||+++.+.............++..|+|||.+.+ ..++.++||||||+++
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l 209 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLL 209 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHH
Confidence 999975431111111112234567999999877 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=207.61 Aligned_cols=190 Identities=34% Similarity=0.572 Sum_probs=159.4
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|.+.+.||.|++|.||++.+..+++.+++|.+...... ......+..|+..++.++|+|++++.+.+. .....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~--~~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS--EKEREDALNEVKILKKLNHPNIIKYYESFE--EKGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC--hHHHHHHHHHHHHHHhcCCCChhheEEEEe--cCCEEEE
Confidence 588999999999999999999888999999988655432 234456789999999999999999999985 3468899
Q ss_pred EEecccC-CHHHHhhcCC--CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 118 IMEYCVG-GLQDMLDSTP--YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++|++++ +|.+.+.... ...++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 9999975 6888887653 367899999999999999999999999999999999999999999999999999765422
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. .......+++.|+|||...+ ..++.++|+||||+++
T Consensus 157 ~--~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~ 193 (258)
T cd08215 157 V--DLAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVL 193 (258)
T ss_pred c--ceecceeeeecccChhHhcc--CCCCccccHHHHHHHH
Confidence 1 12223457788999999877 4488999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=208.29 Aligned_cols=190 Identities=30% Similarity=0.522 Sum_probs=157.5
Q ss_pred eEEee-eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCceE
Q psy787 38 KYVMG-DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 38 ~y~i~-~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 115 (235)
-|++. +.||+|+++.|-.+....++..+|+|++.+... -.+.++.+|+.++.+. .|+||+.++++| ++...+
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g----HsR~RvfREVe~f~~Cqgh~nilqLiefF--Edd~~F 151 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG----HSRSRVFREVETFYQCQGHKNILQLIEFF--EDDTRF 151 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc----hHHHHHHHHHHHHHHhcCCccHHHHHHHh--cccceE
Confidence 34444 589999999999999999999999999988743 3445688999998887 699999999999 777789
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc---EEEeeecccccc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT---LKISDFGVAESL 191 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~~~ 191 (235)
|+|+|.+.| +|...++.. .-+++.++..+++.++.||.+||.+||.||||||+||+....+. +||+||.+..-.
T Consensus 152 YLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 999999965 688888887 77999999999999999999999999999999999999987765 899999988633
Q ss_pred --Cc---cccCCcccccCCCCcccCccccC---CCCCCCCCcccEEEeeeeC
Q psy787 192 --DM---FLHDDTITTSQGSPVFQAPEIAN---GLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 --~~---~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~~Di~slG~~l 235 (235)
+. +..++...++.|+-.|||||++. +....|+.+.|.||||++|
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIl 281 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVIL 281 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHH
Confidence 21 12233344566777899999863 3335688999999999975
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=217.29 Aligned_cols=193 Identities=30% Similarity=0.476 Sum_probs=159.1
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC---Cce
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK---KQK 114 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~ 114 (235)
+|++.+.||.|++|.||++.+..+++.+++|.+..... .......+.+|+..++.++|+|++++.+++.... ...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc--cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 58999999999999999999988899999998875432 1234456889999999999999999999885332 236
Q ss_pred EEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 115 MYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 115 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++++|++++++|.+.+... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~lv~e~~~~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 79 VYIVTELMETDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred eEEEecchhhhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 8999999998888888765 47899999999999999999999999999999999999999999999999999865432
Q ss_pred cc-CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LH-DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........++..|+|||.+.+.. .++.++|+||||+++
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~il 197 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSS-RYTKAIDIWSVGCIF 197 (330)
T ss_pred ccccccccccccccCcCCceeeeccc-CCCcchhHHHHHHHH
Confidence 11 01122334677899999997731 588999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=214.26 Aligned_cols=191 Identities=27% Similarity=0.398 Sum_probs=147.7
Q ss_pred eEEeeeeeccccceEEEEeeccc-----hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSE-----TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
+|++.+.||.|+||.||++.... ....+++|.+...... .....+.+|+..+..+.||||+++++.+ ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS---SELRDLLSEFNLLKQVNHPHVIKLYGAC--SQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH---HHHHHHHHHHHHHhhCCCCCEeeEEEEE--ecC
Confidence 47889999999999999997643 2245777766533211 2234578899999999999999999998 455
Q ss_pred ceEEEEEeccc-CCHHHHhhcCC----------------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCC
Q psy787 113 QKMYLIMEYCV-GGLQDMLDSTP----------------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKP 169 (235)
Q Consensus 113 ~~~~lv~e~~~-~~l~~~~~~~~----------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p 169 (235)
...++++||+. ++|.+++.... ...++...++.++.|++.||.+||+.+++|+||+|
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp 155 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence 67899999997 56888765421 13477889999999999999999999999999999
Q ss_pred CCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 170 GNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 170 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+||++++++.++|+|||++.................+..|+|||...+ ..++.++||||||+++
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l 219 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLL 219 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHH
Confidence 999999999999999999875422111111122234567999998876 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=208.13 Aligned_cols=190 Identities=29% Similarity=0.518 Sum_probs=157.6
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|.+.+.||+|++|.||++.+..++..+++|.+....... .....+.+|+..++.++|+|++++++.+ ......++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~~~h~~i~~~~~~~--~~~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV--KEKEASKKEVILLAKMKHPNIVTFFASF--QENGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc--hhhHHHHHHHHHHHhCCCCChhhhhhee--ccCCeEEE
Confidence 5889999999999999999999899999999886653322 3344678999999999999999999988 55668899
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc-EEEeeeccccccCccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT-LKISDFGVAESLDMFL 195 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~-~~l~dfg~~~~~~~~~ 195 (235)
++|++++ +|.+++.......+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++++|||.+......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~- 155 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS- 155 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC-
Confidence 9999965 7888887665456899999999999999999999999999999999999998864 699999998765421
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||...+ ..++.++|+||||+++
T Consensus 156 -~~~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il 192 (257)
T cd08225 156 -MELAYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVL 192 (257)
T ss_pred -cccccccCCCccccCHHHHcC--CCCCchhhHHHHHHHH
Confidence 112223347788999999876 4488999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=209.59 Aligned_cols=179 Identities=19% Similarity=0.292 Sum_probs=137.9
Q ss_pred eeeccccceEEEEeeccc------------hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 43 DLLGEGSYGKVKEMLDSE------------TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~------------~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
+.||.|++|.||.+.... ....+++|++.... ......+..|+..+..++||||+++++++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-- 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH----RDISLAFFETASMMRQVSHKHIVLLYGVCV-- 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 468999999999997432 22346777654432 233345778889999999999999999985
Q ss_pred CCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc-------EEE
Q psy787 111 KKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT-------LKI 182 (235)
Q Consensus 111 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~-------~~l 182 (235)
.....+++|||++++ |..++... ...+++..++.++.|++.||+|||+.+++|+||||+||+++.++. +++
T Consensus 75 ~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 75 RDVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred cCCCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 445678999999865 55555433 356899999999999999999999999999999999999987664 899
Q ss_pred eeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 183 SDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|||++.... ......++..|+|||.+.. ...++.++||||||+++
T Consensus 154 ~d~g~~~~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l 199 (262)
T cd05077 154 SDPGIPITVL------SRQECVERIPWIAPECVED-SKNLSIAADKWSFGTTL 199 (262)
T ss_pred CCCCCCcccc------CcccccccccccChhhhcC-CCCCCchhHHHHHHHHH
Confidence 9999886432 1122346678999998863 14578899999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=207.45 Aligned_cols=182 Identities=30% Similarity=0.487 Sum_probs=150.0
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.+.|++.+.||+|++|.||++.. +++.+++|.++... ....+.+|+..+..++|+|++++.+.+.. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~ 73 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGL 73 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCc
Confidence 46799999999999999998864 67889999875432 22467899999999999999999999842 246
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++||++++ +|.+++.......++...++.++.|++.|+.+||+.|++||||+|+||+++.++.++|+|||.+.....
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~- 152 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM- 152 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc-
Confidence 899999974 799888766555688999999999999999999999999999999999999999999999999864321
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......+..|+|||.+.+ ..++.++|+||||+++
T Consensus 153 ----~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l 187 (254)
T cd05083 153 ----GVDNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLL 187 (254)
T ss_pred ----cCCCCCCCceecCHHHhcc--CCcCchhhHHHHHHHH
Confidence 1112223467999999876 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=214.86 Aligned_cols=187 Identities=31% Similarity=0.494 Sum_probs=154.5
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
..|++++.||.|++|.||++.+..+++.+++|.+..... ......+.+|+..+..++|+|++++++.+ .....++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYITRYYGSY--LKGTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc---hHHHHHHHHHHHHHHcCCCCccHhhhccc--ccCCceE
Confidence 357788899999999999999988889999998764432 12334688999999999999999999999 4556789
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+|+||+++ +|.+.+.. ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++++|||++..+...
T Consensus 79 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~- 154 (277)
T cd06642 79 IIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT- 154 (277)
T ss_pred EEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc-
Confidence 99999976 57777654 56889999999999999999999999999999999999999999999999998755321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il 191 (277)
T cd06642 155 -QIKRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITA 191 (277)
T ss_pred -chhhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHH
Confidence 111222346778999999977 4488899999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=209.42 Aligned_cols=192 Identities=22% Similarity=0.325 Sum_probs=151.8
Q ss_pred eceEEeeeeeccccceEEEEeeccchhh---heeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLC---RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
.++|+..+.||+|++|.||++.+..+++ .+++|.++.... ......+.+|+..+..++|+|++++.+.+ ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT---EKQRQDFLSEASIMGQFSHHNIIRLEGVV--TKF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC---HHHHHHHHHHHHHHhcCCCCCeeEEEEEE--ccC
Confidence 3578889999999999999998865554 578887754321 22344678899999999999999999998 455
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..++++||++++ +|.+++.... ..+++..+..++.|++.|+++||+.+++|+||+|+||+++.++.++++|||++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 678999999975 6877776543 56899999999999999999999999999999999999999999999999998755
Q ss_pred CccccCCc-ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDT-ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........ ......+..|+|||.+.+ ..++.++|+||||+++
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il 200 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVM 200 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHH
Confidence 32111111 111122356999999876 4478999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=210.13 Aligned_cols=188 Identities=26% Similarity=0.307 Sum_probs=139.6
Q ss_pred eeeccccceEEEEeeccc--hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEe
Q psy787 43 DLLGEGSYGKVKEMLDSE--TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 120 (235)
+.||+|+||.||++.... ....+++|.+.... .......+.+|+..++.++|+||+++++.+ .....++++||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~--~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQC--IESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEE--CCCCceEEEEE
Confidence 358999999999985432 33455666543221 123344578899999999999999999998 45567899999
Q ss_pred cccC-CHHHHhhcCCC---CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 121 YCVG-GLQDMLDSTPY---KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 121 ~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++++ +|.+++..... ...+......++.|++.||+|||+++++||||||+||+++.++.++|+|||++........
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 9975 78888866432 2345677889999999999999999999999999999999999999999999864321111
Q ss_pred CCcccccCCCCcccCccccCCC-----CCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGL-----PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||..... ...++.++||||||+++
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM 199 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHH
Confidence 1111222345679999987431 23468899999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-34 Score=210.23 Aligned_cols=203 Identities=23% Similarity=0.346 Sum_probs=164.4
Q ss_pred eecCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCccee
Q psy787 25 IYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGL 103 (235)
Q Consensus 25 ~~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 103 (235)
..++..+.+-...+.+-+..||.|+||+|++..++.+|+..|+|.++.... ++.+.++..|.....+- ..|||++|
T Consensus 52 ~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkf 128 (361)
T KOG1006|consen 52 LPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKF 128 (361)
T ss_pred cCCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHH
Confidence 344455555556667777899999999999999999999999999876654 46666777787665554 68999999
Q ss_pred eeEEEcCCCceEEEEEecccCC---HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEccCCc
Q psy787 104 VDVFVNDKKQKMYLIMEYCVGG---LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGT 179 (235)
Q Consensus 104 ~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~~~~ 179 (235)
+|..+.++ -.|+.||.+..+ |..++-+-....+++.-+..+.-..+.||.||-.. .|+|||+||+||+++..|.
T Consensus 129 yGa~F~EG--dcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 129 YGALFSEG--DCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhhcCC--ceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC
Confidence 99997544 569999999987 44444444456788888888999999999999865 7999999999999999999
Q ss_pred EEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 180 LKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+||+|||++-.+. .+.......|...|+|||.+..+...+..++|+||||++|
T Consensus 207 vKLCDFGIcGqLv---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL 259 (361)
T KOG1006|consen 207 VKLCDFGICGQLV---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITL 259 (361)
T ss_pred EeeecccchHhHH---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceE
Confidence 9999999886553 3344455668889999999987656699999999999875
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=211.11 Aligned_cols=189 Identities=38% Similarity=0.574 Sum_probs=158.0
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
|++.++||+|++|.||++....+++.+++|++...... ......+..|+..++.+.|+|++++.+.+ .....++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKLLDVI--HTERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc--ccccHHHHHHHHHHHhcCCCCHHHHHhhh--hcCCceEEE
Confidence 67788999999999999999989999999998766521 23345677899999999999999999999 455788999
Q ss_pred EecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCC
Q psy787 119 MEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDD 198 (235)
Q Consensus 119 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 198 (235)
+|+++++|.+++.... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 77 ~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~ 153 (282)
T cd07829 77 FEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--R 153 (282)
T ss_pred ecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc--c
Confidence 9999999999888653 468999999999999999999999999999999999999999999999999987553211 1
Q ss_pred cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 199 TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 199 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......+..|+|||.+.+. ..++.++|+||||+++
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l 189 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIF 189 (282)
T ss_pred ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHH
Confidence 22223356679999998663 2588999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=209.99 Aligned_cols=186 Identities=32% Similarity=0.512 Sum_probs=153.3
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
-|++.+.||.|+||.||++.+..+++.+++|++...... .....+.+|+..+.+++|+|++++++.+. .+...++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYL--KDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHHHhcCCCCEeEEEEEEE--eCCeEEE
Confidence 478889999999999999998888999999987543321 22346788999999999999999999994 5567899
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
||||+++ +|.+++.. ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++..+...
T Consensus 80 v~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~-- 154 (277)
T cd06641 80 IMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-- 154 (277)
T ss_pred EEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc--
Confidence 9999976 57777654 46889999999999999999999999999999999999999999999999988755321
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l 191 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITA 191 (277)
T ss_pred hhhhccccCCccccChhhhcc--CCCCchhhHHHHHHHH
Confidence 111223346778999999876 4478899999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=207.59 Aligned_cols=183 Identities=29% Similarity=0.419 Sum_probs=145.9
Q ss_pred eeeccccceEEEEeeccchh---hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEE
Q psy787 43 DLLGEGSYGKVKEMLDSETL---CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIM 119 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 119 (235)
++||+|++|.||+|.....+ ..+++|.+...... .....+.+|+..++.+.|+|++++++.+ . ...++++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~-~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVC--K-GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEE--c-CCceEEEE
Confidence 46999999999999765444 68899987655432 2344678999999999999999999987 3 33579999
Q ss_pred eccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCC
Q psy787 120 EYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDD 198 (235)
Q Consensus 120 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 198 (235)
|++. ++|.+++... ..+++..++.++.|++.||.+||..+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 75 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 75 ELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred EeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9996 5799988765 468999999999999999999999999999999999999999999999999987553211111
Q ss_pred -cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 199 -TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 199 -~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||...+ ..++.++||||||+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 188 (257)
T cd05060 153 RATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTL 188 (257)
T ss_pred ccccCccccccccCHHHhcC--CCCCccchHHHHHHHH
Confidence 0111112356999999977 4589999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=209.34 Aligned_cols=182 Identities=25% Similarity=0.385 Sum_probs=143.4
Q ss_pred eeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHh---cCCCCcceeeeEEEcCCCceEEEEEe
Q psy787 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM---LQHRNVIGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 44 ~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~---l~h~~i~~~~~~~~~~~~~~~~lv~e 120 (235)
.||+|+||.||++.+..+++.+++|.+........ .....+.++..++.. ..|++++.+.+.+ ...+..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAF--HTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE--ecCCeEEEEEe
Confidence 38999999999999988999999998876544321 112223344443333 3689999999988 44567899999
Q ss_pred cccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCc
Q psy787 121 YCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT 199 (235)
Q Consensus 121 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 199 (235)
|+++ +|.+++... ..+++..+..++.|++.||.+||+.+++|+||||+||+++.++.++++|||++..... ..
T Consensus 78 ~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (279)
T cd05633 78 LMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KK 151 (279)
T ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc----cC
Confidence 9975 587777655 5689999999999999999999999999999999999999999999999999864431 11
Q ss_pred ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 200 ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 200 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.....++..|+|||.... ...++.++|+||||+++
T Consensus 152 ~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l 186 (279)
T cd05633 152 PHASVGTHGYMAPEVLQK-GTAYDSSADWFSLGCML 186 (279)
T ss_pred ccCcCCCcCccCHHHhcC-CCCCCchhhhHHHHHHH
Confidence 223457889999998753 13478899999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=229.37 Aligned_cols=195 Identities=27% Similarity=0.327 Sum_probs=157.4
Q ss_pred EeeeceEEeeeeeccccceEEEEeecc-----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDS-----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
...-.+-+..+.||.|.||+||+++-. +....||||.++.... .+.+++|++|+.++..++|||||+++|+|
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~---~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE---NQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc---HHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 334455677789999999999998753 3456788888876542 24567899999999999999999999999
Q ss_pred EcCCCceEEEEEeccc-CCHHHHhhcCC------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE
Q psy787 108 VNDKKQKMYLIMEYCV-GGLQDMLDSTP------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL 174 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili 174 (235)
. .+..+++|+||+. |+|..++.... ..+++..+.+.++.||+.||.||-++.+|||||..+|.+|
T Consensus 559 ~--~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 559 R--EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred c--cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 5 4567899999996 78999987552 1237888999999999999999999999999999999999
Q ss_pred ccCCcEEEeeeccccccC-ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 175 TLDGTLKISDFGVAESLD-MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 175 ~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++-.+||+|||+++..- .++-.... ...-+.+|||||.+.. +++|.++||||+||+|
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~-~t~lPIRWMppEsIly--~kFTteSDVWs~GVvL 695 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRG-NTLLPIRWMPPESILY--GKFTTESDVWSFGVVL 695 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccC-CceeeeecCCHHHhhc--Ccccchhhhhhhhhhh
Confidence 999999999999998441 11111110 1123567999999988 7799999999999986
|
|
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=238.99 Aligned_cols=195 Identities=33% Similarity=0.570 Sum_probs=164.0
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..-+|+-...||.|.||.||-|....+|...|+|-++.+... .+....+..|.+++..+.|||+++++|+-+ .+.-
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv--HRek 1308 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEV--HREK 1308 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceee--cHHH
Confidence 445788889999999999999999999999999988877765 466667889999999999999999999985 4456
Q ss_pred EEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
++|.||||+ |+|.+++... ...++.....+..|++.|+.|||+.||||||+||.||+++.+|.+|++|||.|..+..
T Consensus 1309 v~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 799999996 5688888775 4466667777889999999999999999999999999999999999999999987743
Q ss_pred ccc--CCcccccCCCCcccCccccCCCCC-CCCCcccEEEeeeeC
Q psy787 194 FLH--DDTITTSQGSPVFQAPEIANGLPE-ISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~--~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~~Di~slG~~l 235 (235)
... ........||+.|||||.+.++.. .-.-++|||||||++
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVV 1431 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVV 1431 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceE
Confidence 321 123335569999999999987653 345699999999984
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=214.08 Aligned_cols=193 Identities=30% Similarity=0.462 Sum_probs=154.3
Q ss_pred eEEeeeeeccccceEEEEeeccch--hhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEc--CCC
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSET--LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVN--DKK 112 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 112 (235)
+|.+.+.||.|+||.||++.+..+ ++.+|+|.+...... ......+.+|+.++.++ .|+||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc--chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 588999999999999999998877 889999987643211 22344577899999998 59999999987532 223
Q ss_pred ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 113 QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 113 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..+++++++++++|.+.+... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++..+.
T Consensus 79 ~~~~~~~e~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 79 NELYLYEELMEADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred CcEEEEEecccCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 467899999999998888654 678999999999999999999999999999999999999999999999999997553
Q ss_pred cccc--CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLH--DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ........++..|+|||.+.+. ..++.++|+||||+++
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l 200 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCIL 200 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHH
Confidence 2111 1112233578889999987541 2478899999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=208.42 Aligned_cols=188 Identities=25% Similarity=0.279 Sum_probs=142.3
Q ss_pred eeeccccceEEEEeecc--chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEe
Q psy787 43 DLLGEGSYGKVKEMLDS--ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 120 (235)
+.||+|+||.||++... .++..+++|.++.... ......+.+|+..+.+++|||++++++.+ .....++++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS---VQEQMKFLEEAQPYRSLQHSNLLQCLGQC--TEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEE--cCCCCcEEEEE
Confidence 35899999999998643 3456678887654331 12233578899999999999999999998 45567899999
Q ss_pred ccc-CCHHHHhhcCC---CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 121 YCV-GGLQDMLDSTP---YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 121 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
|++ ++|.+++.... ....+...+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||.+........
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 997 56888886532 12456677888999999999999999999999999999999999999999999864321111
Q ss_pred CCcccccCCCCcccCccccCCCCC-----CCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPE-----ISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~-----~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+... .++.++|+||||+++
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI 199 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHH
Confidence 111122345677999998854211 357899999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=211.99 Aligned_cols=189 Identities=36% Similarity=0.545 Sum_probs=157.7
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
|++++.||.|++|.||++.+..+++.+++|.+....... .....+..|+..++.++|++++++++.+ ..+..++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE--GIPKTALREIKLLKELNHPNIIKLLDVF--RHKGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc--hhHHHHHHHHHHHHHhcCCCcchHHHhh--ccCCCEEEE
Confidence 577899999999999999998899999999886554321 3345678899999999999999999998 455688999
Q ss_pred EecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCC
Q psy787 119 MEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDD 198 (235)
Q Consensus 119 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 198 (235)
+|++++++.+.+.... ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 77 ~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 77 FEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred EeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 9999999888877643 578999999999999999999999999999999999999999999999999987654221 1
Q ss_pred cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 199 TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 199 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......++..|.|||.+.+. ..++.++|+||||+++
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l 189 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIF 189 (283)
T ss_pred cccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHH
Confidence 12233467789999998763 2588999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=207.78 Aligned_cols=180 Identities=31% Similarity=0.452 Sum_probs=144.5
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHH-HhcCCCCcceeeeEEEcCCCceEEEEEec
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLL-KMLQHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.||.|++|.||+|.+..+++.+++|++........ .....+..|...+ ....|+|++++++.+ ..+..+++++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK-NQVTNVKAERAIMMIQGESPYVAKLYYSF--QSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH-HHHHHHHHHHHHHhhcCCCCCeeeeeeeE--EcCCeEEEEEec
Confidence 578999999999999988999999998865432221 1112234444433 345899999999999 456689999999
Q ss_pred ccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcc
Q psy787 122 CVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (235)
+++ +|.+++... ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++..... .
T Consensus 79 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 79 LNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 965 688888765 5689999999999999999999999999999999999999999999999998864321 2
Q ss_pred cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 201 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....++..|+|||.+.+. .++.++|+||||+++
T Consensus 151 ~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il 183 (260)
T cd05611 151 KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVI 183 (260)
T ss_pred ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHH
Confidence 233467789999998773 488999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=214.79 Aligned_cols=184 Identities=31% Similarity=0.487 Sum_probs=151.3
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
|.....||.|+||.||++.+..+++.+++|++..... .....+.+|+..+..++|||++++++.+. .....+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~iv 96 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYL--VGEELWVL 96 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhhee--eCCeEEEE
Confidence 4455679999999999999988899999999865432 23345788999999999999999999984 45688999
Q ss_pred EecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC
Q psy787 119 MEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 119 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 197 (235)
+|++++ +|.+.+.. ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++..+... .
T Consensus 97 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~ 171 (297)
T cd06659 97 MEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--V 171 (297)
T ss_pred EecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--c
Confidence 999976 57665543 45889999999999999999999999999999999999999999999999988644321 1
Q ss_pred CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 198 DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il 207 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMV 207 (297)
T ss_pred ccccceecCccccCHHHHcc--CCCCchhhHHHHHHHH
Confidence 12223457788999999977 3488999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=222.00 Aligned_cols=200 Identities=25% Similarity=0.313 Sum_probs=161.2
Q ss_pred CCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 28 ~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
...+++---+.-.++++||+|-||.|.+++.. .+.+||+|.++..... ..+..|..|+++|.+++||||+.++++|
T Consensus 529 ~~al~EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~---~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 529 GPALVEFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATK---NARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred CcchhhcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccch---hHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 34455555667889999999999999999864 3589999998776643 3356799999999999999999999999
Q ss_pred EcCCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeec
Q psy787 108 VNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
.. .+.+++++||++ |+|.+++...............++.||++||+||.+.+++|||+.+.|++++.+.++||+|||
T Consensus 605 ~~--DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfg 682 (807)
T KOG1094|consen 605 VQ--DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFG 682 (807)
T ss_pred ec--CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcc
Confidence 63 446899999997 569999988754444555667799999999999999999999999999999999999999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+++.+-.-..-.......-+.+|+|||.+.. +++|.++|+|++|++|
T Consensus 683 msR~lysg~yy~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTl 729 (807)
T KOG1094|consen 683 MSRNLYSGDYYRVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTL 729 (807)
T ss_pred cccccccCCceeeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHH
Confidence 9985521111111112234578999999887 6699999999999864
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=212.28 Aligned_cols=190 Identities=22% Similarity=0.345 Sum_probs=152.2
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCCceEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 116 (235)
.|+..+.||+|++|.||++.+..+++.+++|.+...... .....+.+|+..+.++. |+|++++++.+. .....+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~--~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE---KEQKRLLMDLDVVMRSSDCPYIVKFYGALF--REGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh---HHHHHHHHHHHHHHHhcCCCCEeeeeeEEe--cCCcEE
Confidence 566778899999999999999999999999988654322 33456788999999985 999999999885 445678
Q ss_pred EEEecccCCHHHHhh---cCCCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 117 LIMEYCVGGLQDMLD---STPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 117 lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
++||++++++.++.. ......+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++..+.
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999999887555432 23336789999999999999999999975 99999999999999999999999999987543
Q ss_pred ccccCCcccccCCCCcccCccccCCCC-CCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLP-EISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~slG~~l 235 (235)
. ........++..|+|||.+.+.. ..++.++||||||+++
T Consensus 160 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il 200 (288)
T cd06616 160 D---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITL 200 (288)
T ss_pred c---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHH
Confidence 1 11122334678899999987631 2578899999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=209.20 Aligned_cols=187 Identities=30% Similarity=0.501 Sum_probs=153.8
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC---CCCcceeeeEEEcCCCce
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ---HRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~ 114 (235)
.|++++.||.|++|.||++.+..+++.+++|.+..... ......+.+|+.+++.+. |+|++++++.+. ....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~--~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP---DDDVSDIQREVALLSQLRQSQPPNITKYYGSYL--KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHHHhccCCCCCeeeEeeeee--eCCE
Confidence 57889999999999999999988999999998864321 233345778999998886 999999999984 4567
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
++++||++++ +|.+++.. ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 8999999965 68877754 3688999999999999999999999999999999999999999999999999875542
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .......++..|+|||.+.+ ...++.++|+||||+++
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l 192 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITE-GKYYDTKADIWSLGITI 192 (277)
T ss_pred Cc--cccccccCCcceeCHHHhcc-CCccccchhHHHHHHHH
Confidence 21 22233457788999998764 13468899999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=208.24 Aligned_cols=191 Identities=23% Similarity=0.326 Sum_probs=150.6
Q ss_pred ceEEeeeeeccccceEEEEeeccc-----hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSE-----TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
.+|++++.||.|+||+||+++... ..+.+++|.+.... .......+.+|+.++.+++|+|++++++.+ ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLC--RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEE--CC
Confidence 578999999999999999998643 34567777654322 111335688999999999999999999988 55
Q ss_pred CceEEEEEeccc-CCHHHHhhcCCC-------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEe
Q psy787 112 KQKMYLIMEYCV-GGLQDMLDSTPY-------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKIS 183 (235)
Q Consensus 112 ~~~~~lv~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~ 183 (235)
....+++||+++ ++|.+++..... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence 567899999997 579888876531 268999999999999999999999999999999999999999999999
Q ss_pred eeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|||++...... .........++..|+|||.+.+ ..++.++||||||+++
T Consensus 160 ~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l 208 (275)
T cd05046 160 LLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLM 208 (275)
T ss_pred ccccccccCcc-cccccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHH
Confidence 99988643211 1111122234566999999876 3478899999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=209.41 Aligned_cols=190 Identities=33% Similarity=0.500 Sum_probs=159.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...+.|++.+.||.|++|.||.+.+..+++.+++|++..... ....+.+|+..+..++|+|++++++.+. ...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~ 88 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYL--VGD 88 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEE--ECC
Confidence 456679999999999999999999988899999999875442 3446789999999999999999999995 446
Q ss_pred eEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..++++|+++ ++|.+++.... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 8899999998 57999988753 378999999999999999999999999999999999999999999999999886543
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... .......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 168 ~~~--~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil 206 (286)
T cd06614 168 KEK--SKRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMC 206 (286)
T ss_pred cch--hhhccccCCcccCCHhHhcC--CCCCCccccHHHHHHH
Confidence 211 12223346778999999877 3478999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=206.67 Aligned_cols=187 Identities=22% Similarity=0.287 Sum_probs=138.5
Q ss_pred eeccccceEEEEeeccchh--hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEec
Q psy787 44 LLGEGSYGKVKEMLDSETL--CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 44 ~ig~g~~~~v~~~~~~~~~--~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+||+|+||.||++.....+ ..+++|.+... ........+.+|+..++.++|||++++++.+ ......+++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~--~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQNEFLQQGDPYRILQHPNILQCLGQC--VEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC---CChHHHHHHHHHHHHHhccCCcchhheEEEe--cCCCccEEEEec
Confidence 5899999999998753222 23344443322 2223445788999999999999999999999 455678999999
Q ss_pred ccC-CHHHHhhcCC--CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCC
Q psy787 122 CVG-GLQDMLDSTP--YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDD 198 (235)
Q Consensus 122 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 198 (235)
+++ +|.+++.... ....+...+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++..........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 975 7888887542 2345666788999999999999999999999999999999999999999999875321111111
Q ss_pred cccccCCCCcccCccccCCC-----CCCCCCcccEEEeeeeC
Q psy787 199 TITTSQGSPVFQAPEIANGL-----PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 199 ~~~~~~~~~~~~aPE~~~~~-----~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+... ...++.++||||||+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 198 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTL 198 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHH
Confidence 12234467789999987431 12357799999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=203.98 Aligned_cols=188 Identities=36% Similarity=0.597 Sum_probs=158.4
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|++.+.||+|++|.+|++.+..+++.+++|.+...... ......+.+|+.++.+++|+|++++.+.+. ..+.+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPNIVKYIGSIE--TSDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC--HHHHHHHHHHHHHHHhCCCCCccEEEEEEE--eCCEEEE
Confidence 588999999999999999999888899999998766432 133456889999999999999999999984 4568899
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+++++++ +|.+++... ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (254)
T cd06627 77 ILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS- 153 (254)
T ss_pred EEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc-
Confidence 9999976 688888765 678999999999999999999999999999999999999999999999999998654211
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||...+ ..++.++|+||||+++
T Consensus 154 -~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l 189 (254)
T cd06627 154 -KDDASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTV 189 (254)
T ss_pred -ccccccccchhhcCHhhhcC--CCCCcchhHHHHHHHH
Confidence 11223457788999999877 3388999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=214.78 Aligned_cols=186 Identities=30% Similarity=0.466 Sum_probs=152.7
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
..|.....||.|++|.||++.+..+++.+++|.+.... ......+.+|+..+..++|+|++++++.+. ..+..+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~--~~~~~~ 95 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDMYNSYL--VGDELW 95 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHHHHHHHHHHHHhCCCCcHHHHHHhee--cCCeEE
Confidence 45666678999999999999998889999999875432 223345789999999999999999999984 456889
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++||++++ +|.+++.. ..++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 96 lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (292)
T cd06658 96 VVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE- 171 (292)
T ss_pred EEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc-
Confidence 99999976 57776643 45889999999999999999999999999999999999999999999999998754321
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||...+ ..++.++|+||||+++
T Consensus 172 -~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil 208 (292)
T cd06658 172 -VPKRKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMV 208 (292)
T ss_pred -cccCceeecCccccCHHHHcc--CCCCchhhHHHHHHHH
Confidence 112223457788999999876 4488899999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=209.56 Aligned_cols=193 Identities=26% Similarity=0.400 Sum_probs=155.3
Q ss_pred eEEeeeeeccccceEEEEeecc---chhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCc
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDS---ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (235)
+|++.+.||.|++|.||++.+. .+++.+++|+++.............+.+|+.++.++ .|++++++.+.+ ....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF--QTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee--ecCC
Confidence 4889999999999999998753 467889999987654433334445678899999999 599999999988 5566
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..++||||+++ +|.+.+... ..++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++..+.
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 88999999975 688777654 568899999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .........++..|+|||.+.+.....+.++|+||||+++
T Consensus 157 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il 198 (288)
T cd05583 157 AE-EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198 (288)
T ss_pred cc-cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHH
Confidence 21 1111222346788999999876433478899999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=206.25 Aligned_cols=183 Identities=30% Similarity=0.423 Sum_probs=145.6
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecc
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYC 122 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 122 (235)
+.||+|++|.||++... +++.+++|.+..... ......+.+|+..+..++|+|++++++.+. .....+++||++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP---QELKIKFLSEARILKQYDHPNIVKLIGVCT--QRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCCcCeEEEEEe--cCCccEEEEECC
Confidence 36899999999999854 678899998764432 122345788999999999999999999984 455789999999
Q ss_pred cC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccc
Q psy787 123 VG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT 201 (235)
Q Consensus 123 ~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 201 (235)
++ +|.+++.... ..+++..++.++.+++.+|.++|+.|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 75 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~ 152 (250)
T cd05085 75 PGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSG 152 (250)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCC
Confidence 65 6888776543 467899999999999999999999999999999999999999999999999986442111 11111
Q ss_pred ccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 202 TSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 202 ~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....+..|+|||.+.+ ..++.++|+||||+++
T Consensus 153 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll 184 (250)
T cd05085 153 LKQIPIKWTAPEALNY--GRYSSESDVWSYGILL 184 (250)
T ss_pred CCCCcccccCHHHhcc--CCCCchhHHHHHHHHH
Confidence 2233567999999876 4588999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=212.55 Aligned_cols=191 Identities=30% Similarity=0.477 Sum_probs=155.5
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
....|...+.||.|++|.||++++..+++.+++|.+....... ......+.+|+..++.++|+|++++.+++. ....
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 89 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHT 89 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCcccEEEEEE--cCCe
Confidence 4456888899999999999999998889999999876432221 223345778999999999999999999985 4567
Q ss_pred EEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 115 MYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 115 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
.++++|++.+++.+.+.... .+++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 90 ~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 90 AWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred eEEEEEccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence 89999999988877775443 5688999999999999999999999999999999999999999999999998874431
Q ss_pred ccCCcccccCCCCcccCccccCCC-CCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGL-PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 235 (235)
.....++..|+|||.+.+. ....+.++||||||+++
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il 204 (308)
T cd06634 168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204 (308)
T ss_pred -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHH
Confidence 1233467789999987431 23478899999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=212.92 Aligned_cols=191 Identities=30% Similarity=0.506 Sum_probs=160.2
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
+...-..-|-|+++||.|++|.||+|.++.+|..+|+|.+.. ..+.+++..|+.++++.+.++++++|+.|+-.
T Consensus 27 L~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~ 100 (502)
T KOG0574|consen 27 LNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH 100 (502)
T ss_pred hcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc------cchHHHHHHHHHHHHHcCCchhhhhhhhhccC
Confidence 333334458899999999999999999999999999986532 24556789999999999999999999988733
Q ss_pred CCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 111 KKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 111 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
..+|||||||+ |+..+.++.++ +++++.++..+++.-+++|+|||...-+|||||..||++.-+|..+|.|||.+-
T Consensus 101 --sDLWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAG 177 (502)
T KOG0574|consen 101 --SDLWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAG 177 (502)
T ss_pred --CceEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccc
Confidence 35899999996 67888777654 889999999999999999999999999999999999999999999999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeee
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 234 (235)
.+.. ....-....||+-|+|||++.. -.|...+||||||+.
T Consensus 178 QLTD--TMAKRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGIT 218 (502)
T KOG0574|consen 178 QLTD--TMAKRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGIT 218 (502)
T ss_pred hhhh--hHHhhCccccCcccccHHHHHH--hccchhhhHhhhcch
Confidence 6531 1222234459999999999966 338889999999975
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=207.40 Aligned_cols=183 Identities=27% Similarity=0.426 Sum_probs=143.0
Q ss_pred eeeccccceEEEEeeccchhhh--eeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCceEEEEE
Q psy787 43 DLLGEGSYGKVKEMLDSETLCR--RAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKMYLIM 119 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~--~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~ 119 (235)
+.||.|++|.||++.+..++.. +++|.++... .......+.+|+..+.++ .|||++++++.+ .....++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC---CHHHHHHHHHHHHHHHhhccCCCeeeEEEEE--ecCCCceEEE
Confidence 3589999999999998777654 4666654321 123344678899999999 799999999999 4556789999
Q ss_pred eccc-CCHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEee
Q psy787 120 EYCV-GGLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISD 184 (235)
Q Consensus 120 e~~~-~~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~d 184 (235)
|+++ ++|.+++.... ...++...++.++.|++.||+|||+.|++|+||||+||+++.++.++++|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECC
Confidence 9996 57988886542 13478889999999999999999999999999999999999999999999
Q ss_pred eccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||++..... .........+..|+|||.+.. ..++.++|+||||+++
T Consensus 156 fgl~~~~~~---~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il 201 (270)
T cd05047 156 FGLSRGQEV---YVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLL 201 (270)
T ss_pred CCCccccch---hhhccCCCCccccCChHHHcc--CCCCchhhHHHHHHHH
Confidence 998853221 111111223456999999876 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=206.84 Aligned_cols=182 Identities=25% Similarity=0.364 Sum_probs=143.5
Q ss_pred eeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHH---HHHhcCCCCcceeeeEEEcCCCceEEEEEe
Q psy787 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR---LLKMLQHRNVIGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 44 ~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 120 (235)
.||.|++|.||++.+..+++.+|+|++.+...... .....+..|.. .+....|++++.+.+.+ .....++++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAF--HTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeee--ecCCEEEEEEe
Confidence 37999999999999988999999999876543321 11112233333 34445799999999998 55668899999
Q ss_pred cccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCc
Q psy787 121 YCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT 199 (235)
Q Consensus 121 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 199 (235)
|+.| +|..++... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++..+.. ..
T Consensus 78 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----~~ 151 (278)
T cd05606 78 LMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KK 151 (278)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----cC
Confidence 9975 577777654 5789999999999999999999999999999999999999999999999999875432 11
Q ss_pred ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 200 ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 200 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.....++..|+|||.+.+. ..++.++|+||+|+++
T Consensus 152 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l 186 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCML 186 (278)
T ss_pred CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHH
Confidence 2234578899999998641 2478899999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=208.14 Aligned_cols=184 Identities=34% Similarity=0.507 Sum_probs=151.3
Q ss_pred eccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecccC
Q psy787 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVG 124 (235)
Q Consensus 45 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 124 (235)
||.|++|.||++++..+++.+++|++....... ......+.+|+..+.+++|+|++++++.+ ......++++|++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR-KNQVDQVLTERDILSQAQSPYVVKLYYSF--QGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh-hhHHHHHHHHHHHHHhCCCcchhHHHHhe--ecCcEEEEEEecCCC
Confidence 588999999999998889999999886654322 23445678899999999999999999988 556788999999975
Q ss_pred -CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc------C
Q psy787 125 -GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH------D 197 (235)
Q Consensus 125 -~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~------~ 197 (235)
+|.+++... ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 78 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 78 GDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 788888765 4789999999999999999999999999999999999999999999999998874421111 1
Q ss_pred CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 198 DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......++..|+|||.... ...+.++|+||||+++
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~ 191 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCIL 191 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHH
Confidence 12223446778999999877 3488899999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=204.80 Aligned_cols=187 Identities=24% Similarity=0.351 Sum_probs=150.6
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
..|++.+.||.|++|.||++.+. .+..+++|.+..... ....+.+|++.++++.|++++++++.+ .....++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~ 75 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVC--TERSPIC 75 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEE--ccCCceE
Confidence 47899999999999999999774 467889997754322 234588999999999999999999998 4556789
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+++|++.+ +|.+++.... ..+++..++.++.|++.++++||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 99999975 6887776543 467889999999999999999999999999999999999999999999999887442111
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ........+..|+|||.+.+ ..++.++|+||||+++
T Consensus 155 ~-~~~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l 191 (256)
T cd05112 155 Y-TSSTGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLM 191 (256)
T ss_pred c-cccCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHH
Confidence 1 11112224467999999876 4588999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=206.27 Aligned_cols=190 Identities=24% Similarity=0.357 Sum_probs=149.8
Q ss_pred eceEEeeeeeccccceEEEEeeccch---hhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSET---LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
..+|.+.+.||.|++|.||++.+... ...+++|....... ....+.+.+|+..++.+.|+|++++++.+. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~- 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS---PSVREKFLQEAYIMRQFDHPHIVKLIGVIT--E- 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCchhceeEEEc--C-
Confidence 45799999999999999999986543 34577776654331 233446889999999999999999999883 3
Q ss_pred ceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
...+++||+++ ++|.+++.... ..++...++.++.+++.||.+||+.+++|+||+|+||+++.++.++++|||++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 35689999996 46988886643 45899999999999999999999999999999999999999999999999998755
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... .........+..|+|||.+.. ..++.++||||||+++
T Consensus 158 ~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 198 (270)
T cd05056 158 EDES-YYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCM 198 (270)
T ss_pred cccc-ceecCCCCccccccChhhhcc--CCCCchhhhHHHHHHH
Confidence 3211 111112223457999999876 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=207.15 Aligned_cols=178 Identities=20% Similarity=0.281 Sum_probs=143.4
Q ss_pred eeeccccceEEEEeeccchh----------hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 43 DLLGEGSYGKVKEMLDSETL----------CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~----------~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
+.||+|+||.||++.+..++ ..+++|++..... ....+.+|+.+++.+.|+|++++++.+..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR-----DSLAFFETASLMSQLSHKHLVKLYGVCVR--- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh-----hHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence 46899999999999987665 2356665543321 14568899999999999999999999853
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-------cEEEee
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-------TLKISD 184 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-------~~~l~d 184 (235)
...++++||+++ +|.+++.... ..++...+..++.|++.||.|||+.+++|+||||+||+++.++ .++++|
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 456899999975 5888777653 3688999999999999999999999999999999999999887 799999
Q ss_pred eccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||++..... .....++..|+|||.+.+....++.++|+||||+++
T Consensus 152 fg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~ 196 (259)
T cd05037 152 PGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTL 196 (259)
T ss_pred CCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHH
Confidence 999875431 222345667999999877423588999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=232.90 Aligned_cols=192 Identities=26% Similarity=0.384 Sum_probs=154.4
Q ss_pred eceEEeeeeeccccceEEEEeeccch-hh----heeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSET-LC----RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~-~~----~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
..+-+..+.||+|.||.||.+..... +. .||+|.+++... ......|.+|..++..+.||||++++|+++.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~---~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~- 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS---EQEVSDFLKEALLMSKFDHPNIVSLIGVCLD- 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC---HHHHHHHHHHHHHHhcCCCcceeeEEEeecC-
Confidence 44567788999999999999875433 22 266666544332 3556679999999999999999999999975
Q ss_pred CCceEEEEEecccC-CHHHHhhcCC-----CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEee
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDSTP-----YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISD 184 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~d 184 (235)
....+|++|||++ +|..++++.. ...++..+.+.++.+++.||+||+++.++||||..+|+|++....+||+|
T Consensus 767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred -CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 5567999999975 6999998773 25688899999999999999999999999999999999999999999999
Q ss_pred ecccc-ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAE-SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~-~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||+|+ ..+......... ..-...|||||.+.. +.+|.++||||||++|
T Consensus 846 FGlArDiy~~~yyr~~~~-a~lPvkWm~PEsl~d--~iFtskSDvWsFGVll 894 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGE-AMLPVKWMPPESLKD--GIFTSKSDVWSFGVLL 894 (1025)
T ss_pred cchhHhhhhchheeccCc-cccceecCCHHHHhh--cccccccchhhhHHHH
Confidence 99998 333222222222 123356999999987 7799999999999975
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=212.39 Aligned_cols=197 Identities=26% Similarity=0.379 Sum_probs=153.9
Q ss_pred CceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEE
Q psy787 29 KTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFV 108 (235)
Q Consensus 29 ~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (235)
.-++-.+.++.++++.||+|.||.||++.. .|+.||||++.......+. =+.|+....-++|+||+.|+..=.
T Consensus 203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWf-----rEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWF-----RETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred hHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhh-----hHHHHHHHHHhccchhhhhhhccc
Confidence 334555677899999999999999999988 4889999998765433221 134555555569999999996543
Q ss_pred --cCCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCeEEccC
Q psy787 109 --NDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ--------GIIHKDIKPGNLLLTLD 177 (235)
Q Consensus 109 --~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--------~i~H~dl~p~nili~~~ 177 (235)
.+..-++|+|++|.+ |+|.|++.. ..++....++++..+++||++||.. +|.|||||.+||++..+
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 122246899999996 789999988 5689999999999999999999954 49999999999999999
Q ss_pred CcEEEeeeccccccCcccc--CCcccccCCCCcccCccccCCCCCC--C--CCcccEEEeeeeC
Q psy787 178 GTLKISDFGVAESLDMFLH--DDTITTSQGSPVFQAPEIANGLPEI--S--GYKVDIWSSGVTL 235 (235)
Q Consensus 178 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~--~--~~~~Di~slG~~l 235 (235)
+.+.|+|+|+|...+.... .......+||++|||||++..+-.. + -..+||||||+++
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl 416 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL 416 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence 9999999999986644322 2344567799999999999653211 1 1479999999874
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=206.09 Aligned_cols=178 Identities=26% Similarity=0.372 Sum_probs=145.3
Q ss_pred ceEEeeeee--ccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCc
Q psy787 37 GKYVMGDLL--GEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 37 ~~y~i~~~i--g~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (235)
+.|.+.+.+ |.|+||.||++.+..++..+++|++....... . |+.....+ +|+|++++++.+. ...
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~--e~~~~~~~~~h~~iv~~~~~~~--~~~ 82 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------I--EPMVHQLMKDNPNFIKLYYSVT--TLK 82 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------h--hHHHHHHhhcCCCEEEEEEEEe--cCC
Confidence 466777766 99999999999999999999999987553221 1 22222222 7999999999994 455
Q ss_pred eEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-cEEEeeecccccc
Q psy787 114 KMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-TLKISDFGVAESL 191 (235)
Q Consensus 114 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~ 191 (235)
.+++||||++ ++|.+++... ..+++..+..++.|+++||.+||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 8999999996 5799888765 4789999999999999999999999999999999999999988 9999999998754
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .....++..|+|||.+.+ ..++.++|+||||+++
T Consensus 161 ~~------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il 196 (267)
T PHA03390 161 GT------PSCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLT 196 (267)
T ss_pred CC------CccCCCCCcccChhhhcC--CCCCchhhHHHHHHHH
Confidence 31 122357788999999977 4478899999999864
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=206.07 Aligned_cols=185 Identities=32% Similarity=0.460 Sum_probs=149.2
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEec
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
...||+|++|.||++.+..++..+++|.+..... .....+.+|+.++..++|+|++++++.+ .....+++++|+
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~ 86 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQYLGSD--SENGFFKIFMEQ 86 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCH----HHHHHHHHHHHHHHhcCCCCeeeeeeee--ccCCEEEEEEec
Confidence 3579999999999999888889999997764432 2334688999999999999999999998 455688999999
Q ss_pred ccC-CHHHHhhcCCCCCC--CHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc-CCcEEEeeeccccccCccccC
Q psy787 122 CVG-GLQDMLDSTPYKKF--PIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL-DGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 122 ~~~-~l~~~~~~~~~~~~--~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~~~~~~ 197 (235)
+++ +|.+.+.... ..+ +...+..++.|++.||++||+.|++|+||+|+||+++. ++.++|+|||.+..... ..
T Consensus 87 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--~~ 163 (268)
T cd06624 87 VPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--IN 163 (268)
T ss_pred CCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc--CC
Confidence 975 6888887542 334 77888899999999999999999999999999999976 67899999999875432 11
Q ss_pred CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 198 DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......+++.|+|||.+.+....++.++|+||||+++
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl 201 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTI 201 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHH
Confidence 12223347788999999866444578899999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=213.09 Aligned_cols=189 Identities=36% Similarity=0.535 Sum_probs=153.2
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC---
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK--- 111 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 111 (235)
+.++|.+.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+.+++.++|+||+++.+++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS--EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc--ccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 457899999999999999999999888999999988654221 223345778999999999999999999884321
Q ss_pred -CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 -KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 -~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...++++++++..++..... ..++...+..++.|++.||++||+.+++||||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 91 EFQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred CCceEEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 13568999999887766542 3588899999999999999999999999999999999999999999999999874
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... ......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 167 ~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil 205 (342)
T cd07879 167 ADA-----EMTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIM 205 (342)
T ss_pred CCC-----CCCCceeeecccChhhhcCc-cccCchHHHHHHHHHH
Confidence 431 11223456789999988651 2478899999999874
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=202.47 Aligned_cols=186 Identities=37% Similarity=0.632 Sum_probs=157.4
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
.|.+.+.||+|++|.||++.+..+++.+++|.+..... .....+.+|+..++.+.|++++++.+.+. .....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYL--KKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEe--cCCeEEE
Confidence 37888999999999999999988899999998866542 33456889999999999999999999984 4467899
Q ss_pred EEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++|+++ ++|.+++.... ..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 152 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK- 152 (253)
T ss_pred EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc-
Confidence 999998 57888877653 578999999999999999999999999999999999999999999999999987553211
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 153 --~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il 187 (253)
T cd05122 153 --ARNTMVGTPYWMAPEVING--KPYDYKADIWSLGITA 187 (253)
T ss_pred --cccceecCCcccCHHHHcC--CCCCccccHHHHHHHH
Confidence 1234457788999999987 3488999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=206.76 Aligned_cols=196 Identities=31% Similarity=0.457 Sum_probs=164.5
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
....-.+.|..++.||.|.||+|-+++.+.+++.+|+|++++..+.. .+...--..|-++|+..+||++..+-..| .
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia-kdEVAHTlTE~RVL~~~~HPFLt~LKYsF--Q 238 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA-KDEVAHTLTENRVLQNCRHPFLTSLKYSF--Q 238 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee-hHHhhhhhhHHHHHHhccCcHHHHhhhhh--c
Confidence 33445678999999999999999999999999999999999887665 23233345777889999999999888888 6
Q ss_pred CCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 111 KKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 111 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
....+|+||||..|+ |.-.+... ..+++...+-+...|++||.|||+++|++||||.+|.+++.+|++||.|||+++
T Consensus 239 t~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccch
Confidence 777899999999664 66555443 678999999999999999999999999999999999999999999999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.- ..........+|+|.|+|||++.. .-|+.+.|+|.+|+++
T Consensus 317 E~--I~~g~t~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVM 358 (516)
T KOG0690|consen 317 EE--IKYGDTTKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVM 358 (516)
T ss_pred hc--ccccceeccccCChhhcCchhhcc--ccccceeehhhhhHHH
Confidence 32 112344567889999999999988 4499999999999974
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=208.00 Aligned_cols=186 Identities=26% Similarity=0.367 Sum_probs=145.7
Q ss_pred eeeccccceEEEEeeccchh------hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 43 DLLGEGSYGKVKEMLDSETL------CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~------~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
+.||.|++|.||++...... +.+++|.+..... ......+.+|+..++.++|+||+++++.+ ......+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT---DQEKKEFLKEAHLMSNFNHPNIVKLLGVC--LLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc---hhhHHHHHHHHHHHHhcCCCCeeeEeeee--cCCCCeE
Confidence 35899999999999875433 6788887754321 12344678999999999999999999998 4556789
Q ss_pred EEEeccc-CCHHHHhhcC-----CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-----cEEEeee
Q psy787 117 LIMEYCV-GGLQDMLDST-----PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-----TLKISDF 185 (235)
Q Consensus 117 lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-----~~~l~df 185 (235)
++||+++ ++|.+++... ....+++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .++++||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999996 4788888643 223478889999999999999999999999999999999999887 8999999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|++.................+..|+|||.+.+ ..++.++||||||+++
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il 203 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLM 203 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHcc--CCcccchhHHHHHHHH
Confidence 99875432111111222335678999999877 4589999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=205.03 Aligned_cols=188 Identities=32% Similarity=0.514 Sum_probs=156.9
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|++.++||.|++|.||++.+..+++.+++|.+....... .....+..|+..++.++|+|++++.+.+. .....++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ--KEREDAVNEIRILASVNHPNIISYKEAFL--DGNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH--HHHHHHHHHHHHHHhCCCCCchhhhhhhc--cCCEEEE
Confidence 5899999999999999999998899999999887654332 33456778999999999999999999984 4468899
Q ss_pred EEecccC-CHHHHhhcCC--CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 118 IMEYCVG-GLQDMLDSTP--YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++|++++ +|.+++.... ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999965 6888776521 256888999999999999999999999999999999999999999999999999765422
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 157 ----~~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~ 191 (256)
T cd08530 157 ----MAKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLL 191 (256)
T ss_pred ----CcccccCCccccCHHHHCC--CCCCchhhHHHHHHHH
Confidence 2223447788999999977 4488899999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=193.36 Aligned_cols=187 Identities=25% Similarity=0.385 Sum_probs=150.2
Q ss_pred eeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHh-cCCCCcceeeeEEEcCCCceEEEEE
Q psy787 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM-LQHRNVIGLVDVFVNDKKQKMYLIM 119 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~~lv~ 119 (235)
-+..||+|++|.|=+.++..+|+..|+|.+..... .+.+.++..|+.+..+ ..+|++++|+|.++.+ +.++|.|
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn---~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvwIcM 124 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN---SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVWICM 124 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcC---hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEEEeH
Confidence 34689999999999999999999999998876553 3444566677766554 3789999999988644 4689999
Q ss_pred ecccCCHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 120 EYCVGGLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 120 e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
|.+..+|..+-..- ..+.+++.-+.+++..++.||.|||++ .++|||+||+||+|+.+|++|++|||.+-.+. .
T Consensus 125 E~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~---d 201 (282)
T KOG0984|consen 125 ELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV---D 201 (282)
T ss_pred HHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh---h
Confidence 99999866554322 236788999999999999999999987 89999999999999999999999999986543 2
Q ss_pred CCcccccCCCCcccCccccCCC--CCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGL--PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~~Di~slG~~l 235 (235)
+.......|.+.|+|||.+... +..|+.++||||||+.+
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItm 242 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITM 242 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhh
Confidence 3333446788999999998532 23589999999999864
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=208.70 Aligned_cols=178 Identities=22% Similarity=0.265 Sum_probs=136.4
Q ss_pred eeccccceEEEEeeccch------------------------hhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC
Q psy787 44 LLGEGSYGKVKEMLDSET------------------------LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN 99 (235)
Q Consensus 44 ~ig~g~~~~v~~~~~~~~------------------------~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 99 (235)
.||+|+||.||++....+ ...+++|++.... ......+..|+..+..+.|+|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence 589999999999864321 1346677664432 122345777888899999999
Q ss_pred cceeeeEEEcCCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC
Q psy787 100 VIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG 178 (235)
Q Consensus 100 i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~ 178 (235)
|+++++++. .....++||||++++ |..++... .+.+++..+..++.|++.||+|||+++++||||||+||+++..+
T Consensus 78 iv~~~~~~~--~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 78 LAFVHGVCV--RGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eeeEEEEEE--eCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 999999995 445779999999865 66666543 35788999999999999999999999999999999999997654
Q ss_pred -------cEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 179 -------TLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 179 -------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++++|||.+.... ......++..|+|||.+.+. ..++.++|+||||+++
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~------~~~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l 211 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTAL------SREERVERIPWIAPECVPGG-NSLSTAADKWSFGTTL 211 (274)
T ss_pred cccCccceeeecCCccccccc------cccccccCCcccCchhhcCC-CCCCcHHHHHHHHHHH
Confidence 37999999875332 11223466779999988652 4478999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=213.41 Aligned_cols=189 Identities=21% Similarity=0.243 Sum_probs=148.2
Q ss_pred eeeccc--cceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEe
Q psy787 43 DLLGEG--SYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 43 ~~ig~g--~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 120 (235)
..||.| ++++||++.+..+++.||+|++....... +....+.+|+.++..++|+||+++++++ ......++++|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~--~~~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE--EHLKALQNEVVLSHFFRHPNIMTSWTVF--TTGSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcceEeeeE--ecCCceEEEEe
Confidence 456666 89999999999999999999986543221 2235678899999999999999999999 45567899999
Q ss_pred cccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCc
Q psy787 121 YCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT 199 (235)
Q Consensus 121 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 199 (235)
++.+ ++.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.++.+++.||+.+...........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9975 688888765445689999999999999999999999999999999999999999999999985542211101100
Q ss_pred -----ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 200 -----ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 200 -----~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.....++..|+|||.+.+....++.++||||||+++
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l 200 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITA 200 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHH
Confidence 011124566999999876434478899999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=206.70 Aligned_cols=193 Identities=24% Similarity=0.394 Sum_probs=147.5
Q ss_pred EEeeeeeccccceEEEEeecc---chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC---
Q psy787 39 YVMGDLLGEGSYGKVKEMLDS---ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK--- 112 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 112 (235)
|.+.+.||+|++|.||++... .+++.+++|++...... ......+.+|++.++.+.|||++++++.+.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS--SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC--hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 577889999999999999754 35788999988654322 2234457889999999999999999998853322
Q ss_pred -ceEEEEEeccc-CCHHHHhhcC----CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeec
Q psy787 113 -QKMYLIMEYCV-GGLQDMLDST----PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 113 -~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
...+++++++. ++|.+++... ....++...+..++.|++.||+|||+.+++|+||||+||+++.++.++++|||
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccc
Confidence 13478889986 4676665422 12357888999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+.................++.|++||.... ..++.++||||||+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il 205 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTM 205 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHH
Confidence 9875532111111122234567999999876 4478899999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=208.96 Aligned_cols=192 Identities=23% Similarity=0.368 Sum_probs=153.5
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCc
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (235)
..++|++.+.||+|++|+||++.+..+++.+++|.++..... .....+..|+..+... .|+||+++++.+ ....
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~ 87 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK---EENKRILMDLDVVLKSHDCPYIVKCYGYF--ITDS 87 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh---HHHHHHHHHHHHHHhccCCCchHhhheee--ecCC
Confidence 456799999999999999999999888999999998754322 2233455677666665 599999999999 4556
Q ss_pred eEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..+++||++++.+.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++..+.
T Consensus 88 ~~~~v~e~~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 789999999888777766543 478899999999999999999997 599999999999999999999999999987543
Q ss_pred ccccCCcccccCCCCcccCccccCCCC--CCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLP--EISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~~Di~slG~~l 235 (235)
. ........++..|+|||.+.+.. ..++.++|+||||+++
T Consensus 167 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 208 (296)
T cd06618 167 D---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISL 208 (296)
T ss_pred C---CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHH
Confidence 1 11222334677899999986532 3378899999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=214.94 Aligned_cols=191 Identities=34% Similarity=0.528 Sum_probs=156.6
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC-
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK- 112 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 112 (235)
...++|++.+.||.|++|.||++.+..+++.+++|++...... ......+.+|+.+++.++|+|++++.+.+.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch--hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 4567899999999999999999999989999999987643221 1223456789999999999999999987742221
Q ss_pred ---ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 113 ---QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 113 ---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
..+++++++++++|.+++.. ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 90 EDFQDVYLVTHLMGADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred cccccEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 24899999998899888865 468999999999999999999999999999999999999999999999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ......++..|+|||.+.+. ..++.++||||||+++
T Consensus 167 ~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l 206 (343)
T cd07851 167 HTDD-----EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIM 206 (343)
T ss_pred cccc-----cccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHH
Confidence 5532 12233467789999987542 2478899999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=206.26 Aligned_cols=185 Identities=30% Similarity=0.463 Sum_probs=152.2
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
+|.-.+.||.|++|.||++.+..+++.+++|.+.... ......+.+|+.++..+.|+|++++++.+. .....++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~--~~~~~~~ 93 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYL--VGDELWV 93 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEE--cCCeEEE
Confidence 4555678999999999999988889999999875332 122345778999999999999999999984 4567899
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++|++.+ +|.+++.. ..++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~-- 168 (285)
T cd06648 94 VMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-- 168 (285)
T ss_pred EEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--
Confidence 9999965 68887765 45888999999999999999999999999999999999999999999999987644321
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||...+ ..++.++|+||||+++
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l 205 (285)
T cd06648 169 VPRRKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMV 205 (285)
T ss_pred CcccccccCCccccCHHHhcC--CCCCCcccHHHHHHHH
Confidence 112223457788999999877 3488999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=206.52 Aligned_cols=179 Identities=21% Similarity=0.268 Sum_probs=140.8
Q ss_pred eeeccccceEEEEeeccchhh-------heeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 43 DLLGEGSYGKVKEMLDSETLC-------RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~-------~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
+.||.|+||.||++.+...+. .+++|...... ......+..|+..++.+.|||++++++.+.. ....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH----RNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh----HHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCc
Confidence 468999999999998755433 37777664332 2233457789999999999999999999953 4567
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc--------EEEeeec
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT--------LKISDFG 186 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~--------~~l~dfg 186 (235)
++||||+++ +|.+++.... ..++...++.++.|++.||+|||+.+++|+||||+||+++.++. ++++|||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999975 6888876653 46788899999999999999999999999999999999987764 6899999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+.... ......++..|+|||.+.+. ..++.++||||||+++
T Consensus 154 ~~~~~~------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l 195 (258)
T cd05078 154 ISITVL------PKEILLERIPWVPPECIENP-QNLSLAADKWSFGTTL 195 (258)
T ss_pred cccccC------CchhccccCCccCchhccCC-CCCCchhhHHHHHHHH
Confidence 886432 11223467789999998652 3478899999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-33 Score=205.01 Aligned_cols=200 Identities=27% Similarity=0.497 Sum_probs=162.5
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc--
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN-- 109 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 109 (235)
.+...+.|.-+.+||+|.||.||+|+...+|++|++|.+-..... ........+|+.+|..++|+|++.+++.|..
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK--eGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc--cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 355677899999999999999999999999999998865432211 1223456799999999999999999987732
Q ss_pred ----CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeee
Q psy787 110 ----DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDF 185 (235)
Q Consensus 110 ----~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~df 185 (235)
..+..+|+|+.+|+.+|..++... ...++..++.+++.++..+|.|+|++.|+|||+|+.|++|+.++.++|.||
T Consensus 90 Tp~~r~r~t~ylVf~~cehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred CCcccccceeeeeHHHhhhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 344569999999999988776544 367999999999999999999999999999999999999999999999999
Q ss_pred ccccccCccccC--CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHD--DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+++.+....+. ++.....-|..|.+||.+.|. ..++++.|||+-||++
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCim 219 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIM 219 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHH
Confidence 999766322222 223344457789999999883 4689999999999974
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=202.66 Aligned_cols=186 Identities=24% Similarity=0.328 Sum_probs=142.0
Q ss_pred eeeccccceEEEEeeccc---hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEE
Q psy787 43 DLLGEGSYGKVKEMLDSE---TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIM 119 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 119 (235)
+.||+|+||.||++.+.. .+..+++|.+.... .......+.+|+..++.++|||++++++.+.. .++..++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT---DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP-SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC---CHHHHHHHHHHHHHHccCCCCCcceEEEEeec-CCCCcEEEE
Confidence 368999999999987532 34568888764321 11233467789999999999999999998753 344578999
Q ss_pred eccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc--
Q psy787 120 EYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH-- 196 (235)
Q Consensus 120 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 196 (235)
|++. ++|.+++.... ...+...+..++.|+++|++|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 77 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 77 PYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9996 57888876543 3467778889999999999999999999999999999999999999999999875432110
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+ ..++.++||||||+++
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 192 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLL 192 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHH
Confidence 011112234567999999876 4488999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=232.17 Aligned_cols=200 Identities=30% Similarity=0.475 Sum_probs=157.8
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc---
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN--- 109 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 109 (235)
......|+.++.||+||||.||+++.+-+|+.+|+|.+.... . .+....+.+|++.|.++.|||+++++..+++
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s--~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-S--DKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-H--HHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 346677899999999999999999999999999999887665 1 3445568899999999999999999977651
Q ss_pred --------------------------------------------------------------C-----------------
Q psy787 110 --------------------------------------------------------------D----------------- 110 (235)
Q Consensus 110 --------------------------------------------------------------~----------------- 110 (235)
+
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence 0
Q ss_pred ---------------------------CC--------ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHH
Q psy787 111 ---------------------------KK--------QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155 (235)
Q Consensus 111 ---------------------------~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~ 155 (235)
.. -.+||=||||+.++...+...+...-.....|+++++|++||.
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence 00 2468889999876444444432221146688999999999999
Q ss_pred HHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc----------Cc------cccCCcccccCCCCcccCccccCCCC
Q psy787 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL----------DM------FLHDDTITTSQGSPVFQAPEIANGLP 219 (235)
Q Consensus 156 ~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~----------~~------~~~~~~~~~~~~~~~~~aPE~~~~~~ 219 (235)
|+|++|++||||||.|||++.++.+||+|||++... .. ..+....+...||.-|.|||.+.+..
T Consensus 712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999999999999999999999999999999999861 00 11112344556888899999997744
Q ss_pred C-CCCCcccEEEeeeeC
Q psy787 220 E-ISGYKVDIWSSGVTL 235 (235)
Q Consensus 220 ~-~~~~~~Di~slG~~l 235 (235)
. .|+.++||||||++|
T Consensus 792 ~~~Yn~KiDmYSLGIVl 808 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVL 808 (1351)
T ss_pred cccccchhhhHHHHHHH
Confidence 3 599999999999975
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=219.61 Aligned_cols=194 Identities=23% Similarity=0.320 Sum_probs=161.0
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchh---hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETL---CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
+.....-.|.+.||.|.||.|++++.+..+ ..||+|.++..-. ++.+..|+.|..++.++.||||+++.|+.
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt---ekqrrdFL~EAsIMGQFdHPNIIrLEGVV-- 699 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT---EKQRRDFLSEASIMGQFDHPNIIRLEGVV-- 699 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc---HHHHhhhhhhhhhcccCCCCcEEEEEEEE--
Confidence 344556788899999999999999887655 4678887766543 46677899999999999999999999999
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
...+.+.||+|||+. +|..+++.+. ++++.-++..+++.|+.||+||-+.++|||||..+|||++.+-.+|++|||++
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence 566678999999975 5777777665 67999999999999999999999999999999999999999999999999999
Q ss_pred cccCccccCCcccccC--CCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQ--GSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~--~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.+.... .......- -+.+|.|||.+.- .++|.++||||+|+++
T Consensus 779 Rvledd~-~~~ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVm 824 (996)
T KOG0196|consen 779 RVLEDDP-EAAYTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVM 824 (996)
T ss_pred eecccCC-CccccccCCccceeecChhHhhh--cccCchhhccccceEE
Confidence 9775332 11122222 2357999999987 6699999999999985
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=200.39 Aligned_cols=182 Identities=37% Similarity=0.568 Sum_probs=152.8
Q ss_pred eccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecc-c
Q psy787 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYC-V 123 (235)
Q Consensus 45 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~-~ 123 (235)
||.|++|.||.+.+..+++.+++|++....... ......+..|+..++.++|+|++++++.+ ..+...+++||++ .
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK-RKEVEHTLTERNILSRINHPFIVKLHYAF--QTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc-hHHHHHHHHHHHHHHHcCCCcHHHHHHHe--ecCCeeEEEEecCCC
Confidence 689999999999998889999999987765432 23445688999999999999999999998 5677899999999 4
Q ss_pred CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccccc
Q psy787 124 GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS 203 (235)
Q Consensus 124 ~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 203 (235)
++|.+++... ..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+...... .......
T Consensus 78 ~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~ 153 (250)
T cd05123 78 GELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE--GSRTNTF 153 (250)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccC--CCcccCC
Confidence 5798888765 46899999999999999999999999999999999999999999999999998755321 1123334
Q ss_pred CCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 204 QGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 204 ~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++..|.|||...+ ...+.++|+||||+++
T Consensus 154 ~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~ 183 (250)
T cd05123 154 CGTPEYLAPEVLLG--KGYGKAVDWWSLGVLL 183 (250)
T ss_pred cCCccccChHHhCC--CCCCchhhHHHHHHHH
Confidence 56778999999977 4478899999999864
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=203.06 Aligned_cols=191 Identities=26% Similarity=0.479 Sum_probs=152.4
Q ss_pred eEEeeeeeccccceEEEEeeccc-hhhheeeeeeeeccccCC------CCccccHHHHHHHHHh-cCCCCcceeeeEEEc
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSE-TLCRRAVKIFKKKKLQRI------PNGEINVDREIRLLKM-LQHRNVIGLVDVFVN 109 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~~------~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 109 (235)
.|++.+.||.|++|.||++.+.. .++.+++|.+........ ......+..|+..+.. ++|+|++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 47889999999999999999877 678899998865443221 1222345677777764 6899999999999
Q ss_pred CCCceEEEEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEccCCcEEEeee
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTLDGTLKISDF 185 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~~~~~~l~df 185 (235)
...+..+++|||+++ +|.+++... ....++...++.++.|++.+|.+||+ .+++|+||+|+||+++.++.++|+||
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 456689999999975 687776432 23568999999999999999999996 68999999999999999999999999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|.+...... .......++..|+|||...+ ..++.++|+||||+++
T Consensus 159 g~~~~~~~~---~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll 203 (269)
T cd08528 159 GLAKQKQPE---SKLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCIL 203 (269)
T ss_pred cceeecccc---cccccccCcccCcChhhhcC--CCCchHHHHHHHHHHH
Confidence 999755421 12334457788999999987 4488999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=198.70 Aligned_cols=191 Identities=24% Similarity=0.378 Sum_probs=150.7
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCce
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 114 (235)
.+..+++..||+|+.|.||+++...+|...|+|.+..... .++..++...+.+.... ..|+|++.+|+|+- +..
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N---kee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~d 165 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTD 165 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC---HHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--Cch
Confidence 3455667899999999999999999999999998865442 23334555555554433 58999999999963 335
Q ss_pred EEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+++.||.++.....++... .+++++.-+.++...+++||.||..+ |++|||+||+||+++..|++|++|||++-.+-
T Consensus 166 V~IcMelMs~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv- 243 (391)
T KOG0983|consen 166 VFICMELMSTCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV- 243 (391)
T ss_pred HHHHHHHHHHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee-
Confidence 7889999987655555443 26799999999999999999999876 89999999999999999999999999987553
Q ss_pred cccCCcccccCCCCcccCccccCCC-CCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGL-PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 235 (235)
.+..+....|.+.|||||.+.-. ...|..++||||||+.|
T Consensus 244 --dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITl 284 (391)
T KOG0983|consen 244 --DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITL 284 (391)
T ss_pred --cccccccccCCccccCccccCCCCCCccchhhhhhhhccch
Confidence 23344455688999999999653 34688999999999875
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=205.28 Aligned_cols=182 Identities=30% Similarity=0.450 Sum_probs=148.8
Q ss_pred eeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEe
Q psy787 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 120 (235)
-..+||.|++|.||++....+++.+++|.+.... ......+.+|+..+..++|+|++++++.+. .....+++||
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e 97 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVME 97 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc----hhHHHHHHHHHHHHHhcCCcchhheeeEEE--eCCEEEEEEe
Confidence 3467999999999999998899999999874332 123345788999999999999999999994 4568899999
Q ss_pred cccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCc
Q psy787 121 YCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT 199 (235)
Q Consensus 121 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 199 (235)
|+++ +|.+++.. ..+++..+..++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 98 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~ 172 (292)
T cd06657 98 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPR 172 (292)
T ss_pred cCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--ccc
Confidence 9976 57665543 45788999999999999999999999999999999999999999999999988644321 112
Q ss_pred ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 200 ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 200 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.....++..|+|||...+ ..+++++|+||||+++
T Consensus 173 ~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil 206 (292)
T cd06657 173 RKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMV 206 (292)
T ss_pred ccccccCccccCHHHhcC--CCCCchhhHHHHHHHH
Confidence 233457788999998876 3478899999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=208.09 Aligned_cols=200 Identities=31% Similarity=0.473 Sum_probs=159.3
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccc---cHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI---NVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
.+.++|-+++.||+|||+.||+|.+....+.||||+-.....+..++... -..+|..+-+.+.||.||++|++|. -
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs-l 538 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS-L 538 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee-e
Confidence 46789999999999999999999999999999999765544433222222 2568889999999999999999996 3
Q ss_pred CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC--CcccCCCCCCCeEEccC---CcEEEeee
Q psy787 111 KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ--GIIHKDIKPGNLLLTLD---GTLKISDF 185 (235)
Q Consensus 111 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--~i~H~dl~p~nili~~~---~~~~l~df 185 (235)
+...+|-|.|||+|.-.++...+. ..+++.++..|+.|++.||.||... .|+|-||||.||++-.. |.++|.||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 456789999999987555554443 6799999999999999999999987 59999999999999755 56999999
Q ss_pred ccccccCccccCCc-----ccccCCCCcccCccccCC--CCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDT-----ITTSQGSPVFQAPEIANG--LPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~--~~~~~~~~~Di~slG~~l 235 (235)
|+++.++....... .....||.-|+|||++.- .|.+++.+.||||+|+++
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIF 674 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIF 674 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhh
Confidence 99998864332211 112346777999998643 255788999999999985
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=204.96 Aligned_cols=183 Identities=23% Similarity=0.284 Sum_probs=144.5
Q ss_pred cceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecccC-CHH
Q psy787 49 SYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVG-GLQ 127 (235)
Q Consensus 49 ~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 127 (235)
+++.||+++...+++.+|+|++...... ......+..|+..++.++|+||+++++.+. ....++++|||+++ ++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~--~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCS--KEDLKLLQQEIITSRQLQHPNILPYVTSFI--VDSELYVVSPLMAYGSCE 87 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccc--hhHHHHHHHHHHHHHhcCCcchhhhhheee--cCCeEEEEEeccCCCCHH
Confidence 4456666777778999999998765322 234457889999999999999999999984 45678999999975 688
Q ss_pred HHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc-----CCcccc
Q psy787 128 DMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH-----DDTITT 202 (235)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~ 202 (235)
+++.......+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++++||+.+........ ......
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccc
Confidence 888765556788999999999999999999999999999999999999999999999998864421111 011122
Q ss_pred cCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 203 SQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 203 ~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..++..|+|||.+.+....++.++|+||||+++
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il 200 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITA 200 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHH
Confidence 335667999999876434478899999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=205.62 Aligned_cols=150 Identities=28% Similarity=0.425 Sum_probs=130.6
Q ss_pred cceeecCCceeEeee-ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC----
Q psy787 22 DQVIYDNKTIKVKMI-GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ---- 96 (235)
Q Consensus 22 ~~~~~~~~~~~~~~~-~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~---- 96 (235)
--.=|.+-.+++... ++|.++++||.|.|++||+|+++++.+.||+|+.+...-.+ +....||++|++++
T Consensus 62 ~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYt-----EaAlDEIklL~~v~~~Dp 136 (590)
T KOG1290|consen 62 RKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYT-----EAALDEIKLLQQVREGDP 136 (590)
T ss_pred hcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHH-----HHHHHHHHHHHHHHhcCC
Confidence 344477888889998 99999999999999999999999999999999988765443 23578999999884
Q ss_pred -C---CCcceeeeEEEc--CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCC
Q psy787 97 -H---RNVIGLVDVFVN--DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKP 169 (235)
Q Consensus 97 -h---~~i~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p 169 (235)
| ..++++++.|.. .++.++|+|+|+++..|..+|.....++++...+..|++|++.||.|||.. ||+|.||||
T Consensus 137 ~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKP 216 (590)
T KOG1290|consen 137 NDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKP 216 (590)
T ss_pred CCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCc
Confidence 2 468999998853 344589999999999999999999999999999999999999999999976 999999999
Q ss_pred CCeEEcc
Q psy787 170 GNLLLTL 176 (235)
Q Consensus 170 ~nili~~ 176 (235)
+|||+..
T Consensus 217 ENvLl~~ 223 (590)
T KOG1290|consen 217 ENVLLCS 223 (590)
T ss_pred ceeeeec
Confidence 9999843
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=200.84 Aligned_cols=191 Identities=32% Similarity=0.589 Sum_probs=151.1
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC-CCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI-PNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
+|.+.+.||+|++|.||++.+...+...++|+.+....... ......+..|+.++..++|||++++++.+. .....+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL--ERDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh--cCCceE
Confidence 58999999999999999999887777777777765443321 122334667889999999999999999984 455789
Q ss_pred EEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 117 LIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+++||+++ +|.+++... ....+++..++.++.|++.||.+||+.|++|+||+|+|++++ ++.++|+|||.+.....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-~~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-cCCEeecccCceeecCC
Confidence 99999975 677776542 235689999999999999999999999999999999999997 46799999998875432
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........+++.|+|||...+ ..++.++|+||||+++
T Consensus 158 --~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~ 195 (260)
T cd08222 158 --SCDLATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCIL 195 (260)
T ss_pred --CcccccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHH
Confidence 1112223446778999998876 4478899999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-31 Score=209.54 Aligned_cols=188 Identities=24% Similarity=0.388 Sum_probs=151.8
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHh--cCCCCcceeeeEEEcCC--
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM--LQHRNVIGLVDVFVNDK-- 111 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~-- 111 (235)
....++.+.||+|.||.||+|.. +++.||||++...... .+++|..+... ++|+||+.|++.--...
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kq-------s~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQ-------SFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHH-------HHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 45677889999999999999987 4589999998655433 47777776664 58999999998763211
Q ss_pred CceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC---------CcccCCCCCCCeEEccCCcEE
Q psy787 112 KQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ---------GIIHKDIKPGNLLLTLDGTLK 181 (235)
Q Consensus 112 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---------~i~H~dl~p~nili~~~~~~~ 181 (235)
...++||++|.+ |+|.+++.. ..+++....+++..|+.||+|||+. .|+|||||.+||++..+++..
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 346899999995 789999988 4689999999999999999999964 599999999999999999999
Q ss_pred EeeeccccccCccccCCcccccCCCCcccCccccCCCCCC----CCCcccEEEeeeeC
Q psy787 182 ISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEI----SGYKVDIWSSGVTL 235 (235)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~----~~~~~Di~slG~~l 235 (235)
|+|||+|-.+.-..........+||.+|||||++-+.-.. .-.+.||||+|++|
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVL 414 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVL 414 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHH
Confidence 9999999877533344444457899999999999663211 11479999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=197.20 Aligned_cols=168 Identities=21% Similarity=0.299 Sum_probs=138.6
Q ss_pred ccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecccC-CH
Q psy787 48 GSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVG-GL 126 (235)
Q Consensus 48 g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l 126 (235)
|.+++||++++..+++.+++|.+..... +..+...+....|||++++++.+ .....++++|||+++ +|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---------~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---------YSRERLTIIPHCVPNMVCLHKYI--VSEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh---------hhhHHHHHHhcCCCceeehhhhe--ecCCeEEEEEecCCCCCH
Confidence 8999999999999999999999866531 23445555566799999999998 455688999999975 68
Q ss_pred HHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcccccCCC
Q psy787 127 QDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS 206 (235)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 206 (235)
.+++... ..+++..+..++.|+++||.+||+.|++|+||||+||+++.++.++++|||.+..... .......+
T Consensus 73 ~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~ 145 (237)
T cd05576 73 WSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVE 145 (237)
T ss_pred HHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcC
Confidence 8888765 4689999999999999999999999999999999999999999999999998764432 11223345
Q ss_pred CcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 207 PVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 207 ~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..|+|||...+ ..++.++|+||+|+++
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il 172 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAIL 172 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHH
Confidence 67999999876 4478899999999874
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=217.01 Aligned_cols=190 Identities=26% Similarity=0.381 Sum_probs=155.1
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|+++++||.|+||+||++++..+++.||+|+++...... ......+..|+..+..++|+||++++..+ .....+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN-KNMVHQVQAERDALALSKSPFIVHLYYSL--QSANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC-HHHHHHHHHHHHHHHhcCCCCcCeEEEEE--EECCEE
Confidence 468999999999999999999999899999999987654322 22335678899999999999999999888 455689
Q ss_pred EEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+||+++.++.++|+|||++.....
T Consensus 80 ~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~- 156 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN- 156 (669)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccC-
Confidence 99999996 4688888654 5688899999999999999999999999999999999999999999999999985531
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeee
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGV 233 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 233 (235)
.........+++.|.+||..... ......+++|++|+
T Consensus 157 -~~~~~~~~~~t~~~~~pe~~~~~-~~~~~~s~~~s~g~ 193 (669)
T cd05610 157 -RELNMMDILTTPSMAKPKNDYSR-TPGQVLSLISSLGF 193 (669)
T ss_pred -CcccccccccCccccCccccccC-CCCceeeeeeecCc
Confidence 12233345688889999965432 22345678888874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-32 Score=215.96 Aligned_cols=191 Identities=30% Similarity=0.473 Sum_probs=166.2
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
...+.+++.-||.|+||.|=++........+|+|++++..+.+ .+.++-+..|-+++...+.++|+++|..| .+.++
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTf--rd~ky 494 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTF--RDSKY 494 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHh--ccchh
Confidence 4456777888999999999988776665679999999998887 34455677899999999999999999999 67789
Q ss_pred EEEEEecc-cCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYC-VGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+|++||.| +|.++..++.. +.+++....-++..+++|++|||++||++|||||+|.+++.+|-+||.|||+|+.+.
T Consensus 495 vYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~- 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG- 571 (732)
T ss_pred hhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc-
Confidence 99999999 56699988877 789999999999999999999999999999999999999999999999999999775
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......+.+||+.|.|||.+... .-+.++|.||||+++
T Consensus 572 --~g~KTwTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli 609 (732)
T KOG0614|consen 572 --SGRKTWTFCGTPEYVAPEIILNK--GHDRAVDYWALGILI 609 (732)
T ss_pred --cCCceeeecCCcccccchhhhcc--CcchhhHHHHHHHHH
Confidence 44566678899999999998763 356899999999863
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-31 Score=204.81 Aligned_cols=194 Identities=32% Similarity=0.433 Sum_probs=161.8
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDK 111 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 111 (235)
......|..+..||.|+||+|-++..+.+.+.+|+|++++..+....+.++ -..|.++|... +-|+++.+...| ..
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvec-tm~EKrvLAL~~kppFL~qlHScF--QT 421 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVEC-TMVEKRVLALPGKPPFLVQLHSCF--QT 421 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccc-eehhhhheecCCCCchHHHHHHHh--hh
Confidence 345567899999999999999999999999999999999988777544433 34677777666 456777888887 66
Q ss_pred CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...+|+||||+.| +|-..++.- +.+.+..+.-++..|+-||-+||++||++||||.+||+++.+|+++|.|||+++.
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence 6789999999975 566666554 7788899999999999999999999999999999999999999999999999973
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
-- .......+.+||+.|+|||.+...| |+.+.|+||+|++|
T Consensus 500 ni--~~~~TTkTFCGTPdYiAPEIi~YqP--YgksvDWWa~GVLL 540 (683)
T KOG0696|consen 500 NI--FDGVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLL 540 (683)
T ss_pred cc--cCCcceeeecCCCcccccceEEecc--cccchhHHHHHHHH
Confidence 32 1234456778999999999998855 99999999999975
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=208.00 Aligned_cols=192 Identities=30% Similarity=0.514 Sum_probs=162.3
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEc---CC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVN---DK 111 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~ 111 (235)
.+.|+|.+.||.|.+|.||++....+++..|+|+..... +..+++..|.++++.. .|||++.++++|.- ..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 356899999999999999999999999999999887654 3334577888888887 69999999999852 34
Q ss_pred CceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
.+.+|+|||||+ |+.-+++.......+.+..+..+++.++.|+.+||.+.++|||+|-.||++..++.+||.|||.+..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 468999999996 5688888777678899999999999999999999999999999999999999999999999999987
Q ss_pred cCccccCCcccccCCCCcccCccccCCCC---CCCCCcccEEEeeee
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLP---EISGYKVDIWSSGVT 234 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~~Di~slG~~ 234 (235)
++. ...+-.+..|++.|||||++.-.+ .-|+..+|+||||++
T Consensus 173 lds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGIT 217 (953)
T KOG0587|consen 173 LDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGIT 217 (953)
T ss_pred eec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccce
Confidence 753 334444566999999999985321 236779999999985
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-32 Score=200.44 Aligned_cols=188 Identities=31% Similarity=0.491 Sum_probs=149.2
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc---eEEEE
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ---KMYLI 118 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---~~~lv 118 (235)
-+.||.|.||.||.+.+.++|+.+++|.+..-.-. -....++-+|+++|.-++|.|++...++..-..-. .+|++
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~--L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN--LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHH--HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 36799999999999999999999999976432211 12234577899999999999999888876311111 24678
Q ss_pred EecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCC
Q psy787 119 MEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDD 198 (235)
Q Consensus 119 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 198 (235)
+|.+..+|-..+-+. ..++...+.-+++||+.+|.|||+.+|+||||||.|.++..+..+||+|||+++.-+. ....
T Consensus 136 TELmQSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~-d~~~ 212 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ-RDRL 212 (449)
T ss_pred HHHHHhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch-hhhh
Confidence 888877777766655 7789999999999999999999999999999999999999999999999999985431 1222
Q ss_pred cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 199 TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 199 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.+.-.-|..|.|||.+.|. ..|+.+.||||.||++
T Consensus 213 hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIF 248 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIF 248 (449)
T ss_pred hhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHH
Confidence 23333457789999999985 4689999999999974
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=196.61 Aligned_cols=193 Identities=30% Similarity=0.479 Sum_probs=163.4
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (235)
...+.|.+++.||+|++++|-++++.++.+.+|+|++++.-..+ .++...++.|..++.+- .||+++-+...| ...
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd-dedidwvqtek~vfe~asn~pflvglhscf--qte 323 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNNPFLVGLHSCF--QTE 323 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC-cccchhHHhhHHHHHhccCCCeEEehhhhh--ccc
Confidence 34567999999999999999999999999999999998877665 56666788888888765 689999999988 555
Q ss_pred ceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+++|.||..|+ |-=.++.+ ..++++.+.-+...|+.||+|||+.||++||||.+|++++..|++||.|+|+.+.-
T Consensus 324 srlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred ceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 6789999999765 43333333 67999999999999999999999999999999999999999999999999999743
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
- .+.....+.+||+.|.|||.+++ .-|+++.|+|+||+++
T Consensus 402 l--~~gd~tstfcgtpnyiapeilrg--eeygfsvdwwalgvlm 441 (593)
T KOG0695|consen 402 L--GPGDTTSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLM 441 (593)
T ss_pred C--CCCcccccccCCCcccchhhhcc--cccCceehHHHHHHHH
Confidence 2 12334456789999999999999 5599999999999864
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=204.48 Aligned_cols=192 Identities=29% Similarity=0.449 Sum_probs=156.7
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
.-|..++-||-|+||+|.+++...+...+|.|.+.+..... .....-+.+|-.+|..-+++-+|++|..| .++.++|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySF--QDkdnLY 705 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSF--QDKDNLY 705 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEe--ccCCceE
Confidence 35888899999999999999988888999999887766543 22223466788888888999999999999 7778999
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc-
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF- 194 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 194 (235)
+||+|++| ++-+++... +-+.+..++.++..+..|++++|..|++||||||+||||+.+|++||.|||++.=+..-
T Consensus 706 FVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 99999976 577777665 66888888999999999999999999999999999999999999999999998644110
Q ss_pred ----cc-CCcc----------------------------------cccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 ----LH-DDTI----------------------------------TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ----~~-~~~~----------------------------------~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+. ..+. -..+||+.|+|||++.. ..++..+|+||.|++|
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHHH
Confidence 00 0000 01348889999999987 4489999999999986
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=208.74 Aligned_cols=191 Identities=25% Similarity=0.343 Sum_probs=162.1
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
.-...+..++||-|-+|.||.+.+++....||+|.++... -...+|..|..+++.++|||++++.++| .....
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-----MeveEFLkEAAvMKeikHpNLVqLLGVC--T~EpP 337 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVC--THEPP 337 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-----hhHHHHHHHHHHHHhhcCccHHHHhhhh--ccCCC
Confidence 3345677789999999999999998888899999776443 4456799999999999999999999999 45567
Q ss_pred EEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+|||+|||. |.|.+++++.+...++.-.++.++.||.+||+||..++++||||..+|.++.++..+|+.|||+++.+..
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 899999996 6799999998877788888999999999999999999999999999999999999999999999997754
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.-..+.. -.-...|.|||-+.- ..++.++|||+||++|
T Consensus 418 DTYTAHAG-AKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLL 456 (1157)
T KOG4278|consen 418 DTYTAHAG-AKFPIKWTAPESLAY--NTFSIKSDVWAFGVLL 456 (1157)
T ss_pred CceecccC-ccCcccccCcccccc--cccccchhhHHHHHHH
Confidence 33332222 223456999999987 4499999999999975
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=206.27 Aligned_cols=181 Identities=33% Similarity=0.501 Sum_probs=150.0
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCc
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (235)
....|.+...+|.|+|+.|..+.+..+++..++|++...... ..+|+.++... .|+|+++..+.+ .+..
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~--------~~~e~~~~~~~~~h~niv~~~~v~--~~~~ 389 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD--------NQDEIPISLLVRDHPNIVKSHDVY--EDGK 389 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc--------cccccchhhhhcCCCcceeeccee--cCCc
Confidence 567799999999999999999999999999999999777322 23466554444 799999999999 7788
Q ss_pred eEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE-ccCCcEEEeeecccccc
Q psy787 114 KMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL-TLDGTLKISDFGVAESL 191 (235)
Q Consensus 114 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili-~~~~~~~l~dfg~~~~~ 191 (235)
..|+|||.+.|. +.+.+.... .....+..|+.+|+.|+.+||.+|++||||||+||++ ...++++|+|||.++..
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999999999765 777776642 2337788899999999999999999999999999999 58899999999999865
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... .....-|..|.|||++... .++.++||||||++|
T Consensus 467 ~~~-----~~tp~~t~~y~APEvl~~~--~yt~acD~WSLGvlL 503 (612)
T KOG0603|consen 467 ERS-----CDTPALTLQYVAPEVLAIQ--EYTEACDWWSLGVLL 503 (612)
T ss_pred chh-----hcccchhhcccChhhhccC--CCCcchhhHHHHHHH
Confidence 422 3334456779999999874 499999999999975
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-29 Score=202.43 Aligned_cols=186 Identities=27% Similarity=0.437 Sum_probs=148.0
Q ss_pred EeeeeeccccceEEEEeecc--chhhhe--eeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 40 VMGDLLGEGSYGKVKEMLDS--ETLCRR--AVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 40 ~i~~~ig~g~~~~v~~~~~~--~~~~~~--~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
+..++||.|-||.||.+... +.|+.. |+|.-+... ..++.+.|..|..+++.++||||++++|++.+ ...
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~ 465 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPM 465 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhheeeeeec---cce
Confidence 34479999999999998653 244444 444433322 23557789999999999999999999999952 358
Q ss_pred EEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
|||||.++ |.|..+++.+. ..++......+++||+.||.|||+..++||||..+||++.....+||+|||+++-+...
T Consensus 466 WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999997 67999998764 67888899999999999999999999999999999999999999999999999866321
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.-.......-+..|+|||-++- ..+|.++|||.||+++
T Consensus 545 -~yYkaS~~kLPIKWmaPESINf--RrFTtASDVWMFgVCm 582 (974)
T KOG4257|consen 545 -AYYKASRGKLPIKWMAPESINF--RRFTTASDVWMFGVCM 582 (974)
T ss_pred -chhhccccccceeecCccccch--hcccchhhHHHHHHHH
Confidence 1111112223456999999976 5699999999999974
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-29 Score=207.13 Aligned_cols=180 Identities=32% Similarity=0.460 Sum_probs=144.0
Q ss_pred eeeccccceEE-EEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCceEEEEEe
Q psy787 43 DLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 43 ~~ig~g~~~~v-~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e 120 (235)
+.+|.|+.|++ |++.. .|+.||||.+-..... ..++|+..|+.- .||||+++++.- .++.+.||+.|
T Consensus 515 eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~-------~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalE 583 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFD-------FAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALE 583 (903)
T ss_pred HHcccCCCCcEEEEEee--CCceehHHHHhhHhHH-------HHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEeh
Confidence 57889988765 77665 5789999976544422 367999999987 699999999887 77789999999
Q ss_pred cccCCHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc---CC--cEEEeeeccccccCc
Q psy787 121 YCVGGLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL---DG--TLKISDFGVAESLDM 193 (235)
Q Consensus 121 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~---~~--~~~l~dfg~~~~~~~ 193 (235)
.|..+|.+++... .......-..+.++.|+++|+++||+.+|+||||||+||+|.. ++ +++|+|||+++.++.
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9999999999874 1111222456889999999999999999999999999999987 33 589999999998865
Q ss_pred cccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...+ .+.....|+.+|+|||++.. ...+.++|||||||++
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvf 704 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVF 704 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceE
Confidence 4333 22344568999999999988 4477899999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=206.59 Aligned_cols=192 Identities=24% Similarity=0.311 Sum_probs=129.1
Q ss_pred eeceEEeeeeeccccceEEEEeeccch----hhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEE--
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSET----LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFV-- 108 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-- 108 (235)
..++|.+.+.||+|+||.||++.+..+ +..+|+|.+...... +....+ .+....+.++..+...+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~------e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV------EIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh------HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 456899999999999999999999888 889999976432210 011111 111111222222222111
Q ss_pred --cCCCceEEEEEecccC-CHHHHhhcCCCC------------------CCCHHhHHHHHHHHHHHHHHHHhCCcccCCC
Q psy787 109 --NDKKQKMYLIMEYCVG-GLQDMLDSTPYK------------------KFPIWQAHGYFLQLLDGLEYLHSQGIIHKDI 167 (235)
Q Consensus 109 --~~~~~~~~lv~e~~~~-~l~~~~~~~~~~------------------~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 167 (235)
......++++++|+++ +|.+++...... ......+..++.|++.||.|||+.+|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 1345578999999975 588877654211 0112346679999999999999999999999
Q ss_pred CCCCeEEcc-CCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCC--------------------CCCCcc
Q psy787 168 KPGNLLLTL-DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPE--------------------ISGYKV 226 (235)
Q Consensus 168 ~p~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--------------------~~~~~~ 226 (235)
||+||+++. ++.++|+|||++..+... .........+++.|+|||.+..... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999986 578999999999755321 1122334567889999996543211 123456
Q ss_pred cEEEeeeeC
Q psy787 227 DIWSSGVTL 235 (235)
Q Consensus 227 Di~slG~~l 235 (235)
|||||||+|
T Consensus 361 DVwSlGviL 369 (566)
T PLN03225 361 DIYSAGLIF 369 (566)
T ss_pred ccHHHHHHH
Confidence 999999975
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=196.43 Aligned_cols=197 Identities=29% Similarity=0.451 Sum_probs=164.4
Q ss_pred ecCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC------CCC
Q psy787 26 YDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ------HRN 99 (235)
Q Consensus 26 ~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~ 99 (235)
|+--.+++.+-++|.+..-.|.|-|++|..|.+..-|+.||+|++.....-. + .=+.|+.+|..|. ..|
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~--K---tGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH--K---TGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh--h---hhhHHHHHHHHhhccCchhhhH
Confidence 4445678889999999999999999999999999999999999997655432 1 1257888998884 358
Q ss_pred cceeeeEEEcCCCceEEEEEecccCCHHHHhhcCC-CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC
Q psy787 100 VIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTP-YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG 178 (235)
Q Consensus 100 i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~ 178 (235)
+++++..| ...+++|+|+|.+.-.|.+++.... +-++....+..++.||+.||..|-..|++|.||||+|||+....
T Consensus 496 clrl~r~F--~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 496 CLRLFRHF--KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHHHh--hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc
Confidence 99999988 5678999999999999999987653 35688899999999999999999999999999999999999764
Q ss_pred -cEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 179 -TLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 179 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++|||||.|.... ....+...-..-|.|||.+.|.+ |+...|+||.||+|
T Consensus 574 ~iLKLCDfGSA~~~~----eneitPYLVSRFYRaPEIiLG~~--yd~~iD~WSvgctL 625 (752)
T KOG0670|consen 574 NILKLCDFGSASFAS----ENEITPYLVSRFYRAPEIILGLP--YDYPIDTWSVGCTL 625 (752)
T ss_pred ceeeeccCccccccc----cccccHHHHHHhccCcceeecCc--ccCCccceeeceee
Confidence 58999999997443 23333333445599999999966 99999999999986
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=217.19 Aligned_cols=175 Identities=21% Similarity=0.280 Sum_probs=140.8
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
..+...+.||+|+||.||++.+..++..||+|.+..... ....|+..+++++||||+++++++. .....+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~--~~~~~~ 759 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCR--SEKGAY 759 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEE--cCCCCE
Confidence 346667789999999999999988899999998753321 1235688899999999999999995 445689
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHH---hCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH---SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
+||||+++ +|.+++.. +++..+..++.|++.||+||| +.+++|||+||+||+++.++..++. ++......
T Consensus 760 lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 99999974 68888753 688899999999999999999 6699999999999999988887765 55443221
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+.+ ..++.++||||||+++
T Consensus 834 ------~~~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl 868 (968)
T PLN00113 834 ------TDTKCFISSAYVAPETRET--KDITEKSDIYGFGLIL 868 (968)
T ss_pred ------cCCCccccccccCcccccC--CCCCcccchhhHHHHH
Confidence 1112246788999999887 4589999999999974
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=181.93 Aligned_cols=189 Identities=43% Similarity=0.672 Sum_probs=154.7
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
|.+.+.||.|+++.||++.+..+++.+++|.+...... .....+.+|+..+..++|+|++++++.+. .....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~--~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFE--DPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeee--cCCceEEE
Confidence 56788999999999999999888899999998765432 23456889999999999999999999984 44678999
Q ss_pred EecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC
Q psy787 119 MEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 119 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 197 (235)
+|++++ +|.+++..... .++...+..++.+++.++.+||+.+++|+|++|+|++++.++.++|+|||.+....... .
T Consensus 76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~ 153 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-A 153 (225)
T ss_pred EeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-c
Confidence 999987 79888876532 27889999999999999999999999999999999999999999999999987654221 0
Q ss_pred CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 198 DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......+...|++||... ....++.++|+|+||+++
T Consensus 154 ~~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~ 190 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVIL 190 (225)
T ss_pred ccccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHH
Confidence 1223344667799999983 224477799999999864
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=185.05 Aligned_cols=191 Identities=31% Similarity=0.458 Sum_probs=158.3
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc---
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN--- 109 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 109 (235)
-....+|.-++.++.|.- .|-.|.+...++.+++|........ ..--.+..+|+..+..+.|+||++.+.+|.-
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n--~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN--QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc--CccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 345568999999999998 7777899999999999977655322 2333467799999999999999999999841
Q ss_pred -CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 -DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 -~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
+.-..+|+|||++..+|...+.. .++-..+..+++|++.|+++||+.||+||||||+||++..++.+||.|||++
T Consensus 90 l~~~~e~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHhHHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhh
Confidence 12235799999999999988883 3677889999999999999999999999999999999999999999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..-+ ..........+..|.|||++.+ ..+...+||||+||++
T Consensus 166 r~e~---~~~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~ 207 (369)
T KOG0665|consen 166 RTED---TDFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIM 207 (369)
T ss_pred cccC---cccccCchhheeeccCchheec--cCCcccchhhhhhhHH
Confidence 8554 2234455567788999999998 4499999999999975
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=181.91 Aligned_cols=190 Identities=23% Similarity=0.442 Sum_probs=150.3
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcC
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVND 110 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (235)
...+.+.|.|.+.+|.|.||.+-+++|+.+++.+++|.+.... ..+..|.+|..---.| .|.||+.-|++-+ +
T Consensus 19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-q 92 (378)
T KOG1345|consen 19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAF-Q 92 (378)
T ss_pred ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHh-h
Confidence 4467789999999999999999999999999999999776544 3344677777544444 5899999997766 4
Q ss_pred CCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC--CcEEEeeecc
Q psy787 111 KKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD--GTLKISDFGV 187 (235)
Q Consensus 111 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~--~~~~l~dfg~ 187 (235)
..+.+++++||++ |+|.+-+.. .++.+..-..++.|+++|+.|+|++++||||||.+||+|... .++||+|||.
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred cCceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccc
Confidence 5568899999997 678776655 678888899999999999999999999999999999999643 5799999999
Q ss_pred ccccCccccCCcccccCCCCcccCccccCCC---CCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~l 235 (235)
....+ ...........|.|||..... .-+..+++|+|+||+++
T Consensus 170 t~k~g-----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~ 215 (378)
T KOG1345|consen 170 TRKVG-----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIF 215 (378)
T ss_pred ccccC-----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeee
Confidence 87543 122233345569999975322 12467899999999975
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=200.09 Aligned_cols=191 Identities=28% Similarity=0.376 Sum_probs=156.2
Q ss_pred ceEEeeeeeccccceEEEEeeccc-hhh--heeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSE-TLC--RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~-~~~--~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
+...+.++||+|+||.|+++.++. .|+ .||||+++..... .....|.+|+..+..|+|+|++++||+.++ .
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~---q 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLD---Q 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeecc---c
Confidence 446677899999999999986653 333 5688888765543 245579999999999999999999999963 3
Q ss_pred eEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
-..+|+|.++ |+|.+.+.......+-......++.||+.||.||.+++++||||..+|+++.....+||+|||+.+.+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 4678999997 579999988666778888999999999999999999999999999999999999999999999999775
Q ss_pred ccccCCccc-ccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTIT-TSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......... ...-...|+|||.++. ..++.++|+|++|++|
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTi 305 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTI 305 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhH
Confidence 432222111 1223456999999988 6699999999999975
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=185.53 Aligned_cols=170 Identities=22% Similarity=0.212 Sum_probs=125.7
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccc-hhhheeeeeeeecccc-CCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSE-TLCRRAVKIFKKKKLQ-RIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
....++|.+.+.||+|+||+||+|++.. +++.+|+|.+...... ........+.+|+.++..++|+|+++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 4566789999999999999999998776 6777799876533110 1112345689999999999999988533222
Q ss_pred CCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCC-CCCCeEEccCCcEEEeeeccc
Q psy787 111 KKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDI-KPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 111 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl-~p~nili~~~~~~~l~dfg~~ 188 (235)
+..++||||++|. |. .... .. ...++.+++.+|.+||+.|++|||| ||+||+++.++.++|+|||++
T Consensus 91 --~~~~LVmE~~~G~~L~-~~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLH-LARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred --CCcEEEEEccCCCCHH-HhCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 2469999999875 54 2211 11 1468899999999999999999999 999999998899999999999
Q ss_pred cccCccccCCc------ccccCCCCcccCccccC
Q psy787 189 ESLDMFLHDDT------ITTSQGSPVFQAPEIAN 216 (235)
Q Consensus 189 ~~~~~~~~~~~------~~~~~~~~~~~aPE~~~ 216 (235)
+.+........ .....+++.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 86643221111 12344667789999874
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=170.37 Aligned_cols=191 Identities=23% Similarity=0.327 Sum_probs=156.8
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCC-CCcceeeeEEEcCCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH-RNVIGLVDVFVNDKK 112 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 112 (235)
...+.|.++++||+|+||.+|++....+|+.||+|+-....... .+..|.++.+.+++ .+|+.+..+. .++
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp------qL~yEskvY~iL~~g~GiP~i~~y~--~e~ 83 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP------QLLYESKVYRILQGGVGIPHIRHYG--TEK 83 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc------chhHHHHHHHHhccCCCCchhhhhc--ccc
Confidence 45678999999999999999999999999999999876554332 46789999998865 7888888777 455
Q ss_pred ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC---CcEEEeeecccc
Q psy787 113 QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD---GTLKISDFGVAE 189 (235)
Q Consensus 113 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~---~~~~l~dfg~~~ 189 (235)
.+-++||+..+.+|.+++.... ..++...++-++-||+.-++|+|..+++||||||+|+++.-+ +.+.++|||+++
T Consensus 84 ~ynvlVMdLLGPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 84 DYNVLVMDLLGPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ccceeeeeccCccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 6779999999999999998665 679999999999999999999999999999999999999755 569999999999
Q ss_pred ccCccccCC-----cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDD-----TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+-...... ....+.||-+|.+-....+. .-+.+.|+-|+|.+|
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvL 211 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVL 211 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhccee
Confidence 774322222 23345578888887776652 357789999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=180.18 Aligned_cols=175 Identities=45% Similarity=0.707 Sum_probs=147.1
Q ss_pred cceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecccC-CHH
Q psy787 49 SYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVG-GLQ 127 (235)
Q Consensus 49 ~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 127 (235)
++|.||++....+++.+++|++........ ...+.+|+..++.++|++++++.+.+. .....++++|++++ +|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK---RERILREISILKKLKHPNIVRLYDVFE--DEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH---HHHHHHHHHHHHhCCCCcHHHHHhhee--eCCEEEEEEeCCCCCCHH
Confidence 578999999988889999999876553321 457889999999999999999999994 44678999999987 798
Q ss_pred HHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCC
Q psy787 128 DMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSP 207 (235)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 207 (235)
+++... ..++...++.++.+++.++.+||+.+++|+|++|+||+++.++.++++|||.+...... .......++.
T Consensus 76 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~ 150 (244)
T smart00220 76 DLLKKR--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTP 150 (244)
T ss_pred HHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCc
Confidence 888765 33889999999999999999999999999999999999999999999999999865421 1333455777
Q ss_pred cccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 208 VFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 208 ~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.|+|||...+ ..++.++|+||||+++
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l 176 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVIL 176 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHH
Confidence 8999999876 4478899999999864
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=172.86 Aligned_cols=182 Identities=42% Similarity=0.671 Sum_probs=150.5
Q ss_pred eccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEeccc-
Q psy787 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCV- 123 (235)
Q Consensus 45 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~- 123 (235)
||.|++|.||++....+++.+++|++....... ....+.+|+..+..++|++++++.+.+. .....++++|+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFE--DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeee--cCCeEEEEEecCCC
Confidence 689999999999998778999999887654321 2346889999999999999999999994 4467899999998
Q ss_pred CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc-CCcEEEeeeccccccCccccCCcccc
Q psy787 124 GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL-DGTLKISDFGVAESLDMFLHDDTITT 202 (235)
Q Consensus 124 ~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~ 202 (235)
++|.+++.... ..++...++.++.+++.++.+||+.+++|+||+|.||+++. ++.++|+||+.+........ ....
T Consensus 76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 57888876542 46889999999999999999999999999999999999999 89999999999975532111 1333
Q ss_pred cCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 203 SQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 203 ~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......|++||..... ...+.++|+|+||+++
T Consensus 153 ~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~ 184 (215)
T cd00180 153 IVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVIL 184 (215)
T ss_pred ccCCCCccChhHhccc-CCCCchhhhHHHHHHH
Confidence 4577789999998763 2578899999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=191.52 Aligned_cols=200 Identities=26% Similarity=0.329 Sum_probs=136.1
Q ss_pred eeceEEeeeeeccccceEEEEeecc----------------chhhheeeeeeeeccccCC----------CCccccHHHH
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDS----------------ETLCRRAVKIFKKKKLQRI----------PNGEINVDRE 88 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~----------------~~~~~~~~K~~~~~~~~~~----------~~~~~~~~~e 88 (235)
..++|.+.++||+|+||+||++... ..++.||+|.+........ .........|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999998642 2346789998754321100 0011223446
Q ss_pred HHHHHhcCCCCc-----ceeeeEEEcC------CCceEEEEEecccC-CHHHHhhcCC----------------------
Q psy787 89 IRLLKMLQHRNV-----IGLVDVFVND------KKQKMYLIMEYCVG-GLQDMLDSTP---------------------- 134 (235)
Q Consensus 89 ~~~l~~l~h~~i-----~~~~~~~~~~------~~~~~~lv~e~~~~-~l~~~~~~~~---------------------- 134 (235)
+.++.+++|.++ +++.+++... ..+..++|+||+++ +|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666677766543 5666665321 23467999999975 6877775321
Q ss_pred CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccc
Q psy787 135 YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEI 214 (235)
Q Consensus 135 ~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 214 (235)
....++..+..++.|++.+|.|||+.+++||||||+||+++.++.++|+|||++....... .........++.|+|||.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChhh
Confidence 1123556788899999999999999999999999999999999999999999986443111 111112234688999998
Q ss_pred cCCCCCC--------------------CCCcccEEEeeeeC
Q psy787 215 ANGLPEI--------------------SGYKVDIWSSGVTL 235 (235)
Q Consensus 215 ~~~~~~~--------------------~~~~~Di~slG~~l 235 (235)
+...... ...+.|+||+|++|
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil 422 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLL 422 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHH
Confidence 7542110 11247999999975
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=199.81 Aligned_cols=190 Identities=22% Similarity=0.310 Sum_probs=156.8
Q ss_pred ceEEeeeeeccccceEEEEeeccchhh----heeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLC----RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
......++||+|+||+||++.....++ +|++|++...... +...++..|..++..++|||++++.+++...
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~---~~s~e~LdeAl~masldHpnl~RLLgvc~~s-- 770 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP---KASIELLDEALRMASLDHPNLLRLLGVCMLS-- 770 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc---hhhHHHHHHHHHHhcCCCchHHHHhhhcccc--
Confidence 345556799999999999986544344 5677766544433 3445788999999999999999999999532
Q ss_pred ceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
++-||++|++ |.|.++++... .++.....+.|..||++||.|||.++++||||..+|+++...+.+++.|||+++.+
T Consensus 771 -~~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 771 -TLQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred -hHHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 3789999997 56999998765 77899999999999999999999999999999999999999999999999999988
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.............-...|+|=|.+.. +.++.++||||+||.+
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVti 890 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTI 890 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhH
Confidence 65555555555555667999999887 5699999999999863
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=168.16 Aligned_cols=175 Identities=18% Similarity=0.209 Sum_probs=130.5
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCcccc------HHHHHHHHHhcCCCCcceee
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN------VDREIRLLKMLQHRNVIGLV 104 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~~i~~~~ 104 (235)
...-+.++|++.+.+|.|+||.||++.+ ++..+++|++.+..... .....+ +.+|+..+.++.|++|+.+.
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~-~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRT-ERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCch-HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 3455678999999999999999999766 46689999997765443 222222 57899999999999999999
Q ss_pred eEEEcCC------CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC
Q psy787 105 DVFVNDK------KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD 177 (235)
Q Consensus 105 ~~~~~~~------~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~ 177 (235)
.++.... .+..+++|||++| +|.+... ++. ....+++.++..+|+.|++|||++|+||+++++
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN 171 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC
Confidence 8865332 2357899999987 5766521 222 246699999999999999999999999999988
Q ss_pred CcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 178 GTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+ ++++|||....... .... ...+.. ..+..++|+||||+.+
T Consensus 172 g-i~liDfg~~~~~~e----~~a~----------d~~vle--r~y~~~~di~~lg~~~ 212 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQ----RKAK----------DRIDLE--RHYGIKNEIKDLGYYL 212 (232)
T ss_pred C-EEEEECCCcccccc----hhhH----------HHHHHH--hHhcccccccceeEee
Confidence 8 99999998864321 0000 002222 2355799999999975
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=177.98 Aligned_cols=188 Identities=29% Similarity=0.473 Sum_probs=150.1
Q ss_pred eeeceEEeeeeeccccceEEEEeeccc---hhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSE---TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVN 109 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (235)
.+.+.|.++++||.|.|++||++.+.. ..+.||+|-+....... ++.+|+..|..+ .+.||+++.+.+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~------ri~~El~~L~~~gG~~ni~~~~~~~-- 104 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS------RILNELEMLYRLGGSDNIIKLNGCF-- 104 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch------HHHHHHHHHHHhccchhhhcchhhh--
Confidence 455679999999999999999998876 67899999876655443 589999999999 589999999999
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC-CcEEEeeecc
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD-GTLKISDFGV 187 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~ 187 (235)
..+..+++|+||++- ...++... ++...+..+++.++.||.++|.+||+|||+||+|++.+.. ++-.|+|||+
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechh
Confidence 666789999999975 45555544 5688999999999999999999999999999999999866 6789999999
Q ss_pred ccccCccc--------------c----------------------------CCcccccCCCCcccCccccCCCCCCCCCc
Q psy787 188 AESLDMFL--------------H----------------------------DDTITTSQGSPVFQAPEIANGLPEISGYK 225 (235)
Q Consensus 188 ~~~~~~~~--------------~----------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~ 225 (235)
+...+... + ........||++|.|||++..-+ .-+++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~-~Qtta 258 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP-RQTTA 258 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc-CcCCc
Confidence 87221100 0 00011234889999999987633 34679
Q ss_pred ccEEEeeeeC
Q psy787 226 VDIWSSGVTL 235 (235)
Q Consensus 226 ~Di~slG~~l 235 (235)
.||||-|+++
T Consensus 259 iDiws~GVI~ 268 (418)
T KOG1167|consen 259 IDIWSAGVIL 268 (418)
T ss_pred cceeecccee
Confidence 9999999985
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-27 Score=192.87 Aligned_cols=189 Identities=33% Similarity=0.534 Sum_probs=159.6
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.+.|..+..+|+|.+|.||++++.++++..|+|+++... .++...++.|+.+++..+|+||+.+++.+. .....
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsyl--r~dkl 87 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYL--RRDKL 87 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhh--hhcCc
Confidence 357889999999999999999999999999999998765 345556788999999999999999999995 34467
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++.||||+| +|.+..+-. +++++-++..+++....+++|||++|-+|||+|-.||++.+.|.+++.|||.+-.+...
T Consensus 88 wicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 999999975 577755544 78999999999999999999999999999999999999999999999999988655421
Q ss_pred ccCCcccccCCCCcccCccccC-CCCCCCCCcccEEEeeee
Q psy787 195 LHDDTITTSQGSPVFQAPEIAN-GLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~~~Di~slG~~ 234 (235)
-.......|++.|+|||+-. +..+.+...+|+|++|+.
T Consensus 166 --i~KrksfiGtpywmapEvaaverkggynqlcdiwa~git 204 (829)
T KOG0576|consen 166 --IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGIT 204 (829)
T ss_pred --hhhhhcccCCccccchhHHHHHhcccccccccccccccc
Confidence 22344566999999999752 333568899999999963
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=192.60 Aligned_cols=197 Identities=27% Similarity=0.407 Sum_probs=152.9
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccc-------hhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcce
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSE-------TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIG 102 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 102 (235)
..+...++..+.+.||+|.||.|+++.... ....||+|..+..... .....+..|+.+++.+ .|+|++.
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~---~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS---SEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc---HHHHHHHHHHHHHHHhcCCcchhh
Confidence 344444455777899999999999986321 1456777776655432 4456789999999998 5999999
Q ss_pred eeeEEEcCCCceEEEEEeccc-CCHHHHhhcCC------C--------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCC
Q psy787 103 LVDVFVNDKKQKMYLIMEYCV-GGLQDMLDSTP------Y--------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDI 167 (235)
Q Consensus 103 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~------~--------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 167 (235)
+.+.+. .++.+++|+||+. |.|.+++.... . ..++..+.+.+++|++.||+||++..++||||
T Consensus 367 llG~~t--~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDL 444 (609)
T KOG0200|consen 367 LLGACT--QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDL 444 (609)
T ss_pred heeeec--cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhh
Confidence 999995 4678899999996 67998888764 0 13888999999999999999999999999999
Q ss_pred CCCCeEEccCCcEEEeeeccccccCccccCCcccccC--CCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 168 KPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--GSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 168 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~--~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..+||++..+..+||+|||+++..... ......... -+..|+|||.+.. ..++.++||||+|++|
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~-~~y~~~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L 511 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNK-DYYRTKSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILL 511 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCC-CceEecCCCCccceeecCHHHhcc--CcccccchhhHHHHHH
Confidence 999999999999999999999843210 011111111 2334999999988 6699999999999975
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=173.76 Aligned_cols=195 Identities=26% Similarity=0.318 Sum_probs=153.1
Q ss_pred eeec-eEEeeeeeccccceEEEEeeccchh-hheeeeeeeeccccCCCCccccHHHHHHHHHhcC----CCCcceeeeEE
Q psy787 34 KMIG-KYVMGDLLGEGSYGKVKEMLDSETL-CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ----HRNVIGLVDVF 107 (235)
Q Consensus 34 ~~~~-~y~i~~~ig~g~~~~v~~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~ 107 (235)
.... +|.+.++||.|+||.||++.+...+ ..+|+|+........ ...+..|..++..+. .++++.+.+.+
T Consensus 14 ~~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G 89 (322)
T KOG1164|consen 14 DKVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHG 89 (322)
T ss_pred cccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC----CccchhHHHHHHHHhhhcCCCCCCEEEEec
Confidence 3344 8999999999999999999987664 567888766543221 114677888888876 36888888887
Q ss_pred EcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-----cEEE
Q psy787 108 VNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-----TLKI 182 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-----~~~l 182 (235)
. ....+.++||+.++.+|.++......+.++...+..++.|++.+|+++|+.|++||||||.|+++.... .+.+
T Consensus 90 ~-~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 90 R-STEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred c-CCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence 3 245577999999999999988766668899999999999999999999999999999999999998653 5899
Q ss_pred eeecccc--ccCccccC----C-c-ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 183 SDFGVAE--SLDMFLHD----D-T-ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 183 ~dfg~~~--~~~~~~~~----~-~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|||+++ .+-..... . . .....||..|.++....+ ...+.+.|+||++.++
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l 227 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYML 227 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHH
Confidence 9999998 33111111 1 1 123348899999999988 4488999999988753
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=158.82 Aligned_cols=142 Identities=23% Similarity=0.274 Sum_probs=108.7
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccccCCCC-----cc-----------------ccHHHHHHHHHhcCCCC
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN-----GE-----------------INVDREIRLLKMLQHRN 99 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~-----~~-----------------~~~~~e~~~l~~l~h~~ 99 (235)
..+||+|++|.||+|.+. +|+.||+|++++........ .. .....|++.+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 89999999998764322110 01 12235999999998887
Q ss_pred cceeeeEEEcCCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHH-HhCCcccCCCCCCCeEEccC
Q psy787 100 VIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL-HSQGIIHKDIKPGNLLLTLD 177 (235)
Q Consensus 100 i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l-H~~~i~H~dl~p~nili~~~ 177 (235)
+........ .. .++||||++|+ +....... .+++...+..++.|++.+|.++ |+.|++||||||+||+++ +
T Consensus 81 v~~p~~~~~--~~--~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 81 IPCPEPILL--KS--HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCcEEEe--cC--CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-C
Confidence 754444332 12 28999999875 33332222 5788999999999999999999 799999999999999998 5
Q ss_pred CcEEEeeecccccc
Q psy787 178 GTLKISDFGVAESL 191 (235)
Q Consensus 178 ~~~~l~dfg~~~~~ 191 (235)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 88999999999744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=162.64 Aligned_cols=188 Identities=21% Similarity=0.295 Sum_probs=153.6
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCceE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 115 (235)
-.|++.++||+|+||..+++...-+++.||+|.-...... -.+..|.+..+.| ..++|+.++-+. ..+.+-
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A------PQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~N 99 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA------PQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYN 99 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCc------chHHHHHHHHHHHcCCCCCCceeeec--cccchh
Confidence 3699999999999999999999999999999965333211 1367788888877 568999988776 555667
Q ss_pred EEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-----cEEEeeeccccc
Q psy787 116 YLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-----TLKISDFGVAES 190 (235)
Q Consensus 116 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-----~~~l~dfg~~~~ 190 (235)
.+|++.++.+|.|++.-+. ..++.+.+..++.||+..++++|++.+++|||||+|++|...+ .+.++|||+|+.
T Consensus 100 iLVidLLGPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLLGPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhhCcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8999999999999998775 6799999999999999999999999999999999999997654 389999999987
Q ss_pred cCccccC-----CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHD-----DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...+... ....+..||-+||+-....|. --+.+.|+-|||-++
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvF 226 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVF 226 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhh
Confidence 6432222 223456689999999888773 368899999998654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=153.71 Aligned_cols=144 Identities=24% Similarity=0.239 Sum_probs=111.2
Q ss_pred eeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC-----------------Cc-----cccHHHHHHHHHhcCCC
Q psy787 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP-----------------NG-----EINVDREIRLLKMLQHR 98 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~-----------------~~-----~~~~~~e~~~l~~l~h~ 98 (235)
|.+.||+|++|.||+|.+. +|+.||+|+++........ .. ...+..|...+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999999876321100 00 11235788999999999
Q ss_pred CcceeeeEEEcCCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEcc
Q psy787 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTL 176 (235)
Q Consensus 99 ~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~ 176 (235)
++.....+.. .. .++||||++|. +....... ..++......++.|++.++.++|+ .|++|+||||.||+++
T Consensus 80 ~i~~p~~~~~--~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~- 152 (190)
T cd05145 80 GVPVPEPILL--KK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCCCceEEEe--cC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence 8765555442 12 38999999875 33222222 467888999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccC
Q psy787 177 DGTLKISDFGVAESLD 192 (235)
Q Consensus 177 ~~~~~l~dfg~~~~~~ 192 (235)
++.++|+|||++...+
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-22 Score=178.96 Aligned_cols=120 Identities=19% Similarity=0.315 Sum_probs=90.6
Q ss_pred ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcE------------
Q psy787 113 QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTL------------ 180 (235)
Q Consensus 113 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~------------ 180 (235)
..++.++|+++++|.+++... ...+++..++.+++||+.||.|||++||+||||||+|||+...+.+
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred chhhhhhccCCccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 357888999999999999754 2569999999999999999999999999999999999999665544
Q ss_pred -------EEeeeccccccCcccc--------------CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 181 -------KISDFGVAESLDMFLH--------------DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 181 -------~l~dfg~~~~~~~~~~--------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+++|||+++....... ........+++.|+|||++.+ ..++.++|||||||+|
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~sDVwSlGviL 205 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG--SSSNCASDVYRLGVLL 205 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc--CCCCchhhhhhHHHHH
Confidence 4555555442210000 000011246778999999987 4589999999999975
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-21 Score=146.37 Aligned_cols=146 Identities=23% Similarity=0.280 Sum_probs=111.0
Q ss_pred eEEeeeeeccccceEEEEee-ccchhhheeeeeeeeccccCCC----------------C----ccccHHHHHHHHHhcC
Q psy787 38 KYVMGDLLGEGSYGKVKEML-DSETLCRRAVKIFKKKKLQRIP----------------N----GEINVDREIRLLKMLQ 96 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~-~~~~~~~~~~K~~~~~~~~~~~----------------~----~~~~~~~e~~~l~~l~ 96 (235)
-|.+.++||.|++|.||+|. +..+|+.||+|+++........ . ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999998 6678999999999865421100 0 1123568999999986
Q ss_pred CC--CcceeeeEEEcCCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCC-cccCCCCCCCe
Q psy787 97 HR--NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG-IIHKDIKPGNL 172 (235)
Q Consensus 97 h~--~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~-i~H~dl~p~ni 172 (235)
+. .+++++... ..++|||+++|. +....... ..........++.|++.++.+||+.| ++|+|+||+||
T Consensus 109 ~~~i~~p~~~~~~------~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAWR------RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEec------CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence 53 344444321 237999999884 44433222 34566677899999999999999999 99999999999
Q ss_pred EEccCCcEEEeeeccccccC
Q psy787 173 LLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 173 li~~~~~~~l~dfg~~~~~~ 192 (235)
+++ ++.++++|||.+...+
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-20 Score=139.26 Aligned_cols=136 Identities=21% Similarity=0.251 Sum_probs=101.8
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-----CCCCcceeeeEEEcCC-CceE
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-----QHRNVIGLVDVFVNDK-KQKM 115 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~-~~~~ 115 (235)
.+.||+|+++.||. ++.+... ++|++..... .....+.+|+..++.+ .||||+++++++..+. .+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 36799999999995 6666555 5887765432 2334688999999999 5799999999995432 1343
Q ss_pred E-EEEeccc---CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHH-HHHHhCCcccCCCCCCCeEEccC----CcEEEeeec
Q psy787 116 Y-LIMEYCV---GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGL-EYLHSQGIIHKDIKPGNLLLTLD----GTLKISDFG 186 (235)
Q Consensus 116 ~-lv~e~~~---~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l-~~lH~~~i~H~dl~p~nili~~~----~~~~l~dfg 186 (235)
+ +|+||.+ ++|.+++... .+++. ..++.+++.++ +|||+++|+||||||+||+++.. .+++|+|++
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 4 7899954 5799999653 35544 35677877777 99999999999999999999753 379999944
Q ss_pred ccc
Q psy787 187 VAE 189 (235)
Q Consensus 187 ~~~ 189 (235)
.+.
T Consensus 155 G~~ 157 (210)
T PRK10345 155 GES 157 (210)
T ss_pred CCc
Confidence 443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=150.41 Aligned_cols=190 Identities=40% Similarity=0.596 Sum_probs=152.1
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCC-CcceeeeEEEcCCCceEEE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR-NVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~~l 117 (235)
|.+.+.||.|+|+.||.+.+. ..+++|.+........ .....+.+|+..+..+.|+ +++++.+.+ ......++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIVKLYDFF--QDEGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccch-hHHHHHHHHHHHHHHccCCcceeeEEEEE--ecCCEEEE
Confidence 788999999999999999886 6778888876665431 2456788999999999988 799999999 44455899
Q ss_pred EEecccCC-HHHHhhcCCC-CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-cEEEeeeccccccCcc
Q psy787 118 IMEYCVGG-LQDMLDSTPY-KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-TLKISDFGVAESLDMF 194 (235)
Q Consensus 118 v~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~ 194 (235)
+++++.+. +.+.+..... ..+.......++.|++.++.++|+.+++|||+||+|++++..+ .++++|||.+..+...
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 99999864 6655544321 2688999999999999999999999999999999999999988 7999999999755432
Q ss_pred ccCC----cccccCCCCcccCccccCCCC-CCCCCcccEEEeeee
Q psy787 195 LHDD----TITTSQGSPVFQAPEIANGLP-EISGYKVDIWSSGVT 234 (235)
Q Consensus 195 ~~~~----~~~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~slG~~ 234 (235)
.... ......++..|.|||.+.+.. ...+...|+||+|++
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~ 200 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGIT 200 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHH
Confidence 2221 235566889999999997632 357889999999954
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=153.10 Aligned_cols=192 Identities=22% Similarity=0.232 Sum_probs=144.8
Q ss_pred ceEEeeeeeccccceEEEEeeccc-----hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSE-----TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
.|++....+-.|.||.||.+.... +.+.+.+|.++..... -....+..|...+.-..|+|+..+.+++.+ +
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~---iQv~~~L~es~lly~~sH~nll~V~~V~ie-~ 359 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ---IQVNLLLQESMLLYGASHPNLLSVLGVSIE-D 359 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH---HHHHHHHHHHHHHhcCcCCCccceeEEEee-c
Confidence 357777788899999999984332 3456666766544322 223356788888888899999999999984 4
Q ss_pred CceEEEEEeccc-CCHHHHhhcC------CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEee
Q psy787 112 KQKMYLIMEYCV-GGLQDMLDST------PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISD 184 (235)
Q Consensus 112 ~~~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~d 184 (235)
....+.++++.+ |.|..+++-. ..+.++-.+...++.|++.||.|||+.|++|.||..+|.+|++.-+++|+|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence 557788999987 5688888722 123466678889999999999999999999999999999999999999999
Q ss_pred ecccccc-CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESL-DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~-~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
-.+++-+ +.+..- -...-..+..||+||.+.. ..++.++|+||||++|
T Consensus 440 saLSRDLFP~DYhc-LGDnEnRPvkWMslEal~n--~~yssasDvWsfGVll 488 (563)
T KOG1024|consen 440 SALSRDLFPGDYHC-LGDNENRPVKWMSLEALQN--SHYSSASDVWSFGVLL 488 (563)
T ss_pred chhccccCcccccc-cCCCCCCcccccCHHHHhh--hhhcchhhhHHHHHHH
Confidence 8888733 211111 0111123456999999987 5599999999999874
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.8e-21 Score=166.56 Aligned_cols=193 Identities=26% Similarity=0.352 Sum_probs=147.4
Q ss_pred CCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC---CCCcceee
Q psy787 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ---HRNVIGLV 104 (235)
Q Consensus 28 ~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~ 104 (235)
+..--+.....|.|-+.||.|++|+||+|.+.. |+.+|+|+-++...+. |.-=.+++.+|+ -+-|.++.
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-------fYI~~q~~~RLk~~~~~~~~~~~ 760 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-------FYICLQVMERLKPQMLPSIMHIS 760 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-------eeehHHHHHhhchhhhcchHHHH
Confidence 333344555679999999999999999999876 9999999988877654 211222333343 24455666
Q ss_pred eEEEcCCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-----
Q psy787 105 DVFVNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG----- 178 (235)
Q Consensus 105 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~----- 178 (235)
..++ -.+.-++|++|.+ |+|.+++... +.+++...+.+..||+..++.||..+|+||||||+|++|...-
T Consensus 761 ~a~~--~~~~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 761 SAHV--FQNASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred HHHc--cCCcceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCc
Confidence 5553 2224489999997 6899999844 7899999999999999999999999999999999999996432
Q ss_pred --cEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeee
Q psy787 179 --TLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 179 --~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 234 (235)
-++|+|||.+.-+.-+..........++..|.=+|+..|.+ ++..+|.|.|+.+
T Consensus 837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp--WtYq~DyfGlAa~ 892 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP--WTYQIDYFGLAAT 892 (974)
T ss_pred ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC--CchhhhhHHHHHH
Confidence 39999999886443233444566667888899999999955 8999999998754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.4e-19 Score=130.65 Aligned_cols=137 Identities=19% Similarity=0.163 Sum_probs=102.8
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCCceEEE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~l 117 (235)
+.++..|++|+||+|+++.. .+.+++.+.+.........-....+.+|++++.++. +++++.++++. ..++
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~l 75 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHL 75 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEE
Confidence 34677899999999997765 456666655544433221112235789999999995 47899998863 3589
Q ss_pred EEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCC-CCCCeEEccCCcEEEeeeccccccC
Q psy787 118 IMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDI-KPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 118 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl-~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
+|+|+.|. |...... ....++.|++.++.++|+.|++|+|| ||.||+++.++.++|+|||++...+
T Consensus 76 vmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred EEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 99999875 5432211 11357889999999999999999999 7999999999999999999998543
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=159.82 Aligned_cols=190 Identities=33% Similarity=0.499 Sum_probs=141.4
Q ss_pred eeeeeccccceEEEEeeccchhhheeeeeeeec--cccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKK--KLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
-...+|.|.+|.++.+......+.+..|.+... ......+....+..|+.+-..+.|+|++.......+. ....-.
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~~~~ 399 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DGILQS 399 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--ccchhh
Confidence 446788999997777766655555565544321 1111111112255677777778999998877776432 223334
Q ss_pred EecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC-
Q psy787 119 MEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD- 197 (235)
Q Consensus 119 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 197 (235)
||||+.+|..++.+. ..++..++-.+++|+..|++|+|+.|+.|||+||+|+++..+|.++|+|||.+..+..+...
T Consensus 400 mE~~~~Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhcccHHHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 999988888888875 57888899999999999999999999999999999999999999999999999877543333
Q ss_pred -CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 198 -DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 198 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......+..+|+|||.+.+. .......||||.|+++
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~-~ydpr~vDiwS~~ii~ 515 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGK-EYDPRAVDVWSCGIIY 515 (601)
T ss_pred hhhhcCcccCCcCcCccccccc-ccCcchhhhhhccceE
Confidence 444456688999999999873 3445689999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=133.90 Aligned_cols=137 Identities=24% Similarity=0.330 Sum_probs=107.9
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCC----ccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN----GEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
+.||+|++|.||++.. .+..+++|+........... ....+.+|+..+..+.|++++....++... ...+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEE
Confidence 5789999999999987 67788999765433221100 113467899999999999887777666433 356899
Q ss_pred EecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 119 MEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 119 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
|||++| +|.+.+.... . ....++.+++.+|.++|+.+++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999976 6887775431 1 7788999999999999999999999999999999 88899999998874
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.4e-20 Score=143.13 Aligned_cols=192 Identities=26% Similarity=0.369 Sum_probs=120.3
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC----------CCCcceeeeEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ----------HRNVIGLVDVF 107 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~----------h~~i~~~~~~~ 107 (235)
+....+.||.|+++.||.+.+..+++.+++|++....... ......+.+|.-....+. |-.++...+..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~-~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADAS-ANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTH-TTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccc-hHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 5667789999999999999999999999999998777322 333334444443332221 22233333322
Q ss_pred E-c---------CC--Cc---eEEEEEecccCCHHHHhhc---CCCC--CCCHHhHHHHHHHHHHHHHHHHhCCcccCCC
Q psy787 108 V-N---------DK--KQ---KMYLIMEYCVGGLQDMLDS---TPYK--KFPIWQAHGYFLQLLDGLEYLHSQGIIHKDI 167 (235)
Q Consensus 108 ~-~---------~~--~~---~~~lv~e~~~~~l~~~~~~---~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 167 (235)
. . .+ .. +.+++|+-..++|.+++.. .... .........+..|++..+++||..|++|+||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 0 11 11 3477899888887766542 2111 2233345566689999999999999999999
Q ss_pred CCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCC------CCCCCCCcccEEEeeeeC
Q psy787 168 KPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG------LPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 168 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~~Di~slG~~l 235 (235)
+|+|++++.+|.+.|+||+.....+.... ....+..|.|||.... ....++.+.|.|+||++|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 99999999999999999998875542111 1234467999996633 122478899999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.9e-19 Score=131.16 Aligned_cols=140 Identities=23% Similarity=0.249 Sum_probs=104.8
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC------------------CccccHHHHHHHHHhcCCCC
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP------------------NGEINVDREIRLLKMLQHRN 99 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~ 99 (235)
.|.+.+.||.|++|.||++... +|+.+++|++......... ........|+..+..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888899999999999999874 7899999987654311000 01112567888888887764
Q ss_pred --cceeeeEEEcCCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc
Q psy787 100 --VIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL 176 (235)
Q Consensus 100 --i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~ 176 (235)
++..++. ...+++|||++|. +..... ......++.+++.++.++|+.|++|+||+|.||+++.
T Consensus 95 i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 95 FPVPKPIDW------NRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCCCceeec------CCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence 3343332 2348999999874 543321 1345678999999999999999999999999999999
Q ss_pred CCcEEEeeeccccccC
Q psy787 177 DGTLKISDFGVAESLD 192 (235)
Q Consensus 177 ~~~~~l~dfg~~~~~~ 192 (235)
++.++|+|||++..+.
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=128.85 Aligned_cols=133 Identities=21% Similarity=0.252 Sum_probs=101.2
Q ss_pred eccccceEEEEeeccchhhheeeeeeeeccccCCC----CccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEe
Q psy787 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP----NGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 45 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 120 (235)
||+|++|.||++.. ++..+++|+.......... ....++.+|+.++..+.++++.....++... ...+++||
T Consensus 2 ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~e 77 (199)
T TIGR03724 2 IAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIVME 77 (199)
T ss_pred CCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEEEE
Confidence 79999999999985 5678899986543321110 1124567899999999888765555444323 34589999
Q ss_pred cccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 121 YCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 121 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
+++| +|.+.+.... . .++.+++.+|.++|+.|++|+|++|.||+++ ++.++++|||.+...
T Consensus 78 ~~~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9976 5777664421 1 7899999999999999999999999999999 899999999988743
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-20 Score=160.92 Aligned_cols=191 Identities=23% Similarity=0.247 Sum_probs=142.1
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
.+.-++.||++.|=+|.+|++. .|. +++|++.++.....-.....-..+++ ...+++||.+++.-+. ...+..|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~--~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL--VTDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH--HhhHHHHH
Confidence 6777889999999999999885 334 89999977764332222112223333 4556899999998876 45566789
Q ss_pred EEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC
Q psy787 118 IMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197 (235)
Q Consensus 118 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 197 (235)
|.+|...+|.|.+.-+ .-+..-+.+.++.||+.|+..+|..|++|||||.+||+|..=+.+.|+||...+..--+...
T Consensus 99 vRqyvkhnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHHHhhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9999999999999876 55778899999999999999999999999999999999999999999999987644111111
Q ss_pred Cccc-----ccCCCCcccCccccCCC--------CCC-CCCcccEEEeeeeC
Q psy787 198 DTIT-----TSQGSPVFQAPEIANGL--------PEI-SGYKVDIWSSGVTL 235 (235)
Q Consensus 198 ~~~~-----~~~~~~~~~aPE~~~~~--------~~~-~~~~~Di~slG~~l 235 (235)
+... +......|.|||.+... +.. .+++.||||+||++
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVi 228 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVI 228 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHH
Confidence 1111 11233459999987531 112 57899999999974
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=146.05 Aligned_cols=146 Identities=23% Similarity=0.285 Sum_probs=108.8
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC----CCccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI----PNGEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
.......|...+.||+|+||+||++.... ..+++|+......... .....++.+|+.++..++|++++.+..+.
T Consensus 328 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~ 405 (535)
T PRK09605 328 EEEVKRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYD 405 (535)
T ss_pred ccccccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEE
Confidence 33334455677899999999999987643 3445554332221110 01124578999999999999998877666
Q ss_pred EcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeec
Q psy787 108 VNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
.. ....+++|||++| +|.+++. ....++.+++.+|.+||+.+++|||+||+||++ .++.++|+|||
T Consensus 406 ~~--~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 406 VD--PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred Ee--CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCc
Confidence 43 3346899999976 5777664 346789999999999999999999999999999 57899999999
Q ss_pred cccccC
Q psy787 187 VAESLD 192 (235)
Q Consensus 187 ~~~~~~ 192 (235)
++...+
T Consensus 473 la~~~~ 478 (535)
T PRK09605 473 LGKYSD 478 (535)
T ss_pred ccccCC
Confidence 997543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.1e-18 Score=125.20 Aligned_cols=139 Identities=26% Similarity=0.359 Sum_probs=98.5
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCcc--------------------ccHHHHHHHHHhcCCCC--
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGE--------------------INVDREIRLLKMLQHRN-- 99 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~--------------------~~~~~e~~~l~~l~h~~-- 99 (235)
.+.||+|++|+||++.+. +++.|++|++............ .....|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999986 7899999998764332211110 01135566666664443
Q ss_pred cceeeeEEEcCCCceEEEEEecccCC-HH-HHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEcc
Q psy787 100 VIGLVDVFVNDKKQKMYLIMEYCVGG-LQ-DMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTL 176 (235)
Q Consensus 100 i~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~ 176 (235)
++++++.. ..+++|||++++ +. ..+.... . ...+..++.+++.++.++|. .+++|+||+|+||+++
T Consensus 81 ~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 81 VPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCceEecC------CCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-
Confidence 44444432 248999999873 11 1121111 1 15678899999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccC
Q psy787 177 DGTLKISDFGVAESLD 192 (235)
Q Consensus 177 ~~~~~l~dfg~~~~~~ 192 (235)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-18 Score=126.50 Aligned_cols=94 Identities=37% Similarity=0.478 Sum_probs=79.1
Q ss_pred CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccccc
Q psy787 124 GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS 203 (235)
Q Consensus 124 ~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 203 (235)
|+|.+++.... .++++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||.+..... ...
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~ 64 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-------EQS 64 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-------ccC
Confidence 57888887542 56999999999999999999999998 999999999999999 998875432 112
Q ss_pred CCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 204 QGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 204 ~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+++.|+|||.+.+ ..++.++||||||+++
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il 94 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITL 94 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHH
Confidence 47889999999987 4488999999999974
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=9e-17 Score=123.04 Aligned_cols=139 Identities=18% Similarity=0.231 Sum_probs=101.1
Q ss_pred eec-cccceEEEEeeccchhhheeeeeeeeccc-----cC----CCCccccHHHHHHHHHhcCCCCc--ceeeeEEEcCC
Q psy787 44 LLG-EGSYGKVKEMLDSETLCRRAVKIFKKKKL-----QR----IPNGEINVDREIRLLKMLQHRNV--IGLVDVFVNDK 111 (235)
Q Consensus 44 ~ig-~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-----~~----~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~ 111 (235)
.|| .|+.|+||.+... +..+++|.+..... .. .......+.+|+..+..+.|+++ +.+++......
T Consensus 38 ~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred eeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 466 7888888887663 67889988864321 10 01223457889999999998875 55665543222
Q ss_pred Cc--eEEEEEecccC--CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 112 KQ--KMYLIMEYCVG--GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 112 ~~--~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
.. ..++|+|+++| +|.+++.. ..++.. .+.+++.++.+||+.|++|+||||.||+++.++.++|+|||.
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 21 23599999986 57777654 334443 367899999999999999999999999999989999999998
Q ss_pred cccc
Q psy787 188 AESL 191 (235)
Q Consensus 188 ~~~~ 191 (235)
+...
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 8743
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-19 Score=133.32 Aligned_cols=184 Identities=20% Similarity=0.259 Sum_probs=143.8
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++..+..+|.....|+.|+++.. |..++.|++..+.... ...+.|..|...|+-+.||||+++.+.| ++..++.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~--risrdfneefp~lrifshpnilpvlgac--nsppnlv 263 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTA--RISRDFNEEFPALRIFSHPNILPVLGAC--NSPPNLV 263 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcch--hhcchhhhhCcceeeecCCchhhhhhhc--cCCCCce
Confidence 34556678999999999999884 4566778876665443 4456789999999999999999999999 7888999
Q ss_pred EEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeEEccCCcEEEe--eecccccc
Q psy787 117 LIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLTLDGTLKIS--DFGVAESL 191 (235)
Q Consensus 117 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~nili~~~~~~~l~--dfg~~~~~ 191 (235)
+++.|++ |+|.+++.....--.+..++.+++.+++.+|.|||+.. |.---|+...++|+++-..+|. |--++
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs--- 340 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--- 340 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee---
Confidence 9999997 67999999887666788899999999999999999985 4455789999999998776665 32111
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCC-CCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEI-SGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~~~Di~slG~~l 235 (235)
.+-....-.+.|++||.+...+.- .-.++|+|||+++|
T Consensus 341 ------fqe~gr~y~pawmspealqrkped~n~raadmwsfaill 379 (448)
T KOG0195|consen 341 ------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILL 379 (448)
T ss_pred ------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHH
Confidence 111223356789999998765432 34689999999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=113.91 Aligned_cols=131 Identities=24% Similarity=0.289 Sum_probs=105.8
Q ss_pred eeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCC--CCcceeeeEEEcCCCceEEEE
Q psy787 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH--RNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~~lv 118 (235)
+++.|+.|.++.||++.... ..+++|....... ...+.+|+..+..+++ .++++++... ...+..+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~--~~~~~~~~v 71 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASG--ESDGWSYLL 71 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCccEEE
Confidence 46789999999999998743 6788887754432 3458899999999976 5888888877 444678999
Q ss_pred EecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC---CcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 119 MEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ---GIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 119 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
+|++++. +... +......++.+++.++..+|.. +++|+|++|.||+++..+.++++||+.+..
T Consensus 72 ~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 72 MEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999875 3322 4556677899999999999985 699999999999999989999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.5e-17 Score=128.61 Aligned_cols=136 Identities=28% Similarity=0.480 Sum_probs=102.1
Q ss_pred CCCCcceeeeEEEc-------------------------CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHH
Q psy787 96 QHRNVIGLVDVFVN-------------------------DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQL 150 (235)
Q Consensus 96 ~h~~i~~~~~~~~~-------------------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql 150 (235)
+||||+.+.+.|.+ ..+.++|+||..+..+|..++-.+ ..+.....-++.||
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~---~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR---HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC---CCchHHHHHHHHHH
Confidence 49999999988752 344689999999999999999875 34666778899999
Q ss_pred HHHHHHHHhCCcccCCCCCCCeEEccCC----cEEEeeeccccccCccccC----CcccccCCCCcccCccccCCCCCCC
Q psy787 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDG----TLKISDFGVAESLDMFLHD----DTITTSQGSPVFQAPEIANGLPEIS 222 (235)
Q Consensus 151 ~~~l~~lH~~~i~H~dl~p~nili~~~~----~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~ 222 (235)
++|+.|||++|+.|||+|.+||++.-+. .+.+.|||.+-.-+..... +.....-|.-..+|||..+.-|+..
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 9999999999999999999999995443 3788999977433221111 1122233556699999987655421
Q ss_pred ----CCcccEEEeeee
Q psy787 223 ----GYKVDIWSSGVT 234 (235)
Q Consensus 223 ----~~~~Di~slG~~ 234 (235)
-.++|.|+.|.+
T Consensus 431 avvny~kAD~WA~Gal 446 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGAL 446 (598)
T ss_pred eeeccchhhhhhhhhh
Confidence 248999999864
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.3e-17 Score=137.38 Aligned_cols=174 Identities=32% Similarity=0.469 Sum_probs=138.5
Q ss_pred eccccceEEEEeec---cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCCceEEEEEe
Q psy787 45 LGEGSYGKVKEMLD---SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 45 ig~g~~~~v~~~~~---~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e 120 (235)
+|.|++|.|++++. ...+.-++.|+.++.......+. .-..|-.++...+ ||+++++...+ ......+++.+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~ld 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLILD 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeee--ccccchhHhhh
Confidence 68999999998643 34567788888877665553333 4456677777776 99999999999 56667899999
Q ss_pred cccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCc
Q psy787 121 YCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT 199 (235)
Q Consensus 121 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 199 (235)
+..| .+...+... ..+++.....+...++-++.++|+.+++|+|+|++||+++.+|++++.|||.++.+- .
T Consensus 78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v------~ 149 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV------K 149 (612)
T ss_pred hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhH------h
Confidence 9976 455544443 567778888899999999999999999999999999999999999999999998542 1
Q ss_pred ccccCCCCcccCccccCCCCCCCCCcccEEEeeee
Q psy787 200 ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 200 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 234 (235)
....+|+..|+|||.+++ -..++|.||+|++
T Consensus 150 ~~~~cgt~eymApEI~~g----h~~a~D~ws~gvl 180 (612)
T KOG0603|consen 150 EKIACGTYEYRAPEIING----HLSAADWWSFGVL 180 (612)
T ss_pred hhhcccchhhhhhHhhhc----cCCcccchhhhhh
Confidence 122278999999999984 4579999999986
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.1e-14 Score=105.69 Aligned_cols=142 Identities=18% Similarity=0.174 Sum_probs=99.9
Q ss_pred eeeeccccceEEEEeeccc------hhhheeeeeeeeccccCCCC------------------cccc----HHHHHHHHH
Q psy787 42 GDLLGEGSYGKVKEMLDSE------TLCRRAVKIFKKKKLQRIPN------------------GEIN----VDREIRLLK 93 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~------~~~~~~~K~~~~~~~~~~~~------------------~~~~----~~~e~~~l~ 93 (235)
..+||.|--+.||.|.... .+..+|+|+++.....-... .... ..+|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999997653 35789999887533211000 0112 238999999
Q ss_pred hcCCC--CcceeeeEEEcCCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHH-HhCCcccCCCCC
Q psy787 94 MLQHR--NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL-HSQGIIHKDIKP 169 (235)
Q Consensus 94 ~l~h~--~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l-H~~~i~H~dl~p 169 (235)
++... +++.++... .-++|||+++++ +....... ..++......+..+++.+|..+ |..|++|+||++
T Consensus 82 rl~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 98654 555666542 238999999864 22111111 2345556777889999999988 899999999999
Q ss_pred CCeEEccCCcEEEeeeccccccC
Q psy787 170 GNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 170 ~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.||++. ++.+.++|||.+...+
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 5789999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.2e-14 Score=101.38 Aligned_cols=145 Identities=21% Similarity=0.208 Sum_probs=111.2
Q ss_pred eeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC----CccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP----NGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
....+-+|+-+.|+.+.. .|+.+++|.-......... -...+..+|++.|.+++--+|.-..-++.+..++ .
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~--~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG--Q 86 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC--e
Confidence 567788999999998876 5677677644333222211 1234567899999988766776666666544444 8
Q ss_pred EEEecccC--CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc---EEEeeecccc
Q psy787 117 LIMEYCVG--GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT---LKISDFGVAE 189 (235)
Q Consensus 117 lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~ 189 (235)
|+|||++| ++.+++.+.-.....+.....+++++-+.+.-||..+++||||+.+||++..++. +.++|||++.
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 89999998 6999998876666666666899999999999999999999999999999987764 5899999986
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.1e-16 Score=135.25 Aligned_cols=154 Identities=32% Similarity=0.519 Sum_probs=105.3
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
...|..++.|..|++|.||+++|+.+.+.++.|+ .+..... .+ ++.....|+++
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lil--------Rn---ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLIL--------RN---ILTFAGNPFVV-------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchhh--------hc---cccccCCccee--------------
Confidence 3478899999999999999999999989988843 2222111 01 11111222222
Q ss_pred EEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC---
Q psy787 116 YLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD--- 192 (235)
Q Consensus 116 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~--- 192 (235)
|+-...+... +.++. +++.+++|||+.||+|+|+||+|.+|..-|++++.|||+++..-
T Consensus 136 --------gDc~tllk~~--g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 --------GDCATLLKNI--GPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred --------chhhhhcccC--CCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 2211222221 22222 23889999999999999999999999999999999999886331
Q ss_pred ----------ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 ----------MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ----------~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+.........++++.|.|||++.. ..|+...|+|++|+++
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIl 248 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIIL 248 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHH
Confidence 1111112223468999999999987 4599999999999874
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-16 Score=129.21 Aligned_cols=118 Identities=31% Similarity=0.517 Sum_probs=99.1
Q ss_pred ceEEEEEeccc-CCHHHHhhcC-CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 113 QKMYLIMEYCV-GGLQDMLDST-PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 113 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
.+++|.|++|. .+|.+++... .....+......++.|++.++.| ++.+|+|+||.||+...+..++|+|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36899999996 5799999744 33456777889999999999999 9999999999999999999999999999986
Q ss_pred cCccc----cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFL----HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... .......+.+++.|++||.+.+ ..++.++||||||++|
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil 452 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLIL 452 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHH
Confidence 64332 1234556779999999999999 6699999999999875
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.3e-15 Score=130.16 Aligned_cols=195 Identities=29% Similarity=0.468 Sum_probs=144.7
Q ss_pred eceEEeeeeeccccceEEEEeeccch-hhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCCc
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSET-LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 113 (235)
...|.+.+.||.|+++.+-++....+ ...++.|.+.... ...........|..+-..+. |+|++..++.. ....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~ 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPR 94 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCcc--CCCc
Confidence 56788999999999999977765433 2334444333222 11222233444666656665 99999999998 5666
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHH-hCCcccCCCCCCCeEEccCC-cEEEeeeccccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH-SQGIIHKDIKPGNLLLTLDG-TLKISDFGVAES 190 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH-~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~ 190 (235)
..+++.++..| ++.+.+........+....-.++.|+..++.|+| ..++.|+|++|+|.+++..+ .+++.|||++..
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 78899999755 4666553332236777788899999999999999 99999999999999999999 999999999987
Q ss_pred cCc-cccCCcccccCC-CCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDM-FLHDDTITTSQG-SPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~-~~~~~~~~~~~~-~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.. ...........+ ++.|.|||...+. +...+..|+||+|+++
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l 220 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVL 220 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccc
Confidence 754 233344445567 8999999998772 4567899999999875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.3e-14 Score=117.84 Aligned_cols=144 Identities=22% Similarity=0.297 Sum_probs=97.4
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCC------------------------------------ccccHH
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN------------------------------------GEINVD 86 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~------------------------------------~~~~~~ 86 (235)
+.|++|+.|.||+|... +|+.||||+.++.....-.. .+..+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999864 78999999987653111000 011355
Q ss_pred HHHHHHHhcC----CCCcceeeeEEEcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHH-HHHHHHhC
Q psy787 87 REIRLLKMLQ----HRNVIGLVDVFVNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLD-GLEYLHSQ 160 (235)
Q Consensus 87 ~e~~~l~~l~----h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~-~l~~lH~~ 160 (235)
+|...+.+++ +.+-+.+..++.+- ....+++|||++| ++.+...... ... ....++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~-~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDE-AGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHh-cCC---CHHHHHHHHHHHHHHHHHhC
Confidence 5666666553 33333444444221 2235899999987 4665543221 122 23456666665 47889999
Q ss_pred CcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 161 ~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
|++|+|++|.||++..++.++++|||++..++
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.9e-15 Score=120.26 Aligned_cols=140 Identities=28% Similarity=0.478 Sum_probs=109.5
Q ss_pred HhcCCCCcceeeeEEEcCCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCc-ccCCCCCC
Q psy787 93 KMLQHRNVIGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI-IHKDIKPG 170 (235)
Q Consensus 93 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i-~H~dl~p~ 170 (235)
+.+.|.|+.+|++.++++ +.+++|.++|+ |+|.+.+... ...++..-...+++.++.+|+|+|...+ .|+.++..
T Consensus 2 ~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred cccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 467899999999999755 67899999996 7899988763 3667888888899999999999999876 99999999
Q ss_pred CeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCC--CCC---CCCcccEEEeeeeC
Q psy787 171 NLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGL--PEI---SGYKVDIWSSGVTL 235 (235)
Q Consensus 171 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~---~~~~~Di~slG~~l 235 (235)
|.+++....+|+.|||+....................-|.|||.+.+. ... .+.+.|+||+|+++
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~ 148 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIM 148 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHH
Confidence 999999999999999998755320000111111133449999998763 222 57789999999874
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.3e-14 Score=119.48 Aligned_cols=149 Identities=20% Similarity=0.306 Sum_probs=96.2
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccC--------------------CC----------C----
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR--------------------IP----------N---- 80 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--------------------~~----------~---- 80 (235)
.+..|.. +.|++|+.|.||.|+...+|+.||+|+.++..... .. +
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3556766 78999999999999998779999999998653110 00 0
Q ss_pred --ccccHHHHHHHHHhcC----CCCcceeeeEEEcCCCceEEEEEecccCC-HHHHh--hcCCC--CCCCHHhHHHHHHH
Q psy787 81 --GEINVDREIRLLKMLQ----HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML--DSTPY--KKFPIWQAHGYFLQ 149 (235)
Q Consensus 81 --~~~~~~~e~~~l~~l~----h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~--~~~~~--~~~~~~~~~~~~~q 149 (235)
.+..+.+|...+.+++ +.+.+.+..++.+- ....+++|||+.|. +.+.. ..... ..+....+..++.|
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 0123556666665553 44444444444321 22458999999874 65532 22110 01222233333333
Q ss_pred HHHHHHHHHhCCcccCCCCCCCeEEccCC----cEEEeeeccccccC
Q psy787 150 LLDGLEYLHSQGIIHKDIKPGNLLLTLDG----TLKISDFGVAESLD 192 (235)
Q Consensus 150 l~~~l~~lH~~~i~H~dl~p~nili~~~~----~~~l~dfg~~~~~~ 192 (235)
+...|++|+|++|.||+++.++ +++++|||++..++
T Consensus 276 -------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 -------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3458999999999999999888 89999999987664
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.7e-13 Score=98.69 Aligned_cols=127 Identities=25% Similarity=0.230 Sum_probs=92.5
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCc-ceeeeEEEcCCCceEEEEEe
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV-IGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~lv~e 120 (235)
++.|+.|..+.||++... ++.+++|+...... ....+..|+..+..+.+.++ ++++... .. ..++|||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~--~~~lv~e 71 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFD--PE--TGVLITE 71 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEe--CC--CCeEEEE
Confidence 467889999999998864 67899998754321 12246789988888865444 4454443 32 2379999
Q ss_pred cccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCc-----ccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 121 YCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI-----IHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 121 ~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i-----~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
+++|. +... .. .....+.+++.+|+.||+.++ +|+|++|.||+++ ++.++++||+.+..
T Consensus 72 ~i~G~~l~~~-------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 72 FIEGSELLTE-------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ecCCCccccc-------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 99874 3321 01 113467899999999999985 9999999999999 77899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.7e-13 Score=94.95 Aligned_cols=134 Identities=23% Similarity=0.263 Sum_probs=96.3
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCc----cccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNG----EINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
..+.+|+-+.++.+.. .|..+++|.-.++......-+ ..+-.+|++++.+++-.+++...-+.++.. ...|+
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~--~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD--NGLIV 77 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCEEE
Confidence 3578899999988744 344566665444333321111 234568888998887766666665554344 44899
Q ss_pred EecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 119 MEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 119 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
|||.+|. |.+.+... ...++..+-..+.-||..||+|+||+++||++..+ ++.++|||++..
T Consensus 78 me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 9999986 77677764 14467777788888999999999999999999944 499999999973
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.7e-12 Score=107.40 Aligned_cols=162 Identities=17% Similarity=0.282 Sum_probs=114.7
Q ss_pred eeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecccCCHHHHhhcCCC
Q psy787 56 MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPY 135 (235)
Q Consensus 56 ~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~ 135 (235)
+..+.++.++.+.+++.... .......+-++.++.++||+|++++..+ +..+..|+|+|.+.. |..++...
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~--e~~~~~ylvTErV~P-l~~~lk~l-- 101 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTT--EEEGTLYLVTERVRP-LETVLKEL-- 101 (690)
T ss_pred cceeccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhh--cccCceEEEeecccc-HHHHHHHh--
Confidence 44456778888887765543 2222356777889999999999999999 666789999999854 12222221
Q ss_pred CCCCHHhHHHHHHHHHHHHHHHH-hCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccc
Q psy787 136 KKFPIWQAHGYFLQLLDGLEYLH-SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEI 214 (235)
Q Consensus 136 ~~~~~~~~~~~~~ql~~~l~~lH-~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 214 (235)
+...+...++||+.||.+|| +.+++|+||+.++|+++..|.++|++|.++........ .......-..|..|+.
T Consensus 102 ---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 102 ---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE 176 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence 24566678999999999998 56899999999999999999999999998875542221 1111222234677765
Q ss_pred cCCCCCCCCCcccEEEeeeeC
Q psy787 215 ANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 215 ~~~~~~~~~~~~Di~slG~~l 235 (235)
...+. -..|.|.||+++
T Consensus 177 ~~~s~----~s~D~~~Lg~li 193 (690)
T KOG1243|consen 177 IDPSE----WSIDSWGLGCLI 193 (690)
T ss_pred cCccc----cchhhhhHHHHH
Confidence 53321 467999999863
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.34 E-value=1e-13 Score=106.89 Aligned_cols=181 Identities=21% Similarity=0.273 Sum_probs=121.6
Q ss_pred EEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc---CCCceEEEEEeccc-CCHH
Q psy787 52 KVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN---DKKQKMYLIMEYCV-GGLQ 127 (235)
Q Consensus 52 ~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~~~lv~e~~~-~~l~ 127 (235)
.||++-++..|..++-.-+.................-+..+.++-|.|++++..++-+ ++.....++.||++ |++.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 3566666666666655444433332222222233444556677789999999988742 23446789999996 6788
Q ss_pred HHhhcCCC--CCCCHHhHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeEEccCCcEEEeeeccccccCccccC--Cccc
Q psy787 128 DMLDSTPY--KKFPIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD--DTIT 201 (235)
Q Consensus 128 ~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 201 (235)
.++++... ..++...+.+|+.|+.+||.|||+.. ++|++++.+.+++..+|.++++.-.-...-...... ....
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~ 240 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS 240 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence 88875532 45888899999999999999999984 999999999999999999988742211111100000 0011
Q ss_pred ccCCCCcccCccccCCCCCCCCCcccEEEeeee
Q psy787 202 TSQGSPVFQAPEIANGLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 202 ~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 234 (235)
...+.++|.+||.-.. ...+-++|||++|++
T Consensus 241 ~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTT--TNTTGASDIYKFGMC 271 (458)
T ss_pred ccccCCccccCCcCcc--cccccchhhhhhhHH
Confidence 1235678999997655 346779999999964
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.1e-11 Score=91.03 Aligned_cols=98 Identities=27% Similarity=0.312 Sum_probs=65.7
Q ss_pred cHHHHHHHHHhcCCC--CcceeeeEEEcCCCceEEEEEeccc--CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHH-HH
Q psy787 84 NVDREIRLLKMLQHR--NVIGLVDVFVNDKKQKMYLIMEYCV--GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY-LH 158 (235)
Q Consensus 84 ~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~-lH 158 (235)
...+|.+.|.++... +++.++.+. +. ++||||++ |.....+... .++......++.+++..+.. +|
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~--~~----~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~ 124 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN--RN----VIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLH 124 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE--TT----EEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe--CC----EEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHH
Confidence 467999999999766 456666553 22 79999998 6433333332 12244567788888885554 68
Q ss_pred hCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 159 ~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..|++||||++.||++.++ .+.++|||.+...
T Consensus 125 ~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 125 KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp CTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred hcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 9999999999999999966 9999999988743
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-12 Score=108.06 Aligned_cols=201 Identities=24% Similarity=0.321 Sum_probs=149.0
Q ss_pred ecCCceeEeeeceEEeeeeecc--ccceEEEEeec--cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCc
Q psy787 26 YDNKTIKVKMIGKYVMGDLLGE--GSYGKVKEMLD--SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNV 100 (235)
Q Consensus 26 ~~~~~~~~~~~~~y~i~~~ig~--g~~~~v~~~~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 100 (235)
+....-.+-....+.+.+-+|. |.++.+|.+.. ...+..+++|.-+..... .....+=.+++.....+ .|++.
T Consensus 103 ~~~S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~--p~~~~~k~~~~~s~~~i~~~~~~ 180 (524)
T KOG0601|consen 103 YGASPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP--PLDSKRKLREFLSHHKIDSHENP 180 (524)
T ss_pred cCCCCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC--ccccccccchhhcccccCccccc
Confidence 4444555556667888999999 99999999887 778888888864332221 11112223455555555 48888
Q ss_pred ceeeeEEEcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHH----HHHHHHhCCcccCCCCCCCeEEcc
Q psy787 101 IGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLD----GLEYLHSQGIIHKDIKPGNLLLTL 176 (235)
Q Consensus 101 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~----~l~~lH~~~i~H~dl~p~nili~~ 176 (235)
++.+..+ +.++..++-+|.++.++..+..... ..+++..++....+... |+.++|+..++|-|++|.|+++..
T Consensus 181 v~~~~~~--e~~~~lfiqtE~~~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~ 257 (524)
T KOG0601|consen 181 VRDSPAW--EGSGILFIQTELCGESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTS 257 (524)
T ss_pred cccCccc--ccCCcceeeeccccchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccc
Confidence 8877777 6777889999999988887776542 34777788888888888 999999999999999999999999
Q ss_pred C-CcEEEeeeccccccCccccCC---cccccCCCCcccCccccCCCCCCCCCcccEEEeeee
Q psy787 177 D-GTLKISDFGVAESLDMFLHDD---TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 177 ~-~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 234 (235)
+ ...+++|||+...+....-.. ......+...|++||...+. ++++.|+|+||.+
T Consensus 258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l---~~~~~di~sl~ev 316 (524)
T KOG0601|consen 258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL---ATFASDIFSLGEV 316 (524)
T ss_pred ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc---cchHhhhcchhhh
Confidence 9 889999999998764221111 11122466679999999763 5889999999975
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.3e-10 Score=90.13 Aligned_cols=106 Identities=22% Similarity=0.213 Sum_probs=80.9
Q ss_pred cHHHHHHHHHhcCCCCccee--eeEEEcCC---CceEEEEEecccC--CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHH
Q psy787 84 NVDREIRLLKMLQHRNVIGL--VDVFVNDK---KQKMYLIMEYCVG--GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156 (235)
Q Consensus 84 ~~~~e~~~l~~l~h~~i~~~--~~~~~~~~---~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~ 156 (235)
.+.+|...+..+...+|+.. +.+..... ...-++|||++++ +|.+++......+.+......++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 47789999988865555544 33432111 2346899999987 48888754323455667788999999999999
Q ss_pred HHhCCcccCCCCCCCeEEcc-------CCcEEEeeecccc
Q psy787 157 LHSQGIIHKDIKPGNLLLTL-------DGTLKISDFGVAE 189 (235)
Q Consensus 157 lH~~~i~H~dl~p~nili~~-------~~~~~l~dfg~~~ 189 (235)
||..|++|+|++++||+++. +..+.++||+.+.
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99999999999999999985 3579999999885
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.9e-10 Score=87.15 Aligned_cols=140 Identities=22% Similarity=0.253 Sum_probs=98.1
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCC--CcceeeeEEEcCC-CceEEEEE
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR--NVIGLVDVFVNDK-KQKMYLIM 119 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~-~~~~~lv~ 119 (235)
+.|+.|..+.+|++... +|+.+++|+....... .....+.+|..++..+.+. ++++++....... .+..+++|
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 67889999999998764 3578999987544321 2334678999999998764 4566766652111 13568999
Q ss_pred ecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh---------------------------------------
Q psy787 120 EYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS--------------------------------------- 159 (235)
Q Consensus 120 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~--------------------------------------- 159 (235)
|+++|. +.+.... ..++......++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 999874 4433221 235666666677777777777763
Q ss_pred -----------------CCcccCCCCCCCeEEcc--CCcEEEeeecccc
Q psy787 160 -----------------QGIIHKDIKPGNLLLTL--DGTLKISDFGVAE 189 (235)
Q Consensus 160 -----------------~~i~H~dl~p~nili~~--~~~~~l~dfg~~~ 189 (235)
..++|+|+.|.||+++. ++.+.++||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23589999999999998 5668999999885
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=8.3e-10 Score=81.72 Aligned_cols=142 Identities=15% Similarity=0.156 Sum_probs=99.3
Q ss_pred ccccceEEEEeeccchhhheeeeeeeeccccCC--CCccccHHHHHHHHHhcCCCCcc--eeeeEEE--cCCCceEEEEE
Q psy787 46 GEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI--PNGEINVDREIRLLKMLQHRNVI--GLVDVFV--NDKKQKMYLIM 119 (235)
Q Consensus 46 g~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~--~~~~~~~--~~~~~~~~lv~ 119 (235)
++||.|.|+..... |+.+-+|.-........ .-.+..|.+|+..+..+...+++ ++...-. ......-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 45888888876642 33344443321111110 12445689999999999654443 3331111 12223457999
Q ss_pred ecccC--CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc--EEEeeecccc
Q psy787 120 EYCVG--GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT--LKISDFGVAE 189 (235)
Q Consensus 120 e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~ 189 (235)
|-+++ +|.+++......+.+......++.+++.+++-||+.|+.|+|+.+.||+++..+. +.++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98885 6888887655556788888999999999999999999999999999999987777 9999998765
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.8e-10 Score=85.68 Aligned_cols=139 Identities=22% Similarity=0.294 Sum_probs=101.3
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC------------------CCccccHHHHHHHHHhcCCC--
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI------------------PNGEINVDREIRLLKMLQHR-- 98 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~------------------~~~~~~~~~e~~~l~~l~h~-- 98 (235)
+.+..+||-|--|.||.+.+. .|.++++|.=+.....-. .-.+...++|..+|.++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456689999999999999986 678899985433221110 01123467899999998655
Q ss_pred CcceeeeEEEcCCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC
Q psy787 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD 177 (235)
Q Consensus 99 ~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~ 177 (235)
.++..+++- .-++|||+.+|- |... +++....-.++..|+.-+...-..|++|||+++-||+++++
T Consensus 172 ~VP~P~~~n------RHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 172 KVPKPIAWN------RHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCccccc------cceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC
Confidence 666666653 348999999885 3321 12344555677777777777778999999999999999999
Q ss_pred CcEEEeeecccccc
Q psy787 178 GTLKISDFGVAESL 191 (235)
Q Consensus 178 ~~~~l~dfg~~~~~ 191 (235)
|.+.++||-.+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999988644
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.9e-09 Score=80.94 Aligned_cols=106 Identities=26% Similarity=0.318 Sum_probs=82.0
Q ss_pred ccHHHHHHHHHhcCCCCcc--eeeeEEEcCC--CceEEEEEecccC--CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHH
Q psy787 83 INVDREIRLLKMLQHRNVI--GLVDVFVNDK--KQKMYLIMEYCVG--GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156 (235)
Q Consensus 83 ~~~~~e~~~l~~l~h~~i~--~~~~~~~~~~--~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~ 156 (235)
....+|...+..+...+|. .++.+..... ....++|+|.+++ +|.+++.... ..+......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence 4578899988888655554 3444432211 1245899999987 4888887642 25666788899999999999
Q ss_pred HHhCCcccCCCCCCCeEEccCC---cEEEeeeccccc
Q psy787 157 LHSQGIIHKDIKPGNLLLTLDG---TLKISDFGVAES 190 (235)
Q Consensus 157 lH~~~i~H~dl~p~nili~~~~---~~~l~dfg~~~~ 190 (235)
||..|++|+|+++.|||++.++ .+.++||+-+..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999887 799999998763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.9e-09 Score=81.09 Aligned_cols=140 Identities=21% Similarity=0.205 Sum_probs=98.7
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCC---------------c-----cccHHHHHHHHHhcCCC--Cc
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN---------------G-----EINVDREIRLLKMLQHR--NV 100 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~---------------~-----~~~~~~e~~~l~~l~h~--~i 100 (235)
.+|++|-.+.||+|.. .++..+|+|+++......... + .....+|+..|.++... .+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 4788999999999876 467899999997654332110 0 01245788888888544 44
Q ss_pred ceeeeEEEcCCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEccCC
Q psy787 101 IGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTLDG 178 (235)
Q Consensus 101 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~~~ 178 (235)
++.+... . -.++|||++.. ...-..+. .++.+.....+..+++..|.-|-. .+++|+||+.-||++. ++
T Consensus 133 P~Pi~~~--~----nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 133 PEPIAFR--N----NVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCceeec--C----CeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC
Confidence 5555554 2 28999999754 11111111 223333677788888888888877 8999999999999999 99
Q ss_pred cEEEeeeccccccC
Q psy787 179 TLKISDFGVAESLD 192 (235)
Q Consensus 179 ~~~l~dfg~~~~~~ 192 (235)
.+.+|||+.+...+
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999997654
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.3e-09 Score=87.95 Aligned_cols=141 Identities=21% Similarity=0.224 Sum_probs=110.6
Q ss_pred cceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc--CCCceEEEEEecccC--
Q psy787 49 SYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN--DKKQKMYLIMEYCVG-- 124 (235)
Q Consensus 49 ~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~~lv~e~~~~-- 124 (235)
-..+.|++....+|..+++|.+...+..... .-...+.+++++.|.|+++|.+++.. -....+++|++|+++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n----k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN----KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc----cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 3467799999999999999988333222211 12457889999999999999988852 123468999999986
Q ss_pred CHHHHhhcCC-------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 125 GLQDMLDSTP-------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 125 ~l~~~~~~~~-------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
+|.++..... +...++..+|.++.||..||..+|+.|+..+-|.|.+|++..+.+++|...|....+
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 4777765442 123667899999999999999999999999999999999998889999988888766
Q ss_pred Cc
Q psy787 192 DM 193 (235)
Q Consensus 192 ~~ 193 (235)
..
T Consensus 444 ~~ 445 (655)
T KOG3741|consen 444 QE 445 (655)
T ss_pred cC
Confidence 53
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.5e-10 Score=93.76 Aligned_cols=192 Identities=21% Similarity=0.262 Sum_probs=128.0
Q ss_pred eEeeeceEEeeeeeccccceEEEEeecc-chhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEc
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDS-ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVN 109 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (235)
..-...+|..+..|+.|.|+.++..... .++..+++|-........ .....-..|+.+...+ -|.+.+..+..+.
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~--~~di~sl~ev~l~~~l~~~~~~~g~~~~W~- 336 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF--ASDIFSLGEVILEAILGSHLPSVGKNSSWS- 336 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch--HhhhcchhhhhHhhHhhcccccCCCCCCcc-
Confidence 4456678999999999999999886533 566777777554444332 1112223455555544 5788887776663
Q ss_pred CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC-CcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD-GTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~ 188 (235)
.....++=.|||.+....... .....+++...+++..|++.++.++|+..++|.|++|+||++..+ +..+++||+.+
T Consensus 337 -~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 337 -QLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred -ccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccc
Confidence 233456888999664222111 222567888899999999999999999999999999999999976 67789999988
Q ss_pred cccCccccCCcccccCCCCcccC-ccccCCCCCCCCCcccEEEeeee
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQA-PEIANGLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~a-PE~~~~~~~~~~~~~Di~slG~~ 234 (235)
..+.. .........+++| +|.+... ..+..++|+||||+-
T Consensus 415 t~~~~-----~~~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~ 455 (524)
T KOG0601|consen 415 TRLAF-----SSGVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLS 455 (524)
T ss_pred cccce-----ecccccccccccccchhhccc-ccccccccccccccc
Confidence 74321 1122223333442 4444331 225679999999953
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.3e-09 Score=78.26 Aligned_cols=145 Identities=17% Similarity=0.173 Sum_probs=91.3
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCcc-----ccHHHHHHHHHhcCCCCcc---ee
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGE-----INVDREIRLLKMLQHRNVI---GL 103 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~~i~---~~ 103 (235)
..-+.++|.+.+.+.......|.+... +|+.+++|..+......+.... ....+++..+..++..++. .+
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 344567899999998888887766554 6788899987664422111100 0123444444444433333 32
Q ss_pred eeEEE---cCCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc
Q psy787 104 VDVFV---NDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT 179 (235)
Q Consensus 104 ~~~~~---~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~ 179 (235)
+.+.. ..-....+++|||++|- |.+... +++ .+...+.+++.-+|+.|++|+|..|.|+++. ++.
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~-~~~ 172 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS-NNG 172 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE-CCc
Confidence 32221 01122456899999884 444321 122 2456677889999999999999999999999 555
Q ss_pred EEEeeecccc
Q psy787 180 LKISDFGVAE 189 (235)
Q Consensus 180 ~~l~dfg~~~ 189 (235)
++++|++...
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.4e-08 Score=85.31 Aligned_cols=144 Identities=23% Similarity=0.313 Sum_probs=91.7
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCc------------------------------------cccHH
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNG------------------------------------EINVD 86 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~------------------------------------~~~~~ 86 (235)
+.|++++-|.||.|+.. +|+.||||+.++.-...-..+ +..+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 57899999999999985 499999999877432211110 22345
Q ss_pred HHHHHHHhcC----CCCcceeeeEEEcCCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHH-HHHHHhC
Q psy787 87 REIRLLKMLQ----HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDG-LEYLHSQ 160 (235)
Q Consensus 87 ~e~~~l~~l~----h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~-l~~lH~~ 160 (235)
+|...+.+++ ...-+.+-.++.+ -...-.++|||+.|. +.+...-.. .+.+... ++..++.+ +..+=..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we-~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWE-YTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehh-ccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHHhc
Confidence 5555555553 2333344444432 122348999999884 554432221 4455444 33333333 2223336
Q ss_pred CcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 161 ~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
|+.|+|..|.||++..+|++.+.|||+...++
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 99999999999999999999999999987653
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.2e-09 Score=88.43 Aligned_cols=83 Identities=25% Similarity=0.398 Sum_probs=64.1
Q ss_pred HHHHHHHHhC-CcccCCCCCCCeEEccCCcEEEeeeccccccCccc-------cCCcccccCCCCcccCccccCCCCCCC
Q psy787 151 LDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL-------HDDTITTSQGSPVFQAPEIANGLPEIS 222 (235)
Q Consensus 151 ~~~l~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-------~~~~~~~~~~~~~~~aPE~~~~~~~~~ 222 (235)
+.|+.++|.. ++||+++.|++|.+...+.+|+..|+++....... ...-....+....|.|||.+.+ ...
T Consensus 109 ~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~--~~~ 186 (700)
T KOG2137|consen 109 ADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG--TTN 186 (700)
T ss_pred cchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc--ccc
Confidence 3899999977 79999999999999999999999999876443211 1111112234556999999988 458
Q ss_pred CCcccEEEeeeeC
Q psy787 223 GYKVDIWSSGVTL 235 (235)
Q Consensus 223 ~~~~Di~slG~~l 235 (235)
++++|+||||+++
T Consensus 187 ~~~sd~fSlG~li 199 (700)
T KOG2137|consen 187 TPASDVFSLGVLI 199 (700)
T ss_pred cccccceeeeeEE
Confidence 8999999999974
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.6e-07 Score=74.61 Aligned_cols=183 Identities=13% Similarity=0.125 Sum_probs=117.9
Q ss_pred EeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCc----ceeeeEEEcC-CCc
Q psy787 40 VMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNV----IGLVDVFVND-KKQ 113 (235)
Q Consensus 40 ~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i----~~~~~~~~~~-~~~ 113 (235)
.....||+|+.+.+|-.... ...+-|++....... -...+..|... .||-. +......... ...
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~-------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAA-------QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchH-------HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 34568999999999865432 223567776655332 11222233332 34422 2222211112 222
Q ss_pred eEEEEEecccCC--HHHHhh----cCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 114 KMYLIMEYCVGG--LQDMLD----STPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 114 ~~~lv~e~~~~~--l~~~~~----~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
...++|+.++|- ...+.. .+...-.++.-.++.++.|+.+.+.||..|.+-||++++|+++.+++.++|.|-..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 367889988762 333332 12223466777889999999999999999999999999999999999999997544
Q ss_pred ccccCccccCCcccccCCCCcccCccccC-CCC--CCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIAN-GLP--EISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~--~~~~~~~Di~slG~~l 235 (235)
.... .+..-.....+...|.|||..+ ++- ..-+...|-|.||++|
T Consensus 164 fqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLi 211 (637)
T COG4248 164 FQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLI 211 (637)
T ss_pred eeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHH
Confidence 3322 2445566777889999999875 111 2246789999999864
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.8e-07 Score=78.66 Aligned_cols=142 Identities=19% Similarity=0.218 Sum_probs=91.8
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCC---------------------------------ccccHHHHH
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN---------------------------------GEINVDREI 89 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~---------------------------------~~~~~~~e~ 89 (235)
+.|+..+.+.||+|+... |+.||+|+-++.-...... .+..|.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 578999999999999864 9999999876643222100 023455666
Q ss_pred HHHHhc----CCCC---cceeeeEEEcCCCceEEEEEecccCC---HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh
Q psy787 90 RLLKML----QHRN---VIGLVDVFVNDKKQKMYLIMEYCVGG---LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159 (235)
Q Consensus 90 ~~l~~l----~h~~---i~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~ 159 (235)
+...++ +|.+ -+.+-.++.+- ...-.++|||++|. -.+.+.+ ..++...+..-+.+...-+-+.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~~~~~~qIf~-- 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAIDK---RGISPHDILNKLVEAYLEQIFK-- 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHHHHHHHHHHh--
Confidence 655444 3555 22233444321 22458999999873 3344444 4566665444444444333333
Q ss_pred CCcccCCCCCCCeEEcc----CCcEEEeeecccccc
Q psy787 160 QGIIHKDIKPGNLLLTL----DGTLKISDFGVAESL 191 (235)
Q Consensus 160 ~~i~H~dl~p~nili~~----~~~~~l~dfg~~~~~ 191 (235)
.|++|+|-.|.||++.. +..+.+.|||+...+
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 47999999999999995 457999999988754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.63 E-value=6.4e-07 Score=68.19 Aligned_cols=134 Identities=17% Similarity=0.216 Sum_probs=78.8
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC--cceeeeEEEcCCCceEEEEEe
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN--VIGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~~lv~e 120 (235)
.+|+.|..+.||+. .+..+++|...... ....+.+|.+++..+...+ +++++.+. +..+...++|+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeee
Confidence 56899999999973 24467788765322 1224678999998886444 45666665 44556788999
Q ss_pred cccCC--HHHHh---------------------hcCCCCCCCHHhHHH-HHHH----------HHH-HHHHHHh----CC
Q psy787 121 YCVGG--LQDML---------------------DSTPYKKFPIWQAHG-YFLQ----------LLD-GLEYLHS----QG 161 (235)
Q Consensus 121 ~~~~~--l~~~~---------------------~~~~~~~~~~~~~~~-~~~q----------l~~-~l~~lH~----~~ 161 (235)
+++|. +.... ............... +..+ +.. ...+|.. ..
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 99873 11111 110001111111000 1000 001 1112221 13
Q ss_pred cccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 162 IIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 162 i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
++|+|+.|.|+++++++ +.++||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 68999999999999878 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.2e-08 Score=89.92 Aligned_cols=195 Identities=24% Similarity=0.312 Sum_probs=132.7
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...+.+.+.+.+-+|+++.++.+.-..+|-..+.++........ ....+....+-..+...++|..+.....+ ....
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~-~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rs 877 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR-TNDYESIRSKSNILITPRSPAVVRSFPSF--PCRS 877 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhc-cccccccCCccCccccCCCCceecccCCC--CCCC
Confidence 34567888889999999999998777666544554443322211 11122333444444445566666555554 3344
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..++++++..+ ++...++.. ...+..-....+..+..+.++||...+.|++++|.|.++..++...+.+|+......
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred CcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence 67899999865 577777665 456666777788889999999999999999999999999999999999998443221
Q ss_pred ccccC-----------------------------CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHD-----------------------------DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~-----------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
-..+. .......+++.|.+||.+.+ ..-...+|+|+.|+++
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCL 1025 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhh
Confidence 00000 00112236788999999988 4467799999999864
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.7e-06 Score=67.92 Aligned_cols=143 Identities=22% Similarity=0.262 Sum_probs=103.1
Q ss_pred eeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCc----------------------cccHHHHHHHHHhcCCC
Q psy787 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNG----------------------EINVDREIRLLKMLQHR 98 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~h~ 98 (235)
|-.||..|--+-||.|.. .+|..+|+|+++.....-.... .-....|.+.|.++...
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 446899999999999865 4778899999987554332111 11256888999999888
Q ss_pred CcceeeeEEEcCCCceEEEEEecccCC--HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHH-hCCcccCCCCCCCeEEc
Q psy787 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG--LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH-SQGIIHKDIKPGNLLLT 175 (235)
Q Consensus 99 ~i~~~~~~~~~~~~~~~~lv~e~~~~~--l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH-~~~i~H~dl~p~nili~ 175 (235)
+|+-.-.+.+- .-.|||+|++.. ..-.+.. ..++...+..+-.+++.-|.-|- ..++||.||+--|+++.
T Consensus 227 GIP~PePIlLk----~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILLK----NHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceeee----cceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE
Confidence 88777666642 238999999753 1111111 45666667777777777777664 45899999999999998
Q ss_pred cCCcEEEeeeccccccC
Q psy787 176 LDGTLKISDFGVAESLD 192 (235)
Q Consensus 176 ~~~~~~l~dfg~~~~~~ 192 (235)
+|.+.++|.+.+...+
T Consensus 300 -dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVEHD 315 (520)
T ss_pred -CCEEEEEEccccccCC
Confidence 8899999999876443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.4e-05 Score=59.11 Aligned_cols=131 Identities=21% Similarity=0.232 Sum_probs=91.1
Q ss_pred ceEEeeeeeccccc-eEEEEeeccchhhheeeeeeeeccccCCC-----------------CccccHHHHHHHHHhcC--
Q psy787 37 GKYVMGDLLGEGSY-GKVKEMLDSETLCRRAVKIFKKKKLQRIP-----------------NGEINVDREIRLLKMLQ-- 96 (235)
Q Consensus 37 ~~y~i~~~ig~g~~-~~v~~~~~~~~~~~~~~K~~~~~~~~~~~-----------------~~~~~~~~e~~~l~~l~-- 96 (235)
..++.++.||.|.- |.||+++. .|+.+|+|+++.-...... ....-|.+|.++..+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999987 5779999994331111110 11234789999888885
Q ss_pred -CCCc--ceeeeEEEcC----------------CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHH
Q psy787 97 -HRNV--IGLVDVFVND----------------KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157 (235)
Q Consensus 97 -h~~i--~~~~~~~~~~----------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l 157 (235)
+.++ ++++|+..-. ......||.+|.+..- .++.. -+.+|.+-|..+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHH
Confidence 3345 8888888422 1123467777755432 22322 356677778889
Q ss_pred HhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 158 H~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
|..||+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999988 4578888854
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.4e-05 Score=61.68 Aligned_cols=71 Identities=18% Similarity=0.163 Sum_probs=45.6
Q ss_pred eeccccc-eEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCCceEEEEEec
Q psy787 44 LLGEGSY-GKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 44 ~ig~g~~-~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
.|..|.. +.||++... +..+.+|+..... ...+.+|+.++..+. +-.+++++... ...+..++||++
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~--~~~~~~~lv~e~ 73 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYG--SDDGRAWLLTSA 73 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEE--ecCCccEEEEEe
Confidence 3445544 888988653 3567777654332 124667888888773 34566777766 333456899999
Q ss_pred ccCC
Q psy787 122 CVGG 125 (235)
Q Consensus 122 ~~~~ 125 (235)
++|.
T Consensus 74 i~G~ 77 (244)
T cd05150 74 VPGV 77 (244)
T ss_pred eCCc
Confidence 9874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.4e-06 Score=59.52 Aligned_cols=130 Identities=22% Similarity=0.218 Sum_probs=90.4
Q ss_pred EeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCc-ceeeeEEEcCCCceEEEE
Q psy787 40 VMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV-IGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 40 ~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~lv 118 (235)
++.+.|+.|.+|.||++... |..+++|+-+.... +..+..|.++|..+...++ +.++.+. .+ ++.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~------r~~l~kEakiLeil~g~~~~p~vy~yg--~~----~i~ 90 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP------RRNLEKEAKILEILAGEGVTPEVYFYG--ED----FIR 90 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCcc------hhhHHHHHHHHHHhhhcCCCceEEEec--hh----hhh
Confidence 34578999999999999873 55888887654433 3368899999998876554 4555554 22 566
Q ss_pred EecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCC-CCCeEEccCCcEEEeeeccccccC
Q psy787 119 MEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIK-PGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 119 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~-p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
|||..| .|.+..... + .+-+..++++-.-|-..||-|+.|+ |...++..++.+.|+||..|+...
T Consensus 91 me~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 91 MEYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 999988 565544321 2 2234455666666778899999986 555666666799999999998544
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.31 E-value=3.8e-05 Score=57.04 Aligned_cols=135 Identities=20% Similarity=0.308 Sum_probs=89.4
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCC------------CccccHHHHHHHHHhcC------CCCcceee
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP------------NGEINVDREIRLLKMLQ------HRNVIGLV 104 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~------------~~~~~~~~e~~~l~~l~------h~~i~~~~ 104 (235)
..||+|+.-.||. |+.+ ....+|+..+....... .......+|+.-...+. +.+|++++
T Consensus 7 ~~i~~G~~R~cy~--HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--CCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4689999999985 4433 44478888776611100 11233556666555554 78999999
Q ss_pred eEEEcCCCceEEEEEeccc---C----CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC
Q psy787 105 DVFVNDKKQKMYLIMEYCV---G----GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD 177 (235)
Q Consensus 105 ~~~~~~~~~~~~lv~e~~~---~----~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~ 177 (235)
|.. +.+....+|+|.+. | +|.+++.. ..++. . +...+-.-..+|-+.+|+.+|++|+||++...
T Consensus 84 G~v--eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFV--ETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEE--ecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEec
Confidence 998 66666788888762 2 38887754 34554 3 34444445567788899999999999999755
Q ss_pred C----cEEEee-ecccc
Q psy787 178 G----TLKISD-FGVAE 189 (235)
Q Consensus 178 ~----~~~l~d-fg~~~ 189 (235)
. .+.|+| ||...
T Consensus 155 ~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGEKE 171 (199)
T ss_pred CCCceEEEEEeCCCCcc
Confidence 3 478887 55443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.28 E-value=2e-05 Score=71.08 Aligned_cols=81 Identities=21% Similarity=0.220 Sum_probs=51.9
Q ss_pred eeeeccccceEEEEeeccchh--hheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCc--ceeeeEEEcC-CCceE
Q psy787 42 GDLLGEGSYGKVKEMLDSETL--CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNV--IGLVDVFVND-KKQKM 115 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~--~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~-~~~~~ 115 (235)
++.++.|....+|++.....+ ..+++|........ .....+.+|+.+++.+. |.++ ++++..+.+. .-+..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~---~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL---QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC---ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 577888999999988654322 35666654332211 12235789999999885 6654 6666665321 11457
Q ss_pred EEEEecccCC
Q psy787 116 YLIMEYCVGG 125 (235)
Q Consensus 116 ~lv~e~~~~~ 125 (235)
|+|||+++|.
T Consensus 120 flVME~v~G~ 129 (822)
T PLN02876 120 FYIMEYLEGR 129 (822)
T ss_pred eEEEEecCCc
Confidence 8999999874
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.24 E-value=8.2e-06 Score=62.16 Aligned_cols=76 Identities=21% Similarity=0.299 Sum_probs=49.9
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCC--CcceeeeEEE-cCCCceEEEE
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR--NVIGLVDVFV-NDKKQKMYLI 118 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~-~~~~~~~~lv 118 (235)
++.++.|..+.+|++.... ..+++|+.... .....+.+|..++..+... .++.++.... .......+.+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 4678999999999987754 48888876544 1223467888888877533 3566665332 1233457899
Q ss_pred EecccCC
Q psy787 119 MEYCVGG 125 (235)
Q Consensus 119 ~e~~~~~ 125 (235)
|++++|.
T Consensus 74 ~~~i~g~ 80 (239)
T PF01636_consen 74 MEYIPGR 80 (239)
T ss_dssp EEEESSE
T ss_pred EEEeccc
Confidence 9999885
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.6e-05 Score=58.63 Aligned_cols=100 Identities=26% Similarity=0.300 Sum_probs=77.3
Q ss_pred HHHHHHHHhcCC-CCcceeeeEEEcCCCceEEEEEecccC-CHHHHhhc-CCCCCCCHHhHHHHHHHHHHHHHHHHhC--
Q psy787 86 DREIRLLKMLQH-RNVIGLVDVFVNDKKQKMYLIMEYCVG-GLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEYLHSQ-- 160 (235)
Q Consensus 86 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~~ql~~~l~~lH~~-- 160 (235)
..|.-+++.+++ +++++++|.| +. .++.|+.+. ++...... ......++..+.+++.++++.+.+++..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C--G~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC--GR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC--CC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 468888888876 6999999999 32 678898874 44321000 0113468889999999999999999973
Q ss_pred -CcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 161 -GIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 161 -~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
.+...|++|+|+-+..+++++++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 4677999999999999999999999987644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.6e-05 Score=58.42 Aligned_cols=30 Identities=33% Similarity=0.485 Sum_probs=25.1
Q ss_pred CcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 161 ~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
+++|+|+.|.|++++.++..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 489999999999998655557999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.7e-07 Score=78.37 Aligned_cols=71 Identities=25% Similarity=0.290 Sum_probs=50.4
Q ss_pred ccCCCCCC-CeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 163 IHKDIKPG-NLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 163 ~H~dl~p~-nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++...|. |+++...+..++.||+.++...............+|+.|+|||++.+ ..++.++|||||||+|
T Consensus 499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~--~~~~~~~DiwSlG~il 570 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLG--KPHGPAVDWWALGVCL 570 (669)
T ss_pred CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCC--CCCCcHHHHHHHHHHH
Confidence 34555566 66677777778889998875532222222333468999999999988 4489999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00018 Score=55.02 Aligned_cols=72 Identities=24% Similarity=0.320 Sum_probs=44.8
Q ss_pred eeeeccccceEEEEeeccc-hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC-cceeeeEEEcCCCceEEEEE
Q psy787 42 GDLLGEGSYGKVKEMLDSE-TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN-VIGLVDVFVNDKKQKMYLIM 119 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~~lv~ 119 (235)
++.|..|-...+|++.... .++.+++|+..... .......+|..++..+...+ .++++... +. .++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-----~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~ 71 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-----ELIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIY 71 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-----cceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEE
Confidence 4567778888999886542 24678888765332 11123457888888885433 44444433 22 4799
Q ss_pred ecccC
Q psy787 120 EYCVG 124 (235)
Q Consensus 120 e~~~~ 124 (235)
||++|
T Consensus 72 e~i~G 76 (235)
T cd05157 72 EFIPG 76 (235)
T ss_pred EeeCC
Confidence 99877
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.7e-06 Score=65.12 Aligned_cols=137 Identities=18% Similarity=0.234 Sum_probs=92.8
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeecccc-----------------CC-CCccccHHHHHHHHHhcCC--
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQ-----------------RI-PNGEINVDREIRLLKMLQH-- 97 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-----------------~~-~~~~~~~~~e~~~l~~l~h-- 97 (235)
-+.++.+||-|--+-+|.+.+. .|++.++|+=+...+. .| .-.+....+|+.-+..+..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4677889999999999998774 5677777743221111 00 0012235577777777743
Q ss_pred CCcceeeeEEEcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc
Q psy787 98 RNVIGLVDVFVNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL 176 (235)
Q Consensus 98 ~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~ 176 (235)
-.+++.++.. .-++||+++.| .|.....-. .+-.+...+..-+--|...|++|+|.+-=||++.+
T Consensus 172 fpVPkpiD~~------RH~Vvmelv~g~Pl~~v~~v~--------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 172 FPVPKPIDHN------RHCVVMELVDGYPLRQVRHVE--------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCCccccc------ceeeHHHhhcccceeeeeecC--------ChHHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence 4555666554 45899999877 455433222 22334555555566778899999999999999999
Q ss_pred CCcEEEeeecccc
Q psy787 177 DGTLKISDFGVAE 189 (235)
Q Consensus 177 ~~~~~l~dfg~~~ 189 (235)
++.++++||-...
T Consensus 238 d~~i~vIDFPQmv 250 (465)
T KOG2268|consen 238 DDKIVVIDFPQMV 250 (465)
T ss_pred CCCEEEeechHhh
Confidence 9999999998664
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00016 Score=56.20 Aligned_cols=132 Identities=21% Similarity=0.244 Sum_probs=73.4
Q ss_pred eccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCc-ceeeeEEEcCCCceEEEEEeccc
Q psy787 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV-IGLVDVFVNDKKQKMYLIMEYCV 123 (235)
Q Consensus 45 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~lv~e~~~ 123 (235)
+..|-...+|++. .+++.+++|....... .......+|..+++.+...++ ++++... + + ++|++|++
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~--~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGLAPKPILVN--E--H--WLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--C--EEEEEecc
Confidence 4567778888876 3566788886543221 111235788888888865433 4444433 2 2 68999998
Q ss_pred CC-HHHH-----------------hhcCC--CCCCCHH-hHHHHHHHH---------HHHHHHHHh--------CCcccC
Q psy787 124 GG-LQDM-----------------LDSTP--YKKFPIW-QAHGYFLQL---------LDGLEYLHS--------QGIIHK 165 (235)
Q Consensus 124 ~~-l~~~-----------------~~~~~--~~~~~~~-~~~~~~~ql---------~~~l~~lH~--------~~i~H~ 165 (235)
|. +... +...+ ..+++.. .+..+..++ ...+..+-. ..++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 73 2110 11111 1112221 111221111 111222211 247999
Q ss_pred CCCCCCeEEccCCcEEEeeecccc
Q psy787 166 DIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 166 dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
|+.|.||+++.++ +.++||..+.
T Consensus 152 Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 152 DVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CCCcCcEEEeCCC-CEEEeccccC
Confidence 9999999999766 7899999885
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00047 Score=54.92 Aligned_cols=30 Identities=33% Similarity=0.455 Sum_probs=26.7
Q ss_pred CcccCCCCCCCeEEccC----CcEEEeeeccccc
Q psy787 161 GIIHKDIKPGNLLLTLD----GTLKISDFGVAES 190 (235)
Q Consensus 161 ~i~H~dl~p~nili~~~----~~~~l~dfg~~~~ 190 (235)
.++|+|+.|.||+++.+ +.+.++||.++..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 57999999999999975 8899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.74 E-value=1.6e-05 Score=67.50 Aligned_cols=172 Identities=20% Similarity=0.189 Sum_probs=114.2
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC-cceeeeEEEcCCCceEEE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN-VIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~~l 117 (235)
+...+-+++++.+++++.+...+.... .+++... ....-++.+|.++.||| .+..++-+ +.....++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i 311 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWI 311 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC--Ccccccch
Confidence 445566788999999998887664333 4544333 23456888999999999 33444444 55567889
Q ss_pred EEecccCC--HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 118 IMEYCVGG--LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 118 v~e~~~~~--l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
.+++++++ ....... ..-.+.........+.-..+++++|+..-+|+| ||+.. .+..+..+|+....+...
T Consensus 312 ~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~- 384 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRT- 384 (829)
T ss_pred hhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCcc-
Confidence 99999765 1111111 011233334455566667788999988778887 66555 477899999988766522
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeee
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGV 233 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 233 (235)
.......+++.++|||....+. +....|.|++|.
T Consensus 385 --~~~~t~~~~~~~~~pev~~~~~--~~~~p~~~~~~~ 418 (829)
T KOG0576|consen 385 --MKPRTAIGTPEPLAPEVIQENT--IDGCPDSGSLAV 418 (829)
T ss_pred --cccccCCCCCCCCCchhhcccc--cccCCCccCCCc
Confidence 1344566889999999887733 777889999884
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00043 Score=55.34 Aligned_cols=141 Identities=20% Similarity=0.196 Sum_probs=77.7
Q ss_pred eeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC--cceeeeEE----EcCCCce
Q psy787 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN--VIGLVDVF----VNDKKQK 114 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~----~~~~~~~ 114 (235)
..+.++.|....+|++.. .+ ..+++|+..... ....+..+..++..+...+ +++++... .....+.
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~-~~~vLK~~~~~~------~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DV-GRYILTLYEKRV------KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred eccccCCccccceEEEEe-CC-CcEEEEEecCCC------CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 345677777788998764 23 357788764421 1123556677777764322 34444321 1123456
Q ss_pred EEEEEecccCC-HH----H-------H---hhcCCCC---C----CCHHhHHH---------------HHHHHHHHHHHH
Q psy787 115 MYLIMEYCVGG-LQ----D-------M---LDSTPYK---K----FPIWQAHG---------------YFLQLLDGLEYL 157 (235)
Q Consensus 115 ~~lv~e~~~~~-l~----~-------~---~~~~~~~---~----~~~~~~~~---------------~~~ql~~~l~~l 157 (235)
.+++++|++|. +. . . +...... + ........ ....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999998773 10 0 0 0100000 0 00010000 011123344444
Q ss_pred H-------hCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 158 H-------SQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 158 H-------~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
. ..+++|+|+.+.|++++.++...++||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3 2579999999999999988767899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00017 Score=57.30 Aligned_cols=139 Identities=19% Similarity=0.149 Sum_probs=76.7
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC--cceeeeEE----EcCCCceE
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN--VIGLVDVF----VNDKKQKM 115 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~----~~~~~~~~ 115 (235)
++.+..|....+|++.. .+..+++|+.... ....+..|+.++..+.+.+ +++++... .....+..
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~-------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV-------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC-------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 45677787789998764 3346888876531 1123556777777774333 44443321 11223456
Q ss_pred EEEEecccCCHHHH--------h-------hcC----CCC----CC-CHHhH----------HHHHHHHHHHHHHHHh--
Q psy787 116 YLIMEYCVGGLQDM--------L-------DST----PYK----KF-PIWQA----------HGYFLQLLDGLEYLHS-- 159 (235)
Q Consensus 116 ~lv~e~~~~~l~~~--------~-------~~~----~~~----~~-~~~~~----------~~~~~ql~~~l~~lH~-- 159 (235)
+.++++++|...+. + ... ... .. .+... ......+..++..+..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 88999998741110 0 000 000 00 00000 0011112233444443
Q ss_pred -----CCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 160 -----QGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 160 -----~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
.+++|+|+.|.|++++.++.+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 369999999999999987767899999775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0024 Score=52.71 Aligned_cols=79 Identities=18% Similarity=0.021 Sum_probs=51.0
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeecccc---CCCCccccHHHHHHHHHhcC---CCCcceeeeEEEcCCCceE
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQ---RIPNGEINVDREIRLLKMLQ---HRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~ 115 (235)
.+.||.|....||++.....++.+++|.-.+.... .+.....+...|...|..+. ..++++++.+- + ...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~--~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E--ELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C--CCC
Confidence 36789999999999988643357888865422111 11223345677888887763 24566676664 3 345
Q ss_pred EEEEecccC
Q psy787 116 YLIMEYCVG 124 (235)
Q Consensus 116 ~lv~e~~~~ 124 (235)
++|||++++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 899999875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0013 Score=53.29 Aligned_cols=85 Identities=16% Similarity=-0.041 Sum_probs=52.4
Q ss_pred eeccccceEEEEeeccchhhheeeeeeeecccc---CCCCccccHHHHHHHHHhcC--CC-CcceeeeEEEcCCCceEEE
Q psy787 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQ---RIPNGEINVDREIRLLKMLQ--HR-NVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 44 ~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~~~l 117 (235)
.||-|....||++.+...++.++||.-.+.... .+.-...+...|...|+... .| .+++++.+- .....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc----ccccee
Confidence 478899999999987543367888865433321 23444556667777777653 23 344554442 334578
Q ss_pred EEecccCC--HHHHhhc
Q psy787 118 IMEYCVGG--LQDMLDS 132 (235)
Q Consensus 118 v~e~~~~~--l~~~~~~ 132 (235)
+||+++.. ++..+..
T Consensus 78 vMEdL~~~~ilR~~Li~ 94 (370)
T TIGR01767 78 VMEDLSHHKIARKGLIE 94 (370)
T ss_pred hHhhCccchHHHHHHHc
Confidence 99998653 5555543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0016 Score=51.97 Aligned_cols=146 Identities=15% Similarity=0.197 Sum_probs=78.8
Q ss_pred EeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCC--CCcceeeeEEEcCCCceEEE
Q psy787 40 VMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH--RNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 40 ~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~~l 117 (235)
.+++.+..|-...+|..... +++++++ ++.. ...........+|+..+..+.- -..+..++.+.++.-+..+.
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR--~P~~-~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR--KPPR-GDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe--cCCc-cccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 34455555555555666554 6778887 2221 1112222345677777777643 33444555553222246799
Q ss_pred EEecccCC-HHHHhhcCCC------------------------------CCCCHHhHHHHHHHH--------------HH
Q psy787 118 IMEYCVGG-LQDMLDSTPY------------------------------KKFPIWQAHGYFLQL--------------LD 152 (235)
Q Consensus 118 v~e~~~~~-l~~~~~~~~~------------------------------~~~~~~~~~~~~~ql--------------~~ 152 (235)
||+|++|. +.+....... ..+....+..+..+. ..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 99999872 1111110000 000111111121111 12
Q ss_pred HHHHHHhC--------CcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 153 GLEYLHSQ--------GIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 153 ~l~~lH~~--------~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...+++.. .++|||+.+.|+++++.+-+-++||+++..
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 23344433 378999999999999998899999998863
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0022 Score=51.51 Aligned_cols=30 Identities=33% Similarity=0.411 Sum_probs=25.5
Q ss_pred CCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 160 ~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
.+++|+|+.|.||+++.+...-++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999855555899999875
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.01 Score=48.26 Aligned_cols=138 Identities=17% Similarity=0.186 Sum_probs=75.9
Q ss_pred eeeeccccceEEEEeeccc----hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCc-ceeeeEEEcCCCceEE
Q psy787 42 GDLLGEGSYGKVKEMLDSE----TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV-IGLVDVFVNDKKQKMY 116 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~ 116 (235)
++.+..|-...+|++.... .++.+++|+..... ... ..-.+|..++..+...++ +++++.+ ...
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~-idR~~E~~~~~~l~~~gl~P~~~~~~--~~g---- 109 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELF-FDRDDEIRTFECMSRHGQGPRLLGRF--PNG---- 109 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Cee-echHHHHHHHHHHHHcCCCCceEEEE--CCc----
Confidence 3456568888999875321 24678888775532 122 223678888888854444 3555554 321
Q ss_pred EEEecccCC-HHHH-----------------hhcCC-CC-C-CC-HHhHHHHHHHH-----------------HHHHHHH
Q psy787 117 LIMEYCVGG-LQDM-----------------LDSTP-YK-K-FP-IWQAHGYFLQL-----------------LDGLEYL 157 (235)
Q Consensus 117 lv~e~~~~~-l~~~-----------------~~~~~-~~-~-~~-~~~~~~~~~ql-----------------~~~l~~l 157 (235)
.|++|+++. +... ++... .. . .+ ...+..+..++ ...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 478887652 2110 01111 00 0 11 12222222111 1111112
Q ss_pred ----H----hCCcccCCCCCCCeEEccC-CcEEEeeeccccc
Q psy787 158 ----H----SQGIIHKDIKPGNLLLTLD-GTLKISDFGVAES 190 (235)
Q Consensus 158 ----H----~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~ 190 (235)
. ...++|+|+++.||++++. +.+.++||.++..
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 2257999999999999864 6799999998863
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0074 Score=48.77 Aligned_cols=30 Identities=33% Similarity=0.542 Sum_probs=25.8
Q ss_pred cccCCCCCCCeEEcc-CCcEEEeeecccccc
Q psy787 162 IIHKDIKPGNLLLTL-DGTLKISDFGVAESL 191 (235)
Q Consensus 162 i~H~dl~p~nili~~-~~~~~l~dfg~~~~~ 191 (235)
.+|+|+.+.||++.+ ++.++++||.++-.-
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 689999999999975 478999999988633
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0045 Score=48.68 Aligned_cols=31 Identities=26% Similarity=0.517 Sum_probs=25.6
Q ss_pred CcccCCCCCCCeEEccCCcE-EEeeecccccc
Q psy787 161 GIIHKDIKPGNLLLTLDGTL-KISDFGVAESL 191 (235)
Q Consensus 161 ~i~H~dl~p~nili~~~~~~-~l~dfg~~~~~ 191 (235)
.++|+|++|.|++++.++++ -|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 37999999999999975664 69999988643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.019 Score=47.43 Aligned_cols=78 Identities=14% Similarity=-0.024 Sum_probs=50.4
Q ss_pred eeeeeccccceEEEEeeccchhhheeeeeeeecccc---CCCCccccHHHHHHHHHhcC---CCCcceeeeEEEcCCCce
Q psy787 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQ---RIPNGEINVDREIRLLKMLQ---HRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~ 114 (235)
..+.||-|....||++.+. +..++||.-.+.... .+.-...+...|...|..+. ..++++++.++ ++ .
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--ed--~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--RT--M 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--CC--C
Confidence 3567899999999998873 356778765432221 11123444556677776664 24778888887 43 3
Q ss_pred EEEEEecccC
Q psy787 115 MYLIMEYCVG 124 (235)
Q Consensus 115 ~~lv~e~~~~ 124 (235)
-+++||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 4788999976
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.007 Score=49.73 Aligned_cols=86 Identities=15% Similarity=0.045 Sum_probs=53.3
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccc--cCCCCccccHHHHHHHHHhcC--CC-CcceeeeEEEcCCCceEE
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKL--QRIPNGEINVDREIRLLKMLQ--HR-NVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~~~ 116 (235)
++.||-|....||++.+...++.++||.-.+... ..+.-...+...|...|+... .| .+++++.+= .....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D----~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD----SVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC----cHHhh
Confidence 5678999999999998743346678875433222 223344456667777777663 34 455555543 33457
Q ss_pred EEEecccCC--HHHHhh
Q psy787 117 LIMEYCVGG--LQDMLD 131 (235)
Q Consensus 117 lv~e~~~~~--l~~~~~ 131 (235)
+|||+++.. ++..+.
T Consensus 110 ~vMEdL~~~~ilR~~Li 126 (409)
T PRK12396 110 CVMEDLSDHTILRTALI 126 (409)
T ss_pred HHHHhCcccHHHHHHHH
Confidence 889988643 555553
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0004 Score=63.15 Aligned_cols=146 Identities=21% Similarity=0.303 Sum_probs=100.0
Q ss_pred cHHHHHHHHHhcCCCCcceeeeEEEcCCCce--EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC
Q psy787 84 NVDREIRLLKMLQHRNVIGLVDVFVNDKKQK--MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ 160 (235)
Q Consensus 84 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~--~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~ 160 (235)
....|+..+....|+|.+.++.+.++..... ..+..+++.. ++.+.++.- ...+....+.+..++.+++.++|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHh
Confidence 3456667788889999999999886533222 2234556654 566666665 6788889999999999999999999
Q ss_pred CcccCCCCCC---CeEEccCCcEEEe--eeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeee
Q psy787 161 GIIHKDIKPG---NLLLTLDGTLKIS--DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 161 ~i~H~dl~p~---nili~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 234 (235)
...|.-+..+ +..++..+...+. ||+.+..++. .........+..+.+||.............|+|.+|..
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d---~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD---NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCC---cccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 7666666555 4444555556655 8887775542 22223333555688888887655555666899999864
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.025 Score=46.62 Aligned_cols=29 Identities=24% Similarity=0.209 Sum_probs=24.6
Q ss_pred CCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 160 ~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
...+|.|+-+.||+.. ++.+.++||.++.
T Consensus 227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEec-CCCEEEEEecccc
Confidence 3578999999999875 5679999999886
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.018 Score=45.83 Aligned_cols=105 Identities=15% Similarity=0.084 Sum_probs=64.8
Q ss_pred EeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCC---CCcceeeeEEEcC-CCceE
Q psy787 40 VMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH---RNVIGLVDVFVND-KKQKM 115 (235)
Q Consensus 40 ~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~-~~~~~ 115 (235)
.-.+.|+.|..+.||..... ++ .+.+|+.+... ....+.+|...++.+.. -.++++++.+..+ ..+..
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARSFS------TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEecccc------cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 34568999999999988653 22 45667643211 11258899999998853 3678888776322 23457
Q ss_pred EEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh
Q psy787 116 YLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159 (235)
Q Consensus 116 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~ 159 (235)
++|||+++|. +.+ . ..+......+..+++.++.-||+
T Consensus 89 ~LVmE~i~G~~~~~-~------~~~~~~~~~l~~~l~~~La~LH~ 126 (297)
T PRK10593 89 VLLLERLRGVSVEA-P------ARTPERWEQLKDQIVEGLLAWHR 126 (297)
T ss_pred EEEEeccCCEecCC-C------CCCHHHHHHHHHHHHHHHHHHhC
Confidence 9999999874 332 0 11222334455555566666665
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.011 Score=47.91 Aligned_cols=73 Identities=18% Similarity=0.322 Sum_probs=56.2
Q ss_pred CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
....+.|++|+.-++++.. + .....+++..++.+-+..+.-+... ..-||++.-.||+|+ +|++.|+||-++
T Consensus 296 de~~y~yl~~kdhgt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 296 DETLYLYLHFKDHGTPISI-I-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred CCceEEEEEEecCCceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeee
Confidence 3445677888887666431 1 2235667788888888877777765 588999999999999 999999999999
Q ss_pred c
Q psy787 189 E 189 (235)
Q Consensus 189 ~ 189 (235)
+
T Consensus 369 R 369 (488)
T COG5072 369 R 369 (488)
T ss_pred e
Confidence 7
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.02 Score=45.32 Aligned_cols=72 Identities=17% Similarity=0.115 Sum_probs=43.8
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC---CCCcceeeeEEEcCCCceEEEE
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ---HRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~~lv 118 (235)
.+.++-|.-..+|++. .+++.+.+|+-.. .....|..|..-|+.+. .-.+++++.+.... ..-+++
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLl 90 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSE-------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLL 90 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEG-------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEE
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecCh-------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEE
Confidence 4567888889999877 4667788886552 22236889999999883 34577888777433 334899
Q ss_pred EecccC
Q psy787 119 MEYCVG 124 (235)
Q Consensus 119 ~e~~~~ 124 (235)
+||++.
T Consensus 91 le~l~~ 96 (288)
T PF03881_consen 91 LEFLEM 96 (288)
T ss_dssp EE----
T ss_pred EEeecC
Confidence 999853
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.08 Score=44.58 Aligned_cols=74 Identities=19% Similarity=0.146 Sum_probs=44.2
Q ss_pred eeeeeccccceEEEEeeccc--------hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcc-eeeeEEEcCC
Q psy787 41 MGDLLGEGSYGKVKEMLDSE--------TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVI-GLVDVFVNDK 111 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~--------~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~ 111 (235)
-++.|..|-.-.+|++.... .++.|++|+...... ... .-.+|..++..+...++. ++++.+ .+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te----~lI-dR~~E~~v~~~ls~~gi~P~l~~~f--~g 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD----ELY-NPISEFEVYKTMSKYRIAPQLLNTF--SG 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc----cee-CHHHHHHHHHHHHHCCCCCceEEEe--CC
Confidence 44667778888888876431 146788887754331 111 235677777777544443 455555 22
Q ss_pred CceEEEEEecccCC
Q psy787 112 KQKMYLIMEYCVGG 125 (235)
Q Consensus 112 ~~~~~lv~e~~~~~ 125 (235)
+.+.+|++|.
T Consensus 182 ----g~I~efi~g~ 191 (442)
T PTZ00296 182 ----GRIEEWLYGD 191 (442)
T ss_pred ----CEEEEeeCCc
Confidence 4578888753
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.029 Score=43.96 Aligned_cols=45 Identities=36% Similarity=0.433 Sum_probs=34.6
Q ss_pred HHHHHHHHHHHHHhC--CcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 146 YFLQLLDGLEYLHSQ--GIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 146 ~~~ql~~~l~~lH~~--~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
.+..+-.++.-++.. -.+|+|+.|.|++.++.+.++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 444444555544444 489999999999999989999999998863
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.036 Score=44.23 Aligned_cols=29 Identities=28% Similarity=0.434 Sum_probs=25.3
Q ss_pred CCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 160 ~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
.+++|+|+.+.|++++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 778999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.082 Score=40.22 Aligned_cols=69 Identities=20% Similarity=0.216 Sum_probs=42.1
Q ss_pred eccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC---cceeeeEEEcCCCceEEEEEec
Q psy787 45 LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN---VIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 45 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~---i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+.-|.--..|.+.+. ..++-+|+=.. .....|.+|+.-|..+...| +++++... .+..+.|+|++|
T Consensus 24 v~gG~inea~~v~dg--~~~~FvK~n~~-------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G--~~~~~sylVle~ 92 (286)
T COG3001 24 VSGGDINEAWRLRDG--TDPFFVKCNQR-------EQLSMFTAEADGLELLARSNTITVPKVIAVG--ASRDHSYLVLEY 92 (286)
T ss_pred cCCccccceeEeecC--CcceEEEecch-------hhHHHHHHHHHHHHHHHhcCCccccceEEec--CCCCeeEEEEee
Confidence 333444445554442 24555554221 22346889998888886554 55555555 677789999999
Q ss_pred ccC
Q psy787 122 CVG 124 (235)
Q Consensus 122 ~~~ 124 (235)
.+.
T Consensus 93 L~~ 95 (286)
T COG3001 93 LPT 95 (286)
T ss_pred ccC
Confidence 874
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.02 Score=42.04 Aligned_cols=29 Identities=31% Similarity=0.597 Sum_probs=25.1
Q ss_pred CcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 161 ~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
..+|+|+.|.|+++.+++ ++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 368999999999998766 99999998863
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.71 E-value=0.031 Score=42.21 Aligned_cols=82 Identities=23% Similarity=0.318 Sum_probs=52.0
Q ss_pred HHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC--Cc
Q psy787 85 VDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ--GI 162 (235)
Q Consensus 85 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--~i 162 (235)
+.++.+++.++. +|+++. +.+...+.++.|.|-..- . ....++..=+++|.-.|+. +.
T Consensus 105 y~nky~v~Armh--GilrL~----NDn~~~yGvIlE~Cy~~~-----------i---~~~N~i~agi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 105 YFNKYRVFARMH--GILRLK----NDNNYKYGVILERCYKIK-----------I---NFSNFITAGIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhHHHHhh--heeEee----cCCCceeEEEEeeccCcc-----------c---chhHHHHHhHHHHHHhhccCCCe
Confidence 456667766653 344433 133345667888763220 0 0111333335667888854 69
Q ss_pred ccCCCCCCCeEEccCCcEEEeeec
Q psy787 163 IHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 163 ~H~dl~p~nili~~~~~~~l~dfg 186 (235)
+|||..|+|||.+..|.+||.|=+
T Consensus 165 lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 165 LHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred ecCCCChhheeecCCCCEEecChh
Confidence 999999999999999999999854
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.19 E-value=0.027 Score=42.32 Aligned_cols=29 Identities=41% Similarity=0.762 Sum_probs=20.8
Q ss_pred CcccCCCCCCCeEE-ccCCcEEEeeecccc
Q psy787 161 GIIHKDIKPGNLLL-TLDGTLKISDFGVAE 189 (235)
Q Consensus 161 ~i~H~dl~p~nili-~~~~~~~l~dfg~~~ 189 (235)
.++|+|+.|.||++ ..++.++++||.++.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 47899999999999 788999999999886
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.99 E-value=0.1 Score=41.78 Aligned_cols=29 Identities=14% Similarity=0.155 Sum_probs=27.0
Q ss_pred CcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 161 ~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
+++|+|+.++|++++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 69999999999999989999999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.53 E-value=0.2 Score=37.23 Aligned_cols=30 Identities=20% Similarity=0.442 Sum_probs=25.5
Q ss_pred CCcccCCCCCCCeEEccCC-----cEEEeeecccc
Q psy787 160 QGIIHKDIKPGNLLLTLDG-----TLKISDFGVAE 189 (235)
Q Consensus 160 ~~i~H~dl~p~nili~~~~-----~~~l~dfg~~~ 189 (235)
..++|||+.+.|+++..++ .+.++||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 3589999999999998654 58999999886
|
subfamily of choline kinases |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.47 E-value=0.14 Score=41.36 Aligned_cols=28 Identities=39% Similarity=0.553 Sum_probs=25.4
Q ss_pred cccCCCCCCCeEEccCCc-EEEeeecccc
Q psy787 162 IIHKDIKPGNLLLTLDGT-LKISDFGVAE 189 (235)
Q Consensus 162 i~H~dl~p~nili~~~~~-~~l~dfg~~~ 189 (235)
++|+|+.|.||+++.++. .-++||+.+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999998885 8899999764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 235 | ||||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-82 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-27 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-27 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-25 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-25 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-25 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-25 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-25 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-24 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-24 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-24 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-24 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-23 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-23 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-23 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-23 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-23 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-23 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-23 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-23 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-23 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-23 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-23 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-23 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-23 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-23 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-23 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-23 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-23 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-23 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-23 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-23 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-23 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-23 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-23 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-23 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-23 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-23 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-22 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-22 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-22 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-22 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-22 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-21 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-21 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-21 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-21 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-21 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-21 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-21 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-21 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-21 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-21 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-21 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-21 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-21 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-21 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-21 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-21 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-21 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-21 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-21 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-21 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-21 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-21 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-21 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-21 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-21 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-21 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-21 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-21 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-21 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-21 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-21 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-21 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-21 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-21 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-21 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-21 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-21 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-21 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-21 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-21 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-21 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-21 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-21 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-21 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-21 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-21 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-21 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-21 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-21 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-21 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-21 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-21 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-21 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-21 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-21 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-21 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-21 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-21 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-21 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-21 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-21 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-21 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-21 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-21 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-21 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-21 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-21 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-21 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-20 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-20 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-20 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-20 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-20 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-20 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-20 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-20 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-20 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-20 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-20 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-20 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-20 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-20 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-20 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-20 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-20 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-20 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-20 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-20 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-20 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-20 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-20 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-20 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-20 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-20 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-19 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-19 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-19 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-19 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-19 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-19 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-19 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-19 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-19 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-19 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-19 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-19 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-19 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-19 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-19 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-19 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-19 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-19 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-19 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-18 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-18 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-18 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-18 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-18 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-18 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-18 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-18 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-18 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-18 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-18 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-18 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-18 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-18 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-18 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-18 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-18 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-18 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-18 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-18 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-18 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-18 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-18 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-18 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-18 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-18 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-18 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-18 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-18 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-18 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-18 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-18 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-18 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-18 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-18 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-18 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-18 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-18 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-18 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-18 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-18 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-18 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-18 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-18 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-18 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-18 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-18 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-17 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-17 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-17 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-17 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-17 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 9e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-16 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-16 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-16 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-16 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-16 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-16 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-15 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-13 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-13 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-11 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-08 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-08 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 7e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-05 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-05 |
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 1e-99
Identities = 153/202 (75%), Positives = 175/202 (86%)
Query: 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLK 93
K+IGKY+MGDLLGEGSYGKVKE+LDSETLCRRAVKI KKKKL+RIPNGE NV +EI+LL+
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
L+H+NVI LVDV N++KQKMY++MEYCV G+Q+MLDS P K+FP+ QAHGYF QL+DG
Sbjct: 62 RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
LEYLHSQGI+HKDIKPGNLLLT GTLKIS GVAE+L F DDT TSQGSP FQ PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 214 IANGLPEISGYKVDIWSSGVTL 235
IANGL SG+KVDIWS+GVTL
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTL 203
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-65
Identities = 78/228 (34%), Positives = 112/228 (49%), Gaps = 33/228 (14%)
Query: 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN--------- 84
+ +Y + D +G+GSYG VK + A+K+ KKKL R
Sbjct: 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 85 -------------VDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD 131
V +EI +LK L H NV+ LV+V + + +Y++ E G +++
Sbjct: 70 PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG--PVME 127
Query: 132 STPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
K QA YF L+ G+EYLH Q IIH+DIKP NLL+ DG +KI+DFGV+
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 192 ---DMFLHDDTITTSQGSPVFQAPEIANGLPEI-SGYKVDIWSSGVTL 235
D L + G+P F APE + +I SG +D+W+ GVTL
Sbjct: 188 KGSDALLS-----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-60
Identities = 58/247 (23%), Positives = 105/247 (42%), Gaps = 29/247 (11%)
Query: 10 GDMISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKI 69
G M I + + K K I Y + L +G + K+ L + A+K
Sbjct: 4 GSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKII--LCEKDNKFYALKK 61
Query: 70 FKKKKLQRI-------------PNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116
++K L++ + + E++++ +++ + + N + +Y
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE--VY 119
Query: 117 LIMEYCVGG-------LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIK 168
+I EY +LD PI +L+ Y+H++ I H+D+K
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 169 PGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDI 228
P N+L+ +G +K+SDFG +E ++ D I S+G+ F PE + +G KVDI
Sbjct: 180 PSNILMDKNGRVKLSDFGESE----YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235
Query: 229 WSSGVTL 235
WS G+ L
Sbjct: 236 WSLGICL 242
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-60
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 23 QVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGE 82
+V+ D ++ +YV G LG+G + K E+ D++T A KI K L + P+
Sbjct: 6 EVLVDPRSR-----RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQR 59
Query: 83 INVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIW 141
+ EI + + L H++V+G F + +++++E C L ++ K
Sbjct: 60 EKMSMEISIHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRRRSLLELHKRR--KALTEP 115
Query: 142 QAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA---ESLDMFLHDD 198
+A Y Q++ G +YLH +IH+D+K GNL L D +KI DFG+A E
Sbjct: 116 EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK-- 173
Query: 199 TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
G+P + APE+ + ++VD+WS G +
Sbjct: 174 ---VLCGTPNYIAPEVLSKKGH--SFEVDVWSIGCIM 205
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-60
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR 90
+ + +YV G LG+G + K E+ D++T A KI K L + P+ + EI
Sbjct: 35 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEIS 93
Query: 91 LLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQ 149
+ + L H++V+G F + +++++E C L ++ K +A Y Q
Sbjct: 94 IHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQ 149
Query: 150 LLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA---ESLDMFLHDDTITTSQGS 206
++ G +YLH +IH+D+K GNL L D +KI DFG+A E G+
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK-----VLCGT 204
Query: 207 PVFQAPEIANGLPEISGY--KVDIWSSGVTL 235
P + APE+ + G+ +VD+WS G +
Sbjct: 205 PNYIAPEVLSK----KGHSFEVDVWSIGCIM 231
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-59
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLK 93
+ I + +G+LLG+GS+ V T A+K+ KK + + V E+++
Sbjct: 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQRVQNEVKIHC 66
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLD 152
L+H +++ L + F + +YL++E C G + L + K F +A + Q++
Sbjct: 67 QLKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIIT 123
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA---ESLDMFLHDDTITTSQGSPVF 209
G+ YLHS GI+H+D+ NLLLT + +KI+DFG+A + + T G+P +
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY-----TLCGTPNY 178
Query: 210 QAPEIANGLPEISGYKVDIWSSGVTL 235
+PEIA G + D+WS G
Sbjct: 179 ISPEIATRSAH--GLESDVWSLGCMF 202
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-58
Identities = 73/206 (35%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR 90
+ V + + + LGEG+YG+V+ ++ T AVKI K+ P N+ +EI
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEIC 57
Query: 91 LLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQ 149
+ KML H NV+ YL +EYC GG L D + P P A +F Q
Sbjct: 58 INKMLNHENVVKFYGHRRE--GNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQ 113
Query: 150 LLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF 209
L+ G+ YLH GI H+DIKP NLLL LKISDFG+A + + G+ +
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 210 QAPEIANGLPEISGYKVDIWSSGVTL 235
APE+ E VD+WS G+ L
Sbjct: 174 VAPELLKRR-EFHAEPVDVWSCGIVL 198
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-57
Identities = 73/206 (35%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR 90
+ V + + + LGEG+YG+V+ ++ T AVKI K+ P N+ +EI
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEIC 57
Query: 91 LLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQ 149
+ KML H NV+ YL +EYC GG L D + P P A +F Q
Sbjct: 58 INKMLNHENVVKFYGHRRE--GNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQ 113
Query: 150 LLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF 209
L+ G+ YLH GI H+DIKP NLLL LKISDFG+A + + G+ +
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 210 QAPEIANGLPEISGYKVDIWSSGVTL 235
APE+ E VD+WS G+ L
Sbjct: 174 VAPELLKRR-EFHAEPVDVWSCGIVL 198
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-55
Identities = 58/219 (26%), Positives = 90/219 (41%), Gaps = 20/219 (9%)
Query: 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDR 87
N+ I VK Y + +G G KV ++L+ E A+K ++ +
Sbjct: 1 NECISVK-GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEAD--NQTLDSYRN 56
Query: 88 EIRLLKMLQH--RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG 145
EI L LQ +I L D + D Q +Y++ME L L K W+
Sbjct: 57 EIAYLNKLQQHSDKIIRLYDYEITD--QYIYMVMECGNIDLNSWLKK--KKSIDPWERKS 112
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG 205
Y+ +L+ + +H GI+H D+KP N L+ DG LK+ DFG+A + + G
Sbjct: 113 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 171
Query: 206 SPVFQAPEIANGLPEIS---------GYKVDIWSSGVTL 235
+ + PE + K D+WS G L
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-55
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 20/219 (9%)
Query: 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDR 87
+++ VK Y + +G G KV ++L+ E A+K ++ +
Sbjct: 20 FQSMSVKGR-IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEAD--NQTLDSYRN 75
Query: 88 EIRLLKMLQHRN--VIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG 145
EI L LQ + +I L D + D+ +Y++ME L L K W+
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLKK--KKSIDPWERKS 131
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG 205
Y+ +L+ + +H GI+H D+KP N L+ DG LK+ DFG+A + + G
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 190
Query: 206 SPVFQAPEIANGLPEIS---------GYKVDIWSSGVTL 235
+ + PE + K D+WS G L
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-55
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+++ D+LG+G+ V +T A+K+F R RE +LK L H+
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHK 67
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEY 156
N++ L + + LIME+C G L +L+ + P + ++ G+ +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 157 LHSQGIIHKDIKPGNLLLTL----DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAP 212
L GI+H++IKPGN++ + K++DFG A L+ D+ + G+ + P
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVSLYGTEEYLHP 184
Query: 213 EIANGLPEIS------GYKVDIWSSGVTL 235
++ G VD+WS GVT
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-54
Identities = 72/203 (35%), Positives = 113/203 (55%), Gaps = 10/203 (4%)
Query: 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLK 93
IG YV+GD LG G++GKVK T + AVKI ++K++ + + REI+ LK
Sbjct: 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG-KIKREIQNLK 66
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLD 152
+ +H ++I L V +++MEY GG L D + + + +A F Q+L
Sbjct: 67 LFRHPHIIKLYQVI--STPTDFFMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILS 122
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAP 212
++Y H ++H+D+KP N+LL KI+DFG++ +M + + TS GSP + AP
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS---NMMSDGEFLRTSCGSPNYAAP 179
Query: 213 EIANGLPEISGYKVDIWSSGVTL 235
E+ +G +G +VDIWS GV L
Sbjct: 180 EVISGRL-YAGPEVDIWSCGVIL 201
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-54
Identities = 58/219 (26%), Positives = 90/219 (41%), Gaps = 20/219 (9%)
Query: 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDR 87
N+ I VK Y + +G G KV ++L+ E A+K ++ +
Sbjct: 48 NECISVK-GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEAD--NQTLDSYRN 103
Query: 88 EIRLLKMLQH--RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG 145
EI L LQ +I L D + D Q +Y++ME L L K W+
Sbjct: 104 EIAYLNKLQQHSDKIIRLYDYEITD--QYIYMVMECGNIDLNSWLKK--KKSIDPWERKS 159
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG 205
Y+ +L+ + +H GI+H D+KP N L+ DG LK+ DFG+A + + G
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 206 SPVFQAPEIANGLPEIS---------GYKVDIWSSGVTL 235
+ + PE + K D+WS G L
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-53
Identities = 71/206 (34%), Positives = 119/206 (57%), Gaps = 9/206 (4%)
Query: 30 TIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREI 89
I + IG Y++ + LGEGS+GKVK +T + A+K ++ L++ + + V+REI
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-SDMHMRVEREI 60
Query: 90 RLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQ 149
LK+L+H ++I L DV + +++EY G L D + K+ + +F Q
Sbjct: 61 SYLKLLRHPHIIKLYDVI--TTPTDIVMVIEYAGGELFDYIVE--KKRMTEDEGRRFFQQ 116
Query: 150 LLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF 209
++ +EY H I+H+D+KP NLLL + +KI+DFG++ ++ + + TS GSP +
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS---NIMTDGNFLKTSCGSPNY 173
Query: 210 QAPEIANGLPEISGYKVDIWSSGVTL 235
APE+ NG +G +VD+WS G+ L
Sbjct: 174 AAPEVINGKL-YAGPEVDVWSCGIVL 198
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-53
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+ + +G LG+G +G V + ++ A+K+ K +L++ E + RE+ + L
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-GVEHQLRREVEIQSHL 66
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
+H N++ L F + + +YLI+EY G + L KF + Y +L + L
Sbjct: 67 RHPNILRLYGYFHDATR--VYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 122
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEI 214
Y HS+ +IH+DIKP NLLL G LKI+DFG + T G+ + PE+
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 178
Query: 215 ANGLPEISGY--KVDIWSSGVTL 235
G + KVD+WS GV
Sbjct: 179 IEG----RMHDEKVDLWSLGVLC 197
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-53
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+++ D+LG+G+ V +T A+K+F R + RE +LK L H+
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD---VQMREFEVLKKLNHK 67
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEY 156
N++ L + + LIME+C G L +L+ + P + ++ G+ +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 157 LHSQGIIHKDIKPGNLLLTL----DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAP 212
L GI+H++IKPGN++ + K++DFG A L+ D+ + G+ + P
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVSLYGTEEYLHP 184
Query: 213 EIANGLPEIS------GYKVDIWSSGVTL 235
++ G VD+WS GVT
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 9e-53
Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 28/223 (12%)
Query: 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDR 87
T+ + + +L+G G +G+V + +K K +R
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE--------KAER 53
Query: 88 EIRLLKMLQHRNVIGLVDVFVND--------------KKQKMYLIMEYCVGG-LQDMLDS 132
E++ L L H N++ + K + +++ ME+C G L+ ++
Sbjct: 54 EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 133 TPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192
+K A F Q+ G++Y+HS+ +I++D+KP N+ L +KI DFG+ SL
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173
Query: 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+D T S+G+ + +PE + G +VD+++ G+ L
Sbjct: 174 ---NDGKRTRSKGTLRYMSPEQISSQD--YGKEVDLYALGLIL 211
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 9e-53
Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 31/222 (13%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+ +LG+G++G+V + ++ A+K + + + + E+ LL L H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-----TILSEVMLLASLNH 61
Query: 98 RNVIGLVDVFVND-----------KKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHG 145
+ V+ ++ KK +++ MEYC G L D++ S +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWR 120
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD------------M 193
F Q+L+ L Y+HSQGIIH+D+KP N+ + +KI DFG+A+++ +
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
D +T++ G+ ++ A E+ +G K+D++S G+
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHY-NEKIDMYSLGIIF 221
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-52
Identities = 72/203 (35%), Positives = 115/203 (56%), Gaps = 10/203 (4%)
Query: 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLK 93
IG Y++GD LG G++GKVK T + AVKI ++K++ + + REI+ LK
Sbjct: 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS-LDVVGKIRREIQNLK 71
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLD 152
+ +H ++I L V ++++MEY GG L D + + ++ F Q+L
Sbjct: 72 LFRHPHIIKLYQVI--STPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILS 127
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAP 212
G++Y H ++H+D+KP N+LL KI+DFG++ +M + + TS GSP + AP
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS---NMMSDGEFLRTSCGSPNYAAP 184
Query: 213 EIANGLPEISGYKVDIWSSGVTL 235
E+ +G +G +VDIWSSGV L
Sbjct: 185 EVISGRL-YAGPEVDIWSSGVIL 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-52
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN----VDREI 89
+ KY LG G++G V +D E VK KK+K+ E V EI
Sbjct: 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 90 RLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG--LQDMLDSTPYKKFPIWQAHGYF 147
+L ++H N+I ++D+F N L+ME G L +D P + A F
Sbjct: 81 AILSRVEHANIIKVLDIFENQGF--FQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIF 136
Query: 148 LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSP 207
QL+ + YL + IIH+DIK N+++ D T+K+ DFG A T G+
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA---AYLERGKLFYTFCGTI 193
Query: 208 VFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ APE+ G P G ++++WS GVTL
Sbjct: 194 EYCAPEVLMGNP-YRGPELEMWSLGVTL 220
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-52
Identities = 68/206 (33%), Positives = 110/206 (53%), Gaps = 17/206 (8%)
Query: 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLK 93
IG Y + +G+G++ KVK T A+KI K +L P + RE+R++K
Sbjct: 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN--PTSLQKLFREVRIMK 69
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPY----KKFPIWQAHGYFLQ 149
+L H N++ L +V + ++ +YLIMEY GG ++ D Y + +A F Q
Sbjct: 70 ILNHPNIVKLFEVI--ETEKTLYLIMEYASGG--EVFD---YLVAHGRMKEKEARSKFRQ 122
Query: 150 LLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF 209
++ ++Y H + I+H+D+K NLLL D +KI+DFG + + F + G+P +
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDAFCGAPPY 179
Query: 210 QAPEIANGLPEISGYKVDIWSSGVTL 235
APE+ G + G +VD+WS GV L
Sbjct: 180 AAPELFQG-KKYDGPEVDVWSLGVIL 204
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-52
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRL 91
+ +Y +G G++G + M D T AVK ++ + NV REI
Sbjct: 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-----DENVQREIIN 69
Query: 92 LKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQL 150
+ L+H N++ +V + + +IMEY GG L + + + +F +A +F QL
Sbjct: 70 HRSLRHPNIVRFKEVILT--PTHLAIIMEYASGGELYERICN--AGRFSEDEARFFFQQL 125
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLL--TLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV 208
L G+ Y HS I H+D+K N LL + LKI DFG + + ++ G+P
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPA 182
Query: 209 FQAPEIANGLPEISGYKVDIWSSGVTL 235
+ APE+ E G D+WS GVTL
Sbjct: 183 YIAPEVLLRQ-EYDGKIADVWSCGVTL 208
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-52
Identities = 71/263 (26%), Positives = 117/263 (44%), Gaps = 46/263 (17%)
Query: 17 HRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQ 76
H + +Y +++ KY + +G+GSYG V+ ++++T RA+KI K K++
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 77 RIPNGEI-NVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG---------- 125
+I ++ + E+RL+K L H N+ L +V+ + +Q + L+ME C GG
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVY--EDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 126 -----------------------------LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
+ Q+ L Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 157 LHSQGIIHKDIKPGNLLLTLDG--TLKISDFGVAESLDMFLHDD--TITTSQGSPVFQAP 212
LH+QGI H+DIKP N L + + +K+ DFG+++ + + +TT G+P F AP
Sbjct: 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
Query: 213 EIANGLPEISGYKVDIWSSGVTL 235
E+ N E G K D WS+GV L
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLL 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-51
Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
I + +G LG+G +G V + + A+K+ K +L++ E + REI + L
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-GVEHQLRREIEIQSHL 71
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
+H N++ + + F + K+ +YL++E+ G L L + +F ++ + +L D L
Sbjct: 72 RHPNILRMYNYFHDRKR--IYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADAL 127
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV-AESLDMFLHDDTITTSQGSPVFQAPE 213
Y H + +IH+DIKP NLL+ G LKI+DFG + + T G+ + PE
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-----TMCGTLDYLPPE 182
Query: 214 IANGLPEISGY--KVDIWSSGVTL 235
+ G + KVD+W +GV
Sbjct: 183 MIEG----KTHDEKVDLWCAGVLC 202
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-51
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQ---RIPNGEINVDRE 88
K + +Y +G LLG G +G V + A+K +K ++ +PNG V E
Sbjct: 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT-RVPME 96
Query: 89 IRLLKMLQHR--NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHG 145
+ LLK + VI L+D F ++ LI+E QD+ D T A
Sbjct: 97 VVLLKKVSSGFSGVIRLLDWF--ERPDSFVLILERPEPV-QDLFDFITERGALQEELARS 153
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD-GTLKISDFGVAESLDMFLHDDTITTSQ 204
+F Q+L+ + + H+ G++H+DIK N+L+ L+ G LK+ DFG L D T
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFD 209
Query: 205 GSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
G+ V+ PE G +WS G+ L
Sbjct: 210 GTRVYSPPEWIRYHR-YHGRSAAVWSLGILL 239
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-51
Identities = 69/241 (28%), Positives = 119/241 (49%), Gaps = 22/241 (9%)
Query: 9 DGDMISIFHRVDSDQVIYD----NKTIKVKMIG-KYVMGDLLGEGSYGKVKEMLDSETLC 63
+ I++ + V +D ++++ K + +Y+M LG G+ G+VK + +T
Sbjct: 102 NNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCK 161
Query: 64 RRAVKIFKKKKLQRIPNGEIN----VDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIM 119
+ A++I K+K E + V+ EI +LK L H +I + + F + Y+++
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---DAEDYYIVL 218
Query: 120 EYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT--- 175
E GG ++ D K+ YF Q+L ++YLH GIIH+D+KP N+LL+
Sbjct: 219 ELMEGG--ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 276
Query: 176 LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS-GYKVDIWSSGVT 234
D +KI+DFG ++ + + T G+P + APE+ + VD WS GV
Sbjct: 277 EDCLIKITDFGHSK---ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
Query: 235 L 235
L
Sbjct: 334 L 334
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-50
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP--NGEINVDREI 89
+ +Y +G LLG+G +G V + A+K+ + ++ + + E+
Sbjct: 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 90 RLLKML----QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAH 144
LL + H VI L+D F + ++ L++E + QD+ D T +
Sbjct: 86 ALLWKVGAGGGHPGVIRLLDWF--ETQEGFMLVLERPLPA-QDLFDYITEKGPLGEGPSR 142
Query: 145 GYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD-GTLKISDFGVAESLDMFLHDDTITTS 203
+F Q++ +++ HS+G++H+DIK N+L+ L G K+ DFG LHD+ T
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG----SGALLHDEPYTDF 198
Query: 204 QGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
G+ V+ PE + +WS G+ L
Sbjct: 199 DGTRVYSPPEWISRHQ-YHALPATVWSLGILL 229
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-50
Identities = 58/201 (28%), Positives = 83/201 (41%), Gaps = 16/201 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR-LLKMLQ 96
+ LG GSYG+V ++ E AVK R P E+ K+ Q
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQ 115
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
H + L + +YL E C LQ ++ P Q GY L L +
Sbjct: 116 HPCCVRLEQAWEEGGI--LYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAH 172
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIAN 216
LHSQG++H D+KP N+ L G K+ DFG+ L +G P + APE+
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPELLQ 229
Query: 217 GLPEISGY--KVDIWSSGVTL 235
G Y D++S G+T+
Sbjct: 230 G-----SYGTAADVFSLGLTI 245
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-50
Identities = 57/213 (26%), Positives = 87/213 (40%), Gaps = 17/213 (7%)
Query: 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRL 91
+ G + M + LG G +G V + +T + A+K +++ + EI++
Sbjct: 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN---RERWCLEIQI 65
Query: 92 LKMLQHRNVIGLVDVFVNDKK----QKMYLIMEYCVGG-LQDMLDS-TPYKKFPIWQAHG 145
+K L H NV+ +V +K L MEYC GG L+ L+
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG---TLKISDFGVAESLDMFLHDDTITT 202
+ L YLH IIH+D+KP N++L KI D G A+ LD + T
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTE 182
Query: 203 SQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
G+ + APE+ VD WS G
Sbjct: 183 FVGTLQYLAPELLEQKK--YTVTVDYWSFGTLA 213
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-49
Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN----VDREIRLLK 93
+Y+M LG G+ G+VK + +T + A+KI K+K E + V+ EI +LK
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLD 152
L H +I + + F + Y+++E GG ++ D K+ YF Q+L
Sbjct: 71 KLNHPCIIKIKNFF---DAEDYYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTL---DGTLKISDFGVAESLDMFLHDDTITTSQGSPVF 209
++YLH GIIH+D+KP N+LL+ D +KI+DFG ++ + + T G+P +
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLCGTPTY 182
Query: 210 QAPEIANGLPEIS-GYKVDIWSSGVTL 235
APE+ + VD WS GV L
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-49
Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 16 FHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKL 75
H + +Y TI ++ LG G++G V + + + R +K K +
Sbjct: 5 HHHSSGRENLYFQGTID----DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS 60
Query: 76 QRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQD--MLDS 132
Q ++ EI +LK L H N+I + +VF + MY++ME C GG L + +
Sbjct: 61 Q---VPMEQIEAEIEVLKSLDHPNIIKIFEVF--EDYHNMYIVMETCEGGELLERIVSAQ 115
Query: 133 TPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAE 189
K Q+++ L Y HSQ ++HKD+KP N+L +KI DFG+A
Sbjct: 116 ARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA- 174
Query: 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
++F D+ T + G+ ++ APE+ +K DIWS+GV +
Sbjct: 175 --ELFKSDEHSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVM 215
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 4e-49
Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
++ ++LG G++ +V + T A+K KK R + +++ EI +LK ++H
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR----DSSLENEIAVLKKIKH 65
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEY 156
N++ L D++ + YL+M+ GG ++ D + A Q+L ++Y
Sbjct: 66 ENIVTLEDIY--ESTTHYYLVMQLVSGG--ELFDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 157 LHSQGIIHKDIKPGNLLLTL---DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
LH GI+H+D+KP NLL + + I+DFG++ + ++T+ G+P + APE
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTACGTPGYVAPE 177
Query: 214 IANGLPEISGYKVDIWSSGVTL 235
+ P VD WS GV
Sbjct: 178 VLAQKP--YSKAVDCWSIGVIT 197
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-49
Identities = 63/221 (28%), Positives = 111/221 (50%), Gaps = 11/221 (4%)
Query: 17 HRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQ 76
H S V + + + + KYV +GEGS+GK + +E + K+ +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTED---GRQYVIKEINIS 60
Query: 77 RIPNGEI-NVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTP 134
R+ + E RE+ +L ++H N++ + F + +Y++M+YC GG L +++
Sbjct: 61 RMSSKEREESRREVAVLANMKHPNIVQYRESFE--ENGSLYIVMDYCEGGDLFKRINAQK 118
Query: 135 YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194
F Q +F+Q+ L+++H + I+H+DIK N+ LT DGT+++ DFG+A L+
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS- 177
Query: 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ G+P + +PEI P K DIW+ G L
Sbjct: 178 -TVELARACIGTPYYLSPEICENKP--YNNKSDIWALGCVL 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-49
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 16/203 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI--NVDREIRLLKML 95
Y MG+ LG G + V++ T A K KK++L G ++RE+ +L+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
+H N+I L D+F + K + LI+E GG L D L + +A + Q+LDG+
Sbjct: 66 RHPNIITLHDIF--ENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGV 121
Query: 155 EYLHSQGIIHKDIKPGNLLLT----LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQ 210
YLHS+ I H D+KP N++L + +K+ DFG+A + G+P F
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFV 178
Query: 211 APEIANGLPEISGYKVDIWSSGV 233
APEI N P G + D+WS GV
Sbjct: 179 APEIVNYEP--LGLEADMWSIGV 199
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-48
Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 24/203 (11%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+G GS+G+V M D +T + AVK + + + E+ L
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR---------VEELVACAGLSSP 110
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
++ L + + + ME GG L ++ P +A Y Q L+GLEYL
Sbjct: 111 RIVPLYGAVR--EGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYL 166
Query: 158 HSQGIIHKDIKPGNLLLTLDGTL-KISDFGVAESLDMFLHDDTITTS---QGSPVFQAPE 213
H++ I+H D+K N+LL+ DG+ + DFG A L ++ T G+ APE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 214 IANGLPEISGY--KVDIWSSGVT 234
+ G KVDIWSS
Sbjct: 227 VVMG----KPCDAKVDIWSSCCM 245
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-48
Identities = 47/211 (22%), Positives = 86/211 (40%), Gaps = 17/211 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
Y+ LGEG + V + A+K + Q RE + ++ H
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREE----AQREADMHRLFNH 85
Query: 98 RNVIGLVDVFVNDK--KQKMYLIMEYCVGG-LQDMLDSTPYKK--FPIWQAHGYFLQLLD 152
N++ LV + ++ K + +L++ + G L + ++ K Q L +
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-------ESLDMFLHDDTITTSQG 205
GLE +H++G H+D+KP N+LL +G + D G E L +
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 206 SPVFQAPEIANGLP-EISGYKVDIWSSGVTL 235
+ ++APE+ + + + D+WS G L
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVL 236
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-48
Identities = 53/227 (23%), Positives = 100/227 (44%), Gaps = 33/227 (14%)
Query: 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLK 93
+ + + LG G +G V E + C A+K + + V RE++ L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL---AREKVMREVKALA 58
Query: 94 MLQHRNVIGLVDVFVND----------KKQKMYLIMEYCVGG-LQDMLDSTPYKKFP--- 139
L+H ++ + ++ K +Y+ M+ C L+D ++ +
Sbjct: 59 KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 140 -IWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD------ 192
FLQ+ + +E+LHS+G++H+D+KP N+ T+D +K+ DFG+ ++D
Sbjct: 119 VCLH---IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 193 ----MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
T G+ ++ +PE +G +KVDI+S G+ L
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNS--YSHKVDIFSLGLIL 220
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-48
Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 16/203 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI--NVDREIRLLKML 95
Y +G+ LG G + VK+ + T A K KK++ + G ++RE+ +L+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
H NVI L DV+ + + + LI+E GG L D L + +A + Q+LDG+
Sbjct: 73 LHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGV 128
Query: 155 EYLHSQGIIHKDIKPGNLLLTL----DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQ 210
YLH++ I H D+KP N++L +K+ DFG+A ++ G+P F
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTPEFV 185
Query: 211 APEIANGLPEISGYKVDIWSSGV 233
APEI N P G + D+WS GV
Sbjct: 186 APEIVNYEP--LGLEADMWSIGV 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-48
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
Y + + +G GS+G+VK + T RRA K K ++ + +EI ++K L H
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR----FKQEIEIMKSLDH 65
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEY 156
N+I L + F + +YL+ME C GG ++ + + F A +L + Y
Sbjct: 66 PNIIRLYETF--EDNTDIYLVMELCTGG--ELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 157 LHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
H + H+D+KP N L D LK+ DFG+A F + T G+P + +P+
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA---ARFKPGKMMRTKVGTPYYVSPQ 178
Query: 214 IANGLPEISGYKVDIWSSGVTL 235
+ L + G + D WS+GV +
Sbjct: 179 V---LEGLYGPECDEWSAGVMM 197
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-48
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKL----QRIPNGEINVDREIRLLK 93
KY D++G G V+ + T AVKI + +++ RE +L+
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 94 ML-QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLL 151
+ H ++I L+D + + M+L+ + G ++ D T + LL
Sbjct: 155 QVAGHPHIITLIDSY--ESSSFMFLVFDLMRKG--ELFDYLTEKVALSEKETRSIMRSLL 210
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQA 211
+ + +LH+ I+H+D+KP N+LL + +++SDFG + + + G+P + A
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS---CHLEPGEKLRELCGTPGYLA 267
Query: 212 PEIANGLPEIS----GYKVDIWSSGVTL 235
PEI + + G +VD+W+ GV L
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-48
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKL-----QRIPNGEINVDREIRLL 92
Y ++LG G V+ + T AVKI + + +E+ +L
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 93 KML-QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQL 150
+ + H N+I L D + + +L+ + G L D L T + L
Sbjct: 78 RKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRAL 133
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQ 210
L+ + LH I+H+D+KP N+LL D +K++DFG + + + G+P +
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVCGTPSYL 190
Query: 211 APEI--ANGLPEISGY--KVDIWSSGVTL 235
APEI + GY +VD+WS+GV +
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 9e-48
Identities = 70/203 (34%), Positives = 105/203 (51%), Gaps = 16/203 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI--NVDREIRLLKML 95
Y G+ LG G + VK+ + T + A K KK++ + G +++RE+ +LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
QH NVI L +V+ + K + LI+E GG L D L + +A + Q+L+G+
Sbjct: 72 QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGV 127
Query: 155 EYLHSQGIIHKDIKPGNLLLT----LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQ 210
YLHS I H D+KP N++L +KI DFG+A +D + G+P F
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFV 184
Query: 211 APEIANGLPEISGYKVDIWSSGV 233
APEI N P G + D+WS GV
Sbjct: 185 APEIVNYEP--LGLEADMWSIGV 205
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 9e-48
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI-NVDREIRLLKMLQ 96
Y + +++G+G + V+ ++ ET + AVKI K P ++ RE + ML+
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD-----STPYKKFPIWQAHGYFLQLL 151
H +++ L++ + +Y++ E+ G D+ + + A Y Q+L
Sbjct: 85 HPHIVELLETY--SSDGMLYMVFEFMDGA--DLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTL---DGTLKISDFGVAESLDMFLHDDTITTSQGSPV 208
+ L Y H IIH+D+KP +LL +K+ FGV ++ + G+P
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV--AIQLGESGLVAGGRVGTPH 198
Query: 209 FQAPEIANGLPEISGYKVDIWSSGVTL 235
F APE+ E G VD+W GV L
Sbjct: 199 FMAPEVVKR--EPYGKPVDVWGCGVIL 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-47
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+Y + +LG+GS+G+V + D T AVK+ K + RE+ LLK L H
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDH 80
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEY 156
N++ L ++ + Y++ E GG ++ D K+F A Q+ G+ Y
Sbjct: 81 PNIMKLFEIL--EDSSSFYIVGELYTGG--ELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 157 LHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
+H I+H+D+KP N+LL D +KI DFG++ F + + G+ + APE
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPE 193
Query: 214 IANGLPEISGYKVDIWSSGVTL 235
+ L K D+WS+GV L
Sbjct: 194 V---LRGTYDEKCDVWSAGVIL 212
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-47
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
Y + + LG+G++ V+ + T A KI KKL ++RE R+ + LQH
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQH 64
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEY 156
N++ L D ++ YL+ + GG ++ + + + A Q+L+ + Y
Sbjct: 65 PNIVRLHDSI--QEESFHYLVFDLVTGG--ELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 157 LHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
HS GI+H+++KP NLLL +K++DFG+A + G+P + +PE
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPE 177
Query: 214 IANGLPEISGY--KVDIWSSGVTL 235
+ Y VDIW+ GV L
Sbjct: 178 VLKK----DPYSKPVDIWACGVIL 197
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-47
Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
Y + +G GSYG+ +++ K + + + E+ LL+ L
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT--EAEKQMLVSEVNLLREL 62
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKK--FPIWQAHGYFLQLLD 152
+H N++ D ++ +Y++MEYC GG L ++ ++ QL
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 153 GLEYLHSQG-----IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSP 207
L+ H + ++H+D+KP N+ L +K+ DFG+A L+ T G+P
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTP 180
Query: 208 VFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ +PE N + K DIWS G L
Sbjct: 181 YYMSPEQMNRMS--YNEKSDIWSLGCLL 206
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-47
Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 19/235 (8%)
Query: 2 GDKDDEVDGDMISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSET 61
G K ++ D I+ + V ++ Y + + LG G++G V ++ T
Sbjct: 20 GPKINDYDKFYEDIWKKYVPQPVEVKQGSVY----DYYDILEELGSGAFGVVHRCVEKAT 75
Query: 62 LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEY 121
K V EI ++ L H +I L D F + K +M LI+E+
Sbjct: 76 GRVFVAKFINTPYPLDKYT----VKNEISIMNQLHHPKLINLHDAF--EDKYEMVLILEF 129
Query: 122 CVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT--LDG 178
GG L D + + YK + Y Q +GL+++H I+H DIKP N++
Sbjct: 130 LSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS 188
Query: 179 TLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGV 233
++KI DFG+A L+ D+ + + + F APEI + E G+ D+W+ GV
Sbjct: 189 SVKIIDFGLATKLN---PDEIVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGV 238
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-47
Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+ +LG+G+YG V D R A+K ++ + + EI L K L
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS----QPLHEEIALHKHL 76
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAH--GYFLQLLD 152
+H+N++ + F + + + ME GG L +L S + + Y Q+L+
Sbjct: 77 KHKNIVQYLGSFS--ENGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILE 133
Query: 153 GLEYLHSQGIIHKDIKPGNLLL-TLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQA 211
GL+YLH I+H+DIK N+L+ T G LKISDFG ++ L + T G+ + A
Sbjct: 134 GLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMA 191
Query: 212 PEIANGLPEISGYKVDIWSSGVT 234
PEI + P G DIWS G T
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCT 214
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-47
Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 16/203 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI--NVDREIRLLKML 95
Y +G+ LG G + VK+ + T A K KK++ + G ++RE+ +L+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
H N+I L DV+ + + + LI+E GG L D L + +A + Q+LDG+
Sbjct: 73 LHPNIITLHDVY--ENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGV 128
Query: 155 EYLHSQGIIHKDIKPGNLLLT----LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQ 210
YLH++ I H D+KP N++L +K+ DFG+A ++ G+P F
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTPEFV 185
Query: 211 APEIANGLPEISGYKVDIWSSGV 233
APEI N P G + D+WS GV
Sbjct: 186 APEIVNYEP--LGLEADMWSIGV 206
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-47
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
KY++ + LG G +G V +++ + K K K ++ V +EI +L + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-----LVKKEISILNIARH 60
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPI--WQAHGYFLQLLDGLE 155
RN++ L + F + +++ +I E+ G D+ + F + + Y Q+ + L+
Sbjct: 61 RNILHLHESF--ESMEELVMIFEFISGL--DIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 156 YLHSQGIIHKDIKPGNLLLT--LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
+LHS I H DI+P N++ T+KI +FG A D +P + APE
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPE 173
Query: 214 IANGLPEISGYKVDIWSSGV 233
+ D+WS G
Sbjct: 174 VHQHDV--VSTATDMWSLGT 191
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 7e-47
Identities = 36/227 (15%), Positives = 63/227 (27%), Gaps = 35/227 (15%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
K + + L G V + D E L A+K+F E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELE-RLHEATFAAARLLG 121
Query: 98 RN------------------------VIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDST 133
+ L + L+M L+ + +
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 134 PY-----KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188
+ I H QL+ L S+G++H P NL + DG L + D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ S + E N + ++ W G+++
Sbjct: 242 -----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-47
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 38 KYVMG--DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
Y + ++LG G +G+V + ++ T + A KI K + ++ V EI ++ L
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE----VKNEISVMNQL 143
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPI--WQAHGYFLQLLDG 153
H N+I L D F + K + L+MEY GG ++ D + + + + Q+ +G
Sbjct: 144 DHANLIQLYDAF--ESKNDIVLVMEYVDGG--ELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 154 LEYLHSQGIIHKDIKPGNLLLT--LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQA 211
+ ++H I+H D+KP N+L +KI DFG+A + + + G+P F A
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK---PREKLKVNFGTPEFLA 256
Query: 212 PEIANGLPEISGYKVDIWSSGV 233
PE+ N + D+WS GV
Sbjct: 257 PEVVNYDF--VSFPTDMWSVGV 276
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-46
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
Y + + LG+G++ V+ + T A KI KKL ++RE R+ + LQH
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQH 87
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEY 156
N++ L D ++ YL+ + GG ++ + + + A Q+L+ + Y
Sbjct: 88 PNIVRLHDSI--QEESFHYLVFDLVTGG--ELFEDIVAREFYSEADASHCIQQILESIAY 143
Query: 157 LHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
HS GI+H+++KP NLLL +K++DFG+A + G+P + +PE
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPE 200
Query: 214 IANGLPEISGYKVDIWSSGVTL 235
+ P VDIW+ GV L
Sbjct: 201 VLKKDP--YSKPVDIWACGVIL 220
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-46
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
Y + + LG G++G V + + T A K V +EI+ + +L+H
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET----VRKEIQTMSVLRH 213
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPI--WQAHGYFLQLLDGLE 155
++ L D F + +M +I E+ GG ++ + + + +A Y Q+ GL
Sbjct: 214 PTLVNLHDAF--EDDNEMVMIYEFMSGG--ELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 156 YLHSQGIIHKDIKPGNLLLTL--DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
++H +H D+KP N++ T LK+ DFG+ ++ + G+ F APE
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVTTGTAEFAAPE 326
Query: 214 IANGLPEISGYKVDIWSSGV 233
+A G P GY D+WS GV
Sbjct: 327 VAEGKP--VGYYTDMWSVGV 344
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-46
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+ + LG G+ V T A+K+ KK ++I V EI +L L H
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI------VRTEIGVLLRLSH 107
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEY 156
N+I L ++F + ++ L++E GG ++ D + A Q+L+ + Y
Sbjct: 108 PNIIKLKEIF--ETPTEISLVLELVTGG--ELFDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 157 LHSQGIIHKDIKPGNLLLTL---DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
LH GI+H+D+KP NLL D LKI+DFG++ + H + T G+P + APE
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS---KIVEHQVLMKTVCGTPGYCAPE 220
Query: 214 IANGLPEISGYKVDIWSSGV 233
I G G +VD+WS G+
Sbjct: 221 ILRGCA--YGPEVDMWSVGI 238
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-46
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 40 VMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR- 98
+ LG G + V++ + T A K KK++ + + EI +L++ +
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD--CRAEILHEIAVLELAKSCP 89
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
VI L +V+ + ++ LI+EY GG + + + Q+L+G+ YL
Sbjct: 90 RVINLHEVY--ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 158 HSQGIIHKDIKPGNLLL---TLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEI 214
H I+H D+KP N+LL G +KI DFG++ H + G+P + APEI
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS---RKIGHACELREIMGTPEYLAPEI 204
Query: 215 ANGLPEISGYKVDIWSSGVTL 235
N P D+W+ G+
Sbjct: 205 LNYDP--ITTATDMWNIGIIA 223
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-46
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 34 KMIGKYVMGDLLGEGSYG---KVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR 90
+ + + +G G + + +LD + + V+IF + +EI
Sbjct: 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD----AKARADCIKEID 84
Query: 91 LLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKK--FP---IWQAH 144
LLK L H NVI F+ D ++ +++E G L M+ +K P +W+
Sbjct: 85 LLKQLNHPNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK-- 140
Query: 145 GYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ 204
YF+QL LE++HS+ ++H+DIKP N+ +T G +K+ D G+ +
Sbjct: 141 -YFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLV 197
Query: 205 GSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
G+P + +PE + +K DIWS G L
Sbjct: 198 GTPYYMSPERIHENG--YNFKSDIWSLGCLL 226
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-46
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 20/223 (8%)
Query: 17 HRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQ 76
H + +Y T +Y + +LG+GS+G+V + D T AVK+ K +
Sbjct: 6 HHSSGRENLYFQGTFA----ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 77 RIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPY 135
+ RE+ LLK L H N++ L ++ + Y++ E GG L D +
Sbjct: 62 NKD--TSTILREVELLKKLDHPNIMKLFEILEDSSS--FYIVGELYTGGELFDEIIKR-- 115
Query: 136 KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAESLD 192
K+F A Q+ G+ Y+H I+H+D+KP N+LL D +KI DFG++
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS---T 172
Query: 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
F + + G+ + APE+ G K D+WS+GV L
Sbjct: 173 CFQQNTKMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVIL 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-46
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN---------VDRE 88
Y LG G+YG+V + +A+K+ KK + + + N + E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 89 IRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYF 147
I LLK L H N+I L DVF + K YL+ E+ GG L + + + KF A
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGELFEQIIN--RHKFDECDAANIM 152
Query: 148 LQLLDGLEYLHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAESLDMFLHDDTITTSQ 204
Q+L G+ YLH I+H+DIKP N+LL +KI DFG++ F D +
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS---SFFSKDYKLRDRL 209
Query: 205 GSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
G+ + APE+ L + K D+WS GV +
Sbjct: 210 GTAYYIAPEV---LKKKYNEKCDVWSCGVIM 237
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-45
Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+Y +LG+GS+G+V D T AVK+ K+++++ + ++ RE++LLK L H
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDH 85
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
N++ L + F + YL+ E GG L D + S K+F A Q+L G+ Y
Sbjct: 86 PNIMKLYEFFEDKGY--FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITY 141
Query: 157 LHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
+H I+H+D+KP NLLL D ++I DFG++ F + G+ + APE
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAPE 198
Query: 214 IANGLPEISGYKVDIWSSGVTL 235
+ +G K D+WS+GV L
Sbjct: 199 VLHG---TYDEKCDVWSTGVIL 217
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-45
Identities = 53/224 (23%), Positives = 83/224 (37%), Gaps = 36/224 (16%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLL-KMLQ 96
V +LG GS G V S AVK EI+LL +
Sbjct: 16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDI-------ALMEIKLLTESDD 67
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDML-----DSTPYKKFPIWQAHGYFLQLL 151
H NVI + +Y+ +E C LQD++ K + Q+
Sbjct: 68 HPNVIRYYCSE--TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLT-------------LDGTLKISDFGVAESL--DMFLH 196
G+ +LHS IIH+D+KP N+L++ + + ISDFG+ + L
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 197 DDTITTSQGSPVFQAPEIANGLPEIS-----GYKVDIWSSGVTL 235
+ G+ ++APE+ + +DI+S G
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-45
Identities = 68/202 (33%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
Y LG G+YG+V D T RA+KI +K + + E+ +LK+L H
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS--NSKLLEEVAVLKLLDH 95
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
N++ L D F + + YL+ME GG L D + KF A Q+L G+ Y
Sbjct: 96 PNIMKLYDFFEDKRN--YYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTY 151
Query: 157 LHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
LH I+H+D+KP NLLL D +KI DFG++ +F + + G+ + APE
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKMKERLGTAYYIAPE 208
Query: 214 IANGLPEISGYKVDIWSSGVTL 235
+ L + K D+WS GV L
Sbjct: 209 V---LRKKYDEKCDVWSIGVIL 227
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-45
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 27 DNKTIKVKMIGK--YVMGDLLGEGSYGKV--KEMLDSETLCRRAVKIFKKKKLQRIPNGE 82
++ V ++GK + D+LG G+ G + + M D+ AVK +
Sbjct: 12 GDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNR---DVAVKRILPECFS------ 62
Query: 83 INVDREIRLLKML-QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIW 141
DRE++LL+ +H NVI +Q Y+ +E C LQ+ ++
Sbjct: 63 -FADREVQLLRESDEHPNVIRYFCTE--KDRQFQYIAIELCAATLQEYVEQ-KDFAHLGL 118
Query: 142 QAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT-----LKISDFGVAESLDMFLH 196
+ Q GL +LHS I+H+D+KP N+L+++ ISDFG+ + L + H
Sbjct: 119 EPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 197 DDTITTSQ-GSPVFQAPEIANGLPEIS-GYKVDIWSSGVTL 235
+ + G+ + APE+ + + + Y VDI+S+G
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-45
Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+Y + + LG+G++ V+ + A I KKL ++RE R+ ++L+H
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA--RDHQKLEREARICRLLKH 69
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEY 156
N++ L D ++ YLI + GG ++ + + + A Q+L+ + +
Sbjct: 70 PNIVRLHDSI--SEEGHHYLIFDLVTGG--ELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 157 LHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
H G++H+++KP NLLL +K++DFG+A ++ G+P + +PE
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTPGYLSPE 183
Query: 214 IANGLPEISGYKVDIWSSGVTL 235
+ P G VD+W+ GV L
Sbjct: 184 VLRKDP--YGKPVDLWACGVIL 203
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 7e-45
Identities = 40/237 (16%), Positives = 77/237 (32%), Gaps = 46/237 (19%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ- 96
V G +LG+ E D ET V + + N + E+ L++L+
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRG 132
Query: 97 ------------------------HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD- 131
+ +I + + + + LQ +
Sbjct: 133 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 192
Query: 132 ----STPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187
S+ +K LQ++ L LH G++H ++P +++L G + ++ F
Sbjct: 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGLPEIS---------GYKVDIWSSGVTL 235
+ D S S F+ PE+ IS + D W+ G+ +
Sbjct: 253 L------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-43
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR-LLKMLQ 96
Y + + +G GSY K + T AVKI K K + EI LL+ Q
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQ 74
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLE 155
H N+I L DV+ D + +Y++ E GG ++LD K F +A + +E
Sbjct: 75 HPNIITLKDVY--DDGKYVYVVTELMKGG--ELLDKILRQKFFSEREASAVLFTITKTVE 130
Query: 156 YLHSQGIIHKDIKPGNLLLTLDG----TLKISDFGVAESLDMFLHDDTITTSQGSPVFQA 211
YLH+QG++H+D+KP N+L + +++I DFG A+ L + + T + F A
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVA 188
Query: 212 PEIANGLPEISGY--KVDIWSSGVTL 235
PE+ GY DIWS GV L
Sbjct: 189 PEVLER----QGYDAACDIWSLGVLL 210
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-43
Identities = 44/218 (20%), Positives = 83/218 (38%), Gaps = 28/218 (12%)
Query: 38 KYVMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLL 92
+ LLGEG++ +V ++ D++ + +K+ K + + L
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF----YIGTQLMERL 121
Query: 93 KMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLD---STPYKKFPIWQAHGYFL 148
K + + + L+ E G L + ++ +TP K P + +
Sbjct: 122 KPSMQHMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLT-----------LDGTLKISDFGVAESLDMFLHD 197
++L +E +H IIH DIKP N +L L L + D G + + +F
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 198 DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
T + FQ E+ + P Y++D + T+
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKP--WNYQIDYFGVAATV 275
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-43
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-H 97
+ LGEGS+ ++ + ++ AVKI K+ N +EI LK+ + H
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA-------NTQKEITALKLCEGH 65
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGLEY 156
N++ L +VF + +L+ME GG ++ + K F +A +L+ + +
Sbjct: 66 PNIVKLHEVF--HDQLHTFLVMELLNGG--ELFERIKKKKHFSETEASYIMRKLVSAVSH 121
Query: 157 LHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
+H G++H+D+KP NLL T + +KI DFG A + + T + + APE
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPE 179
Query: 214 IANGLPEISGY--KVDIWSSGVTL 235
+ N +GY D+WS GV L
Sbjct: 180 LLNQ----NGYDESCDLWSLGVIL 199
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-43
Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 28/230 (12%)
Query: 18 RVDSDQVIYDNKTIKVKMIGKYV-MGDLLGEGSYGKVKEMLDSETLCRRAVKIFK----- 71
+ D + K + + G+++ +G GS+ V + LD+ET A +
Sbjct: 6 QQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT 65
Query: 72 KKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN--DKKQKMYLIMEYCVGG-LQD 128
K + QR E +LK LQH N++ D + + K+ + L+ E G L+
Sbjct: 66 KSERQRFKE-------EAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT 118
Query: 129 MLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLT-LDGTLKISDF 185
L +K I + Q+L GL++LH++ IIH+D+K N+ +T G++KI D
Sbjct: 119 YLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176
Query: 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
G+A G+P F APE+ E VD+++ G+ +
Sbjct: 177 GLAT----LKRASFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCM 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-42
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-H 97
V +LG G GKV ++ + T + A+K+ + R RE+ L
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR---------REVELHWRASQC 114
Query: 98 RNVIGLVDVF--VNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
+++ +VDV+ + ++ + ++ME GG L + + F +A + + +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 155 EYLHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQA 211
+YLHS I H+D+KP NLL T + LK++DFG A +++TT +P + A
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVA 231
Query: 212 PEIANGLPEISGY--KVDIWSSGVTL 235
PE+ Y D+WS GV +
Sbjct: 232 PEVLGP----EKYDKSCDMWSLGVIM 253
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-42
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 27/208 (12%)
Query: 38 KYVMG-DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
Y + +LG G GKV E T + A+K+ R +E+
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR---------QEVDHHWQAS 79
Query: 97 -HRNVIGLVDVF--VNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLD 152
+++ ++DV+ ++ K+ + +IME GG L + + F +A +
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 153 GLEYLHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF 209
+++LHS I H+D+KP NLL T D LK++DFG A + + T +P +
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQNALQTPCYTPYY 195
Query: 210 QAPEIANGLPEISGY--KVDIWSSGVTL 235
APE+ Y D+WS GV +
Sbjct: 196 VAPEVLGP----EKYDKSCDMWSLGVIM 219
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-42
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 38 KYVMG-DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
Y + D+LGEG++ +V+ ++ T AVKI +K+ V RE+ +L Q
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH----IRSRVFREVEMLYQCQ 68
Query: 97 -HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-TPYKKFPIWQAHGYFLQLLDGL 154
HRNV+ L++ F +++ + YL+ E GG +L + F +A + L
Sbjct: 69 GHRNVLELIEFF--EEEDRFYLVFEKMRGG--SILSHIHKRRHFNELEASVVVQDVASAL 124
Query: 155 EYLHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVA-----ESLDMFLHDDTITTSQGS 206
++LH++GI H+D+KP N+L +KI DF + + + T GS
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 207 PVFQAPEIANGL-PEISGY--KVDIWSSGVTL 235
+ APE+ E S Y + D+WS GV L
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-41
Identities = 52/226 (23%), Positives = 84/226 (37%), Gaps = 44/226 (19%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLL-KMLQ 96
++ + +G G +G V + + C A+K KK E N RE+ + Q
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG--SVDEQNALREVYAHAVLGQ 69
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLD--STPYKKFP---IWQAHGYFLQL 150
H +V+ + + M + EYC GG L D + F + LQ+
Sbjct: 70 HSHVVRYFSAWA--EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD---LLLQV 124
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDG-------------------TLKISDFGVAESL 191
GL Y+HS ++H DIKP N+ ++ KI D G +
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGY--KVDIWSSGVTL 235
+G F A E+ L E + K DI++ +T+
Sbjct: 185 SS------PQVEEGDSRFLANEV---LQENYTHLPKADIFALALTV 221
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-41
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+GEGS G V + + + AVK+ +K QR + E+ +++ QH
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR----RELLFNEVVIMRDYQH 101
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFL-QLLDGLE 155
NV+ + ++ ++++++ME+ GG L D++ + I +L L
Sbjct: 102 FNVVEMYKSYL--VGEELWVLMEFLQGGALTDIVSQVRLNEEQI----ATVCEAVLQALA 155
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI---TTSQGSPVFQAP 212
YLH+QG+IH+DIK ++LLTLDG +K+SDFG + + + G+P + AP
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI-----SKDVPKRKSLVGTPYWMAP 210
Query: 213 EIANGLPEISGYKVDIWSSGVT 234
E+ + +VDIWS G+
Sbjct: 211 EVISRSL--YATEVDIWSLGIM 230
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-41
Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
KY + +G+G+ G V +D T A++ ++ + + + EI +++ ++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK----KELIINEILVMRENKN 76
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFL-QLLDGLE 155
N++ +D ++ +++++MEY GG L D++ T + I + L LE
Sbjct: 77 PNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQI----AAVCRECLQALE 130
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI---TTSQGSPVFQAP 212
+LHS +IH+DIK N+LL +DG++K++DFG + +T G+P + AP
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-----TPEQSKRSTMVGTPYWMAP 185
Query: 213 EIANGLPEISGYKVDIWSSGVT 234
E+ G KVDIWS G+
Sbjct: 186 EVVTRKA--YGPKVDIWSLGIM 205
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-40
Identities = 55/236 (23%), Positives = 100/236 (42%), Gaps = 26/236 (11%)
Query: 21 SDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN 80
DQ + +T+++ + + + +L EG + V E D + A+K + ++
Sbjct: 13 RDQSDFVGQTVELGEL-RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRA 71
Query: 81 GEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQ------KMYLIMEYCVGGLQDMLDST 133
+ +E+ +K L H N++ K++ + L+ E C G L + L
Sbjct: 72 ----IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM 127
Query: 134 PYK-KFPIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLTLDGTLKISDFGVAES 190
+ F Q ++++H Q IIH+D+K NLLL+ GT+K+ DFG A +
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187
Query: 191 LDMFLHDDTIT----------TSQGSPVFQAPEIANGLPEIS-GYKVDIWSSGVTL 235
+ + T +P+++ PEI + G K DIW+ G L
Sbjct: 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-40
Identities = 58/205 (28%), Positives = 107/205 (52%), Gaps = 19/205 (9%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+ + LG+G++GKV + + ET A K+ + K + + + EI +L H
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL----EDYIVEIEILATCDH 75
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
++ L+ + K+++++E+C GG + ++ + Q Q+L+ L +
Sbjct: 76 PYIVKLLGAYY--HDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNF 132
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT---TSQGSPVFQAPE 213
LHS+ IIH+D+K GN+L+TL+G ++++DFGV+ T+ + G+P + APE
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN-----LKTLQKRDSFIGTPYWMAPE 187
Query: 214 -IANGLPEISGY--KVDIWSSGVTL 235
+ + + Y K DIWS G+TL
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITL 212
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-40
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+ +G GS+G V D A+K Q + ++ +E+R L+ L+H
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQKLRH 113
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
N I ++ ++ +L+MEYC+G D+L+ K + L GL YL
Sbjct: 114 PNTIQYRGCYL--REHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYL 170
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG 217
HS +IH+D+K GN+LL+ G +K+ DFG A + + G+P + APE+
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILA 224
Query: 218 LPEIS-GYKVDIWSSGVT 234
+ E KVD+WS G+T
Sbjct: 225 MDEGQYDGKVDVWSLGIT 242
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-39
Identities = 68/203 (33%), Positives = 106/203 (52%), Gaps = 25/203 (12%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+ + +G+GS+G+V + +D+ T A+KI L+ + ++ +EI +L
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID---LEEAEDEIEDIQQEITVLSQCDSP 80
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFL-QLLDGLEY 156
V ++ K K+++IMEY GG D+L+ P + I L ++L GL+Y
Sbjct: 81 YVTKYYGSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQI----ATILREILKGLDY 134
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI---TTSQGSPVFQAPE 213
LHS+ IH+DIK N+LL+ G +K++DFGVA L DT T G+P + APE
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-----TDTQIKRNTFVGTPFWMAPE 189
Query: 214 IANGLPEISGY--KVDIWSSGVT 234
+ S Y K DIWS G+T
Sbjct: 190 VIKQ----SAYDSKADIWSLGIT 208
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-39
Identities = 66/204 (32%), Positives = 97/204 (47%), Gaps = 26/204 (12%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK-KKKLQRIPNGEINVDREIRLLKMLQ 96
+ + + LGEGSYG V + + ET A+K + LQ I EI +++
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK-------EISIMQQCD 82
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
+V+ + K ++++MEYC G + D++ K + L GLE
Sbjct: 83 SPHVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLE 139
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT---TSQGSPVFQAP 212
YLH IH+DIK GN+LL +G K++DFGVA L DT+ T G+P + AP
Sbjct: 140 YLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL-----TDTMAKRNTVIGTPFWMAP 194
Query: 213 EIANGLPEISGY--KVDIWSSGVT 234
E+ GY DIWS G+T
Sbjct: 195 EVIQE----IGYNCVADIWSLGIT 214
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 139 bits (350), Expect = 3e-39
Identities = 31/229 (13%), Positives = 69/229 (30%), Gaps = 33/229 (14%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQ---------------------R 77
V G +LG+ E D ET V + + +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 78 IPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM---YLIMEYCVGGLQDMLDS-- 132
R I +++ ++ V ++++ + + + LQ +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 133 ---TPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189
+ +K LQ++ L LH G++H ++P +++L G + ++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPE---ISGYKVDIWSSGVTL 235
P A + + + D W+ G+ +
Sbjct: 260 RDGASAVSPI-GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-39
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR-IPNGEINVDREIRLLK 93
M+ KY +GEGSYG V + + +T A+K F + + I + REIR+LK
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL---REIRMLK 57
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
L+H N++ L++VF ++ ++L+ EYC + LD + P Q L
Sbjct: 58 QLKHPNLVNLLEVFRRKRR--LHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQA 114
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV----- 208
+ + H IH+D+KP N+L+T +K+ DFG A L P
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL-------------TGPSDYYDD 161
Query: 209 ------FQAPEIANGLPEISGYKVDIWSSG 232
+++PE+ G + VD+W+ G
Sbjct: 162 EVATRWYRSPELLVGDTQYGP-PVDVWAIG 190
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-39
Identities = 38/207 (18%), Positives = 82/207 (39%), Gaps = 14/207 (6%)
Query: 37 GKYVMGDLLGEG--SYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VDREIRLLK 93
G Y + ++G+G V T V+ L+ N + + E+ + K
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN---LEACSNEMVTFLQGELHVSK 81
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLD 152
+ H N++ F+ +++++ + G +D++ + +L
Sbjct: 82 LFNHPNIVPYRATFI--ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH-----DDTITTSQGSP 207
L+Y+H G +H+ +K ++L+++DG + +S S+ D S
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 208 VFQAPEIANGLPEISGYKVDIWSSGVT 234
+ +PE+ + K DI+S G+T
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGIT 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-39
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 42/217 (19%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD----REIRLLK 93
+Y +G G+YG V + D + V + K ++ G + RE+ LL+
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHS--GHFVAL-KSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 94 MLQ---HRNVIGLVDVFV---NDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYF 147
L+ H NV+ L+DV D++ K+ L+ E+ L+ LD P P
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 148 LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSP 207
Q L GL++LH+ I+H+D+KP N+L+T GT+K++DFG+A
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-------------SYQ 173
Query: 208 V----------FQAPEIANGLPEISGY--KVDIWSSG 232
+ ++APE+ S Y VD+WS G
Sbjct: 174 MALTPVVVTLWYRAPEVLLQ----STYATPVDMWSVG 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-39
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 38/210 (18%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR----IPNGEINVDREIRLLK 93
KY + +GEG+YG V + + ET V + K+ +L +P+ + REI LLK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRET--HEIVAL-KRVRLDDDDEGVPSSAL---REICLLK 56
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
L+H+N++ L DV +DKK + L+ E+C L+ DS + QLL G
Sbjct: 57 ELKHKNIVRLHDVLHSDKK--LTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKG 113
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV----- 208
L + HS+ ++H+D+KP NLL+ +G LK+++FG+A + G PV
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-------------GIPVRCYSA 160
Query: 209 ------FQAPEIANGLPEISGYKVDIWSSG 232
++ P++ G S +D+WS+G
Sbjct: 161 EVVTLWYRPPDVLFGAKLYST-SIDMWSAG 189
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-38
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
Y + +++G G+ V+ + + A+K L++ + +EI+ + H
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN---LEKCQTSMDELLKEIQAMSQCHHP 73
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAH-----GYFL-QLL 151
N++ FV K +++L+M+ GG + D++ K L ++L
Sbjct: 74 NIVSYYTSFV--VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI---TTSQGSPV 208
+GLEYLH G IH+D+K GN+LL DG+++I+DFGV+ L T G+P
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 209 FQAPEIANGLPEISGY--KVDIWSSGVT 234
+ APE+ + ++ GY K DIWS G+T
Sbjct: 192 WMAPEV---MEQVRGYDFKADIWSFGIT 216
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-38
Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML- 95
G + + +L+G G+YG+V + +T A+K+ + EI +EI +LK
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIK--QEINMLKKYS 78
Query: 96 QHRNVIGLVDVFVN----DKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQL 150
HRN+ F+ +++L+ME+C G + D++ +T ++
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI---TTSQGSP 207
L GL +LH +IH+DIK N+LLT + +K+ DFGV+ L D T+ T G+P
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-----DRTVGRRNTFIGTP 193
Query: 208 VFQAPE-IANGLPEISGY--KVDIWSSGVT 234
+ APE IA + Y K D+WS G+T
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGIT 223
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-38
Identities = 67/231 (29%), Positives = 107/231 (46%), Gaps = 38/231 (16%)
Query: 17 HRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQ 76
H S V + + + + KY L+GEGSYG V + + +T R V I KK
Sbjct: 5 HHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDT--GRIVAI-KKFLES 61
Query: 77 R----IPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS 132
+ + REI+LLK L+H N++ L++V K+ YL+ E+ + D L+
Sbjct: 62 DDDKMVKKIAM---REIKLLKQLRHENLVNLLEVCKKKKR--WYLVFEFVDHTILDDLEL 116
Query: 133 TPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192
P Y Q+++G+ + HS IIH+DIKP N+L++ G +K+ DFG A +L
Sbjct: 117 FP-NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL- 174
Query: 193 MFLHDDTITTSQGSPV-----------FQAPEIANGLPEISGYKVDIWSSG 232
+P ++APE+ G + VD+W+ G
Sbjct: 175 ------------AAPGEVYDDEVATRWYRAPELLVGDVKYGK-AVDVWAIG 212
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-38
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 37/209 (17%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR---IPNGEINVDREIRLLKM 94
Y+ D LGEG+Y V + T V + K+ +L+ P I RE+ LLK
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLT--DNLVAL-KEIRLEHEEGAPCTAI---REVSLLKD 56
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
L+H N++ L D+ +K + L+ EY L+ LD + + QLL GL
Sbjct: 57 LKHANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGL 113
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV------ 208
Y H Q ++H+D+KP NLL+ G LK++DFG+A + P
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAK-------------SIPTKTYDNE 160
Query: 209 -----FQAPEIANGLPEISGYKVDIWSSG 232
++ P+I G + S ++D+W G
Sbjct: 161 VVTLWYRPPDILLGSTDYST-QIDMWGVG 188
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-38
Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 31/208 (14%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLLKML 95
+Y D LGEG + V + D T A+K K +G IN REI+LL+ L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG-INRTALREIKLLQEL 69
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H N+IGL+D F + + L+ ++ L+ ++ Y L L GLE
Sbjct: 70 SHPNIIGLLDAFGHKSN--ISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLE 126
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV------- 208
YLH I+H+D+KP NLLL +G LK++DFG+A+S GSP
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF-------------GSPNRAYTHQV 173
Query: 209 ----FQAPEIANGLPEISGYKVDIWSSG 232
++APE+ G VD+W+ G
Sbjct: 174 VTRWYRAPELLFGARMYGV-GVDMWAVG 200
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-37
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 42/204 (20%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLL-KMLQH 97
V +LG G GKV ++ + T + A+K+ + R RE+ L + Q
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR---------REVELHWRASQC 70
Query: 98 RNVIGLVDVF--VNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
+++ +VDV+ + ++ + ++ME GG L + + F +A + + +
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 155 EYLHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQA 211
+YLHS I H+D+KP NLL T + LK++DFG A
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------A 167
Query: 212 PEIANGLPEISGYKVDIWSSGVTL 235
E E D+WS GV +
Sbjct: 168 KET---TGEKYDKSCDMWSLGVIM 188
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-37
Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 39/210 (18%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR----IPNGEINVDREIRLLK 93
KY + +GEG+YG V + DS+ R V + K+ +L IP+ I REI LLK
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQG---RIVAL-KRIRLDAEDEGIPSTAI---REISLLK 74
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
L H N++ L+DV +++ + L+ E+ L+ +LD Q Y QLL G
Sbjct: 75 ELHHPNIVSLIDVIHSERC--LTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRG 131
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV----- 208
+ + H I+H+D+KP NLL+ DG LK++DFG+A + G PV
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF-------------GIPVRSYTH 178
Query: 209 ------FQAPEIANGLPEISGYKVDIWSSG 232
++AP++ G + S VDIWS G
Sbjct: 179 EVVTLWYRAPDVLMGSKKYST-SVDIWSIG 207
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-37
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 40/213 (18%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR---IPNGEINVDREIRLLKM 94
++ + LG G+Y V + L+ T V + K+ KL P+ I REI L+K
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTT--GVYVAL-KEVKLDSEEGTPSTAI---REISLMKE 59
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKK----FPIWQAHGYFLQL 150
L+H N++ L DV + K + L+ E+ L+ +DS + + QL
Sbjct: 60 LKHENIVRLYDVIHTENK--LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV-- 208
L GL + H I+H+D+KP NLL+ G LK+ DFG+A + G PV
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-------------GIPVNT 164
Query: 209 ---------FQAPEIANGLPEISGYKVDIWSSG 232
++AP++ G S +DIWS G
Sbjct: 165 FSSEVVTLWYRAPDVLMGSRTYST-SIDIWSCG 196
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-37
Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 20/207 (9%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNG-EINVDREIRLLKMLQ 96
KY +G+G++G+V + +T + V + KK ++ G I REI++L++L+
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKT--GQKVAL-KKVLMENEKEGFPITALREIKILQLLK 74
Query: 97 HRNVIGLVDVFV------NDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQL 150
H NV+ L+++ N K +YL+ ++C L +L + KF + + L
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQML 133
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT-TSQGSPV- 208
L+GL Y+H I+H+D+K N+L+T DG LK++DFG+A + + + T++ V
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR---VV 190
Query: 209 ---FQAPEIANGLPEISGYKVDIWSSG 232
++ PE+ G + +D+W +G
Sbjct: 191 TLWYRPPELLLGERDYGP-PIDLWGAG 216
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-37
Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 26 YDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINV 85
Y++ ++ Y + LG G Y +V E ++ + VKI K K ++I
Sbjct: 25 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI------- 77
Query: 86 DREIRLLKMLQ-HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTP----YKKFPI 140
REI++L+ L+ N+I L D+ + + L+ E+ +++T Y+
Sbjct: 78 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH--------VNNTDFKQLYQTLTD 129
Query: 141 WQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL-TLDGTLKISDFGVAESLDMFLHDDT 199
+ Y ++L L+Y HS GI+H+D+KP N+++ L++ D+G+AE
Sbjct: 130 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH---PGQE 186
Query: 200 ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
S F+ PE+ Y +D+WS G L
Sbjct: 187 YNVRVASRYFKGPELLVDYQMYD-YSLDMWSLGCML 221
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-37
Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 39/210 (18%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR----IPNGEINVDREIRLLK 93
KY + +GEG+YG V + ++ + KK +L++ IP+ I REI +LK
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYG---ETFAL-KKIRLEKEDEGIPSTTI---REISILK 55
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
L+H N++ L DV K+ + L+ E+ L+ +LD A + LQLL+G
Sbjct: 56 ELKHSNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNG 112
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV----- 208
+ Y H + ++H+D+KP NLL+ +G LKI+DFG+A + G PV
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF-------------GIPVRKYTH 159
Query: 209 ------FQAPEIANGLPEISGYKVDIWSSG 232
++AP++ G + S +DIWS G
Sbjct: 160 EIVTLWYRAPDVLMGSKKYST-TIDIWSVG 188
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-37
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 27/209 (12%)
Query: 40 VMGDLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+ +++G G +GKV + + + AVK + + I NV +E +L ML+H
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDEV---AVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
N+I L V + K+ + L+ME+ GG L +L K+ P + +Q+ G+ YL
Sbjct: 67 NIIALRGVCL--KEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYL 121
Query: 158 HSQG---IIHKDIKPGNLLLT--------LDGTLKISDFGVAESLDMFLHDDTITTSQGS 206
H + IIH+D+K N+L+ + LKI+DFG+A H T ++ G+
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGA 177
Query: 207 PVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ APE+ D+WS GV L
Sbjct: 178 YAWMAPEVIRASM--FSKGSDVWSYGVLL 204
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-36
Identities = 68/215 (31%), Positives = 104/215 (48%), Gaps = 44/215 (20%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR----IPNGEINVDREIRLLK 93
+Y LGEG+YG+V + +D+ T V I K+ +L+ +P I RE+ LLK
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVT--NETVAI-KRIRLEHEEEGVPGTAI---REVSLLK 88
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
LQHRN+I L V ++ + ++LI EY L+ +D P + + QL++G
Sbjct: 89 ELQHRNIIELKSVIHHNHR--LHLIFEYAENDLKKYMDKNP--DVSMRVIKSFLYQLING 144
Query: 154 LEYLHSQGIIHKDIKPGNLLLTL-----DGTLKISDFGVAESLDMFLHDDTITTSQGSPV 208
+ + HS+ +H+D+KP NLLL++ LKI DFG+A + G P+
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-------------GIPI 191
Query: 209 -----------FQAPEIANGLPEISGYKVDIWSSG 232
++ PEI G S VDIWS
Sbjct: 192 RQFTHEIITLWYRPPEILLGSRHYST-SVDIWSIA 225
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-36
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 50/220 (22%)
Query: 38 KYVMGDLLGEGSYGKV---KEMLDSETLCRRAVKIFKKKKLQR----IPNGEINVDREIR 90
+Y +GEG+YGKV +++ + A+K + ++Q +P I RE+
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFV--ALK---RVRVQTGEEGMPLSTI---REVA 63
Query: 91 LLKMLQ---HRNVIGLVDVFV---NDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAH 144
+L+ L+ H NV+ L DV D++ K+ L+ E+ L LD P P
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 145 GYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ 204
QLL GL++LHS ++H+D+KP N+L+T G +K++DFG+A
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY------------- 170
Query: 205 GSPV----------FQAPEIANGLPEISGY--KVDIWSSG 232
+ ++APE+ S Y VD+WS G
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVG 206
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-35
Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 32 KVKMIGKY-VMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR 90
+ ++ + G +G G+YG V + + + + K+ + I REI
Sbjct: 15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYAL-KQIEGTGISMSAC---REIA 70
Query: 91 LLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDS-------TPYKKFPIWQA 143
LL+ L+H NVI L VF++ +K++L+ +Y L ++ + P
Sbjct: 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 144 HGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD----GTLKISDFGVAESLDMFLHDDT 199
Q+LDG+ YLH+ ++H+D+KP N+L+ + G +KI+D G A + L
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK--- 187
Query: 200 ITTSQGSPV-----FQAPEIANGLPEISGYKVDIWSSG 232
+ PV ++APE+ G + +DIW+ G
Sbjct: 188 -PLADLDPVVVTFWYRAPELLLGARHYTK-AIDIWAIG 223
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-35
Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 40 VMGDLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+G +G GS+G V K + AVK+ P E+ +L+ +H
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGDV----AVKMLNVTAPT--PQQLQAFKNEVGVLRKTRHV 80
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
N++ + ++ ++ ++C G L L + KF + + Q G++YL
Sbjct: 81 NILLFMGYS---TAPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYL 136
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE-IAN 216
H++ IIH+D+K N+ L D T+KI DFG+A + GS ++ APE I
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 217 GLPEISGYKVDIWSSGVTL 235
++ D+++ G+ L
Sbjct: 197 QDSNPYSFQSDVYAFGIVL 215
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-35
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 32/209 (15%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDR---EIRLLK 93
G+Y + + G G + LD + R V + K E + L
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALD-RNVNGRPVVL----KGLVHSGDAEAQAMAMAERQFLA 134
Query: 94 MLQHRNVIGLVDV---FVNDKKQKMYLIMEYCVGG--LQDMLDSTPYKKFPIWQAHGYFL 148
+ H +++ + + Y++MEY VGG L+ +K P+ +A Y L
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY-VGGQSLKRSKG----QKLPVAEAIAYLL 189
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--GS 206
++L L YLHS G+++ D+KP N++LT + LK+ D G ++ + G+
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLT-EEQLKLIDLGAVSRIN--------SFGYLYGT 240
Query: 207 PVFQAPEIANGLPEISGYKVDIWSSGVTL 235
P FQAPEI P + DI++ G TL
Sbjct: 241 PGFQAPEIVRTGPTV---ATDIYTVGRTL 266
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-34
Identities = 41/220 (18%), Positives = 76/220 (34%), Gaps = 32/220 (14%)
Query: 27 DNKTIKVKMIGKYVMGDLLGEGSYGKV-------KEMLDSETLCRRAVKIFKKKKLQRIP 79
+ I K + L E G++ ++ VK+ K +
Sbjct: 3 KHSGIDFKQL---NFLTKLNENHSGELWKGRWQGNDI---------VVKVLKVRDWS--T 48
Query: 80 NGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKF 138
+ + E L++ H NV+ ++ + LI + G L ++L
Sbjct: 49 RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV 108
Query: 139 PIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196
QA + L + G+ +LH+ I + ++++ D T +IS V S
Sbjct: 109 DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--- 165
Query: 197 DDTITTSQGSPVFQAPEIANGLP-EISGYKVDIWSSGVTL 235
+P + APE P + + D+WS V L
Sbjct: 166 ----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-34
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 27/203 (13%)
Query: 40 VMGDLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+ +++G G++G V K ++ + A+K + + ++ E+R L + H
Sbjct: 11 EVEEVVGRGAFGVVCKAKWRAKDV---AIKQIESESERK------AFIVELRQLSRVNHP 61
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML-DSTPYKKFPIWQAHGYFLQLLDGLEY 156
N++ L + L+MEY GG L ++L + P + A + LQ G+ Y
Sbjct: 62 NIVKLYGAC----LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 157 LHS---QGIIHKDIKPGNLLLTLDGT-LKISDFGVAESLDMFLHDDTITTSQGSPVFQAP 212
LHS + +IH+D+KP NLLL GT LKI DFG A + +T ++GS + AP
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAWMAP 172
Query: 213 EIANGLPEISGYKVDIWSSGVTL 235
E+ G K D++S G+ L
Sbjct: 173 EVFEGSN--YSEKCDVFSWGIIL 193
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-34
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 32/213 (15%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK---IFKKKKL-QRIPNGEINVDREIRLLK 93
+ + LLGEG+YG V T A+K F K R REI++LK
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-------REIKILK 64
Query: 94 MLQHRNVIGLVDVFVNDKKQKM---YLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL-Q 149
+H N+I + ++ D + Y+I E L ++ + I Q YF+ Q
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-Q---YFIYQ 120
Query: 150 LLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV- 208
L ++ LH +IH+D+KP NLL+ + LK+ DFG+A +D D++ T Q S +
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 209 -------FQAPEIANGLPEISGY--KVDIWSSG 232
++APE+ + + Y +D+WS G
Sbjct: 181 EFVATRWYRAPEV---MLTSAKYSRAMDVWSCG 210
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-34
Identities = 67/207 (32%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK----IFKKKKL-QRIPNGEINVDREIRLL 92
+Y +G G+YG V D++T R AVK F+ +R RE+RLL
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-------RELRLL 82
Query: 93 KMLQHRNVIGLVDVFVNDKK----QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL 148
K ++H NVIGL+DVF + +YL+ L +++ + +
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD----DHVQFLI 138
Query: 149 -QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSP 207
Q+L GL+Y+HS IIH+D+KP NL + D LKI DFG+A + T
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR----- 193
Query: 208 VFQAPEIANGLPEISGY--KVDIWSSG 232
++APEI + Y VDIWS G
Sbjct: 194 WYRAPEI---MLNWMHYNQTVDIWSVG 217
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-34
Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 36/220 (16%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK----IFKKKKL-QRIPNGEINVDREIRLL 92
KY + LG+G+YG V + +D T AVK F+ QR REI +L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-------REIMIL 62
Query: 93 K-MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL-QL 150
+ H N++ L++V D + +YL+ +Y L ++ + + Q Y + QL
Sbjct: 63 TELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK-Q---YVVYQL 118
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQ 210
+ ++YLHS G++H+D+KP N+LL + +K++DFG++ S + +
Sbjct: 119 IKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 211 APEIANGL------------PEI----SGY--KVDIWSSG 232
+ + PEI + Y +D+WS G
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-34
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 45/215 (20%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK---IFKKKKLQRIPNGEINVDREIRLLKM 94
Y ++G GS+G V + ++ A+K K+ K RE+++++
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRK 103
Query: 95 LQHRNVIGLVDVFV----NDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG-YFL- 148
L H N++ L F + + L+++Y + + K + + ++
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLD-GTLKISDFGVAESLDMFLHDDTITTSQGSP 207
QL L Y+HS GI H+DIKP NLLL D LK+ DFG A+ L +G P
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----------VRGEP 212
Query: 208 V--------FQAPEIANGLPEISGY--KVDIWSSG 232
++APE+ G + Y +D+WS+G
Sbjct: 213 NVSYICSRYYRAPELIFGATD---YTSSIDVWSAG 244
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-34
Identities = 56/229 (24%), Positives = 100/229 (43%), Gaps = 45/229 (19%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK----IFKKKKL-QRIPNGEINVDREIRLL 92
+Y + L+G GSYG V E D A+K +F+ +RI REI +L
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-------REIAIL 106
Query: 93 KMLQHRNVIGLVDVFV---NDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG-YFL 148
L H +V+ ++D+ + +K ++Y+++E + + + + + H L
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV----YLTELHIKTLL 162
Query: 149 -QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSP 207
LL G++Y+HS GI+H+D+KP N L+ D ++K+ DFG+A ++D + ++
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 208 VFQAPEIANGL------------------PEI----SGY--KVDIWSSG 232
PE+ Y +D+WS G
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-34
Identities = 43/208 (20%), Positives = 86/208 (41%), Gaps = 22/208 (10%)
Query: 40 VMGDLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+G+L+G+G +G+V E A+++ ++ + RE+ + +H
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGEV----AIRLIDIERDN--EDQLKAFKREVMAYRQTRHE 89
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
NV+ + + + +I C G L ++ + + +++ G+ YL
Sbjct: 90 NVVLFMGACM--SPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVA---ESLDMFLHDDTITTSQGSPVFQAPEI 214
H++GI+HKD+K N+ +G + I+DFG+ L +D + G APEI
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 215 ANGLPEISGY-------KVDIWSSGVTL 235
L + D+++ G
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIW 233
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-34
Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 40/224 (17%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK----IFKKKKL-QRIPNGEINVDREIRLL 92
Y++ L+G GSYG V D T A+K +F+ +RI REI +L
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-------REITIL 79
Query: 93 KMLQHRNVIGLVDVFVNDKKQKM---YLIMEYCVGGLQDMLDSTPYKKFPIWQAHG-YFL 148
L+ +I L D+ + D K Y+++E L+ + + + + H L
Sbjct: 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT----PIFLTEEHIKTIL 135
Query: 149 -QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSP 207
LL G ++H GIIH+D+KP N LL D ++K+ DFG+A +++ + + + +
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 208 VFQAPEIANGL-------------PEI----SGY--KVDIWSSG 232
PE+ Y +DIWS+G
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 9e-34
Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 24/202 (11%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKI----FKKKKLQRIPNGEINVDREIRLLKMLQHRNV 100
LG G+YG V++M + AVK ++ +R+ ++++ ++ +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLM-DLDI-----SMRTVDCPFT 68
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAH-GYFL-QLLDGLEYLH 158
+ + +++ ME L K I + G ++ LE+LH
Sbjct: 69 VTFYGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 159 SQG-IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI--TTSQGSPVFQAPEIA 215
S+ +IH+D+KP N+L+ G +K+ DFG++ L D + G + APE
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-----VDDVAKDIDAGCKPYMAPERI 181
Query: 216 NGLPEISGY--KVDIWSSGVTL 235
N GY K DIWS G+T+
Sbjct: 182 NPELNQKGYSVKSDIWSLGITM 203
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-34
Identities = 44/231 (19%), Positives = 83/231 (35%), Gaps = 32/231 (13%)
Query: 20 DSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRR----AVKIFKKKKL 75
S+ T+ I +G+G +G V + L + A+K
Sbjct: 5 GSEFPKSRLPTLADNEI---EYEKQIGKGGFGLVHK----GRLVKDKSVVAIKSLILGDS 57
Query: 76 QRIPNGEINVD---REIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLD 131
+ RE+ ++ L H N++ L + ++ME+ G L L
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM----HNPPRMVMEFVPCGDLYHRLL 113
Query: 132 STPYKKFPIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLTLDG-----TLKISD 184
L + G+EY+ +Q I+H+D++ N+ L K++D
Sbjct: 114 DKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172
Query: 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
FG+++ +++ G+ + APE E K D +S + L
Sbjct: 173 FGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-33
Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 29/214 (13%)
Query: 40 VMGDLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+ + +G+G YG+V + E + AVKIF + + + E+ ML+H
Sbjct: 11 TLLECVGKGRYGEVWRGSWQGENV---AVKIFSSRDEK-----SWFRETELYNTVMLRHE 62
Query: 99 NVIGLV--DVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
N++G + D+ +++LI Y G L D L L + GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLA 119
Query: 156 YLHSQ--------GIIHKDIKPGNLLLTLDGTLKISDFGVA--ESLDMFLHDDTITTSQG 205
+LH + I H+D+K N+L+ +G I+D G+A S D G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 206 SPVFQAPEIANGLPEISGY----KVDIWSSGVTL 235
+ + APE+ + ++ + +VDIW+ G+ L
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-33
Identities = 49/203 (24%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 40 VMGDLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+ + +G GS+G V + + AVKI ++ RE+ ++K L+H
Sbjct: 40 NIKEKIGAGSFGTVHRAEWHGSDV---AVKILMEQDFH--AERVNEFLREVAIMKRLRHP 94
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML-DSTPYKKFPIWQAHGYFLQLLDGLEY 156
N++ + + + ++ EY G L +L S ++ + + G+ Y
Sbjct: 95 NIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 157 LHSQG--IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--GSPVFQAP 212
LH++ I+H+++K NLL+ T+K+ DFG++ +++ G+P + AP
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR----LKASTFLSSKSAAGTPEWMAP 208
Query: 213 EIANGLPEISGYKVDIWSSGVTL 235
E+ P S K D++S GV L
Sbjct: 209 EVLRDEP--SNEKSDVYSFGVIL 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK----IFKKKKL-QRIPNGEINVDREIRLL 92
Y +G G+YG V +D T + A+K F+ + +R RE+RLL
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-------RELRLL 78
Query: 93 KMLQHRNVIGLVDVFVNDKK----QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL 148
K ++H NVIGL+DVF D+ YL+M + L ++ + + +
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE----DRIQFLV 134
Query: 149 -QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSP 207
Q+L GL Y+H+ GIIH+D+KPGNL + D LKI DFG+A D + +T
Sbjct: 135 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR----- 189
Query: 208 VFQAPEIANGLPEISGY--KVDIWSSG 232
++APE+ + Y VDIWS G
Sbjct: 190 WYRAPEV---ILNWMRYTQTVDIWSVG 213
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV 100
G +LGEGS+ V + T A+KI +K+ + + N V RE ++ L H
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPFF 92
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
+ L F +D+K +Y + Y G ++ + F Y +++ LE
Sbjct: 93 VKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKI------GSFDETCTRFYTAEIVSALE 144
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
YLH +GIIH+D+KP N+LL D ++I+DFG A+ L + G+ + +PE+
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204
Query: 216 NGLPEISGYKVDIWSSGVTL 235
+ D+W+ G +
Sbjct: 205 TEKS--ACKSSDLWALGCII 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-33
Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 34/208 (16%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK----IFKKKKL-QRIPNGEINVDREIRLL 92
YV +G G+YG V +D + + A+K F+ + +R RE+ LL
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-------RELLLL 77
Query: 93 KMLQHRNVIGLVDVFVNDKK----QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAH-GYF 147
K +QH NVIGL+DVF YL+M + LQ ++ + Y
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM------GLKFSEEKIQYL 131
Query: 148 L-QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS 206
+ Q+L GL+Y+HS G++H+D+KPGNL + D LKI DFG+A D + +T
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR---- 187
Query: 207 PVFQAPEIANGLPEISGY--KVDIWSSG 232
++APE+ + Y VDIWS G
Sbjct: 188 -WYRAPEV---ILSWMHYNQTVDIWSVG 211
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-33
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 33/208 (15%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK----IFKKKKL-QRIPNGEINVDREIRLL 92
+Y +G G+ G V D+ A+K F+ + +R RE+ L+
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-------RELVLM 115
Query: 93 KMLQHRNVIGLVDVFVNDKK----QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG-YF 147
K + H+N+I L++VF K Q +YL+ME L ++ + + Y
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYL 169
Query: 148 L-QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS 206
L Q+L G+++LHS GIIH+D+KP N+++ D TLKI DFG+A + +T +
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVT 226
Query: 207 PVFQAPEIANGLPEISGYK--VDIWSSG 232
++APE+ G GYK VDIWS G
Sbjct: 227 RYYRAPEVILG----MGYKENVDIWSVG 250
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-33
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 34/214 (15%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD----------- 86
Y + + GSYG V +DSE V I K++ + V+
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDSEG---IPVAI---KRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 87 -REIRLLKMLQHRNVIGLVDVFVNDKKQKM---YLIMEYCVGGLQDMLDSTPYKKFPIWQ 142
REIRLL H N++GL D+FV+ ++ M YL+ E L ++ ++ I
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISP 133
Query: 143 AHG-YFL-QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200
H YF+ +L GL LH G++H+D+ PGN+LL + + I DF +A D
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTA---DANK 190
Query: 201 TTSQGSPVFQAPEIANGLPEISGY--KVDIWSSG 232
T ++APE+ + + G+ VD+WS+G
Sbjct: 191 THYVTHRWYRAPEL---VMQFKGFTKLVDMWSAG 221
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-32
Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 25/203 (12%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKI----FKKKKLQRIPNGEINVDREIRLLKMLQHRNV 100
+G G+YG V +M+ + AVK +K+ +++ +++V +++ +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM-DLDV-----VMRSSDCPYI 83
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDST-PYKKFPIWQAH-GYFL-QLLDGLEYL 157
+ + ++ ME I + G + L +L
Sbjct: 84 VQFYGALFRE--GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 158 HSQG-IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI--TTSQGSPVFQAPEI 214
IIH+DIKP N+LL G +K+ DFG++ L D+I T G + APE
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL-----VDSIAKTRDAGCRPYMAPER 196
Query: 215 ANGLPEISGY--KVDIWSSGVTL 235
+ GY + D+WS G+TL
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITL 219
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK---IFKKKKL-QRIPNGEINVDREIRLLK 93
+Y +GEG+YG V D+ R A+K F+ + QR REI++L
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-------REIKILL 80
Query: 94 MLQHRNVIGLVDVFVNDKKQKM---YLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL-Q 149
+H N+IG+ D+ ++M Y++ + L +L + YFL Q
Sbjct: 81 RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN----DHICYFLYQ 136
Query: 150 LLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV- 208
+L GL+Y+HS ++H+D+KP NLLL LKI DFG+A D T V
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY---VA 193
Query: 209 ---FQAPEIANGLPEISGY--KVDIWSSG 232
++APEI + GY +DIWS G
Sbjct: 194 TRWYRAPEI---MLNSKGYTKSIDIWSVG 219
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 33/208 (15%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK----IFKKKKL-QRIPNGEINVDREIRLL 92
+Y +G G+ G V D+ A+K F+ + +R RE+ L+
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-------RELVLM 78
Query: 93 KMLQHRNVIGLVDVFVNDKK----QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG-YF 147
K + H+N+IGL++VF K Q +Y++ME L ++ + + Y
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYL 132
Query: 148 L-QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS 206
L Q+L G+++LHS GIIH+D+KP N+++ D TLKI DFG+A + +T +
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVT 189
Query: 207 PVFQAPEIANGLPEISGYK--VDIWSSG 232
++APE+ G GYK VDIWS G
Sbjct: 190 RYYRAPEVILG----MGYKENVDIWSVG 213
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 27 DNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQ--RIPNGEIN 84
D KT + + I Y ++G GS+G V + E+ V I KK LQ R N
Sbjct: 31 DGKTGEQREI-AYTNCKVIGNGSFGVVFQAKLVES---DEVAI--KKVLQDKRFKN---- 80
Query: 85 VDREIRLLKMLQHRNVIGLVDVFV----NDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPI 140
RE++++++++H NV+ L F + + L++EY + K +
Sbjct: 81 --RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTM 138
Query: 141 WQAH--GYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD-GTLKISDFGVAESLDMFLHD 197
Y QLL L Y+HS GI H+DIKP NLLL G LK+ DFG A+ L
Sbjct: 139 PMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI---AG 195
Query: 198 DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSG 232
+ + S ++APE+ G + +DIWS+G
Sbjct: 196 EPNVSYICSRYYRAPELIFGATNYTT-NIDIWSTG 229
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-32
Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 24/201 (11%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKI----FKKKKLQRIPNGEINVDREIRLLKMLQHRNV 100
+G G+ G+V +M +T AVK K++ +RI +++V +LK +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM-DLDV-----VLKSHDCPYI 86
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ 160
+ F+ + +++ ME + + P + ++ L YL +
Sbjct: 87 VQCFGTFITN--TDVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEK 143
Query: 161 -GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI--TTSQGSPVFQAPE-IAN 216
G+IH+D+KP N+LL G +K+ DFG++ L D S G + APE I
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRL-----VDDKAKDRSAGCAAYMAPERIDP 198
Query: 217 GLPEISGY--KVDIWSSGVTL 235
P Y + D+WS G++L
Sbjct: 199 PDPTKPDYDIRADVWSLGISL 219
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-31
Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 40/218 (18%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK--IFKKKKL-QRIPNGEINVDREIRLLKM 94
+Y+ LG G G V +D++ R A+K + + + REI++++
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-------REIKIIRR 64
Query: 95 LQHRNVIGLVDVFVNDKKQK------------MYLIMEYCVGGLQDMLDSTPYKKFPIWQ 142
L H N++ + ++ Q +Y++ EY L ++L+ P + +
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE----E 120
Query: 143 AHGYFL-QLLDGLEYLHSQGIIHKDIKPGNLLL-TLDGTLKISDFGVAESLDMFLHDDTI 200
F+ QLL GL+Y+HS ++H+D+KP NL + T D LKI DFG+A +D
Sbjct: 121 HARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 201 TTSQGSPV----FQAPEIANGLPEISGY--KVDIWSSG 232
+ + +++P + L + Y +D+W++G
Sbjct: 181 LSEG---LVTKWYRSPRL---LLSPNNYTKAIDMWAAG 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-31
Identities = 53/264 (20%), Positives = 102/264 (38%), Gaps = 70/264 (26%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK-------KKKLQR------------- 77
+ +G G +G V E + C A+K + ++K+ R
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 78 ----------------------------------IPNGEINVDREIRLLKMLQHRNVIGL 103
P+ +IR + +N +G
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 104 VDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFP-IWQAHGYFLQLLDGLEYLHSQG 161
+ K +Y+ M+ C L+D ++ + F+Q+ + +E+LHS+G
Sbjct: 127 LQPS--SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI----------TTSQGSPVFQA 211
++H+D+KP N+ T+D +K+ DFG+ ++D + T+ T G+ ++ +
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 212 PEIANGLPEISGYKVDIWSSGVTL 235
PE +G +KVDI+S G+ L
Sbjct: 245 PEQIHGNN--YSHKVDIFSLGLIL 266
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-31
Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 25/198 (12%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKI----FKKKKLQRIPNGEINVDREIRLLKMLQHRNV 100
LG G+ G V ++ + A K+ K +I RE+++L +
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------RELQVLHECNSPYI 93
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159
+G F +D ++ + ME+ GG L +L + P + ++ GL YL
Sbjct: 94 VGFYGAFYSD--GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE 149
Query: 160 QG-IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTIT-TSQGSPVFQAPEIANG 217
+ I+H+D+KP N+L+ G +K+ DFGV+ L D++ + G+ + +PE G
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQG 204
Query: 218 LPEISGYKVDIWSSGVTL 235
+ DIWS G++L
Sbjct: 205 TH--YSVQSDIWSMGLSL 220
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-31
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK-IFKKKKLQRIPNGEINVDREIRLLKMLQ 96
++ + + G+G++G V+ + T A+K + + R N E+ + ++ L +L
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNREL---QIMQDLAVLH 77
Query: 97 HRNVIGLVDVFV-----NDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG-YFL-Q 149
H N++ L F + + + ++MEY L + ++ FL Q
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 150 LLDGLEYLH--SQGIIHKDIKPGNLLL-TLDGTLKISDFGVAESLDMFLHDDTITTSQGS 206
L+ + LH S + H+DIKP N+L+ DGTLK+ DFG A+ L + S
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS---PSEPNVAYICS 194
Query: 207 PVFQAPEIANGLPEISGY--KVDIWSSG 232
++APE+ G Y VDIWS G
Sbjct: 195 RYYRAPELIFGNQH---YTTAVDIWSVG 219
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 34/206 (16%)
Query: 44 LLGEGSYGKVKEMLDSETLCRR-------AVKIFKKKKLQRIPNGEI-NVDREIRLLKML 95
+G+GS+GKV + ++ A+K K+K + E+ NV +E+++++ L
Sbjct: 22 AIGKGSFGKV-------CIVQKNDTKKMYAMKYMNKQKC--VERNEVRNVFKELQIMQGL 72
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQL 150
+H ++ L F +++ M+++++ +GG LQ F + +L
Sbjct: 73 EHPFLVNLWYSFQDEED--MFMVVDLLLGGDLRYHLQQN------VHFKEETVKLFICEL 124
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQ 210
+ L+YL +Q IIH+D+KP N+LL G + I+DF +A M + ITT G+ +
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYM 181
Query: 211 APEIANGLPEIS-GYKVDIWSSGVTL 235
APE+ + + VD WS GVT
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTA 207
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 40 VMGDLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
M +G+G YG+V E + AVK+F + + EI +++H
Sbjct: 40 QMVKQIGKGRYGEVWMGKWRGEKV---AVKVFFTTEEA-----SWFRETEIYQTVLMRHE 91
Query: 99 NVIGLV--DVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
N++G + D+ ++YLI +Y G L D L S + GL
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLC 148
Query: 156 YLHSQ--------GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI--TTSQG 205
+LH++ I H+D+K N+L+ +GT I+D G+A ++ I T G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 206 SPVFQAPEIANGLPEI----SGYKVDIWSSGVTL 235
+ + PE+ + S D++S G+ L
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-30
Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 40 VMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN 99
+ G++LG+G +G+ ++ T + K+ ++ + +E+++++ L+H N
Sbjct: 13 IHGEVLGKGCFGQAIKV----THRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
V+ + V K +++ I EY GG L+ ++ S ++P Q + + G+ YLH
Sbjct: 69 VLKFIGVLY--KDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVA------------ESLDMFLHDDTITTSQGS 206
S IIH+D+ N L+ + + ++DFG+A T G+
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 207 PVFQAPEIANGLPEISGYKVDIWSSGVTL 235
P + APE+ NG KVD++S G+ L
Sbjct: 186 PYWMAPEMINGRS--YDEKVDVFSFGIVL 212
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-30
Identities = 67/241 (27%), Positives = 101/241 (41%), Gaps = 65/241 (26%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVK---IFKKKKLQRIPNGEINVDREIRLLKM 94
KY +G LG GS+G V E+ D E+ R A+K + K RE+ ++K+
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-----------RELDIMKV 56
Query: 95 LQHRNVIGLVDVFVNDKKQKM------------------------------------YLI 118
L H N+I LVD F ++ +I
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 119 MEYCVGGLQDMLDSTPYKKFPIWQAH-GYFL-QLLDGLEYLHSQGIIHKDIKPGNLLL-T 175
MEY L +L S I ++ QL + ++HS GI H+DIKP NLL+ +
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 176 LDGTLKISDFGVAESLDMFLHDDTITTSQGSPV----FQAPEIANGLPEISGYKVDIWSS 231
D TLK+ DFG A+ L + + + ++APE+ G E + +D+WS
Sbjct: 177 KDNTLKLCDFGSAKKLI----PSEPSVAY---ICSRFYRAPELMLGATEYTP-SIDLWSI 228
Query: 232 G 232
G
Sbjct: 229 G 229
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-30
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 40 VMGDLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
V+ + +G+G +G+V + E + AVKIF ++ + + EI ML+H
Sbjct: 45 VLQESIGKGRFGEVWRGKWRGEEV---AVKIFSSREER-----SWFREAEIYQTVMLRHE 96
Query: 99 NVIGLV--DVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
N++G + D N +++L+ +Y G L D L+ + L GL
Sbjct: 97 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLA 153
Query: 156 YLHSQ--------GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI--TTSQG 205
+LH + I H+D+K N+L+ +GT I+D G+A D I G
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213
Query: 206 SPVFQAPEIANGLPEISGY----KVDIWSSGVTL 235
+ + APE+ + + + + DI++ G+
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 8e-30
Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 17/207 (8%)
Query: 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRR-AVKIFKKKKLQRIPNGEINVDREIRLL 92
G Y + L+G G G V E D R A+K+ + L P + RE R
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAED-TVRERIVALKLMSET-LSSDPVFRTRMQREARTA 88
Query: 93 KMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLL 151
LQ +V+ + D D + Y+ M G L ML +A Q+
Sbjct: 89 GRLQEPHVVPIHDFGEIDGQL--YVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIG 144
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ---GSPV 208
L+ H+ G H+D+KP N+L++ D + DFG+A + D+ +T G+
Sbjct: 145 SALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT----DEKLTQLGNTVGTLY 200
Query: 209 FQAPEIANGLPEISGYKVDIWSSGVTL 235
+ APE + + Y+ DI++ L
Sbjct: 201 YMAPERFSESH--ATYRADIYALTCVL 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 35 MIGK-----YVMGDLLGEGSYGKVKEMLDSETLCRR-AVKIFKKKKLQRIPNGEINVDRE 88
MIGK Y + D LG G V D L + A+K + +RE
Sbjct: 4 MIGKIINERYKIVDKLGGGGMSTVYLAED-TILNIKVAIKAIFIP-PREKEETLKRFERE 61
Query: 89 IRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYF 147
+ L H+N++ ++DV D YL+MEY G L + ++S + + A +
Sbjct: 62 VHNSSQLSHQNIVSMIDVDEEDDCY--YLVMEYIEGPTLSEYIES--HGPLSVDTAINFT 117
Query: 148 LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--- 204
Q+LDG+++ H I+H+DIKP N+L+ + TLKI DFG+A++L + ++T +
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS----ETSLTQTNHVL 173
Query: 205 GSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
G+ + +PE A G E + DI+S G+ L
Sbjct: 174 GTVQYFSPEQAKG--EATDECTDIYSIGIVL 202
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 23/200 (11%)
Query: 44 LLGEGSYGKVKEMLDSETLCRR-------AVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+LG+G +G+V C+ A K +KK++++ GE E ++L+ +
Sbjct: 191 VLGKGGFGEV-------CACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVN 242
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
R V+ L + K + L++ GG L+ + FP +A Y ++ GLE
Sbjct: 243 SRFVVSLAYAYET--KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
LH + I+++D+KP N+LL G ++ISD G+A + TI G+ + APE+
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTVGYMAPEVV 357
Query: 216 NGLPEISGYKVDIWSSGVTL 235
+ D W+ G L
Sbjct: 358 KNER--YTFSPDWWALGCLL 375
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 28/204 (13%)
Query: 44 LLGEGSYGKVKEMLDSETLCRR-------AVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+LG G +G+V C+ A K KK+L++ G E ++L +
Sbjct: 192 VLGRGGFGEV-------FACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVH 243
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLL 151
R ++ L F K + L+M GG + ++ + P F +A Y Q++
Sbjct: 244 SRFIVSLAYAFET--KTDLCLVMTIMNGGDIRYHIYNVDEDNP--GFQEPRAIFYTAQIV 299
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQA 211
GLE+LH + II++D+KP N+LL DG ++ISD G+A ++ G+P F A
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMA 357
Query: 212 PEIANGLPEISGYKVDIWSSGVTL 235
PE+ G + VD ++ GVTL
Sbjct: 358 PELLLGEE--YDFSVDYFALGVTL 379
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-29
Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 36/216 (16%)
Query: 41 MGDLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN 99
+ ++ G +G V K L +E + AVKIF + Q + E+ L ++H N
Sbjct: 28 LLEVKARGRFGCVWKAQLLNEYV---AVKIFPIQDKQ-----SWQNEYEVYSLPGMKHEN 79
Query: 100 VIGLV--DVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLL----D 152
++ + + ++LI + G L D L + W +
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS----WNE---LCHIAETMAR 132
Query: 153 GLEYLHSQ----------GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITT 202
GL YLH I H+DIK N+LL + T I+DFG+A +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 203 SQGSPVFQAPEIANGLPEISGY---KVDIWSSGVTL 235
G+ + APE+ G ++D+++ G+ L
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-29
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 40 VMGDLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+ +L+G G YG V K LD + AVK+F Q ++ I + +++H
Sbjct: 16 KLLELIGRGRYGAVYKGSLDERPV---AVKVFSFANRQ-----NFINEKNIYRVPLMEHD 67
Query: 99 NVIGLV---DVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
N+ + + D + + L+MEY G L L + + GL
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGL 124
Query: 155 EYLHSQ---------GIIHKDIKPGNLLLTLDGTLKISDFGVA-----ESLDMFLHDDTI 200
YLH++ I H+D+ N+L+ DGT ISDFG++ L +D
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 201 TTSQ-GSPVFQAPEIANG-----LPEISGYKVDIWSSGVTL 235
S+ G+ + APE+ G E + +VD+++ G+
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 28/201 (13%)
Query: 44 LLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+LG+GS+GKV D+ L A+K+ KK L + E +L + H
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLY--AMKVLKKATL--KVRDRVRTKMERDILVEVNHP 86
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
++ L F + K+YLI+++ GG L F Y +L
Sbjct: 87 FIVKLHYAFQT--EGKLYLILDFLRGGDLFTRLSKE------VMFTEEDVKFYLAELALA 138
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTITTSQGSPVFQAP 212
L++LHS GII++D+KP N+LL +G +K++DFG++ ES+D H+ + G+ + AP
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID---HEKKAYSFCGTVEYMAP 195
Query: 213 EIANGLPEISGYKVDIWSSGV 233
E+ N D WS GV
Sbjct: 196 EVVNRRGH--TQSADWWSFGV 214
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 44 LLGEGSYGKVKEMLDSETLCRR-------AVKIFKKKK-LQRIPNGEINVDREIRLLKML 95
++G G++G+V+ L R A+K+ K + ++R + +R+I +
Sbjct: 76 VIGRGAFGEVQ-------LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI--MAFA 126
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
V+ L F +D+ +Y++MEY GG D+++ P A Y +++ L+
Sbjct: 127 NSPWVVQLFYAFQDDRY--LYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVVLALD 182
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
+HS G IH+D+KP N+LL G LK++DFG ++ T+ G+P + +PE+
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC-DTAVGTPDYISPEVL 241
Query: 216 NGLPEISGY--KVDIWSSGV 233
Y + D WS GV
Sbjct: 242 KSQGGDGYYGRECDWWSVGV 261
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-27
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 44 LLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+LG G+YGKV D+ L A+K+ KK + + + E ++L+ ++
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLY--AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 118
Query: 99 N-VIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLLD 152
++ L F + K++LI++Y GG L ++F + Y +++
Sbjct: 119 PFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVL 170
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAP 212
LE+LH GII++DIK N+LL +G + ++DFG+++ + + G+ + AP
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMAP 229
Query: 213 EIANGLPEISGYKVDIWSSGV 233
+I G VD WS GV
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGV 250
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-27
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRR-AVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+Y +G++LG G +V D R AVK+ + L R P+ + RE + L
Sbjct: 12 DRYELGEILGFGGMSEVHLARD-LRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAAL 69
Query: 96 QHRNVIGLVDVFVNDKKQKM--YLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLD 152
H ++ + D + Y++MEY G L+D++ + +A
Sbjct: 70 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQ 127
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS-QGSPVFQA 211
L + H GIIH+D+KP N++++ +K+ DFG+A ++ + T T + G+ + +
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 212 PEIANGLPEISGYKVDIWSSGVTL 235
PE A G + + D++S G L
Sbjct: 188 PEQARG--DSVDARSDVYSLGCVL 209
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 30/203 (14%)
Query: 44 LLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEI-NVDREIRLLKMLQHR 98
LLG+G++GKV +L + A+KI +K+ + I E+ + E R+L+ +H
Sbjct: 12 LLGKGTFGKV--ILVREKATGRYY--AMKILRKEVI--IAKDEVAHTVTESRVLQNTRHP 65
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
+ L F ++ +MEY GG L + F +A Y +++
Sbjct: 66 FLTALKYAFQT--HDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSA 117
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTITTSQGSPVFQAP 212
LEYLHS+ ++++DIK NL+L DG +KI+DFG+ E + T+ T G+P + AP
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS---DGATMKTFCGTPEYLAP 174
Query: 213 EIANGLPEISGYKVDIWSSGVTL 235
E+ G VD W GV +
Sbjct: 175 EVLEDNDY--GRAVDWWGLGVVM 195
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-27
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 44 LLGEGSYGKVKEML-------DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+LG+G YGKV ++ + A+K+ KK + R + E +L+ ++
Sbjct: 24 VLGKGGYGKV--FQVRKVTGANTGKIF--AMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLL 151
H ++ L+ F K+YLI+EY GG L+ F A Y ++
Sbjct: 80 HPFIVDLIYAFQT--GGKLYLILEYLSGGELFMQLERE------GIFMEDTACFYLAEIS 131
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTITTSQGSPVFQ 210
L +LH +GII++D+KP N++L G +K++DFG+ ES+ T G+ +
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH---DGTVTHTFCGTIEYM 188
Query: 211 APEIANGLPEISGYKVDIWSSGV 233
APEI VD WS G
Sbjct: 189 APEILMRSGH--NRAVDWWSLGA 209
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 25/197 (12%)
Query: 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGL 103
LG GS+G+V + E+ A+KI K+K+ ++ E + E R+L+ + ++ L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE-HTLNEKRILQAVNFPFLVKL 106
Query: 104 VDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
F ++ +Y++MEY GG L+ + +F A Y Q++ EYLH
Sbjct: 107 EFSFKDNSN--LYMVMEYVAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLH 158
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGL 218
S +I++D+KP NLL+ G ++++DFG A+ + T G+P APEI
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEIILS- 212
Query: 219 PEISGY--KVDIWSSGV 233
GY VD W+ GV
Sbjct: 213 ---KGYNKAVDWWALGV 226
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 33/205 (16%)
Query: 44 LLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEI---NVDREIRLLKMLQ 96
+LG+GS+GKV L + A+K KK + + + ++ V++ + L +
Sbjct: 24 MLGKGSFGKV--FLAEFKKTNQFF--AIKALKKDVV--LMDDDVECTMVEKRV-LSLAWE 76
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLL 151
H + + F K+ ++ +MEY GG +Q KF + +A Y +++
Sbjct: 77 HPFLTHMFCTFQT--KENLFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYAAEII 128
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTITTSQGSPVFQ 210
GL++LHS+GI+++D+K N+LL DG +KI+DFG+ E++ D T G+P +
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML---GDAKTNTFCGTPDYI 185
Query: 211 APEIANGLPEISGYKVDIWSSGVTL 235
APEI G + VD WS GV L
Sbjct: 186 APEILLGQK--YNHSVDWWSFGVLL 208
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 4e-27
Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 40/209 (19%)
Query: 44 LLGEGSYGKVKEMLDSETLCRR-------AVKIFKKKKLQRIPNGEINVDREIRLL---K 93
++G G +G+V CR+ A+K KK+++ GE E +L
Sbjct: 196 IIGRGGFGEV-------YGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVS 247
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFL 148
++ + F K+ I++ GG L F Y
Sbjct: 248 TGDCPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQH------GVFSEADMRFYAA 299
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV 208
+++ GLE++H++ ++++D+KP N+LL G ++ISD G+A S G+
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHG 355
Query: 209 FQAPEIANGLPEISGY--KVDIWSSGVTL 235
+ APE+ L + Y D +S G L
Sbjct: 356 YMAPEV---LQKGVAYDSSADWFSLGCML 381
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-27
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 29/203 (14%)
Query: 44 LLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEI-NVDREIRLLKMLQHR 98
LLG+G++GKV +L + A+KI KK+ + + E+ + E R+L+ +H
Sbjct: 155 LLGKGTFGKV--ILVKEKATGRYY--AMKILKKEVI--VAKDEVAHTLTENRVLQNSRHP 208
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
+ L F ++ +MEY GG L + F +A Y +++
Sbjct: 209 FLTALKYSFQT--HDRLCFVMEYANGGELFFHLSRE------RVFSEDRARFYGAEIVSA 260
Query: 154 LEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAP 212
L+YLHS+ ++++D+K NL+L DG +KI+DFG+ + + T+ T G+P + AP
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIK-DGATMKTFCGTPEYLAP 318
Query: 213 EIANGLPEISGYKVDIWSSGVTL 235
E+ G VD W GV +
Sbjct: 319 EVLEDNDY--GRAVDWWGLGVVM 339
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-27
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 33/205 (16%)
Query: 44 LLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEIN---VDREIRLLKMLQ 96
++G+GS+GKV +L E AVK+ +KK + + E +R + LLK ++
Sbjct: 45 VIGKGSFGKV--LLARHKAEEVFY--AVKVLQKKAI--LKKKEEKHIMSERNV-LLKNVK 97
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLL 151
H ++GL F K+Y +++Y GG LQ + F +A Y ++
Sbjct: 98 HPFLVGLHFSFQT--ADKLYFVLDYINGGELFYHLQRE------RCFLEPRARFYAAEIA 149
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTITTSQGSPVFQ 210
L YLHS I+++D+KP N+LL G + ++DFG+ E+++ H+ T +T G+P +
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE---HNSTTSTFCGTPEYL 206
Query: 211 APEIANGLPEISGYKVDIWSSGVTL 235
APE+ + P VD W G L
Sbjct: 207 APEVLHKQPY--DRTVDWWCLGAVL 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-27
Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 44 LLGEGSYGKVK--EMLDSETLCRRAVKIFKKKKLQRIPNGEIN-VDREIRLLKMLQHRNV 100
++G G++ +V +M + + A+KI K + + GE++ E +L R +
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVY--AMKIMNKWDM--LKRGEVSCFREERDVLVNGDRRWI 123
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD--STPYKKFPIWQAHGYFLQLLDGLEYLH 158
L F ++ +YL+MEY VGG D+L S ++ P A Y +++ ++ +H
Sbjct: 124 TQLHFAFQDENY--LYLVMEYYVGG--DLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGL 218
G +H+DIKP N+LL G ++++DFG L + G+P + +PEI +
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPEILQAV 238
Query: 219 PEISGYK-----VDIWSSGVTL 235
G D W+ GV
Sbjct: 239 GGGPGTGSYGPECDWWALGVFA 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 33/205 (16%)
Query: 44 LLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEI---NVDREIRLLKMLQ 96
+LG+GS+GKV ML ++ L AVKI KK + I + ++ V++ + L +
Sbjct: 348 VLGKGSFGKV--MLSERKGTDELY--AVKILKKDVV--IQDDDVECTMVEKRV-LALPGK 400
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLL 151
+ L F ++Y +MEY GG +Q + +F A Y ++
Sbjct: 401 PPFLTQLHSCFQT--MDRLYFVMEYVNGGDLMYHIQQV------GRFKEPHAVFYAAEIA 452
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTITTSQGSPVFQ 210
GL +L S+GII++D+K N++L +G +KI+DFG+ E++ T T G+P +
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW---DGVTTKTFCGTPDYI 509
Query: 211 APEIANGLPEISGYKVDIWSSGVTL 235
APEI P G VD W+ GV L
Sbjct: 510 APEIIAYQPY--GKSVDWWAFGVLL 532
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 33/201 (16%)
Query: 44 LLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN 99
LG GS+G+V L + A+K+ KK+ + R+ E + + E +L ++ H
Sbjct: 13 TLGTGSFGRV--HLIRSRHNGRYY--AMKVLKKEIVVRLKQVE-HTNDERLMLSIVTHPF 67
Query: 100 VIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
+I + F + ++ +++IM+Y GG L+ ++FP A Y ++ L
Sbjct: 68 IIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLAL 119
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEI 214
EYLHS+ II++D+KP N+LL +G +KI+DFG A+ + D T G+P + APE+
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEV 174
Query: 215 ANGLPEISGY--KVDIWSSGV 233
+ Y +D WS G+
Sbjct: 175 VST----KPYNKSIDWWSFGI 191
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 33/205 (16%)
Query: 44 LLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEIN---VDREIRLLKMLQ 96
++G GSY KV +L ++ + A+K+ KK+ + + +I+ ++ + +
Sbjct: 16 VIGRGSYAKV--LLVRLKKTDRIY--AMKVVKKELV--NDDEDIDWVQTEKHV-FEQASN 68
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLL 151
H ++GL F + +++ ++EY GG +Q +K P A Y ++
Sbjct: 69 HPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAEIS 120
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTITTSQGSPVFQ 210
L YLH +GII++D+K N+LL +G +K++D+G+ E L DT +T G+P +
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR---PGDTTSTFCGTPNYI 177
Query: 211 APEIANGLPEISGYKVDIWSSGVTL 235
APEI G G+ VD W+ GV +
Sbjct: 178 APEILRGEDY--GFSVDWWALGVLM 200
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 33/205 (16%)
Query: 44 LLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEIN---VDREIRLLKMLQ 96
+LG+GS+GKV ML ++ L AVK+ KK + + + ++ ++ I L
Sbjct: 30 VLGKGSFGKV--MLARVKETGDLY--AVKVLKKDVI--LQDDDVECTMTEKRI-LSLARN 82
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLL 151
H + L F +++ +ME+ GG +Q ++F +A Y +++
Sbjct: 83 HPFLTQLFCCFQT--PDRLFFVMEFVNGGDLMFHIQKS------RRFDEARARFYAAEII 134
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTITTSQGSPVFQ 210
L +LH +GII++D+K N+LL +G K++DFG+ E + + T T G+P +
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC---NGVTTATFCGTPDYI 191
Query: 211 APEIANGLPEISGYKVDIWSSGVTL 235
APEI + G VD W+ GV L
Sbjct: 192 APEILQEMLY--GPAVDWWAMGVLL 214
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 33/205 (16%)
Query: 44 LLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEIN---VDREIRLLKMLQ 96
++G GSY KV +L ++ + A+++ KK+ + + +I+ ++ + +
Sbjct: 59 VIGRGSYAKV--LLVRLKKTDRIY--AMRVVKKELV--NDDEDIDWVQTEKHV-FEQASN 111
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLL 151
H ++GL F + +++ ++EY GG +Q +K P A Y ++
Sbjct: 112 HPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAEIS 163
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTITTSQGSPVFQ 210
L YLH +GII++D+K N+LL +G +K++D+G+ E L DT +T G+P +
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR---PGDTTSTFCGTPNYI 220
Query: 211 APEIANGLPEISGYKVDIWSSGVTL 235
APEI G G+ VD W+ GV +
Sbjct: 221 APEILRGEDY--GFSVDWWALGVLM 243
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 57/251 (22%), Positives = 99/251 (39%), Gaps = 46/251 (18%)
Query: 5 DDEVDGDMISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCR 64
D G +H + D +Y++ LG G + V D
Sbjct: 1 DYRPGG-----YHPAFKGEPYKD---------ARYILVRKLGWGHFSTVWLAKDMVNNTH 46
Query: 65 RAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-----------HRNVIGLVDVFV--NDK 111
A+KI + K+ E EI+LL+ + +++ L+D F
Sbjct: 47 VAMKIVRGDKVYT-EAAED----EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 101
Query: 112 KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPG 170
+ ++ E L ++ ++ P+ QLL GL+Y+H + GIIH DIKP
Sbjct: 102 GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPE 161
Query: 171 NLLLTL------DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGY 224
N+L+ + +KI+D G A + + + Q + +++PE+ G P G
Sbjct: 162 NVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSIQ-TREYRSPEVLLGAP--WGC 214
Query: 225 KVDIWSSGVTL 235
DIWS+ +
Sbjct: 215 GADIWSTACLI 225
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-26
Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 33/205 (16%)
Query: 44 LLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEI---NVDREIRLLKMLQ 96
+LG+GS+GKV ML ++ L AVKI KK + I + ++ V++ + L +
Sbjct: 27 VLGKGSFGKV--MLSERKGTDELY--AVKILKKDVV--IQDDDVECTMVEKRV-LALPGK 79
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQLL 151
+ L F ++Y +MEY GG +Q + +F A Y ++
Sbjct: 80 PPFLTQLHSCFQT--MDRLYFVMEYVNGGDLMYHIQQV------GRFKEPHAVFYAAEIA 131
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA-ESLDMFLHDDTITTSQGSPVFQ 210
GL +L S+GII++D+K N++L +G +KI+DFG+ E++ T T G+P +
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW---DGVTTKTFCGTPDYI 188
Query: 211 APEIANGLPEISGYKVDIWSSGVTL 235
APEI P G VD W+ GV L
Sbjct: 189 APEIIAYQPY--GKSVDWWAFGVLL 211
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 53/202 (26%), Positives = 104/202 (51%), Gaps = 21/202 (10%)
Query: 44 LLGEGSYGKVK--EMLDSETLCRRAVKIFKKKKLQRIPNGE-INVDREIRLLKMLQHRNV 100
++G G++G+V ++ +++ + A+KI K ++ + +R++ L + +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVF--AMKILNKWEMLKRAETACFREERDV--LVNGDSKWI 136
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD--STPYKKFPIWQAHGYFLQLLDGLEYLH 158
L F +D +YL+M+Y VGG D+L S + P A Y +++ ++ +H
Sbjct: 137 TTLHYAFQDDNN--LYLVMDYYVGG--DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--GSPVFQAPEIAN 216
+H+DIKP N+L+ ++G ++++DFG L + D T+ +S G+P + +PEI
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL---MEDGTVQSSVAVGTPDYISPEILQ 249
Query: 217 GLPEIS---GYKVDIWSSGVTL 235
+ G + D WS GV +
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCM 271
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+Y + ++G+GS+G+V + D + A+K+ + +K EIR+L+ L+
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH-RQAAE----EIRILEHLR 151
Query: 97 HR------NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQL 150
+ NVI +++ F + + + E L +++ ++ F + + +
Sbjct: 152 KQDKDNTMNVIHMLENF--TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDG--TLKISDFGVAESLDMFLHDDTITTSQGSPV 208
L L+ LH IIH D+KP N+LL G +K+ DFG + + H T Q S
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQ-SRF 264
Query: 209 FQAPEIANGLPEISGYKVDIWSSGVTL 235
++APE+ G G +D+WS G L
Sbjct: 265 YRAPEVILGAR--YGMPIDMWSLGCIL 289
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 58/244 (23%), Positives = 95/244 (38%), Gaps = 37/244 (15%)
Query: 11 DMISIFHRVDSDQVIYDNKTIKVKMIGK---------YVMGDLLGEGSYGKVKEMLDSET 61
+I + + + + + K V+G+ +G G++G+V
Sbjct: 80 LLID-HLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRAD 138
Query: 62 LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEY 121
AVK ++ + + +E R+LK H N++ L+ V +KQ +Y++ME
Sbjct: 139 NTLVAVKSCRETLPPDLKAKFL---QEARILKQYSHPNIVRLIGVCT--QKQPIYIVMEL 193
Query: 122 CVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTL 180
GG L + + + G+EYL S+ IH+D+ N L+T L
Sbjct: 194 VQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVL 252
Query: 181 KISDFGVAESLDMFLHDDTITTSQGSPVF----QAPEIANGLPEISGYKV-----DIWSS 231
KISDFG++ D S G APE N Y D+WS
Sbjct: 253 KISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEALN-------YGRYSSESDVWSF 301
Query: 232 GVTL 235
G+ L
Sbjct: 302 GILL 305
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 40 VMGDLLGEGSYGKVKE----MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
LGEG +GKV + T AVK K P +EI +L+ L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG---PQHRSGWKQEIDILRTL 90
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H ++I + + L+MEY G + D P + Q + Q+ +G+
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLG--SLRDYLPRHSIGLAQLLLFAQQICEGMA 148
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG--SPVF-QAP 212
YLH+Q IH+D+ N+LL D +KI DFG+A+ + + + SPVF AP
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWYAP 206
Query: 213 EIANGLPEISGY-----KVDIWSSGVTL 235
E D+WS GVTL
Sbjct: 207 ECLK-------EYKFYYASDVWSFGVTL 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-25
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 40 VMGDLLGEGSYGKVKE----MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
LG+G++G V+ L T AVK + P+ + + REI++LK L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG----PDQQRDFQREIQILKAL 81
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
++ V +Q + L+MEY G L+D L + + Y Q+ G+
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGM 140
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG--SPVF-QA 211
EYL S+ +H+D+ N+L+ + +KI+DFG+A+ L L D + SP+F A
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP--LDKDYYVVREPGQSPIFWYA 198
Query: 212 PEIANGLPEISGY-----KVDIWSSGVTL 235
PE + + D+WS GV L
Sbjct: 199 PESLS-------DNIFSRQSDVWSFGVVL 220
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-24
Identities = 26/158 (16%), Positives = 54/158 (34%), Gaps = 10/158 (6%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRR-AVKIFKKKKLQRIPNGEINVDREIRLLKML 95
G+Y + G + + LD L R+ A+ + + L +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALD-TALDRQVALTFVDPQ-GVLPDDVLQETLSRTLRLSRI 88
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
V ++DV ++ E+ GG LQ++ D++P A L
Sbjct: 89 DKPGVARVLDVVHTR--AGGLVVAEWIRGGSLQEVADTSP----SPVGAIRAMQSLAAAA 142
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192
+ H G+ P + +++DG + ++ +
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDAN 180
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-24
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 33/212 (15%)
Query: 40 VMGDLLGEGSYGKVKE----MLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLL 92
LG+G++G V+ L T AVK + + E ++ REI +L
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-------HSTEEHLRDFEREIEIL 96
Query: 93 KMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLL 151
K LQH N++ V + ++ + LIMEY G L+D L ++ + Y Q+
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQIC 155
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG--SPVF 209
G+EYL ++ IH+D+ N+L+ + +KI DFG+ + L + + SP+F
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP--QDKEYYKVKEPGESPIF 213
Query: 210 -QAPEIANGLPEISGY-----KVDIWSSGVTL 235
APE D+WS GV L
Sbjct: 214 WYAPESLT-------ESKFSVASDVWSFGVVL 238
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-24
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 40 VMGDLLGEGSYGKVKE----MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
LGEG +GKV+ T + AVK K + ++ +EI +L+ L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA---DLKKEIEILRNL 80
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
H N++ + D + LIME+ G L++ L K + Q Y +Q+ G+
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGM 139
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG--SPVF-QA 211
+YL S+ +H+D+ N+L+ + +KI DFG+ ++++ + T SPVF A
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE--TDKEYYTVKDDRDSPVFWYA 197
Query: 212 PEIANGLPEISGY-----KVDIWSSGVTL 235
PE D+WS GVTL
Sbjct: 198 PECLM-------QSKFYIASDVWSFGVTL 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-24
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 33/212 (15%)
Query: 40 VMGDLLGEGSYGKVKE----MLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLL 92
LG+G++G V+ L T AVK + + E ++ REI +L
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-------HSTEEHLRDFEREIEIL 65
Query: 93 KMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLL 151
K LQH N++ V + ++ + LIMEY G L+D L ++ + Y Q+
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQIC 124
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG--SPVF 209
G+EYL ++ IH+D+ N+L+ + +KI DFG+ + L + + SP+F
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP--QDKEFFKVKEPGESPIF 182
Query: 210 -QAPEIANGLPEISGY-----KVDIWSSGVTL 235
APE D+WS GV L
Sbjct: 183 WYAPESLT-------ESKFSVASDVWSFGVVL 207
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-23
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 40 VMGDLLGEGSYGKVKE--MLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLLKM 94
M LG G YG+V E AVK K+ + V+ +E ++K
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTV--AVKTLKE--------DTMEVEEFLKEAAVMKE 272
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
++H N++ L+ V ++ Y+I E+ G L D L ++ Q+
Sbjct: 273 IKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQ 210
+EYL + IH+++ N L+ + +K++DFG++ + DT T G+ P+ +
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSR----LMTGDTYTAHAGAKFPIKWT 386
Query: 211 APEIANGLPEISGYKVDIWSSGVTL 235
APE K D+W+ GV L
Sbjct: 387 APESLA--YNKFSIKSDVWAFGVLL 409
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-23
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 37/209 (17%)
Query: 40 VMGDLLGEGSYGKVKE-MLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLLKML 95
+ + LG G +G+V + T AVK K G ++ D E L+K L
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTKV--AVKSLK--------QGSMSPDAFLAEANLMKQL 65
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
QH+ ++ L V ++ +Y+I EY G L D L + K I + Q+ +G+
Sbjct: 66 QHQRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQA 211
++ + IH+D++ N+L++ + KI+DFG+A + D+ T +G+ P+ + A
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTA 178
Query: 212 PEIANGLPEISGYKV-----DIWSSGVTL 235
PE N Y D+WS G+ L
Sbjct: 179 PEAIN-------YGTFTIKSDVWSFGILL 200
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-23
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 37/209 (17%)
Query: 40 VMGDLLGEGSYGKVKE-MLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLLKML 95
+ LG G +G+V + T AVK K G ++V+ E ++K L
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTKV--AVKTMKP--------GSMSVEAFLAEANVMKTL 240
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
QH ++ L V K+ +Y+I E+ G L D L S K P+ + + Q+ +G+
Sbjct: 241 QHDKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQA 211
++ + IH+D++ N+L++ KI+DFG+A + D+ T +G+ P+ + A
Sbjct: 298 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR----VIEDNEYTAREGAKFPIKWTA 353
Query: 212 PEIANGLPEISGYKV-----DIWSSGVTL 235
PE N + D+WS G+ L
Sbjct: 354 PEAIN-------FGSFTIKSDVWSFGILL 375
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-22
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 40 VMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLLKMLQ 96
M LG G YG+V E + + AVK K + V+ +E ++K ++
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--------EDTMEVEEFLKEAAVMKEIK 67
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H N++ L+ V ++ Y+I E+ G L D L ++ Q+ +E
Sbjct: 68 HPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PVF-QAP 212
YL + IH+D+ N L+ + +K++DFG++ + DT T G+ P+ AP
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR----LMTGDTYTAHAGAKFPIKWTAP 181
Query: 213 EIANGLPEISGYKV-----DIWSSGVTL 235
E Y D+W+ GV L
Sbjct: 182 ESLA-------YNKFSIKSDVWAFGVLL 202
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 3e-22
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 27/203 (13%)
Query: 41 MGDLLGEGSYGKVKE-MLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLLKMLQ 96
+ LG+G +G+V + T A+K K G ++ + +E +++K L+
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRV--AIKTLKP--------GTMSPEAFLQEAQVMKKLR 320
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H ++ L V ++ +Y++ EY G L D L K + Q Q+ G+
Sbjct: 321 HEKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PVF-QAP 212
Y+ +H+D++ N+L+ + K++DFG+A + D+ T QG+ P+ AP
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAP 433
Query: 213 EIANGLPEISGYKVDIWSSGVTL 235
E A K D+WS G+ L
Sbjct: 434 EAAL--YGRFTIKSDVWSFGILL 454
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-22
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+Y + L+G+GS+G+V + D A+KI K KK +I E+RLL+++
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL-NQAQI----EVRLLELMN 108
Query: 97 HR------NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQL 150
++ L F + + L+ E L D+L +T ++ + + Q+
Sbjct: 109 KHDTEMKYYIVHLKRHF--MFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 151 LDGLEYLHSQ--GIIHKDIKPGNLLLTLDG--TLKISDFGVAESLDMFLHDDTITTSQGS 206
L +L + IIH D+KP N+LL +KI DFG + L Q S
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQ-S 221
Query: 207 PVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+++PE+ G+P +D+WS G L
Sbjct: 222 RFYRSPEVLLGMP--YDLAIDMWSLGCIL 248
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-21
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 27/204 (13%)
Query: 40 VMGDLLGEGSYGKVKE-MLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLLKML 95
+ LG+G +G+V + T A+K K G ++ + +E +++K L
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTRV--AIKTLKP--------GTMSPEAFLQEAQVMKKL 236
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
+H ++ L V ++ +Y++ EY G L D L K + Q Q+ G+
Sbjct: 237 RHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PVF-QA 211
Y+ +H+D++ N+L+ + K++DFG+A + D+ T QG+ P+ A
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTA 349
Query: 212 PEIANGLPEISGYKVDIWSSGVTL 235
PE A K D+WS G+ L
Sbjct: 350 PEAAL--YGRFTIKSDVWSFGILL 371
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-21
Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 39/208 (18%)
Query: 40 VMGDLLGEGSYGKVKE-MLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLLKMLQ 96
+ +G+G +G V + AVK K N E ++ L+
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGNKV---AVKCIK--------NDATAQAFLAEASVMTQLR 72
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H N++ L+ V + ++K +Y++ EY G L D L S + L + + +E
Sbjct: 73 HSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQAP 212
YL +H+D+ N+L++ D K+SDFG+ + + +T PV + AP
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAP 183
Query: 213 EIANGLPEISGYKV-----DIWSSGVTL 235
E K D+WS G+ L
Sbjct: 184 EALR-------EKKFSTKSDVWSFGILL 204
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-21
Identities = 50/226 (22%), Positives = 88/226 (38%), Gaps = 42/226 (18%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRR-AVKIFK-KKKLQRIPNGEINVDREIRLLKM 94
+Y + D LGEG++GKV E +D + R AVKI K + EI++L+
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA--ARS----EIQVLEH 67
Query: 95 LQHR------NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFL 148
L + +++ F + + ++ E D + + F +
Sbjct: 68 LNTTDPNSTFRCVQMLEWF--EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAY 125
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLT-------------------LDGTLKISDFGVAE 189
Q+ + +LHS + H D+KP N+L ++ +K+ DFG A
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184
Query: 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ + T + ++APE+ L D+WS G L
Sbjct: 185 ---TYDDEHHSTLVS-TRHYRAPEVILALG--WSQPCDVWSIGCIL 224
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-20
Identities = 60/208 (28%), Positives = 86/208 (41%), Gaps = 26/208 (12%)
Query: 40 VMGDLLGEGSYGKVKE---MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+ + LG+GS+G V+ S AVK K L + P + RE+ + L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLD 79
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
HRN+I L V + M ++ E G L D L F + Y +Q+ +G+
Sbjct: 80 HRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PVF-QAP 212
YL S+ IH+D+ NLLL +KI DFG+ +L +DD + P AP
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHRKVPFAWCAP 193
Query: 213 EIANGLPEISGY-----KVDIWSSGVTL 235
E D W GVTL
Sbjct: 194 ESLK-------TRTFSHASDTWMFGVTL 214
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-20
Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 37/209 (17%)
Query: 40 VMGDLLGEGSYGKVKE-MLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLLKML 95
+ LG G +G VK + AVK+ K+ G ++ D +E + + L
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYDV--AVKMIKE--------GSMSEDEFFQEAQTMMKL 60
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
H ++ V K+ +Y++ EY G L + L S K Q + +G+
Sbjct: 61 SHPKLVKFYGVCS--KEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGM 117
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQA 211
+L S IH+D+ N L+ D +K+SDFG+ ++ DD +S G+ PV + A
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR----YVLDDQYVSSVGTKFPVKWSA 173
Query: 212 PEIANGLPEISGYKV-----DIWSSGVTL 235
PE+ + Y D+W+ G+ +
Sbjct: 174 PEVFH-------YFKYSSKSDVWAFGILM 195
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 49/208 (23%), Positives = 85/208 (40%), Gaps = 39/208 (18%)
Query: 40 VMGDLLGEGSYGKVKE-MLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLLKMLQ 96
+ +G+G +G V + AVK K + E ++ L+
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNKV---AVKCIKNDATAQ--------AFLAEASVMTQLR 244
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H N++ L+ V + ++K +Y++ EY G L D L S + L + + +E
Sbjct: 245 HSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQAP 212
YL +H+D+ N+L++ D K+SDFG+ + + +T PV + AP
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAP 355
Query: 213 EIANGLPEISGYKV-----DIWSSGVTL 235
E K D+WS G+ L
Sbjct: 356 EALR-------EKKFSTKSDVWSFGILL 376
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-20
Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 37/209 (17%)
Query: 40 VMGDLLGEGSYGKVKE-MLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLLKML 95
+G G +G V ++ A+K ++ G ++ + E ++ L
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDKV--AIKTIRE--------GAMSEEDFIEEAEVMMKL 60
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
H ++ L V + ++ + L+ E+ G L D L + F G L + +G+
Sbjct: 61 SHPKLVQLYGVCL--EQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGM 117
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQA 211
YL +IH+D+ N L+ + +K+SDFG+ F+ DD T+S G+ PV + +
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR----FVLDDQYTSSTGTKFPVKWAS 173
Query: 212 PEIANGLPEISGYKV-----DIWSSGVTL 235
PE+ + + D+WS GV +
Sbjct: 174 PEVFS-------FSRYSSKSDVWSFGVLM 195
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-20
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 37/209 (17%)
Query: 40 VMGDLLGEGSYGKVKE-MLDSETLCRRAVKIFKKKKLQRIPNGEINVD---REIRLLKML 95
LG G +G VK + A+K+ K+ G ++ D E +++ L
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYDV--AIKMIKE--------GSMSEDEFIEEAKVMMNL 76
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
H ++ L V K++ +++I EY G L + L +F Q + + +
Sbjct: 77 SHEKLVQLYGVCT--KQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAM 133
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQA 211
EYL S+ +H+D+ N L+ G +K+SDFG++ ++ DD T+S GS PV +
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR----YVLDDEYTSSVGSKFPVRWSP 189
Query: 212 PEIANGLPEISGYKV-----DIWSSGVTL 235
PE+ Y DIW+ GV +
Sbjct: 190 PEVLM-------YSKFSSKSDIWAFGVLM 211
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-20
Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 30/208 (14%)
Query: 40 VMGDLLGEGSYGKVKE---MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+G +GEG +G V + M A+K K + +E ++
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFD 74
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H +++ L+ V + +++IME C G L+ L + Y QL L
Sbjct: 75 HPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALA 130
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PVF-QAP 212
YL S+ +H+DI N+L++ + +K+ DFG++ ++ D T + P+ AP
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR----YMEDSTYYKASKGKLPIKWMAP 186
Query: 213 EIANGLPEISGYKV-----DIWSSGVTL 235
E N ++ D+W GV +
Sbjct: 187 ESIN-------FRRFTSASDVWMFGVCM 207
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-20
Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 31/215 (14%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
M LG+GS+G V K ++ E R A+K + R E ++K
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVMKE 84
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML--------DSTPYKKFPIWQAHG 145
+V+ L+ V + Q +IME G L+ L ++ + +
Sbjct: 85 FNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG 205
++ DG+ YL++ +H+D+ N ++ D T+KI DFG+ D++ D +G
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKG 200
Query: 206 S-PV-FQAPE-IANGLPEISGY--KVDIWSSGVTL 235
PV + +PE + +G+ + D+WS GV L
Sbjct: 201 LLPVRWMSPESLKDGV-----FTTYSDVWSFGVVL 230
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 5e-20
Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 30/208 (14%)
Query: 40 VMGDLLGEGSYGKVKE---MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+G +GEG +G V + M A+K K + +E ++
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFD 449
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H +++ L+ V + +++IME C G L+ L + Y QL L
Sbjct: 450 HPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALA 505
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PVF-QAP 212
YL S+ +H+DI N+L++ + +K+ DFG++ ++ D T + P+ AP
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR----YMEDSTYYKASKGKLPIKWMAP 561
Query: 213 EIANGLPEISGYKV-----DIWSSGVTL 235
E N ++ D+W GV +
Sbjct: 562 ESIN-------FRRFTSASDVWMFGVCM 582
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-20
Identities = 47/224 (20%), Positives = 81/224 (36%), Gaps = 34/224 (15%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+++ +G+G++G+V + AVK+ + K + +I E +LK +Q
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-RSAKI----EADILKKIQ 89
Query: 97 HR-----NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLL 151
+ N++ F M LI E L +++ Y F I Y +++L
Sbjct: 90 NDDINNNNIVKYHGKF--MYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ------G 205
L YL + H D+KP N+LL K + + ++ G
Sbjct: 148 KALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 206 SPVFQ--------------APEIANGLPEISGYKVDIWSSGVTL 235
F+ APE+ L D+WS G L
Sbjct: 208 CATFKSDYHGSIINTRQYRAPEVILNLG--WDVSSDMWSFGCVL 249
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-19
Identities = 52/225 (23%), Positives = 89/225 (39%), Gaps = 40/225 (17%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRR-AVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+Y + LGEG++GKV E LD + A+KI + R + EI +LK +
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR-EAARL----EINVLKKI 73
Query: 96 QHR------NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQ 149
+ + + + D F + M + E + L ++ +P+ Q
Sbjct: 74 KEKDKENKFLCVLMSDWF--NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 150 LLDGLEYLHSQGIIHKDIKPGNLLLT-------------------LDGTLKISDFGVAES 190
L L +LH + H D+KP N+L + +++++DFG A
Sbjct: 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-- 189
Query: 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
F H + TT + ++ PE+ L D+WS G L
Sbjct: 190 --TFDH-EHHTTIVATRHYRPPEVILELG--WAQPCDVWSIGCIL 229
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-19
Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 29/214 (13%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
++G +LGEG +G V K+ + AVK K E +K
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKV--AVKTMKLDNSS--QREIEEFLSEAACMKD 92
Query: 95 LQHRNVIGLVDVFVND---KKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGY 146
H NVI L+ V + K +I+ + G L T K P+ +
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 147 FLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS 206
+ + G+EYL ++ +H+D+ N +L D T+ ++DFG+++ ++ D
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK--KIYSGDYYRQGRIAK 210
Query: 207 -PV-FQAPE-IANGLPEISGY--KVDIWSSGVTL 235
PV + A E +A+ + Y K D+W+ GVT+
Sbjct: 211 MPVKWIAIESLADRV-----YTSKSDVWAFGVTM 239
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-19
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
+G LG G++G+V + + T AVK+ K+ + E+++L
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---EHRALMSELKILIH 86
Query: 95 L-QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML----DSTPYKKFPIWQAHGYFL 148
+ H NV+ L+ + +I+E+C G L L + K + FL
Sbjct: 87 IGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 149 QLLD----------GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDD 198
L G+E+L S+ IH+D+ N+LL+ +KI DFG+A D++ D
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPD 203
Query: 199 TITTSQGS-PV-FQAPE-IANGLPEISGY--KVDIWSSGVTL 235
+ P+ + APE I + + Y + D+WS GV L
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRV-----YTIQSDVWSFGVLL 240
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-19
Identities = 57/261 (21%), Positives = 92/261 (35%), Gaps = 76/261 (29%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
G+Y + LG G + V D + A+K+ K + EIRLLK ++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK-----SAEHYTETALDEIRLLKSVR 91
Query: 97 --------HRNVIGLVDVF----VNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAH 144
V+ L+D F VN + ++ E L + + Y+ P+
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTH--ICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 145 GYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLD-------------------------- 177
Q+L GL+YLH++ IIH DIKP N+LL+++
Sbjct: 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 178 -----------------------GTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEI 214
+KI+D G A + + I T Q +++ E+
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQ----YRSLEV 264
Query: 215 ANGLPEISGYKVDIWSSGVTL 235
G DIWS+
Sbjct: 265 LIGSG--YNTPADIWSTACMA 283
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-19
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 26/213 (12%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
+G +LG+G +G V K+ S AVK+ K + E RE +K
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKV--AVKMLKADIIASSDIEEF--LREAACMKE 81
Query: 95 LQHRNVIGLVDVFVND----KKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHG 145
H +V LV V + + +I+ + G L P+
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG 205
+ + + G+EYL S+ IH+D+ N +L D T+ ++DFG++ ++ D
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR--KIYSGDYYRQGCAS 199
Query: 206 S-PV-FQAPE-IANGLPEISGYKVDIWSSGVTL 235
PV + A E +A+ + D+W+ GVT+
Sbjct: 200 KLPVKWLALESLADN---LYTVHSDVWAFGVTM 229
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-19
Identities = 45/209 (21%), Positives = 88/209 (42%), Gaps = 32/209 (15%)
Query: 40 VMGDLLGEGSYGKVKE---MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
V+ +LGEG +G+V E AVK KK + + E ++K L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT---LDNKEKFMSEAVIMKNLD 71
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLD--STPYKKFPIWQAHGYFLQLLDGL 154
H +++ L+ + +++ ++IME G ++ + Y LQ+ +
Sbjct: 72 HPHIVKLIGII---EEEPTWIIMELYPYG--ELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQA 211
YL S +H+DI N+L+ +K+ DFG++ ++ D+ + + P+ + +
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE----DEDYYKASVTRLPIKWMS 182
Query: 212 PEIANGLPEISGYKV-----DIWSSGVTL 235
PE N ++ D+W V +
Sbjct: 183 PESIN-------FRRFTTASDVWMFAVCM 204
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-19
Identities = 46/210 (21%), Positives = 88/210 (41%), Gaps = 31/210 (14%)
Query: 41 MGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+++G G +G V + + C AVK + + E ++K
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVS---QFLTEGIIMKDF 83
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
H NV+ L+ + + +++ Y G L++ + + + G+ LQ+ G+
Sbjct: 84 SHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGM 141
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS-----PV- 208
+YL S+ +H+D+ N +L T+K++DFG+A ++D + PV
Sbjct: 142 KYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVK 197
Query: 209 FQAPE-IANGLPEISGY--KVDIWSSGVTL 235
+ A E + + K D+WS GV L
Sbjct: 198 WMALESLQTQK-----FTTKSDVWSFGVLL 222
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 5e-19
Identities = 54/228 (23%), Positives = 100/228 (43%), Gaps = 31/228 (13%)
Query: 21 SDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKE----MLDSETLCRRAVKIFKKKKLQ 76
SD +K + +K + LG G++G V++ M + A+K+ K+ +
Sbjct: 320 SDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV--AIKVLKQGTEK 377
Query: 77 RIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPY 135
+ RE +++ L + ++ L+ V + + + L+ME GG L L
Sbjct: 378 ADTEEMM---REAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKR- 430
Query: 136 KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195
++ P+ Q+ G++YL + +H+++ N+LL KISDFG++++L
Sbjct: 431 EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA-- 488
Query: 196 HDDTITTSQGS--PVF-QAPEIANGLPEISGYKV-----DIWSSGVTL 235
D T P+ APE N ++ D+WS GVT+
Sbjct: 489 DDSYYTARSAGKWPLKWYAPECIN-------FRKFSSRSDVWSYGVTM 529
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-19
Identities = 42/209 (20%), Positives = 87/209 (41%), Gaps = 30/209 (14%)
Query: 40 VMGDLLGEGSYGKVKE-MLDSETLCRR---AVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+LG G++G V + + E + A+K ++ P + E ++ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASV 74
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
+ +V L+ + + LI + G L D + + +Q+ G+
Sbjct: 75 DNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 130
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PVF-QA 211
YL + ++H+D+ N+L+ +KI+DFG+A+ L ++ ++G P+ A
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG---AEEKEYHAEGGKVPIKWMA 187
Query: 212 PEIANGLPEISGYKV-----DIWSSGVTL 235
E +++ D+WS GVT+
Sbjct: 188 LESIL-------HRIYTHQSDVWSYGVTV 209
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-19
Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLL 92
G LG G++GKV + + + + AVK+ K + + E++++
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-----AHADEKEALMSELKIM 103
Query: 93 KML-QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML--DSTPYKKFPIWQAHGYFL 148
L QH N++ L+ + +I EYC G L + L S + P +
Sbjct: 104 SHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 149 QLLD----------GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDD 198
D G+ +L S+ IH+D+ N+LLT KI DFG+A D+ +
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMNDSN 219
Query: 199 TITTSQGS-PV-FQAPE-IANGLPEISGY--KVDIWSSGVTL 235
I PV + APE I + + Y + D+WS G+ L
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCV-----YTVQSDVWSYGILL 256
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 6e-19
Identities = 46/207 (22%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
+++G G +G V + + C AVK + E ++K
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIG---EVSQFLTEGIIMKD 146
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
H NV+ L+ + + +++ Y G L++ + + + G+ LQ+ G
Sbjct: 147 FSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKG 204
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS---PV-F 209
+++L S+ +H+D+ N +L T+K++DFG+A DM+ + ++ PV +
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKW 262
Query: 210 QAPE-IANGLPEISGYKVDIWSSGVTL 235
A E + K D+WS GV L
Sbjct: 263 MALESLQTQ---KFTTKSDVWSFGVLL 286
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-19
Identities = 48/202 (23%), Positives = 86/202 (42%), Gaps = 27/202 (13%)
Query: 45 LGEGSYGKVKE-MLDSETLCRR-AVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIG 102
LG G++G VK+ + + + AVKI K + P + + E +++ L + ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVR 82
Query: 103 LVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG 161
++ + + + L+ME G L L + Q+ G++YL
Sbjct: 83 MIGIC---EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQAPEIANGL 218
+H+D+ N+LL KISDFG++++L ++ PV + APE N
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWYAPECIN-- 193
Query: 219 PEISGYKV-----DIWSSGVTL 235
Y D+WS GV +
Sbjct: 194 -----YYKFSSKSDVWSFGVLM 210
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-19
Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 31/204 (15%)
Query: 45 LGEGSYGKVKE----MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV 100
LG G++G V++ M + A+K+ K+ + + RE +++ L + +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDV--AIKVLKQGTEKADTEEMM---REAQIMHQLDNPYI 72
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS 159
+ L+ V + + + L+ME GG L L ++ P+ Q+ G++YL
Sbjct: 73 VRLIGVC---QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEE 128
Query: 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PVF-QAPEIAN 216
+ +H+D+ N+LL KISDFG++++L D T P+ APE N
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECIN 186
Query: 217 GLPEISGYKV-----DIWSSGVTL 235
++ D+WS GVT+
Sbjct: 187 -------FRKFSSRSDVWSYGVTM 203
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 8e-19
Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 40/224 (17%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
G LG G++GKV ++ S+ AVK+ K + E+++L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE---ALMSELKVLSY 82
Query: 95 L-QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML------DSTPYKKFPIWQAHGY 146
L H N++ L+ +I EYC G L + L I +
Sbjct: 83 LGNHMNIVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 147 FLQLLD----------GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196
L L D G+ +L S+ IH+D+ N+LLT KI DFG+A D+
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR--DIKND 198
Query: 197 DDTITTSQGS-PV-FQAPE-IANGLPEISGY--KVDIWSSGVTL 235
+ + PV + APE I N + Y + D+WS G+ L
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCV-----YTFESDVWSYGIFL 237
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-18
Identities = 49/215 (22%), Positives = 84/215 (39%), Gaps = 41/215 (19%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDR-----EI 89
+ ++G G G+V + + A+K K G R E
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPV--AIKALKA--------GYTERQRRDFLSEA 101
Query: 90 RLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFL 148
++ H N+I L V + + ++ EY G L L + +F I Q G
Sbjct: 102 SIMGQFDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLR 158
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS-- 206
+ G+ YL G +H+D+ N+L+ + K+SDFG++ + D T+ G
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR--VLEDDPDAAYTTTGGKI 216
Query: 207 PV-FQAPEIANGLPEISGYKV-----DIWSSGVTL 235
P+ + APE ++ D+WS GV +
Sbjct: 217 PIRWTAPEAIA-------FRTFSSASDVWSFGVVM 244
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-18
Identities = 51/222 (22%), Positives = 85/222 (38%), Gaps = 41/222 (18%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
V+ LGEG++GKV +L + AVK K+ + + RE LL M
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----ESARQDFQREAELLTM 99
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML-------------DSTPYKKFPI 140
LQH++++ V + + + ++ EY G L L + +
Sbjct: 100 LQHQHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 141 WQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200
Q Q+ G+ YL +H+D+ N L+ +KI DFG++ ++
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD----IYSTDY 213
Query: 201 TTSQGSPVF----QAPE-IANGLPEISGY--KVDIWSSGVTL 235
G + PE I + + D+WS GV L
Sbjct: 214 YRVGGRTMLPIRWMPPESILYRK-----FTTESDVWSFGVVL 250
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-18
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
++G+G +G V + + C A+K + + RE L++
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQC--AIKSLSRITEMQQVE---AFLREGLLMRG 78
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
L H NV+ L+ + + + ++++ Y G L + S P + + + LQ+ G
Sbjct: 79 LNHPNVLALIGI-MLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARG 136
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS-----PV 208
+EYL Q +H+D+ N +L T+K++DFG+A + D + Q PV
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLAR----DILDREYYSVQQHRHARLPV 192
Query: 209 -FQAPE-IANGLPEISGYKVDIWSSGVTL 235
+ A E + K D+WS GV L
Sbjct: 193 KWTALESLQTYRFTT---KSDVWSFGVLL 218
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-18
Identities = 42/209 (20%), Positives = 83/209 (39%), Gaps = 30/209 (14%)
Query: 40 VMGDLLGEGSYGKVKE--MLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLLKML 95
+LG G +G V + + + V I K ++ + + + L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCI---KVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
H +++ L+ + + L+ +Y G L D + + +Q+ G+
Sbjct: 73 DHAHIVRLLGLC---PGSSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGM 128
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQA 211
YL G++H+++ N+LL ++++DFGVA+ L DD + P+ + A
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP---PDDKQLLYSEAKTPIKWMA 185
Query: 212 PEIANGLPEISGYKV-----DIWSSGVTL 235
E + + D+WS GVT+
Sbjct: 186 LESIH-------FGKYTHQSDVWSYGVTV 207
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-18
Identities = 52/225 (23%), Positives = 82/225 (36%), Gaps = 46/225 (20%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
V+ LGEG++GKV + ++ AVK K L + RE LL
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA----RKDFQREAELLTN 73
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML-------DSTPYKKFPIWQAHGY 146
LQH +++ V + ++ EY G L L + +
Sbjct: 74 LQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 147 FLQLL-------DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT 199
Q+L G+ YL SQ +H+D+ N L+ + +KI DFG++ ++
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD----VYSTD 187
Query: 200 ITTSQGSPVF----QAPEIANGLPEISGYKV-----DIWSSGVTL 235
G + PE Y+ D+WS GV L
Sbjct: 188 YYRVGGHTMLPIRWMPPESIM-------YRKFTTESDVWSFGVIL 225
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-18
Identities = 47/209 (22%), Positives = 86/209 (41%), Gaps = 28/209 (13%)
Query: 40 VMGDLLGEGSYGKVKE----MLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
++G G +G+V + + A+K K ++ E ++
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQF 103
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
H N+I L V K + M +I EY G L L +F + Q G + G+
Sbjct: 104 SHHNIIRLEGVIS--KYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGM 160
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQA 211
+YL + +H+D+ N+L+ + K+SDFG++ + + T+ G P+ + A
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR--VLEDDPEATYTTSGGKIPIRWTA 218
Query: 212 PEIANGLPEISGYKV-----DIWSSGVTL 235
PE + Y+ D+WS G+ +
Sbjct: 219 PEAIS-------YRKFTSASDVWSFGIVM 240
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-18
Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 35/217 (16%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
+ LG G++G+V M + + + AVK + ++ E++ E ++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ---DELDFLMEALIISK 89
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML-----DSTPYKKFPIWQAHGYFL 148
H+N++ + V + + +++ME GG L+ L + +
Sbjct: 90 FNHQNIVRCIGVSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDG---TLKISDFGVAESLDMFLHDDTITTSQG 205
+ G +YL IH+DI N LLT G KI DFG+A ++ + G
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGG 203
Query: 206 S---PV-FQAPE-IANGLPEISGY--KVDIWSSGVTL 235
PV + PE G+ + K D WS GV L
Sbjct: 204 CAMLPVKWMPPEAFMEGI-----FTSKTDTWSFGVLL 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-18
Identities = 57/231 (24%), Positives = 90/231 (38%), Gaps = 49/231 (21%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
V+G LGEG +GKV + AVK+ K+ ++ E +LK
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE---LRDLLSEFNVLKQ 82
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML------------DSTPYKKFPIW 141
+ H +VI L + + LI+EY G L+ L +
Sbjct: 83 VNHPHVIKLYGACS--QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 142 QAHGYFLQLLD----------GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
L + D G++YL ++H+D+ N+L+ +KISDFG++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR-- 198
Query: 192 DMFLHDDTITTSQGS-PV-FQAPEIANGLPEISGYKV-----DIWSSGVTL 235
D++ D + SQG PV + A E + D+WS GV L
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLF-------DHIYTTQSDVWSFGVLL 242
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-18
Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 44/226 (19%)
Query: 40 VMGDLLGEGSYGKV---------KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR 90
+G LGEG++G+V K+ AVK+ K ++ ++ E+
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTV--AVKMLKDDATEK---DLSDLVSEME 92
Query: 91 LLKML-QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAH 144
++KM+ +H+N+I L+ + +Y+I+EY G L+ + I +
Sbjct: 93 MMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 145 GYFLQLLD----------GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194
+ D G+EYL SQ IH+D+ N+L+T + +KI+DFG+A D+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DIN 208
Query: 195 LHDDTITTSQGS-PV-FQAPE-IANGLPEISGY--KVDIWSSGVTL 235
D T+ G PV + APE + + + Y + D+WS GV +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRV-----YTHQSDVWSFGVLM 249
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 8e-18
Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 35/217 (16%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
+ LG G++G+V M + + + AVK + ++ E++ E ++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ---DELDFLMEALIISK 130
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML-----DSTPYKKFPIWQAHGYFL 148
H+N++ + V + + ++++E GG L+ L + +
Sbjct: 131 FNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 149 QLLDGLEYLHSQGIIHKDIKPGNLLLTLDG---TLKISDFGVAESLDMFLHDDTITTSQG 205
+ G +YL IH+DI N LLT G KI DFG+A ++ G
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGG 244
Query: 206 S---PV-FQAPE-IANGLPEISGY--KVDIWSSGVTL 235
PV + PE G+ + K D WS GV L
Sbjct: 245 CAMLPVKWMPPEAFMEGI-----FTSKTDTWSFGVLL 276
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 9e-18
Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 48/228 (21%)
Query: 40 VMGDLLGEGSYGKV---------KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD--RE 88
+G LGEG +G+V K+ AVK+ K ++ + D E
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTV--AVKMLKDDATEKDLS-----DLVSE 136
Query: 89 IRLLKML-QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML--------------DS 132
+ ++KM+ +H+N+I L+ + +Y+I+EY G L++ L +
Sbjct: 137 MEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 133 TPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192
P ++ QL G+EYL SQ IH+D+ N+L+T + +KI+DFG+A D
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--D 252
Query: 193 MFLHDDTITTSQGS-PV-FQAPE-IANGLPEISGY--KVDIWSSGVTL 235
+ D T+ G PV + APE + + + Y + D+WS GV +
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRV-----YTHQSDVWSFGVLM 295
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-17
Identities = 56/225 (24%), Positives = 79/225 (35%), Gaps = 45/225 (20%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
+ LGE +GKV E A+K K K + E L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL---REEFRHEAMLRAR 68
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-----LQDMLDSTPYKKFPIWQAHGYFLQ 149
LQH NV+ L+ V K Q + +I YC G L + + L+
Sbjct: 69 LQHPNVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 150 LLD----------GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT 199
D G+EYL S ++HKD+ N+L+ +KISD G+ ++
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAAD 182
Query: 200 ITTSQGSPVF----QAPEIANGLPEISGYKV-----DIWSSGVTL 235
G+ + APE Y DIWS GV L
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIM-------YGKFSIDSDIWSYGVVL 220
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-17
Identities = 42/209 (20%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 40 VMGDLLGEGSYGKVKE---MLDSETLCRR-AVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+LG G++G V + + + E + A+K ++ P + E ++ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASV 74
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
+ +V L+ + + + LI + G L D + + +Q+ G+
Sbjct: 75 DNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 130
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQA 211
YL + ++H+D+ N+L+ +KI+DFG+A+ L ++ ++G P+ + A
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG---AEEKEYHAEGGKVPIKWMA 187
Query: 212 PEIANGLPEISGYKV-----DIWSSGVTL 235
E +++ D+WS GVT+
Sbjct: 188 LESIL-------HRIYTHQSDVWSYGVTV 209
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 40 VMGDLLGEGSYGKVKE-MLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLLKMLQ 96
+ ++G G +G+V L + +V I K L+ + D E ++
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAI---KTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H N+I L V K + + ++ EY G L L +F + Q G + G++
Sbjct: 105 HPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMK 161
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS--PV-FQAP 212
YL G +H+D+ N+L+ + K+SDFG+ L+ + T++G P+ + +P
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE--DDPEAAYTTRGGKIPIRWTSP 219
Query: 213 EIANGLPEISGY-----KVDIWSSGVTL 235
E Y D+WS G+ L
Sbjct: 220 EAIA-------YRKFTSASDVWSYGIVL 240
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 44/226 (19%)
Query: 40 VMGDLLGEGSYGKV---------KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR 90
V+G LGEG++G+V K+ + T AVK+ K ++ ++ E+
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV--AVKMLKSDATEK---DLSDLISEME 126
Query: 91 LLKML-QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDS----TPYKKFPIWQAH 144
++KM+ +H+N+I L+ + +Y+I+EY G L++ L + +
Sbjct: 127 MMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 145 GYFLQLLD----------GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194
L D G+EYL S+ IH+D+ N+L+T D +KI+DFG+A D+
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIH 242
Query: 195 LHDDTITTSQGS-PV-FQAPE-IANGLPEISGY--KVDIWSSGVTL 235
D T+ G PV + APE + + + Y + D+WS GV L
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRI-----YTHQSDVWSFGVLL 283
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-17
Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 48/224 (21%)
Query: 40 VMGDLLGEGSYGKVKE-MLDSETLCRR-AVKIFKKKKLQRIPNGEINVD--REIRLLKML 95
D++GEG++G+V + + + L A+K K+ + D E+ +L L
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-----DFAGELEVLCKL 82
Query: 96 -QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML--------------DSTPYKKFP 139
H N+I L+ + +YL +EY G L D L ++
Sbjct: 83 GHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 140 IWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT 199
Q + + G++YL + IH+D+ N+L+ + KI+DFG++ +
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG------QEV 194
Query: 200 ITTSQGS--PV-FQAPEIANGLPEISGYKV-----DIWSSGVTL 235
PV + A E N Y V D+WS GV L
Sbjct: 195 YVKKTMGRLPVRWMAIESLN-------YSVYTTNSDVWSYGVLL 231
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-17
Identities = 49/229 (21%), Positives = 91/229 (39%), Gaps = 45/229 (19%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
+GEG++G+V +L E AVK+ K++ + + + RE L+
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM---QADFQREAALMAE 106
Query: 95 LQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML------------DSTPYKKFPIW 141
+ N++ L+ V + M L+ EY G L + L S + +
Sbjct: 107 FDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 142 QAHGYFLQLLD----------GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
L + G+ YL + +H+D+ N L+ + +KI+DFG++
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR-- 222
Query: 192 DMFLHDDTITTSQGS-PV-FQAPE-IANGLPEISGY--KVDIWSSGVTL 235
+++ D + P+ + PE I Y + D+W+ GV L
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYNR-----YTTESDVWAYGVVL 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-16
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 49/231 (21%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVD--REIRLL 92
G +LG G++GKV + + + AVK+ K+K + E++++
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-----ADSSEREALMSELKMM 102
Query: 93 KML-QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML-----------DSTPYKKFP 139
L H N++ L+ +YLI EYC G L + L +K
Sbjct: 103 TQLGSHENIVNLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 140 IWQAHGYFLQLLD----------GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189
+ L D G+E+L + +H+D+ N+L+T +KI DFG+A
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 190 SLDMFLHDDTITTSQGS-PV-FQAPE-IANGLPEISGY--KVDIWSSGVTL 235
D+ + + PV + APE + G+ Y K D+WS G+ L
Sbjct: 221 --DIMSDSNYVVRGNARLPVKWMAPESLFEGI-----YTIKSDVWSYGILL 264
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-16
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 36/207 (17%)
Query: 44 LLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIG 102
L+G G +GKV K +L A+K + Q G + EI L +H +++
Sbjct: 46 LIGHGVFGKVYKGVLRDGAKV--ALKRRTPESSQ----GIEEFETEIETLSFCRHPHLVS 99
Query: 103 LVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPI-WQAHGYFLQLLD-------G 153
L+ F +++ + + LI +Y G L+ L + + W+ Q L+ G
Sbjct: 100 LIG-FCDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSMSWE------QRLEICIGAARG 151
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT-ITTS-QGSPVFQA 211
L YLH++ IIH+D+K N+LL + KI+DFG+++ D T ++T +G+ +
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL--DQTHLSTVVKGTLGYID 209
Query: 212 PEIANGLPEISGY---KVDIWSSGVTL 235
PE I G K D++S GV L
Sbjct: 210 PEYF-----IKGRLTEKSDVYSFGVVL 231
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-15
Identities = 43/214 (20%), Positives = 76/214 (35%), Gaps = 34/214 (15%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRR--AVKIFKKKKLQRIPNGEINVDREIRLL 92
+ + LG+G++ K+ +E+ D L +K+ K N + ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMM 66
Query: 93 KMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLL 151
L H++++ V V + L+ E+ G L L I QL
Sbjct: 67 SKLSHKHLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLA 123
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTL--------KISDFGVAESLDMFLHDDTITTS 203
+ +L +IH ++ N+LL + K+SD G++ + I
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI----TVLPKDILQ- 178
Query: 204 QGSPV-FQAPE-IANGLPEISGYKVDIWSSGVTL 235
+ + PE I N D WS G TL
Sbjct: 179 --ERIPWVPPECIENPKNLNL--ATDKWSFGTTL 208
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-15
Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 42 GDLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV 100
G+ +GEG +G V K +++ T+ AVK + D+EI+++ QH N+
Sbjct: 36 GNKMGEGGFGVVYKGYVNNTTV---AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92
Query: 101 IGLVDVFVNDKKQKMYLIMEY-CVGGLQDMLDSTPYKKFPIWQ-----AHGYFLQLLDGL 154
+ L+ F +D L+ Y G L D L W A G +G+
Sbjct: 93 VELLG-FSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG----AANGI 146
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ--GSPVFQAP 212
+LH IH+DIK N+LL T KISDFG+A + + F T+ TS+ G+ + AP
Sbjct: 147 NFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF--AQTVMTSRIVGTTAYMAP 204
Query: 213 EIANGLPEISGYKVDIWSSGVTL 235
E G EI+ K DI+S GV L
Sbjct: 205 EALRG--EIT-PKSDIYSFGVVL 224
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 4e-14
Identities = 38/155 (24%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
K+ +G +G GS+G++ + +T A+K+ K + E ++ ++LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP------QLLYESKIYRILQ 60
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
I V F + L+M+ L+D+ + +K + Q+++ +E+
Sbjct: 61 GGTGIPNVRWFGVEGDYN-VLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEF 118
Query: 157 LHSQGIIHKDIKPGNLLLTLDGT---LKISDFGVA 188
+HS+ +H+DIKP N L+ L + I DFG+A
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 9e-14
Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+Y +G +G GS+G + D A+K+ K + E ++ KM+Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQLHIESKIYKMMQ 62
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
I + + ++ME L+D+ + +KF + Q++ +EY
Sbjct: 63 GGVGIPTIRWCGAEGDYN-VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEY 120
Query: 157 LHSQGIIHKDIKPGNLLLTLDGT---LKISDFGVA 188
+HS+ IH+D+KP N L+ L + I DFG+A
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-13
Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 35/208 (16%)
Query: 44 LLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIG 102
+LG G +GKV K L TL AVK K+++ Q GE+ E+ ++ M HRN++
Sbjct: 37 ILGRGGFGKVYKGRLADGTLV--AVKRLKEERTQG---GELQFQTEVEMISMAVHRNLLR 91
Query: 103 LVDVFVNDKKQKMYLIMEY-CVGGLQDMLDSTPYKKFPI-WQ-----AHGYFLQLLDGLE 155
L F +++ L+ Y G + L P + P+ W A G GL
Sbjct: 92 LRG-FCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG----SARGLA 145
Query: 156 YLHSQG---IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT-ITTS-QGSPVFQ 210
YLH IIH+D+K N+LL + + DFG+A+ +D + DT +TT+ +G+
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD---YKDTHVTTAVRGTIGHI 202
Query: 211 APEIANGLPEISGY---KVDIWSSGVTL 235
APE +G K D++ GV L
Sbjct: 203 APEYL-----STGKSSEKTDVFGYGVML 225
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-13
Identities = 34/171 (19%), Positives = 69/171 (40%), Gaps = 26/171 (15%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
++V+G +G G +G + + + A + K++ NG + E++ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHV---VKVEYQENGPL--FSELKFYQRVA 91
Query: 97 HRNVIGLVDVF---------------VNDKKQKMY--LIMEYCVGGLQDMLDSTPYKKFP 139
++ I + + K + Y ++ME LQ + F
Sbjct: 92 KKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ--NGTFK 149
Query: 140 IWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKI--SDFGVA 188
+++LD LEY+H +H DIK NLLL ++ +D+G++
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-13
Identities = 36/157 (22%), Positives = 68/157 (43%), Gaps = 13/157 (8%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
Y +G +GEGS+G + E + + A+K ++ + E R K+L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP------QLRDEYRTYKLLA 63
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
I V F + L+++ L+D+LD +KF + Q+L ++
Sbjct: 64 GCTGIPNVYYFGQEGLHN-VLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQS 121
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLK-----ISDFGVA 188
+H + ++++DIKP N L+ + + DFG+
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-13
Identities = 29/167 (17%), Positives = 60/167 (35%), Gaps = 15/167 (8%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRR--------AVKI-FKKKKLQRIPNGEINVDR 87
++ + + G + E + TL ++K+ K +L N +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 88 --EIRLLKMLQHRNVIGLVDVFVNDKKQKMY--LIMEYCVGGLQDMLDSTPYKKFPIWQA 143
++ K L ++ + Q Y L++ LQ LD +P
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161
Query: 144 HGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKI--SDFGVA 188
+LLD LE+LH +H ++ N+ + + ++ + +G A
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-12
Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 13/157 (8%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+ +G +G G++G+++ + T A+K+ K + E R K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLH------LEYRFYKQLG 62
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
+ I V F K +++E L+D+ D + F + +QL+ +EY
Sbjct: 63 SGDGIPQVYYFGPCGKYN-AMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEY 120
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLK-----ISDFGVA 188
+HS+ +I++D+KP N L+ G I DF +A
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 8e-12
Identities = 38/171 (22%), Positives = 67/171 (39%), Gaps = 23/171 (13%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+ +G +G+G +G + D + K++ NG + E++ +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFT--ELKFYQRAA 91
Query: 97 HRNVIGLVDVF---------------VNDKKQKMY--LIMEYCVGGLQDMLDSTPYKKFP 139
I ++DK K Y +IM+ LQ + ++ K+F
Sbjct: 92 KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFS 150
Query: 140 IWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKI--SDFGVA 188
L++LD LEY+H +H DIK NLLL ++ D+G+A
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 6e-11
Identities = 37/195 (18%), Positives = 64/195 (32%), Gaps = 46/195 (23%)
Query: 45 LGEGSYGKVKEMLDSETLCRRAVKI----------FKKKKLQRIPNGEINVDREIRLLKM 94
+GEG +G+V + + T A+KI +K EI + +E+ LL
Sbjct: 28 IGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 95 L---QHRNVIGLVDVFV----------------------------NDKKQKMYLIMEYCV 123
+ IGL V K ++++++E+
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 124 GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKI 182
GG L+ K + A QL L + H+D+ GN+LL K+
Sbjct: 146 GG--IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKL 203
Query: 183 SDFGVAESLDMFLHD 197
+S +
Sbjct: 204 HYTLNGKSSTIPSCG 218
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-08
Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 148 LQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS- 206
Q+ G+E+L S+ IH+D+ N+LL+ +KI DFG+A D++ D +
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYVRKGDARL 257
Query: 207 PV-FQAPE-IANGLPEISGYKVDIWSSGVTL 235
P+ + APE I + + + D+WS GV L
Sbjct: 258 PLKWMAPETIFDR---VYTIQSDVWSFGVLL 285
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-08
Identities = 33/185 (17%), Positives = 65/185 (35%), Gaps = 11/185 (5%)
Query: 40 VMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM 94
+G LG G++G+V + + T AVK+ K+ ++ E+++L
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILIH 81
Query: 95 L-QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLD 152
+ H NV+ L+ + +I+E+C G L L S + P F Q D
Sbjct: 82 IGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKD 140
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAP 212
+ + D + G ++ E + + + +
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200
Query: 213 EIANG 217
++A G
Sbjct: 201 QVAKG 205
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 3e-05
Identities = 34/198 (17%), Positives = 64/198 (32%), Gaps = 45/198 (22%)
Query: 17 HRVDSD--QVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKK 74
H +D + + Y K I +V + K++ D I K++
Sbjct: 5 HHMDFETGEHQYQYKDILSVFEDAFV-DNF-------DCKDVQDMPK------SILSKEE 50
Query: 75 LQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY-LIME------------- 120
+ I + V +RL L + +V FV + + Y +M
Sbjct: 51 IDHIIMSKDAVSGTLRLFWTLLSKQE-EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMT 109
Query: 121 ----YCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL-HSQGI-IHKDIKPGNLLL 174
L + D+ + K+ + + Y L+L L L ++ + I + G +
Sbjct: 110 RMYIEQRDRLYN--DNQVFAKYNVSRLQPY-LKLRQALLELRPAKNVLIDGVLGSGKTWV 166
Query: 175 TLD-----GTLKISDFGV 187
LD DF +
Sbjct: 167 ALDVCLSYKVQCKMDFKI 184
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 235 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.82 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.49 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.23 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.75 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.74 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.5 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.5 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.43 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.32 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.14 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.94 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.79 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.65 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.58 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.55 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.51 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.51 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.45 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.29 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.21 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.16 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.96 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.76 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.12 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.97 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.95 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.63 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.31 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=312.76 Aligned_cols=191 Identities=38% Similarity=0.648 Sum_probs=152.8
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++++.||+|+||+||+|++..+|+.||+|++.+..... ......+.+|+.+++.++||||+++++++ .+...+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~--~~~~~~ 88 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-SDMQGRIEREISYLRLLRHPHIIKLYDVI--KSKDEI 88 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEE--EECCEE
Confidence 478999999999999999999999999999999998765443 34455789999999999999999999999 566789
Q ss_pred EEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 116 YLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 116 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
|+||||++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++++||+|||+++...
T Consensus 89 ~ivmEy~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~--- 163 (275)
T 3hyh_A 89 IMVIEYAGNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--- 163 (275)
T ss_dssp EEEEECCCEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC---
Confidence 999999998999999876 679999999999999999999999999999999999999999999999999998553
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........||+.|+|||++.+.+ ..++++|||||||+|
T Consensus 164 ~~~~~~~~~GT~~Y~APE~~~~~~-y~~~~~DiwSlGvil 202 (275)
T 3hyh_A 164 DGNFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVIL 202 (275)
T ss_dssp -----------CTTSCHHHHSSSS-CCCTHHHHHHHHHHH
T ss_pred CCCccCCeeECcccCChhhhcCCC-CCCChhhhHHHHHHH
Confidence 222334567999999999998732 346899999999974
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=319.64 Aligned_cols=194 Identities=28% Similarity=0.464 Sum_probs=170.7
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++++.||+|+||+||+|++..+++.||+|++.+..... ......+.+|+.+++.++||||+++++++ ++...
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~~~ 106 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTF--QDDEK 106 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EeCCE
Confidence 3467999999999999999999999999999999998765443 34456789999999999999999999999 56678
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+|+||||++| +|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 107 ~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999975 699999875 6799999999999999999999999999999999999999999999999999987653
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...........||+.|+|||++.+ ..++.++|||||||+|
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvil 224 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCII 224 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHH
T ss_pred CCCcccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHH
Confidence 333344556789999999999988 4489999999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=322.77 Aligned_cols=192 Identities=29% Similarity=0.533 Sum_probs=162.1
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++++.||+|+||+||+|++..+|+.||+|++....... .....+.+|+.+++.++||||+++++++ .+.+.+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~--~~~~~~ 98 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS--KEREESRREVAVLANMKHPNIVQYRESF--EENGSL 98 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEE--EETTEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH--HHHHHHHHHHHHHHHCCCCCCCcEEEEE--EECCEE
Confidence 468999999999999999999999999999999998765432 3456789999999999999999999999 556789
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
|+|||||+| +|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999975 7999998776677899999999999999999999999999999999999999999999999999866421
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........||+.|+|||++.+ ..++.++|||||||+|
T Consensus 179 --~~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvil 215 (350)
T 4b9d_A 179 --VELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVL 215 (350)
T ss_dssp --HHHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred --cccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHH
Confidence 112234569999999999988 4589999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=312.33 Aligned_cols=186 Identities=30% Similarity=0.427 Sum_probs=163.9
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
..|+++++||+|+||+||+|++..+|+.||+|++..... .....+.+|+.+++.++||||+++++++ ...+.+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~--~~~~~~~ 147 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSY--LVGDELW 147 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----SSGGGGHHHHHHHHHCCCTTBCCEEEEE--EETTEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCEEE
Confidence 469999999999999999999999999999999976542 3445688999999999999999999999 4566899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+|||||+| +|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 148 ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-- 222 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-- 222 (346)
T ss_dssp EEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred EEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--
Confidence 99999976 68888875 5699999999999999999999999999999999999999999999999999986642
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........||+.|+|||++.+ ..++.++|||||||+|
T Consensus 223 ~~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvil 260 (346)
T 4fih_A 223 EVPRRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMV 260 (346)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred CCCcccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHH
Confidence 2233445679999999999987 4489999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=314.07 Aligned_cols=186 Identities=30% Similarity=0.440 Sum_probs=163.6
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
+.|+++++||+|+||+||+|++..+|+.||+|++.... ......+.+|+.+++.++||||++++++|. ..+.+|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~--~~~~~~ 224 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYL--VGDELW 224 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT----CSSGGGHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCCCceEEEEE--ECCEEE
Confidence 46999999999999999999999999999999997653 234456899999999999999999999994 566899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+|||||+| +|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..+..
T Consensus 225 iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~-- 299 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-- 299 (423)
T ss_dssp EEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--
T ss_pred EEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--
Confidence 99999976 58888865 5699999999999999999999999999999999999999999999999999986642
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........||+.|+|||++.+ ..++.++|||||||+|
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvil 337 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMV 337 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred CCccccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHH
Confidence 2233445679999999999987 4589999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=300.98 Aligned_cols=196 Identities=29% Similarity=0.450 Sum_probs=164.6
Q ss_pred CceeEeeeceE-EeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 29 KTIKVKMIGKY-VMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 29 ~~~~~~~~~~y-~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
..++....++| ++.++||+|+||+||+|.+..++..||+|++....... ...+.+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~ 94 (290)
T 3fpq_A 17 KAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSW 94 (290)
T ss_dssp CEEEECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhcCcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34444455666 67788999999999999999999999999997665432 3456789999999999999999999998
Q ss_pred Ec--CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeEEcc-CCcEE
Q psy787 108 VN--DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLTL-DGTLK 181 (235)
Q Consensus 108 ~~--~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~nili~~-~~~~~ 181 (235)
.. .....+|+||||++| +|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+|
T Consensus 95 ~~~~~~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vK 172 (290)
T 3fpq_A 95 ESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp EEEETTEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEE
T ss_pred eeccCCCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEE
Confidence 53 234578999999975 699999765 67999999999999999999999998 999999999999974 78999
Q ss_pred EeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 182 ISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+|||+|+... ........||+.|+|||++.+ .++.++|||||||+|
T Consensus 173 l~DFGla~~~~----~~~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvil 219 (290)
T 3fpq_A 173 IGDLGLATLKR----ASFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCM 219 (290)
T ss_dssp ECCTTGGGGCC----TTSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHH
T ss_pred EEeCcCCEeCC----CCccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHH
Confidence 99999997543 233445679999999998865 389999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=306.58 Aligned_cols=189 Identities=30% Similarity=0.469 Sum_probs=156.5
Q ss_pred ceEEeeeeeccccceEEEEeecc---chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDS---ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
++|++++.||+|+||+||+|++. .+++.||+|++++..... .....+.+|+.++..++||||+++++++ .+.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~~ 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAF--QTEG 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEE--EETT
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEE--EECC
Confidence 68999999999999999999863 467889999997665432 3344678899999999999999999999 5567
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+|+||||++| +|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 89999999975 699998876 679999999999999999999999999999999999999999999999999998543
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. .........||+.|+|||++.+ ..++.++|||||||+|
T Consensus 178 ~--~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvil 216 (304)
T 3ubd_A 178 D--HEKKAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLM 216 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHH
T ss_pred C--CCccccccccCcccCCHHHhcc--CCCCCCCcccchHHHH
Confidence 2 2233445679999999999987 4489999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=303.13 Aligned_cols=185 Identities=30% Similarity=0.398 Sum_probs=157.3
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.+.|++.++||+|+||+||+|++..+|+.||+|+++.... ..+|+.++..++||||+++++++ .+.+.+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~--~~~~~~ 125 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAV--REGPWV 125 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEE--EETTEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEE--EECCEE
Confidence 4579999999999999999999999999999999975431 24799999999999999999999 456789
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-cEEEeeeccccccCc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-TLKISDFGVAESLDM 193 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~ 193 (235)
|+||||++| +|.+++... +.+++..+..++.|++.||.|||+++|+||||||+|||++.++ ++||+|||+++.+..
T Consensus 126 ~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 999999975 699999765 6799999999999999999999999999999999999999887 699999999986642
Q ss_pred cccCC---cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDD---TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvil 246 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMM 246 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred CCcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHH
Confidence 21111 1223469999999999988 4489999999999975
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=299.09 Aligned_cols=194 Identities=27% Similarity=0.492 Sum_probs=152.4
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC-----
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK----- 111 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 111 (235)
++|++++.||+|+||+||+|++..+|+.||+|+++.... ....+.+.+|+.+++.++||||+++++.+.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR---ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 569999999999999999999999999999999875532 233457889999999999999999999986433
Q ss_pred -----CceEEEEEecccC-CHHHHhhcCCC-CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEee
Q psy787 112 -----KQKMYLIMEYCVG-GLQDMLDSTPY-KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISD 184 (235)
Q Consensus 112 -----~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~d 184 (235)
..++|++||||++ +|.+++..... ...+...++.++.|++.||+|||++||+||||||+||+++.++.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 2357999999965 79998876532 2244556889999999999999999999999999999999999999999
Q ss_pred eccccccCccccC----------CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHD----------DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||+++.++..... .......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvil 220 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLIL 220 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHH
Confidence 9999876432111 11233469999999999988 4599999999999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=297.83 Aligned_cols=193 Identities=26% Similarity=0.445 Sum_probs=154.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...+++++.++||+|+||+||+|+... .+|+|+++..... .+..+.|.+|+.++.+++||||+++++++. . +
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~--~~~~~~f~~E~~il~~l~HpNIV~l~g~~~--~-~ 104 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPT--PEQFQAFRNEVAVLRKTRHVNILLFMGYMT--K-D 104 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--S-S
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--C-C
Confidence 345678899999999999999998743 4899988654322 234567899999999999999999999873 2 3
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 57999999975 6999887543 579999999999999999999999999999999999999999999999999998664
Q ss_pred ccccCCcccccCCCCcccCccccCCC-CCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGL-PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 235 (235)
............||+.|+|||++.+. .+.++.++|||||||+|
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl 227 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVL 227 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHH
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHH
Confidence 33333344556799999999998642 23589999999999975
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=297.05 Aligned_cols=196 Identities=28% Similarity=0.311 Sum_probs=161.1
Q ss_pred EeeeceEEeeeeeccccceEEEEeec-----cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLD-----SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
+...+++++.++||+|+||+||+|.. ..+++.||+|+++... .......|.+|+.++.+++||||+++++++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 34556789999999999999999974 3467889999986543 234456799999999999999999999999
Q ss_pred EcCCCceEEEEEeccc-CCHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCe
Q psy787 108 VNDKKQKMYLIMEYCV-GGLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNL 172 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~ni 172 (235)
.....+++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+++++||||||+||
T Consensus 99 --~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NI 176 (308)
T 4gt4_A 99 --TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV 176 (308)
T ss_dssp --CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred --EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccce
Confidence 45567899999997 57999986532 24589999999999999999999999999999999999
Q ss_pred EEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 173 LLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 173 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+++.++.+||+|||+++...............+|+.|+|||.+.+ ..++.++||||||++|
T Consensus 177 Ll~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl 237 (308)
T 4gt4_A 177 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVL 237 (308)
T ss_dssp EECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred EECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC--CCCCccchhhhHHHHH
Confidence 999999999999999986643222233344568899999999987 5599999999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=299.46 Aligned_cols=192 Identities=27% Similarity=0.326 Sum_probs=157.6
Q ss_pred eceEEeeeeeccccceEEEEeecc-----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDS-----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
.++|.+.++||+|+||+||+|++. .++..||+|+++... ......|.+|+.++.+++||||+++++++ .
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~f~~E~~il~~l~HpnIV~l~g~~--~ 85 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS----DNARKDFHREAELLTNLQHEHIVKFYGVC--V 85 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC----HHHHHHHHHHHHHHTTCCCTTBCCEEEEE--C
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC----hHHHHHHHHHHHHHHhCCCCCCccEEEEE--e
Confidence 467999999999999999999754 357889999986432 23456799999999999999999999999 4
Q ss_pred CCceEEEEEeccc-CCHHHHhhcC-----------CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC
Q psy787 111 KKQKMYLIMEYCV-GGLQDMLDST-----------PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG 178 (235)
Q Consensus 111 ~~~~~~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~ 178 (235)
..+.+++||||++ |+|.+++... ....+++..+..++.|++.||.|||+++|+||||||+||+++.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 5667899999997 5799998753 235799999999999999999999999999999999999999999
Q ss_pred cEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 179 TLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+||+|||+++...............+|+.|+|||.+.+ ..++.++||||||++|
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl 220 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVL 220 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHH
Confidence 999999999985542221122223347889999999987 4599999999999974
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=304.87 Aligned_cols=196 Identities=28% Similarity=0.472 Sum_probs=165.0
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc----C
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN----D 110 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 110 (235)
..++|++++.||+|+||+||+|++..+|+.||+|+++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV--VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS--HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc--hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 346899999999999999999999999999999998654322 2334567899999999999999999998742 2
Q ss_pred CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 111 KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 111 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
..+.+|+||||++|+|.+++... +++++..+..+++||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 130 ~~~~~~ivmE~~~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 130 EFKSVYVVLDLMESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp TCCCEEEEEECCSEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred cCCEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 34678999999999999999775 6899999999999999999999999999999999999999999999999999986
Q ss_pred cCccc--cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFL--HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.... .........||+.|+|||++.+. ..++.++|||||||+|
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il 253 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIF 253 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHH
T ss_pred cccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHH
Confidence 53211 12234456799999999998763 3478999999999974
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=297.82 Aligned_cols=193 Identities=25% Similarity=0.295 Sum_probs=153.7
Q ss_pred eeceEEeeeeeccccceEEEEeecc-----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDS-----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
...++.+.++||+|+||+||+|+.. .+++.||+|+++... ....+.|.+|+.++.+++||||+++++++
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~f~~E~~il~~l~HpnIV~l~g~~-- 112 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----ESARQDFQREAELLTMLQHQHIVRFFGVC-- 112 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEE--
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCcEEEEE--
Confidence 4467999999999999999999753 467899999986432 23456799999999999999999999999
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCC-------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTP-------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT 175 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~-------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~ 175 (235)
.....+++||||+++ +|.+++.... ..++++..++.++.|++.||.|||+++|+||||||+||+++
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 556679999999975 6999887542 24689999999999999999999999999999999999999
Q ss_pred cCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 176 LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 176 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++.+||+|||+++.+.............+|+.|+|||.+.+ ..++.++|||||||+|
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl 250 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVL 250 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC--CCCCccccccchHHHH
Confidence 999999999999986543222222334568999999999988 5599999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=290.82 Aligned_cols=197 Identities=25% Similarity=0.356 Sum_probs=159.5
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccch-----hhheeeeeeeeccccCCCCccccHHHHHHHHHhcCC-CCcceeeeE
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSET-----LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH-RNVIGLVDV 106 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~ 106 (235)
+...++|++.++||+|+||+||+|.+..+ ++.||+|.++.... ......+.+|+.++..+.| |||++++++
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~---~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC---hHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 34457899999999999999999986543 35678887754432 1234568899999999976 899999999
Q ss_pred EEcCCCceEEEEEecccC-CHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q psy787 107 FVNDKKQKMYLIMEYCVG-GLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGN 171 (235)
Q Consensus 107 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~n 171 (235)
|.+ .+..+++|||||++ +|.+++.... ...+++..+..++.|++.||+|||+++++||||||+|
T Consensus 137 ~~~-~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 137 CTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp ECC-TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEe-cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 853 33468999999975 6999987532 2458899999999999999999999999999999999
Q ss_pred eEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 172 LLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 172 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+++.++.+||+|||+++.+.............+|+.|+|||.+.+ ..++.++|||||||+|
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLL 277 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc--CCCCCcccEeehHHHH
Confidence 9999999999999999986643222223334457889999999987 5599999999999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=303.43 Aligned_cols=191 Identities=24% Similarity=0.370 Sum_probs=161.4
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHH---HHHHHhcCCCCcceeeeEEEcCC
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDRE---IRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
..++|++++.||+|+||+||+|++..+|+.||+|++.+...... .....+.+| +.++..++||||+++++.| .+
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~-~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f--~~ 263 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAF--HT 263 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE--EC
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchh-hhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE--EE
Confidence 35789999999999999999999999999999999987665432 222334444 4455566899999999999 56
Q ss_pred CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...+|+||||++| +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++..
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 7789999999975 699998875 6799999999999999999999999999999999999999999999999999986
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.. ......+||+.|+|||++.+. ..++.++|||||||+|
T Consensus 342 ~~~----~~~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvil 381 (689)
T 3v5w_A 342 FSK----KKPHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCML 381 (689)
T ss_dssp CSS----CCCCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHH
T ss_pred cCC----CCCCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHH
Confidence 542 234456799999999998641 3489999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=281.15 Aligned_cols=190 Identities=26% Similarity=0.361 Sum_probs=150.5
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC--c
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK--Q 113 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~ 113 (235)
..+|.+.++||+|+||+||+|.+ +|+.||+|+++.... .......|+..+..++||||+++++++.++.. .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 35789999999999999999987 588999999864431 11223456666778899999999999975432 3
Q ss_pred eEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCeEEccCCcEEEee
Q psy787 114 KMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ--------GIIHKDIKPGNLLLTLDGTLKISD 184 (235)
Q Consensus 114 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--------~i~H~dl~p~nili~~~~~~~l~d 184 (235)
.+++||||++ |+|.+++.. .++++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 6899999997 579999876 4689999999999999999999987 899999999999999999999999
Q ss_pred eccccccCccccC--CcccccCCCCcccCccccCCCC----CCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHD--DTITTSQGSPVFQAPEIANGLP----EISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~----~~~~~~~Di~slG~~l 235 (235)
||+++........ .......||+.|+|||++.+.. ..++.++|||||||+|
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl 208 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHH
Confidence 9999865432211 1223456999999999987631 1367799999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=281.93 Aligned_cols=188 Identities=25% Similarity=0.468 Sum_probs=153.6
Q ss_pred eeeceEEeeeeeccccceEEEEeecc---chhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDS---ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVN 109 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (235)
.+.++|++.++||+|+||+||+|++. .+++.||+|.+.... ....+.+|+.++..+ .||||+++++++
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------~~~~~~~E~~~l~~~~~h~nIv~l~~~~-- 89 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------HPIRIAAELQCLTVAGGQDNVMGVKYCF-- 89 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------CHHHHHHHHHHHHHTCSBTTBCCCSEEE--
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------CHHHHHHHHHHHHHhcCCCCCceEEEEE--
Confidence 35678999999999999999999764 467899999875432 234578999999988 699999999999
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC-CcEEEeeecc
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD-GTLKISDFGV 187 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~ 187 (235)
....++|+||||+++ +|.+++. .+++..+..+++||+.||+|||++||+||||||+||+++.+ +.++|+|||+
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 556789999999974 6888873 48999999999999999999999999999999999999876 7999999999
Q ss_pred ccccCcccc--------------------------CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLH--------------------------DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~--------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+....... ........||+.|+|||++.+. ..++.++||||+||++
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il 237 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIF 237 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHH
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHH
Confidence 975432110 1112334699999999999763 2478999999999974
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=296.86 Aligned_cols=190 Identities=29% Similarity=0.542 Sum_probs=164.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++++.||+|+||+||+|++..+|+.||+|++..... .....+.+|+.+|+.++||||++++++| ....
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~ 227 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE----SDKETVRKEIQTMSVLRHPTLVNLHDAF--EDDN 227 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHHHTCCTTBCCEEEEE--ECSS
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch----hhHHHHHHHHHHHHhCCCCCCCeEEEEE--EECC
Confidence 345789999999999999999999999999999999876432 2345688999999999999999999999 5677
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC--CcEEEeeeccccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD--GTLKISDFGVAES 190 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~--~~~~l~dfg~~~~ 190 (235)
.+|++|||++| +|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+||+++.+ +.+||+|||++..
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 89999999975 6988886543 579999999999999999999999999999999999999854 7899999999986
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+. .........||+.|+|||++.+ ..++.++|||||||+|
T Consensus 307 ~~---~~~~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvil 346 (573)
T 3uto_A 307 LD---PKQSVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLS 346 (573)
T ss_dssp CC---TTSEEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHH
T ss_pred cc---CCCceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHH
Confidence 64 2334455679999999999988 4489999999999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=269.83 Aligned_cols=194 Identities=36% Similarity=0.645 Sum_probs=167.0
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
....++|++.+.||+|+||+||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++ ...
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~~ 81 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-SDMHMRVEREISYLKLLRHPHIIKLYDVI--TTP 81 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCSHHHHHHHHHHTTCCCTTBCCEEEEE--ECS
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc-hhHHHHHHHHHHHHHhCCCCCCCeEEEEE--EeC
Confidence 456789999999999999999999999999999999997654332 23445688999999999999999999999 456
Q ss_pred ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 113 QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 113 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..+++||||++|+|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred CEEEEEEECCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 689999999988899988765 679999999999999999999999999999999999999999999999999997554
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ........+++.|+|||.+.+.. ..++++||||||+++
T Consensus 160 ~---~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il 198 (336)
T 3h4j_B 160 D---GNFLKTSCGSPNYAAPEVINGKL-YAGPEVDVWSCGIVL 198 (336)
T ss_dssp T---SBTTCCCTTSTTTSCGGGSCCSG-GGCHHHHHHHHHHHH
T ss_pred C---CcccccccCCcCcCCHHHHcCCC-CCCCccchhHHHHHH
Confidence 2 22334556899999999997732 247899999999974
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=266.89 Aligned_cols=192 Identities=34% Similarity=0.602 Sum_probs=165.0
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++ ....
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~~~ 87 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN--PTSLQKLFREVRIMKILNHPNIVKLFEVI--ETEK 87 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEE--EECC
Confidence 4577999999999999999999999999999999999765432 23345678999999999999999999999 5567
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++|||++++ +|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.+++++|+|||++....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 89999999965 798888765 679999999999999999999999999999999999999999999999999997553
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........+++.|+|||.+.+.. ..++++||||||++|
T Consensus 166 ---~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il 204 (328)
T 3fe3_A 166 ---VGGKLDAFCGAPPYAAPELFQGKK-YDGPEVDVWSLGVIL 204 (328)
T ss_dssp ---SSCGGGTTSSSGGGCCHHHHHTCC-CCSHHHHHHHHHHHH
T ss_pred ---CCCccccccCCcceeCcccccCCC-cCCchhhhhhhHHHH
Confidence 223445567899999999997732 235799999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=260.00 Aligned_cols=200 Identities=30% Similarity=0.444 Sum_probs=162.7
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC-CCccccHHHHHHHHHhcC---CCCcceeeeE
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI-PNGEINVDREIRLLKMLQ---HRNVIGLVDV 106 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~ 106 (235)
++....++|++++.||+|+||+||++++..+++.||+|++........ ......+.+|+..++.++ ||||++++++
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 455667899999999999999999999999999999999976553322 222345677887777664 9999999999
Q ss_pred EEcCCC---ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEe
Q psy787 107 FVNDKK---QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKIS 183 (235)
Q Consensus 107 ~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~ 183 (235)
+..... ..++++||+++++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp EEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred eeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 864332 25799999999999999988766669999999999999999999999999999999999999999999999
Q ss_pred eeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|||++..... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 209 (308)
T 3g33_A 163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIF 209 (308)
T ss_dssp SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHH
T ss_pred eCccccccCC---CcccCCccccccccCchHHcC--CCCCchHHHHHHHHHH
Confidence 9999986542 223344568999999999977 4489999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=260.80 Aligned_cols=191 Identities=30% Similarity=0.532 Sum_probs=163.5
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||+|+||+||+|.+..+++.+|+|++...... ......+.+|+.++..++||||+++++++ .....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS--TTHHHHHHHHHHHHTTCCCTTBCCEEEEE--EETTEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc--CCcchHHHHHHHHHhcCCCCCEeeEEeEE--EeCCEEE
Confidence 6899999999999999999999999999999999765432 23345678999999999999999999999 4566899
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+|||++++++.+.+.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... .
T Consensus 78 lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 154 (292)
T 3o0g_A 78 LVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--P 154 (292)
T ss_dssp EEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--C
T ss_pred EEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--c
Confidence 999999999888776643 6799999999999999999999999999999999999999999999999999986542 1
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 192 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIF 192 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHH
T ss_pred cccccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHH
Confidence 2223345578899999998762 2378999999999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=264.66 Aligned_cols=191 Identities=31% Similarity=0.475 Sum_probs=164.0
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++++.||+|+||+||++++..+++.+|+|++++..... ......+.+|+.++..++||||+++++.+ .....+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~--~~~~~~ 80 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAF--QTHDRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEE--ECSSEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhCCCCcCcceEEEE--EeCCEE
Confidence 468999999999999999999999999999999998764332 23445678999999999999999999999 556689
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++||||+++ +|..++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 157 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS- 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc-
Confidence 999999975 688888765 6789999999999999999999999999999999999999999999999999975321
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 158 -~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 195 (337)
T 1o6l_A 158 -DGATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVM 195 (337)
T ss_dssp -TTCCBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHH
T ss_pred -CCCcccccccChhhCChhhhcC--CCCCchhhcccchhHH
Confidence 1223345568999999999987 4589999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=262.47 Aligned_cols=198 Identities=30% Similarity=0.444 Sum_probs=163.8
Q ss_pred ceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 30 TIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 30 ~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
.++..+.++|++++.||+|+||.||++++..+++.+|+|++....... ......+.+|+..+..++||||+++++++
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-- 80 (294)
T 4eqm_A 4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK-EETLKRFEREVHNSSQLSHQNIVSMIDVD-- 80 (294)
T ss_dssp CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCBTTBCCEEEEE--
T ss_pred chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcccc-HHHHHHHHHHHHHHhcCCCCCCceEEEee--
Confidence 456677889999999999999999999999999999999986554322 23345688999999999999999999999
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
.....+++|||++++ +|.+++... .++++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA 158 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence 566789999999975 799988765 57999999999999999999999999999999999999999999999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...... .........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 159 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l 202 (294)
T 4eqm_A 159 KALSET-SLTQTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVL 202 (294)
T ss_dssp TTC--------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHH
T ss_pred cccccc-cccccCccccCccccCHhHhcC--CCCCchHhHHHHHHHH
Confidence 865421 1122233458999999999987 4488999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=267.83 Aligned_cols=193 Identities=30% Similarity=0.481 Sum_probs=164.4
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (235)
...++|++++.||+|+||+||++++..+++.+|+|++++..... ......+..|..++.++ +||||+++++++ ...
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~-~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~--~~~ 125 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCF--QTE 125 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEE--ECS
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-HHHHHHHHHHHHHHHhcCCCCCcCeeEEEE--EEC
Confidence 34578999999999999999999999999999999998765543 34455678899999877 899999999999 556
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+++||||+++ +|..++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 789999999976 688888765 67999999999999999999999999999999999999999999999999999753
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .........+|+.|+|||++.+ ..++.++||||||++|
T Consensus 204 ~~--~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvll 243 (396)
T 4dc2_A 204 LR--PGDTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLM 243 (396)
T ss_dssp CC--TTCCBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred cc--CCCccccccCCcccCCchhhcC--CCCChHHHHHHHHHHH
Confidence 21 2233445678999999999988 4589999999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=267.26 Aligned_cols=194 Identities=30% Similarity=0.488 Sum_probs=166.8
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++++.||+|+||+||++++..+++.+|+|++.+..... ......+.+|+.++..++||||+++++++ ....
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~~~ 88 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLWYSF--QDEE 88 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc-HHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EeCC
Confidence 34678999999999999999999999999999999997765433 23445688999999999999999999999 5566
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++|||++.| +|..++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 89999999965 688888765 679999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCcccccCCCCcccCccccCCCC-CCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLP-EISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~slG~~l 235 (235)
.........+++.|+|||.+.+.. ..++.++||||||++|
T Consensus 167 ---~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il 207 (384)
T 4fr4_A 167 ---RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTA 207 (384)
T ss_dssp ---TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHH
T ss_pred ---CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHH
Confidence 223344567999999999986532 3478999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=260.19 Aligned_cols=197 Identities=31% Similarity=0.472 Sum_probs=163.0
Q ss_pred ceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 30 TIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 30 ~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
...+.+.++|++++.||+|+||+||+|.+. +++.+|+|++...... ......+.+|+.+++.++||||+++++++
T Consensus 14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-- 88 (311)
T 3niz_A 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED--EGIPSTAIREISLLKELHHPNIVSLIDVI-- 88 (311)
T ss_dssp -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccccc--chhhHHHHHHHHHHHHcCCCCEeeeeeEE--
Confidence 356678899999999999999999999985 5899999998655322 23345688999999999999999999999
Q ss_pred CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 110 DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
.....+++|||+++++|.+.+.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 89 HSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp CCSSCEEEEEECCSEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCCEEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence 5667899999999999888887653 568999999999999999999999999999999999999999999999999998
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... .........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 168 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 210 (311)
T 3niz_A 168 AFGI--PVRSYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIF 210 (311)
T ss_dssp ETTS--CCC---CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHH
T ss_pred ecCC--CcccccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHH
Confidence 6542 12223344578999999998762 3478999999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=264.53 Aligned_cols=193 Identities=33% Similarity=0.554 Sum_probs=165.8
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC--CccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP--NGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
.+.++|++.+.||+|+||+||++.+..+|+.+|+|+++........ .....+.+|+.++..++||||+++++++ ..
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~--~~ 86 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY--EN 86 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE--EC
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE--Ee
Confidence 4567899999999999999999999999999999999876644322 1345688999999999999999999999 55
Q ss_pred CceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC----cEEEeeec
Q psy787 112 KQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG----TLKISDFG 186 (235)
Q Consensus 112 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~----~~~l~dfg 186 (235)
...+++|||+++ ++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 678999999996 5799988765 6799999999999999999999999999999999999998777 79999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++..... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 165 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil 208 (361)
T 2yab_A 165 LAHEIED---GVEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVIT 208 (361)
T ss_dssp SCEECCT---TCCCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred CceEcCC---CCccccCCCCccEECchHHcC--CCCCccccHHHHHHHH
Confidence 9986542 223345568999999999987 4489999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=260.78 Aligned_cols=188 Identities=31% Similarity=0.515 Sum_probs=163.8
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++++.||+|+||+||++++..+|+.+|+|++++..... ......+.+|..++..++||||+++++.+ .....+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~~ 81 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTF--QDAQQI 81 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEE--ECSSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEE--EeCCEE
Confidence 468999999999999999999999999999999998764432 23445678899999999999999999999 556689
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++||||+++ +|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 999999975 799988875 6789999999999999999999999999999999999999999999999999975532
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 193 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILI 193 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHH
T ss_pred ----ccccccCCccccCHhHhcC--CCCCcccchhhhHHHH
Confidence 2334568999999999987 4589999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=266.87 Aligned_cols=193 Identities=31% Similarity=0.459 Sum_probs=159.2
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (235)
...++|++++.||+|+||+||++++..+++.||+|++++..... ......+..|..++..+ .||||+++++++ ...
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~--~~~ 96 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLFCCF--QTP 96 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-HTTHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcc-hhHHHHHHHHHHHHHhccCCCceeeEEEEE--EeC
Confidence 34578999999999999999999999999999999998754332 23345577899999988 699999999999 556
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+|+||||++| +|..++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 689999999975 688888765 67999999999999999999999999999999999999999999999999999743
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 175 ~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 214 (353)
T 3txo_A 175 IC--NGVTTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLL 214 (353)
T ss_dssp CC-----------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHH
T ss_pred cc--CCccccccCCCcCeEChhhcCC--CCcCCccCCCcchHHH
Confidence 21 2223345568999999999977 4489999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=261.71 Aligned_cols=202 Identities=76% Similarity=1.207 Sum_probs=169.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
++.++|++.+.||+|+||.||++.+..+++.+++|+++.............+.+|+.++..++|+||+++++++......
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 35689999999999999999999999999999999998765443344556789999999999999999999998766667
Q ss_pred eEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 114 KMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 114 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.+++|||++++++.+++.......+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999998888888877667899999999999999999999999999999999999999999999999999986643
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...........+++.|+|||.+.+....++.++||||||+++
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 203 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHH
Confidence 333333445568899999999976444457899999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=257.75 Aligned_cols=188 Identities=29% Similarity=0.499 Sum_probs=162.0
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++++.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+. ....
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~ 91 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYL--VGDE 91 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc----cHHHHHHHHHHHHhcCCCCCCCeEeEEEE--ECCE
Confidence 45689999999999999999999999999999999875542 33456889999999999999999999994 4567
Q ss_pred EEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+++||||++ ++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 899999996 568888876 4589999999999999999999999999999999999999999999999999876542
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 169 --~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 206 (297)
T 3fxz_A 169 --EQSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMA 206 (297)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHH
T ss_pred --cccccCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHH
Confidence 1223334568999999999987 4489999999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=261.91 Aligned_cols=192 Identities=30% Similarity=0.488 Sum_probs=164.0
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCc
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (235)
..++|++++.||+|+||+||++++..+++.+|+|++++..... ......+.+|..++..+ +||||+++++++ ....
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~--~~~~ 83 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCF--QTES 83 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECSS
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc-hHHHHHHHHHHHHHHhcCCCCccCeEEEEE--EeCC
Confidence 3578999999999999999999999999999999998765432 23344578899999887 899999999999 5566
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++||||+++ +|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 89999999965 688888765 579999999999999999999999999999999999999999999999999997532
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. .........+++.|+|||.+.+ ..++.++||||||++|
T Consensus 162 ~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 200 (345)
T 3a8x_A 162 R--PGDTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLM 200 (345)
T ss_dssp C--TTCCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred C--CCCcccccCCCccccCccccCC--CCCChHHhHHHHHHHH
Confidence 1 1223345568999999999987 4589999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=262.11 Aligned_cols=193 Identities=33% Similarity=0.498 Sum_probs=163.4
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (235)
...++|++.+.||+|+||+||+|++..+++.||+|++++..... ......+..|..++..+ +||||+++++.+ ...
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~--~~~ 90 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTF--QTK 90 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEE--ECS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEE--EeC
Confidence 35678999999999999999999999999999999998764332 23344577888888876 899999999999 556
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+++||||++| +|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 689999999965 698888765 57899999999999999999999999999999999999999999999999999754
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 169 ~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 208 (345)
T 1xjd_A 169 ML--GDAKTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLL 208 (345)
T ss_dssp CC--TTCCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred cc--CCCcccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHH
Confidence 21 1223445668999999999987 4489999999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=268.68 Aligned_cols=194 Identities=27% Similarity=0.449 Sum_probs=163.8
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++++.||+|+||+||++++..+++.+|+|++++..... ......+.+|+.++..++||||+++++++ .....
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~~~~ 143 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAF--QDDRY 143 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEE--ECSSE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EECCE
Confidence 4568999999999999999999999999999999997754433 23445688999999999999999999999 55678
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+|+||||++| +|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 9999999965 68888865 4689999999999999999999999999999999999999999999999999976542
Q ss_pred cccCCcccccCCCCcccCccccCCCCC--CCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPE--ISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~~Di~slG~~l 235 (235)
. .........+++.|+|||.+.+.+. .++.++||||||++|
T Consensus 221 ~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvil 263 (410)
T 3v8s_A 221 E-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263 (410)
T ss_dssp T-SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHH
T ss_pred C-CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHH
Confidence 1 1112335679999999999876322 277899999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=257.49 Aligned_cols=193 Identities=35% Similarity=0.576 Sum_probs=165.2
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCC--ccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN--GEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
...++|.+.+.||+|+||.||++.+..+++.+|+|++.......... ....+.+|+.++..++||||+++++++ ..
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~ 85 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY--EN 85 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE--EC
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE--Ee
Confidence 34578999999999999999999999999999999998765443221 345688999999999999999999999 45
Q ss_pred CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC----cEEEeeec
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG----TLKISDFG 186 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~----~~~l~dfg 186 (235)
...+++|||++++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 6689999999964 799988765 6799999999999999999999999999999999999999887 79999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++..... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 164 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 207 (326)
T 2y0a_A 164 LAHKIDF---GNEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVIT 207 (326)
T ss_dssp TCEECCT---TSCCCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred CCeECCC---CCccccccCCcCcCCceeecC--CCCCcHHHHHHHHHHH
Confidence 9986542 223334568999999999987 4589999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=261.23 Aligned_cols=193 Identities=36% Similarity=0.573 Sum_probs=161.2
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++++.||+|+||+||++.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++ .....
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~~~ 79 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHR--REGNI 79 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEE--ECSSE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc---chHHHHHHHHHHHHhCCCCCCCeEEEEE--ecCCe
Confidence 457999999999999999999999999999999998755432 2335688999999999999999999999 55668
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.++||||+++ +|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 8999999976 688888655 5699999999999999999999999999999999999999999999999999976543
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...........+++.|+|||.+.+. ...+.++||||||++|
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il 198 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVL 198 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHH
T ss_pred CCcccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHH
Confidence 2222333455689999999998762 2247789999999974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=268.97 Aligned_cols=196 Identities=24% Similarity=0.405 Sum_probs=164.2
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|+++++||+|+||+||++++..+++.+|+|++++..... ......+.+|..++..++||||+++++.+ .....
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~--~~~~~ 148 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAF--QDDNN 148 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEE--ECSSE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE--eeCCE
Confidence 3468999999999999999999999999999999998754433 23344588999999999999999999999 55678
Q ss_pred EEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+++||||++ |+|.+++.... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 999999996 46988887632 6799999999999999999999999999999999999999999999999999975532
Q ss_pred cccCCcccccCCCCcccCccccCC---CCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANG---LPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~~Di~slG~~l 235 (235)
. .........+++.|+|||++.. ....++.++||||||++|
T Consensus 228 ~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil 271 (437)
T 4aw2_A 228 D-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271 (437)
T ss_dssp T-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHH
T ss_pred C-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHH
Confidence 1 1122234568999999999861 124588999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=270.10 Aligned_cols=204 Identities=27% Similarity=0.430 Sum_probs=165.8
Q ss_pred cCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeE
Q psy787 27 DNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDV 106 (235)
Q Consensus 27 ~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 106 (235)
.+......+.++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.++|+||++++++
T Consensus 16 ~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 93 (432)
T 3n9x_A 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED--LIDCKRILREITILNRLKSDYIIRLYDL 93 (432)
T ss_dssp TTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS--HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC--hHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 33444455678999999999999999999999999999999998654221 2334568899999999999999999999
Q ss_pred EEcCCC---ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEe
Q psy787 107 FVNDKK---QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKIS 183 (235)
Q Consensus 107 ~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~ 183 (235)
+..... ..+|+|||+++++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~ 171 (432)
T 3n9x_A 94 IIPDDLLKFDELYIVLEIADSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVC 171 (432)
T ss_dssp CCCSCTTTCCCEEEEEECCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EecCCCCcCCeEEEEEecCCcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEc
Confidence 854321 568999999999999998765 679999999999999999999999999999999999999999999999
Q ss_pred eeccccccCccccC--------------------CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 184 DFGVAESLDMFLHD--------------------DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 184 dfg~~~~~~~~~~~--------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|||++......... .......+++.|+|||.+... ..++.++|||||||+|
T Consensus 172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il 242 (432)
T 3n9x_A 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIF 242 (432)
T ss_dssp CCTTCEEC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHH
T ss_pred cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHH
Confidence 99999866422111 123455689999999986431 4589999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=263.81 Aligned_cols=191 Identities=29% Similarity=0.439 Sum_probs=165.8
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
....++|++++.||+|+||+||++++..+++.+|+|++.+..... ......+.+|+.++..++||||+++++.+ ...
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~ 113 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSF--KDN 113 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECS
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc-HHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EcC
Confidence 445689999999999999999999999999999999997765433 23445678999999999999999999999 456
Q ss_pred ceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+++||||++ ++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceec
Confidence 68999999996 5798888765 56999999999999999999999999999999999999999999999999999855
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ......+++.|+|||.+.+ ..++.++||||||++|
T Consensus 192 ~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 228 (350)
T 1rdq_E 192 KG-----RTWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLI 228 (350)
T ss_dssp SS-----CBCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred cC-----CcccccCCccccCHHHhcC--CCCCCcCCEecccHhH
Confidence 32 2234568999999999987 4589999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=268.59 Aligned_cols=201 Identities=27% Similarity=0.363 Sum_probs=169.5
Q ss_pred ceeecCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC------
Q psy787 23 QVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ------ 96 (235)
Q Consensus 23 ~~~~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~------ 96 (235)
..-+.+..++..+.++|+++++||+|+||+||+|++..+++.||+|++.... .....+.+|+.+++.++
T Consensus 23 ~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~ 97 (397)
T 1wak_A 23 KGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-----HYTETALDEIRLLKSVRNSDPND 97 (397)
T ss_dssp C--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHSCTTC
T ss_pred CCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-----cchHHHHHHHHHHHHHhhcCCCC
Confidence 3346677888888999999999999999999999999999999999986432 23346788999999886
Q ss_pred --CCCcceeeeEEEcC--CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCC
Q psy787 97 --HRNVIGLVDVFVND--KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGN 171 (235)
Q Consensus 97 --h~~i~~~~~~~~~~--~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~n 171 (235)
|+||+++++.+... ....+++|||++++++.+.+.......+++..++.++.||+.||.|||++ |++||||||+|
T Consensus 98 ~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N 177 (397)
T 1wak_A 98 PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177 (397)
T ss_dssp GGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred CCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 77899999988521 45678999999999988888877667799999999999999999999998 99999999999
Q ss_pred eEEccCC-------------------------------------------------cEEEeeeccccccCccccCCcccc
Q psy787 172 LLLTLDG-------------------------------------------------TLKISDFGVAESLDMFLHDDTITT 202 (235)
Q Consensus 172 ili~~~~-------------------------------------------------~~~l~dfg~~~~~~~~~~~~~~~~ 202 (235)
|+++.++ .++|+|||++..... ....
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~ 252 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTE 252 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCS
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCcc
Confidence 9999775 799999999975542 2334
Q ss_pred cCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 203 SQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 203 ~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..+++.|+|||++.+ ..++.++||||||++|
T Consensus 253 ~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 283 (397)
T 1wak_A 253 DIQTRQYRSLEVLIG--SGYNTPADIWSTACMA 283 (397)
T ss_dssp CCSCGGGCCHHHHHT--SCCCTHHHHHHHHHHH
T ss_pred CCCCCcccCChhhcC--CCCCcHHHHHHHHHHH
Confidence 468899999999987 4489999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=268.29 Aligned_cols=197 Identities=29% Similarity=0.475 Sum_probs=155.6
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDK 111 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 111 (235)
....++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.++..+. |+||+++++++..++
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC--hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 34567999999999999999999999999999999988644222 233456779999999997 999999999997666
Q ss_pred CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 112 KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 112 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
...+|+|||+++++|..++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+
T Consensus 83 ~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 83 DRDVYLVFDYMETDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp SSCEEEEEECCSEEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred CCEEEEEecccCcCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 668999999999999988876 46899999999999999999999999999999999999999999999999999755
Q ss_pred Cccc-------------------cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFL-------------------HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... .........+++.|+|||.+.+. ..++.++|||||||+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il 221 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCIL 221 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHH
Confidence 3210 11122334688999999998762 3488999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=272.38 Aligned_cols=197 Identities=26% Similarity=0.455 Sum_probs=152.6
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC--
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK-- 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (235)
...++|++++.||+|+||+||+|++..+++.||+|++...... ......+.+|+.++..++|+||+++++++....
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED--LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS--HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC--HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence 4557899999999999999999999999999999988643221 233456889999999999999999999985432
Q ss_pred -CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 -KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 -~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...+|+|||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 128 ~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 128 KFDELYVVLEIADSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp TCCCEEEEECCCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred cCceEEEEEeccccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 2578999999999999988765 6799999999999999999999999999999999999999999999999999986
Q ss_pred cCccccC-------------------------CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHD-------------------------DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~-------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....... .......+|+.|+|||++... ..++.++|||||||+|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il 274 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIF 274 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHH
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHH
Confidence 6422111 122334578899999986431 4589999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=267.62 Aligned_cols=192 Identities=27% Similarity=0.492 Sum_probs=162.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|+||+||++.+..+|+.+|+|++....... .....+.+|+.+++.++||||+++++++ ...+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~--~~~~ 83 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA--RDHQKLEREARICRLLKHPNIVRLHDSI--SEEG 83 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH--HHHHHHHHHHHHHHHCCBTTBCCEEEEE--ECSS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCcCCCeEEEEE--EECC
Confidence 45678999999999999999999999999999999987655332 3345688999999999999999999999 5667
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc---CCcEEEeeecccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL---DGTLKISDFGVAE 189 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~---~~~~~l~dfg~~~ 189 (235)
.+++|||++.+ +|.+.+... ..+++..+..++.|++.||.|||++|++||||||+||+++. ++.++|+|||++.
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 89999999975 698888876 67999999999999999999999999999999999999984 5789999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... .........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 162 ~~~~--~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvil 203 (444)
T 3soa_A 162 EVEG--EQQAWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVIL 203 (444)
T ss_dssp CCCT--TCCBCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred EecC--CCceeecccCCcccCCHHHhcC--CCCCCccccHHHHHHH
Confidence 6542 1222334568999999999987 4589999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=261.26 Aligned_cols=192 Identities=30% Similarity=0.522 Sum_probs=163.6
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
....++|++.+.||+|+||.||++.+..+++.+|+|++...... ......+.+|+.++..++||||+++++++ ...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~ 100 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSI--QEE 100 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE--ECS
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EeC
Confidence 34567899999999999999999999999999999999765432 23345688999999999999999999999 556
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC---cEEEeeeccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG---TLKISDFGVA 188 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~---~~~l~dfg~~ 188 (235)
...++|||++.+ +|.+.+... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 688999999975 688888765 6789999999999999999999999999999999999998654 5999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 179 ~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 220 (362)
T 2bdw_A 179 IEVND---SEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVIL 220 (362)
T ss_dssp BCCTT---CCSCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred eEecC---CcccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHH
Confidence 86542 222334568999999999987 4589999999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=259.22 Aligned_cols=200 Identities=29% Similarity=0.405 Sum_probs=162.2
Q ss_pred eecCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCccee
Q psy787 25 IYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGL 103 (235)
Q Consensus 25 ~~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 103 (235)
.+++...+....++|+++++||+|+||+||+|++..+++.||+|++...... .........|+..+..+ +|+||+++
T Consensus 45 ~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~~~~~~~h~~iv~l 122 (311)
T 3p1a_A 45 GYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG--PKDRARKLAEVGSHEKVGQHPCCVRL 122 (311)
T ss_dssp TCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS--HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC--hHHHHHHHHHHHHHHHhcCCCcEEEE
Confidence 3455556666678999999999999999999999999999999987544322 12233445566555555 89999999
Q ss_pred eeEEEcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEe
Q psy787 104 VDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKIS 183 (235)
Q Consensus 104 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~ 183 (235)
++++ ...+.+++|||+++++|.+.+.... ..+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+
T Consensus 123 ~~~~--~~~~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~ 199 (311)
T 3p1a_A 123 EQAW--EEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLG 199 (311)
T ss_dssp EEEE--EETTEEEEEEECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEEC
T ss_pred EEEE--EeCCEEEEEEeccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEc
Confidence 9999 4567899999999999888887653 569999999999999999999999999999999999999999999999
Q ss_pred eeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|||++..... ........+++.|+|||.+.+ .++.++||||||++|
T Consensus 200 DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il 245 (311)
T 3p1a_A 200 DFGLLVELGT---AGAGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTI 245 (311)
T ss_dssp CCTTCEECC---------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHH
T ss_pred cceeeeeccc---CCCCcccCCCccccCHhHhcC---CCCchhhHHHHHHHH
Confidence 9999876542 223334558999999999875 378999999999974
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=269.84 Aligned_cols=192 Identities=31% Similarity=0.457 Sum_probs=159.1
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC-
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK- 111 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 111 (235)
....++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++....
T Consensus 58 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 58 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135 (464)
T ss_dssp EEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred eeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccC--hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence 35678999999999999999999999999999999998765322 233456789999999999999999999995322
Q ss_pred ---CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 112 ---KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 112 ---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
...+|+||||+++++.+.+.. .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++
T Consensus 136 ~~~~~~~~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp TTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred cccCCeEEEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 246899999999998887753 4899999999999999999999999999999999999999999999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... ........+++.|+|||.+.+ ..++.++||||||++|
T Consensus 212 ~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il 253 (464)
T 3ttj_A 212 RTAGT---SFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIM 253 (464)
T ss_dssp --------CCCC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHH
T ss_pred eecCC---CcccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHH
Confidence 86542 223344568999999999988 4589999999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=258.11 Aligned_cols=194 Identities=29% Similarity=0.416 Sum_probs=152.7
Q ss_pred eeeceEEeeeeeccccceEEEEeecc---chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDS---ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
...++|++.+.||+|+||+||++++. .+++.+|+|+++.............+.+|+.++..++||||+++++++ .
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~ 91 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF--Q 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE--E
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE--E
Confidence 34578999999999999999999874 688999999998765443334455678899999999999999999999 4
Q ss_pred CCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
..+.+++|||++++ +|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 56689999999975 688888765 568999999999999999999999999999999999999999999999999987
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... .........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 170 ~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 211 (327)
T 3a62_A 170 ESIH--DGTVTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALM 211 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHH
T ss_pred cccc--CCccccccCCCcCccCHhhCcC--CCCCCcccchhHHHHH
Confidence 4421 1122334568999999999987 4489999999999974
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=258.02 Aligned_cols=193 Identities=30% Similarity=0.488 Sum_probs=149.3
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++++.||+|+||+||++.+..+++.||+|+++.... ......+.+|+.+++.++||||+++++++ ...+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~ 77 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVI--HTENK 77 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTTBCCEEEEE--CCTTE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCCcceEEEEE--EECCe
Confidence 35689999999999999999999999999999999875542 23445688999999999999999999999 56678
Q ss_pred EEEEEecccCCHHHHhhcCC----CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 115 MYLIMEYCVGGLQDMLDSTP----YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 115 ~~lv~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
+++|||+++++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99999999999888876432 24589999999999999999999999999999999999999999999999999986
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 158 ~~~~--~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 199 (317)
T 2pmi_A 158 FGIP--VNTFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCIL 199 (317)
T ss_dssp TTSC--CCCCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHH
T ss_pred cCCC--cccCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHH
Confidence 5421 1223344678999999998762 2478999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=255.64 Aligned_cols=190 Identities=32% Similarity=0.505 Sum_probs=157.8
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||+|+||+||+|++ .+++.+|+|++...... ......+.+|+.+++.++||||+++++++ .....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~ 76 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYDVI--HTKKRLV 76 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG--GCCCHHHHHHHHGGGGCCCTTBCCEEEEE--ECSSCEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc--cccchhHHHHHHHHHhcCCCCEeeeeeEE--ccCCeEE
Confidence 5899999999999999999998 67899999998655432 23345678999999999999999999999 4556889
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+|||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 77 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 153 (288)
T 1ob3_A 77 LVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-- 153 (288)
T ss_dssp EEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--
Confidence 999999999988887643 56899999999999999999999999999999999999999999999999999755321
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 191 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIF 191 (288)
T ss_dssp --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHH
T ss_pred ccccccccccccccCchheeCC-CCCCcHHHHHHHHHHH
Confidence 1222334578999999998752 3478999999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=253.35 Aligned_cols=197 Identities=39% Similarity=0.621 Sum_probs=158.1
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC----------------------CCccccHHHHHHH
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI----------------------PNGEINVDREIRL 91 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~----------------------~~~~~~~~~e~~~ 91 (235)
...++|++.+.||+|+||.||+|.+..+++.||+|++........ ......+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 456899999999999999999999999999999999976543221 1123568899999
Q ss_pred HHhcCCCCcceeeeEEEcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q psy787 92 LKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPG 170 (235)
Q Consensus 92 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~ 170 (235)
++.++||||+++++++.......+++|||++++ +|.++.. ...+++..++.++.|++.||.|||+.|++|+||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999999999999999975556789999999976 4655433 257999999999999999999999999999999999
Q ss_pred CeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCC-CCCcccEEEeeeeC
Q psy787 171 NLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEI-SGYKVDIWSSGVTL 235 (235)
Q Consensus 171 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~~~Di~slG~~l 235 (235)
||+++.++.++|+|||++...... ........+++.|+|||.+.+.... .+.++||||||+++
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l 230 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHH
T ss_pred HEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHH
Confidence 999999999999999999865421 1223345689999999999764322 47789999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=261.10 Aligned_cols=193 Identities=31% Similarity=0.414 Sum_probs=163.7
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (235)
...++|++++.||+|+||+||++++..+++.||+|++++..... ......+..|..++..+ .||+|+++++.+ ...
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~--~~~ 93 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTM 93 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEE--ECS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEE--EcC
Confidence 34678999999999999999999999999999999998765433 23445677899998877 799999999999 556
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+|+||||++| +|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 689999999975 698888765 56999999999999999999999999999999999999999999999999999753
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 172 ~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 211 (353)
T 2i0e_A 172 IW--DGVTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLL 211 (353)
T ss_dssp CC--TTCCBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHH
T ss_pred cc--CCcccccccCCccccChhhhcC--CCcCCcccccchHHHH
Confidence 21 1223445668999999999987 4489999999999974
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=255.52 Aligned_cols=193 Identities=27% Similarity=0.468 Sum_probs=161.6
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|+||+||++.+..+++.+++|++.... ......+.+|+.++..++||||+++++++. ...
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~ 80 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD----EETQRTFLKEVKVMRCLEHPNVLKFIGVLY--KDK 80 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--ETT
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCcCcccEEEEEe--cCC
Confidence 34578999999999999999999999999999999874422 234456889999999999999999999994 456
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..++|||++++ +|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred eeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 88999999975 7998887643 678999999999999999999999999999999999999999999999999998653
Q ss_pred ccccCC------------cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDD------------TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...... ......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l 212 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVL 212 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHH
Confidence 221111 0113458899999999987 4589999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=255.70 Aligned_cols=197 Identities=27% Similarity=0.451 Sum_probs=164.2
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
....++|++.+.||+|+||+||++.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 45567899999999999999999999999999999998754432 234567899999999999999999999976666
Q ss_pred ceEEEEEeccc-CCHHHHhhcCCC-CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE----ccCCcEEEeeec
Q psy787 113 QKMYLIMEYCV-GGLQDMLDSTPY-KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL----TLDGTLKISDFG 186 (235)
Q Consensus 113 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili----~~~~~~~l~dfg 186 (235)
..+++|||+++ ++|.+++..... ..+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 68899999997 578888876532 348999999999999999999999999999999999999 667789999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCC------CCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGL------PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~~Di~slG~~l 235 (235)
++..... ........+++.|+|||.+... ...++.++||||||+++
T Consensus 162 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 213 (319)
T 4euu_A 162 AARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (319)
T ss_dssp TCEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHH
T ss_pred CceecCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHH
Confidence 9986542 2233345688999999987511 14588999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=258.48 Aligned_cols=188 Identities=27% Similarity=0.524 Sum_probs=161.7
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
+.++|++.+.||+|+||+||++.+..+++.+|+|++.... .....+.+|+.++..++||||+++++++ .....
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~~~ 75 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESF--ESMEE 75 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEE--EETTE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-----ccHHHHHHHHHHHHhCCCCCCCeEeEEE--ecCCE
Confidence 4578999999999999999999999999999999886432 3344678999999999999999999999 45668
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc--CCcEEEeeecccccc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL--DGTLKISDFGVAESL 191 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~~~~ 191 (235)
++++||++++ +|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++. ++.++|+|||++..+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999999975 6988886542 46899999999999999999999999999999999999987 789999999999865
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 155 ~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 193 (321)
T 1tki_A 155 KP---GDNFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLV 193 (321)
T ss_dssp CT---TCEEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHH
T ss_pred CC---CCccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHH
Confidence 42 223344568899999999987 4488999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=261.21 Aligned_cols=196 Identities=24% Similarity=0.343 Sum_probs=167.1
Q ss_pred ecCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-----CCCc
Q psy787 26 YDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-----HRNV 100 (235)
Q Consensus 26 ~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i 100 (235)
......+..+.++|+++++||+|+||+||+|++..+++.||+|+++... .....+..|+.++..+. |+||
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-----KYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-----HHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-----hhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 3345556677889999999999999999999999999999999986422 22345678999999986 9999
Q ss_pred ceeeeEEEcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc----
Q psy787 101 IGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL---- 176 (235)
Q Consensus 101 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~---- 176 (235)
+++++.+. ....+++|||+++++|.+++.......++...++.++.|++.||.|||+.|++||||||+||+++.
T Consensus 99 v~~~~~~~--~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 99 VKYHGKFM--YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp CCEEEEEE--ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred ecccceee--ECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence 99999994 456899999999888999998876677999999999999999999999999999999999999975
Q ss_pred ---------------------CCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 177 ---------------------DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 177 ---------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++.++|+|||++..... ......+++.|+|||.+.+ ..++.++||||||++|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 249 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILN--LGWDVSSDMWSFGCVL 249 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcC--CCCCCccchHHHHHHH
Confidence 78899999999975432 2234568899999999988 4489999999999974
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=262.16 Aligned_cols=198 Identities=18% Similarity=0.248 Sum_probs=166.1
Q ss_pred eeeceEEeeeeeccc--cceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 34 KMIGKYVMGDLLGEG--SYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g--~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
...++|++++.||+| +||+||++++..+++.||+|++...... ......+.+|+.+++.++||||+++++++. .
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~ 97 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS--NEMVTFLQGELHVSKLFNHPNIVPYRATFI--A 97 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--E
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC--hHHHHHHHHHHHHHHhCCCCCCCcEeEEEE--E
Confidence 345789999999999 9999999999999999999999765432 234456788999999999999999999994 5
Q ss_pred CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
.+.+++|||++++ +|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 5689999999975 699998877667799999999999999999999999999999999999999999999999998864
Q ss_pred cCcccc-----CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLH-----DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...... ........++..|+|||.+.+....++.++||||||+++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il 227 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 227 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHH
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHH
Confidence 421111 111223357888999999987444589999999999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=258.00 Aligned_cols=198 Identities=28% Similarity=0.526 Sum_probs=164.8
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC--
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK-- 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (235)
...++|++++.||+|+||+||+|++..+++.||+|++...... ......+.+|+.++..++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS--SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc--ccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 3568999999999999999999999999999999988665432 234456789999999999999999999986432
Q ss_pred ----CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 112 ----KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 112 ----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
.+.+++|||++++++.+.+.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+
T Consensus 92 ~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -----CEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccCCceEEEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 45789999999999888877654 5699999999999999999999999999999999999999999999999999
Q ss_pred ccccCccc--cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFL--HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+..+.... .........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il 219 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIM 219 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHH
T ss_pred cccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHH
Confidence 97653211 12223345578999999998762 3478999999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=265.49 Aligned_cols=196 Identities=26% Similarity=0.403 Sum_probs=163.6
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++++.||+|+||+||++++..+++.||+|++++..... ......+.+|..++..++|+||+++++.+ .....
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~--~~~~~ 135 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK-RGEVSCFREERDVLVNGDRRWITQLHFAF--QDENY 135 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-HGGGCCHHHHHHHHHHSCTTTBCCEEEEE--ECSSE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-HHHHHHHHHHHHHHHhcCCCCeeeEEEEE--eeCCE
Confidence 4578999999999999999999999999999999997644322 23345688999999999999999999999 55678
Q ss_pred EEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+|+||||++ |+|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+++++|+|||++.....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 999999996 57988887542 4689999999999999999999999999999999999999999999999999986542
Q ss_pred cccCCcccccCCCCcccCccccCCC-----CCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGL-----PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~~Di~slG~~l 235 (235)
. .........+++.|+|||.+... ...++.++||||||+++
T Consensus 215 ~-~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvil 260 (412)
T 2vd5_A 215 D-GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260 (412)
T ss_dssp T-SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHH
T ss_pred C-CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHH
Confidence 1 11122345689999999998621 13478999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=271.88 Aligned_cols=194 Identities=28% Similarity=0.414 Sum_probs=167.3
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|+||.||++++..+|+.||+|++.+..... ......+.+|+.++..++||||+++++.+ ....
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~--~~~~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAY--ETKD 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEE--eeCC
Confidence 34578999999999999999999999999999999997765433 23445678999999999999999999999 5566
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++||||++| +|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 89999999965 69888887655669999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ........+++.|+|||.+.+ ..++.++||||||++|
T Consensus 338 ~---~~~~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvil 375 (576)
T 2acx_A 338 E---GQTIKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLL 375 (576)
T ss_dssp T---TCCEECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHH
T ss_pred c---CccccccCCCccccCHHHHcC--CCCCccchHHHHHHHH
Confidence 2 223344578999999999987 4589999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=261.17 Aligned_cols=193 Identities=30% Similarity=0.473 Sum_probs=155.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHH-HHhcCCCCcceeeeEEEcCCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRL-LKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~ 112 (235)
...++|++++.||+|+||+||++++..+++.+|+|++++..... ......+..|..+ ++.++||||+++++.+ ...
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~--~~~ 111 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSF--QTA 111 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEE--ECS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHHhCCCCCCCCEEEEE--EeC
Confidence 45678999999999999999999999999999999998776543 2333345566665 4567999999999999 456
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+|+||||++| +|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.+++++|+|||++...
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 689999999975 688888765 57899999999999999999999999999999999999999999999999999753
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 190 ~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 229 (373)
T 2r5t_A 190 IE--HNSTTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVL 229 (373)
T ss_dssp BC--CCCCCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred cc--CCCccccccCCccccCHHHhCC--CCCCchhhhHHHHHHH
Confidence 21 1223445668999999999987 4589999999999974
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=256.15 Aligned_cols=191 Identities=20% Similarity=0.260 Sum_probs=161.8
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (235)
...++|++.+.||+|+||+||++.+..+++.||+|++.... ....+.+|+.++..+ .|+||+++++++. ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~~ 77 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS------RAPQLHLEYRFYKQLGSGDGIPQVYYFGP--CG 77 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC------SSCCHHHHHHHHHHHCSCTTSCCEEEEEE--ET
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc------chHHHHHHHHHHHHhhCCCCCCEEEEEEe--cC
Confidence 34578999999999999999999998999999999886443 223588999999999 9999999999984 45
Q ss_pred ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc-----EEEeeecc
Q psy787 113 QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT-----LKISDFGV 187 (235)
Q Consensus 113 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~-----~~l~dfg~ 187 (235)
...++|||+++++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||+
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 78 KYNAMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp TEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred CccEEEEEeCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 6889999999778999988652 67999999999999999999999999999999999999998887 99999999
Q ss_pred ccccCccccCC-----cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDD-----TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+..+....... ......+++.|+|||.+.+ ..++.++||||||++|
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 207 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMF 207 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHH
Confidence 98653221111 1235568999999999988 4489999999999974
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=258.67 Aligned_cols=196 Identities=22% Similarity=0.303 Sum_probs=160.0
Q ss_pred CceeEeeeceEEeeeeeccccceEEEEe-----eccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC---CCCc
Q psy787 29 KTIKVKMIGKYVMGDLLGEGSYGKVKEM-----LDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ---HRNV 100 (235)
Q Consensus 29 ~~~~~~~~~~y~i~~~ig~g~~~~v~~~-----~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i 100 (235)
........++|++.+.||+|+||+||+| .+..+++.||+|+++... ...+..|+..+..+. |+|+
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~i 129 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMF 129 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGB
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhh
Confidence 3344455678999999999999999999 467788999999986432 335778888888886 8999
Q ss_pred ceeeeEEEcCCCceEEEEEeccc-CCHHHHhhcC---CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc
Q psy787 101 IGLVDVFVNDKKQKMYLIMEYCV-GGLQDMLDST---PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL 176 (235)
Q Consensus 101 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~ 176 (235)
+.+++.+. ..+..++||||++ |+|.+++... ....+++..++.++.|++.||+|||+.||+||||||+||+++.
T Consensus 130 v~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 130 MKFYSAHL--FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207 (365)
T ss_dssp CCEEEEEE--CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred hhhheeee--cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence 99999994 4557899999997 5798888642 2367999999999999999999999999999999999999998
Q ss_pred -----------CCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 177 -----------DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 177 -----------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++.++|+|||++..+.............+++.|+|||++.+ ..++.++||||||++|
T Consensus 208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 275 (365)
T 3e7e_A 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATV 275 (365)
T ss_dssp GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHH
T ss_pred cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHH
Confidence 89999999999975543333344455678999999999988 4489999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=258.61 Aligned_cols=195 Identities=32% Similarity=0.491 Sum_probs=155.0
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
.....++|+++++||+|+||+||++.+..+++.||+|+++..... ......+.+|+.+++.++||||+++++++ ..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~ 104 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE--EGVPGTAIREVSLLKELQHRNIIELKSVI--HH 104 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEE--EE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc--cccchhHHHHHHHHHHcCCCCcceEEEEE--ec
Confidence 455678999999999999999999999999999999998755432 23345677999999999999999999999 45
Q ss_pred CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc-----cCCcEEEeeec
Q psy787 112 KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT-----LDGTLKISDFG 186 (235)
Q Consensus 112 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~-----~~~~~~l~dfg 186 (235)
...+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++ ..+.++|+|||
T Consensus 105 ~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 105 NHRLHLIFEYAENDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp TTEEEEEEECCSEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred CCEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 6689999999999999999876 5699999999999999999999999999999999999994 44559999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++...... ........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 183 ~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 228 (329)
T 3gbz_A 183 LARAFGIP--IRQFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIW 228 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHH
T ss_pred CccccCCc--ccccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHH
Confidence 99765421 2223344578899999998762 2478999999999974
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=257.23 Aligned_cols=196 Identities=29% Similarity=0.475 Sum_probs=162.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC-CCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI-PNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
.+.++|++.+.||+|+||+||++.+..+++.||+|++........ ......+.+|+.++..++||||+++++++ ...
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~ 98 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY--SSD 98 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE--EET
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE--EeC
Confidence 456789999999999999999999999999999999976543322 22345688999999999999999999999 456
Q ss_pred ceEEEEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc---EEEeeec
Q psy787 113 QKMYLIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT---LKISDFG 186 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~---~~l~dfg 186 (235)
..+++|||++++ +|.+.+... ....+++..++.++.|++.||.|||++|++||||||+||+++.++. ++|+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 689999999975 687776543 2245899999999999999999999999999999999999987655 9999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++...... ........+++.|+|||.+.+ ..++.++||||||++|
T Consensus 179 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 223 (351)
T 3c0i_A 179 VAIQLGES--GLVAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVIL 223 (351)
T ss_dssp TCEECCTT--SCBCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred ceeEecCC--CeeecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHH
Confidence 99865421 122334568999999999987 4489999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=255.35 Aligned_cols=196 Identities=26% Similarity=0.478 Sum_probs=159.0
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC--
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK-- 112 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 112 (235)
..++|++++.||+|+||.||+|++..+++.||+|+++... .......+.+|+.++..++||||+++++.+.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 4578999999999999999999999999999999997543 23445678899999999999999999999864322
Q ss_pred -----------------------------------------------------ceEEEEEecccC-CHHHHhhcCCC-CC
Q psy787 113 -----------------------------------------------------QKMYLIMEYCVG-GLQDMLDSTPY-KK 137 (235)
Q Consensus 113 -----------------------------------------------------~~~~lv~e~~~~-~l~~~~~~~~~-~~ 137 (235)
.+++++||++++ +|.+++..... ..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 248999999975 79988876532 23
Q ss_pred CCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC----------CcccccCCCC
Q psy787 138 FPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD----------DTITTSQGSP 207 (235)
Q Consensus 138 ~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~ 207 (235)
.+...++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......... .......+++
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 455568999999999999999999999999999999999999999999999866432111 1223345889
Q ss_pred cccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 208 VFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 208 ~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.|+|||.+.+ ..++.++||||||+++
T Consensus 241 ~y~aPE~~~~--~~~~~~~Di~slG~il 266 (332)
T 3qd2_B 241 LYMSPEQIHG--NNYSHKVDIFSLGLIL 266 (332)
T ss_dssp GGSCHHHHHC--CCCCTHHHHHHHHHHH
T ss_pred CccChHHhcC--CCCcchhhHHHHHHHH
Confidence 9999999987 4589999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=258.28 Aligned_cols=191 Identities=30% Similarity=0.486 Sum_probs=161.2
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++++.||+|+||+||+|++..+++.||+|++....... ......+.+|+.++..++||||+++++++. ....
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~ 128 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHT 128 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCe
Confidence 3456999999999999999999998899999999987553222 123346889999999999999999999994 4568
Q ss_pred EEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 115 MYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 115 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
.++||||+.|++.+.+.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 129 ~~lv~e~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 89999999999888876433 6789999999999999999999999999999999999999999999999999975531
Q ss_pred ccCCcccccCCCCcccCccccCCC-CCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGL-PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 235 (235)
.....+++.|+|||.+.+. ...++.++||||||+++
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il 243 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 243 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHH
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHH
Confidence 2345689999999998431 24588999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=267.91 Aligned_cols=195 Identities=31% Similarity=0.421 Sum_probs=166.4
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|+||+||++++..+|+.||+|++.+..... ......+.+|+.++..++||||+++++.+ ....
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~--~~~~ 258 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAF--ETKT 258 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEE--eeCC
Confidence 34578999999999999999999999999999999998765443 23445688999999999999999999999 5567
Q ss_pred eEEEEEecccC-CHHHHhhcCC--CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTP--YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
.+|+||||++| +|.+++.... ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 89999999975 6888886543 35699999999999999999999999999999999999999999999999999986
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+... ........+++.|+|||.+.+ ..++.++||||||++|
T Consensus 339 ~~~~--~~~~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvil 379 (543)
T 3c4z_A 339 LKAG--QTKTKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTL 379 (543)
T ss_dssp CCTT--CCCBCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred ccCC--CcccccccCCccccChhhhcC--CCCChHHhcCcchHHH
Confidence 5421 122234578999999999987 4589999999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=266.90 Aligned_cols=195 Identities=36% Similarity=0.616 Sum_probs=166.5
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
+....++|.+.+.||+|+||+||+|.+..+|+.||+|++....... ......+.+|+.+++.++||||+++++++ ..
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~--~~ 87 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS-LDVVGKIRREIQNLKLFRHPHIIKLYQVI--ST 87 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH-TTTHHHHHHHHHHHTTCCCTTBCCEEEEE--EC
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EE
Confidence 3456789999999999999999999999999999999997664332 23345688999999999999999999999 45
Q ss_pred CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...+++|||++++ +|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 6689999999965 799988765 6799999999999999999999999999999999999999999999999999986
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... ........+++.|+|||.+.+.. ..+.++||||||+++
T Consensus 166 ~~~---~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil 206 (476)
T 2y94_A 166 MSD---GEFLRTSCGSPNYAAPEVISGRL-YAGPEVDIWSSGVIL 206 (476)
T ss_dssp CCT---TCCBCCCCSCSTTCCHHHHTTCC-BCSHHHHHHHHHHHH
T ss_pred ccc---cccccccCCCcCeEChhhccCCC-CCCCcceehhhHHHH
Confidence 542 22334556899999999998732 347899999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=252.39 Aligned_cols=194 Identities=34% Similarity=0.560 Sum_probs=165.5
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCC--ccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN--GEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
....++|++.+.||+|+||.||++.+..+++.+|+|++.......... ....+.+|+.++..++||||+++++++ .
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~ 85 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY--E 85 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE--E
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE--e
Confidence 345678999999999999999999999999999999998765443221 345688999999999999999999999 4
Q ss_pred CCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC----cEEEeee
Q psy787 111 KKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG----TLKISDF 185 (235)
Q Consensus 111 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~----~~~l~df 185 (235)
....+++|||+++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 5668999999996 4799988765 6789999999999999999999999999999999999999887 7999999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|++..... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 164 g~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 208 (321)
T 2a2a_A 164 GLAHEIED---GVEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVIT 208 (321)
T ss_dssp TTCEECCT---TCCCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred ccceecCc---cccccccCCCCCccCcccccC--CCCCCccccHHHHHHH
Confidence 99986542 222334558899999999987 4489999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=255.86 Aligned_cols=194 Identities=33% Similarity=0.463 Sum_probs=164.2
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC----CCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI----PNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
...++|++++.||+|+||+||++++..+++.||+|+++....... ......+.+|+.++..++||||+++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~-- 98 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF-- 98 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE--
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE--
Confidence 356789999999999999999999999999999999987654332 12344678899999999999999999999
Q ss_pred CCCceEEEEEeccc-C-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 110 DKKQKMYLIMEYCV-G-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 110 ~~~~~~~lv~e~~~-~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
.....+++|||++. | +|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 56678999999985 4 688888765 5799999999999999999999999999999999999999999999999999
Q ss_pred ccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+..... ........+++.|+|||.+.+.+ ..+.++||||||+++
T Consensus 177 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il 220 (335)
T 3dls_A 177 AAYLER---GKLFYTFCGTIEYCAPEVLMGNP-YRGPELEMWSLGVTL 220 (335)
T ss_dssp CEECCT---TCCBCEECSCGGGCCHHHHTTCC-BCSHHHHHHHHHHHH
T ss_pred ceECCC---CCceeccCCCccccChhhhcCCC-CCCCcccchhHHHHH
Confidence 986542 22233456899999999998732 237899999999974
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=256.85 Aligned_cols=190 Identities=29% Similarity=0.491 Sum_probs=154.3
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||+|+||+||++.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++ .....++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDII--HTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEE--ECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhHHHHHHHHHhcCCCCCCeeeeEE--eeCCEEE
Confidence 6899999999999999999999999999999998655432 2223455799999999999999999999 4566789
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+|||+++++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..... .
T Consensus 77 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~ 153 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--P 153 (324)
T ss_dssp EEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEecccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--C
Confidence 999999999998887653 5689999999999999999999999999999999999999999999999999875432 1
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 191 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIF 191 (324)
T ss_dssp ---------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHH
T ss_pred ccccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHH
Confidence 2223344578899999998762 3478999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=257.57 Aligned_cols=199 Identities=24% Similarity=0.412 Sum_probs=157.9
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
...+.++|++.+.||+|+||+||++++..+++.||+|++....... ......+.+|+..+..++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS-HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC-HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 3456789999999999999999999999999999999987643322 223346789999999999999999999985433
Q ss_pred C--ceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 112 K--QKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 112 ~--~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
. ..+++||||++ ++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred CCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 2 25699999996 5799988765 57899999999999999999999999999999999999999999999999999
Q ss_pred cccCccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..+...... .......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l 209 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVL 209 (311)
T ss_dssp ------------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHH
Confidence 865422111 22223457899999999987 4589999999999974
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=258.04 Aligned_cols=195 Identities=28% Similarity=0.446 Sum_probs=160.2
Q ss_pred eeeceEEeeeeeccccceEEEEeecc-------chhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeee
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDS-------ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVD 105 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 105 (235)
...++|++.+.||+|+||+||+|.+. .++..||+|+++.... ......+.+|+.++..+ +||||+++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB---HHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC---HHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 34578999999999999999999863 3456799998865421 23345688999999999 8999999999
Q ss_pred EEEcCCCceEEEEEecccC-CHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q psy787 106 VFVNDKKQKMYLIMEYCVG-GLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPG 170 (235)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~ 170 (235)
++ .....+++||||+++ +|.+++.... ...++...++.++.|++.||.|||++|++||||||+
T Consensus 155 ~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 155 AC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EE--CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EE--ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 99 556678999999975 7999887653 235889999999999999999999999999999999
Q ss_pred CeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 171 NLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 171 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||+++.++.++|+|||++................+++.|+|||.+.+ ..++.++||||||+++
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il 295 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLM 295 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHH
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHH
Confidence 99999999999999999986543222222333446778999999987 4589999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=255.55 Aligned_cols=195 Identities=33% Similarity=0.536 Sum_probs=156.7
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC-CccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP-NGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
..++|++++.||+|+||.||++.+..+++.||+|++......... .....+.+|+.++..++||||+++++++ ....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~ 85 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF--GHKS 85 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE--CCTT
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE--eeCC
Confidence 457899999999999999999999999999999998765433211 2234678999999999999999999999 5566
Q ss_pred eEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 114 KMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 114 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
..++|||+++++|.+.+.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+..
T Consensus 86 ~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 86 NISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred ceEEEEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 789999999999888887643 5688999999999999999999999999999999999999999999999999986642
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 165 ~--~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 203 (346)
T 1ua2_A 165 P--NRAYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCIL 203 (346)
T ss_dssp C--CCCCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHH
T ss_pred C--cccCCcccccccccCchHhhCC-CCCCchhhhHhHHHHH
Confidence 1 2223345688999999998652 3478899999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=255.93 Aligned_cols=191 Identities=31% Similarity=0.469 Sum_probs=154.0
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC--
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK-- 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (235)
...++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC--hHHHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence 5678999999999999999999999999999999998754321 233456789999999999999999999995322
Q ss_pred --CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 112 --KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 112 --~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
...+++|||+++++|.+.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 100 ~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 100 EEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp TTCCEEEEEEECCSEEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ccccceEEEEEcCCCCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 13789999999999888885 348899999999999999999999999999999999999999999999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 176 ~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 216 (371)
T 2xrw_A 176 TAGT---SFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIM 216 (371)
T ss_dssp -----------------CTTCCHHHHTT--CCCCTTHHHHHHHHHH
T ss_pred cccc---ccccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHH
Confidence 5532 222334568899999999987 4489999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=266.88 Aligned_cols=193 Identities=30% Similarity=0.460 Sum_probs=154.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++++.||+|+||.||++.+..+++.||+|+++...... ......+.+|+.++..++||||+++++++ ....
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~--~~~~ 221 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYSF--QTHD 221 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEE--EETT
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh-hHHHHHHHHHHHHHHhCCCCeEeeEEEEE--eeCC
Confidence 34578999999999999999999999999999999998654332 23344577899999999999999999999 4556
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
.+++||||+++ +|.+.+... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||++...
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 89999999976 688888765 578999999999999999999998 99999999999999999999999999999754
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .........+++.|+|||++.+ ..++.++||||||++|
T Consensus 300 ~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 339 (446)
T 4ejn_A 300 IK--DGATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVM 339 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHH
T ss_pred cC--CCcccccccCCccccCHhhcCC--CCCCCccchhhhHHHH
Confidence 21 2223345668999999999977 4589999999999974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=247.03 Aligned_cols=192 Identities=19% Similarity=0.266 Sum_probs=162.6
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDK 111 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 111 (235)
....++|++.+.||+|++|+||++.+..+++.||+|++.... ....+.+|+..+..+ .|++++++++++ ..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~~~~l~~~~~i~~~~~~~--~~ 77 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFG--QE 77 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTTCCCEEEEE--EE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC------ccHHHHHHHHHHHHHhcCCCCCeEEeec--CC
Confidence 456678999999999999999999998899999999886432 233588999999999 799999999998 55
Q ss_pred CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc-----EEEeeec
Q psy787 112 KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT-----LKISDFG 186 (235)
Q Consensus 112 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~-----~~l~dfg 186 (235)
....+++||+++++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||
T Consensus 78 ~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 78 GLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred CceeEEEEEecCCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 66889999999888999998653 46999999999999999999999999999999999999987765 9999999
Q ss_pred cccccCccccC-----CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHD-----DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++......... .......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 208 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVF 208 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHH
Confidence 99866432221 12234558899999999987 4489999999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=247.93 Aligned_cols=191 Identities=30% Similarity=0.524 Sum_probs=162.6
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|++|.||++.+..+++.+++|++...... ......+.+|+.++..++||||+++++++ ....
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~ 78 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSI--QEES 78 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC--HHHHHHHHHHHHHHHHcCCCCcCeEEEEE--EcCC
Confidence 3567899999999999999999999999999999998765532 23345678999999999999999999999 5566
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc---EEEeeecccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT---LKISDFGVAE 189 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~ 189 (235)
..+++||++++ +|.+.+... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 88999999976 687877765 56899999999999999999999999999999999999987665 9999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 157 ~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 197 (284)
T 3kk8_A 157 EVND---SEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVIL 197 (284)
T ss_dssp ECCS---SCBCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred Eccc---CccccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHH
Confidence 5542 222334568899999999987 4489999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=256.38 Aligned_cols=189 Identities=33% Similarity=0.480 Sum_probs=151.6
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++++.||+|+||+||++++..+++.||+|++.... .....+.+|+..++.++||||+++++++. ...
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~ 89 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-----AIDENVQREIINHRSLRHPNIVRFKEVIL--TPT 89 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-----TSCHHHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-----cccHHHHHHHHHHHhCCCCCCCcEEEEEe--eCC
Confidence 45678999999999999999999999999999999986543 22346889999999999999999999994 566
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc--EEEeeeccccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT--LKISDFGVAES 190 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~ 190 (235)
.+++||||+++ +|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 89999999965 688888765 57999999999999999999999999999999999999987765 99999999874
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .........+++.|+|||.+.+.. ..+.++||||||+++
T Consensus 168 ~~---~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il 208 (361)
T 3uc3_A 168 SV---LHSQPKSTVGTPAYIAPEVLLRQE-YDGKIADVWSCGVTL 208 (361)
T ss_dssp ----------------CTTSCHHHHHCSS-CCHHHHHHHHHHHHH
T ss_pred cc---ccCCCCCCcCCCCcCChhhhcCCC-CCCCeeeeehhHHHH
Confidence 32 122333456899999999987632 233459999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=265.74 Aligned_cols=195 Identities=31% Similarity=0.557 Sum_probs=164.2
Q ss_pred CceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEE
Q psy787 29 KTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFV 108 (235)
Q Consensus 29 ~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (235)
........++|++++.||+|+||+||++.+..+++.||+|++....... .....+.+|+.+++.++||||+++++++
T Consensus 14 ~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~- 90 (486)
T 3mwu_A 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEIL- 90 (486)
T ss_dssp CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred ccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEE-
Confidence 3344457789999999999999999999999999999999997655432 3456788999999999999999999999
Q ss_pred cCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc---cCCcEEEee
Q psy787 109 NDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT---LDGTLKISD 184 (235)
Q Consensus 109 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~---~~~~~~l~d 184 (235)
.....+++|||++.+ +|.+.+... ..+++..++.++.|++.||.|||+.|++||||||+||+++ .++.++|+|
T Consensus 91 -~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 167 (486)
T 3mwu_A 91 -EDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIID 167 (486)
T ss_dssp -ECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred -EcCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEE
Confidence 566789999999975 688888765 6799999999999999999999999999999999999995 445799999
Q ss_pred eccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||++..+.. ........+++.|+|||.+.+ .++.++||||||+++
T Consensus 168 fg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il 212 (486)
T 3mwu_A 168 FGLSTCFQQ---NTKMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVIL 212 (486)
T ss_dssp CSCTTTBCC---C----CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHH
T ss_pred CCcCeECCC---CCccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHH
Confidence 999986542 223345568999999999876 378999999999974
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=248.54 Aligned_cols=193 Identities=26% Similarity=0.453 Sum_probs=164.4
Q ss_pred ceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 30 TIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 30 ~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
++.....++|++++.||+|+||.||++.+..+++.+++|++.... ..+.+|+.++..++||||+++++++..
T Consensus 4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (284)
T 2a19_B 4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDG 75 (284)
T ss_dssp CCCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence 445566789999999999999999999998899999999886542 257799999999999999999998742
Q ss_pred --------------CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE
Q psy787 110 --------------DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL 174 (235)
Q Consensus 110 --------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili 174 (235)
.....++++||++++ +|.+++.......+++..++.++.|++.||.+||+.|++|+||||+||++
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL 155 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE
Confidence 124568999999986 79999976655679999999999999999999999999999999999999
Q ss_pred ccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 175 TLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 175 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.++.++|+|||++..... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 211 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKN---DGKRTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLIL 211 (284)
T ss_dssp EETTEEEECCCTTCEESSC---CSCCCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHH
T ss_pred cCCCCEEECcchhheeccc---cccccccCCcccccChhhhcc--CCCcchhhhHHHHHHH
Confidence 9999999999999976542 122334458899999999977 4489999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=253.92 Aligned_cols=196 Identities=27% Similarity=0.376 Sum_probs=158.6
Q ss_pred EeeeceEEeeeeeccccceEEEEee----ccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEE
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFV 108 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (235)
....++|++++.||+|+||+||+++ +..+++.||+|++.... ......+.+|+.++..++||||+++++++.
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3456789999999999999999998 66788999999886432 233356889999999999999999999986
Q ss_pred cCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 109 NDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 109 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
..+...+++|||++++ +|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 5555678999999965 7999887653 4589999999999999999999999999999999999999999999999999
Q ss_pred ccccCccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+......... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 207 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVL 207 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHH
Confidence 9865422111 11223345667999999987 4489999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=258.00 Aligned_cols=190 Identities=30% Similarity=0.503 Sum_probs=161.5
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++++.||+|+||+||+|.+..+++.+|+|++..... .....+.+|+.++..++||||+++++++ ....
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~ 121 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP----LDKYTVKNEISIMNQLHHPKLINLHDAF--EDKY 121 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHTTCCSTTBCCEEEEE--ECSS
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch----hhHHHHHHHHHHHHhCCCcCCCeEEEEE--EeCC
Confidence 346789999999999999999999999999999999875432 2234688999999999999999999999 4567
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc--CCcEEEeeeccccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL--DGTLKISDFGVAES 190 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~~~ 190 (235)
.+++|||++++ +|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++. .+.++|+|||++..
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 89999999975 6888887542 46899999999999999999999999999999999999974 46799999999986
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 201 ~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il 240 (387)
T 1kob_A 201 LNP---DEIVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLG 240 (387)
T ss_dssp CCT---TSCEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHH
T ss_pred cCC---CcceeeeccCCCccCchhccC--CCCCCcccEeeHhHHH
Confidence 542 222334568999999999987 4589999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=251.12 Aligned_cols=191 Identities=31% Similarity=0.499 Sum_probs=154.0
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++++.||+|++|+||++.+..+++.+|+|++...... ......+.+|+.++..++||||+++++++ .....+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~ 77 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD--PVIKKIALREIRMLKQLKHPNLVNLLEVF--RRKRRL 77 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEE--EETTEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHhCCCCCccchhhee--ecCCeE
Confidence 57899999999999999999999999999999988654322 12345577999999999999999999999 456688
Q ss_pred EEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++|||+++++ |.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp EEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999876 55555544 66899999999999999999999999999999999999999999999999999765421
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il 193 (311)
T 4agu_A 156 --SDYYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVF 193 (311)
T ss_dssp ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHH
T ss_pred --ccccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHH
Confidence 1222344578889999998652 3478999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=254.00 Aligned_cols=188 Identities=32% Similarity=0.505 Sum_probs=147.7
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
....++|++.+.||+|+||+||++.+..+++.||+|+++... ....+.+|+.++..++||||+++++++ ...
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~ 120 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIF--ETP 120 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEE--ECS
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeE--ecC
Confidence 445678999999999999999999999899999999987543 223577899999999999999999999 456
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc---CCcEEEeeeccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL---DGTLKISDFGVA 188 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~---~~~~~l~dfg~~ 188 (235)
..+++|||++++ +|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++. ++.++|+|||++
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred CeEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 689999999975 798888765 56899999999999999999999999999999999999975 788999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... ........+++.|+|||.+.+ ..++.++||||||++|
T Consensus 199 ~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 240 (349)
T 2w4o_A 199 KIVEH---QVLMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIIT 240 (349)
T ss_dssp -----------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred cccCc---ccccccccCCCCccCHHHhcC--CCCCcccchHHHHHHH
Confidence 75532 122334568899999999987 4589999999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=244.82 Aligned_cols=188 Identities=31% Similarity=0.578 Sum_probs=162.1
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
.+.++|++.+.||+|+||+||++.+..++..+++|++..... .....+.+|+.+++.++||||+++++++ ....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~ 79 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETF--EDNT 79 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSS
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEE--ecCC
Confidence 456789999999999999999999999999999998876542 3345688999999999999999999999 4566
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE---ccCCcEEEeeecccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL---TLDGTLKISDFGVAE 189 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~ 189 (235)
..++|||++++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||++ +.++.++|+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 89999999975 688888765 568999999999999999999999999999999999999 778899999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ........+++.|+|||.+.+ .++.++||||||+++
T Consensus 158 ~~~~---~~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l 197 (277)
T 3f3z_A 158 RFKP---GKMMRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMM 197 (277)
T ss_dssp ECCT---TSCBCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHH
T ss_pred eccC---ccchhccCCCCCccChHHhcc---cCCchhhehhHHHHH
Confidence 6542 223344568899999999865 278999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=250.06 Aligned_cols=192 Identities=24% Similarity=0.391 Sum_probs=151.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|+||+||++.+ +++.+|+|++...... ......+.+|+.++.+++||||+++++++ ....
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~ 107 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH--AERVNEFLREVAIMKRLRHPNIVLFMGAV--TQPP 107 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSTT
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEE--EECC
Confidence 3457899999999999999999976 5788999998755432 23345688999999999999999999999 5566
Q ss_pred eEEEEEecccC-CHHHHhhcCCC-CCCCHHhHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPY-KKFPIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
.+++||||+++ +|.+++..... ..+++..++.++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++.
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 78999999975 79888876521 23899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... .........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 188 ~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 229 (309)
T 3p86_A 188 LKAS--TFLSSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVIL 229 (309)
T ss_dssp ----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHH
T ss_pred cccc--cccccccCCCCccccChhhhcC--CCCCchhhHHHHHHHH
Confidence 5432 1122334568899999999988 4489999999999974
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=256.18 Aligned_cols=198 Identities=28% Similarity=0.398 Sum_probs=162.2
Q ss_pred EeeeceEEeeeeeccccceEEEEeecc---chhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEE
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDS---ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFV 108 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 108 (235)
....++|++.+.||+|+||+||++++. .+++.||+|+++.............+.+|+.++..+ .|+||+++++.+
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~- 128 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF- 128 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE-
Confidence 344579999999999999999999874 578999999997655433334445567899999999 699999999999
Q ss_pred cCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 109 NDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 109 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
.....+++||||+++ +|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+
T Consensus 129 -~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 129 -QTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred -eeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 455688999999975 798888765 5689999999999999999999999999999999999999999999999999
Q ss_pred ccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+..+... .........+++.|+|||.+.+....++.++||||||++|
T Consensus 206 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il 252 (355)
T 1vzo_A 206 SKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 252 (355)
T ss_dssp EEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHH
T ss_pred CeecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHH
Confidence 9755321 1222334568999999999986444578899999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=247.36 Aligned_cols=190 Identities=32% Similarity=0.536 Sum_probs=160.3
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++.+.||+|++|+||++.+..+++.+++|++....... ......+.+|+.++..++||||+++++++ .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 83 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYF--HDATR 83 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-HTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccch-hhHHHHHHHHHHHHHcCCCCCCcchhheE--ecCCE
Confidence 4578999999999999999999999999999999987654332 23345688999999999999999999999 45668
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.+++||++++ +|.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~- 160 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 160 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC-
Confidence 8999999975 688888765 568999999999999999999999999999999999999999999999999886443
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 197 (279)
T 3fdn_A 161 ---SSRRTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLC 197 (279)
T ss_dssp ----------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHH
T ss_pred ---cccccccCCCCCccCHhHhcc--CCCCccchhHhHHHHH
Confidence 222334568899999999987 4588999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=251.00 Aligned_cols=195 Identities=19% Similarity=0.249 Sum_probs=155.5
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeecccc-CCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQ-RIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
..++|++++.||+|+||+||++.+..+++.+++|+..+.... ........+.+|+.++..++||||+++++++ . ..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~-~~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC--P-GS 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE--C-BS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE--c-CC
Confidence 346899999999999999999999888887555544332211 1123345678899999999999999999988 3 34
Q ss_pred eEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..++|||++. ++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred ccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 6889999997 56888887542 578999999999999999999999999999999999999999999999999998764
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
............++..|+|||.+.+ ..++.++||||||+++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 207 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTV 207 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred cccccccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHH
Confidence 3333333344457778999999977 4589999999999974
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=254.36 Aligned_cols=194 Identities=27% Similarity=0.414 Sum_probs=155.3
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCC--CCcceeeeEEEcCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH--RNVIGLVDVFVNDK 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~ 111 (235)
...++|++++.||+|+||+||++.+. +++.||+|++...... ......+.+|+.++..++| +||+++++++ ..
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~--~~ 80 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD--NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE--IT 80 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE--EC
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccc--hHHHHHHHHHHHHHHhhhhcCCceEEEeeeE--ee
Confidence 34668999999999999999999884 6889999998765422 2333568899999999986 9999999999 45
Q ss_pred CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 112 KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 112 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
...+++|||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++ ++.++|+|||++..+
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred CCEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 6689999997778899999876 6799999999999999999999999999999999999997 688999999999866
Q ss_pred CccccCCcccccCCCCcccCccccCC---------CCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANG---------LPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~---------~~~~~~~~~Di~slG~~l 235 (235)
.............+++.|+|||.+.+ ....++.++||||||++|
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il 210 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHH
Confidence 43222223335568999999999853 114478899999999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=248.46 Aligned_cols=185 Identities=30% Similarity=0.475 Sum_probs=158.4
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYL 117 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 117 (235)
.|...++||+|+||.||+|++..+|+.||+|++.... ......+.+|+.++..++||||+++++.+. .....++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHFNVVEMYKSYL--VGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEE--ETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEE--ECCEEEE
Confidence 4888889999999999999998899999999986543 233456889999999999999999999994 4567899
Q ss_pred EEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 118 IMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 118 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
||||+++ +|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 120 v~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 194 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-- 194 (321)
T ss_dssp EECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--
T ss_pred EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--
Confidence 9999975 58887754 56899999999999999999999999999999999999999999999999998765421
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il 231 (321)
T 2c30_A 195 VPKRKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMV 231 (321)
T ss_dssp SCCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred ccccccccCCccccCHhhhcC--CCCCchhhHHHHHHHH
Confidence 122344568999999999987 4589999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=245.39 Aligned_cols=193 Identities=32% Similarity=0.571 Sum_probs=144.8
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++.+.||+|+||.||++.+..+++.+++|++....... ......+.+|+.++..++||||+++++++ .....
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 85 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQRVQNEVKIHCQLKHPSILELYNYF--EDSNY 85 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTBCCTTBCCEEEEE--ECSSE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHhCCCCCeEeEEEEE--ccCCe
Confidence 3468999999999999999999998899999999997654332 23345688999999999999999999999 45668
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.+++||++++ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999975 6888877543 5789999999999999999999999999999999999999999999999999976542
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 165 ~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 202 (278)
T 3cok_A 165 P--HEKHYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMF 202 (278)
T ss_dssp -------------------------------CTHHHHHHHHH
T ss_pred C--CCcceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHH
Confidence 1 122234457889999999987 4488999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=246.62 Aligned_cols=194 Identities=30% Similarity=0.549 Sum_probs=164.6
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
....++|++.+.||+|+||.||++.+..+++.+++|++....... ......+.+|+.+++.++|+||+++++++ ...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~ 87 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFHGFF--EDN 87 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEE--ECS
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC-HHHHHHHHHHHHHHHhCCCCCEeeeeeee--ccC
Confidence 345678999999999999999999999999999999987654332 23345688999999999999999999999 456
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
...+++||++++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 689999999975 688887765 57899999999999999999999999999999999999999999999999999765
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 166 ~~--~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 205 (294)
T 2rku_A 166 EY--DGERKKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIM 205 (294)
T ss_dssp CS--TTCCBCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHH
T ss_pred cc--CccccccccCCCCcCCcchhcc--CCCCchhhHHHHHHHH
Confidence 32 1222334568889999999987 4488999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=255.33 Aligned_cols=193 Identities=34% Similarity=0.512 Sum_probs=156.3
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
.....++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 20 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS--HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred eeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC--HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 345568999999999999999999999999999999988543221 233456789999999999999999999995332
Q ss_pred C----ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 112 K----QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 112 ~----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
. ..+++|||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccCceEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 1 35699999998889988876 4689999999999999999999999999999999999999999999999999
Q ss_pred ccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+..... ......+++.|+|||.+.+. ..++.++|||||||++
T Consensus 175 a~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 216 (367)
T 1cm8_A 175 ARQADS-----EMTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIM 216 (367)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHH
T ss_pred cccccc-----ccCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHH
Confidence 985532 23345678899999998652 3488999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=247.58 Aligned_cols=195 Identities=31% Similarity=0.486 Sum_probs=163.5
Q ss_pred eeeceEEeeeeeccccceEEEEeecc-chhhheeeeeeeeccccCCCCccccHHHHHHHHHhc---CCCCcceeeeEEEc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDS-ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML---QHRNVIGLVDVFVN 109 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~ 109 (235)
...++|++++.||+|+||+||++++. .+++.||+|++....... .....+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 34578999999999999999999985 678899999997665332 3334567788777766 89999999999852
Q ss_pred ---CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeec
Q psy787 110 ---DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 110 ---~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
.....++++||+++++|.+++.......+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 24567899999999999999988766679999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++..... ........++..|+|||.+.+ ..++.++||||||+++
T Consensus 166 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 209 (326)
T 1blx_A 166 LARIYSF---QMALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIF 209 (326)
T ss_dssp SCCCCCG---GGGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred ccccccC---CCCccccccccceeCHHHHhc--CCCCcchhHHHHHHHH
Confidence 9976542 122334567889999999987 4589999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=263.72 Aligned_cols=195 Identities=33% Similarity=0.550 Sum_probs=161.4
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC---------CCccccHHHHHHHHHhcCCCCcc
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI---------PNGEINVDREIRLLKMLQHRNVI 101 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~ 101 (235)
....+.++|+++++||+|+||+||+|.+..+++.+|+|++........ ......+.+|+.+++.++||||+
T Consensus 30 ~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 109 (504)
T 3q5i_A 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109 (504)
T ss_dssp ECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred cCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 344567899999999999999999999999999999999987653321 13345688999999999999999
Q ss_pred eeeeEEEcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC--
Q psy787 102 GLVDVFVNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-- 178 (235)
Q Consensus 102 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-- 178 (235)
++++++ .....+++|||++++ +|.+.+... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++
T Consensus 110 ~~~~~~--~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 110 KLFDVF--EDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp CEEEEE--ECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCC
T ss_pred eEEEEE--EcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCC
Confidence 999999 566789999999975 688888765 6799999999999999999999999999999999999999776
Q ss_pred -cEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 179 -TLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 179 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++|+|||++..... ........+++.|+|||.+.+ .++.++||||||+++
T Consensus 186 ~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il 237 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIM 237 (504)
T ss_dssp SSEEECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHH
T ss_pred ccEEEEECCCCEEcCC---CCccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHH
Confidence 699999999986542 233445568999999999864 378999999999974
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=243.31 Aligned_cols=191 Identities=35% Similarity=0.597 Sum_probs=160.6
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCC--ccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN--GEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
.++|++.+.||+|+||+||++.+..+++.+++|+++......... ....+.+|+.++..++||||+++++++ ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~ 81 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF--ENKT 81 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee--cCCC
Confidence 468999999999999999999999899999999998765443222 345688999999999999999999999 4566
Q ss_pred eEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC----cEEEeeeccc
Q psy787 114 KMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG----TLKISDFGVA 188 (235)
Q Consensus 114 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~----~~~l~dfg~~ 188 (235)
..+++||+++ ++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred eEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 8899999996 5799988765 5789999999999999999999999999999999999998877 7999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 160 ~~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 201 (283)
T 3bhy_A 160 HKIEA---GNEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVIT 201 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred eeccC---CCcccccCCCcCccCcceecC--CCCCcchhhhhHHHHH
Confidence 76532 122334458889999999987 4488999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=257.46 Aligned_cols=194 Identities=34% Similarity=0.587 Sum_probs=152.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccC----CCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR----IPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
...++|.+.+.||+|+||+||+|.+..+++.||+|++....... .......+.+|+.++..++||||+++++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-- 209 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-- 209 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE--
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE--
Confidence 34678999999999999999999999999999999998764321 122334688999999999999999999998
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC---cEEEeee
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG---TLKISDF 185 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~---~~~l~df 185 (235)
. ...+++|||++++ +|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+||
T Consensus 210 ~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 210 D-AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp E-SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred e-cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeec
Confidence 3 3357899999965 688887765 6799999999999999999999999999999999999997654 4999999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCCC-CCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGL-PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 235 (235)
|++..... ........+++.|+|||.+.+. ...++.++||||||++|
T Consensus 287 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il 334 (419)
T 3i6u_A 287 GHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334 (419)
T ss_dssp STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHH
T ss_pred ccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHH
Confidence 99986542 2233445689999999998541 23478899999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=254.44 Aligned_cols=190 Identities=35% Similarity=0.550 Sum_probs=155.4
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC---
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND--- 110 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 110 (235)
...++|++++.||+|+||+||+|.+..+++.||+|++..... ...+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 345789999999999999999999999999999998864321 234799999999999999999998532
Q ss_pred ---------------------------------CCceEEEEEecccCCHHHHhhc--CCCCCCCHHhHHHHHHHHHHHHH
Q psy787 111 ---------------------------------KKQKMYLIMEYCVGGLQDMLDS--TPYKKFPIWQAHGYFLQLLDGLE 155 (235)
Q Consensus 111 ---------------------------------~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~ 155 (235)
...++++|||+++++|.+.+.. .....+++..++.++.|++.||.
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 2345889999999987776653 22367999999999999999999
Q ss_pred HHHhCCcccCCCCCCCeEEc-cCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeee
Q psy787 156 YLHSQGIIHKDIKPGNLLLT-LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 156 ~lH~~~i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 234 (235)
|||+.|++||||||+||+++ .++.++|+|||++..+.. ........+++.|+|||.+.+. ..++.++||||||++
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHH
Confidence 99999999999999999997 678999999999986532 2233445678899999998762 347899999999997
Q ss_pred C
Q psy787 235 L 235 (235)
Q Consensus 235 l 235 (235)
+
T Consensus 232 l 232 (383)
T 3eb0_A 232 F 232 (383)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=252.68 Aligned_cols=195 Identities=24% Similarity=0.313 Sum_probs=158.5
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhh---eeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCR---RAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~---~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
+...++|++.+.||+|+||+||++.+..+++. ||+|+++.... ......+.+|+.++..++||||+++++++
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-- 119 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT---ERQRRDFLSEASIMGQFDHPNIIRLEGVV-- 119 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEE--
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEE--
Confidence 34567899999999999999999998766554 99998864321 23345688999999999999999999999
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
.....+++|||++++ +|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 120 TRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp CGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 556678999999965 7888886543 57999999999999999999999999999999999999999999999999999
Q ss_pred cccCccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......... .......++..|+|||.+.+ ..++.++||||||++|
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il 244 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVM 244 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHH
T ss_pred cccccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHH
Confidence 866432111 11222335667999999977 4589999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=244.54 Aligned_cols=191 Identities=30% Similarity=0.530 Sum_probs=163.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|++|.||++.+..+++.+++|++....... ......+.+|+.++..++|+||+++++++ ....
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~ 87 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYNYF--HDRK 87 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSS
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEEEE--EcCC
Confidence 34578999999999999999999999899999999987654332 23345688999999999999999999999 4566
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..+++||++++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 88999999975 798888765 568999999999999999999999999999999999999999999999999986543
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. .......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 166 ~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 202 (284)
T 2vgo_A 166 S----LRRRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLC 202 (284)
T ss_dssp S----SCBCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHH
T ss_pred c----cccccccCCCCcCCHHHhcc--CCCCcccchhhHHHHH
Confidence 2 22334568899999999987 4589999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=254.91 Aligned_cols=197 Identities=28% Similarity=0.441 Sum_probs=162.3
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccc-------hhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCccee
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSE-------TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGL 103 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 103 (235)
.....++|++.+.||+|+||+||+|.+.. .+..+|+|+++.... ......+.+|+.++..+ +||||+++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC---HHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 34556899999999999999999998643 335789998865421 23345688999999999 89999999
Q ss_pred eeEEEcCCCceEEEEEecccC-CHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCC
Q psy787 104 VDVFVNDKKQKMYLIMEYCVG-GLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIK 168 (235)
Q Consensus 104 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~ 168 (235)
++++ ...+.+++|||++++ +|.+++.... ...+++..++.++.|++.||.|||+.|++|||||
T Consensus 141 ~~~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 218 (382)
T 3tt0_A 141 LGAC--TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218 (382)
T ss_dssp EEEE--CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred eeee--ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 9999 556678999999975 7999987653 2458999999999999999999999999999999
Q ss_pred CCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 169 PGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 169 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+||+++.++.++|+|||++................++..|+|||.+.+ ..++.++||||||+++
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il 283 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLL 283 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHH
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHH
Confidence 9999999999999999999986643222233334456778999999987 4589999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=253.64 Aligned_cols=201 Identities=35% Similarity=0.592 Sum_probs=160.3
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccC-CCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR-IPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
..+.++|++.+.||+|+||+||++.+..+++.+|+|++....... .......+.+|+.++..++||||+++++++ ..
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~ 99 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY--ED 99 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE--EC
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh--cc
Confidence 356789999999999999999999999999999999997654322 234446788999999999999999999999 55
Q ss_pred CceEEEEEecccC-CHHHHhhcCC--------------------------------------CCCCCHHhHHHHHHHHHH
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTP--------------------------------------YKKFPIWQAHGYFLQLLD 152 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~--------------------------------------~~~~~~~~~~~~~~ql~~ 152 (235)
...+++|||++++ +|.+++.... ...+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 6789999999965 6888875210 112356778899999999
Q ss_pred HHHHHHhCCcccCCCCCCCeEEccCC--cEEEeeeccccccCccccC--CcccccCCCCcccCccccCCCCCCCCCcccE
Q psy787 153 GLEYLHSQGIIHKDIKPGNLLLTLDG--TLKISDFGVAESLDMFLHD--DTITTSQGSPVFQAPEIANGLPEISGYKVDI 228 (235)
Q Consensus 153 ~l~~lH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 228 (235)
||.|||+.+++|+||||+||+++.++ .++|+|||++..+...... .......+++.|+|||.+.+....++.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999998776 8999999999865322111 1234556899999999997644568899999
Q ss_pred EEeeeeC
Q psy787 229 WSSGVTL 235 (235)
Q Consensus 229 ~slG~~l 235 (235)
||||++|
T Consensus 260 wslG~il 266 (345)
T 3hko_A 260 WSAGVLL 266 (345)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=259.17 Aligned_cols=190 Identities=27% Similarity=0.474 Sum_probs=162.7
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc------CCCCcceeee
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML------QHRNVIGLVD 105 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~ 105 (235)
.....++|++++.||+|+||+||+|.+..+++.||+|+++... .....+..|+.++..+ .|+||+++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-----chHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 3556778999999999999999999999999999999986432 2234567788888877 4679999999
Q ss_pred EEEcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc--EEEe
Q psy787 106 VFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT--LKIS 183 (235)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~--~~l~ 183 (235)
.+ .....++++||+++++|.+++.......+++..++.++.|++.||.|||+.+++||||||+||+++.++. ++|+
T Consensus 167 ~~--~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 167 NF--TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp EE--EETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred ec--ccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEe
Confidence 99 4556899999999999999998876677999999999999999999999999999999999999999887 9999
Q ss_pred eeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|||++.... .......+++.|+|||.+.+ ..++.++|||||||+|
T Consensus 245 DFG~a~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il 289 (429)
T 3kvw_A 245 DFGSSCYEH-----QRVYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCIL 289 (429)
T ss_dssp CCTTCEETT-----CCCCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHH
T ss_pred ecccceecC-----CcccccCCCCCccChHHHhC--CCCCchHHHHhHHHHH
Confidence 999996443 22334568899999999987 4489999999999974
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=255.76 Aligned_cols=196 Identities=26% Similarity=0.382 Sum_probs=159.6
Q ss_pred eeeceEEeeeeeccccceEEEEee-----ccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEE
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEML-----DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVF 107 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~-----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 107 (235)
...++|++.+.||+|+||.||++. +..+++.||+|+++.... ......+.+|+.++..+ .||||+++++++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC---HHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 345789999999999999999998 667789999999865432 22335688999999999 789999999998
Q ss_pred EcCCCceEEEEEecccC-CHHHHhhcCCC---------------------------------------------------
Q psy787 108 VNDKKQKMYLIMEYCVG-GLQDMLDSTPY--------------------------------------------------- 135 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------------------------------------------- 135 (235)
.. ....++++|||+++ +|.+++.....
T Consensus 96 ~~-~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 96 TK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp CS-TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred ec-CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 53 23458999999975 79988876532
Q ss_pred -------------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCcccc
Q psy787 136 -------------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITT 202 (235)
Q Consensus 136 -------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 202 (235)
..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..............
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence 1288899999999999999999999999999999999999999999999999986543222223334
Q ss_pred cCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 203 SQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 203 ~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..+++.|+|||.+.+ ..++.++||||||+++
T Consensus 255 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il 285 (359)
T 3vhe_A 255 ARLPLKWMAPETIFD--RVYTIQSDVWSFGVLL 285 (359)
T ss_dssp CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred cCCCceeEChhhhcC--CCCCchhhhhhHHHHH
Confidence 456788999999977 4589999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=263.64 Aligned_cols=192 Identities=34% Similarity=0.585 Sum_probs=165.0
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
....++|++.+.||+|+||+||++.+..+++.+|+|++....... ......+.+|+.+++.++||||+++++++ ...
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~ 98 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKLYEFF--EDK 98 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-SSCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECS
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-chHHHHHHHHHHHHHhCCCCCCCcEEEEE--EeC
Confidence 456678999999999999999999999999999999997665433 34456788999999999999999999999 566
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE---ccCCcEEEeeeccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL---TLDGTLKISDFGVA 188 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~ 188 (235)
..+++|||++.+ +|.+.+... ..+++..++.++.|++.||.|||++|++||||||+||++ ..++.++|+|||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 789999999965 688888766 679999999999999999999999999999999999999 45688999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..+.. ........+++.|+|||.+.+ .++.++||||||+++
T Consensus 177 ~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il 217 (484)
T 3nyv_A 177 THFEA---SKKMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVIL 217 (484)
T ss_dssp HHBCC---CCSHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHH
T ss_pred EEccc---ccccccCCCCccccCceeecC---CCCCcceeHHHHHHH
Confidence 76542 233345568999999999865 378999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=261.95 Aligned_cols=190 Identities=34% Similarity=0.564 Sum_probs=157.4
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
.+.++|++++.||+|+||+||+|++..++..+|+|++....... .....+.+|+.+++.++||||+++++++ ....
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~ 109 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNSKLLEEVAVLKLLDHPNIMKLYDFF--EDKR 109 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEE--ECSS
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHhCCCCCCCeEEEEE--EeCC
Confidence 45678999999999999999999999999999999998765433 3345688999999999999999999999 5567
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC---CcEEEeeecccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD---GTLKISDFGVAE 189 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~---~~~~l~dfg~~~ 189 (235)
.+++||||+++ +|.+.+... ..+++..++.++.|++.||.|||+.|++||||||+||+++.. +.++|+|||++.
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 89999999975 688888765 678999999999999999999999999999999999999764 449999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ........+++.|+|||.+.+ .++.++||||||+++
T Consensus 188 ~~~~---~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il 227 (494)
T 3lij_A 188 VFEN---QKKMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVIL 227 (494)
T ss_dssp ECBT---TBCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHH
T ss_pred ECCC---CccccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHH
Confidence 6542 223345568999999999864 378999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=258.69 Aligned_cols=198 Identities=26% Similarity=0.437 Sum_probs=163.5
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
+....++|++.+.||+|+||+||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 345577999999999999999999999999999999998754432 33456789999999999999999999997666
Q ss_pred CceEEEEEecccC-CHHHHhhcCCC-CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE----ccCCcEEEeee
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTPY-KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL----TLDGTLKISDF 185 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili----~~~~~~~l~df 185 (235)
...+++||||+++ +|.+++..... ..+++..++.++.|++.||.|||+.|++||||||+||++ +.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 6688999999975 79888876432 348999999999999999999999999999999999999 66677999999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCCC------CCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGL------PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~~Di~slG~~l 235 (235)
|++..... ........+++.|+|||.+.+. ...++.++||||||+++
T Consensus 161 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il 213 (396)
T 4eut_A 161 GAARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (396)
T ss_dssp GGCEECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHH
T ss_pred CCceEccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHH
Confidence 99986542 2223345689999999987531 02367899999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=249.86 Aligned_cols=193 Identities=31% Similarity=0.547 Sum_probs=164.5
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|.+.+.||+|+||.||++.+..+++.+++|++....... ......+.+|+.+++.++|+||+++++++ ....
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~ 114 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFHGFF--EDND 114 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSS
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEE--ecCC
Confidence 44578999999999999999999999999999999987654332 23445688999999999999999999999 4566
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.++++||++++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 89999999975 688887765 578999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........++..|+|||.+.+ ..++.++||||||+++
T Consensus 193 ~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 231 (335)
T 2owb_A 193 YD--GERKKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIM 231 (335)
T ss_dssp ST--TCCBCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHH
T ss_pred cC--cccccccCCCccccCHHHhcc--CCCCchhhHHHHHHHH
Confidence 21 222334568899999999977 4488999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=255.01 Aligned_cols=193 Identities=27% Similarity=0.438 Sum_probs=155.5
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC--CCCcceeeeEEEcCCC
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ--HRNVIGLVDVFVNDKK 112 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 112 (235)
...+|++++.||+|+||+||++.+.. ++.||+|++...... ......+.+|+.++..++ |+||+++++++. ..
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~--~~ 128 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD--NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--TD 128 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CS
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc--HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe--cC
Confidence 34579999999999999999998865 889999998765432 233456889999999996 599999999984 45
Q ss_pred ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 113 QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 113 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..+++|||+.+++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++ ++.++|+|||++..+.
T Consensus 129 ~~~~lv~E~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 129 QYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp SEEEEEEECCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred CEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 579999997677899999876 5789999999999999999999999999999999999996 6899999999998664
Q ss_pred ccccCCcccccCCCCcccCccccCCC---------CCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGL---------PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~---------~~~~~~~~Di~slG~~l 235 (235)
............+++.|+|||++.+. ...++.++||||||++|
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil 257 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHH
Confidence 32222223455689999999998541 13488899999999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=247.91 Aligned_cols=195 Identities=25% Similarity=0.337 Sum_probs=153.4
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
....++|++.+.||+|+||.||++.+..+++.+++|++....... ......+.+|+..+..++||||+++++++. ..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~ 106 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD-PVFRTRMQREARTAGRLQEPHVVPIHDFGE--ID 106 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--ET
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC-HHHHHHHHHHHHHHhhcCCCCeeEEEEEEe--eC
Confidence 345689999999999999999999998899999999987554322 223356889999999999999999999994 45
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
+.++++||++++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred CeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 688999999976 799988765 57899999999999999999999999999999999999999999999999998755
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... .........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 185 ~~~-~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 225 (309)
T 2h34_A 185 TDE-KLTQLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVL 225 (309)
T ss_dssp -------------CCGGGCCGGGTCC------CCCHHHHHHHHH
T ss_pred ccc-ccccccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHH
Confidence 321 1122234458889999999987 4588999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=248.32 Aligned_cols=196 Identities=27% Similarity=0.371 Sum_probs=159.6
Q ss_pred eeeceEEeeeeeccccceEEEEee----ccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
....+|++++.||+|+||.||+++ +..+++.||+|++..... ......+.+|+.++..++|+||+++++++..
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc---chhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 345679999999999999999998 677899999999875542 2344578899999999999999999999976
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
.....++++||++++ +|.+++.... ..+++..++.++.|++.||++||+.|++|+||||+||+++.++.++|+|||++
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 655778999999975 7999885543 56899999999999999999999999999999999999999999999999999
Q ss_pred cccCccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 219 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTL 219 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHH
Confidence 866432111 12223446777999999977 4478899999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=243.20 Aligned_cols=193 Identities=35% Similarity=0.566 Sum_probs=162.3
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++.+.||+|++|.||++.+..+++.+++|++..... ......+.+|+.++..++|+||+++++++ .....
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 79 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHR--REGNI 79 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEE--EETTE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEE--EcCCE
Confidence 35789999999999999999999998999999999875543 23345688999999999999999999999 45568
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.+++||++++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 8999999976 788888654 5789999999999999999999999999999999999999999999999999976532
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...........+++.|+|||.+.+.. ..+.++||||||+++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il 198 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVL 198 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSS-BCHHHHHHHHHHHHH
T ss_pred CcchhcccCCccccCccChHHHhcCC-CCCCcchHHHHHHHH
Confidence 22222233456888999999997632 246789999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=254.62 Aligned_cols=188 Identities=30% Similarity=0.488 Sum_probs=150.3
Q ss_pred eeeceEEee-eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHh-cCCCCcceeeeEEEc--
Q psy787 34 KMIGKYVMG-DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM-LQHRNVIGLVDVFVN-- 109 (235)
Q Consensus 34 ~~~~~y~i~-~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~-- 109 (235)
...+.|.+. +.||.|+||+||++.+..+++.||+|+++.. ..+.+|+.++.+ .+|+||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 345677777 7899999999999999999999999998532 246788887754 589999999998842
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc---CCcEEEeee
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL---DGTLKISDF 185 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~---~~~~~l~df 185 (235)
.+...+++||||+++ +|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++. ++.++|+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 235678999999975 7999998765567999999999999999999999999999999999999997 688999999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|++..... ........+++.|+|||++.+ ..++.++||||||++|
T Consensus 209 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 253 (400)
T 1nxk_A 209 GFAKETTS---HNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIM 253 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCC--CCSSSHHHHHHHHHHH
T ss_pred ccccccCC---CCccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHH
Confidence 99985532 222345567899999999977 5589999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=249.99 Aligned_cols=196 Identities=32% Similarity=0.518 Sum_probs=157.8
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
+-....++|++++.||+|+||.||++++..+++.||+|++...... ......+.+|+.++..++||||+++++++ .
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~ 94 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD--KMVKKIAMREIKLLKQLRHENLVNLLEVC--K 94 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE--E
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc--hHHHHHHHHHHHHHhhCCCCCEeeEEEEe--e
Confidence 4445678999999999999999999999999999999988654322 22334577899999999999999999999 4
Q ss_pred CCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 111 KKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 111 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
....+++|||+++++ |.++.... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 95 ~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 172 (331)
T 4aaa_A 95 KKKRWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR 172 (331)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred cCCEEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCce
Confidence 566889999999886 44444433 569999999999999999999999999999999999999999999999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... ........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 173 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il 215 (331)
T 4aaa_A 173 TLAAP--GEVYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLV 215 (331)
T ss_dssp -------------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHH
T ss_pred eecCC--ccccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHH
Confidence 55321 2223345588899999998762 2478999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=247.39 Aligned_cols=192 Identities=24% Similarity=0.328 Sum_probs=164.1
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|++|+||++.+..+++.+++|++.... .....+.+|+.+++.++||||+++++++ ....
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~ 82 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREP 82 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-----THHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEE--ccCC
Confidence 35678999999999999999999999999999999886432 3345688999999999999999999999 5666
Q ss_pred eEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++|||+++ ++|.+++.......+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 7899999997 579999988766779999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 163 ~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 202 (288)
T 3kfa_A 163 GDT-YTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLL 202 (288)
T ss_dssp SSS-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred CCc-cccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHH
Confidence 221 112223335678999999977 4489999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=249.48 Aligned_cols=186 Identities=31% Similarity=0.502 Sum_probs=141.6
Q ss_pred eeceEEee---eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcC
Q psy787 35 MIGKYVMG---DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVND 110 (235)
Q Consensus 35 ~~~~y~i~---~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 110 (235)
..++|.+. +.||+|+||+||++.+..+++.+|+|++.... ...+.+|+.++..+. ||||+++++++ .
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~l~~l~~h~niv~~~~~~--~ 76 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-------EANTQKEITALKLCEGHPNIVKLHEVF--H 76 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-------HHHHHHHHHHHHHTTTCTTBCCEEEEE--E
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh-------hhhHHHHHHHHHHhcCCCCeeEEEEEE--E
Confidence 34577776 78999999999999999999999999986432 235778999999996 99999999999 5
Q ss_pred CCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC---cEEEeeec
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG---TLKISDFG 186 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~---~~~l~dfg 186 (235)
.....++|||++++ +|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 77 DQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred cCCEEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 56788999999975 799988876 6799999999999999999999999999999999999998766 79999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++..... .........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 155 ~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il 199 (325)
T 3kn6_A 155 FARLKPP--DNQPLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVIL 199 (325)
T ss_dssp TCEECCC--------------------------CCCCHHHHHHHHHHHH
T ss_pred cceecCC--CCCcccccCCCcCccCHHHhcC--CCCCCccchHHHHHHH
Confidence 9975532 1223334557899999999987 4489999999999974
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=253.82 Aligned_cols=206 Identities=21% Similarity=0.226 Sum_probs=157.4
Q ss_pred cCCceeEeeeceEEeeeeeccccceEEEEeeccch-----hhheeeeeeeeccccCCC-------CccccHHHHHHHHHh
Q psy787 27 DNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSET-----LCRRAVKIFKKKKLQRIP-------NGEINVDREIRLLKM 94 (235)
Q Consensus 27 ~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~~~~~-------~~~~~~~~e~~~l~~ 94 (235)
.+..+.....++|++++.||+|+||+||++.+..+ ++.||+|++......... .....+..++..+..
T Consensus 25 ~g~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~ 104 (364)
T 3op5_A 25 VGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRK 104 (364)
T ss_dssp TTCEEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCcEeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhh
Confidence 34444445566999999999999999999987654 588999988654311000 001123344455666
Q ss_pred cCCCCcceeeeEEEcCC--CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCe
Q psy787 95 LQHRNVIGLVDVFVNDK--KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNL 172 (235)
Q Consensus 95 l~h~~i~~~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~ni 172 (235)
++|+||+++++++.... ....++|||+++++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||
T Consensus 105 l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Ni 183 (364)
T 3op5_A 105 LKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNL 183 (364)
T ss_dssp CSCCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred ccCCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHE
Confidence 78999999999986432 35689999999778999887643 6799999999999999999999999999999999999
Q ss_pred EEc--cCCcEEEeeeccccccCccccC-----CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 173 LLT--LDGTLKISDFGVAESLDMFLHD-----DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 173 li~--~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+++ .++.++|+|||++..+...... .......+++.|+|||.+.+ ..++.++||||||++|
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l 251 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCM 251 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHH
Confidence 999 7899999999999765422111 11123448999999999988 4489999999999974
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=249.74 Aligned_cols=200 Identities=20% Similarity=0.296 Sum_probs=153.5
Q ss_pred ceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccc-cCCCCccccHHHHHHHHHhcCCCCcceeeeEEE
Q psy787 30 TIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKL-QRIPNGEINVDREIRLLKMLQHRNVIGLVDVFV 108 (235)
Q Consensus 30 ~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (235)
.+.....++|++.+.||+|+||+||++.+..+++.+++|+..+... .........+.+|+.++..++||||+++++++.
T Consensus 8 ~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 87 (327)
T 3poz_A 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp SSEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred HHhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 3445566789999999999999999999888888775544332221 112244457889999999999999999999995
Q ss_pred cCCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 109 NDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 109 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
. . ..+++++++. ++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.+++++|+|||+
T Consensus 88 ~--~-~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 88 T--S-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp S--S-SEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred c--C-CeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcc
Confidence 3 2 3678889886 56888887653 5789999999999999999999999999999999999999999999999999
Q ss_pred ccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+................++..|+|||.+.+ ..++.++||||||+++
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il 209 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTV 209 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred eeEccCCcccccccCCCccccccChHHhcc--CCCCchhhhhhhHHHH
Confidence 986643333333334446778999999987 4589999999999974
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=252.04 Aligned_cols=189 Identities=23% Similarity=0.318 Sum_probs=155.7
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC--Cce
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK--KQK 114 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 114 (235)
++|++.+.||+|+||+||++++. ++.||+|++.... ........|+..+..++||||+++++++.... ...
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 58999999999999999999874 7899999986543 22234567888899999999999999996433 345
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC----------CcccCCCCCCCeEEccCCcEEEe
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ----------GIIHKDIKPGNLLLTLDGTLKIS 183 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----------~i~H~dl~p~nili~~~~~~~l~ 183 (235)
+++||||+++ +|.+++.. ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 7999999975 79999876 4589999999999999999999999 99999999999999999999999
Q ss_pred eeccccccCccccCCcccccCCCCcccCccccCCCC---CCCCCcccEEEeeeeC
Q psy787 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLP---EISGYKVDIWSSGVTL 235 (235)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~~Di~slG~~l 235 (235)
|||++..+.............+++.|+|||.+.+.. ..++.++||||||+++
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il 228 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHH
Confidence 999998664333333334456899999999987621 1356688999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=253.69 Aligned_cols=195 Identities=33% Similarity=0.483 Sum_probs=147.3
Q ss_pred ceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 30 TIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 30 ~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
.......++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 99 (367)
T 2fst_X 22 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLLDVFTP 99 (367)
T ss_dssp TEEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CcccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 34556778999999999999999999999999999999988653211 2234567899999999999999999999853
Q ss_pred C----CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeee
Q psy787 110 D----KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDF 185 (235)
Q Consensus 110 ~----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~df 185 (235)
. ....+++++++++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 100 ARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CSSGGGCCCCEEEEECCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred CCccccCCeEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeec
Confidence 2 1246799999998888887765 56899999999999999999999999999999999999999999999999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|++..... ......++..|+|||.+.+. ..++.++|||||||++
T Consensus 177 G~a~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 220 (367)
T 2fst_X 177 GLARHTAD-----EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIM 220 (367)
T ss_dssp -------------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHH
T ss_pred cccccccc-----cCCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHH
Confidence 99975431 23345688999999998762 3488999999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=251.94 Aligned_cols=200 Identities=33% Similarity=0.504 Sum_probs=161.8
Q ss_pred eeecCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCccee
Q psy787 24 VIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGL 103 (235)
Q Consensus 24 ~~~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 103 (235)
...+.......+.++|.+.+.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++
T Consensus 29 ~~~~~~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~ 106 (371)
T 4exu_A 29 YKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHENVIGL 106 (371)
T ss_dssp EEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS--HHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred eeeeeccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc--hhHHHHHHHHHHHHHhcCCCCchhh
Confidence 33444455567789999999999999999999999999999999998654322 2334567899999999999999999
Q ss_pred eeEEEcCCCc----eEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc
Q psy787 104 VDVFVNDKKQ----KMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT 179 (235)
Q Consensus 104 ~~~~~~~~~~----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~ 179 (235)
++++...... .++++||+++++|.+.+. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.
T Consensus 107 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~ 182 (371)
T 4exu_A 107 LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE 182 (371)
T ss_dssp SEEECSCSSSTTCCCCEEEEECCCEEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred hhheeccCCcccceeEEEEEccccccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC
Confidence 9999533221 249999999998887774 34899999999999999999999999999999999999999999
Q ss_pred EEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 180 LKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++|+|||++..... ......+++.|+|||.+.+. ..++.++||||||+++
T Consensus 183 ~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 232 (371)
T 4exu_A 183 LKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIM 232 (371)
T ss_dssp EEECSTTCC-------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHH
T ss_pred EEEEecCccccccc-----CcCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHH
Confidence 99999999975532 23345578999999998762 3488999999999974
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=259.86 Aligned_cols=194 Identities=27% Similarity=0.370 Sum_probs=158.5
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|+||.||++.+..+++.||+|+++.... ......+.+|+.+++.++||||+++++++ ....
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~ 185 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP---PDLKAKFLQEARILKQYSHPNIVRLIGVC--TQKQ 185 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC---HHHHTTTTHHHHHHTTCCCTTBCCEEEEE--CSSS
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC---HHHHHHHHHHHHHHHhCCCCCEEEEEEEE--ecCC
Confidence 345689999999999999999999988899999998864321 22334688999999999999999999999 5556
Q ss_pred eEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++|||+++ ++|.+++.... ..++...++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 7899999997 57888887542 458999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
............++..|+|||.+.+ ..++.++||||||++|
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il 305 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILL 305 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHH
Confidence 2111111111223567999999976 4588999999999974
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=242.97 Aligned_cols=194 Identities=23% Similarity=0.306 Sum_probs=156.0
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
.....++|++.+.||+|+||+||++.+..+++.||+|++...... ..+.+|+.++..++|++++..+..+. ..
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~-~~ 76 (296)
T 4hgt_A 4 ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCG-AE 76 (296)
T ss_dssp -------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C------CCHHHHHHHHHHHTTSTTCCCEEEEE-EE
T ss_pred ccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc------hHHHHHHHHHHHhcCCCCCCeeeeec-CC
Confidence 445678999999999999999999999899999999986554322 35889999999999988777777664 34
Q ss_pred CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE---ccCCcEEEeeeccc
Q psy787 112 KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL---TLDGTLKISDFGVA 188 (235)
Q Consensus 112 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~ 188 (235)
....+++||+++++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++
T Consensus 77 ~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 77 GDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred CCceEEEEEccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 56789999999888999887543 569999999999999999999999999999999999999 78899999999999
Q ss_pred cccCccccC-----CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHD-----DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......... .......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 205 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVL 205 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHH
Confidence 866432211 12234568899999999988 4489999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=252.13 Aligned_cols=193 Identities=30% Similarity=0.456 Sum_probs=161.0
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC---C
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK---K 112 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~ 112 (235)
.++|++++.||+|+||+||++.+..+++.||+|++.... .......+.+|+.++..++||||+++++++.... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc---CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 368999999999999999999999999999999986432 1233356889999999999999999999985322 2
Q ss_pred ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 113 QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 113 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..++++||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 103 ~~~~iv~e~~~~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 103 KDVYIVQDLMETDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CCEEEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEcccCcCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 46899999999999998876 468999999999999999999999999999999999999999999999999998664
Q ss_pred ccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... .......+++.|+|||.+.+. ..++.++||||||+++
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il 222 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCIL 222 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHH
Confidence 32211 122345689999999986542 3478999999999974
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=252.80 Aligned_cols=196 Identities=22% Similarity=0.298 Sum_probs=160.4
Q ss_pred EeeeceEEeeeeeccccceEEEEeecc-----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDS-----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
....++|++++.||+|+||.||++.+. .+++.||+|+++.... ......+.+|+.++..++||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344578999999999999999999886 3558899999865431 23345688999999999999999999999
Q ss_pred EcCCCceEEEEEecccC-CHHHHhhcCC----------------------CCCCCHHhHHHHHHHHHHHHHHHHhCCccc
Q psy787 108 VNDKKQKMYLIMEYCVG-GLQDMLDSTP----------------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIH 164 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H 164 (235)
.....+++||||+++ +|.+++.... ...+++..++.++.|++.||.|||+.|++|
T Consensus 120 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 120 --AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred --ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 556678999999975 7999887642 156899999999999999999999999999
Q ss_pred CCCCCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 165 KDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 165 ~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+||||+||+++.++.++|+|||++................++..|+|||.+.+ ..++.++||||||+++
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il 266 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVL 266 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc--CCcCcccccHHHHHHH
Confidence 99999999999999999999999976543222222334456788999999877 4489999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=247.48 Aligned_cols=194 Identities=27% Similarity=0.471 Sum_probs=161.5
Q ss_pred EeeeceEEee-eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcC
Q psy787 33 VKMIGKYVMG-DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVND 110 (235)
Q Consensus 33 ~~~~~~y~i~-~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 110 (235)
+.+.++|.+. +.||+|+||+||++.+..+++.||+|++....... .....+.+|+.++..+. ||||+++++++ .
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~iv~~~~~~--~ 99 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ--DCRAEILHEIAVLELAKSCPRVINLHEVY--E 99 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE--ECHHHHHHHHHHHHHTTTCTTBCCEEEEE--E
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHHhccCCCCEEEEEEEE--E
Confidence 3456788988 89999999999999999999999999997655332 34456889999999985 69999999999 5
Q ss_pred CCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc---CCcEEEeeec
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL---DGTLKISDFG 186 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~---~~~~~l~dfg 186 (235)
....+++|||++.+ +|.+++.......+++..++.++.|++.||.+||+.|++||||||+||+++. ++.++|+|||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 66789999999976 6888887665678999999999999999999999999999999999999997 7899999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++..... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 180 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 223 (327)
T 3lm5_A 180 MSRKIGH---ACELREIMGTPEYLAPEILNY--DPITTATDMWNIGIIA 223 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred cccccCC---ccccccccCCcCccCCeeecC--CCCCchhhHHHHHHHH
Confidence 9986542 222334568999999999987 4589999999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=243.86 Aligned_cols=196 Identities=31% Similarity=0.549 Sum_probs=159.7
Q ss_pred CceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEE
Q psy787 29 KTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFV 108 (235)
Q Consensus 29 ~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (235)
....-.+.++|++.+.||+|+||+||++.+..+++.+++|++..... ......+.+|+.+++.++||||+++++++
T Consensus 14 ~~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~- 89 (285)
T 3is5_A 14 LYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPNIIKIFEVF- 89 (285)
T ss_dssp CEESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred CCCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCchHHhHHHhe-
Confidence 33444567899999999999999999999999999999999876542 23345788999999999999999999999
Q ss_pred cCCCceEEEEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc---cCCcEEE
Q psy787 109 NDKKQKMYLIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT---LDGTLKI 182 (235)
Q Consensus 109 ~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~---~~~~~~l 182 (235)
......++|||++++ +|.+.+... ....+++..++.++.|++.||.+||+.|++|+||||+||+++ .++.++|
T Consensus 90 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl 168 (285)
T 3is5_A 90 -EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKI 168 (285)
T ss_dssp -ECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred -ecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEE
Confidence 556689999999975 688877543 226689999999999999999999999999999999999994 4578999
Q ss_pred eeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 183 SDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|||++..... ........+++.|+|||.+.+ .++.++||||||+++
T Consensus 169 ~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il 215 (285)
T 3is5_A 169 IDFGLAELFKS---DEHSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVM 215 (285)
T ss_dssp CCCCCCCC-------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHH
T ss_pred EeeecceecCC---cccCcCcccccCcCChHHhcc---CCCcccCeehHHHHH
Confidence 99999976542 222344568899999999864 378999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=242.38 Aligned_cols=189 Identities=22% Similarity=0.305 Sum_probs=157.6
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++++.||+|+||+||++.+. +++.+|+|++.... .....+.+|+.++.+++||||+++++++ .....
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~ 79 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVC--LEQAP 79 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSS
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-----cCHHHHHHHHHHHHhCCCCCEeeEEEEE--ecCCc
Confidence 3468999999999999999999886 46779999887543 2234688999999999999999999999 55667
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
++++||++++ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred eEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 8999999975 6888886543 5689999999999999999999999999999999999999999999999999975532
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........++..|+|||.+.+ ..++.++||||||+++
T Consensus 159 ~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 197 (269)
T 4hcu_A 159 DQ-YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLM 197 (269)
T ss_dssp HH-HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred cc-cccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHH
Confidence 11 112223345677999999977 4489999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=256.94 Aligned_cols=198 Identities=24% Similarity=0.296 Sum_probs=158.5
Q ss_pred eeEeeeceEEeeeeeccccceEEEEee-----ccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeee
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEML-----DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVD 105 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~-----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 105 (235)
+.....++|++++.||+|+||+||+|. +..+++.||+|+++.... ......+.+|+.++..++||||+++++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~ 141 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS---EQDELDFLMEALIISKFNHQNIVRCIG 141 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC---HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC---hhhHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 344556889999999999999999998 445678899998854321 233446889999999999999999999
Q ss_pred EEEcCCCceEEEEEecccC-CHHHHhhcCC-----CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-
Q psy787 106 VFVNDKKQKMYLIMEYCVG-GLQDMLDSTP-----YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG- 178 (235)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~- 178 (235)
++ ......++|||++++ +|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 142 ~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 142 VS--LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp EE--CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred EE--ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCC
Confidence 99 455677999999965 7999887643 24589999999999999999999999999999999999999555
Q ss_pred --cEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 179 --TLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 179 --~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++|+|||++................+++.|+|||.+.+ ..++.++||||||++|
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il 276 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLL 276 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHH
Confidence 499999999975532222223334456888999999877 4589999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=269.27 Aligned_cols=193 Identities=31% Similarity=0.414 Sum_probs=164.2
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (235)
...++|++++.||+|+||+||++++..+++.||+|++++..... ......+..|..++..+ .|++|+.+++.+ ...
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~--~~~ 414 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTM 414 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEEC--BCS
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEE--EeC
Confidence 34578999999999999999999999999999999998764433 24445677888888877 799999999999 666
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++..
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred CEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 789999999975 688888765 57999999999999999999999999999999999999999999999999999753
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .........+|+.|+|||++.+ ..++.++||||||++|
T Consensus 493 ~~--~~~~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvil 532 (674)
T 3pfq_A 493 IW--DGVTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLL 532 (674)
T ss_dssp CC--TTCCBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHH
T ss_pred cc--CCcccccccCCCcccCHhhhcC--CCCCccceEechHHHH
Confidence 21 2233445678999999999987 4589999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=250.66 Aligned_cols=187 Identities=34% Similarity=0.546 Sum_probs=157.3
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDK 111 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 111 (235)
..+.++|++.+.||.|+||+||++.+..+++.+|+|++..... ...+|+.++.++ +||||+++++++ ..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~--~~ 87 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVY--DD 87 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEE--EC
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEE--Ec
Confidence 3467789999999999999999999999999999999865432 245788888887 799999999999 56
Q ss_pred CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC-C---cEEEeeec
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD-G---TLKISDFG 186 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~-~---~~~l~dfg 186 (235)
...+++|||++++ +|.+.+... ..+++..+..++.|++.||.|||+.|++||||||+||++... + .++|+|||
T Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 88 GKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 6789999999965 688888765 679999999999999999999999999999999999998543 2 49999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++..... .........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 166 ~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 210 (342)
T 2qr7_A 166 FAKQLRA--ENGLLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLL 210 (342)
T ss_dssp TCEECBC--TTCCBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHH
T ss_pred CcccCcC--CCCceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHH
Confidence 9986532 1223345568999999999976 3478899999999974
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=250.52 Aligned_cols=196 Identities=26% Similarity=0.397 Sum_probs=158.5
Q ss_pred EeeeceEEeeeeeccccceEEEEeec-----cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeE
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLD-----SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDV 106 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 106 (235)
+...++|++.+.||+|+||+||++.+ ..++..||+|++..... ......+.+|+.++..+ .||||++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD---SSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC---HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34557899999999999999999986 34667899999875432 23456788999999999 89999999999
Q ss_pred EEcCCCceEEEEEecccC-CHHHHhhcCCC---------------------CCCCHHhHHHHHHHHHHHHHHHHhCCccc
Q psy787 107 FVNDKKQKMYLIMEYCVG-GLQDMLDSTPY---------------------KKFPIWQAHGYFLQLLDGLEYLHSQGIIH 164 (235)
Q Consensus 107 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H 164 (235)
+ ...+.+++|||++++ +|.+++..... ..+++..++.++.|++.||.|||+.|++|
T Consensus 118 ~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 195 (344)
T 1rjb_A 118 C--TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 195 (344)
T ss_dssp E--CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred E--eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 9 456678999999965 79998876532 23789999999999999999999999999
Q ss_pred CCCCCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 165 KDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 165 ~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+||||+||+++.++.++|+|||++................+++.|+|||.+.+ ..++.++||||||++|
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il 264 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILL 264 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHH
Confidence 99999999999999999999999986643222222233346778999999877 4489999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=242.15 Aligned_cols=194 Identities=36% Similarity=0.606 Sum_probs=156.6
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
....++|++.+.||+|++|.||++.+..+++.+++|++....... ......+.+|+..+..++||||+++++++ ...
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~ 83 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRS-LDVVGKIKREIQNLKLFRHPHIIKLYQVI--STP 83 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECS
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccc-hhHHHHHHHHHHHHhcCCCCCEeEEEEEE--ecC
Confidence 345689999999999999999999998899999999997654332 23445688999999999999999999999 456
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
...+++||++++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred CeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 688999999965 799988765 56899999999999999999999999999999999999999999999999999765
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........+++.|+|||.+.+.. ..+.++||||||+++
T Consensus 162 ~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l 201 (276)
T 2h6d_A 162 SD---GEFLRTSCGSPNYAAPEVISGRL-YAGPEVDIWSCGVIL 201 (276)
T ss_dssp CC----------------CCTGGGTTSC-CCHHHHHHHHHHHHH
T ss_pred CC---CcceecccCCccccCHHHHcCCC-CCCccchHHHHHHHH
Confidence 42 12223445788999999997632 236899999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=245.59 Aligned_cols=193 Identities=26% Similarity=0.495 Sum_probs=162.4
Q ss_pred cCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeee
Q psy787 27 DNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVD 105 (235)
Q Consensus 27 ~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~ 105 (235)
....+.....++|++++.||+|+||+||+|++..+++.||+|+++... ...+.+|+.++..++ |+||+++++
T Consensus 26 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~ 98 (330)
T 3nsz_A 26 ESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLAD 98 (330)
T ss_dssp GGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred hhhhhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeee
Confidence 445566667789999999999999999999999999999999986332 346889999999997 999999999
Q ss_pred EEEcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-cEEEe
Q psy787 106 VFVNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-TLKIS 183 (235)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-~~~l~ 183 (235)
++........+++||++.+ +|.+++. .+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+
T Consensus 99 ~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~ 173 (330)
T 3nsz_A 99 IVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 173 (330)
T ss_dssp EEECTTTCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred eeccCCCCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEE
Confidence 9975556788999999975 5777664 378899999999999999999999999999999999999776 89999
Q ss_pred eeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|||++..... ........++..|+|||.+.+. ..++.++||||||++|
T Consensus 174 Dfg~a~~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il 221 (330)
T 3nsz_A 174 DWGLAEFYHP---GQEYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCML 221 (330)
T ss_dssp CCTTCEECCT---TCCCCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHH
T ss_pred eCCCceEcCC---CCccccccccccccChhhhcCC-CcCCchhhHHHHHHHH
Confidence 9999975542 2233345688889999998652 3488999999999974
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=241.68 Aligned_cols=194 Identities=23% Similarity=0.305 Sum_probs=160.8
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
.....++|++.+.||+|++|+||++++..+++.+|+|++..... ...+.+|+.++..++|++++..+..+. ..
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~-~~ 76 (296)
T 3uzp_A 4 ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCG-AE 76 (296)
T ss_dssp -CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEE-EE
T ss_pred cceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCcccccc-CC
Confidence 34567899999999999999999999989999999998765432 235889999999999988777776654 34
Q ss_pred CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE---ccCCcEEEeeeccc
Q psy787 112 KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL---TLDGTLKISDFGVA 188 (235)
Q Consensus 112 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~ 188 (235)
....+++||+++++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++
T Consensus 77 ~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 77 GDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred CCceEEEEEecCCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 56789999999888999987543 579999999999999999999999999999999999999 47889999999999
Q ss_pred cccCccccC-----CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHD-----DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......... .......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 205 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVL 205 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHH
Confidence 866432211 11234568899999999988 4489999999999974
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=251.42 Aligned_cols=208 Identities=18% Similarity=0.225 Sum_probs=160.1
Q ss_pred eeecCCceeEeeeceEEeeeeeccccceEEEEeeccc---hhhheeeeeeeeccccCC-------CCccccHHHHHHHHH
Q psy787 24 VIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSE---TLCRRAVKIFKKKKLQRI-------PNGEINVDREIRLLK 93 (235)
Q Consensus 24 ~~~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~-------~~~~~~~~~e~~~l~ 93 (235)
.+..+..+.....++|++.+.||+|+||+||+|.+.. ++..+++|+......... ......+.+|+..+.
T Consensus 24 ~l~~g~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~ 103 (345)
T 2v62_A 24 PFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103 (345)
T ss_dssp -CCTTCEEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred cCCCCCeeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhc
Confidence 3445555566667899999999999999999999876 788999998875432100 001223567888888
Q ss_pred hcCCCCcceeeeEEEc--CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q psy787 94 MLQHRNVIGLVDVFVN--DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGN 171 (235)
Q Consensus 94 ~l~h~~i~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~n 171 (235)
.++|+||+++++++.. .....+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+|
T Consensus 104 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 181 (345)
T 2v62_A 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAAN 181 (345)
T ss_dssp TCSCCCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred cccccCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHH
Confidence 8999999999999864 225688999999977899998765 479999999999999999999999999999999999
Q ss_pred eEEccCC--cEEEeeeccccccCcccc-----CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 172 LLLTLDG--TLKISDFGVAESLDMFLH-----DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 172 ili~~~~--~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+++.++ .++|+|||++..+..... ........++..|+|||.+.+ ..++.++||||||++|
T Consensus 182 Ill~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 250 (345)
T 2v62_A 182 LLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCM 250 (345)
T ss_dssp EEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHH
T ss_pred EEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHH
Confidence 9999887 999999999976532111 111234568899999999987 4589999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=250.60 Aligned_cols=194 Identities=26% Similarity=0.352 Sum_probs=160.9
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
....++|++.+.||+|+||+||++.+. +++.||+|++.... ......+.+|+.++..++||||+++++++ ...
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~ 107 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES----SQGIEEFETEIETLSFCRHPHLVSLIGFC--DER 107 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC----SSHHHHHHHHHHGGGSCCCTTBCCEEEEC--CCT
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEE--cCC
Confidence 346679999999999999999999964 68899999875442 23445688999999999999999999999 556
Q ss_pred ceEEEEEecccC-CHHHHhhcCCC--CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPY--KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
+..++|||++++ +|.+++..... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 678999999975 78888865432 358999999999999999999999999999999999999999999999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...............+++.|+|||.+.+ ..++.++||||||+++
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 231 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVL 231 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHH
T ss_pred ccccccccccccccCCCccccCHHHhcC--CCCCcccchHhHHHHH
Confidence 5432222222333447889999999877 4589999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=260.91 Aligned_cols=191 Identities=19% Similarity=0.267 Sum_probs=151.6
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHH---HHHHhcCCCCcceee-------e
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREI---RLLKMLQHRNVIGLV-------D 105 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~ 105 (235)
.++|++.+.||+|+||+||+|.+..+|+.||+|++....... ......+.+|+ ..+..++||||++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC-TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc-hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 578999999999999999999998899999999998654433 23445688999 455555899999998 5
Q ss_pred EEEcCCC----------c-----eEEEEEecccCCHHHHhhcCCCCCCC-------HHhHHHHHHHHHHHHHHHHhCCcc
Q psy787 106 VFVNDKK----------Q-----KMYLIMEYCVGGLQDMLDSTPYKKFP-------IWQAHGYFLQLLDGLEYLHSQGII 163 (235)
Q Consensus 106 ~~~~~~~----------~-----~~~lv~e~~~~~l~~~~~~~~~~~~~-------~~~~~~~~~ql~~~l~~lH~~~i~ 163 (235)
++...+. + ..+++||+++|+|.+++... ..++ +..++.++.|++.||+|||+.|++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~--~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL--LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHH--HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhc--cccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 5422111 0 37899999988999998764 2233 478888999999999999999999
Q ss_pred cCCCCCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCC---------CCCCCCcccEEEeeee
Q psy787 164 HKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGL---------PEISGYKVDIWSSGVT 234 (235)
Q Consensus 164 H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---------~~~~~~~~Di~slG~~ 234 (235)
||||||+||+++.++.++|+|||++.... .......+ +.|+|||.+.+. ...++.++||||||++
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 99999999999999999999999997533 22334456 889999999763 0158999999999997
Q ss_pred C
Q psy787 235 L 235 (235)
Q Consensus 235 l 235 (235)
|
T Consensus 303 l 303 (377)
T 3byv_A 303 I 303 (377)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=245.41 Aligned_cols=195 Identities=30% Similarity=0.500 Sum_probs=157.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCC-
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDK- 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~- 111 (235)
...++|++++.||+|+||.||++.+..+++.+++|++.... .....+.+|+.++..+ +||||+++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 35678999999999999999999999899999999986543 3345688999999998 7999999999996532
Q ss_pred ---CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 112 ---KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 112 ---~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
...+++|||++++ +|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 4678999999976 799998876556799999999999999999999999999999999999999999999999999
Q ss_pred ccccCccccCCcccccCCCCcccCccccCCC---CCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~l 235 (235)
+...... ........+++.|+|||.+... ...++.++||||||+++
T Consensus 176 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 224 (326)
T 2x7f_A 176 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224 (326)
T ss_dssp TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHH
T ss_pred ceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHH
Confidence 8765421 1122344588999999998621 24578999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=243.67 Aligned_cols=188 Identities=29% Similarity=0.489 Sum_probs=159.1
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
.+.++|.+.+.||+|+||+||++.+..+++.+++|+++.... .....+.+|+.++..++||||+++++++ ....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~ 79 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDSSLENEIAVLKKIKHENIVTLEDIY--ESTT 79 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc----cchHHHHHHHHHHHhCCCCCeeehhhhc--ccCC
Confidence 456789999999999999999999998999999999975432 2234688999999999999999999999 4566
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE---ccCCcEEEeeecccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL---TLDGTLKISDFGVAE 189 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~ 189 (235)
.++++||++++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 89999999975 788888765 568999999999999999999999999999999999999 677899999999987
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... .......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 158 ~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 197 (304)
T 2jam_A 158 MEQN----GIMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIT 197 (304)
T ss_dssp CCCC----BTTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHH
T ss_pred ecCC----CccccccCCCCccChHHhcc--CCCCchhhHHHHHHHH
Confidence 4431 22233458899999999987 4589999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=247.21 Aligned_cols=195 Identities=26% Similarity=0.386 Sum_probs=160.6
Q ss_pred eeeceEEeeeeeccccceEEEEee-----ccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEE
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEML-----DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVF 107 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~-----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 107 (235)
...++|++.+.||+|+||+||++. +..+++.+|+|+++.... ......+.+|+.++..+ +||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH---LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh---HHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 445789999999999999999997 355788999999865432 12345688999999999 999999999999
Q ss_pred EcCCCceEEEEEecccC-CHHHHhhcCCC----------------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q psy787 108 VNDKKQKMYLIMEYCVG-GLQDMLDSTPY----------------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPG 170 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~ 170 (235)
......+++||++++ +|.+++..... ..+++..++.++.|++.||.+||+.|++|+||||+
T Consensus 97 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 97 --TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp --CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred --ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 555678999999975 79998876532 25899999999999999999999999999999999
Q ss_pred CeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 171 NLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 171 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||+++.++.++|+|||++................+++.|+|||.+.+ ..++.++||||||+++
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 237 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFL 237 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHH
Confidence 99999999999999999986643222222223345678999999877 4589999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=249.06 Aligned_cols=195 Identities=30% Similarity=0.455 Sum_probs=154.9
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCC-------ccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN-------GEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
..++|++++.||+|+||.||++.+.. ++.||+|++.......... ....+.+|+.++..++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45789999999999999999998864 8999999987655432111 125688999999999999999999998
Q ss_pred Ec---CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEee
Q psy787 108 VN---DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISD 184 (235)
Q Consensus 108 ~~---~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~d 184 (235)
.. .....+++|||+++++|.+.+.... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 64 2334789999999999888887543 5799999999999999999999999999999999999999999999999
Q ss_pred eccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||++..... ........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 178 fg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 224 (362)
T 3pg1_A 178 FNLAREDTA---DANKTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVM 224 (362)
T ss_dssp TTC------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHH
T ss_pred cCccccccc---ccccceecccceecCcHHhcCC-CCCCcHhHHHhHHHHH
Confidence 999974431 2223345578889999998762 3478999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=243.85 Aligned_cols=192 Identities=26% Similarity=0.394 Sum_probs=159.1
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDK 111 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 111 (235)
....++|++.+.||+|++|+||++.+..+++.+|+|++...... ......+.+|+..+..+ +||||+++++++. .
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~--~ 82 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG--SVDEQNALREVYAHAVLGQHSHVVRYFSAWA--E 82 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT--SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE--E
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeeee--c
Confidence 34567899999999999999999999989999999998765432 23445678899999998 9999999999994 5
Q ss_pred CceEEEEEecccC-CHHHHhhcCC--CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC-----------
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTP--YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD----------- 177 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~----------- 177 (235)
...+++|||++++ +|.+++.... ...+++..++.++.|++.||.|||++|++|+||||+||+++.+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence 5688999999965 7998887542 2568999999999999999999999999999999999999844
Q ss_pred --------CcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 178 --------GTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 178 --------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..++|+|||.+..... .....+++.|+|||.+.+. ..+++++||||||+++
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il 221 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQEN-YTHLPKADIFALALTV 221 (289)
T ss_dssp -------CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHH
T ss_pred cccccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCC-CCCCchhhHHHHHHHH
Confidence 4799999999975532 2234488999999999763 2466899999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=241.57 Aligned_cols=196 Identities=31% Similarity=0.483 Sum_probs=165.9
Q ss_pred CCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 28 ~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
...+......+|++++.||+|++|.||++.+..+++.+++|++..... ......+.+|+.++..++|+||+++++.+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 89 (303)
T 3a7i_A 13 MQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSY 89 (303)
T ss_dssp CTTCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 344455666789999999999999999999988999999999876543 23456788999999999999999999999
Q ss_pred EcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeec
Q psy787 108 VNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
. ....+++|||++++ +|.+++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus 90 ~--~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg 164 (303)
T 3a7i_A 90 L--KDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFG 164 (303)
T ss_dssp E--ETTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred e--cCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecc
Confidence 5 45678999999976 68888764 568999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++...... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 165 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 209 (303)
T 3a7i_A 165 VAGQLTDT--QIKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITA 209 (303)
T ss_dssp TCEECBTT--BCCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred cceecCcc--ccccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHH
Confidence 99765421 122334568889999999987 4588999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=241.39 Aligned_cols=189 Identities=24% Similarity=0.303 Sum_probs=157.3
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++++.||+|+||.||++.+. ++..+|+|+++.... ....+.+|+..+..++||||+++++++ .....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~ 77 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVC--SKEYP 77 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSS
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEE--ccCCc
Confidence 4578999999999999999999775 567799999865432 234688999999999999999999999 56678
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+++|||++++ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred eEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 8999999965 6888887642 4589999999999999999999999999999999999999999999999999975532
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........++..|+|||.+.+ ..++.++||||||+++
T Consensus 157 ~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 195 (268)
T 3sxs_A 157 DQ-YVSSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILM 195 (268)
T ss_dssp TC-EEECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHH
T ss_pred hh-hhcccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHH
Confidence 11 112223335667999999977 4488999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=241.57 Aligned_cols=195 Identities=21% Similarity=0.299 Sum_probs=161.4
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC---CccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP---NGEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
+.....++|++.+.||+|+||+||++.+..+++.+|+|++......... .....+.+|+.++..++||||+++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 3445567999999999999999999999999999999998765433211 1125688999999999999999999998
Q ss_pred EcCCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeEEccCCc-----
Q psy787 108 VNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLTLDGT----- 179 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~nili~~~~~----- 179 (235)
.... +++||+++ ++|.+.+.... ..+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.
T Consensus 93 --~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 93 --HNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp --TTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred --cCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence 4443 69999997 57888776543 57999999999999999999999999 999999999999988776
Q ss_pred EEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 180 LKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++|+|||++.... .......+++.|+|||.+.+....++.++||||||+++
T Consensus 168 ~kl~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l 218 (287)
T 4f0f_A 168 AKVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218 (287)
T ss_dssp EEECCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHH
T ss_pred EEeCCCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHH
Confidence 9999999997443 23344568899999999855445578999999999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=249.07 Aligned_cols=196 Identities=26% Similarity=0.381 Sum_probs=160.2
Q ss_pred EeeeceEEeeeeeccccceEEEEeecc-----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDS-----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
....++|++.+.||+|+||.||++.+. .+++.+|+|++..... ......+.+|+.++..++||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS---PSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC---HHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 334678999999999999999999873 3457899998864321 23345688999999999999999999999
Q ss_pred EcCCCceEEEEEeccc-CCHHHHhhcCCC----------------------CCCCHHhHHHHHHHHHHHHHHHHhCCccc
Q psy787 108 VNDKKQKMYLIMEYCV-GGLQDMLDSTPY----------------------KKFPIWQAHGYFLQLLDGLEYLHSQGIIH 164 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~----------------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H 164 (235)
.....++++||+++ ++|.+++..... ..+++..++.++.|++.||.|||+.|++|
T Consensus 96 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 96 --SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred --ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 55667899999997 579999876532 34889999999999999999999999999
Q ss_pred CCCCCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 165 KDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 165 ~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+||||+||+++.++.++|+|||++................+++.|+|||.+.+ ..++.++||||||+++
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 242 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLL 242 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHH
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHH
Confidence 99999999999999999999999976543222222333446778999999977 4489999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=247.05 Aligned_cols=200 Identities=21% Similarity=0.334 Sum_probs=159.8
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC-
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND- 110 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 110 (235)
.....++|++.+.||+|+||.||++.+..+++.||+|++.... ......+.+|+.++..++||||+++++++...
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE----QQDREEAQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS----HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC----HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 3344578999999999999999999998899999999886542 23345688999999999999999999998632
Q ss_pred -CCceEEEEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeec
Q psy787 111 -KKQKMYLIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 111 -~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
.....+++||++.+ +|.+++... ....+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence 34578999999976 788888652 23679999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCC-------cccccCCCCcccCccccCCCCC-CCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDD-------TITTSQGSPVFQAPEIANGLPE-ISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~-~~~~~~Di~slG~~l 235 (235)
++.......... ......+++.|+|||.+.+... .++.++||||||+++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 236 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHH
Confidence 887543211110 0112346889999999875322 368899999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=252.31 Aligned_cols=187 Identities=30% Similarity=0.542 Sum_probs=152.0
Q ss_pred ceEEe--eeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 37 GKYVM--GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 37 ~~y~i--~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
+.|.+ .+.||+|+||.||++.+..+++.||+|+++.... .....+.+|+.++..++||||+++++++ .....
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~~~ 160 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM----KDKEEVKNEISVMNQLDHANLIQLYDAF--ESKND 160 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc----ccHHHHHHHHHHHHhCCCCCCCeEEEEE--EECCE
Confidence 34555 6789999999999999999999999999876432 2345688999999999999999999999 45668
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE--ccCCcEEEeeecccccc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL--TLDGTLKISDFGVAESL 191 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili--~~~~~~~l~dfg~~~~~ 191 (235)
+++||||+++ +|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||++ +.++.++|+|||++...
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 9999999975 6888776542 468999999999999999999999999999999999999 55678999999999865
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........+++.|+|||.+.+ ..++.++||||||++|
T Consensus 240 ~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 278 (373)
T 2x4f_A 240 KP---REKLKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIA 278 (373)
T ss_dssp CT---TCBCCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHH
T ss_pred CC---ccccccccCCCcEeChhhccC--CCCCcHHhHHHHHHHH
Confidence 42 223334568999999999987 4589999999999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=247.32 Aligned_cols=199 Identities=20% Similarity=0.299 Sum_probs=154.2
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccc-cCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKL-QRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
......++|++++.||+|+||+||++.+..+++.+++|+..+... .........+.+|+.++..++||||+++++++..
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 344456789999999999999999999988888886665443322 2223445678899999999999999999999953
Q ss_pred CCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
. ..+++++++. ++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++
T Consensus 89 --~-~~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 89 --S-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp --S-SEEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred --C-CceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 2 3678889886 46888887653 56899999999999999999999999999999999999999999999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
................++..|+|||.+.+ ..++.++||||||+++
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il 209 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTV 209 (327)
T ss_dssp ---------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred eEccCccccccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHH
Confidence 86643333333334446778999999987 4589999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=250.17 Aligned_cols=198 Identities=15% Similarity=0.194 Sum_probs=160.8
Q ss_pred ecCCceeEeeeceEEeeeeeccccceEEEEeeccc--------hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCC
Q psy787 26 YDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSE--------TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97 (235)
Q Consensus 26 ~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~--------~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 97 (235)
..+..+.....++|++.+.||+|+||+||++.+.. .++.+|+|++... ..+.+|+.++.+++|
T Consensus 31 ~~g~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h 101 (352)
T 2jii_A 31 PTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAK 101 (352)
T ss_dssp CTTCEEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCC
T ss_pred CCCceeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcc
Confidence 33444444446899999999999999999999887 4889999998643 258899999999999
Q ss_pred CCcce---------------eeeEEEcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCc
Q psy787 98 RNVIG---------------LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGI 162 (235)
Q Consensus 98 ~~i~~---------------~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i 162 (235)
|||++ +++++.. ....+++|||+++++|.+++.......+++..++.++.|++.||.|||+.|+
T Consensus 102 ~niv~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i 180 (352)
T 2jii_A 102 PLQVNKWKKLYSTPLLAIPTCMGFGVH-QDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEY 180 (352)
T ss_dssp HHHHHHHHHHTTCTTCSCCCCCEEEEE-TTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cchhhhhhhhccCCccCccchhhcccc-CCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 99887 5566642 3568899999997789999987655679999999999999999999999999
Q ss_pred ccCCCCCCCeEEccCC--cEEEeeeccccccCccccC-----CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 163 IHKDIKPGNLLLTLDG--TLKISDFGVAESLDMFLHD-----DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 163 ~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+||||||+||+++.++ .++|+|||++..+...... .......+++.|+|||.+.+ ..++.++||||||++|
T Consensus 181 vH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 258 (352)
T 2jii_A 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCM 258 (352)
T ss_dssp BCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred cCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHH
Confidence 9999999999999988 8999999999866432111 11123468889999999987 4589999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=253.12 Aligned_cols=189 Identities=29% Similarity=0.463 Sum_probs=155.1
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC----
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND---- 110 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 110 (235)
...+|++.+.||+|+||+||++.+..+++.||+|++..... ...+|+.+++.++|+||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 45589999999999999999999999999999998864321 234799999999999999999988532
Q ss_pred CCceEEEEEecccCCHHHHhhc--CCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC-CcEEEeeecc
Q psy787 111 KKQKMYLIMEYCVGGLQDMLDS--TPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD-GTLKISDFGV 187 (235)
Q Consensus 111 ~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~ 187 (235)
...++++||||+++++.+.+.. .....+++..++.++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||+
T Consensus 124 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 124 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp TEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred cceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 2335789999999987766543 223679999999999999999999999999999999999999965 5689999999
Q ss_pred ccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++.+.. ........+++.|+|||++.+. ..++.++|||||||+|
T Consensus 204 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il 247 (420)
T 1j1b_A 204 AKQLVR---GEPNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVL 247 (420)
T ss_dssp CEECCT---TCCCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHH
T ss_pred hhhccc---CCCceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHH
Confidence 986532 2223345678999999998762 2488999999999974
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=245.62 Aligned_cols=198 Identities=26% Similarity=0.446 Sum_probs=153.9
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
......++|++.+.||+|+||.||++.+..+++.+|+|++....... ......+.+|+..+..++|+||+++++.+.
T Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-- 102 (310)
T 2wqm_A 26 MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD-AKARADCIKEIDLLKQLNHPNVIKYYASFI-- 102 (310)
T ss_dssp GTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--
T ss_pred cccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--
Confidence 34456779999999999999999999998899999999987543322 233456889999999999999999999995
Q ss_pred CCceEEEEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
..+..+++||++++ +|.+++... ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 45688999999976 788887642 236689999999999999999999999999999999999999999999999999
Q ss_pred ccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+...... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 183 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il 226 (310)
T 2wqm_A 183 GRFFSSK--TTAAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLL 226 (310)
T ss_dssp ------------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred eeeecCC--CccccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHH
Confidence 8755321 122233457889999999987 4589999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=261.24 Aligned_cols=193 Identities=24% Similarity=0.320 Sum_probs=163.2
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
+....+|++.+.||+|+||.||++.+..++..||+|+++... .....+.+|+.++..++||||+++++++ ...
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~--~~~ 288 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVC--TRE 288 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEE--CSS
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEE--ecC
Confidence 334578999999999999999999998889999999986432 3345789999999999999999999999 455
Q ss_pred ceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+++|||+++ ++|.+++.......++...++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++...
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 67899999997 57999998766577999999999999999999999999999999999999999999999999999865
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... .......++..|+|||.+.+ ..++.++||||||++|
T Consensus 369 ~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l 409 (495)
T 1opk_A 369 TGDTY-TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLL 409 (495)
T ss_dssp TTCCE-ECCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHH
T ss_pred cCCce-eecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHH
Confidence 32111 11222335678999999977 4589999999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=242.94 Aligned_cols=197 Identities=30% Similarity=0.467 Sum_probs=155.3
Q ss_pred ecCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeee
Q psy787 26 YDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVD 105 (235)
Q Consensus 26 ~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 105 (235)
.....+.....++|++++.||+|+||.||++.+..+++.|++|++.... ....+.+|+.++..++||||+++++
T Consensus 18 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (314)
T 3com_A 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYG 91 (314)
T ss_dssp ------------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCchhhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEE
Confidence 3444555667789999999999999999999999899999999886532 3456889999999999999999999
Q ss_pred EEEcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEee
Q psy787 106 VFVNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISD 184 (235)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~d 184 (235)
.+. ....++++||++++ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus 92 ~~~--~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 168 (314)
T 3com_A 92 SYF--KNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLAD 168 (314)
T ss_dssp EEE--ETTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EEE--eCCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEee
Confidence 994 45678999999976 7888886332 6789999999999999999999999999999999999999999999999
Q ss_pred eccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||++...... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 169 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 215 (314)
T 3com_A 169 FGVAGQLTDT--MAKRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITA 215 (314)
T ss_dssp CTTCEECBTT--BSCBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHH
T ss_pred cccchhhhhh--ccccCccCCCCCccChhhcCC--CCCCccccHHHHHHHH
Confidence 9999755321 122334458889999999987 4489999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=249.49 Aligned_cols=198 Identities=23% Similarity=0.344 Sum_probs=143.6
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhh---heeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLC---RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
...++|++.+.||+|+||+||+|.+..+++ .+|+|+++..... ......+.+|+.+++.++||||+++++++...
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA--SSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC--HHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 345689999999999999999999877765 7899988765432 23456788999999999999999999999643
Q ss_pred CCc----eEEEEEecccC-CHHHHhhcCC----CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEE
Q psy787 111 KKQ----KMYLIMEYCVG-GLQDMLDSTP----YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLK 181 (235)
Q Consensus 111 ~~~----~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~ 181 (235)
... .++++||++.+ +|.+++.... ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 221 24899999976 6888875432 12589999999999999999999999999999999999999999999
Q ss_pred EeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 182 ISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+|||++................+++.|+|||.+.+ ..++.++||||||+++
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 229 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTM 229 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcC--CCCCCccchhhHHHHH
Confidence 999999986543222222233446678999999977 4589999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=249.20 Aligned_cols=198 Identities=27% Similarity=0.440 Sum_probs=161.2
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
....+.++|++.+.||+|+||+||++.+..+++.||+|++.... .......+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD---KPLFALRTLREIKILKHFKHENIITIFNIQRPD 81 (353)
T ss_dssp CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc---cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence 34456789999999999999999999999899999999985432 122344677999999999999999999987432
Q ss_pred ---CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 111 ---KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 111 ---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
.....+++||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+
T Consensus 82 ~~~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 82 SFENFNEVYIIQELMQTDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CSTTCCCEEEEECCCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ccCccceEEEEEeccCccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 2357899999999999988876 4689999999999999999999999999999999999999999999999999
Q ss_pred ccccCccccCC--------cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDD--------TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.......... ......+++.|+|||.+.+. ..++.++||||||+++
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il 213 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCIL 213 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHH
Confidence 98654211111 12234578899999987541 3488999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=244.89 Aligned_cols=194 Identities=23% Similarity=0.302 Sum_probs=146.0
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++++.||+|+||+||++.+..+++.+|+|+++...... .....+..+...++.++||||+++++++. ..+.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--~~~~ 80 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ--EQKRLLMDLDISMRTVDCPFTVTFYGALF--REGD 80 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH--HHHHHHHHHHHHHHhCCCCeEEEEeeeee--ccCC
Confidence 4578999999999999999999999999999999986553221 11222334444567789999999999994 4567
Q ss_pred EEEEEecccCCHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 115 MYLIMEYCVGGLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 115 ~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
.++|||+++++|.+++... ....+++..++.++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 8999999999887776531 236799999999999999999999998 9999999999999999999999999999765
Q ss_pred CccccCCcccccCCCCcccCccccCC--CCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANG--LPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~~Di~slG~~l 235 (235)
.. ........+++.|+|||.+.. ....++.++||||||+++
T Consensus 161 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 203 (290)
T 3fme_A 161 VD---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 203 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHH
T ss_pred cc---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHH
Confidence 42 222233458899999999632 124588999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=253.65 Aligned_cols=195 Identities=27% Similarity=0.464 Sum_probs=147.4
Q ss_pred eeeceEEee-eeeccccceEEEEeecc--chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 34 KMIGKYVMG-DLLGEGSYGKVKEMLDS--ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 34 ~~~~~y~i~-~~ig~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
...+.|.+. ++||+|+||+||+|++. .+++.||+|++.... ....+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS------CCHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC------CCHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 345668874 58999999999999854 578899999885432 233678999999999999999999999766
Q ss_pred CCceEEEEEecccCCHHHHhhcC-------CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE----ccCCc
Q psy787 111 KKQKMYLIMEYCVGGLQDMLDST-------PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL----TLDGT 179 (235)
Q Consensus 111 ~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili----~~~~~ 179 (235)
....+++||||++++|.+.+... ....+++..++.++.||+.||.|||+.|++||||||+||++ +.++.
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 67789999999999988877532 12358999999999999999999999999999999999999 66789
Q ss_pred EEEeeeccccccCccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 180 LKISDFGVAESLDMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++|+|||++..+...... .......+++.|+|||.+.+. ..++.++|||||||+|
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il 226 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIF 226 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHH
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHH
Confidence 999999999866432111 223345689999999998762 3488999999999974
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=247.10 Aligned_cols=192 Identities=26% Similarity=0.398 Sum_probs=161.5
Q ss_pred ceeEeeeceEEeeeeeccccceEEEEeec-cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCC------Ccce
Q psy787 30 TIKVKMIGKYVMGDLLGEGSYGKVKEMLD-SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR------NVIG 102 (235)
Q Consensus 30 ~~~~~~~~~y~i~~~ig~g~~~~v~~~~~-~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~ 102 (235)
..+..+.++|++++.||+|+||+||++.+ ..+++.||+|+++... .....+.+|+.++..+.|+ ++++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 81 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-----RYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-----HHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-----chhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence 34556778999999999999999999987 5578999999986432 2234577899888888655 4899
Q ss_pred eeeEEEcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc------
Q psy787 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL------ 176 (235)
Q Consensus 103 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~------ 176 (235)
+++++ ...+.+++|||+++++|.+++......++++..++.++.|++.||.|||+.|++||||||+||+++.
T Consensus 82 ~~~~~--~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 82 MLEWF--EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp EEEEE--EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred eeccc--ccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 99998 4566899999999889999998876667999999999999999999999999999999999999987
Q ss_pred -------------CCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 177 -------------DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 177 -------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++.++|+|||++.... .......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 224 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDD-----EHHSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCIL 224 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETT-----SCCCSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHH
T ss_pred cCCccccccccccCCCceEeeCcccccCc-----cccccccCCccccChHHhhC--CCCCcchhhHHHHHHH
Confidence 5679999999997543 12234568899999999987 4489999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=245.35 Aligned_cols=195 Identities=26% Similarity=0.407 Sum_probs=162.5
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++++.||+|++|.||++.+..+++.+++|++...... ......+.+|+.++..++||||+++++.+.......
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT--EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC--HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 457999999999999999999999999999999998765432 234456889999999999999999999887666778
Q ss_pred EEEEEecccC-CHHHHhhcCC--CCCCCHHhHHHHHHHHHHHHHHHHhCC-----cccCCCCCCCeEEccCCcEEEeeec
Q psy787 115 MYLIMEYCVG-GLQDMLDSTP--YKKFPIWQAHGYFLQLLDGLEYLHSQG-----IIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
++++||++++ +|.+++.... ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999975 7988887532 245899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++...... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 162 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 206 (279)
T 2w5a_A 162 LARILNHD--TSFAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLL 206 (279)
T ss_dssp HHHHC-----CHHHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHH
T ss_pred hheeeccc--cccccccCCCccccChHHhcc--CCCCchhhHHHHHHHH
Confidence 98755321 111223457889999999977 4488999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=248.20 Aligned_cols=196 Identities=28% Similarity=0.442 Sum_probs=158.6
Q ss_pred EeeeceEEeeeeeccccceEEEEeecc-------chhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceee
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDS-------ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLV 104 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 104 (235)
....++|++.+.||+|+||+||+|.+. .++..||+|+++.... ......+.+|+.++..+ +||||++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc---HHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 445679999999999999999999864 4567899998864421 23345688999999999 899999999
Q ss_pred eEEEcCCCceEEEEEecccC-CHHHHhhcCCC--------------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCC
Q psy787 105 DVFVNDKKQKMYLIMEYCVG-GLQDMLDSTPY--------------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKP 169 (235)
Q Consensus 105 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p 169 (235)
+++ ...+.+++|||++++ +|.+++..... ..+++..++.++.|++.||.|||+.|++|+||||
T Consensus 108 ~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 108 GAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEE--CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEE--ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 999 556678999999975 79998876532 3488999999999999999999999999999999
Q ss_pred CCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 170 GNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 170 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+||+++.++.++|+|||++................+++.|+|||.+.+ ..++.++||||||+++
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 249 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLM 249 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHH
Confidence 999999999999999999986543222222333446778999999876 4488999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=239.37 Aligned_cols=189 Identities=29% Similarity=0.427 Sum_probs=160.0
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc--CCCc
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN--DKKQ 113 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 113 (235)
...|++.+.||+|+||+||++.+..++..+++|++....... .....+.+|+.+++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH--HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 445899999999999999999999999999999987655432 345568899999999999999999998853 2346
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeEEc-cCCcEEEeeecccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLT-LDGTLKISDFGVAE 189 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~ 189 (235)
.+++|||++++ +|.+++... ..++...++.++.|++.||.|||+.+ ++|+||||+||+++ .++.++|+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 78999999965 799988765 66899999999999999999999999 99999999999998 78899999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... ........+++.|+|||.+.+ .++.++||||||+++
T Consensus 181 ~~~----~~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l 219 (290)
T 1t4h_A 181 LKR----ASFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCM 219 (290)
T ss_dssp GCC----TTSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHH
T ss_pred ccc----ccccccccCCcCcCCHHHHhc---cCCCcchHHHHHHHH
Confidence 443 223334568899999998864 378999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=243.41 Aligned_cols=201 Identities=25% Similarity=0.411 Sum_probs=148.5
Q ss_pred ecCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeee
Q psy787 26 YDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVD 105 (235)
Q Consensus 26 ~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 105 (235)
.......+...++|++.++||+|+||+||++.+.. .+++|+++..... ......+.+|+.+++.++|+||+++++
T Consensus 13 ~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (289)
T 3og7_A 13 RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPT--PQQLQAFKNEVGVLRKTRHVNILLFMG 87 (289)
T ss_dssp -----CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCCCCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCC--HHHHHHHHHHHHHHHhCCCCcEEEEEe
Confidence 44455566677899999999999999999998743 4899988655432 233456889999999999999999999
Q ss_pred EEEcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEee
Q psy787 106 VFVNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISD 184 (235)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~d 184 (235)
+. ....++++||++++ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|
T Consensus 88 ~~---~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~D 163 (289)
T 3og7_A 88 YS---TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGD 163 (289)
T ss_dssp EE---CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECC
T ss_pred ec---cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcc
Confidence 66 33457999999975 6888886543 6789999999999999999999999999999999999999999999999
Q ss_pred eccccccCccccCCcccccCCCCcccCccccCCC-CCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGL-PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 235 (235)
||++................+++.|+|||.+... ...++.++||||||+++
T Consensus 164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 215 (289)
T 3og7_A 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215 (289)
T ss_dssp CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHH
T ss_pred ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHH
Confidence 9999765433333334445689999999998621 13478899999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=244.14 Aligned_cols=188 Identities=21% Similarity=0.281 Sum_probs=156.7
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhh-------heeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeE
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLC-------RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDV 106 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~-------~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 106 (235)
...++|++.+.||+|+||+||++.+..+++ .+++|++.... ......+.+|+.++..++||||++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 345789999999999999999999887764 58888875443 2344568899999999999999999999
Q ss_pred EEcCCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc------
Q psy787 107 FVNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT------ 179 (235)
Q Consensus 107 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~------ 179 (235)
+ ......++|||+++ ++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.
T Consensus 81 ~--~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 81 C--VCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp E--CCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred E--EeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccc
Confidence 9 45567799999997 57999887653 44899999999999999999999999999999999999998887
Q ss_pred --EEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 180 --LKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 180 --~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++|+|||++.... ......++..|+|||.+.+ ...++.++||||||+++
T Consensus 158 ~~~kl~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il 208 (289)
T 4fvq_A 158 PFIKLSDPGISITVL------PKDILQERIPWVPPECIEN-PKNLNLATDKWSFGTTL 208 (289)
T ss_dssp CEEEECCCCSCTTTS------CHHHHHHTTTTSCHHHHHC-GGGCCHHHHHHHHHHHH
T ss_pred ceeeeccCccccccc------CccccCCcCcccCHHHhCC-CCCCCchhHHHHHHHHH
Confidence 9999999987442 1122346778999999875 23488999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=248.45 Aligned_cols=194 Identities=28% Similarity=0.474 Sum_probs=161.8
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC----CccccHHHHHHHHHhc-CCCCcceeeeEEEc
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP----NGEINVDREIRLLKML-QHRNVIGLVDVFVN 109 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (235)
..++|++.+.||+|++|.||+|.+..+|+.||+|++......... .....+.+|+.++..+ +||||+++++++
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-- 169 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-- 169 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE--
Confidence 447899999999999999999999889999999998765422111 1134577899999999 799999999998
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
......++||||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 556789999999976 688888765 57899999999999999999999999999999999999999999999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCC----CCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGL----PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~~Di~slG~~l 235 (235)
..+.. ........+++.|+|||.+.+. ...++.++||||||+++
T Consensus 248 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il 295 (365)
T 2y7j_A 248 CHLEP---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295 (365)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHH
T ss_pred cccCC---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHH
Confidence 76542 2233455689999999988532 12478899999999974
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=241.08 Aligned_cols=190 Identities=25% Similarity=0.341 Sum_probs=155.3
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++++.||+|+||+||++.+. ++..+|+|+++.... ....+.+|+.++..++|+||+++++++ ....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~ 92 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVC--TKQR 92 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSS
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-----CHHHHHHHHHHHhcCCCCCEeeEEEEE--ecCC
Confidence 45678999999999999999999775 567899999875432 234688999999999999999999999 5667
Q ss_pred eEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++|||+++ ++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 8899999996 46888887633 569999999999999999999999999999999999999999999999999997553
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 172 ~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l 211 (283)
T 3gen_A 172 DDE-YTSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLM 211 (283)
T ss_dssp CHH-HHSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHH
T ss_pred ccc-cccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHH
Confidence 211 111223335677999999987 4489999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=248.61 Aligned_cols=194 Identities=28% Similarity=0.411 Sum_probs=162.2
Q ss_pred eeceEEeeeeeccccceEEEEee----ccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
..++|++++.||+|+||.||+++ +..+++.|++|++.... ......+.+|+.++..++|+||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG----PDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC----HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 34689999999999999999998 67788999999886543 23345688999999999999999999999766
Q ss_pred CCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 111 KKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 111 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
....+++|||+++ ++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 7778999999995 57988887642 468999999999999999999999999999999999999999999999999998
Q ss_pred ccCccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........ .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 220 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVL 220 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHH
Confidence 65422111 12223446777999999977 4488999999999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=241.65 Aligned_cols=194 Identities=28% Similarity=0.502 Sum_probs=156.4
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC----
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND---- 110 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 110 (235)
..++|++++.||+|+||.||++.+..+++.+++|++.... .....+.+|+.++..++||||+++++.+.+.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 4578999999999999999999998899999999986532 2334688999999999999999999988642
Q ss_pred -------CCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEE
Q psy787 111 -------KKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKI 182 (235)
Q Consensus 111 -------~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l 182 (235)
....++++||++++ +|.+++.... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 24678999999975 7999987643 46788899999999999999999999999999999999999999999
Q ss_pred eeeccccccCcccc------------CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 183 SDFGVAESLDMFLH------------DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 183 ~dfg~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|||++........ ........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il 221 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIF 221 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHH
Confidence 99999975532110 1122344578889999998762 3588999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=245.30 Aligned_cols=195 Identities=29% Similarity=0.513 Sum_probs=155.6
Q ss_pred EeeeceEEee-eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcC
Q psy787 33 VKMIGKYVMG-DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVND 110 (235)
Q Consensus 33 ~~~~~~y~i~-~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (235)
....++|++. +.||+|+||+||++.+..+++.||+|++.... ......+.+|+.++.++ +||||+++++++ .
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~--~ 81 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFF--E 81 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEE--E
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEE--e
Confidence 3456789996 78999999999999999999999999987543 23445688999999885 799999999999 4
Q ss_pred CCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc---EEEeeec
Q psy787 111 KKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT---LKISDFG 186 (235)
Q Consensus 111 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~---~~l~dfg 186 (235)
....+++|||+++ ++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred eCCEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 5568999999997 5799888765 57899999999999999999999999999999999999998776 9999999
Q ss_pred cccccCccc-----cCCcccccCCCCcccCccccCCCC---CCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFL-----HDDTITTSQGSPVFQAPEIANGLP---EISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~-----~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~~Di~slG~~l 235 (235)
++....... .........+++.|+|||.+.+.. ..++.++||||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il 216 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHH
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHH
Confidence 987553111 111222345889999999986411 2378899999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=248.27 Aligned_cols=194 Identities=30% Similarity=0.451 Sum_probs=156.0
Q ss_pred CceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEE
Q psy787 29 KTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFV 108 (235)
Q Consensus 29 ~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (235)
...+.....+|++++.||+|+||+||+|.+..+++ +++|.+..... ...+|+.+++.++||||+++++++.
T Consensus 32 ~~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~--------~~~~E~~il~~l~h~niv~l~~~~~ 102 (394)
T 4e7w_A 32 GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR--------FKNRELQIMRIVKHPNVVDLKAFFY 102 (394)
T ss_dssp SSSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc--------hHHHHHHHHHhCCCCCcceEEEEEE
Confidence 34456677899999999999999999999877766 77776654321 1237999999999999999999986
Q ss_pred cCC----CceEEEEEecccCCHHHHhhc--CCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc-cCCcEE
Q psy787 109 NDK----KQKMYLIMEYCVGGLQDMLDS--TPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT-LDGTLK 181 (235)
Q Consensus 109 ~~~----~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~-~~~~~~ 181 (235)
... ..++++||||+++++...+.. .....+++..++.++.|++.||.|||+.|++||||||+||+++ .++.++
T Consensus 103 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~k 182 (394)
T 4e7w_A 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLK 182 (394)
T ss_dssp EESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred ecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEE
Confidence 432 234789999999886655542 1236789999999999999999999999999999999999999 789999
Q ss_pred EeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 182 ISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+|||++..... ........+++.|+|||.+.+. ..++.++|||||||+|
T Consensus 183 L~DFG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il 232 (394)
T 4e7w_A 183 LIDFGSAKILIA---GEPNVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVM 232 (394)
T ss_dssp ECCCTTCEECCT---TCCCCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHH
T ss_pred EeeCCCcccccC---CCCCcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHH
Confidence 999999986532 2233345678899999998762 3488999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=243.91 Aligned_cols=193 Identities=35% Similarity=0.582 Sum_probs=155.0
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeecccc----CCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQ----RIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
+.++|++.+.||+|+||.||++.+..+++.||+|++...... ........+.+|+.++..++||||+++++++.
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-- 85 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-- 85 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc--
Confidence 457899999999999999999999999999999998765432 11223346889999999999999999999984
Q ss_pred CCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc---EEEeeec
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT---LKISDFG 186 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~---~~l~dfg 186 (235)
.. .+++|||++++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||
T Consensus 86 ~~-~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 86 AE-DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp SS-SEEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred CC-ceEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 33 37999999975 788888765 67999999999999999999999999999999999999987664 9999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCC-CCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANG-LPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~~Di~slG~~l 235 (235)
++..... ........+++.|+|||.+.+ ....++.++||||||+++
T Consensus 163 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 209 (322)
T 2ycf_A 163 HSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209 (322)
T ss_dssp TCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHH
T ss_pred cceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHH
Confidence 9976532 112233458899999998732 124478999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=247.91 Aligned_cols=196 Identities=26% Similarity=0.380 Sum_probs=159.6
Q ss_pred eeeceEEeeeeeccccceEEEEeec-----cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEE
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLD-----SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVF 107 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 107 (235)
...++|++.+.||+|+||+||++.+ ..+++.||+|+++.... ......+.+|+.++..+ +||||+++++++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC---cHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3467999999999999999999973 45778999999865432 22334688999999999 789999999998
Q ss_pred EcCCCceEEEEEecccC-CHHHHhhcCCC--------------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCe
Q psy787 108 VNDKKQKMYLIMEYCVG-GLQDMLDSTPY--------------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNL 172 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~ni 172 (235)
.. ....++++||++++ +|.+++..... ..+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 101 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 101 TK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp CC-TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ec-CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 53 33468999999975 79999876532 1278899999999999999999999999999999999
Q ss_pred EEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 173 LLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 173 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+++.++.++|+|||++................+++.|+|||.+.+ ..++.++||||||+++
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il 240 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLL 240 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHH
Confidence 999999999999999986543222222333446778999999977 4589999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=253.02 Aligned_cols=186 Identities=26% Similarity=0.374 Sum_probs=156.5
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|+||+||++... ++.||+|+++... ..+.+.+|+.++..++||||+++++++.. ...
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 260 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKG 260 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEEC-TTS
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEc-CCC
Confidence 44578999999999999999999874 6789999986432 34578999999999999999999999863 334
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++|||++++ +|.+++.......++...++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++....
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 68999999975 79999987654558999999999999999999999999999999999999999999999999997443
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ......++..|+|||.+.+ ..++.++||||||++|
T Consensus 341 ~-----~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l 376 (450)
T 1k9a_A 341 S-----TQDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILL 376 (450)
T ss_dssp -----------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHH
T ss_pred c-----cccCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHH
Confidence 1 1122346778999999987 4589999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=247.30 Aligned_cols=194 Identities=25% Similarity=0.396 Sum_probs=162.1
Q ss_pred CCceeEeeeceEEeeeeeccccceEEEEeeccchh-hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC------c
Q psy787 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETL-CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN------V 100 (235)
Q Consensus 28 ~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------i 100 (235)
...++..+.++|++++.||+|+||+||++.+..++ +.||+|+++... .....+.+|+.++..++|++ +
T Consensus 10 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~ 84 (355)
T 2eu9_A 10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-----KYREAARLEINVLKKIKEKDKENKFLC 84 (355)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHHCTTSCSCB
T ss_pred ccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-----cchhHHHHHHHHHHHHhhcCCCCceeE
Confidence 34455667889999999999999999999987776 689999986432 23345778999999887655 8
Q ss_pred ceeeeEEEcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE------
Q psy787 101 IGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL------ 174 (235)
Q Consensus 101 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili------ 174 (235)
+.+.+++ ...+.++++||++++++.+.+.......+++..++.++.|++.||.|||+.|++||||||+||++
T Consensus 85 ~~~~~~~--~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 85 VLMSDWF--NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp CCEEEEE--EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEE
T ss_pred EEeeeee--eeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccc
Confidence 8888888 45668999999999898888887765679999999999999999999999999999999999999
Q ss_pred -------------ccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 175 -------------TLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 175 -------------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..++.++|+|||++.... .......+++.|+|||.+.+ ..++.++||||||++|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 229 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDH-----EHHTTIVATRHYRPPEVILE--LGWAQPCDVWSIGCIL 229 (355)
T ss_dssp EEECCC-CCCEEEESCCCEEECCCTTCEETT-----SCCCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred ccccccccccccccCCCcEEEeecCcccccc-----ccccCCcCCCcccCCeeeec--CCCCCccchHHHHHHH
Confidence 567889999999997543 22234568899999999987 4589999999999974
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=252.12 Aligned_cols=195 Identities=23% Similarity=0.346 Sum_probs=150.1
Q ss_pred EeeeceEEeeeeeccccceEEEEeecc---chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDS---ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
+...++|.+.+.||+|+||+||++++. .++..||+|+++... .......+.+|+.++.+++||||+++++++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-- 115 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVV-- 115 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence 345568999999999999999999876 467789999886542 123345688999999999999999999999
Q ss_pred CCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
.....+++||||++ ++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 55567899999996 57998887543 57899999999999999999999999999999999999999999999999999
Q ss_pred cccCccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......... .......++..|+|||.+.+ ..++.++||||||++|
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il 240 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVL 240 (373)
T ss_dssp -------------------CTTSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred cccccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHH
Confidence 865422111 11112234567999999977 4589999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=251.34 Aligned_cols=196 Identities=24% Similarity=0.387 Sum_probs=165.4
Q ss_pred cCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeE
Q psy787 27 DNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDV 106 (235)
Q Consensus 27 ~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 106 (235)
....+.....++|++++.||+|+||+||++.+..+++.+|+|++..... ......+.+|+.++..++||||++++++
T Consensus 23 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 99 (360)
T 3eqc_A 23 QKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGA 99 (360)
T ss_dssp HHHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred hhhcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC---HHHHHHHHHHHHHHHHCCCCCEEEEeEE
Confidence 3445667778899999999999999999999999999999999876421 2334568899999999999999999999
Q ss_pred EEcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEccCCcEEEee
Q psy787 107 FVNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISD 184 (235)
Q Consensus 107 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~~~~~~l~d 184 (235)
+. ..+.+++||||+++ +|.+++... ..+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|
T Consensus 100 ~~--~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~D 175 (360)
T 3eqc_A 100 FY--SDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 175 (360)
T ss_dssp EE--ETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECC
T ss_pred EE--ECCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEE
Confidence 94 45689999999975 799988765 5689999999999999999999996 999999999999999999999999
Q ss_pred eccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||++..... .......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 176 fg~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 220 (360)
T 3eqc_A 176 FGVSGQLID----SMANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSL 220 (360)
T ss_dssp CCCCHHHHH----HC----CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHH
T ss_pred CCCCccccc----ccccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHH
Confidence 999874421 12234468899999999987 4589999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=243.44 Aligned_cols=199 Identities=26% Similarity=0.369 Sum_probs=148.6
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEc--
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVN-- 109 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-- 109 (235)
+....+|++.+.||+|+||.||++++..+++.||+|++.... ......+.+|+..+..+. ||||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE----EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS----HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc----hHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 334458999999999999999999999999999999885543 233446789999999996 9999999999842
Q ss_pred ----CCCceEEEEEecccCCHHHHhhcC-CCCCCCHHhHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeEEccCCcEEE
Q psy787 110 ----DKKQKMYLIMEYCVGGLQDMLDST-PYKKFPIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLTLDGTLKI 182 (235)
Q Consensus 110 ----~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~nili~~~~~~~l 182 (235)
.....++++||+++|+|.+++... ....+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|
T Consensus 100 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred cccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence 344568999999999988888652 2356999999999999999999999999 999999999999999999999
Q ss_pred eeeccccccCccccCC----------cccccCCCCcccCccccCC-CCCCCCCcccEEEeeeeC
Q psy787 183 SDFGVAESLDMFLHDD----------TITTSQGSPVFQAPEIANG-LPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 183 ~dfg~~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~-~~~~~~~~~Di~slG~~l 235 (235)
+|||++.......... ......+++.|+|||.+.. ....++.++||||||+++
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il 243 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHH
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHH
Confidence 9999998654221110 1113447888999999832 124478899999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=238.94 Aligned_cols=188 Identities=31% Similarity=0.509 Sum_probs=145.9
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++.+.||+|+||.||++.+. ++.+|+|+++.............+.+|+.++..++||||+++++++ ...+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 80 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC--LKEPN 80 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE--CCC--
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--ecCCc
Confidence 4578999999999999999999874 7889999987765544344456788999999999999999999999 55667
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCC---cccCCCCCCCeEEcc--------CCcEEE
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG---IIHKDIKPGNLLLTL--------DGTLKI 182 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~nili~~--------~~~~~l 182 (235)
.+++||++++ +|.+++.. ..+++..++.++.|++.||.+||+.| ++|+||||+||+++. ++.++|
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 8999999975 57777753 57899999999999999999999999 889999999999986 677999
Q ss_pred eeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 183 SDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|||++..... .......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 158 ~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 204 (271)
T 3dtc_A 158 TDFGLAREWHR----TTKMSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLL 204 (271)
T ss_dssp CCCCC-----------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHH
T ss_pred ccCCccccccc----ccccCCCCccceeCHHHhcc--CCCCchhhHHHHHHHH
Confidence 99999975532 22224468899999999977 4489999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=240.35 Aligned_cols=192 Identities=22% Similarity=0.347 Sum_probs=146.3
Q ss_pred eeeceEEeeeeeccccceEEEEeeccch---hhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSET---LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
...++|++.+.||+|+||.||++.+..+ +..+++|+.+... .......+.+|+..+..++||||+++++++.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-- 86 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-- 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCccceEEEEEc--
Confidence 3457899999999999999999988654 3457787765432 1233456889999999999999999999983
Q ss_pred CCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
.+..++|||++++ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred -cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 3457899999976 7998887653 568999999999999999999999999999999999999999999999999998
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 165 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l 207 (281)
T 1mp8_A 165 YMEDST-YYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCM 207 (281)
T ss_dssp ---------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHH
T ss_pred ccCccc-ccccccCCCcccccChhhccc--CCCCCccCchHHHHHH
Confidence 654211 112223345678999999976 4488999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=243.34 Aligned_cols=198 Identities=25% Similarity=0.316 Sum_probs=149.4
Q ss_pred eeeceEEeeeeeccccceEEEEeeccc---hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSE---TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
...++|.+.+.||+|+||+||+|.+.. +++.+|+|+++..... ......+.+|+..+..++||||+++++++...
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS--QREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc--hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 345689999999999999999997654 5568999998755332 13345688999999999999999999999643
Q ss_pred CCc---eEEEEEecccC-CHHHHhhcC----CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEE
Q psy787 111 KKQ---KMYLIMEYCVG-GLQDMLDST----PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKI 182 (235)
Q Consensus 111 ~~~---~~~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l 182 (235)
... ..+++||++++ +|.+++... ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 332 46999999975 688887432 2356999999999999999999999999999999999999999999999
Q ss_pred eeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 183 SDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|||++................+++.|+|||.+.+ ..++.++||||||+++
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 239 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTM 239 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcC--CCccchhhhHHHHHHH
Confidence 99999986543222222333446778999999977 4589999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=252.89 Aligned_cols=193 Identities=18% Similarity=0.179 Sum_probs=142.6
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc--CCCCcceee-------eE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML--QHRNVIGLV-------DV 106 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~ 106 (235)
..+|++.+.||+|+||+||++.+..+++.||+|++....... ......+..|+.++..+ +|||+++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS-RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTH-HHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccc-ccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 345999999999999999999999999999999998765322 23334566775555544 699987755 33
Q ss_pred EEcCCC---------------ceEEEEEecccCCHHHHhhcCCCCCCCHHhH------HHHHHHHHHHHHHHHhCCcccC
Q psy787 107 FVNDKK---------------QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQA------HGYFLQLLDGLEYLHSQGIIHK 165 (235)
Q Consensus 107 ~~~~~~---------------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~------~~~~~ql~~~l~~lH~~~i~H~ 165 (235)
+..... ..+++||||++++|.+++.... ..+....+ ..++.|++.||+|||++|++||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 322221 4589999999999999998642 23344455 6777999999999999999999
Q ss_pred CCCCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 166 DIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 166 dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||||+||+++.++.++|+|||++..... ......+++.|+|||.+.+....++.++||||||++|
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 9999999999999999999999985532 1113445689999999976334589999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=245.18 Aligned_cols=193 Identities=34% Similarity=0.527 Sum_probs=157.8
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
....+.++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.++..++||||+++++++...
T Consensus 18 ~~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 18 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 95 (353)
T ss_dssp EEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cccccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc--hHHHHHHHHHHHHHHhcCCCCcccHhheEecc
Confidence 3455678999999999999999999999999999999998654321 22345678999999999999999999999533
Q ss_pred CC----ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeec
Q psy787 111 KK----QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 111 ~~----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
.. ..++++||+++++|.+.+. ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQTDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp SSGGGCCCCEEEEECCSEEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred cccccceeEEEEeccccCCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecc
Confidence 22 2359999999988877664 348999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++..... ......+++.|+|||.+.+. ..++.++||||||+++
T Consensus 172 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il 214 (353)
T 3coi_A 172 LARHADA-----EMTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIM 214 (353)
T ss_dssp CTTC-------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHH
T ss_pred cccCCCC-----CccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHH
Confidence 9975432 22334578899999998752 3478999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=244.27 Aligned_cols=193 Identities=27% Similarity=0.393 Sum_probs=148.2
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC--
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK-- 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (235)
...++|++.+.||+|+||+||++.+..+++.||+|++.... .....+..++..+..++||||+++++++....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-----TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-----cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 45678999999999999999999999999999999885432 23345677888888899999999999985422
Q ss_pred ---CceEEEEEecccCCHHHHhhc--CCCCCCCHHhHHHHHHHHHHHHHHHH--hCCcccCCCCCCCeEEcc-CCcEEEe
Q psy787 112 ---KQKMYLIMEYCVGGLQDMLDS--TPYKKFPIWQAHGYFLQLLDGLEYLH--SQGIIHKDIKPGNLLLTL-DGTLKIS 183 (235)
Q Consensus 112 ---~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~dl~p~nili~~-~~~~~l~ 183 (235)
..+++++||++++++...+.. .....++...++.++.|++.||.+|| +.|++||||||+||+++. ++.++|+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 224789999999987665542 23367899999999999999999999 999999999999999997 8899999
Q ss_pred eeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|||++..... ........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 175 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il 222 (360)
T 3e3p_A 175 DFGSAKKLSP---SEPNVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIF 222 (360)
T ss_dssp CCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHH
T ss_pred eCCCceecCC---CCCcccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHH
Confidence 9999986542 2223345578999999998652 3478999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=246.02 Aligned_cols=194 Identities=27% Similarity=0.394 Sum_probs=160.2
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
....++|++.+.||+|+||+||++.+. +++.||+|++...... .....+.+|+.++..++||||+++++++ ...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~ 99 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGFC--MTP 99 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEE--CCS
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccceEEEE--ecC
Confidence 345678999999999999999999854 6899999998765432 2334688999999999999999999999 455
Q ss_pred ceEEEEEecccC-CHHHHhhcCCC--CCCCHHhHHHHHHHHHHHHHHHHhC---CcccCCCCCCCeEEccCCcEEEeeec
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPY--KKFPIWQAHGYFLQLLDGLEYLHSQ---GIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
...++|||++++ +|.+++..... ..+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 677999999975 79988876532 3489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++...... .........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 180 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 225 (326)
T 3uim_A 180 LAKLMDYK-DTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVML 225 (326)
T ss_dssp SCEECCSS-SSCEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHH
T ss_pred cccccCcc-cccccccccCCcCccCHHHhcc--CCCCccccchhHHHHH
Confidence 99865421 2222334458999999999977 4489999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=242.47 Aligned_cols=196 Identities=26% Similarity=0.479 Sum_probs=154.6
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc--
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN-- 109 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 109 (235)
+..+.++|++++.||+|++|.||++.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS----HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC----hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 3456789999999999999999999999999999999886543 2334567899999999999999999998732
Q ss_pred ----------CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc-cCC
Q psy787 110 ----------DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT-LDG 178 (235)
Q Consensus 110 ----------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~-~~~ 178 (235)
......+++||+++++|.+++.. .++++..++.++.|++.||.+||+.|++|+||||+||+++ .++
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT
T ss_pred cccccccccccccCceeEEeeccCCCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC
Confidence 23357899999999999988864 5689999999999999999999999999999999999997 567
Q ss_pred cEEEeeeccccccCcccc-CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 179 TLKISDFGVAESLDMFLH-DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 179 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++|+|||++........ ........++..|+|||.+.+ ...++.++||||||+++
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il 215 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIF 215 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC-TTCCCHHHHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcC-cccCCchhhhHhHHHHH
Confidence 899999999986542111 112233446888999998754 13478999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=247.11 Aligned_cols=195 Identities=25% Similarity=0.309 Sum_probs=158.9
Q ss_pred eeeceEEeeeeeccccceEEEEeecc-----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEE
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDS-----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFV 108 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (235)
...++|++.+.||+|+||.||+|.+. .+++.+++|++..... ......+.+|+.+++.++|+||+++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 97 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS---MRERIEFLNEASVMKEFNCHHVVRLLGVV- 97 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC---HHHHHHHHHHHHHGGGCCCTTBCCEEEEE-
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC---HHHHHHHHHHHHHHHhcCCCCEeeeEEEE-
Confidence 45678999999999999999999876 4678899998864321 12334688999999999999999999999
Q ss_pred cCCCceEEEEEecccC-CHHHHhhcCC--------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc
Q psy787 109 NDKKQKMYLIMEYCVG-GLQDMLDSTP--------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT 179 (235)
Q Consensus 109 ~~~~~~~~lv~e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~ 179 (235)
......++|||++++ +|.+++.... ...++...++.++.|++.||.+||+.|++||||||+||+++.++.
T Consensus 98 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 98 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred -ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 556678999999975 7888886531 245789999999999999999999999999999999999999999
Q ss_pred EEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 180 LKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++|+|||++................+++.|+|||.+.+ ..++.++||||||+++
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 230 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVL 230 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHH
Confidence 99999999975532222222223345778999999877 4489999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=245.82 Aligned_cols=197 Identities=27% Similarity=0.377 Sum_probs=159.8
Q ss_pred eEeeeceEEeeeeeccccceEEEEee----ccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEML----DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
.....++|++++.||+|+||.||++. +..+++.||+|++.... ......+.+|+.+++.++|+||+++++++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC----SHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34456679999999999999999998 56788999999986532 23445688999999999999999999998
Q ss_pred EcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeec
Q psy787 108 VNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
.......+++|||++++ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence 65555578999999975 7999887653 568999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++......... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 238 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVL 238 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHH
Confidence 99866422111 11123345667999999977 4478999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=247.97 Aligned_cols=196 Identities=25% Similarity=0.355 Sum_probs=158.6
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhh-----heeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeE
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLC-----RRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDV 106 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 106 (235)
+...++|++.+.||+|+||+||++.+..+++ .+++|++..... ......+.+|+.++..+ +||||++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH---ADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC---hHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3445789999999999999999999876654 688888754431 22345688999999999 89999999999
Q ss_pred EEcCCCceEEEEEecccC-CHHHHhhcCC------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeE
Q psy787 107 FVNDKKQKMYLIMEYCVG-GLQDMLDSTP------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLL 173 (235)
Q Consensus 107 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nil 173 (235)
+ .....+++|||++++ +|.+++.... ...++...++.++.|++.||.|||+.|++|+||||+||+
T Consensus 119 ~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 119 C--THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp E--CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred E--ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 9 556678999999975 7888886431 246899999999999999999999999999999999999
Q ss_pred EccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 174 LTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 174 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++.++.++|+|||++................++..|+|||.+.+ ..++.++||||||+++
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 256 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILL 256 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHH
Confidence 99999999999999986542222212223335678999999877 4489999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=243.72 Aligned_cols=199 Identities=28% Similarity=0.481 Sum_probs=157.6
Q ss_pred CCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 28 ~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
.........++|++++.||+|+||.||++.+..+++.+++|++.... ......+.+|+.++..++||||+++++++
T Consensus 10 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 85 (302)
T 2j7t_A 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAY 85 (302)
T ss_dssp CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeee
Confidence 33334456788999999999999999999999899999999986543 23445688999999999999999999999
Q ss_pred EcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeec
Q psy787 108 VNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFG 186 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 186 (235)
. ....++++||++++ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus 86 ~--~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 162 (302)
T 2j7t_A 86 Y--HDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFG 162 (302)
T ss_dssp E--CC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred e--eCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECC
Confidence 5 45678999999976 5777766432 568999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCCcccccCCCCcccCccccCC---CCCCCCCcccEEEeeeeC
Q psy787 187 VAESLDMFLHDDTITTSQGSPVFQAPEIANG---LPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~~Di~slG~~l 235 (235)
++..... .........+++.|+|||.+.. ....++.++||||||+++
T Consensus 163 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 212 (302)
T 2j7t_A 163 VSAKNLK--TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212 (302)
T ss_dssp HHHHHHH--HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHH
T ss_pred CCccccc--cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHH
Confidence 8753321 1111223458889999998731 114478999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=239.17 Aligned_cols=194 Identities=22% Similarity=0.273 Sum_probs=152.7
Q ss_pred eeceEEeeeeeccccceEEEEeeccchh---hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETL---CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
...+|++.+.||+|+||+||++.+..++ ..+++|.+.... .......+.+|+.+++.++||||+++++++. ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~ 98 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RS 98 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC-CS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC---CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE-cC
Confidence 3457999999999999999999865433 246777665322 1233456889999999999999999999975 34
Q ss_pred CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
.+..+++||++++ +|.+++.... ..++...++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 4578899999976 7998887543 6689999999999999999999999999999999999999999999999999986
Q ss_pred cCcccc--CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLH--DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...... ........+++.|+|||.+.+ ..+++++||||||+++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 222 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLL 222 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred ccccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHH
Confidence 532211 112223346678999999977 4489999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=238.08 Aligned_cols=196 Identities=28% Similarity=0.440 Sum_probs=162.1
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCC-----CCccccHHHHHHHHHhcC-CCCcceeeeE
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI-----PNGEINVDREIRLLKMLQ-HRNVIGLVDV 106 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~ 106 (235)
....++|++.+.||+|++|.||++.+..+++.||+|++........ ......+.+|+.++..+. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 4567899999999999999999999999999999999876542111 112345779999999995 9999999999
Q ss_pred EEcCCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeee
Q psy787 107 FVNDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDF 185 (235)
Q Consensus 107 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~df 185 (235)
+ ......++|||+++ ++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus 93 ~--~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 93 Y--ETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp E--ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred e--ccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence 9 55678999999997 4799988765 57899999999999999999999999999999999999999999999999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCC----CCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANG----LPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~~Di~slG~~l 235 (235)
|++..... ........+++.|+|||.+.+ ....++.++||||||+++
T Consensus 169 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l 219 (298)
T 1phk_A 169 GFSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219 (298)
T ss_dssp TTCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred cchhhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHH
Confidence 99976542 223344568889999998742 123478899999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=251.28 Aligned_cols=193 Identities=22% Similarity=0.301 Sum_probs=157.8
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
..+.++|+++++||+|+||.||++.+..+++.||+|++..... ...+.+|+.++..+.|.+.+..+..+. ...
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~il~~L~~~~~i~~i~~~~-~~~ 75 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLLYESKIYRILQGGTGIPNVRWFG-VEG 75 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS------SCCHHHHHHHHHHTTTSTTCCCEEEEE-EET
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc------cHHHHHHHHHHHHhcCCCCCCeEEEEE-eeC
Confidence 4567899999999999999999999989999999998765432 235889999999998754444443332 345
Q ss_pred ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE---ccCCcEEEeeecccc
Q psy787 113 QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL---TLDGTLKISDFGVAE 189 (235)
Q Consensus 113 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~ 189 (235)
...++|||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.
T Consensus 76 ~~~~lvme~~g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 76 DYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp TEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CEEEEEEECCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 6789999999888999987543 579999999999999999999999999999999999999 578899999999998
Q ss_pred ccCccccCC-----cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDD-----TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+....... ......++..|+|||.+.+ ..++.++||||||++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil 203 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVL 203 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHH
Confidence 664322111 1224568899999999988 4589999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=235.98 Aligned_cols=188 Identities=22% Similarity=0.317 Sum_probs=157.1
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++.+.||+|++|.||++.+. +++.+++|++..... ....+.+|+.++..++||||+++++++ ......
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~ 78 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVC--LEQAPI 78 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSSC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEE--ccCCCe
Confidence 468999999999999999999885 567899999875432 234688999999999999999999999 455678
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
+++||++++ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999975 7998887653 56899999999999999999999999999999999999999999999999999755321
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. ........++..|+|||.+.+ ..++.++||||||+++
T Consensus 158 ~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 195 (267)
T 3t9t_A 158 Q-YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLM 195 (267)
T ss_dssp H-HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred c-ccccccccccccccChhhhcC--CCccchhchhhhHHHH
Confidence 1 111223345678999999976 4488999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=247.12 Aligned_cols=193 Identities=29% Similarity=0.455 Sum_probs=161.4
Q ss_pred CceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CC-----Ccce
Q psy787 29 KTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HR-----NVIG 102 (235)
Q Consensus 29 ~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~ 102 (235)
...+....++|++.+.||+|+||+||+|.+..+++.||+|+++... .....+..|+.++..+. |+ ++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-----AFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-----HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-----HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 3445667899999999999999999999999999999999986432 22335677888888775 44 4899
Q ss_pred eeeEEEcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHH--hCCcccCCCCCCCeEEc--cCC
Q psy787 103 LVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH--SQGIIHKDIKPGNLLLT--LDG 178 (235)
Q Consensus 103 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~dl~p~nili~--~~~ 178 (235)
+.+.+. ....+++|||+++++|.+++.......+++..+..++.|++.||.||| ..||+||||||+||++. .++
T Consensus 121 ~~~~~~--~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 121 LKRHFM--FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEEE--ETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred eeeeec--cCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence 999884 456899999999999999998876677999999999999999999999 47999999999999995 467
Q ss_pred cEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 179 TLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++|+|||++..... ......+++.|+|||.+.+ ..++.++||||||++|
T Consensus 199 ~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il 248 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCIL 248 (382)
T ss_dssp CEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred cEEEEeccCceeccc-----ccccccCCccccChHHHcC--CCCCcHHHHHHHHHHH
Confidence 899999999976532 2334568889999999988 4489999999999974
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=240.79 Aligned_cols=192 Identities=27% Similarity=0.383 Sum_probs=153.1
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHh--cCCCCcceeeeEEEc
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM--LQHRNVIGLVDVFVN 109 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~ 109 (235)
.....++|++++.||+|+||+||++.+ +++.||+|++.... ...+..|..++.. ++||||+++++.+..
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~ 73 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-------EKSWFRETELYNTVMLRHENILGFIASDMT 73 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-------chhhHHHHHHHHHhhccCcCeeeEEEeecc
Confidence 345678999999999999999999987 68899999986432 2235566666666 799999999998753
Q ss_pred --CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHH--------hCCcccCCCCCCCeEEccCC
Q psy787 110 --DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH--------SQGIIHKDIKPGNLLLTLDG 178 (235)
Q Consensus 110 --~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH--------~~~i~H~dl~p~nili~~~~ 178 (235)
.....++++||++++ +|.+++.. ..+++..++.++.|++.||.||| +.+++||||||+||+++.++
T Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 74 SRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred ccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence 234568999999975 79998854 56899999999999999999999 99999999999999999999
Q ss_pred cEEEeeeccccccCccccC--CcccccCCCCcccCccccCCCCC----CCCCcccEEEeeeeC
Q psy787 179 TLKISDFGVAESLDMFLHD--DTITTSQGSPVFQAPEIANGLPE----ISGYKVDIWSSGVTL 235 (235)
Q Consensus 179 ~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~----~~~~~~Di~slG~~l 235 (235)
.++|+|||++......... .......+++.|+|||.+.+... .++.++||||||+++
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il 213 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHH
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHH
Confidence 9999999999754321111 11223468999999999976321 245799999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=246.28 Aligned_cols=199 Identities=24% Similarity=0.288 Sum_probs=155.2
Q ss_pred ceeEeeeceEEeeeeeccccceEEEEee-----ccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceee
Q psy787 30 TIKVKMIGKYVMGDLLGEGSYGKVKEML-----DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLV 104 (235)
Q Consensus 30 ~~~~~~~~~y~i~~~ig~g~~~~v~~~~-----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 104 (235)
.+.+...++|++++.||+|+||.||++. +..+++.||+|++..... ......+.+|+.++..++||||++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS---EQDELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC---HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc---hhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence 3455677899999999999999999998 456778899998863321 23345688999999999999999999
Q ss_pred eEEEcCCCceEEEEEeccc-CCHHHHhhcCCC-----CCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC-
Q psy787 105 DVFVNDKKQKMYLIMEYCV-GGLQDMLDSTPY-----KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD- 177 (235)
Q Consensus 105 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~- 177 (235)
+++ ......++|||+++ ++|.+++..... ..++...++.++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 100 ~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 100 GVS--LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 177 (327)
T ss_dssp EEE--CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS
T ss_pred EEE--cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC
Confidence 999 45567799999995 579999886532 348899999999999999999999999999999999999844
Q ss_pred --CcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 178 --GTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 178 --~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..++|+|||++................+++.|+|||.+.+ ..++.++||||||+++
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 235 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLL 235 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHH
Confidence 4699999999875432222222333456788999999877 4489999999999974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=237.86 Aligned_cols=191 Identities=20% Similarity=0.226 Sum_probs=158.5
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|+||+||++.+. ++.+|+|+++...... .....+.+|+.++..++||||+++++++......
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWST--RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCH--HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCH--HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 34578999999999999999999984 7889999987654322 3345688999999999999999999999655457
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
.++++||++++ +|.+++.......+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++++||+++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 88999999975 7999998775557999999999999999999999999 99999999999999999999998887753
Q ss_pred cCccccCCcccccCCCCcccCccccCCCC-CCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLP-EISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~slG~~l 235 (235)
.. .....+++.|+|||.+.+.. ..++.++||||||+++
T Consensus 163 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il 201 (271)
T 3kmu_A 163 FQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201 (271)
T ss_dssp TS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHH
T ss_pred ec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHH
Confidence 22 22345788999999987632 1233479999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=244.88 Aligned_cols=194 Identities=26% Similarity=0.417 Sum_probs=162.5
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCc-------------cccHHHHHHHHHhcCCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNG-------------EINVDREIRLLKMLQHRN 99 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~-------------~~~~~~e~~~l~~l~h~~ 99 (235)
....++|++++.||+|+||.||++.+ +++.||+|++........... ...+.+|+.++..++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 44578999999999999999999998 889999999987654431110 157889999999999999
Q ss_pred cceeeeEEEcCCCceEEEEEecccC-CHHHH------hhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCC
Q psy787 100 VIGLVDVFVNDKKQKMYLIMEYCVG-GLQDM------LDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGN 171 (235)
Q Consensus 100 i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~------~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~n 171 (235)
|+++++++. ....+++|||++++ +|.++ +.......+++..++.++.|++.||.|||+ .|++|+||+|+|
T Consensus 105 i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 105 CLTCEGIIT--NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp BCCCSEEEE--SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred cceEEEEEe--eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 999999994 45689999999976 78887 555445789999999999999999999999 999999999999
Q ss_pred eEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCC-cccEEEeeeeC
Q psy787 172 LLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGY-KVDIWSSGVTL 235 (235)
Q Consensus 172 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~-~~Di~slG~~l 235 (235)
|+++.++.++|+|||.+..... .......++..|+|||.+.+.. .++. ++||||||+++
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~il 242 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNES-SYNGAKVDIWSLGICL 242 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCC-CEEHHHHHHHHHHHHH
T ss_pred EEEcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCC-CCCcchhhHHHHHHHH
Confidence 9999999999999999975532 2334556889999999998732 3444 99999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=242.65 Aligned_cols=193 Identities=30% Similarity=0.395 Sum_probs=156.8
Q ss_pred eeceE-EeeeeeccccceEEEEe----eccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 35 MIGKY-VMGDLLGEGSYGKVKEM----LDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 35 ~~~~y-~i~~~ig~g~~~~v~~~----~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
+.++| +++++||+|+||+||++ .+..+++.||+|+++.... ......+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG---PQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC---hHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence 44455 99999999999999665 4556889999999865421 2334568899999999999999999999976
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
.....+++|||++++ +|.+++... .+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred CCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccc
Confidence 656789999999975 799988764 4899999999999999999999999999999999999999999999999999
Q ss_pred cccCccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 227 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTL 227 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHH
Confidence 866422111 11223446777999999977 4488999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=237.20 Aligned_cols=191 Identities=31% Similarity=0.555 Sum_probs=160.0
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
....++|++++.||+|++|+||++.+..+++.+++|++...... ......+.+|+.++..++||||+++++++ ...
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~ 93 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEIL--EDS 93 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECS
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEE--eCC
Confidence 34567999999999999999999999889999999999765543 24456788999999999999999999999 456
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC---cEEEeeeccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG---TLKISDFGVA 188 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~---~~~l~dfg~~ 188 (235)
..+++++|++.+ +|.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred CeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 688999999965 688887765 5689999999999999999999999999999999999997644 6999999998
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...... .......+++.|+|||.+.+ .++.++||||||+++
T Consensus 172 ~~~~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l 212 (287)
T 2wei_A 172 TCFQQN---TKMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVIL 212 (287)
T ss_dssp GTBCCC---SSCSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHH
T ss_pred eeecCC---CccccccCcccccChHHhcC---CCCCchhhHhHHHHH
Confidence 755421 12222336778999999876 278999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=242.46 Aligned_cols=192 Identities=25% Similarity=0.376 Sum_probs=155.8
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhhe--eeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRR--AVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVND 110 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~--~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (235)
...++|++.+.||+|+||.||++.+..++..+ ++|.++.... ......+.+|+.++..+ +||||+++++++ .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--~ 96 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS---KDDHRDFAGELEVLCKLGHHPNIINLLGAC--E 96 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEE--E
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc---hHHHHHHHHHHHHHHhccCCCchhhhceee--e
Confidence 44579999999999999999999998888765 8887764321 23445688999999999 899999999999 4
Q ss_pred CCceEEEEEecccC-CHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT 175 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~ 175 (235)
....+++|||++++ +|.+++.... ...+++..++.++.|++.||.+||+.|++|+||||+||+++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 55689999999965 7999887652 24689999999999999999999999999999999999999
Q ss_pred cCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 176 LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 176 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++.++|+|||++..... ........++..|+|||.+.+ ..++.++||||||+++
T Consensus 177 ~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 231 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLL 231 (327)
T ss_dssp GGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHH
T ss_pred CCCeEEEcccCcCccccc---cccccCCCCCccccChhhhcc--ccCCchhcchHHHHHH
Confidence 999999999999874321 112233346778999999976 4488999999999974
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=239.46 Aligned_cols=190 Identities=29% Similarity=0.376 Sum_probs=157.0
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
|...+.||+|+||+||++.+ +++.+++|++..............+.+|+.++..++||||+++++++ ......+++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv 108 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS--SDGDDLCLV 108 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSCEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE--ecCCceEEE
Confidence 44458999999999999987 57889999987655444345556789999999999999999999999 555678999
Q ss_pred Eeccc-CCHHHHhhcCC-CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 119 MEYCV-GGLQDMLDSTP-YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 119 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
||+++ ++|.+++.... ..++++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 99996 57888886432 25689999999999999999999999999999999999999999999999999976543222
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+ .++.++||||||+++
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il 224 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVL 224 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHH
T ss_pred cccccccCCCcCcCChHHhcC---CCCccchhHHHHHHH
Confidence 222334568899999999865 268899999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=241.68 Aligned_cols=194 Identities=23% Similarity=0.352 Sum_probs=151.5
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchh----hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETL----CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
...++|++.+.||+|+||+||++.+..++ ..||+|+++.... ......+.+|+.++..++||||+++++++
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-- 115 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT---EKQRVDFLGEAGIMGQFSHHNIIRLEGVI-- 115 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEE--
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEE--
Confidence 34568999999999999999999876543 3589998864321 23344688999999999999999999999
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
.....+++|||++++ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 566789999999976 7888887643 57899999999999999999999999999999999999999999999999999
Q ss_pred cccCccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 240 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVM 240 (333)
T ss_dssp ----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHH
T ss_pred hhhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHH
Confidence 865422111 11122335678999999977 4588999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=239.13 Aligned_cols=195 Identities=27% Similarity=0.428 Sum_probs=154.3
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC--CCCcceeeeEEEcC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ--HRNVIGLVDVFVND 110 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 110 (235)
....++|++++.||+|+||.||++.+. +++.+|+|++...... ......+.+|+.++..++ |+||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-- 98 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD--NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-- 98 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE--
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc--ccchHHHHHHHHHHHhccccCCceEEEEEEee--
Confidence 345568999999999999999999885 5888999998765432 233456889999999997 599999999994
Q ss_pred CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 111 KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 111 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
....++++||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++..
T Consensus 99 ~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 99 TDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp CSSEEEEEECCCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred cCCEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence 55689999997778899999876 5789999999999999999999999999999999999996 58999999999986
Q ss_pred cCccccCCcccccCCCCcccCccccCCC---------CCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGL---------PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~---------~~~~~~~~Di~slG~~l 235 (235)
..............+++.|+|||.+.+. ...++.++||||||+++
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il 229 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHH
Confidence 6432222223345688999999998651 13578899999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=241.72 Aligned_cols=201 Identities=28% Similarity=0.432 Sum_probs=162.2
Q ss_pred ecCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC--CccccHHHHHHHHHhcC--CCCcc
Q psy787 26 YDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP--NGEINVDREIRLLKMLQ--HRNVI 101 (235)
Q Consensus 26 ~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~--~~~~~~~~e~~~l~~l~--h~~i~ 101 (235)
..+........++|++.+.||+|+||.||++.+..+++.||+|++......... .....+.+|+.++..+. |+|++
T Consensus 32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 334455667788999999999999999999999999999999999876543311 23356778999999996 59999
Q ss_pred eeeeEEEcCCCceEEEEEeccc--CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc-cCC
Q psy787 102 GLVDVFVNDKKQKMYLIMEYCV--GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT-LDG 178 (235)
Q Consensus 102 ~~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~-~~~ 178 (235)
++++++ .....+++++|++. ++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++ .++
T Consensus 112 ~~~~~~--~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 112 RLLDWF--ERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp CEEEEE--ECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT
T ss_pred EEEEEE--ecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC
Confidence 999999 45668899999996 5699888765 6789999999999999999999999999999999999999 678
Q ss_pred cEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 179 TLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.++|+|||++..... .......+++.|+|||.+.+. ...+.++||||||+++
T Consensus 188 ~~kL~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il 239 (320)
T 3a99_A 188 ELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILL 239 (320)
T ss_dssp EEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHH
T ss_pred CEEEeeCcccccccc----ccccCCCCCccCCChHHhccC-CCCCccchHHhHHHHH
Confidence 999999999986542 223345588999999998652 2346789999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=236.71 Aligned_cols=189 Identities=26% Similarity=0.371 Sum_probs=155.6
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++++.||+|+||.||++.+. +++.+++|++.... .....+.+|+.++..++||||+++++++. .+.
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~ 81 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVT---QEP 81 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSS
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-----ccHHHHHHHHHHHHhCCCcCcceEEEEEc---CCC
Confidence 3468999999999999999999875 55789999886443 23456889999999999999999999983 235
Q ss_pred EEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
.+++||+++ ++|.+++.......+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 789999996 5799988764334689999999999999999999999999999999999999999999999999986542
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........++..|+|||.+.+ ..++.++||||||+++
T Consensus 162 ~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 200 (279)
T 1qpc_A 162 NE-YTAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILL 200 (279)
T ss_dssp SC-EECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHH
T ss_pred cc-cccccCCCCccCccChhhhcc--CCCCchhhhHHHHHHH
Confidence 11 111223345678999999976 4488999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=253.26 Aligned_cols=191 Identities=26% Similarity=0.358 Sum_probs=157.7
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
+...++|++.+.||+|+||+||++.+. .+..||+|+++... .....+.+|+.+++.++||||+++++++. .
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~ 254 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT---K 254 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---S
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---C
Confidence 445678999999999999999999875 45789999987543 33557899999999999999999999983 3
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+++|||++.+ +|.+++.......++...++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++...
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 467999999964 7999987654346889999999999999999999999999999999999999999999999999865
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... .......++..|+|||.+.+ ..++.++||||||++|
T Consensus 335 ~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l 375 (454)
T 1qcf_A 335 EDNEY-TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILL 375 (454)
T ss_dssp CCHHH-HTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred CCCce-eccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHH
Confidence 32111 11122335678999999976 4589999999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=240.52 Aligned_cols=199 Identities=21% Similarity=0.299 Sum_probs=142.6
Q ss_pred CceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHH-HHHhcCCCCcceeeeEE
Q psy787 29 KTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR-LLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 29 ~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~ 107 (235)
........++|++++.||+|+||.||++.+..+++.||+|++...... .....+..|+. .++.++||||+++++++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~~~~~~ 90 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE---KEQKQLLMDLDVVMRSSDCPYIVQFYGAL 90 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH---HHHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc---hHHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence 333444567899999999999999999999989999999998754321 22234555665 56667999999999999
Q ss_pred EcCCCceEEEEEecccCCHHHHhhc---CCCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEccCCcEEEe
Q psy787 108 VNDKKQKMYLIMEYCVGGLQDMLDS---TPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKIS 183 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~~~~~~l~ 183 (235)
. ..+..++|||+++++|.+++.. .....+++..+..++.|++.||.+||+. |++|+||||+||+++.++.++|+
T Consensus 91 ~--~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~ 168 (327)
T 3aln_A 91 F--REGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLC 168 (327)
T ss_dssp E--CSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred E--eCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEc
Confidence 5 4568899999999987777653 2236789999999999999999999999 99999999999999999999999
Q ss_pred eeccccccCccccCCcccccCCCCcccCccccCCC--CCCCCCcccEEEeeeeC
Q psy787 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGL--PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~~Di~slG~~l 235 (235)
|||++..... ........+++.|+|||.+... ...++.++||||||+++
T Consensus 169 Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 219 (327)
T 3aln_A 169 DFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITL 219 (327)
T ss_dssp CCSSSCC---------------------------------CCSHHHHHHHHHHH
T ss_pred cCCCceeccc---ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHH
Confidence 9999976532 1222233588899999998421 13478999999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=236.13 Aligned_cols=192 Identities=23% Similarity=0.321 Sum_probs=153.5
Q ss_pred eeeceEEeeeeeccccceEEEEeeccc---hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSE---TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
...++|++.+.||+|+||+||++.+.. ++..+++|++..... ......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-- 83 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT---LDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-- 83 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC---HHHHHHHHHHHHHHHHHCCTTBCCEEEEEC--
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC---chHHHHHHHHHHHHHhCCCCCcceEEEEEc--
Confidence 345789999999999999999998543 345689998765421 233456889999999999999999999983
Q ss_pred CCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
. +..+++||++++ +|.+++.... ..++...++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 84 E-EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred C-CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 3 345899999975 6888887643 568999999999999999999999999999999999999999999999999998
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...... ........++..|+|||.+.+ ..++.++||||||+++
T Consensus 162 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 204 (281)
T 3cc6_A 162 YIEDED-YYKASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCM 204 (281)
T ss_dssp CC----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred cccccc-ccccccCCCCcceeCchhhcc--CCCCchhccHHHHHHH
Confidence 654211 112223446778999999976 4488999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=237.70 Aligned_cols=191 Identities=25% Similarity=0.338 Sum_probs=154.2
Q ss_pred eceEEeee-eeccccceEEEEe--eccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 36 IGKYVMGD-LLGEGSYGKVKEM--LDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 36 ~~~y~i~~-~ig~g~~~~v~~~--~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
.++|++.+ .||+|+||+||++ ....+++.+++|+++..... ......+.+|+.++..++||||+++++++ . .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~-~ 89 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGIC--E-A 89 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE--E-S
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEE--C-C
Confidence 35899998 9999999999999 45667889999998765322 23345688999999999999999999998 2 3
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..++++||++++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 467899999974 799998875 56899999999999999999999999999999999999999999999999999765
Q ss_pred CccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 210 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLM 210 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHH
T ss_pred ccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHH
Confidence 422111 11122335678999999976 4478899999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=251.49 Aligned_cols=191 Identities=24% Similarity=0.312 Sum_probs=153.5
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
+...++|++.++||+|+||+||++.+.. +..||+|+++... .....+.+|+.+++.++||||+++++++. .
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~- 250 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVS--E- 250 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEc--C-
Confidence 3456789999999999999999998864 3569999886543 23356899999999999999999999984 3
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+++|||++++ +|.+++.......+++..++.++.|++.||+|||+++++||||||+||+++.++.++|+|||++...
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 467999999975 7999987544456899999999999999999999999999999999999999999999999999865
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ........++..|+|||.+.+ ..++.++||||||++|
T Consensus 331 ~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l 371 (452)
T 1fmk_A 331 EDNE-YTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILL 371 (452)
T ss_dssp -------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred CCCc-eecccCCcccccccCHhHHhc--CCCCccccHHhHHHHH
Confidence 3211 111222335678999999877 4589999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=238.38 Aligned_cols=185 Identities=26% Similarity=0.380 Sum_probs=149.0
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++.+.||+|++|+||++.+ +++.+++|+++.. .....+.+|+.++..++||||+++++++.+ ..+.
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 89 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGG 89 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECC-C--C
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCCc
Confidence 357899999999999999999987 4788999988643 234568899999999999999999999753 3446
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
++++||++++ +|.+++.......+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999976 799988765333488999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+.+ ..++.++||||||+++
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 204 (278)
T 1byg_A 170 -----TQDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILL 204 (278)
T ss_dssp -----------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred -----cccCCCccccccCHHHhCC--CCCCchhcHHHHHHHH
Confidence 1223346778999999976 4588999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=245.05 Aligned_cols=189 Identities=28% Similarity=0.416 Sum_probs=158.7
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-----------CCCccee
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-----------HRNVIGL 103 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~ 103 (235)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.++.++. |+||+++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-----cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 4578999999999999999999999999999999986432 22345778888888876 7899999
Q ss_pred eeEEEcC--CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEcc----
Q psy787 104 VDVFVND--KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTL---- 176 (235)
Q Consensus 104 ~~~~~~~--~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~---- 176 (235)
++.+... ....++++||+++++|.+++.......+++..++.++.|++.||.|||++ |++|+||||+||+++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9998543 22378999999988899999887667799999999999999999999998 9999999999999953
Q ss_pred --CCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 177 --DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 177 --~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+.++|+|||++..... ......+++.|+|||.+.+ ..++.++||||||++|
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il 225 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLG--APWGCGADIWSTACLI 225 (373)
T ss_dssp TTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHH
T ss_pred cCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHH
Confidence 34799999999975542 2233468899999999987 4489999999999974
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=233.11 Aligned_cols=192 Identities=23% Similarity=0.285 Sum_probs=154.1
Q ss_pred ceEEeeeeeccccceEEEEeeccchh---hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETL---CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
-.|.+.+.||+|+||+||++.+..++ ..+++|++.... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 96 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT---EMQQVEAFLREGLLMRGLNHPNVLALIGIMLP-PEG 96 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC-SSS
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc---cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec-CCC
Confidence 37888899999999999999864443 368888875422 12334568899999999999999999999953 233
Q ss_pred eEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..+++||++. ++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 4589999995 57888887643 678999999999999999999999999999999999999999999999999997553
Q ss_pred ccc--cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFL--HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... .........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 218 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLL 218 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred CCcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHH
Confidence 211 1222333456778999999987 4589999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=233.99 Aligned_cols=191 Identities=25% Similarity=0.395 Sum_probs=154.9
Q ss_pred eceEEeee-eeccccceEEEEeecc--chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 36 IGKYVMGD-LLGEGSYGKVKEMLDS--ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 36 ~~~y~i~~-~ig~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
.++|.+.+ .||+|+||.||++.+. .++..+++|+++... .......+.+|+.++..++||||+++++++. .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~ 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ---A 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---S
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc---chhHHHHHHHHHHHHHhCCCCCEeEEEEEec---C
Confidence 45788877 9999999999999753 467789999987542 1234456889999999999999999999982 3
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
+.+++|||++++ +|.+++... ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 358999999976 688888654 256999999999999999999999999999999999999999999999999999865
Q ss_pred CccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...... .......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 203 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTM 203 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHH
T ss_pred ccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHH
Confidence 321111 11223345788999999976 4488999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=239.44 Aligned_cols=195 Identities=29% Similarity=0.479 Sum_probs=140.3
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++.+.||+|++|.||++.+..+++.||+|++...... .....+.+|+..+..++||||+++++.+. ....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ---TSMDELLKEIQAMSQCHHPNIVSYYTSFV--VKDE 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEE--SSSC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc---hhHHHHHHHHHHHhhcCCCCEeeEEEEEe--ecCC
Confidence 456899999999999999999999889999999988654322 23346788999999999999999999994 4557
Q ss_pred EEEEEecccC-CHHHHhhc------CCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 115 MYLIMEYCVG-GLQDMLDS------TPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
.++|||++++ +|.+++.. .....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 8999999965 68888764 1235689999999999999999999999999999999999999999999999999
Q ss_pred ccccCcccc---CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLH---DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+........ ........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il 217 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITA 217 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHH
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHH
Confidence 875532111 1112334588899999988541 2378899999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=245.23 Aligned_cols=188 Identities=29% Similarity=0.380 Sum_probs=146.4
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCceE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 115 (235)
.+|.+.+.||+|+||+|+. ....+++.||+|++.... ...+.+|+.+++.+ +||||+++++.+ .....+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~l~~~~--~~~~~~ 93 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC-------FSFADREVQLLRESDEHPNVIRYFCTE--KDRQFQ 93 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT-------EEECHHHHHHHHHSCCCTTBCCEEEEE--EETTEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEE--ecCCEE
Confidence 4799999999999999764 344578999999885432 23467899999999 799999999998 556688
Q ss_pred EEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC-----CcEEEeeeccccc
Q psy787 116 YLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD-----GTLKISDFGVAES 190 (235)
Q Consensus 116 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~-----~~~~l~dfg~~~~ 190 (235)
++|||+++++|.+++.... ...+...++.++.|++.||.|||+.|++||||||+||+++.+ ..++|+|||++..
T Consensus 94 ~lv~E~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 94 YIAIELCAATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEECCSEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEECCCCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 9999999999999988654 345556778999999999999999999999999999999532 2588999999986
Q ss_pred cCccccC-CcccccCCCCcccCccccCCC-CCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHD-DTITTSQGSPVFQAPEIANGL-PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 235 (235)
....... .......+++.|+|||.+.+. ...++.++|||||||++
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il 219 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHH
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHH
Confidence 6422111 223345689999999998742 13477899999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=239.39 Aligned_cols=193 Identities=27% Similarity=0.450 Sum_probs=140.5
Q ss_pred CCceeEeeeceEEeee-eeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHH-HHHHhcCCCCcceeee
Q psy787 28 NKTIKVKMIGKYVMGD-LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREI-RLLKMLQHRNVIGLVD 105 (235)
Q Consensus 28 ~~~~~~~~~~~y~i~~-~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~ 105 (235)
+......+.++|++++ .||+|+||+||++.+..+++.||+|++.... ....++ ..+..+.|+||+++++
T Consensus 19 p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~e~~~~~~~~~h~~i~~~~~ 89 (336)
T 3fhr_A 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---------KARQEVDHHWQASGGPHIVCILD 89 (336)
T ss_dssp -CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---------HHHHHHHHHHHHTTSTTBCCEEE
T ss_pred CCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---------HHHHHHHHHHHhcCCCChHHHHH
Confidence 3444456778999976 5999999999999999999999999985432 123333 3456679999999999
Q ss_pred EEEc--CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC---Cc
Q psy787 106 VFVN--DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD---GT 179 (235)
Q Consensus 106 ~~~~--~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~---~~ 179 (235)
++.. .....+++||||+++ +|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++.+ +.
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCC
T ss_pred HHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCce
Confidence 9843 224568999999976 79999987765679999999999999999999999999999999999999864 45
Q ss_pred EEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 180 LKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++|+|||++.... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 170 ~kl~Dfg~~~~~~----~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il 219 (336)
T 3fhr_A 170 LKLTDFGFAKETT----QNALQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIM 219 (336)
T ss_dssp EEECCCTTCEEC----------------------------CHHHHHHHHHHHHHHH
T ss_pred EEEeccccceecc----ccccccCCCCcCccChhhhCC--CCCCchhhHHHHHHHH
Confidence 9999999997543 222334557889999999976 4588999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=233.90 Aligned_cols=189 Identities=33% Similarity=0.461 Sum_probs=153.3
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
|.....||+|+||.||++.+..+++.|++|.+.... ......+.+|+.++..++||||+++++++ ...+.++++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~lv 97 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSF--SENGFIKIF 97 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEE--EETTEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEE--EeCCcEEEE
Confidence 334458999999999999999999999999987543 23345688999999999999999999999 455688999
Q ss_pred Eeccc-CCHHHHhhcCC-CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc-CCcEEEeeeccccccCccc
Q psy787 119 MEYCV-GGLQDMLDSTP-YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL-DGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 119 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~~~~ 195 (235)
||+++ ++|.+++.... ...+++..++.++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||++......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~- 176 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI- 176 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC-
Confidence 99996 57888887653 235678889999999999999999999999999999999987 889999999999765421
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+.+..++.++||||||+++
T Consensus 177 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 215 (295)
T 2clq_A 177 -NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTI 215 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHH
T ss_pred -CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHH
Confidence 122334568889999999866333478899999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=242.24 Aligned_cols=192 Identities=21% Similarity=0.285 Sum_probs=145.7
Q ss_pred ceEEeeeeeccccceEEEEeeccch---hhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSET---LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
..|.+.+.||+|+||+||++.+..+ +..+++|.++... .......+.+|+.++..++||||+++++++.. ..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS---CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC-CSS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCC
Confidence 4689999999999999999986433 3457888765322 12344568899999999999999999998753 345
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..++||||+++ +|.+++.... ..++...++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 67899999975 7999887543 568899999999999999999999999999999999999999999999999997553
Q ss_pred cccc--CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLH--DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ........++..|+|||.+.+ ..++.++||||||+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il 286 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLL 286 (373)
T ss_dssp --------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHH
Confidence 2111 111223346678999999977 4589999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=236.58 Aligned_cols=198 Identities=23% Similarity=0.326 Sum_probs=143.0
Q ss_pred ceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 30 TIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 30 ~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
.......++|++++.||+|+||.||++.+..+++.||+|++....... .....+..+...+..++||||+++++++.
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~h~~i~~~~~~~~- 94 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGTFI- 94 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH--HHHHHHHHHHHHHHTTTCTTBCCEEEEEE-
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch--HHHHHHHHHHHHHHhcCCCceeeEEEEEe-
Confidence 344556789999999999999999999999899999999987553221 11223334445677789999999999994
Q ss_pred CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
....++++||++++.+..+.... ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++
T Consensus 95 -~~~~~~lv~e~~~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 95 -TNTDVFIAMELMGTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp -CSSEEEEEECCCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred -cCCcEEEEEeccCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 45688999999965555554432 26789999999999999999999996 9999999999999999999999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCC---CCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~l 235 (235)
..... ........+++.|+|||.+.+. ...++.++||||||+++
T Consensus 173 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 219 (318)
T 2dyl_A 173 GRLVD---DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219 (318)
T ss_dssp -----------------CCTTCCHHHHC--------CCTHHHHHHHHHHH
T ss_pred hhccC---CccccccCCCccccChhhcccccccccCCccccchhhHHHHH
Confidence 75532 1222344588899999998531 23578899999999974
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=238.02 Aligned_cols=184 Identities=22% Similarity=0.266 Sum_probs=148.9
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccC----CCCccccHHHHHHHHHhcC---------CCCcce
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR----IPNGEINVDREIRLLKMLQ---------HRNVIG 102 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~~~~e~~~l~~l~---------h~~i~~ 102 (235)
.++|++.+.||+|+||+||+|++ +++.||+|++....... .......+.+|+.+++.++ |+||+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 57899999999999999999988 67999999998765431 1223356889999988885 777777
Q ss_pred eeeEEEcC----------------------------CCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHH
Q psy787 103 LVDVFVND----------------------------KKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDG 153 (235)
Q Consensus 103 ~~~~~~~~----------------------------~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~ 153 (235)
+.+.+... ....+++||||+.++ +.+.+.. ..+++..++.++.|++.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 77664311 256899999999654 6666543 568999999999999999
Q ss_pred HHHHH-hCCcccCCCCCCCeEEccCC--------------------cEEEeeeccccccCccccCCcccccCCCCcccCc
Q psy787 154 LEYLH-SQGIIHKDIKPGNLLLTLDG--------------------TLKISDFGVAESLDMFLHDDTITTSQGSPVFQAP 212 (235)
Q Consensus 154 l~~lH-~~~i~H~dl~p~nili~~~~--------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aP 212 (235)
|.||| +.||+||||||+||+++.++ .++|+|||+++.... ....+++.|+||
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP 246 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence 99999 99999999999999999887 899999999985532 123588999999
Q ss_pred cccCCCCCCCCCcccEEEeeee
Q psy787 213 EIANGLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 213 E~~~~~~~~~~~~~Di~slG~~ 234 (235)
|++.+.. +.++|||||+++
T Consensus 247 E~~~g~~---~~~~Diwsl~~~ 265 (336)
T 2vuw_A 247 DLFTGDG---DYQFDIYRLMKK 265 (336)
T ss_dssp GGGCCCS---SHHHHHHHHHHH
T ss_pred hhhcCCC---ccceehhhhhCC
Confidence 9998733 789999998653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=253.27 Aligned_cols=191 Identities=24% Similarity=0.313 Sum_probs=157.3
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
+...++|++.++||+|+||+||++.+.. +..||+|+++... .....+.+|+.+++.++|+||+++++++. .
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~- 333 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVS--E- 333 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEe--e-
Confidence 3456789999999999999999998864 3669999987543 23356899999999999999999999984 3
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+++||||+.+ +|.+++.......+++..++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++...
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 467999999975 7999987544456899999999999999999999999999999999999999999999999999865
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... .......++..|+|||.+.+ ..++.++||||||++|
T Consensus 414 ~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l 454 (535)
T 2h8h_A 414 EDNEY-TARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILL 454 (535)
T ss_dssp CCHHH-HTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred CCCce-ecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHH
Confidence 32110 11122335677999999877 4589999999999974
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=234.87 Aligned_cols=194 Identities=24% Similarity=0.354 Sum_probs=151.9
Q ss_pred CCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHh--cCCCCcceeee
Q psy787 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM--LQHRNVIGLVD 105 (235)
Q Consensus 28 ~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~ 105 (235)
+........++|++++.||+|+||.||++.+. ++.||+|++..... .....|..++.. ++|+||+++++
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-------~~~~~e~~~~~~~~~~h~~i~~~~~ 98 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE-------ASWFRETEIYQTVLMRHENILGFIA 98 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH-------HHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc-------chhhhHHHHHHHHhhcCCCeeeEEE
Confidence 34455566789999999999999999999874 78999999854321 223445555544 48999999999
Q ss_pred EEEcCCC--ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCeEE
Q psy787 106 VFVNDKK--QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ--------GIIHKDIKPGNLLL 174 (235)
Q Consensus 106 ~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--------~i~H~dl~p~nili 174 (235)
.+..... ..+++||||+++ +|.+++.. ..+++..++.++.|++.||.|||+. |++||||||+||++
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp EEEESCGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred EEccCCCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence 9865432 678999999975 79999876 4689999999999999999999999 99999999999999
Q ss_pred ccCCcEEEeeeccccccCccccCC--cccccCCCCcccCccccCCCCCCCCCc------ccEEEeeeeC
Q psy787 175 TLDGTLKISDFGVAESLDMFLHDD--TITTSQGSPVFQAPEIANGLPEISGYK------VDIWSSGVTL 235 (235)
Q Consensus 175 ~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~------~Di~slG~~l 235 (235)
+.++.++|+|||++..+....... ......+++.|+|||.+.+.. .+.. +||||||+++
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~DiwslG~il 242 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL--NRNHFQSYIMADMYSFGLIL 242 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC--CTTCTHHHHHHHHHHHHHHH
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc--CCccccCccccchHHHHHHH
Confidence 999999999999997553221111 112446889999999997733 3443 8999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=236.39 Aligned_cols=197 Identities=25% Similarity=0.430 Sum_probs=151.8
Q ss_pred ceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC--CccccHHHHHHHHHhc----CCCCccee
Q psy787 30 TIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP--NGEINVDREIRLLKML----QHRNVIGL 103 (235)
Q Consensus 30 ~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~--~~~~~~~~e~~~l~~l----~h~~i~~~ 103 (235)
...+...++|++.+.||+|+||.||++.+..+++.||+|++......... .....+.+|+..+..+ +|+||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 34566778999999999999999999999999999999998765433211 2234567899999988 89999999
Q ss_pred eeEEEcCCCceEEEEEec-cc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc-cCCcE
Q psy787 104 VDVFVNDKKQKMYLIMEY-CV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT-LDGTL 180 (235)
Q Consensus 104 ~~~~~~~~~~~~~lv~e~-~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~-~~~~~ 180 (235)
++++ ......++++|+ +. ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.+
T Consensus 104 ~~~~--~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 104 LDWF--ETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EEEC-------CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEE
T ss_pred EEEE--ecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeE
Confidence 9998 445677999998 44 5799988875 5689999999999999999999999999999999999999 78999
Q ss_pred EEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 181 KISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+|+|||++..... .......++..|+|||.+.+. ...+.++||||||+++
T Consensus 180 kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il 229 (312)
T 2iwi_A 180 KLIDFGSGALLHD----EPYTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILL 229 (312)
T ss_dssp EECCCSSCEECCS----SCBCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHH
T ss_pred EEEEcchhhhccc----CcccccCCcccccCceeeecC-CCCCccchHHHHHHHH
Confidence 9999999986542 223345588899999988652 2235689999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=232.61 Aligned_cols=182 Identities=31% Similarity=0.502 Sum_probs=146.9
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++.+.||+|+||+||++.+. ++.+++|++... .....+.+|+..+..++||||+++++.+. + .
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~--~ 73 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE------SERKAFIVELRQLSRVNHPNIVKLYGACL--N--P 73 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST------THHHHHHHHHHHHHHCCCTTBCCEEEBCT--T--T
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh------hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C--C
Confidence 3568999999999999999999874 678999987532 33456889999999999999999999883 2 3
Q ss_pred EEEEEecccC-CHHHHhhcCCC-CCCCHHhHHHHHHHHHHHHHHHHh---CCcccCCCCCCCeEEccCCc-EEEeeeccc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPY-KKFPIWQAHGYFLQLLDGLEYLHS---QGIIHKDIKPGNLLLTLDGT-LKISDFGVA 188 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~nili~~~~~-~~l~dfg~~ 188 (235)
.++||||+++ +|.+++..... ..++...++.++.|++.||.|||+ .|++|+||||+||+++.++. ++|+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 6899999965 79998876532 247888999999999999999999 89999999999999998886 799999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... ......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il 193 (307)
T 2eva_A 154 CDIQT-----HMTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIIL 193 (307)
T ss_dssp ----------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHH
T ss_pred ccccc-----ccccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHH
Confidence 75432 1223458899999999987 4589999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=237.45 Aligned_cols=189 Identities=26% Similarity=0.365 Sum_probs=147.1
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHH--HHHhcCCCCcceeeeEEE---c
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR--LLKMLQHRNVIGLVDVFV---N 109 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~--~l~~l~h~~i~~~~~~~~---~ 109 (235)
..++|++++.||+|+||+||++.+ +++.||+|++..... ..+..|.. .+..++|+||+++++.+. .
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR-------QNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH-------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch-------hhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 457899999999999999999976 678999999864432 22333443 344579999999997542 2
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC---------CcccCCCCCCCeEEccCCc
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ---------GIIHKDIKPGNLLLTLDGT 179 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---------~i~H~dl~p~nili~~~~~ 179 (235)
.....+++||||+++ +|.+++... ..++..++.++.|++.||.|||+. |++||||||+||+++.++.
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred CCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 344578999999965 799998764 458889999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccCcccc------CCcccccCCCCcccCccccCCCC-----CCCCCcccEEEeeeeC
Q psy787 180 LKISDFGVAESLDMFLH------DDTITTSQGSPVFQAPEIANGLP-----EISGYKVDIWSSGVTL 235 (235)
Q Consensus 180 ~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~-----~~~~~~~Di~slG~~l 235 (235)
++|+|||++..+..... ........+++.|+|||.+.+.. ..++.++||||||+++
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il 225 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHH
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHH
Confidence 99999999976542111 11222345889999999987621 1356789999999974
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=253.32 Aligned_cols=184 Identities=25% Similarity=0.344 Sum_probs=148.4
Q ss_pred eeeccccceEEEEee--ccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEe
Q psy787 43 DLLGEGSYGKVKEML--DSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~--~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 120 (235)
++||+|+||+||++. ...+++.||+|+++..... ......+.+|+.++..++||||+++++++. . ..+++|||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~-~~~~lv~E 449 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGICE--A-ESWMLVME 449 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC--GGGHHHHHHHHHHHHHCCCTTBCCEEEEEE--S-SSEEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--c-CCEEEEEE
Confidence 489999999999994 4567789999998765332 234467899999999999999999999983 3 35789999
Q ss_pred cccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC-C
Q psy787 121 YCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD-D 198 (235)
Q Consensus 121 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~ 198 (235)
++++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+...... .
T Consensus 450 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 450 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9975 699988765 67899999999999999999999999999999999999999999999999999865321111 1
Q ss_pred cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 199 TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 199 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+.+ ..++.++||||||++|
T Consensus 528 ~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l 562 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLM 562 (635)
T ss_dssp -------CGGGSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHH
Confidence 1222335678999999977 4589999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=251.72 Aligned_cols=190 Identities=24% Similarity=0.397 Sum_probs=151.0
Q ss_pred ceEEeee-eeccccceEEEEeecc--chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 37 GKYVMGD-LLGEGSYGKVKEMLDS--ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 37 ~~y~i~~-~ig~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
+++.+.+ .||+|+||+||++.+. .++..||+|+++... .......+.+|+.++..++||||+++++++. . .
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~--~-~ 408 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--A-E 408 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE--S-S
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEec--c-C
Confidence 4556666 8999999999999764 456779999987542 2344567899999999999999999999984 2 3
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++|||++++ +|.+++... ...+++..++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++..+.
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 58999999975 688888654 3569999999999999999999999999999999999999999999999999998653
Q ss_pred ccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... .......++..|+|||.+.+ ..++.++||||||++|
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l 529 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTM 529 (613)
T ss_dssp --------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred CCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHH
Confidence 21111 11112234578999999976 4589999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=238.82 Aligned_cols=198 Identities=25% Similarity=0.345 Sum_probs=159.0
Q ss_pred ecCCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHh--cCCCCccee
Q psy787 26 YDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKM--LQHRNVIGL 103 (235)
Q Consensus 26 ~~~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~ 103 (235)
..+..+...+.++|++.+.||+|+||+||++.+ +++.||+|++.... ...+.+|..++.. ++||||+++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~ni~~~ 101 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-------ERSWFREAEIYQTVMLRHENILGF 101 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-------HHHHHHHHHHHHHSCCCCTTBCCE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-------HHHHHHHHHHHHHhhcCCCcEEEE
Confidence 444455566678999999999999999999987 48899999985432 2356788888887 789999999
Q ss_pred eeEEEcCCC--ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHH--------hCCcccCCCCCCCe
Q psy787 104 VDVFVNDKK--QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH--------SQGIIHKDIKPGNL 172 (235)
Q Consensus 104 ~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH--------~~~i~H~dl~p~ni 172 (235)
++.+..... ..+++|||++++ +|.+++.. ..+++..++.++.|++.||.||| +.+++|+||||+||
T Consensus 102 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NI 178 (342)
T 1b6c_B 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178 (342)
T ss_dssp EEEEECCCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGE
T ss_pred EeeecccCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHE
Confidence 999964332 278999999976 79999876 46899999999999999999999 89999999999999
Q ss_pred EEccCCcEEEeeeccccccCccccCC--cccccCCCCcccCccccCCCCC----CCCCcccEEEeeeeC
Q psy787 173 LLTLDGTLKISDFGVAESLDMFLHDD--TITTSQGSPVFQAPEIANGLPE----ISGYKVDIWSSGVTL 235 (235)
Q Consensus 173 li~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~----~~~~~~Di~slG~~l 235 (235)
+++.++.++|+|||++.......... ......+++.|+|||.+.+... .++.++||||||++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il 247 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHH
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHH
Confidence 99999999999999997554221111 2234468899999999876321 133689999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=233.72 Aligned_cols=197 Identities=28% Similarity=0.374 Sum_probs=147.4
Q ss_pred eEeeeceEEeeeeeccccceEEEEeeccc-hh--hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEE
Q psy787 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSE-TL--CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFV 108 (235)
Q Consensus 32 ~~~~~~~y~i~~~ig~g~~~~v~~~~~~~-~~--~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (235)
.....++|++.+.||+|++|+||++.+.. ++ ..+++|+++...... ......+.+|+.++..++||||+++++++.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 34455789999999999999999997533 22 368999887654332 234457889999999999999999999994
Q ss_pred cCCCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 109 NDKKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 109 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
. . ..++++|++. ++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||+
T Consensus 92 ~--~-~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 92 T--P-PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp S--S-SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred c--C-CceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccc
Confidence 3 2 3789999997 57888887542 5689999999999999999999999999999999999999999999999999
Q ss_pred ccccCccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+......... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 214 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTL 214 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHH
T ss_pred cccccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHH
Confidence 9765422111 11223346678999999977 4478999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=243.94 Aligned_cols=196 Identities=28% Similarity=0.328 Sum_probs=147.7
Q ss_pred ceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEE
Q psy787 30 TIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFV 108 (235)
Q Consensus 30 ~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 108 (235)
..+....+.|.+.+.||+|+||+||.+. ..+|+.||+|++.... ...+.+|+.++..+ +||||+++++.+
T Consensus 8 ~~~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~- 78 (434)
T 2rio_A 8 NFEQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSE- 78 (434)
T ss_dssp CCSCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEE-
T ss_pred chhhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEE-
Confidence 3444556678888999999999998653 4578999999886432 22467899999876 899999999998
Q ss_pred cCCCceEEEEEecccCCHHHHhhcCCCCC-----CCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC------
Q psy787 109 NDKKQKMYLIMEYCVGGLQDMLDSTPYKK-----FPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD------ 177 (235)
Q Consensus 109 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~------ 177 (235)
.....+++|||+++++|.+++....... .++..++.++.|++.||.|||+.|++||||||+||+++.+
T Consensus 79 -~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~ 157 (434)
T 2rio_A 79 -TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTAD 157 (434)
T ss_dssp -ECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSC
T ss_pred -ecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccc
Confidence 5567899999999999999997653221 1334567899999999999999999999999999999754
Q ss_pred -------CcEEEeeeccccccCccccC--CcccccCCCCcccCccccCCC-----CCCCCCcccEEEeeeeC
Q psy787 178 -------GTLKISDFGVAESLDMFLHD--DTITTSQGSPVFQAPEIANGL-----PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 178 -------~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~~Di~slG~~l 235 (235)
+.++|+|||++......... .......+++.|+|||.+.+. ...++.++||||||+++
T Consensus 158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il 229 (434)
T 2rio_A 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229 (434)
T ss_dssp CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHH
T ss_pred cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHH
Confidence 47999999999866432111 112244689999999998652 24588999999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=251.95 Aligned_cols=195 Identities=29% Similarity=0.421 Sum_probs=157.8
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc---
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN--- 109 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 109 (235)
....++|++.+.||+|+||+||++.+..+|+.||+|++..... ......+.+|+.++..++||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS---PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC---HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC---HHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 3445899999999999999999999999999999998865321 2334568899999999999999999998732
Q ss_pred -CCCceEEEEEecccC-CHHHHhhcCC-CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc---EEEe
Q psy787 110 -DKKQKMYLIMEYCVG-GLQDMLDSTP-YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT---LKIS 183 (235)
Q Consensus 110 -~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~---~~l~ 183 (235)
......++||||+++ +|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 125677999999964 7999887643 236899999999999999999999999999999999999997765 8999
Q ss_pred eeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 184 DFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|||++..... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 167 DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviL 213 (676)
T 3qa8_A 167 DLGYAKELDQ---GELCTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLA 213 (676)
T ss_dssp SCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHH
T ss_pred cccccccccc---ccccccccCCcccCChHHhcc--CCCCchhHHHHHHHHH
Confidence 9999986542 222334568899999999987 4589999999999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=256.89 Aligned_cols=188 Identities=27% Similarity=0.436 Sum_probs=152.8
Q ss_pred eeEeeeceEEeeeeeccccceEEEEeeccc-hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc
Q psy787 31 IKVKMIGKYVMGDLLGEGSYGKVKEMLDSE-TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN 109 (235)
Q Consensus 31 ~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (235)
.+..+.++|++.++||+|+||+||++.+.. +++.|++|++..... ......+.+|+.++..++||||+++++++..
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD---AEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC---HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC---HHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 345667899999999999999999999876 689999998764321 2334467899999999999999999999864
Q ss_pred CCC---ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeee
Q psy787 110 DKK---QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDF 185 (235)
Q Consensus 110 ~~~---~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~df 185 (235)
... ...|+||||++| +|.+.+.. .+++..++.++.|++.||.|||++||+||||||+||+++.+ .++|+||
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCC
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEec
Confidence 322 126999999976 57665433 68999999999999999999999999999999999999974 9999999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|++..... .....+++.|+|||++.+. ++.++||||||++|
T Consensus 226 G~a~~~~~------~~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l 266 (681)
T 2pzi_A 226 GAVSRINS------FGYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTL 266 (681)
T ss_dssp TTCEETTC------CSCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHH
T ss_pred ccchhccc------CCccCCCccccCHHHHcCC---CCCceehhhhHHHH
Confidence 99985542 1345689999999998652 48899999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=250.00 Aligned_cols=192 Identities=23% Similarity=0.365 Sum_probs=152.4
Q ss_pred eeeceEEeeeeeccccceEEEEeeccch---hhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSET---LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
...++|++.+.||+|+||+||+|.+..+ +..+++|.++... .......+.+|+.++..++||||+++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-- 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-- 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--
Confidence 3457899999999999999999987543 3457777664322 1233456889999999999999999999983
Q ss_pred CCceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 111 KKQKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 111 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
. +..++|||+++ ++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred c-CceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 2 35789999997 57998887653 468999999999999999999999999999999999999999999999999998
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...... ........+++.|+|||.+.+ ..++.++||||||+++
T Consensus 540 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il 582 (656)
T 2j0j_A 540 YMEDST-YYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCM 582 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred ecCCCc-ceeccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHH
Confidence 654211 112223345678999999977 4589999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=231.94 Aligned_cols=193 Identities=21% Similarity=0.394 Sum_probs=151.8
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
...++|++.+.||+|+||.||++.+. ..+++|+++..... ......+.+|+.++..++|+||+++++++. ...
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~---~~~avk~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~ 102 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWH---GEVAIRLIDIERDN--EDQLKAFKREVMAYRQTRHENVVLFMGACM--SPP 102 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEES---SSEEEEECCCCSCC--CCCCCCCCTTGGGGTTCCCTTBCCCCEEEE--CSS
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEc---CeEEEEEeecCCCC--HHHHHHHHHHHHHHhcCCCCCEeEEEEEEe--cCC
Confidence 34678999999999999999999874 35899988765432 234456778999999999999999999994 455
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.++++||++++ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||||+||+++ ++.++|+|||++....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 78999999975 6888887643 5689999999999999999999999999999999999998 7899999999987542
Q ss_pred ccc---cCCcccccCCCCcccCccccCCC-------CCCCCCcccEEEeeeeC
Q psy787 193 MFL---HDDTITTSQGSPVFQAPEIANGL-------PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~---~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~~Di~slG~~l 235 (235)
... .........+++.|+|||.+.+. ...++.++||||||+++
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il 233 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHH
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHH
Confidence 111 11222334477889999998642 13468899999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=235.95 Aligned_cols=192 Identities=20% Similarity=0.290 Sum_probs=144.2
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCC-CCc---------c-----
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH-RNV---------I----- 101 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i---------~----- 101 (235)
.+|.+.+.||+|+||+||+|.+..+|+.||+|++....... ......+.+|+.++..+.| .+. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~-~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCcc-HHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 46889999999999999999999999999999987544333 2445668899999888876 211 1
Q ss_pred -------eeeeEEEcCC---CceEEEEEecccCCHHHHhh-----cCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCC
Q psy787 102 -------GLVDVFVNDK---KQKMYLIMEYCVGGLQDMLD-----STPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKD 166 (235)
Q Consensus 102 -------~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~d 166 (235)
.+...+.... ...++++|+.+.++|.+++. ......+++..++.++.|++.||+|||++|++|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 1111111111 23468899998999888885 22235577888999999999999999999999999
Q ss_pred CCCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCC--------CCCCCCCcccEEEeeeeC
Q psy787 167 IKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG--------LPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 167 l~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~~Di~slG~~l 235 (235)
|||+||+++.++.++|+|||++...... .....+ +.|+|||.+.+ ....++.++||||||++|
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999998755421 334456 88999999821 113478899999999974
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=218.97 Aligned_cols=164 Identities=16% Similarity=0.148 Sum_probs=138.2
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
.+.++|++.+.||+|+||.||++++..+++.||+|++....... ......+.+|+..+..+.|+||+++++++ ...+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~--~~~~ 104 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP-DDVLQETLSRTLRLSRIDKPGVARVLDVV--HTRA 104 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEE--EETT
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC-HHHHHHHHHHHHHHhcCCCCCcceeeEEE--EECC
Confidence 45678999999999999999999999999999999987654322 22335688999999999999999999999 4556
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+|+||||++| +|.+++... .....+..++.|++.||.|||++|++||||||+||+++.++.++|++++
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred cEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 89999999975 788888542 3666789999999999999999999999999999999999999998433
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|++| ++.++||||||++|
T Consensus 175 ----------------~~~~---------~~~~~Di~slG~il 192 (286)
T 3uqc_A 175 ----------------TMPD---------ANPQDDIRGIGASL 192 (286)
T ss_dssp ----------------CCTT---------CCHHHHHHHHHHHH
T ss_pred ----------------ccCC---------CCchhHHHHHHHHH
Confidence 2222 57899999999974
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=217.34 Aligned_cols=167 Identities=31% Similarity=0.516 Sum_probs=141.6
Q ss_pred eeeceEEee-eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHH-HhcCCCCcceeeeEEEc--
Q psy787 34 KMIGKYVMG-DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLL-KMLQHRNVIGLVDVFVN-- 109 (235)
Q Consensus 34 ~~~~~y~i~-~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~-- 109 (235)
...++|.++ +.||+|+||.||++.+..+++.||+|++... ..+.+|+..+ +..+||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 455778887 7899999999999999999999999998532 2467888887 55689999999998843
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc---CCcEEEeee
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL---DGTLKISDF 185 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~---~~~~~l~df 185 (235)
.....+++|||++++ +|.+++.......+++..++.++.|++.||.|||+.|++|+||||+||+++. ++.++|+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 235678999999975 7999998876567999999999999999999999999999999999999998 788999999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|++.... + ..++.++||||||+++
T Consensus 165 g~a~~~~------------------------~--~~~~~~~DiwslG~il 188 (299)
T 3m2w_A 165 GFAKETT------------------------G--EKYDKSCDMWSLGVIM 188 (299)
T ss_dssp TTCEECT------------------------T--CGGGGHHHHHHHHHHH
T ss_pred ccccccc------------------------c--ccCCchhhHHHHHHHH
Confidence 9886332 1 2367899999999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=234.34 Aligned_cols=179 Identities=20% Similarity=0.121 Sum_probs=126.4
Q ss_pred eeccccceEEEEeeccchhhheeeeeeeeccccCCC------CccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCceEE
Q psy787 44 LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP------NGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 44 ~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 116 (235)
....|+.+.+..++....|+.+++|++.+....... ...+.+.+|+.+|+++ .|+||+++++++ ++.+.+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--ed~~~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG--ENAQSGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE--ECSSEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE--EECCEEE
Confidence 456777777777777788999999999765433211 2234688999999999 699999999999 6778999
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
|||||++| +|.+++... ++++.. +++.||+.||.|+|++||+||||||+|||++.+|++||+|||+++....
T Consensus 319 LVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~-- 391 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ-- 391 (569)
T ss_dssp EEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC--
Confidence 99999986 699999876 556654 5899999999999999999999999999999999999999999986643
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeee
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVT 234 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 234 (235)
.........+|+.|+|||++.+. +..++|+||+|++
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g~---~~~~~d~~s~g~~ 427 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAEN---KSWNGFWRSAPVH 427 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC-------------------
T ss_pred CCccccCceechhhccHHHhCCC---CCCcccccccccc
Confidence 22233445689999999999763 5678999999985
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-29 Score=209.44 Aligned_cols=179 Identities=17% Similarity=0.159 Sum_probs=125.4
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC----CccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP----NGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
.+...+.||+|+||+||++.. .++.+++|........... ...+++.+|+.++.+++||||+++..++....
T Consensus 337 ~~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-- 412 (540)
T 3en9_A 337 RKIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD-- 412 (540)
T ss_dssp -----------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--
T ss_pred cCCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--
Confidence 334567899999999999944 5678888876553322110 11235789999999999999995554443233
Q ss_pred eEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
..++||||++ ++|.+++.. +..++.|++.+|.|||+++++||||||+||+++. +++|+|||+++...
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred ccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 4599999997 578888765 4579999999999999999999999999999998 99999999998664
Q ss_pred ccccCC-----cccccCCCCcccCccccCCCCCCCCCcccEEEee
Q psy787 193 MFLHDD-----TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSG 232 (235)
Q Consensus 193 ~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 232 (235)
...... ......+|+.|+|||++.+....|+..+|+||..
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~v 525 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEII 525 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHH
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHH
Confidence 321111 1124568899999999865323366678888753
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=174.50 Aligned_cols=132 Identities=22% Similarity=0.278 Sum_probs=103.9
Q ss_pred eeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC--------------CccccHHHHHHHHHhcCCCCcceeeeE
Q psy787 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP--------------NGEINVDREIRLLKMLQHRNVIGLVDV 106 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 106 (235)
+.+.||+|++|.||++.+ .+|+.+|+|+++........ .....+.+|+.++..++ | +++.+.
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 349999999999999999 78999999998754332110 02345789999999998 4 566665
Q ss_pred EEcCCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeee
Q psy787 107 FVNDKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDF 185 (235)
Q Consensus 107 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~df 185 (235)
+ .. +..++||||++| +|.+ +.. .....++.|++.||.+||+.|++||||||+||+++ ++.++|+||
T Consensus 170 ~--~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 170 Y--AW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp E--EE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred E--ec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 4 22 345999999976 6776 321 24567999999999999999999999999999999 999999999
Q ss_pred cccc
Q psy787 186 GVAE 189 (235)
Q Consensus 186 g~~~ 189 (235)
|++.
T Consensus 237 G~a~ 240 (282)
T 1zar_A 237 PQSV 240 (282)
T ss_dssp TTCE
T ss_pred CCCe
Confidence 9986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-23 Score=158.90 Aligned_cols=141 Identities=20% Similarity=0.199 Sum_probs=107.7
Q ss_pred eEEeeeeeccccceEEEEeeccchhhh--eeeeeeeeccccCCC--------------------CccccHHHHHHHHHhc
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCR--RAVKIFKKKKLQRIP--------------------NGEINVDREIRLLKML 95 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~--~~~K~~~~~~~~~~~--------------------~~~~~~~~e~~~l~~l 95 (235)
-|.+.+.||+|+||.||+|.+..+|+. +|+|+++........ .....+.+|+..+..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999998778888 999997654321100 0012578899999999
Q ss_pred CCCCc--ceeeeEEEcCCCceEEEEEecccC------CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHH-hCCcccCC
Q psy787 96 QHRNV--IGLVDVFVNDKKQKMYLIMEYCVG------GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH-SQGIIHKD 166 (235)
Q Consensus 96 ~h~~i--~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH-~~~i~H~d 166 (235)
.|+++ +.++.. ...++||||+++ .|.+.... .++..+..++.|++.+|.+|| +.|++|||
T Consensus 128 ~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrD 196 (258)
T 1zth_A 128 KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHAD 196 (258)
T ss_dssp HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 88764 333332 134899999953 46555432 235578889999999999999 99999999
Q ss_pred CCCCCeEEccCCcEEEeeecccccc
Q psy787 167 IKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 167 l~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
|||.||+++. .++|+|||++...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999997 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.82 E-value=5e-20 Score=148.17 Aligned_cols=140 Identities=16% Similarity=0.230 Sum_probs=100.2
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC--Cc--------c--------ccHHHHHHHHHhcCCCCc
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP--NG--------E--------INVDREIRLLKMLQHRNV 100 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~--~~--------~--------~~~~~e~~~l~~l~h~~i 100 (235)
|++.++||.|++|.||+|.+. +|+.||+|+++........ .. . .....|...+.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999985 6899999998754332110 00 0 012346667777755554
Q ss_pred ceeeeEEEcCCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-
Q psy787 101 IGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG- 178 (235)
Q Consensus 101 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~- 178 (235)
.....+.. .. .++||||++|. |..+.. ......++.|++.+|.+||+.|++||||||.|||+++++
T Consensus 176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SCCCEEEE--ET--TEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCCeeeec--cC--ceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 33222221 11 27999999874 543321 224567899999999999999999999999999999877
Q ss_pred ---------cEEEeeecccccc
Q psy787 179 ---------TLKISDFGVAESL 191 (235)
Q Consensus 179 ---------~~~l~dfg~~~~~ 191 (235)
.+.|+||+.+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 3899999988643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=5.2e-13 Score=102.87 Aligned_cols=139 Identities=16% Similarity=0.111 Sum_probs=105.7
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCCce
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 114 (235)
.+.|++...++.|+.+.||++... ++.+++|+....... ....+.+|+.+++.+. +..+++++..+ ...+.
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~----~~~~~~~E~~~l~~l~~~~~vP~v~~~~--~~~~~ 84 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFE--RHDGW 84 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEE--EETTE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC----CHHHHHHHHHHHHHHhcCCCCCeEEEEE--ecCCc
Confidence 346888888998999999998753 578899987654221 1235889999999884 56788888887 34567
Q ss_pred EEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh----------------------------------
Q psy787 115 MYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS---------------------------------- 159 (235)
Q Consensus 115 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---------------------------------- 159 (235)
.|+|||+++|. +.+... +......++.+++.++..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred eEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 89999999884 655421 122345788999999999998
Q ss_pred -------------------------CCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 160 -------------------------QGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 160 -------------------------~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
..++|+|++|.||+++++..+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348899999999999865456799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.33 E-value=1.2e-11 Score=94.95 Aligned_cols=132 Identities=16% Similarity=0.093 Sum_probs=92.8
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC--cceeeeEEEcCCCceE
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN--VIGLVDVFVNDKKQKM 115 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~ 115 (235)
.+.+....+.|..+.||++.. .+|..+++|+.... ....+..|+.+++.+.+.+ +++++... ...+..
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~--~~~~~~ 90 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVV--TEAGRD 90 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCeEEEec--cCCCCC
Confidence 344444334566699999865 45678999986433 1235788999999885444 55677776 344568
Q ss_pred EEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCC---------------------------------
Q psy787 116 YLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG--------------------------------- 161 (235)
Q Consensus 116 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--------------------------------- 161 (235)
+++||+++|. + . .. ..+ ...++.+++..|..||+..
T Consensus 91 ~~v~e~i~G~~l-~-~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 91 WLLLGEVPGQDL-L-SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp EEEEECCSSEET-T-TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred EEEEEecCCccc-C-cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 9999999885 4 3 11 112 2357778888888888753
Q ss_pred -------------------------cccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 162 -------------------------IIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 162 -------------------------i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
++|+|++|.||+++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 8999999999999866556699999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.23 E-value=5.8e-11 Score=95.58 Aligned_cols=140 Identities=16% Similarity=0.256 Sum_probs=99.6
Q ss_pred eeeeeccccceEEEEeeccchhhheeeeeee--eccccCCCCccccHHHHHHHHHhcCC--CCcceeeeEEEcCCC-ceE
Q psy787 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFK--KKKLQRIPNGEINVDREIRLLKMLQH--RNVIGLVDVFVNDKK-QKM 115 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~--~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~-~~~ 115 (235)
.++.|+.|.++.+|++... +..+++|+.. ..... .....+.+|+.+++.+.. ..+++++..+.+... +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 3577899999999998764 3567788765 33211 123368889999999864 457778877732211 457
Q ss_pred EEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-----------------------------------
Q psy787 116 YLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS----------------------------------- 159 (235)
Q Consensus 116 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~----------------------------------- 159 (235)
++|||+++|. +.+. ....++......++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 8999999874 3321 11346788888999999999999997
Q ss_pred -----------------------CCcccCCCCCCCeEEccCCc--EEEeeecccc
Q psy787 160 -----------------------QGIIHKDIKPGNLLLTLDGT--LKISDFGVAE 189 (235)
Q Consensus 160 -----------------------~~i~H~dl~p~nili~~~~~--~~l~dfg~~~ 189 (235)
..++|+|++|.||+++.++. +.|+||+.+.
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 35899999999999997753 6899999886
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=1.9e-08 Score=78.92 Aligned_cols=132 Identities=23% Similarity=0.213 Sum_probs=90.2
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCC--cceeeeEEEcCCCc---eE
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRN--VIGLVDVFVNDKKQ---KM 115 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~~~---~~ 115 (235)
++.++.|....+|++. ..+++|+.... .....+.+|...++.+. +.. ++.++... .... ..
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~ 91 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMS 91 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCS
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc------chHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcc
Confidence 3458889999999864 46788875422 22345789999998883 333 33443332 2222 34
Q ss_pred EEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-----------------------------------
Q psy787 116 YLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS----------------------------------- 159 (235)
Q Consensus 116 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~----------------------------------- 159 (235)
|+||++++|. +..... ..++......++.+++..+..||+
T Consensus 92 ~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 92 FAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp CEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred eEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 7899999884 443222 235666777788888888888875
Q ss_pred -----------------------CCcccCCCCCCCeEEcc--CCcEEEeeeccccc
Q psy787 160 -----------------------QGIIHKDIKPGNLLLTL--DGTLKISDFGVAES 190 (235)
Q Consensus 160 -----------------------~~i~H~dl~p~nili~~--~~~~~l~dfg~~~~ 190 (235)
..++|+|++|.||+++. ...+.++||+.+..
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 13699999999999998 45578999998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=1.5e-07 Score=73.95 Aligned_cols=132 Identities=24% Similarity=0.253 Sum_probs=86.3
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCC---CcceeeeEEEcCCCceEEEEE
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR---NVIGLVDVFVNDKKQKMYLIM 119 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~~~lv~ 119 (235)
+.++.|....||++ +..+++|+.... .....+.+|..++..+.+. .++.++.... ...+..+++|
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~------~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~ 92 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKSQ------QGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGY 92 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESSH------HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEE
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCCc------hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEE
Confidence 45677888899987 467888874221 2234688999999998642 3556655553 2344568999
Q ss_pred ecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC--------------------------------------
Q psy787 120 EYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-------------------------------------- 160 (235)
Q Consensus 120 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-------------------------------------- 160 (235)
++++|. +..... ..++......++.++...|..||+.
T Consensus 93 e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 93 RKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp ECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred eccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 999885 443211 1234444445555555555555532
Q ss_pred ----------------------CcccCCCCCCCeEEcc---CCcE-EEeeeccccc
Q psy787 161 ----------------------GIIHKDIKPGNLLLTL---DGTL-KISDFGVAES 190 (235)
Q Consensus 161 ----------------------~i~H~dl~p~nili~~---~~~~-~l~dfg~~~~ 190 (235)
.++|+|++|.|++++. ++.+ .|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999997 4554 7999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=2.2e-07 Score=71.49 Aligned_cols=130 Identities=16% Similarity=0.096 Sum_probs=87.1
Q ss_pred eccccc-eEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCCceEEEEEecc
Q psy787 45 LGEGSY-GKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQKMYLIMEYC 122 (235)
Q Consensus 45 ig~g~~-~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~ 122 (235)
+..|.. +.||+......+..+++|+...... ..+..|...++.+. +-.+++++.++ ...+..++||+++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~-------~~~~~E~~~l~~l~~~vPVP~v~~~~--~~~~~~~lvme~l 102 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVA-------NDVTDEMVRLNWLTAFMPLPTIKHFI--RTPDDAWLLTTAI 102 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHH-------HHHHHHHHHHHHHTTTSCCCCEEEEE--EETTEEEEEEECC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCH-------hHHHHHHHHHHHhccCCCcCeEEEEE--EECCeEEEEEEee
Confidence 333433 4689887776777888887654432 24778998888874 33466777777 4456789999999
Q ss_pred cCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC-----------------------------------------
Q psy787 123 VGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ----------------------------------------- 160 (235)
Q Consensus 123 ~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----------------------------------------- 160 (235)
+|. +.+..... ......++.++...|.-||+.
T Consensus 103 ~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 103 PGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 884 44433221 123334555555555555531
Q ss_pred -----------------CcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 161 -----------------GIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 161 -----------------~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 16899999999999976666799999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=2e-06 Score=69.98 Aligned_cols=79 Identities=15% Similarity=-0.037 Sum_probs=48.2
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccc-c--CCCCccccHHHHHHHHHhcCC--C-CcceeeeEEEcCCCceE
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKL-Q--RIPNGEINVDREIRLLKMLQH--R-NVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~--~~~~~~~~~~~e~~~l~~l~h--~-~i~~~~~~~~~~~~~~~ 115 (235)
++.||.|..+.||++.....++.+++|...+... . .......++..|...+..+.. + .+++++... .. ..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~--~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE--MA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT--TT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CC--cc
Confidence 4678999999999997665677899997653321 0 111233456788888887742 3 344555432 33 34
Q ss_pred EEEEecccC
Q psy787 116 YLIMEYCVG 124 (235)
Q Consensus 116 ~lv~e~~~~ 124 (235)
++|||++++
T Consensus 111 ~lvmE~l~g 119 (397)
T 2olc_A 111 VTVMEDLSH 119 (397)
T ss_dssp EEEECCCTT
T ss_pred EEEEEeCCC
Confidence 799999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=2.2e-06 Score=68.61 Aligned_cols=85 Identities=7% Similarity=0.088 Sum_probs=52.2
Q ss_pred Eeeeee-ccccceEEEEeecc--c----hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCC---CCcceeeeEEEc
Q psy787 40 VMGDLL-GEGSYGKVKEMLDS--E----TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH---RNVIGLVDVFVN 109 (235)
Q Consensus 40 ~i~~~i-g~g~~~~v~~~~~~--~----~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~ 109 (235)
..++.| +.|....+|++... . ++..+++|+........ ......+.+|+.+++.+.. -.+++++....+
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~-~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVP-VFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCC-SSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccc-cCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 345677 78888999987643 0 25678888764432000 0012357889988888742 356777776632
Q ss_pred CC-CceEEEEEecccCC
Q psy787 110 DK-KQKMYLIMEYCVGG 125 (235)
Q Consensus 110 ~~-~~~~~lv~e~~~~~ 125 (235)
.. -+..++|||+++|.
T Consensus 102 ~~~~g~~~~v~e~l~G~ 118 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGV 118 (357)
T ss_dssp STTTSSCEEEEECCCCB
T ss_pred CCccCCceEEEEecCCC
Confidence 11 13468999999873
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.21 E-value=1.6e-05 Score=62.12 Aligned_cols=68 Identities=15% Similarity=-0.028 Sum_probs=43.3
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCc-ceeeeEEEcCCCceEEEEEe
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV-IGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~lv~e 120 (235)
++.|+.|....+|++ ..+++|+...... ......+|+.+++.+...++ ++++... ...+ +++++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~--~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-----EYINRANEAVAAREAAKAGVSPEVLHVD--PATG--VMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTC--CEEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc-----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCC--EEEEe
Confidence 677888999999988 5678888764321 11234578888877743333 4555443 3333 68999
Q ss_pred cc-cC
Q psy787 121 YC-VG 124 (235)
Q Consensus 121 ~~-~~ 124 (235)
|+ +|
T Consensus 88 ~i~~g 92 (301)
T 3dxq_A 88 YIAGA 92 (301)
T ss_dssp CCTTC
T ss_pred ecCCC
Confidence 99 65
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.14 E-value=1.9e-05 Score=62.57 Aligned_cols=30 Identities=23% Similarity=0.387 Sum_probs=27.2
Q ss_pred CCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 160 ~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
..++|+|+++.||+++.++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.94 E-value=0.00015 Score=59.34 Aligned_cols=31 Identities=26% Similarity=0.470 Sum_probs=27.0
Q ss_pred HhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 158 H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
+...++|+|++|.||+++.++ +.++||+.+.
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSF 260 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence 456799999999999998766 9999998775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00022 Score=55.98 Aligned_cols=73 Identities=18% Similarity=0.138 Sum_probs=53.4
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC---CCCcceeeeEEEcCCCceEEEE
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ---HRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~~lv 118 (235)
++.|+.|....+|++.. .+..+++|+..... ...+..|...++.+. ...+++++... ...+..++|
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~-------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~--~~~g~~~lv 109 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSY-------RSMFRAEADQLALLAKTNSINVPLVYGIG--NSQGHSFLL 109 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGG-------HHHHHHHHHHHHHHHHTTSSBCCCEEEEE--ECSSEEEEE
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCccc-------HHHHHHHHHHHHHHHhhCCCCcceEEEEe--ecCCceEEE
Confidence 46788999999999876 35678888765321 335788988888873 35677787776 344678999
Q ss_pred EecccCC
Q psy787 119 MEYCVGG 125 (235)
Q Consensus 119 ~e~~~~~ 125 (235)
||+++|.
T Consensus 110 me~l~G~ 116 (312)
T 3jr1_A 110 LEALNKS 116 (312)
T ss_dssp EECCCCC
T ss_pred EEeccCC
Confidence 9999863
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00041 Score=53.63 Aligned_cols=76 Identities=16% Similarity=-0.032 Sum_probs=52.0
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCC---CcceeeeEEEcCCCce
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR---NVIGLVDVFVNDKKQK 114 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~ 114 (235)
...-++.+|.|..+.||++.. .+|+.+++|+..... ......+..|...|+.+... .+++++... .
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~---- 84 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA----PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D---- 84 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC----CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC----cchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----
Confidence 456678899999999999875 467889998654332 22233578899999988532 344554442 2
Q ss_pred EEEEEecccC
Q psy787 115 MYLIMEYCVG 124 (235)
Q Consensus 115 ~~lv~e~~~~ 124 (235)
-+++||+..+
T Consensus 85 ~~lv~e~l~~ 94 (288)
T 3f7w_A 85 RTLAMEWVDE 94 (288)
T ss_dssp TEEEEECCCC
T ss_pred ceEEEEeecc
Confidence 2789999864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00033 Score=57.50 Aligned_cols=71 Identities=15% Similarity=0.142 Sum_probs=46.2
Q ss_pred eeeeccccceEEEEeeccc-------hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCc-ceeeeEEEcCCCc
Q psy787 42 GDLLGEGSYGKVKEMLDSE-------TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV-IGLVDVFVNDKKQ 113 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~ 113 (235)
++.|+.|....+|++.... .+..+++|+..... ....+..|..++..+...++ +++++.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~------~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~-- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE------TESHLVAESVIFTLLSERHLGPKLYGIF--SG-- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC------CHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT--
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC------cHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC--
Confidence 4667888889999987542 24678888873211 11245578888888743333 5666665 32
Q ss_pred eEEEEEecccC
Q psy787 114 KMYLIMEYCVG 124 (235)
Q Consensus 114 ~~~lv~e~~~~ 124 (235)
.+|++|++|
T Consensus 148 --g~v~e~l~G 156 (429)
T 1nw1_A 148 --GRLEEYIPS 156 (429)
T ss_dssp --EEEECCCCE
T ss_pred --CEEEEEeCC
Confidence 389999876
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00047 Score=55.58 Aligned_cols=136 Identities=18% Similarity=0.211 Sum_probs=76.1
Q ss_pred eeeccccceEEEEeeccc-------hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCCce
Q psy787 43 DLLGEGSYGKVKEMLDSE-------TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 114 (235)
+.|.-|....+|++.... .++.+++|+.... ......+.+|..+++.+. +.-.+++++.+ ++
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~--- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-----LQGVDSLVLESVMFAILAERSLGPQLYGVF--PE--- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT---
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-----cchHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC---
Confidence 456667788888887632 3467888875331 122334568988888874 33335666655 33
Q ss_pred EEEEEecccCC-HH--HH---------------hhcCC---CCCCC--HHhHHHHHHHHHH-------------------
Q psy787 115 MYLIMEYCVGG-LQ--DM---------------LDSTP---YKKFP--IWQAHGYFLQLLD------------------- 152 (235)
Q Consensus 115 ~~lv~e~~~~~-l~--~~---------------~~~~~---~~~~~--~~~~~~~~~ql~~------------------- 152 (235)
.+||+|++|. +. ++ +.... ..... ...+.++..++..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 2899999873 11 10 01111 01111 2344445444321
Q ss_pred HHHHH----HhC----CcccCCCCCCCeEEccC----CcEEEeeecccc
Q psy787 153 GLEYL----HSQ----GIIHKDIKPGNLLLTLD----GTLKISDFGVAE 189 (235)
Q Consensus 153 ~l~~l----H~~----~i~H~dl~p~nili~~~----~~~~l~dfg~~~ 189 (235)
.+..| ... .++|+|+.+.||+++.+ +.+.++||.++.
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 12332 222 48999999999999876 689999999886
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.0021 Score=53.19 Aligned_cols=72 Identities=18% Similarity=0.281 Sum_probs=45.7
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCc-ceeeeEEEcCCCceEEEEEe
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV-IGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~lv~e 120 (235)
++.|+.|....+|++.....+..+++|+..... .....-.+|..++..+...++ +++++.+ .+ ..|++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-----~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v~e 181 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-----DEIINREREKKISCILYNKNIAKKIYVFF--TN----GRIEE 181 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-----CSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT----EEEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-----hhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC----eEEEE
Confidence 456787888999998765434678898874431 111123589999998865444 5666665 32 25999
Q ss_pred cccC
Q psy787 121 YCVG 124 (235)
Q Consensus 121 ~~~~ 124 (235)
|++|
T Consensus 182 ~I~G 185 (458)
T 2qg7_A 182 FMDG 185 (458)
T ss_dssp CCCS
T ss_pred eeCC
Confidence 9976
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.0012 Score=51.81 Aligned_cols=141 Identities=14% Similarity=0.144 Sum_probs=74.3
Q ss_pred eeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC--cceeeeEE----EcCCCce
Q psy787 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN--VIGLVDVF----VNDKKQK 114 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~----~~~~~~~ 114 (235)
-++.|+.|....+|++... +..+++|+..... ....+..|..++..+...+ +++++... +....+.
T Consensus 26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEECC---EEEEEEEES--SCCEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred EeeccCCCcccceEEEEeC--CccEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 3466777888899988653 2367888876531 1224667777777764322 33333211 0011245
Q ss_pred EEEEEecccCC-HH---------------HHhhcC---CCC---CCCHHhHHHHH---------------HHHHHHHHHH
Q psy787 115 MYLIMEYCVGG-LQ---------------DMLDST---PYK---KFPIWQAHGYF---------------LQLLDGLEYL 157 (235)
Q Consensus 115 ~~lv~e~~~~~-l~---------------~~~~~~---~~~---~~~~~~~~~~~---------------~ql~~~l~~l 157 (235)
.++++++++|. +. .+.... ... ..........+ ..+...+..+
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 68999999873 10 011110 000 01111111100 1133344444
Q ss_pred Hh-------CCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 158 HS-------QGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 158 H~-------~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
.. .+++|+|+.+.||+++.++.+.++||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 42 368999999999999876556899998774
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0011 Score=53.06 Aligned_cols=72 Identities=19% Similarity=0.155 Sum_probs=41.9
Q ss_pred eeeeccccceEEEEeeccch--------hhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC-cceeeeEEEcCCC
Q psy787 42 GDLLGEGSYGKVKEMLDSET--------LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN-VIGLVDVFVNDKK 112 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~--------~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~ 112 (235)
++.|+.|....+|++..... +..+++|+...... .......|..++..+...+ .+++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-----ELYNTISEFEVYKTMSKYKIAPQLLNTF--N-- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-----ceecHHHHHHHHHHHHhcCCCCceEEec--C--
Confidence 35677788889998875432 25778887644221 1113467888888775333 45666554 2
Q ss_pred ceEEEEEecccC
Q psy787 113 QKMYLIMEYCVG 124 (235)
Q Consensus 113 ~~~~lv~e~~~~ 124 (235)
+ +++++|++|
T Consensus 109 ~--~~v~e~i~G 118 (369)
T 3c5i_A 109 G--GRIEEWLYG 118 (369)
T ss_dssp T--EEEEECCCS
T ss_pred C--cEEEEEecC
Confidence 2 689999987
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0012 Score=52.16 Aligned_cols=30 Identities=27% Similarity=0.423 Sum_probs=26.3
Q ss_pred CCcccCCCCCCCeEEccC----CcEEEeeecccc
Q psy787 160 QGIIHKDIKPGNLLLTLD----GTLKISDFGVAE 189 (235)
Q Consensus 160 ~~i~H~dl~p~nili~~~----~~~~l~dfg~~~ 189 (235)
..++|+|+.+.||+++.+ +.+.++||+.+.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 468999999999999874 679999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.006 Score=47.83 Aligned_cols=75 Identities=16% Similarity=0.156 Sum_probs=44.5
Q ss_pred eeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCC--cceeeeE---EEcCCCceEEE
Q psy787 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRN--VIGLVDV---FVNDKKQKMYL 117 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~---~~~~~~~~~~l 117 (235)
..++ |....+|++.. .+|+.+++|+..+.. .....+..|...+..+...+ ++.++.. .+....+..++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~-----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER-----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT-----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC-----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 3456 78888998764 345678999876432 12234667777777774222 3444332 00011346688
Q ss_pred EEecccC
Q psy787 118 IMEYCVG 124 (235)
Q Consensus 118 v~e~~~~ 124 (235)
++++++|
T Consensus 105 l~~~i~G 111 (328)
T 1zyl_A 105 VFPSVGG 111 (328)
T ss_dssp EEECCCC
T ss_pred EEEecCC
Confidence 9999987
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0071 Score=47.90 Aligned_cols=30 Identities=27% Similarity=0.417 Sum_probs=26.7
Q ss_pred CCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 160 QGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 160 ~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
..++|+|+.+.||+++.++.+.++||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 358999999999999988889999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.012 Score=48.09 Aligned_cols=72 Identities=14% Similarity=0.113 Sum_probs=45.5
Q ss_pred eeeeccccceEEEEeeccch-------hhheeeeeeeeccccCCCCccccHHHHHHHHHhcCC-CCcceeeeEEEcCCCc
Q psy787 42 GDLLGEGSYGKVKEMLDSET-------LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH-RNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 113 (235)
++.+..|....+|++..... ++.+++|+..... .......+|..+++.+.. .-.+++++.+ .+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-----~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~-- 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-----GKFYDSKVELDVFRYLSNINIAPNIIADF--PE-- 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC------CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-----chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence 35666788888998875421 4678888764432 111234678888888743 3345666544 22
Q ss_pred eEEEEEecccC
Q psy787 114 KMYLIMEYCVG 124 (235)
Q Consensus 114 ~~~lv~e~~~~ 124 (235)
+.|++|++|
T Consensus 146 --~~I~efI~G 154 (424)
T 3mes_A 146 --GRIEEFIDG 154 (424)
T ss_dssp --EEEEECCCS
T ss_pred --CEEEEEeCC
Confidence 689999987
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.12 E-value=0.099 Score=42.32 Aligned_cols=28 Identities=32% Similarity=0.509 Sum_probs=24.2
Q ss_pred cccCCCCCCCeEEc------cCCcEEEeeecccc
Q psy787 162 IIHKDIKPGNLLLT------LDGTLKISDFGVAE 189 (235)
Q Consensus 162 i~H~dl~p~nili~------~~~~~~l~dfg~~~ 189 (235)
++|+|+.+.||++. .++.+.++||.++.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 67999999999993 45679999999886
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.97 E-value=0.0031 Score=46.42 Aligned_cols=92 Identities=16% Similarity=0.128 Sum_probs=58.7
Q ss_pred CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCccccc
Q psy787 125 GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS 203 (235)
Q Consensus 125 ~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 203 (235)
+|.+.+.... .++++.++|.++.|.+.+|.-+-. ..-..+=..|..+++..+|++.+.+ ..+.
T Consensus 34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 4788777665 899999999999999999887622 1222344567899999999888774 1110
Q ss_pred CCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 204 QGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 204 ~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.....+.|||... ...+.+.=|||||++|
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tL 126 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIII 126 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHH
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHH
Confidence 1223477888763 1246677889998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.95 E-value=4.6 Score=29.60 Aligned_cols=83 Identities=11% Similarity=0.053 Sum_probs=57.6
Q ss_pred CCCCcceeeeEEEcCCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHH-HHHhCCcccCCCCCCCeE
Q psy787 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE-YLHSQGIIHKDIKPGNLL 173 (235)
Q Consensus 96 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~-~lH~~~i~H~dl~p~nil 173 (235)
.||++ -..+- ...+.+.+.++.-+.. -...+ ..++....++++.+|+.... ++ ..-+|--|+|+|++
T Consensus 48 ~~~~f--~~~I~--~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDID--VSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEE--ECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEE
T ss_pred cCCCC--CeEEE--EeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEE
Confidence 67777 22232 3445666766665443 23333 34688899999999888655 33 45578889999999
Q ss_pred EccCCcEEEeeecccc
Q psy787 174 LTLDGTLKISDFGVAE 189 (235)
Q Consensus 174 i~~~~~~~l~dfg~~~ 189 (235)
++.++.+++.=.|+..
T Consensus 117 f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 117 FNRALEPFFLHVGVKE 132 (219)
T ss_dssp ECTTCCEEESCCEETT
T ss_pred EeCCCcEEEEEcCCcc
Confidence 9999999999877654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.63 E-value=3.1 Score=30.42 Aligned_cols=84 Identities=15% Similarity=0.153 Sum_probs=58.3
Q ss_pred CCCCcceeeeEEEcCCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE
Q psy787 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL 174 (235)
Q Consensus 96 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili 174 (235)
.||++++. .+- .....+.+.++.-+.. -...+ ...+....++++.+++....+++ .-+|--|+|+|+++
T Consensus 43 ~~~~Fl~~-~I~--e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELT--ELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEE--ECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEE
T ss_pred cCCcccce-EEE--EcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEE
Confidence 67888876 333 3344566666654422 22223 34688899999999988774443 34788899999999
Q ss_pred ccCCcEEEeeecccc
Q psy787 175 TLDGTLKISDFGVAE 189 (235)
Q Consensus 175 ~~~~~~~l~dfg~~~ 189 (235)
+.++.+++.=.|+..
T Consensus 113 ~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 113 TRDGLPIAKTRGLQN 127 (215)
T ss_dssp CTTSCEEESCCEETT
T ss_pred cCCCCEEEEEccCcc
Confidence 999999999777643
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.31 E-value=0.18 Score=41.65 Aligned_cols=62 Identities=8% Similarity=-0.023 Sum_probs=16.1
Q ss_pred eeeeeccccceEEEEeeccchhhheee------eeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEE
Q psy787 41 MGDLLGEGSYGKVKEMLDSETLCRRAV------KIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVF 107 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~~~~~~~~------K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (235)
+.++|| ||.||.+.......+||+ |..+..... .+....+.++..+.....|+|+++.+++.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~--~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS--EKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCcccccccccc--ccccccccccccccccccccccCCCcceE
Confidence 445565 999999877655567888 544332221 23334567788888888999998887655
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 235 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-46 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-42 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-39 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-37 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-37 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-35 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-51
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 11/213 (5%)
Query: 26 YDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINV 85
Y++ T + + + LG+G++GKV + + ET A K+ K + + +
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED----Y 56
Query: 86 DREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG 145
EI +L H N++ L+D F + +++++E+C GG D + + Q
Sbjct: 57 MVEIDILASCDHPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQV 114
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG 205
Q LD L YLH IIH+D+K GN+L TLDG +K++DFGV+ + G
Sbjct: 115 VCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIG 172
Query: 206 SPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235
+P + APE+ YK D+WS G+TL
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 205
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-50
Identities = 69/200 (34%), Positives = 95/200 (47%), Gaps = 7/200 (3%)
Query: 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+ + + LGEG+YG+V+ ++ T AVKI K R + N+ +EI + KML
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPENIKKEICINKML 60
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H NV+ YL +EYC GG P P A +F QL+ G+
Sbjct: 61 NHENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVV 117
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
YLH GI H+DIKP NLLL LKISDFG+A + + G+ + APE+
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 216 NGLPEISGYKVDIWSSGVTL 235
VD+WS G+ L
Sbjct: 178 KRRE-FHAEPVDVWSCGIVL 196
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-49
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+ + +G LG+G +G V + ++ A+K+ K +L++ E + RE+ + L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHL 63
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
+H N++ L F + + +YLI+EY G + L KF + Y +L + L
Sbjct: 64 RHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANAL 119
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEI 214
Y HS+ +IH+DIKP NLLL G LKI+DFG + TT G+ + PE+
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEM 175
Query: 215 ANGLPEISGYKVDIWSSGVTL 235
G KVD+WS GV
Sbjct: 176 IEGRM--HDEKVDLWSLGVLC 194
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 158 bits (401), Expect = 1e-47
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+ Y + + LG G++G V + + T A K + V +EI+ + +L
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES----DKETVRKEIQTMSVL 80
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
+H ++ L D F +D + M +I E+ GG + + K +A Y Q+ GL
Sbjct: 81 RHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 156 YLHSQGIIHKDIKPGNLLLTLD--GTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
++H +H D+KP N++ T LK+ DFG+ LD ++ + G+ F APE
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQSVKVTTGTAEFAAPE 195
Query: 214 IANGLPEISGYKVDIWSSGVTL 235
+A G P GY D+WS GV
Sbjct: 196 VAEGKP--VGYYTDMWSVGVLS 215
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-47
Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
KY + +G+G+ G V +D T A++ ++ + + + EI +++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK----KELIINEILVMRENK 75
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
+ N++ +D ++ + ++++MEY GG + D Q + L LE+
Sbjct: 76 NPNIVNYLDSYLVGDE--LWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQALEF 131
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIAN 216
LHS +IH+DIK N+LL +DG++K++DFG + +T G+P + APE+
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVT 189
Query: 217 GLPEISGYKVDIWSSGVTL 235
G KVDIWS G+
Sbjct: 190 RKA--YGPKVDIWSLGIMA 206
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 9e-47
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 8/199 (4%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+ G +LGEGS+ V + T A+KI +K+ + + N V RE ++ L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDH 67
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
+ L F +D+K +Y + Y G L + F Y +++ LEY
Sbjct: 68 PFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEY 123
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIAN 216
LH +GIIH+D+KP N+LL D ++I+DFG A+ L + G+ + +PE+
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 217 GLPEISGYKVDIWSSGVTL 235
+ D+W+ G +
Sbjct: 184 EKS--ACKSSDLWALGCII 200
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 9e-47
Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+ LG G+ G V ++ + A K+ + I N + RE+++L
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN---QIIRELQVLHECNS 63
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
++G F +D + + + ME+ GG L +L + P + ++ GL Y
Sbjct: 64 PYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTY 119
Query: 157 LHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
L + I+H+D+KP N+L+ G +K+ DFGV+ L D + G+ + +PE
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERL 175
Query: 216 NGLPEISGYKVDIWSSGVTL 235
G + DIWS G++L
Sbjct: 176 QGTH--YSVQSDIWSMGLSL 193
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (389), Expect = 2e-46
Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 11/199 (5%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+ +G GS+G V D A+K Q ++ +E+R L+ L+H
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRH 74
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
N I ++ + +L+MEYC+G D L K + L GL YL
Sbjct: 75 PNTIQYRGCYLREHT--AWLVMEYCLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG 217
HS +IH+D+K GN+LL+ G +K+ DFG A + + G+P + APE+
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILA 185
Query: 218 LPEIS-GYKVDIWSSGVTL 235
+ E KVD+WS G+T
Sbjct: 186 MDEGQYDGKVDVWSLGITC 204
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-46
Identities = 49/201 (24%), Positives = 91/201 (45%), Gaps = 11/201 (5%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
G+ +G +G GS+G V + + AVK+ P E+ +L+ +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDV---AVKMLNVTAPT--PQQLQAFKNEVGVLRKTR 62
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H N++ + + + ++ ++C G L L KF + + Q G++
Sbjct: 63 HVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMD 118
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
YLH++ IIH+D+K N+ L D T+KI DFG+A + GS ++ APE+
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 216 NGLPEIS-GYKVDIWSSGVTL 235
+ ++ D+++ G+ L
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVL 199
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (376), Expect = 8e-45
Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
Y + +G GSYG+ +++ K + + + E+ LL+ L+H
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT--EAEKQMLVSEVNLLRELKH 62
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLD--STPYKKFPIWQAHGYFLQLLDGL 154
N++ D ++ +Y++MEYC GG L ++ + + QL L
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 155 EYLHSQG-----IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF 209
+ H + ++H+D+KP N+ L +K+ DFG+A L+ G+P +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYY 180
Query: 210 QAPEIANGLPEISGYKVDIWSSGVTL 235
+PE N + K DIWS G L
Sbjct: 181 MSPEQMNRMS--YNEKSDIWSLGCLL 204
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-44
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 37 GKYV-MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
G+++ +G GS+ V + LD+ET A + +KL + + E +LK L
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGL 65
Query: 96 QHRNVIGLVDVFVNDKKQK--MYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLD 152
QH N++ D + + K K + L+ E G L+ L +K I + Q+L
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILK 123
Query: 153 GLEYLHSQG--IIHKDIKPGNLLLT-LDGTLKISDFGVAESLDMFLHDDTITTSQGSPVF 209
GL++LH++ IIH+D+K N+ +T G++KI D G+A G+P F
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEF 179
Query: 210 QAPEIANGLPEISGYKVDIWSSGVTL 235
APE+ VD+++ G+ +
Sbjct: 180 MAPEMYEEKY---DESVDVYAFGMCM 202
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 149 bits (377), Expect = 4e-44
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 13/204 (6%)
Query: 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLK 93
+ Y + + LG G++G V ++ T K P + V EI ++
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMN 81
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
L H +I L D F + +M LI+E+ GG + K + Y Q +G
Sbjct: 82 QLHHPKLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139
Query: 154 LEYLHSQGIIHKDIKPGNLLLTL--DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQA 211
L+++H I+H DIKP N++ ++KI DFG+A L+ D+ + + + F A
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN---PDEIVKVTTATAEFAA 196
Query: 212 PEIANGLPEISGYKVDIWSSGVTL 235
PEI + P G+ D+W+ GV
Sbjct: 197 PEIVDREP--VGFYTDMWAIGVLG 218
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-43
Identities = 50/201 (24%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
KY++ + LG G +G V +++ + K K K ++ V +EI +L + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-----QVLVKKEISILNIARH 60
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
RN++ L + F + ++ + +I E+ G + + ++++ ++ + Y Q+ + L++
Sbjct: 61 RNILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQF 117
Query: 157 LHSQGIIHKDIKPGNLLLTLD--GTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEI 214
LHS I H DI+P N++ T+KI +FG A L D +P + APE+
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---PGDNFRLLFTAPEYYAPEV 174
Query: 215 ANGLPEISGYKVDIWSSGVTL 235
D+WS G +
Sbjct: 175 HQHDV--VSTATDMWSLGTLV 193
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-43
Identities = 49/199 (24%), Positives = 83/199 (41%), Gaps = 17/199 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+ + +G+G +G V AVK K + E ++ L+H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQ------AFLAEASVMTQLRH 59
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
N++ L+ V V +K +Y++ EY G L D L S + L + + +EY
Sbjct: 60 SNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIAN 216
L +H+D+ N+L++ D K+SDFG+ + T T + + APE
Sbjct: 119 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALR 173
Query: 217 GLPEISGYKVDIWSSGVTL 235
+ K D+WS G+ L
Sbjct: 174 E--KKFSTKSDVWSFGILL 190
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 143 bits (362), Expect = 1e-42
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI-----NVDREIRLL 92
Y ++LG G V+ + T AVKI E+ +E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 93 KMLQ-HRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQL 150
+ + H N+I L D + + +L+ + G L D L + L
Sbjct: 64 RKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRAL 119
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQ 210
L+ + LH I+H+D+KP N+LL D +K++DFG + LD + + G+P +
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREVCGTPSYL 176
Query: 211 APEIANGLPEIS----GYKVDIWSSGVTL 235
APEI + G +VD+WS+GV +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIM 205
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 3e-42
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 16/202 (7%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
Y D+LG G++ +V D T A+K KK L+ E +++ EI +L ++H
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK---EGSMENEIAVLHKIKH 66
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
N++ L D++ + +YLIM+ GG L D + + A Q+LD ++Y
Sbjct: 67 PNIVALDDIYESGG--HLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKY 122
Query: 157 LHSQGIIHKDIKPGNLLLTL---DGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPE 213
LH GI+H+D+KP NLL D + ISDFG+++ D ++T+ G+P + APE
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED---PGSVLSTACGTPGYVAPE 179
Query: 214 IANGLPEISGYKVDIWSSGVTL 235
+ P VD WS GV
Sbjct: 180 VLAQKP--YSKAVDCWSIGVIA 199
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 6e-42
Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+ + LG G +G+V + + AVK K+ + E L+K LQH
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQH 67
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
+ ++ L V + +Y+I EY G L D L + K I + Q+ +G+ +
Sbjct: 68 QRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIAN 216
+ + IH+D++ N+L++ + KI+DFG+A ++ ++ + APE N
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAIN 183
Query: 217 GLPEISGYKVDIWSSGVTL 235
K D+WS G+ L
Sbjct: 184 YGTF--TIKSDVWSFGILL 200
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-41
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 32 KVKMIGKY-VMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIR 90
K +I Y V +LG G GKV ++ + T + A+K+ + R RE+
Sbjct: 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR---------REVE 56
Query: 91 -LLKMLQHRNVIGLVDVFVN--DKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGY 146
+ Q +++ +VDV+ N ++ + ++ME GG L + + F +A
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 147 FLQLLDGLEYLHSQGIIHKDIKPGNLLLTL---DGTLKISDFGVAESLDMFLHDDTITTS 203
+ + ++YLHS I H+D+KP NLL T + LK++DFG A+ +++TT
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---SHNSLTTP 173
Query: 204 QGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+P + APE+ D+WS GV +
Sbjct: 174 CYTPYYVAPEVLGPEK--YDKSCDMWSLGVIM 203
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-41
Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 12/204 (5%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGE--INVDREIRLLKM 94
+Y +G LLG G +G V + A+K +K ++ V E+ LLK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 95 LQ--HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLD 152
+ VI L+D F LI+E T A +F Q+L+
Sbjct: 64 VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLD-GTLKISDFGVAESLDMFLHDDTITTSQGSPVFQA 211
+ + H+ G++H+DIK N+L+ L+ G LK+ DFG L D T G+ V+
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA----LLKDTVYTDFDGTRVYSP 177
Query: 212 PEIANGLPEISGYKVDIWSSGVTL 235
PE G +WS G+ L
Sbjct: 178 PEWIRYHR-YHGRSAAVWSLGILL 200
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (351), Expect = 4e-41
Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 9/203 (4%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+Y +G++LG G +V D AVK+ + + P+ + RE + L
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALN 65
Query: 97 HRNVIGLVDVFVNDKKQK--MYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
H ++ + D + Y++MEY G L+D++ + +A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQA 123
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS-QGSPVFQAP 212
L + H GIIH+D+KP N++++ +K+ DFG+A ++ + T T + G+ + +P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 213 EIANGLPEISGYKVDIWSSGVTL 235
E A G + D++S G L
Sbjct: 184 EQARGDS--VDARSDVYSLGCVL 204
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 7e-41
Identities = 63/198 (31%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+++ +LG+GS+GKV +T A+K KK + + E + + L +H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
+ + F + ++ +MEY GG L + S KF + +A Y +++ GL++L
Sbjct: 64 FLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFL 119
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG 217
HS+GI+++D+K N+LL DG +KI+DFG+ + L D T G+P + APEI G
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM--LGDAKTNTFCGTPDYIAPEILLG 177
Query: 218 LPEISGYKVDIWSSGVTL 235
+ VD WS GV L
Sbjct: 178 QK--YNHSVDWWSFGVLL 193
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 1e-40
Identities = 45/203 (22%), Positives = 78/203 (38%), Gaps = 7/203 (3%)
Query: 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
I + ++G G +G+V R K K + E ++
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H NVI L V + +I E+ G D +F + Q G + G++
Sbjct: 85 DHPNVIHLEGVVTKSTP--VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS---QGSPVFQAP 212
YL +H+D+ N+L+ + K+SDFG++ L+ D T T++ + + AP
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 213 EIANGLPEISGYKVDIWSSGVTL 235
E D+WS G+ +
Sbjct: 203 EAIQYRK--FTSASDVWSYGIVM 223
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (351), Expect = 1e-40
Identities = 60/200 (30%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+ + + LG GS+G+V + A+K+ KK+ + R + + E +L ++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIV 61
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
H +I + F + Q++++IM+Y GG L ++FP A Y ++ LE
Sbjct: 62 THPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLL-RKSQRFPNPVAKFYAAEVCLALE 118
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIA 215
YLHS+ II++D+KP N+LL +G +KI+DFG A+ + D T G+P + APE+
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEVV 173
Query: 216 NGLPEISGYKVDIWSSGVTL 235
+ P +D WS G+ +
Sbjct: 174 STKP--YNKSIDWWSFGILI 191
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-40
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 9/202 (4%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+Y +GEG+YG V D+ R A+K + Q REI++L +
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ---RTLREIKILLRFR 64
Query: 97 HRNVIGLVDVFVND--KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGL 154
H N+IG+ D+ ++ K ++ + +G D+ + + Q+L GL
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGA--DLYKLLKTQHLSNDHICYFLYQILRGL 122
Query: 155 EYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL-HDDTITTSQGSPVFQAPE 213
+Y+HS ++H+D+KP NLLL LKI DFG+A D H +T + ++APE
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 214 IANGLPEISGYKVDIWSSGVTL 235
I + +DIWS G L
Sbjct: 183 IMLN-SKGYTKSIDIWSVGCIL 203
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 6e-40
Identities = 58/208 (27%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+ KY +G+G++G+V + +T + A+K + + I REI++L++L
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLL 66
Query: 96 QHRNVIGLVDVFV------NDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQ 149
+H NV+ L+++ N K +YL+ ++C L L S KF + +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQM 125
Query: 150 LLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF--LHDDTITTSQGSP 207
LL+GL Y+H I+H+D+K N+L+T DG LK++DFG+A + + + T +
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 208 VFQAPEIANGLPEISGYKVDIWSSGVTL 235
++ PE+ G + G +D+W +G +
Sbjct: 186 WYRPPELLLGERDY-GPPIDLWGAGCIM 212
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 6e-40
Identities = 55/201 (27%), Positives = 83/201 (41%), Gaps = 10/201 (4%)
Query: 39 YVMGDLLGEGSYGKV---KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+ + LG+GS+G V + S AVK K L + P + RE+ + L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSL 68
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLE 155
HRN+I L V + M ++ E G F + Y +Q+ +G+
Sbjct: 69 DHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 156 YLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPV-FQAPEI 214
YL S+ IH+D+ NLLL +KI DFG+ +L + + P + APE
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 215 ANGLPEISGYKVDIWSSGVTL 235
+ D W GVTL
Sbjct: 186 LKT--RTFSHASDTWMFGVTL 204
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-39
Identities = 65/194 (33%), Positives = 96/194 (49%), Gaps = 7/194 (3%)
Query: 43 DLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNG-EINVDREIRLLKMLQHRNVI 101
D LGEG + V + D T A+K K +G REI+LL+ L H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 102 GLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG 161
GL+D F + + L+ ++ L+ ++ P Y L L GLEYLH
Sbjct: 64 GLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKA-YMLMTLQGLEYLHQHW 120
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEI 221
I+H+D+KP NLLL +G LK++DFG+A+S + T + ++APE+ G
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 222 SGYKVDIWSSGVTL 235
G VD+W+ G L
Sbjct: 179 -GVGVDMWAVGCIL 191
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-39
Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 8/200 (4%)
Query: 38 KYVMGDL-LGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
++ D+ LG G++G V++ + + V I K K + RE +++ L
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAI-KVLKQGTEKADTEEMMREAQIMHQLD 67
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
+ ++ L+ V + + + L+ME GG ++ P+ Q+ G++Y
Sbjct: 68 NPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 124
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS-QGSPVFQAPEIA 215
L + +H+D+ N+LL KISDFG++++L T ++ + + APE
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 216 NGLPEISGYKVDIWSSGVTL 235
N + D+WS GVT+
Sbjct: 185 NFRK--FSSRSDVWSYGVTM 202
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 5e-39
Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 7/198 (3%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+ + +GEG+YG V + + T A+K + REI LLK L H
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE--GVPSTAIREISLLKELNH 60
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
N++ L+DV + K+YL+ E+ L+ +D++ P+ Y QLL GL +
Sbjct: 61 PNIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG 217
HS ++H+D+KP NLL+ +G +K++DFG+A + + T T + ++APEI G
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLG 176
Query: 218 LPEISGYKVDIWSSGVTL 235
VDIWS G
Sbjct: 177 CKYY-STAVDIWSLGCIF 193
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 135 bits (340), Expect = 5e-39
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 26 YDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINV 85
Y++ ++ Y + LG G Y +V E ++ + VKI K K ++I
Sbjct: 24 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI------- 76
Query: 86 DREIRLLKMLQ-HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAH 144
REI++L+ L+ N+I L D+ + + L+ E+ L Y+ +
Sbjct: 77 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL----YQTLTDYDIR 132
Query: 145 GYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-TLKISDFGVAESLDMFLHDDTITTS 203
Y ++L L+Y HS GI+H+D+KP N+++ + L++ D+G+AE +
Sbjct: 133 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE---FYHPGQEYNVR 189
Query: 204 QGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
S F+ PE+ Y +D+WS G L
Sbjct: 190 VASRYFKGPELLVDYQMY-DYSLDMWSLGCML 220
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 134 bits (339), Expect = 2e-38
Identities = 45/203 (22%), Positives = 88/203 (43%), Gaps = 12/203 (5%)
Query: 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGE--INVDREIRLLK 93
+ + + ++G G +G+V ++T A+K KK+++ +N + L+
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 94 MLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLD 152
++ + F K+ I++ GG L L + F Y +++
Sbjct: 63 TGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIIL 118
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAP 212
GLE++H++ ++++D+KP N+LL G ++ISD G+A S G+ + AP
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAP 174
Query: 213 EIANGLPEISGYKVDIWSSGVTL 235
E+ D +S G L
Sbjct: 175 EVLQKGVAY-DSSADWFSLGCML 196
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-38
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
Y ++G GS+G V + ++ A+K + K + +RE+++++ L H
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--------NRELQIMRKLDHC 73
Query: 99 NVIGLVDVFVNDKKQK----MYLIMEYCVGGLQDMLD--STPYKKFPIWQAHGYFLQLLD 152
N++ L F + ++K + L+++Y + + S + P+ Y QL
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 153 GLEYLHSQGIIHKDIKPGNLLLTLDG-TLKISDFGVAESLDMFLHDDTITTSQGSPVFQA 211
L Y+HS GI H+DIKP NLLL D LK+ DFG A+ L + + S ++A
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV---RGEPNVSYICSRYYRA 190
Query: 212 PEIANGLPEISGYKVDIWSSGVTL 235
PE+ G + +D+WS+G L
Sbjct: 191 PELIFGATDY-TSSIDVWSAGCVL 213
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-38
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRR-AVKIFKKKKLQRIPNGEINVDREIRLL 92
+ +Y +GEG+YGKV + D + R A+K + + + ++ RE+ +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVL 61
Query: 93 KML---QHRNVIGLVDVFV---NDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGY 146
+ L +H NV+ L DV D++ K+ L+ E+ L LD P P
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 147 FLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGS 206
QLL GL++LHS ++H+D+KP N+L+T G +K++DFG+A +T+ +
Sbjct: 122 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVT 178
Query: 207 PVFQAPEIANGLPEISGYKVDIWSSGVTL 235
++APE+ VD+WS G
Sbjct: 179 LWYRAPEVLLQSS--YATPVDLWSVGCIF 205
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 9e-38
Identities = 52/259 (20%), Positives = 94/259 (36%), Gaps = 34/259 (13%)
Query: 7 EVDGDMISIFHRVDSDQVIYDNKTIKVKM-----IGKYVMGDLLGEGSYGKVKEMLDSET 61
E M+ + D++ D + + + G +LG G++GKV
Sbjct: 2 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 61
Query: 62 LCRRAVKIFKKKKLQR--IPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKMYLI 118
K L+ + + E++++ L H N++ L+ +YLI
Sbjct: 62 SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP--IYLI 119
Query: 119 MEYCVGG-LQDML---------------------DSTPYKKFPIWQAHGYFLQLLDGLEY 156
EYC G L + L + + Q+ G+E+
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIAN 216
L + +H+D+ N+L+T +KI DFG+A + + ++ + APE
Sbjct: 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 239
Query: 217 GLPEISGYKVDIWSSGVTL 235
I K D+WS G+ L
Sbjct: 240 E--GIYTIKSDVWSYGILL 256
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-37
Identities = 69/206 (33%), Positives = 104/206 (50%), Gaps = 18/206 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEI--NVDREIRLLKML 95
Y G+ LG G + VK+ + T + A K KK++ + G +++RE+ +LK +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIW--QAHGYFLQLLDG 153
QH NVI L +V+ N + LI+E GG L +K + +A + Q+L+G
Sbjct: 71 QHPNVITLHEVYENKT--DVILILELVAGG---ELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 154 LEYLHSQGIIHKDIKPGNLLLTLDGT----LKISDFGVAESLDMFLHDDTITTSQGSPVF 209
+ YLHS I H D+KP N++L +KI DFG+A +D + G+P F
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEF 182
Query: 210 QAPEIANGLPEISGYKVDIWSSGVTL 235
APEI N P G + D+WS GV
Sbjct: 183 VAPEIVNYEP--LGLEADMWSIGVIT 206
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 1e-37
Identities = 44/199 (22%), Positives = 83/199 (41%), Gaps = 13/199 (6%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+ LG+G +G+V + T R A+K K + +E +++K L+H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRH 71
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIW-QAHGYFLQLLDGLEY 156
++ L V + +Y++ EY G K+ Q Q+ G+ Y
Sbjct: 72 EKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 157 LHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIAN 216
+ +H+D++ N+L+ + K++DFG+A ++ ++ + APE A
Sbjct: 129 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAAL 187
Query: 217 GLPEISGYKVDIWSSGVTL 235
K D+WS G+ L
Sbjct: 188 YGR--FTIKSDVWSFGILL 204
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-37
Identities = 41/198 (20%), Positives = 79/198 (39%), Gaps = 6/198 (3%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
+ +G +GEG +G V + + K K + +E ++ H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
+++ L+ V + +++IME C G + Y QL L YL
Sbjct: 68 PHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG 217
S+ +H+DI N+L++ + +K+ DFG++ ++ + + + + APE N
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINF 183
Query: 218 LPEISGYKVDIWSSGVTL 235
D+W GV +
Sbjct: 184 --RRFTSASDVWMFGVCM 199
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-37
Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 13/195 (6%)
Query: 45 LGEGSYGKVKEMLDSETLCRR--AVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIG 102
LG G++G VK+ + AVKI K + P + + E +++ L + ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVR 72
Query: 103 LVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG 161
++ + + L+ME G L L + Q+ G++YL
Sbjct: 73 MIGICEAES---WMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 162 IIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS-QGSPVFQAPEIANGLPE 220
+H+D+ N+LL KISDFG++++L + T + + APE N
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK- 186
Query: 221 ISGYKVDIWSSGVTL 235
K D+WS GV +
Sbjct: 187 -FSSKSDVWSFGVLM 200
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-37
Identities = 44/197 (22%), Positives = 79/197 (40%), Gaps = 11/197 (5%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
LG G +G VK A+K+ K+ + E E +++ L H
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQY-DVAIKMIKEGSMS-----EDEFIEEAKVMMNLSHE 59
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
++ L V + +++I EY G +F Q + + +EYL
Sbjct: 60 KLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGL 218
S+ +H+D+ N L+ G +K+SDFG++ + + + S+ + PE+
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLMYS 176
Query: 219 PEISGYKVDIWSSGVTL 235
K DIW+ GV +
Sbjct: 177 K--FSSKSDIWAFGVLM 191
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (327), Expect = 3e-37
Identities = 45/207 (21%), Positives = 83/207 (40%), Gaps = 18/207 (8%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+Y +G +G GS+G + D A+K+ K + E ++ KM+Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP------QLHIESKIYKMMQ 60
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
I + + ++ME L+D+ + +KF + Q++ +EY
Sbjct: 61 GGVGIPTIRWCGAEG-DYNVMVMELLGPSLEDL-FNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 157 LHSQGIIHKDIKPGNLLLTLDG---TLKISDFGVAESLD-----MFLHDDTITTSQGSPV 208
+HS+ IH+D+KP N L+ L + I DFG+A+ + G+
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 209 FQAPEIANGLPEISGYKVDIWSSGVTL 235
+ + G+ + D+ S G L
Sbjct: 179 YASINTHLGIE--QSRRDDLESLGYVL 203
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 4e-37
Identities = 68/224 (30%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 16 FHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKL 75
F+R + + ++ + Y +G G+YG V +D T + A+K +
Sbjct: 4 FYRQEVTKTAWEVR-------AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ 56
Query: 76 QRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK----QKMYLIMEYCVGGLQDMLD 131
+ RE+RLLK ++H NVIGL+DVF D+ YL+M + L ++
Sbjct: 57 SEL--FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK 114
Query: 132 STPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191
++K + Q+L GL Y+H+ GIIH+D+KPGNL + D LKI DFG+A
Sbjct: 115 ---HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171
Query: 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
D +T + ++APE+ VDIWS G +
Sbjct: 172 -----DSEMTGYVVTRWYRAPEVILNWMRY-TQTVDIWSVGCIM 209
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 4e-37
Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
V+ + +G+G +G+V AVKIF ++ + + EI ML+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEV--AVKIFSSREER-----SWFREAEIYQTVMLR 55
Query: 97 HRNVIGLVDVFV--NDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDG 153
H N++G + N +++L+ +Y G L D L+ + L G
Sbjct: 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASG 112
Query: 154 LEYLHSQ--------GIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQ- 204
L +LH + I H+D+K N+L+ +GT I+D G+A D I +
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172
Query: 205 -GSPVFQAPEIANGLPEISGY----KVDIWSSGVTL 235
G+ + APE+ + + + + DI++ G+
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 128 bits (323), Expect = 8e-37
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 20/221 (9%)
Query: 19 VDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRI 78
+D YD ++ M LG G YG+V E + + AVK K+ ++
Sbjct: 2 MDPSSPNYDKWEMERT---DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE 58
Query: 79 PNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKK 137
+E ++K ++H N++ L+ V + Y+I E+ G L D L ++
Sbjct: 59 -----EFLKEAAVMKEIKHPNLVQLLGVCTREPP--FYIITEFMTYGNLLDYLRECNRQE 111
Query: 138 FPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD 197
Q+ +EYL + IH+D+ N L+ + +K++DFG++ +
Sbjct: 112 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR----LMTG 167
Query: 198 DTITTSQGSPV---FQAPEIANGLPEISGYKVDIWSSGVTL 235
DT T G+ + APE K D+W+ GV L
Sbjct: 168 DTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLL 206
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-36
Identities = 44/199 (22%), Positives = 83/199 (41%), Gaps = 6/199 (3%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKI-FKKKKLQRIPNGEINVDREIRLLKMLQH 97
++G G +G+V + + + ++ V + K K ++ E ++ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
N+I L V + M +I EY G D +F + Q G + G++YL
Sbjct: 69 HNIIRLEGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL-DMFLHDDTITTSQGSPVFQAPEIAN 216
+ +H+D+ N+L+ + K+SDFG++ L D T + + + APE +
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 217 GLPEISGYKVDIWSSGVTL 235
D+WS G+ +
Sbjct: 187 YRKFT--SASDVWSFGIVM 203
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-35
Identities = 41/197 (20%), Positives = 78/197 (39%), Gaps = 11/197 (5%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR 98
+G G +G V + A+K ++ + E + E ++ L H
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHP 60
Query: 99 NVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLH 158
++ L V + + L+ E+ G T F G L + +G+ YL
Sbjct: 61 KLVQLYGVCLEQ--APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 159 SQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGL 218
+IH+D+ N L+ + +K+SDFG+ + + + T + + +PE+ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFS 177
Query: 219 PEISGYKVDIWSSGVTL 235
K D+WS GV +
Sbjct: 178 R--YSSKSDVWSFGVLM 192
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 125 bits (314), Expect = 2e-35
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
KY + +GEG+YG V + ++ A+K + +K REI +LK L+H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED--EGIPSTTIREISILKELKH 59
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
N++ L DV +++ L+ E+ L+ +LD A + LQLL+G+ Y
Sbjct: 60 SNIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYC 116
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG 217
H + ++H+D+KP NLL+ +G LKI+DFG+A + + T + ++AP++ G
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMG 174
Query: 218 LPEISGYKVDIWSSGVT 234
+ +DIWS G
Sbjct: 175 SKKY-STTIDIWSVGCI 190
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 3e-35
Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 16 FHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKL 75
F+R + ++ I++ + +Y +G G+YG V D++T R AVK +
Sbjct: 4 FYRQELNKTIWE-------VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 56
Query: 76 QRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK---QKMYLIMEYCVGGLQDMLDS 132
I RE+RLLK ++H NVIGL+DVF + ++ + +G + +
Sbjct: 57 SII--HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 114
Query: 133 TPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192
+K Q+L GL+Y+HS IIH+D+KP NL + D LKI DFG+A D
Sbjct: 115 --CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172
Query: 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+T + ++APEI VDIWS G +
Sbjct: 173 D-----EMTGYVATRWYRAPEIMLNWMHY-NQTVDIWSVGCIM 209
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (313), Expect = 3e-35
Identities = 37/209 (17%), Positives = 77/209 (36%), Gaps = 20/209 (9%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
Y +G +GEGS+G + E + + A+K ++ + E R K+L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP------QLRDEYRTYKLLA 58
Query: 97 HRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEY 156
I V + + L+++ G + L +KF + Q+L ++
Sbjct: 59 GCTGIPNV-YYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 157 LHSQGIIHKDIKPGNLLLTL-----DGTLKISDFGVAESLD-----MFLHDDTITTSQGS 206
+H + ++++DIKP N L+ + + DFG+ + + G+
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 207 PVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ + G + D+ + G
Sbjct: 177 ARYMSINTHLGRE--QSRRDDLEALGHVF 203
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-35
Identities = 38/198 (19%), Positives = 81/198 (40%), Gaps = 6/198 (3%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKK-KLQRIPNGEINVDREIRLLKMLQH 97
+ +LG G++G V + L + + + K+ + P + E ++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
+V L+ + + + LI + G + +Q+ G+ YL
Sbjct: 71 PHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG 217
+ ++H+D+ N+L+ +KI+DFG+A+ L + + + A E
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 218 LPEISGYKVDIWSSGVTL 235
I ++ D+WS GVT+
Sbjct: 188 --RIYTHQSDVWSYGVTV 203
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (312), Expect = 4e-35
Identities = 46/226 (20%), Positives = 84/226 (37%), Gaps = 35/226 (15%)
Query: 38 KYVMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLL 92
+GEG++G+V +L E AVK+ K++ + + + RE L+
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM---QADFQREAALM 70
Query: 93 KMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPY---------------- 135
+ N++ L+ V K M L+ EY G L + L S
Sbjct: 71 AEFDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 136 ------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189
+ Q+ G+ YL + +H+D+ N L+ + +KI+DFG++
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
++ + + PE + D+W+ GV L
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVL 232
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-35
Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 24/213 (11%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QH 97
D++GEG++G+V + + R I K+ K + + E+ +L L H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAI-KRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML--------------DSTPYKKFPIWQ 142
N+I L+ + +YL +EY G L D L ++ Q
Sbjct: 71 PNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 143 AHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITT 202
+ + G++YL + IH+D+ N+L+ + KI+DFG++ + T
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKKTM 185
Query: 203 SQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ + A E N + D+WS GV L
Sbjct: 186 GRLPVRWMAIESLNY--SVYTTNSDVWSYGVLL 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-35
Identities = 52/227 (22%), Positives = 109/227 (48%), Gaps = 9/227 (3%)
Query: 12 MISIFHRVDSDQVIYDNKTIKVKMIGKYVMGDLLGEGSYGKV---KEMLDSETLCRRAVK 68
++++ H + + + + + ++ + + +LG G+YGKV +++ +T A+K
Sbjct: 2 LLTVKHELRTANLTGHAEKVGIE---NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK 58
Query: 69 IFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQD 128
+ KK + + + E ++L+ ++ + + + K++LI++Y GG
Sbjct: 59 VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET-KLHLILDYINGGELF 117
Query: 129 MLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188
S + F + Y +++ LE+LH GII++DIK N+LL +G + ++DFG++
Sbjct: 118 THLSQRER-FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176
Query: 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ + G+ + AP+I G VD WS GV +
Sbjct: 177 KEFVADETERAYDF-CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 222
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 7e-35
Identities = 41/197 (20%), Positives = 77/197 (39%), Gaps = 7/197 (3%)
Query: 42 GDLLGEGSYGKV-KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNV 100
+++G G +G V L + + K E ++K H NV
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAV-KSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 101 IGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ 160
+ L+ + + + +++ Y G + G+ LQ+ G+++L S+
Sbjct: 91 LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAESL--DMFLHDDTITTSQGSPVFQAPEIANGL 218
+H+D+ N +L T+K++DFG+A + F T ++ + A E
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209
Query: 219 PEISGYKVDIWSSGVTL 235
K D+WS GV L
Sbjct: 210 KF--TTKSDVWSFGVLL 224
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (312), Expect = 1e-34
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 11/209 (5%)
Query: 26 YDNKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINV 85
++ + + ++ LG GS+G+V + E+ A+KI K+K+ ++ E +
Sbjct: 30 WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE-HT 88
Query: 86 DREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHG 145
E R+L+ + ++ L F D ++ G + L +F A
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF 145
Query: 146 YFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQG 205
Y Q++ EYLHS +I++D+KP NLL+ G ++++DFG A+ T G
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCG 200
Query: 206 SPVFQAPEIANGLPEISGYKVDIWSSGVT 234
+P APEI VD W+ GV
Sbjct: 201 TPEALAPEIILSKG--YNKAVDWWALGVL 227
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-34
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 32 KVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRL 91
KV M + LLG+G++GKV + + T A+KI +K+ + + + E R+
Sbjct: 1 KVTM-NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRV 58
Query: 92 LKMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQL 150
L+ +H + L F ++ +MEY GG L L + F +A Y ++
Sbjct: 59 LQNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEI 114
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQ 210
+ LEYLHS+ ++++DIK NL+L DG +KI+DFG+ + T+ T G+P +
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYL 172
Query: 211 APEIANGLPEISGYKVDIWSSGVTL 235
APE+ G VD W GV +
Sbjct: 173 APEVLEDND--YGRAVDWWGLGVVM 195
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 7e-34
Identities = 55/241 (22%), Positives = 94/241 (39%), Gaps = 34/241 (14%)
Query: 19 VDSDQVIYDNK-TIKVKMIGKYVMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKK 72
+D Q+ YD+K + G LG G++GKV ++ S+ AVK+ K
Sbjct: 7 IDPTQLPYDHKWEFPRN---RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63
Query: 73 KKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML 130
+ E+++L L H N++ L+ +I EYC G L + L
Sbjct: 64 SAHL---TEREALMSELKVLSYLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFL 118
Query: 131 ----------------DSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL 174
+ + Q+ G+ +L S+ IH+D+ N+LL
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178
Query: 175 TLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVT 234
T KI DFG+A + + ++ + APE + ++ D+WS G+
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIF 236
Query: 235 L 235
L
Sbjct: 237 L 237
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-32
Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 8/198 (4%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH 97
KY + +GEG+YG V + + ET A+K + + REI LLK L+H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKH 60
Query: 98 RNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYL 157
+N++ L DV +D +K+ L+ E+C + + QLL GL +
Sbjct: 61 KNIVRLHDVLHSD--KKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 158 HSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANG 217
HS+ ++H+D+KP NLL+ +G LK+++FG+A + +++ ++ P
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG---IPVRCYSAEVVTLWYRPPDVLF 174
Query: 218 LPEISGYKVDIWSSGVTL 235
++ +D+WS+G
Sbjct: 175 GAKLYSTSIDMWSAGCIF 192
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 6e-32
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRR-------AVKIFKKKKLQRIPNGEINVDREIR 90
+ V+G LGEG++G+V + AVK+ K ++ ++ E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEME 70
Query: 91 LLKML-QHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML--------------DSTP 134
++KM+ +H+N+I L+ D +Y+I+EY G L++ L P
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 135 YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194
++ Q+ G+EYL S+ IH+D+ N+L+T D +KI+DFG+A +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ T + + APE ++ D+WS GV L
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLL 227
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 7e-32
Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 21/212 (9%)
Query: 38 KYVMGDLLGEGSYGKV-----KEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLL 92
K M LG+GS+G V K ++ E R A+K + R I E ++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR---ERIEFLNEASVM 77
Query: 93 KMLQHRNVIGLVDVFVNDKKQKMYLIMEYCVGG-LQDML--------DSTPYKKFPIWQA 143
K +V+ L+ V Q +IME G L+ L ++ + +
Sbjct: 78 KEFNCHHVVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 144 HGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTS 203
++ DG+ YL++ +H+D+ N ++ D T+KI DFG+ + +
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 204 QGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
+ +PE + D+WS GV L
Sbjct: 196 LLPVRWMSPESLKD--GVFTTYSDVWSFGVVL 225
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 3e-31
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML 95
+ +Y +G G+ G V D+ A+K + RE+ L+K +
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCV 73
Query: 96 QHRNVIGLVDVFVNDKK----QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLL 151
H+N+I L++VF K Q +YL+ME L ++ + + Q+L
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQML 129
Query: 152 DGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQA 211
G+++LHS GIIH+D+KP N+++ D TLKI DFG+A + +T + ++A
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRA 186
Query: 212 PEIANGLPEISGYKVDIWSSGVT 234
PE+ G+ VDIWS G
Sbjct: 187 PEVILGMGY--KENVDIWSVGCI 207
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-29
Identities = 43/215 (20%), Positives = 81/215 (37%), Gaps = 19/215 (8%)
Query: 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQR--IPNGEINVDREIRLLKML 95
+ +G LG G++G+V E + K L+ + + E+++L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 96 QHRNVIGLVDVFVNDKKQKMYLIMEYCVGGLQDML---------------DSTPYKKFPI 140
H + + + +I+E+C G + +
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 141 WQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTI 200
Y Q+ G+E+L S+ IH+D+ N+LL+ +KI DFG+A +
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 201 TTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
++ + APE + + D+WS GV L
Sbjct: 194 GDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLL 226
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.3 bits (246), Expect = 4e-25
Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ 96
+Y++ LG G + V D A+KI + K+ + EI+LL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-----EAAEDEIKLLQRVN 67
Query: 97 HRN-----------VIGLVDVFVNDKKQKMYLIMEYCVGGLQ--DMLDSTPYKKFPIWQA 143
+ ++ L+D F + ++++M + V G ++ ++ P+
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 144 HGYFLQLLDGLEYL-HSQGIIHKDIKPGNLLLTLDG-TLKISDFGVAESLDMFLHDDTIT 201
QLL GL+Y+ GIIH DIKP N+L+ + + +A+ + +D+ T
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 202 TSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235
S + +++PE+ G P G DIWS+ +
Sbjct: 188 NSIQTREYRSPEVLLGAP--WGCGADIWSTACLI 219
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 3e-19
Identities = 34/205 (16%), Positives = 69/205 (33%), Gaps = 31/205 (15%)
Query: 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFK------KKKLQRIPNGEINVDREIRLL 92
+G L+GEG V E VK K KK ++ G+++
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 93 KMLQHRNVIGLVDVFVNDKK--QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQL 150
+ R + L + V + ++ME + + +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRVRVENPDEVLDMI 112
Query: 151 LDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQ 210
L+ + + +GI+H D+ N+L++ + + I DF + + +G
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG----------EEGWREIL 161
Query: 211 APEIANGLPEIS---GYKVDIWSSG 232
++ N + S + DI S+
Sbjct: 162 ERDVRNIITYFSRTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 235 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.68 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.43 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.31 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.27 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-49 Score=302.78 Aligned_cols=192 Identities=35% Similarity=0.566 Sum_probs=162.0
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++++.||+|+||+||+|++..+|+.||+|++...... ...+.+.+|+.+++.++||||+++++++ .+.+.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~~~~~~--~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHR--REGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEE--EETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHhCCCCCEeeEeeee--ccCcee
Confidence 35899999999999999999999999999999999765432 3345689999999999999999999999 456689
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
|+||||+++ +|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++++||+|||++..+...
T Consensus 79 ~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999975 699888755 67999999999999999999999999999999999999999999999999999866432
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..........||+.|+|||++.+.+ .++.++|||||||+|
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~~DiwSlGvil 196 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVL 196 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSS-BCHHHHHHHHHHHHH
T ss_pred CccccccceeeCcCccCHhHhcCCC-CCCCceeeeHhHHHH
Confidence 2233344567999999999987632 346789999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=297.11 Aligned_cols=188 Identities=33% Similarity=0.539 Sum_probs=165.1
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||+|+||+||+|++..+++.||+|++.+..... ......+.+|+.+++.++||||+++++++ .+.+.++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~~~~ 82 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYF--HDATRVY 82 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSSEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC-hHHHHHHHHHHHHHHhcCCCCCCeEEEEE--EECCEEE
Confidence 57999999999999999999999999999999997665443 34456688999999999999999999999 5567899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 83 ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-- 158 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 158 (263)
T ss_dssp EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--
T ss_pred EEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC--
Confidence 99999975 688888765 6799999999999999999999999999999999999999999999999999975532
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 159 --~~~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvil 194 (263)
T d2j4za1 159 --SRRTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLC 194 (263)
T ss_dssp --CCCEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHH
T ss_pred --CcccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHH
Confidence 23345568999999999988 4489999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=298.49 Aligned_cols=186 Identities=29% Similarity=0.502 Sum_probs=162.3
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|+++++||+|+||+||+|++..+|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++ ...+.+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~~~ 93 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSY--LVGDELW 93 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEE--EETTEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC----hHHHHHHHHHHHHHhCCCCCEeeEeEEE--EECCEEE
Confidence 479999999999999999999999999999999876542 3345689999999999999999999999 4566899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||++| +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.+++++|+|||++..+..
T Consensus 94 ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~-- 168 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-- 168 (293)
T ss_dssp EEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred EEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--
Confidence 99999976 58877665 4699999999999999999999999999999999999999999999999999986642
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........||+.|+|||.+.+ ..++.++|||||||+|
T Consensus 169 ~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvil 206 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMA 206 (293)
T ss_dssp TTCCBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHH
T ss_pred ccccccccccCCCccChhhhcC--CCCCchhceehHhHHH
Confidence 2233445569999999999988 4589999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=300.60 Aligned_cols=192 Identities=28% Similarity=0.476 Sum_probs=163.6
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||+|+||+||+|++..+++.||+|++.+..... ......+.+|+.++++++||||+++++++ .+.+.+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~~~~~ 84 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTF--QDDEKLY 84 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCSTTBCCEEEEE--ECSSEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC-HHHHHHHHHHHHHHHHcCCCCeeEEEEEE--EECCEEE
Confidence 57999999999999999999999999999999998765433 23445688999999999999999999999 5567899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+....
T Consensus 85 ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999975 688888766 679999999999999999999999999999999999999999999999999998765333
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........||+.|+|||++.+ ..++.++|||||||+|
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvil 200 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCII 200 (288)
T ss_dssp -------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHH
T ss_pred cccccccccCCccccCceeecc--CCCCcccceehhhHHH
Confidence 3334445679999999999988 4489999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-47 Score=297.71 Aligned_cols=188 Identities=30% Similarity=0.473 Sum_probs=159.7
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
..|+++++||+|+||+||+|++..+++.||+|++....... ......+.+|+.+++.++||||+++++++. +...+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--ETTEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEE--ECCEEE
Confidence 46999999999999999999999999999999987654332 233456889999999999999999999994 556899
Q ss_pred EEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+.++ +..++... .++++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 92 iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~--- 166 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA--- 166 (309)
T ss_dssp EEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS---
T ss_pred EEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC---
Confidence 999999876 44344443 679999999999999999999999999999999999999999999999999997543
Q ss_pred cCCcccccCCCCcccCccccCCC-CCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGL-PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 235 (235)
......||+.|+|||++.+. ...++.++|||||||++
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvil 204 (309)
T d1u5ra_ 167 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204 (309)
T ss_dssp ---SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHH
T ss_pred ---CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHH
Confidence 22345699999999998653 24588999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=297.26 Aligned_cols=191 Identities=31% Similarity=0.475 Sum_probs=166.9
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++++.||+|+||+||+|++..+|+.||+|++++..... ......+.+|+.+++.++||||+++++++ .+...+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~~~~~ 80 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAF--QTHDRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEE--ECSSEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeee--cccccc
Confidence 468999999999999999999999999999999998765443 23455688999999999999999999999 566789
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
|+||||++| +|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.+|.++|+|||+++....
T Consensus 81 ~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~- 157 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS- 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred ccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc-
Confidence 999999975 588888776 6789999999999999999999999999999999999999999999999999986532
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........||+.|+|||.+.+ ..++.++|||||||+|
T Consensus 158 -~~~~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvil 195 (337)
T d1o6la_ 158 -DGATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVM 195 (337)
T ss_dssp -TTCCBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHH
T ss_pred -CCcccccceeCHHHhhhhhccC--CCCChhhcccchhhHH
Confidence 2233445668999999999988 4589999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=295.34 Aligned_cols=194 Identities=25% Similarity=0.417 Sum_probs=154.1
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++++.||+|+||+||+|++..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+...+.+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH--HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH--HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 367999999999999999999999999999999987665432 334568899999999999999999999976666788
Q ss_pred EEEEecccC-CHHHHhhcC--CCCCCCHHhHHHHHHHHHHHHHHHHhCC-----cccCCCCCCCeEEccCCcEEEeeecc
Q psy787 116 YLIMEYCVG-GLQDMLDST--PYKKFPIWQAHGYFLQLLDGLEYLHSQG-----IIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
|+||||+++ +|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999975 688887643 2367999999999999999999999976 99999999999999999999999999
Q ss_pred ccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+..+.. .........+|+.|+|||++.+ ..++.++||||||++|
T Consensus 161 a~~~~~--~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvil 204 (269)
T d2java1 161 ARILNH--DTSFAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLL 204 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred eeeccc--CCCccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHH
Confidence 986642 1223345668999999999987 4589999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=294.36 Aligned_cols=190 Identities=32% Similarity=0.533 Sum_probs=160.9
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
+.|++++.||+|+||+||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++ ...+.++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAF--YYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEE--EETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEE--eeCCeEE
Confidence 46999999999999999999999999999999987643 24456789999999999999999999999 4566899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++.... .++++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 86 lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~- 163 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT- 163 (288)
T ss_dssp EEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-
T ss_pred EEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC-
Confidence 99999976 5877766432 57999999999999999999999999999999999999999999999999999755321
Q ss_pred cCCcccccCCCCcccCccccCCC---CCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGL---PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~l 235 (235)
........||+.|+|||++... ...++.++|||||||+|
T Consensus 164 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvil 205 (288)
T d2jfla1 164 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 205 (288)
T ss_dssp -HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHH
T ss_pred -cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHH
Confidence 1223345689999999998432 23478999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-46 Score=294.43 Aligned_cols=187 Identities=31% Similarity=0.513 Sum_probs=163.8
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||+|+||+||+|++..+|+.||+|++++..... ......+.+|+.+++.++||||+++++++ .....+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~~~ 80 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTF--QDAQQIF 80 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEE--ECSSEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHhccCcChhheeeeE--eeCCeee
Confidence 57999999999999999999999999999999998665433 34456788999999999999999999999 5667899
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+.| ++...+... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 81 ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp EEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 99999976 477777765 6788999999999999999999999999999999999999999999999999986542
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 157 ---~~~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvil 191 (316)
T d1fota_ 157 ---VTYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILI 191 (316)
T ss_dssp ---CBCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHH
T ss_pred ---ccccccCcccccCHHHHcC--CCCCchhhccccchhH
Confidence 2334679999999999988 4489999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-46 Score=294.84 Aligned_cols=189 Identities=33% Similarity=0.545 Sum_probs=148.3
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
+.+.|++.+.||+|+||+||+|++..+++.||+|++....... ....+.+|+.++..++||||+++++++ .+.+.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG---KEGSMENEIAVLHKIKHPNIVALDDIY--ESGGH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEE--ECSSE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh---HHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCE
Confidence 4567999999999999999999999999999999998665432 234578999999999999999999999 56678
Q ss_pred EEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc---cCCcEEEeeeccccc
Q psy787 115 MYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT---LDGTLKISDFGVAES 190 (235)
Q Consensus 115 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~ 190 (235)
+|+||||++ |+|.+++... ..+++..+..++.||+.||+|||++|++||||||+||++. .++.++|+|||++..
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999999997 5799999765 6799999999999999999999999999999999999995 468899999999985
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+. ........||+.|+|||++.+ ..++.++|||||||+|
T Consensus 160 ~~~---~~~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvil 199 (307)
T d1a06a_ 160 EDP---GSVLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIA 199 (307)
T ss_dssp ----------------CTTSCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred ccC---CCeeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHH
Confidence 542 223345569999999999988 4589999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=299.83 Aligned_cols=188 Identities=25% Similarity=0.399 Sum_probs=162.4
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|+++++||+|+||+||+|++..+|+.||+|+++.... ......+.+|+.+++.++||||+++++++ .....
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAF--YSDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC---TTHHHHHHHHGGGGGGCCCTTBCCEEEEE--ECSSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCE
Confidence 45789999999999999999999999999999999875431 23445788999999999999999999999 45668
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhC-CcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQ-GIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
+++||||+++ +|.+++... ..+++..++.++.|++.||.|||++ ||+||||||+||+++.++++||+|||+|..+.
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999975 698888765 6799999999999999999999974 99999999999999999999999999998553
Q ss_pred ccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. .......||+.|+|||++.+ ..++.++|||||||++
T Consensus 157 ~----~~~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil 193 (322)
T d1s9ja_ 157 D----SMANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSL 193 (322)
T ss_dssp H----HTC---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHH
T ss_pred C----CccccccCCccccCchHHcC--CCCCcHHHHHHHHHHH
Confidence 2 22334579999999999988 4599999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=289.15 Aligned_cols=192 Identities=35% Similarity=0.578 Sum_probs=166.1
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCC--ccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN--GEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
+.++|++++.||+|+||+||+|++..+|+.||+|++++........ ....+.+|+.+++.++||||+++++++ .+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~ 85 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY--ENK 85 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECS
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EEC
Confidence 4568999999999999999999999999999999998766543222 345688999999999999999999999 566
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC----cEEEeeecc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG----TLKISDFGV 187 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~----~~~l~dfg~ 187 (235)
..+|+||||+++ +|.+++... ..+++..++.++.|++.||+|||+.+++||||||+||+++.++ .++++|||+
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence 789999999975 699988765 6799999999999999999999999999999999999998776 499999999
Q ss_pred ccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+..... ........+++.|+|||.+.+ ..++.++|||||||+|
T Consensus 164 a~~~~~---~~~~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvil 206 (293)
T d1jksa_ 164 AHKIDF---GNEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVIT 206 (293)
T ss_dssp CEECTT---SCBCSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred hhhcCC---CccccccCCCCcccCHHHHcC--CCCCCcccchhhhHHH
Confidence 986642 233445568899999999987 4589999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-46 Score=291.70 Aligned_cols=191 Identities=24% Similarity=0.314 Sum_probs=163.5
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+.+|+.++..++||||+++++++ ...+.
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~ 87 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPP 87 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccE--eeCCe
Confidence 3468999999999999999999999999999999886432 3345689999999999999999999999 45567
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
++++|||+++ +|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 8999999974 688888877667899999999999999999999999999999999999999999999999999986642
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. ........++..|+|||.+.+ ..++.++||||||++|
T Consensus 168 ~~-~~~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l 206 (287)
T d1opja_ 168 DT-YTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLL 206 (287)
T ss_dssp SS-SEEETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHH
T ss_pred CC-ceeeccccccccccChHHHcC--CCCCchhhhhhHHHHH
Confidence 21 112223346788999999987 4589999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=284.05 Aligned_cols=193 Identities=28% Similarity=0.449 Sum_probs=162.0
Q ss_pred eEeeeceE-EeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc-
Q psy787 32 KVKMIGKY-VMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN- 109 (235)
Q Consensus 32 ~~~~~~~y-~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 109 (235)
+....++| ++.++||+|+||+||+|.+..+++.||+|.+....... ...+.+.+|+.++++++||||+++++++..
T Consensus 3 g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 80 (270)
T d1t4ha_ 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWEST 80 (270)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred CcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEeec
Confidence 34445566 67778999999999999999999999999987665332 334568899999999999999999999853
Q ss_pred -CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCC--cccCCCCCCCeEEc-cCCcEEEee
Q psy787 110 -DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQG--IIHKDIKPGNLLLT-LDGTLKISD 184 (235)
Q Consensus 110 -~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~~l~d 184 (235)
.....+++||||+++ +|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++ +++.+||+|
T Consensus 81 ~~~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~D 158 (270)
T d1t4ha_ 81 VKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 158 (270)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred cccCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEee
Confidence 234678999999975 698888765 67999999999999999999999998 99999999999996 478999999
Q ss_pred eccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||+++... ........||+.|+|||++.+ .++.++|||||||+|
T Consensus 159 FGla~~~~----~~~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvil 202 (270)
T d1t4ha_ 159 LGLATLKR----ASFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCM 202 (270)
T ss_dssp TTGGGGCC----TTSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHH
T ss_pred cCcceecc----CCccCCcccCccccCHHHhCC---CCCCcCchhhHHHHH
Confidence 99997543 233345679999999999865 389999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-45 Score=295.06 Aligned_cols=189 Identities=30% Similarity=0.506 Sum_probs=163.1
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..+.|++++.||+|+||+||+|++..+|+.||+|+++.... .....+.+|+.+++.++||||+++++++ .....
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~--~~~~~ 100 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP----LDKYTVKNEISIMNQLHHPKLINLHDAF--EDKYE 100 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHTTCCSTTBCCEEEEE--ECSSE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch----hHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCE
Confidence 45779999999999999999999999999999999876532 2334678999999999999999999999 56678
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEc--cCCcEEEeeecccccc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLT--LDGTLKISDFGVAESL 191 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~--~~~~~~l~dfg~~~~~ 191 (235)
+|+||||++| +|.+.+.... .++++..++.++.||+.||+|||++||+||||||+|||++ .++.++|+|||++..+
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 9999999975 6888776542 5699999999999999999999999999999999999998 5688999999999866
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. .........+++.|+|||++.+ ..++.++|||||||+|
T Consensus 180 ~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil 218 (352)
T d1koba_ 180 N---PDEIVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLG 218 (352)
T ss_dssp C---TTSCEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHH
T ss_pred C---CCCceeeccCcccccCHHHHcC--CCCCCccchHHHHHHH
Confidence 4 2233445668999999999988 4589999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-45 Score=294.64 Aligned_cols=188 Identities=30% Similarity=0.449 Sum_probs=164.9
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++++.||+|+||+||+|++..+|+.||+|++.+..... ......+.+|+.+++.++||||+++++++ .....+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~~~ 116 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSF--KDNSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHHcCCCcEeeccccc--cccccc
Confidence 479999999999999999999999999999999997655433 34445688999999999999999999999 566788
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++|||++.+ +|...+... ..+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+|||+++.+..
T Consensus 117 ~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred ccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 999999975 588888765 5799999999999999999999999999999999999999999999999999986642
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 194 ----~~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvil 228 (350)
T d1rdqe_ 194 ----RTWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLI 228 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred ----ccccccCccccCCHHHHcC--CCCCccccccchhHHH
Confidence 2234568999999999988 4589999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-45 Score=294.22 Aligned_cols=189 Identities=30% Similarity=0.544 Sum_probs=162.8
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
+.++|++++.||+|+||+||+|++..+|+.||+|++..... ...+.+.+|+.++..++||||+++++++ .+.+.
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~ 97 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE----SDKETVRKEIQTMSVLRHPTLVNLHDAF--EDDNE 97 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH----HHHHHHHHHHHHHHHTCCTTBCCEEEEE--EETTE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch----hhHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCE
Confidence 45789999999999999999999999999999999865432 2345688999999999999999999999 45678
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc--CCcEEEeeecccccc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL--DGTLKISDFGVAESL 191 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~~~~ 191 (235)
+|+||||++| +|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||++.. ++.++|+|||++..+
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 9999999975 6888886543 56999999999999999999999999999999999999964 578999999999866
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. .........+|+.|+|||++.+ ..++.++|||||||++
T Consensus 177 ~---~~~~~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvil 215 (350)
T d1koaa2 177 D---PKQSVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLS 215 (350)
T ss_dssp C---TTSCEEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHH
T ss_pred c---cccccceecCcccccCHHHHcC--CCCChhHhhhhhhHHH
Confidence 4 2233445678999999999988 4489999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=284.30 Aligned_cols=191 Identities=25% Similarity=0.423 Sum_probs=154.0
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++.+.||+|+||+||+|+.. ..||+|+++..... ......|.+|+.++.+++||||+++++++. .+.+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~---~~~~ 78 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT--PQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQL 78 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC--TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe---ccEE
Confidence 467899999999999999999764 35999998755433 244567889999999999999999999873 3457
Q ss_pred EEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999997 57999887543 56999999999999999999999999999999999999999999999999999866533
Q ss_pred ccCCcccccCCCCcccCccccCCCC-CCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLP-EISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~slG~~l 235 (235)
..........+|+.|+|||++.+.. ..++.++||||||++|
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l 199 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHH
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHH
Confidence 3333444567899999999986532 3478999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=284.16 Aligned_cols=192 Identities=32% Similarity=0.543 Sum_probs=163.4
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||+|+||+||+|.+..+|+.||+|+++..... ......+.+|+.++++++||||+++++++ .++..+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~--~~~~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVI--HTENKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEE--EETTEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCcEEEecccc--cccccee
Confidence 5899999999999999999999999999999999755432 23456788999999999999999999999 5567899
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
+|||++++++...+.......+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.++.... .
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~ 155 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--P 155 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--C
T ss_pred EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--C
Confidence 99999999888888777668899999999999999999999999999999999999999999999999999975532 2
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+... ..++.++||||||+++
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvil 193 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIF 193 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHH
T ss_pred cccceeecccceeeehhhhccc-cCCCccccccccchhh
Confidence 2334445689999999987662 3468899999999974
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=279.16 Aligned_cols=187 Identities=22% Similarity=0.329 Sum_probs=149.4
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||+|+||+||+|.+. +++.||+|+++... ...+.+.+|+.++.+++||||+++++++. ..+.++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~--~~~~~~ 76 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCL--EQAPIC 76 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-----CcHHHHHHHHHHHHhcCCCCcccccceec--cCCceE
Confidence 57999999999999999999875 56789999886432 33457899999999999999999999994 456789
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ +|.+++.... ..+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++......
T Consensus 77 lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 99999975 6888876553 568899999999999999999999999999999999999999999999999998664221
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........++..|+|||.+.+ ..++.++||||||++|
T Consensus 156 -~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil 192 (263)
T d1sm2a_ 156 -YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLM 192 (263)
T ss_dssp ----------CTTSCCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred -ceeecceecCcccCChHHhcC--CCCCchhhhcchHHHH
Confidence 122233457889999999988 4599999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=284.24 Aligned_cols=190 Identities=33% Similarity=0.500 Sum_probs=162.1
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHH-hcCCCCcceeeeEEEcCCCceE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLK-MLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
++|++++.||+|+||+||+|.+..+++.||+|++++..... ......+..|...+. .++||||+++++++ ..++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~--~~~~~~ 78 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTF--QTKENL 78 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEE--ECSSEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEE--ccCCce
Confidence 57999999999999999999999999999999998755433 233445666776655 68999999999999 566789
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
|+||||+++ +|.+++... ..+++..++.++.|++.||.|||+++++||||||+||+++.+++++|+|||++.....
T Consensus 79 yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~- 155 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 155 (320)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred eEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc-
Confidence 999999975 699888765 6789999999999999999999999999999999999999999999999999985532
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........||+.|+|||.+.+ ..+++++|||||||++
T Consensus 156 -~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil 193 (320)
T d1xjda_ 156 -GDAKTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLL 193 (320)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHH
T ss_pred -ccccccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHH
Confidence 2233444578999999999988 4589999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.5e-45 Score=281.78 Aligned_cols=197 Identities=24% Similarity=0.425 Sum_probs=159.2
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC--
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK-- 111 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (235)
.+.++|++.+.||+|+||+||+|++..+++.||+|+++...... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 45678999999999999999999999999999999997654432 233456889999999999999999999986433
Q ss_pred CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...+|+||||++| +|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++..+++|||.+..
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred CceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence 3468999999975 588887765 6799999999999999999999999999999999999999999999999998875
Q ss_pred cCccc-cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFL-HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... .........|++.|+|||++.+ ..+++++||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvil 204 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVL 204 (277)
T ss_dssp CC----------------TTCCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred hccccccccccccccCcccccCHHHHcC--CCCCcceecccchHHH
Confidence 43221 1223344568999999999987 4589999999999974
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-44 Score=278.61 Aligned_cols=193 Identities=27% Similarity=0.437 Sum_probs=164.8
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCC-----ccccHHHHHHHHHhcC-CCCcceeeeEEEc
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN-----GEINVDREIRLLKMLQ-HRNVIGLVDVFVN 109 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 109 (235)
.++|++.+.||+|+||+||+|++..+++.+|+|++.+........ ....+.+|+.++..+. ||||+++++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 79 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 79 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence 468999999999999999999999999999999998765443211 1235789999999996 99999999999
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
.+++.+|+||||+++ +|.+++... .++++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++
T Consensus 80 ~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 80 ETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhe
Confidence 567789999999975 799999765 67999999999999999999999999999999999999999999999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCC----CCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGL----PEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~~Di~slG~~l 235 (235)
..+.. ........+|+.|+|||.+.+. ...++.++||||||++|
T Consensus 158 ~~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvil 205 (277)
T d1phka_ 158 CQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 205 (277)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred eEccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhh
Confidence 86642 2334456689999999988531 23468899999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=285.44 Aligned_cols=188 Identities=27% Similarity=0.525 Sum_probs=162.4
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
++++|++++.||+|+||+||+|.+..+++.||+|+++... .....+.+|+.+++.++||||+++++++ .+.+.
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~--~~~~~ 75 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESF--ESMEE 75 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEE--EETTE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEE--EECCE
Confidence 5689999999999999999999999999999999997543 2334578999999999999999999999 55678
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC--CcEEEeeecccccc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD--GTLKISDFGVAESL 191 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~--~~~~l~dfg~~~~~ 191 (235)
+|+||||++| +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.+ ..++|+|||++...
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999999975 6998887652 469999999999999999999999999999999999999855 47999999999865
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
. .........+++.|+|||...+ ..++.++|||||||++
T Consensus 155 ~---~~~~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvil 193 (321)
T d1tkia_ 155 K---PGDNFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLV 193 (321)
T ss_dssp C---TTCEEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHH
T ss_pred c---cCCcccccccccccccchhccC--CCCCchhhcccHHHHH
Confidence 3 2233445568899999999987 4589999999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=280.56 Aligned_cols=188 Identities=26% Similarity=0.372 Sum_probs=157.2
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++.++||+|+||+||+|.+. +++.||+|+++... .....+.+|+.++.+++||||+++++++. . +.+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~--~-~~~ 82 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVT--Q-EPI 82 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-SSC
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-----CCHHHHHHHHHHHHhCCCCCEeEEEeeec--c-CCe
Confidence 458999999999999999999875 56789999886432 33456899999999999999999999873 2 356
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++||||+++ +|.+++.......+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||+++.+...
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 899999975 6888776654456999999999999999999999999999999999999999999999999999866421
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........+++.|+|||.+.+ ..++.++||||||++|
T Consensus 163 -~~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl 200 (272)
T d1qpca_ 163 -EYTAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILL 200 (272)
T ss_dssp -CEECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHH
T ss_pred -ccccccccCCcccccChHHHhC--CCCCchhhhhhhHHHH
Confidence 1122234457889999999977 4589999999999974
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-44 Score=282.60 Aligned_cols=192 Identities=23% Similarity=0.346 Sum_probs=145.8
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhh---eeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCR---RAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~---~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
.++|++.+.||+|+||+||+|++..+++. +|+|.+.... .......|.+|+.++..++||||+++++++ ...
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~--~~~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNVIHLEGVV--TKS 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCCccEEEEE--eeC
Confidence 57899999999999999999998776653 5566554322 223445789999999999999999999999 455
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
+.+++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++.+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 678999999976 5777776543 57899999999999999999999999999999999999999999999999999866
Q ss_pred CccccCC---cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDD---TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
....... ......+++.|+|||.+.+ ..++.++|||||||+|
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVM 223 (299)
T ss_dssp -----------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHH
T ss_pred cCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHH
Confidence 4322211 1122346788999999987 4589999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-44 Score=288.33 Aligned_cols=190 Identities=24% Similarity=0.376 Sum_probs=158.6
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHH---HHHHHhcCCCCcceeeeEEEcCCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDRE---IRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
.++|++++.||+|+||+||+|++..+|+.||+|++.+..... ......+.+| +.++..+.||||+++++++ ...
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~--~~~ 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMSYAF--HTP 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-HTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE--ECS
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcch-hhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE--EEC
Confidence 468999999999999999999999999999999997655433 1222234444 5556666899999999999 556
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
+.+|+||||++| +|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..+
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred CEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 789999999975 699888765 67899999999999999999999999999999999999999999999999999865
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.. .......||+.|+|||++... ..++.++|||||||+|
T Consensus 158 ~~----~~~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvil 196 (364)
T d1omwa3 158 SK----KKPHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCML 196 (364)
T ss_dssp SS----SCCCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHH
T ss_pred CC----CcccccccccccchhHHhhcC-CCCCcccchhHHHHHH
Confidence 42 233455699999999998641 3478999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=280.09 Aligned_cols=189 Identities=34% Similarity=0.540 Sum_probs=153.0
Q ss_pred eeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC-CccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEE
Q psy787 41 MGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP-NGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIM 119 (235)
Q Consensus 41 i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 119 (235)
.++.||+|+||+||+|++..+|+.||+|+++........ .....+.+|+.+++.++||||+++++++ ..++.+++||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~--~~~~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF--GHKSNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE--CCTTCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee--ccCCceeehh
Confidence 467899999999999999999999999998765543322 2245688999999999999999999999 5667889999
Q ss_pred ecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccCCc
Q psy787 120 EYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHDDT 199 (235)
Q Consensus 120 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 199 (235)
||+.+++...+... ...+++..+..+++||+.||+|||++|++||||||+||+++.++.+||+|||++...... ...
T Consensus 80 E~~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~ 156 (299)
T d1ua2a_ 80 DFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRA 156 (299)
T ss_dssp ECCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCC
T ss_pred hhhcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC--ccc
Confidence 99988755555433 267899999999999999999999999999999999999999999999999999865422 222
Q ss_pred ccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 200 ITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 200 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.....+|+.|+|||.+.+. ..++.++|||||||++
T Consensus 157 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil 191 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCIL 191 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHH
T ss_pred ccceecChhhccHHHHccC-CCCChhhhhhhcchHH
Confidence 3345689999999998652 3478999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-44 Score=282.39 Aligned_cols=188 Identities=30% Similarity=0.489 Sum_probs=159.0
Q ss_pred eeeceEEeee-eeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEc--
Q psy787 34 KMIGKYVMGD-LLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVN-- 109 (235)
Q Consensus 34 ~~~~~y~i~~-~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-- 109 (235)
.+.++|.+++ .||+|+||+||+|++..+++.||+|+++.. ..+.+|+.++.++ +||||++++++|..
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 3467899886 599999999999999999999999998543 2467899886654 89999999999843
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc---CCcEEEeee
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL---DGTLKISDF 185 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~---~~~~~l~df 185 (235)
.....+|+|||||+| +|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++. .+.++|+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence 235678999999975 7999998765567999999999999999999999999999999999999986 456999999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+++.... ........|++.|+|||++.+ ..++.++|||||||+|
T Consensus 159 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvil 203 (335)
T d2ozaa1 159 GFAKETTS---HNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIM 203 (335)
T ss_dssp TTCEECCC---CCCCCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHH
T ss_pred ceeeeccC---CCccccccCCcccCCcHHHcC--CCCCHHHHHHhhchhH
Confidence 99986542 233445679999999999987 4589999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=282.99 Aligned_cols=194 Identities=26% Similarity=0.400 Sum_probs=156.7
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhh-----heeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEE
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLC-----RRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFV 108 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 108 (235)
-.++|++.+.||+|+||+||+|++..+++ .||+|.+..... ......+.+|+.++.++ +||||+++++++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~- 110 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD---SSEREALMSELKMMTQLGSHENIVNLLGAC- 110 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC---HHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-
Confidence 34689999999999999999998765443 578887754432 24455788999999998 899999999999
Q ss_pred cCCCceEEEEEecccC-CHHHHhhcCCC---------------------CCCCHHhHHHHHHHHHHHHHHHHhCCcccCC
Q psy787 109 NDKKQKMYLIMEYCVG-GLQDMLDSTPY---------------------KKFPIWQAHGYFLQLLDGLEYLHSQGIIHKD 166 (235)
Q Consensus 109 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~d 166 (235)
...+.+++||||+++ +|.+++..... ..+++..++.++.|++.||+|||+++|+|||
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 111 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred -eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 566678999999975 69998876531 3588899999999999999999999999999
Q ss_pred CCCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 167 IKPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 167 l~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|||+||+++.++.+||+|||+++...............+|+.|+|||.+.+ ..++.++|||||||+|
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil 256 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILL 256 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC--CCCCcceeccchhHHH
Confidence 999999999999999999999986643322223334457889999999987 5589999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=276.37 Aligned_cols=196 Identities=31% Similarity=0.484 Sum_probs=162.9
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccch-hhheeeeeeeeccccCCCCccccHHHHHHHHHhc---CCCCcceeeeEEE
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSET-LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML---QHRNVIGLVDVFV 108 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~ 108 (235)
+...++|+++++||+|+||+||+|++..+ ++.||+|+++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~ 80 (305)
T d1blxa_ 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80 (305)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence 34567999999999999999999998765 5678999997765432 3344566788777665 7999999999985
Q ss_pred c---CCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeee
Q psy787 109 N---DKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDF 185 (235)
Q Consensus 109 ~---~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~df 185 (235)
. +....++++||++++++...........+++..++.++.|++.||+|||+++|+||||||+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred ccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecch
Confidence 3 2345789999999988766666666678999999999999999999999999999999999999999999999999
Q ss_pred ccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 186 GVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|++.... .........||+.|+|||.+.+ ..++.++|||||||++
T Consensus 161 g~~~~~~---~~~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il 205 (305)
T d1blxa_ 161 GLARIYS---FQMALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIF 205 (305)
T ss_dssp CSCCCCC---GGGGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHH
T ss_pred hhhhhhc---ccccCCCcccChhhcCcchhcC--CCCChhehhhchHHHH
Confidence 9987553 2234456679999999999988 4489999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=276.29 Aligned_cols=191 Identities=30% Similarity=0.486 Sum_probs=159.6
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCC--CccccHHHHHHHHHhcC--CCCcceeeeEEEcCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIP--NGEINVDREIRLLKMLQ--HRNVIGLVDVFVNDK 111 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~--~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 111 (235)
.++|++.+.||+|+||+||+|++..+|+.||+|++.+....... ....++.+|+.+++.+. ||||+++++++ ..
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~--~~ 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--ER 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE--EC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE--ee
Confidence 46899999999999999999999999999999999876544321 22345778999999986 89999999999 56
Q ss_pred CceEEEEEecccC--CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccC-CcEEEeeeccc
Q psy787 112 KQKMYLIMEYCVG--GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLD-GTLKISDFGVA 188 (235)
Q Consensus 112 ~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~ 188 (235)
.+.+++|||++.+ ++.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccc
Confidence 6789999999965 477777665 679999999999999999999999999999999999999854 78999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.... ........||+.|+|||.+.+. ..++.++|||||||+|
T Consensus 159 ~~~~----~~~~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvil 200 (273)
T d1xwsa_ 159 ALLK----DTVYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILL 200 (273)
T ss_dssp EECC----SSCBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHH
T ss_pred eecc----cccccccccCCCcCCHHHHcCC-CCCCcccccccceeee
Confidence 7543 2233456689999999998762 2346789999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=271.87 Aligned_cols=187 Identities=25% Similarity=0.346 Sum_probs=158.1
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|+++++||+|+||+||++++. +++.||+|+++... .....+.+|+.++.+++||||+++++++ ...+.++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~--~~~~~~~ 75 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVC--TKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-----SCHHHHHHHHHHHHTCCCTTBCCEEEEE--CCSSSEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-----CCHHHHHHHHHHHHhcCCCceeeEEEEE--eeCCceE
Confidence 57889999999999999999974 77889999987543 2335689999999999999999999999 4556799
Q ss_pred EEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
+||||+++ ++..++.... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++..+...
T Consensus 76 iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~- 153 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD- 153 (258)
T ss_dssp EEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-
T ss_pred EEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-
Confidence 99999975 5777655443 67899999999999999999999999999999999999999999999999999865432
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........++..|+|||.+.+ ..++.++||||||+++
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l 191 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLM 191 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred CceeecccCCCCCcCCcHHhcC--CCCCcceeecccchhh
Confidence 2223334558889999999987 4489999999999974
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=276.33 Aligned_cols=192 Identities=23% Similarity=0.372 Sum_probs=149.8
Q ss_pred eceEEeeeeeccccceEEEEeeccchh----hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETL----CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK 111 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (235)
.++|++.+.||+|+||+||+|.+..++ ..||+|.+..... ......+.+|+.++.+++||||+++++++ ..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~~~g~~--~~ 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT---EKQRVDFLGEAGIMGQFSHHNIIRLEGVI--SK 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEE--CS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC---hHHHHHHHHHHHHHHhcCCCCEeeeeEEE--ec
Confidence 357999999999999999999876544 3688998754332 23344688999999999999999999999 45
Q ss_pred CceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...++++||++.++ +.+.+.... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 56789999999765 666655443 6799999999999999999999999999999999999999999999999999986
Q ss_pred cCcccc-CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLH-DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+..... ........++..|+|||.+.+ ..++.++||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil 203 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVM 203 (283)
T ss_dssp --------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHH
T ss_pred ccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHH
Confidence 643211 122223457889999999987 5689999999999974
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=274.89 Aligned_cols=188 Identities=24% Similarity=0.340 Sum_probs=152.9
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceE
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 115 (235)
.++|++.+.||+|+||+||+|++..+ +.||+|+++... .....|.+|+.++.+++|+||+++++++. + +.+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~--~-~~~ 86 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVS--E-EPI 86 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-SSC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-----CCHHHHHHHHHHHHhcccCCEeEEEEEEe--c-CCe
Confidence 57899999999999999999998655 569999986443 33457899999999999999999999983 3 346
Q ss_pred EEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcc
Q psy787 116 YLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMF 194 (235)
Q Consensus 116 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 194 (235)
++||||+++ +|..++.......+++..++.++.|++.||+|||+++++||||||+||+++.++.++|+|||+++.....
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 899999975 5777776655467999999999999999999999999999999999999999999999999999865321
Q ss_pred ccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 195 LHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 195 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.........+++.|+|||.+.. ..++.++||||||++|
T Consensus 167 -~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil 204 (285)
T d1fmka3 167 -EYTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILL 204 (285)
T ss_dssp ----------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred -CceeeccccccccccChHHHhC--CCCCcHHhhhcchHHH
Confidence 1122334558899999999977 5589999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-43 Score=272.81 Aligned_cols=190 Identities=25% Similarity=0.397 Sum_probs=154.7
Q ss_pred ceEEeee-eeccccceEEEEeeccc--hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCc
Q psy787 37 GKYVMGD-LLGEGSYGKVKEMLDSE--TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 37 ~~y~i~~-~ig~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (235)
++|.+.+ +||+|+||+||+|.+.. ++..||+|+++.... ......+.+|+.++.+++||||+++++++. . +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~-~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYIVRLIGVCQ--A-E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--S-S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC---HHHHHHHHHHHHHHHhCCCCCEeeEeeeec--c-C
Confidence 4688888 49999999999997654 345789999865431 234457899999999999999999999983 3 3
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccC
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLD 192 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 192 (235)
.+++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++.+.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 57899999985 6888775443 579999999999999999999999999999999999999999999999999998664
Q ss_pred ccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 193 MFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 193 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... .......+++.|+|||.+.+ ..++.++||||||++|
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l 202 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTM 202 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHH
T ss_pred ccccccccccccccCccccChHHHhC--CCCCccchhhcchHHH
Confidence 32211 22223457889999999977 4589999999999974
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-43 Score=275.64 Aligned_cols=190 Identities=22% Similarity=0.328 Sum_probs=148.3
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhhe----eeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRR----AVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~----~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
..|++++.||+|+||+||+|.+..+|+.+ |+|.++.. ...+....+.+|+.++.+++||||+++++++.+ +
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLT--S 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 46999999999999999999988888754 44444322 223445678999999999999999999999953 2
Q ss_pred ceEEEEEeccc-CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCV-GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
..+++++++. ++|.+.+.... ..+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||+++..
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred -CeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 4567777775 56888777653 67999999999999999999999999999999999999999999999999999866
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.............+++.|+|||.+.+ ..++.++||||||++|
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTV 203 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred ccccccccccccccCccccChHHHhc--CCCChhhhhhhHHHHH
Confidence 43223333334457899999999987 4589999999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=273.52 Aligned_cols=184 Identities=25% Similarity=0.344 Sum_probs=149.1
Q ss_pred eeeccccceEEEEeec--cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEEEe
Q psy787 43 DLLGEGSYGKVKEMLD--SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLIME 120 (235)
Q Consensus 43 ~~ig~g~~~~v~~~~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 120 (235)
++||+|+||+||+|.+ ..+++.||+|+++..... ......+.+|+.++++++||||+++++++. . +.+++|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~g~~~--~-~~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGICE--A-ESWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--S-SSEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC--HHHHHHHHHHHHHHHhCCCCCCceEEEEec--c-CCEEEEEE
Confidence 4699999999999974 345678999998654322 234457899999999999999999999983 3 34689999
Q ss_pred cccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccccC-C
Q psy787 121 YCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLHD-D 198 (235)
Q Consensus 121 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~ 198 (235)
|+++ +|.+++... ..+++..++.++.|++.||+|||+++++||||||+||+++.++.++++|||+++.+...... .
T Consensus 88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9975 698888776 67999999999999999999999999999999999999999999999999999865432221 1
Q ss_pred cccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 199 TITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 199 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 166 ~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l 200 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLM 200 (277)
T ss_dssp C----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHH
T ss_pred cccccCCCceecCchhhcC--CCCCchhhhccchhhh
Confidence 2223457889999999987 4589999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-42 Score=270.07 Aligned_cols=190 Identities=32% Similarity=0.505 Sum_probs=157.8
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|+++++||+|+||+||+|++. +++.||+|+++..... ......+.+|+.++++++||||+++++.+. ..+..+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~ 76 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYDVIH--TKKRLV 76 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG--GCCCHHHHHHHHGGGGCCCTTBCCEEEEEE--CSSCEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCcEEeeeeecc--cCCcee
Confidence 58999999999999999999885 7799999999765433 244567889999999999999999999994 556789
Q ss_pred EEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc
Q psy787 117 LIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH 196 (235)
Q Consensus 117 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 196 (235)
++++++.+++...+.... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++++|||.+..... .
T Consensus 77 i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~ 153 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--P 153 (286)
T ss_dssp EEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc--C
Confidence 999999988666665433 7799999999999999999999999999999999999999999999999999986542 1
Q ss_pred CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+. ..+++++||||||+++
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l 191 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIF 191 (286)
T ss_dssp --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHH
T ss_pred ccccceecccchhhhHHHHhCC-CCCCcceeehhcCcHH
Confidence 2233344588899999998762 3478999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=277.20 Aligned_cols=192 Identities=34% Similarity=0.513 Sum_probs=156.6
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC-
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK- 111 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 111 (235)
....++|+++++||+|+||+||+|.+..+|+.||+|+++..... ......+.+|+.+++.++||||++++++|...+
T Consensus 14 ~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 14 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS--HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred eecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC--hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 34678999999999999999999999999999999998754322 233456889999999999999999999995332
Q ss_pred ---CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccc
Q psy787 112 ---KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVA 188 (235)
Q Consensus 112 ---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 188 (235)
...+|+|||+++.+|...... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++++|||++
T Consensus 92 ~~~~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ccccceEEEEEecccccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccce
Confidence 235799999997777777655 56999999999999999999999999999999999999999999999999999
Q ss_pred cccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...+ .......+++.|+|||.+.+. ..++.++|||||||+|
T Consensus 169 ~~~~-----~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil 209 (346)
T d1cm8a_ 169 RQAD-----SEMTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIM 209 (346)
T ss_dssp EECC-----SSCCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHH
T ss_pred eccC-----CccccccccccccCHHHHcCC-CCCCccchhhcchHHH
Confidence 8654 233456689999999998652 3478999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=270.78 Aligned_cols=198 Identities=28% Similarity=0.526 Sum_probs=159.4
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC---
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND--- 110 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 110 (235)
...++|+++++||+|+||+||+|++..+|+.||+|++...... ......+.+|+.+++.++|+|++++++++...
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT--TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 3468999999999999999999999999999999998765443 24456688999999999999999999998532
Q ss_pred ---CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecc
Q psy787 111 ---KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGV 187 (235)
Q Consensus 111 ---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 187 (235)
....++++||++++++....... ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||+
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ccccCceEEEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecce
Confidence 23468999999988766655433 36789999999999999999999999999999999999999999999999999
Q ss_pred ccccCcccc--CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 188 AESLDMFLH--DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 188 ~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+..+..... ........+|+.|+|||.+.+. ..+++++|||||||++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil 212 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIM 212 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHH
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCcee
Confidence 975532111 1222334589999999998762 2478999999999974
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-41 Score=265.89 Aligned_cols=190 Identities=19% Similarity=0.274 Sum_probs=159.9
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCC-CCcceeeeEEEcCCCc
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH-RNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 113 (235)
+.++|++.++||+|+||+||+|++..+|+.||+|++.... ....+.+|++.+..+.| +|++.+++++ ....
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~------~~~~~~~e~~~~~~l~~~~~i~~~~~~~--~~~~ 74 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFG--QEGL 74 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTTCCCEEEEE--EETT
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc------CcHHHHHHHHHHHHhcCCCCCCEEEEEe--ecCC
Confidence 4578999999999999999999999999999999875543 22357889999999975 8999999988 4566
Q ss_pred eEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc-----CCcEEEeeeccc
Q psy787 114 KMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL-----DGTLKISDFGVA 188 (235)
Q Consensus 114 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~-----~~~~~l~dfg~~ 188 (235)
..++|||+++++|.+.+.... ..++...+..++.|++.||++||++|++||||||+||+++. .+.++|+|||++
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ccEEEEEecCCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 889999999999998887653 57899999999999999999999999999999999999974 567999999999
Q ss_pred cccCccccC-----CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 189 ESLDMFLHD-----DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 189 ~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.+...... .......||+.|+|||.+.+ ..+++++||||||+++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l 203 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVF 203 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHH
Confidence 866422111 12334568999999999988 4489999999999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=268.18 Aligned_cols=190 Identities=23% Similarity=0.354 Sum_probs=143.5
Q ss_pred eceEEeeeeeccccceEEEEeeccchhh---heeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLC---RRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
.++|++.+.||+|+||+||+|.+..++. .||+|.++... .......+.+|+.++++++||||+++++++. .
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT---E 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---S
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---c
Confidence 3689999999999999999998765543 45666553222 2233457899999999999999999999983 3
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
+.+++|||++++ ++.+++.... ..+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++.+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 467999999976 5777665543 67899999999999999999999999999999999999999999999999999865
Q ss_pred CccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... .........+++.|+|||.+.+ ..++.++||||||++|
T Consensus 159 ~~~-~~~~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil 199 (273)
T d1mp8a_ 159 EDS-TYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCM 199 (273)
T ss_dssp -------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHH
T ss_pred cCC-cceeccceecCcccchhhHhcc--CCCCCccccccchHHH
Confidence 421 1222334457889999999987 4589999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=272.00 Aligned_cols=186 Identities=30% Similarity=0.480 Sum_probs=155.1
Q ss_pred eEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEc----CCCc
Q psy787 38 KYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVN----DKKQ 113 (235)
Q Consensus 38 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 113 (235)
+|+.+++||+|+||+||+|++..+|+.||+|+++.... ...+|+.++++++|+||+++++++.. .+..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 79999999999999999999999999999999865431 23479999999999999999999853 2344
Q ss_pred eEEEEEecccCCHHHHhhc--CCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-cEEEeeeccccc
Q psy787 114 KMYLIMEYCVGGLQDMLDS--TPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-TLKISDFGVAES 190 (235)
Q Consensus 114 ~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~ 190 (235)
++++||||+++++...+.. .....+++..++.+++|++.||+|||++||+||||||+||+++.++ .++|+|||++..
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 6899999999876555432 2336799999999999999999999999999999999999999775 899999999986
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.. ........+++.|+|||.+.+. ..++.++|||||||++
T Consensus 173 ~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il 213 (350)
T d1q5ka_ 173 LVR---GEPNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVL 213 (350)
T ss_dssp CCT---TSCCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHH
T ss_pred ccC---CcccccccccccccChHHhhcc-cCCCcceeecccceEE
Confidence 542 2333455689999999988652 3589999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-41 Score=270.45 Aligned_cols=192 Identities=27% Similarity=0.492 Sum_probs=159.7
Q ss_pred CCceeEeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeE
Q psy787 28 NKTIKVKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDV 106 (235)
Q Consensus 28 ~~~~~~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~ 106 (235)
...+.....++|+++++||+|+||+||+|++..+++.||+|+++... ..++.+|+.++..+. ||||++++++
T Consensus 26 ~~~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~ 98 (328)
T d3bqca1 26 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADI 98 (328)
T ss_dssp GCCCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred hcccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEE
Confidence 33444445689999999999999999999999999999999986432 346889999999995 9999999999
Q ss_pred EEcCCCceEEEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCC-cEEEee
Q psy787 107 FVNDKKQKMYLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDG-TLKISD 184 (235)
Q Consensus 107 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~-~~~l~d 184 (235)
+.......+++|||+++++ |.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|
T Consensus 99 ~~~~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~D 173 (328)
T d3bqca1 99 VKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLID 173 (328)
T ss_dssp EECTTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEecCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecc
Confidence 9655667899999999875 54432 4689999999999999999999999999999999999998665 589999
Q ss_pred eccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||++..... ........+++.|+|||.+.+. ..++.++||||||+++
T Consensus 174 FG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l 220 (328)
T d3bqca1 174 WGLAEFYHP---GQEYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCML 220 (328)
T ss_dssp GGGCEECCT---TCCCCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHH
T ss_pred cccceeccC---CCcccccccCccccCcccccCC-CCCCcccchhhhhhhh
Confidence 999986542 2234455688999999998763 3478999999999974
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=270.05 Aligned_cols=194 Identities=26% Similarity=0.387 Sum_probs=148.8
Q ss_pred eceEEeeeeeccccceEEEEeeccc-----hhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEc
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSE-----TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVN 109 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (235)
.++|++.++||+|+||+||+|.+.. +++.||+|+++..... .....+..|...+.++ .|+||+.+++.+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~- 87 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVNLLGACT- 87 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc---HHHHHHHHHHHHHHhhcCCCeEEEeeeeec-
Confidence 3689999999999999999998543 4567899988654322 2334577788777776 6889999999885
Q ss_pred CCCceEEEEEecccC-CHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEE
Q psy787 110 DKKQKMYLIMEYCVG-GLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLL 174 (235)
Q Consensus 110 ~~~~~~~lv~e~~~~-~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili 174 (235)
..+..++++|||+++ +|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+||++
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 334568999999974 6888886542 2358899999999999999999999999999999999999
Q ss_pred ccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 175 TLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 175 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+.++.+||+|||+++...............+|+.|+|||.+.+ ..++.++||||||+++
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil 226 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLL 226 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc--CCCCcccceeehHHHH
Confidence 9999999999999986643333333444568899999999987 5589999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-42 Score=273.61 Aligned_cols=198 Identities=29% Similarity=0.433 Sum_probs=157.1
Q ss_pred cCCceeEe---eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCccee
Q psy787 27 DNKTIKVK---MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGL 103 (235)
Q Consensus 27 ~~~~~~~~---~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 103 (235)
.+..+++. +.++|+++++||+|+||+||+|++..+|+.||+|++...... .....++.+|+.++.+++||||+++
T Consensus 4 ~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~~ 81 (355)
T d2b1pa1 4 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIISL 81 (355)
T ss_dssp EEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS--HHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred EEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC--HHHHHHHHHHHHHHHhcCCCCeeEE
Confidence 34555564 347899999999999999999999999999999999765432 2334568899999999999999999
Q ss_pred eeEEEcC----CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc
Q psy787 104 VDVFVND----KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT 179 (235)
Q Consensus 104 ~~~~~~~----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~ 179 (235)
++++... ....+|+||||+.+++...+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.
T Consensus 82 ~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~ 157 (355)
T d2b1pa1 82 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 157 (355)
T ss_dssp SEEECSCCSTTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred EEEEecccccccCceeEEEEeccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc
Confidence 9999533 346899999999988777664 45899999999999999999999999999999999999999999
Q ss_pred EEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 180 LKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
++++|||++.... .........+|+.|+|||.+.+ ..+++++||||+||++
T Consensus 158 ~kl~df~~~~~~~---~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l 208 (355)
T d2b1pa1 158 LKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIM 208 (355)
T ss_dssp EEECCCCC------------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHH
T ss_pred eeeechhhhhccc---cccccccccccccccChhhhcC--CCCCCCcccccccchH
Confidence 9999999987554 2334445568899999999988 4589999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-42 Score=270.63 Aligned_cols=195 Identities=28% Similarity=0.419 Sum_probs=163.6
Q ss_pred eceEEeeeeeccccceEEEEeec---cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCC-CCcceeeeEEEcCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLD---SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQH-RNVIGLVDVFVNDK 111 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~---~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 111 (235)
.++|+++++||+|+||+||+|++ ..+|+.||+|+++...........+.+.+|+.++.+++| |||+++++.+ .+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~--~~ 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF--QT 100 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE--EE
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee--cc
Confidence 37899999999999999999986 446889999999876654444556678899999999977 8999999999 56
Q ss_pred CceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccc
Q psy787 112 KQKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAES 190 (235)
Q Consensus 112 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 190 (235)
...++++||++.+ +|.+.+... ..+++..+..++.||+.||.|+|+++++||||||+||+++.++.++|+|||++..
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 6789999999975 688888776 5678999999999999999999999999999999999999999999999999986
Q ss_pred cCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 191 LDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+... .........+++.|+|||.+.+.+..++.++|||||||+|
T Consensus 179 ~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iL 222 (322)
T d1vzoa_ 179 FVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 222 (322)
T ss_dssp CCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHH
T ss_pred hccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHH
Confidence 6432 2223345568899999999977555678899999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-41 Score=264.28 Aligned_cols=193 Identities=23% Similarity=0.314 Sum_probs=157.2
Q ss_pred EeeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 33 VKMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 33 ~~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
.+..++|++++.||+|+||+||+|++..+|+.||+|++.... ....+..|+.+++.++|++++..+..+. ...
T Consensus 3 ~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~------~~~~~~~E~~i~~~l~~~~~i~~~~~~~-~~~ 75 (299)
T d1ckia_ 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTIRWCG-AEG 75 (299)
T ss_dssp CEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT------TSCCHHHHHHHHHHSTTSTTCCCEEEEE-EET
T ss_pred CeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc------cCHHHHHHHHHHHHccCCCcccEEEEEE-ecC
Confidence 345678999999999999999999999999999999876543 2235789999999998877666655543 345
Q ss_pred ceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEcc---CCcEEEeeecccc
Q psy787 113 QKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTL---DGTLKISDFGVAE 189 (235)
Q Consensus 113 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~---~~~~~l~dfg~~~ 189 (235)
...++|||++++++...+.... ..+++..+..++.|++.||+|||++||+||||||+||++.. +..++++|||++.
T Consensus 76 ~~~~ivme~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 76 DYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp TEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred CEEEEEEEEcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 6789999999998877776543 67999999999999999999999999999999999999864 3469999999998
Q ss_pred ccCccccC-----CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHD-----DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
.+...... .......||+.|+|||.+.+ ..+++++||||||+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l 203 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVL 203 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHH
Confidence 66432211 12234468999999999988 4489999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=270.22 Aligned_cols=194 Identities=30% Similarity=0.457 Sum_probs=157.1
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCC---
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDK--- 111 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 111 (235)
+..+|+++++||+|+||+||+|++..+|+.||+|++.+... ......+.+|+.+++.++|||++++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC---HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC---hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 34689999999999999999999999999999999865431 233446789999999999999999999985322
Q ss_pred CceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 112 KQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 112 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
...++++++.++++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 234677777777889999876 46899999999999999999999999999999999999999999999999999865
Q ss_pred Ccccc-CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLH-DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
..... ........+++.|+|||.+... ..++.++||||+|+++
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il 203 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCIL 203 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHH
T ss_pred cCCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCcee
Confidence 32211 1223445688899999998552 3478899999999974
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-42 Score=268.95 Aligned_cols=193 Identities=23% Similarity=0.332 Sum_probs=158.2
Q ss_pred eceEEeeeeeccccceEEEEeecc-----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDS-----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
.++|++.+.||+|+||+||+|+.. .+++.||+|+++.... ......+.+|+.++++++|||++++++.+ .
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~E~~il~~l~h~niv~~~~~~--~ 86 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEFDNPNIVKLLGVC--A 86 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEE--C
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC---hHHHHHHHHHHHHHHhcCCCCcccceeee--c
Confidence 357999999999999999999753 3567899998864332 23345789999999999999999999999 4
Q ss_pred CCceEEEEEeccc-CCHHHHhhcCC----------------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCC
Q psy787 111 KKQKMYLIMEYCV-GGLQDMLDSTP----------------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDI 167 (235)
Q Consensus 111 ~~~~~~lv~e~~~-~~l~~~~~~~~----------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 167 (235)
.....+++||+++ |+|.+++.... ...++...++.++.|++.||+|||+++++||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 5667899999997 46888886432 234788899999999999999999999999999
Q ss_pred CCCCeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 168 KPGNLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 168 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||+||+++.++.+||+|||+++.+.............+++.|+|||.+.+ ..++.++||||||++|
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl 232 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVL 232 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhH
Confidence 99999999999999999999986643333333344567888999999987 4599999999999974
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=266.44 Aligned_cols=185 Identities=26% Similarity=0.383 Sum_probs=150.0
Q ss_pred eeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCce
Q psy787 35 MIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 35 ~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (235)
..++|++.++||+|+||.||+|+. .|+.||+|+++.. ...+.+.+|+.++.+++||||+++++++.+. .+.
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~ 75 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGG 75 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---C
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCc
Confidence 456799999999999999999987 4678999998643 3345689999999999999999999998633 345
Q ss_pred EEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCc
Q psy787 115 MYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDM 193 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 193 (235)
+++||||+++ +|.+++.......+++..++.++.|++.||.|||+.+++||||||+||+++.++.++++|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 7999999975 699888765445689999999999999999999999999999999999999999999999999975432
Q ss_pred cccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 194 FLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 194 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
......++..|+|||.+.+ ..+++++||||||+++
T Consensus 156 -----~~~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il 190 (262)
T d1byga_ 156 -----TQDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILL 190 (262)
T ss_dssp -----------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred -----CCccccccccCCChHHHhC--CCCChHHHHHhHHHHH
Confidence 2233456788999999977 4589999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-41 Score=262.62 Aligned_cols=190 Identities=28% Similarity=0.498 Sum_probs=159.7
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMY 116 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 116 (235)
++|++++.||+|+||+||+|++..+++.||+|+++..... ......+.+|+.+++.++|+||+++++++ ......+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~--~~~~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS--TTHHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC--hHHHHHHHHHHHHHHhcCcCCEEeecccc--cccccee
Confidence 5899999999999999999999999999999999765432 34456788999999999999999999999 5566889
Q ss_pred EEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCccc
Q psy787 117 LIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFL 195 (235)
Q Consensus 117 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 195 (235)
++++++.++ +..++... +.+++..++.++.|++.||+|||++||+||||||+||+++.++.++++|||.+......
T Consensus 78 iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~- 154 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154 (292)
T ss_dssp EEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC-
T ss_pred EEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC-
Confidence 999999876 55444443 67899999999999999999999999999999999999999999999999999866421
Q ss_pred cCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 196 HDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 196 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|.|||.+.+. ..++.++|||||||++
T Consensus 155 -~~~~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il 192 (292)
T d1unla_ 155 -VRCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIF 192 (292)
T ss_dssp -CSCCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHH
T ss_pred -CccceeeccccchhhhhHhccC-CCCCchhhccccchHH
Confidence 2223334467789999988762 3468899999999974
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=267.54 Aligned_cols=192 Identities=24% Similarity=0.375 Sum_probs=153.7
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEEEcCCCce
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVFVNDKKQK 114 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 114 (235)
.++|++.++||+|+||+||+|.+..++..+++++........ ....+.+.+|+.++.++ +||||+++++++. ..+.
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~~ 85 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGY 85 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE--ETTE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEe--cCCe
Confidence 478999999999999999999998887754444333222222 24456799999999998 7999999999995 4568
Q ss_pred EEEEEecccC-CHHHHhhcC--------------CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCc
Q psy787 115 MYLIMEYCVG-GLQDMLDST--------------PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGT 179 (235)
Q Consensus 115 ~~lv~e~~~~-~l~~~~~~~--------------~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~ 179 (235)
+++||||+++ +|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||+++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 9999999974 699888654 2357899999999999999999999999999999999999999999
Q ss_pred EEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 180 LKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
+||+|||+++.... ........++..|+|||.+.+ ..++.++||||||+++
T Consensus 166 ~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil 216 (309)
T d1fvra_ 166 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLL 216 (309)
T ss_dssp EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHH
T ss_pred eEEccccccccccc---cccccceecCCcccchHHhcc--CCCCccceeehhHHHH
Confidence 99999999975542 122233457889999999977 5589999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=265.18 Aligned_cols=193 Identities=28% Similarity=0.377 Sum_probs=146.4
Q ss_pred eceEEeeeeeccccceEEEEeeccch---hhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSET---LCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK 112 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (235)
.++|++.+.||+|+||+||+|+.... ...||+|++++..... .+....+.+|+.++.+++||||+++++++. +
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~--~- 82 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVL--T- 82 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--e-
Confidence 46799999999999999999975432 2468899887665433 344457899999999999999999999994 3
Q ss_pred ceEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccccc
Q psy787 113 QKMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESL 191 (235)
Q Consensus 113 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 191 (235)
+.+++||||+++ ++.+.+.... ..+++..++.++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.+
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 356899999975 6777766543 56999999999999999999999999999999999999999999999999999866
Q ss_pred CccccC-CcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 192 DMFLHD-DTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 192 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
...... .......++..|+|||.+.+ ..++.++||||||++|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil 204 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTL 204 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHH
T ss_pred ccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHH
Confidence 432221 12223346778999999987 4589999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=263.73 Aligned_cols=195 Identities=28% Similarity=0.443 Sum_probs=156.1
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchh-------hheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeee
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETL-------CRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVD 105 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 105 (235)
...++|++.+.||+|+||.||+|++..++ ..||+|+++.... ......+.+|...+.++ +||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC---hHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 34568999999999999999999865443 4689998865432 23345678888888888 8999999999
Q ss_pred EEEcCCCceEEEEEecccC-CHHHHhhcCC--------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q psy787 106 VFVNDKKQKMYLIMEYCVG-GLQDMLDSTP--------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPG 170 (235)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~ 170 (235)
++ ...+.+++||||+.+ +|.+++.... ...+++..++.++.|++.||+|||+.+++||||||+
T Consensus 87 ~~--~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 87 AC--TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EE--CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred cc--ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 99 456678999999975 6888887553 245899999999999999999999999999999999
Q ss_pred CeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 171 NLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 171 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||+++.++.++|+|||++................+++.|+|||.+.+ ..++.++||||||+++
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl 227 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLL 227 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHH
Confidence 99999999999999999987754444444455668889999999977 5599999999999974
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-41 Score=263.60 Aligned_cols=195 Identities=26% Similarity=0.385 Sum_probs=160.8
Q ss_pred eeeceEEeeeeeccccceEEEEeec-----cchhhheeeeeeeeccccCCCCccccHHHHHHHHHhc-CCCCcceeeeEE
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLD-----SETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKML-QHRNVIGLVDVF 107 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 107 (235)
...++|++.+.||+|+||.||+|.. ..+++.||+|+++.... ......+.+|+.++..+ +||||+++++++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH---LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC---HHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 3457999999999999999999964 35678899999865432 23345688999999999 699999999999
Q ss_pred EcCCCceEEEEEecccC-CHHHHhhcCC----------------CCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q psy787 108 VNDKKQKMYLIMEYCVG-GLQDMLDSTP----------------YKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPG 170 (235)
Q Consensus 108 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~ 170 (235)
.....++++|||+++ +|.+++.... ...+++..+..++.|++.||+|||+++++||||||+
T Consensus 97 --~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 97 --TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp --CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred --eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 556678999999975 6888876542 235889999999999999999999999999999999
Q ss_pred CeEEccCCcEEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 171 NLLLTLDGTLKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 171 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
||+++.++.++++|||.++...............+++.|+|||.+.+ ..++.++||||||++|
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l 237 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFL 237 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHH
Confidence 99999999999999999986653322233334457889999999977 5589999999999974
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-40 Score=257.40 Aligned_cols=187 Identities=22% Similarity=0.299 Sum_probs=149.7
Q ss_pred eeeeccccceEEEEeeccchh---hheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCCceEEEE
Q psy787 42 GDLLGEGSYGKVKEMLDSETL---CRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKKQKMYLI 118 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 118 (235)
.++||+|+||+||+|.+..++ ..||+|.++... .......+.+|+.++.+++||||+++++++.. ..+..++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC---CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE-TTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe-cCCceEEE
Confidence 578999999999999876543 247888775322 12344679999999999999999999999863 34578999
Q ss_pred EecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeeccccccCcccc-
Q psy787 119 MEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAESLDMFLH- 196 (235)
Q Consensus 119 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 196 (235)
|||+++ +|.+++... ....+...++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999986 577766654 35678888999999999999999999999999999999999999999999999986532211
Q ss_pred -CCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 197 -DDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 197 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
........+++.|+|||.+.+ ..++.++||||||++|
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl 224 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLL 224 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred cceecccccccccccChHHHhc--CCCCChhHhhhhHHHH
Confidence 112223457889999999877 5589999999999974
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=259.29 Aligned_cols=193 Identities=25% Similarity=0.315 Sum_probs=159.4
Q ss_pred eceEEeeeeeccccceEEEEeecc-----chhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDS-----ETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND 110 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (235)
.++|++.+.||+|+||+||+|.+. .+++.||+|+++... .......+.+|+.++.+++||||+++++++ .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~--~ 93 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVV--S 93 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE--C
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE--e
Confidence 468999999999999999999875 345789999886432 123345688999999999999999999999 4
Q ss_pred CCceEEEEEecccC-CHHHHhhcC--------CCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEE
Q psy787 111 KKQKMYLIMEYCVG-GLQDMLDST--------PYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLK 181 (235)
Q Consensus 111 ~~~~~~lv~e~~~~-~l~~~~~~~--------~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~ 181 (235)
.....++|||++++ +|.+++... ....++...+..++.|++.||.|||+++++||||||+||+++.++++|
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 55678999999975 687776532 123578889999999999999999999999999999999999999999
Q ss_pred EeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 182 ISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+|||+++.+.............+++.|+|||.+.+ ..++.++||||||++|
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il 225 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVL 225 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHcc--CCCCcccccccHHHHH
Confidence 999999987654433334444567899999999987 4588999999999874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=263.44 Aligned_cols=191 Identities=35% Similarity=0.524 Sum_probs=153.9
Q ss_pred eeeceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcC---
Q psy787 34 KMIGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVND--- 110 (235)
Q Consensus 34 ~~~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 110 (235)
...++|+++++||+|+||+||+|++..+|+.||+|+++..... ......+.+|+.+++.++|+|++++++++...
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence 3467899999999999999999999999999999998754322 13334678999999999999999999998421
Q ss_pred -CCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 111 -KKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 111 -~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
+...++++++..+++|.+++.. .++++..++.++.||+.||.|||++||+||||||+||+++.++.++++|||.+.
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred ccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhc
Confidence 2234566666556779988854 569999999999999999999999999999999999999999999999999997
Q ss_pred ccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 190 SLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
... .......+++.|+|||...+. ..++.++||||||+++
T Consensus 170 ~~~-----~~~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l 209 (348)
T d2gfsa1 170 HTD-----DEMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIM 209 (348)
T ss_dssp CCT-----GGGSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHH
T ss_pred ccC-----cccccccccccccCchhhcCC-ccCCcccchhhhhHHH
Confidence 543 233345577889999987652 3468899999999974
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-40 Score=257.89 Aligned_cols=190 Identities=26% Similarity=0.361 Sum_probs=149.5
Q ss_pred eceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEEcCCC--c
Q psy787 36 IGKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFVNDKK--Q 113 (235)
Q Consensus 36 ~~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~ 113 (235)
..+|.+.+.||+|+||+||+|+. +|+.||+|+++.... .......|+..+..++||||+++++++..+.. .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 35789999999999999999986 678999998854321 11223455556667899999999999975433 3
Q ss_pred eEEEEEecccC-CHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh--------CCcccCCCCCCCeEEccCCcEEEee
Q psy787 114 KMYLIMEYCVG-GLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS--------QGIIHKDIKPGNLLLTLDGTLKISD 184 (235)
Q Consensus 114 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~--------~~i~H~dl~p~nili~~~~~~~l~d 184 (235)
.+++||||+++ +|.+++.. ..+++..++.++.|++.||.|+|+ +||+||||||+||+++.++.+||+|
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 68999999965 79999876 458999999999999999999996 5899999999999999999999999
Q ss_pred eccccccCcccc--CCcccccCCCCcccCccccCCCCC----CCCCcccEEEeeeeC
Q psy787 185 FGVAESLDMFLH--DDTITTSQGSPVFQAPEIANGLPE----ISGYKVDIWSSGVTL 235 (235)
Q Consensus 185 fg~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~----~~~~~~Di~slG~~l 235 (235)
||+++....... ........+|+.|+|||.+.+... .++.++||||||++|
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl 208 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHH
Confidence 999986632211 122334568999999999875321 256789999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-36 Score=240.47 Aligned_cols=197 Identities=27% Similarity=0.411 Sum_probs=155.5
Q ss_pred cCCceeEeee-ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC---------
Q psy787 27 DNKTIKVKMI-GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ--------- 96 (235)
Q Consensus 27 ~~~~~~~~~~-~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------- 96 (235)
.|..+++.+. ++|+++++||+|+||+||+|++..+|+.||+|++++... ....+.+|+++++.+.
T Consensus 2 ~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-----~~~~~~~Ei~~l~~l~~~~~~~~~~ 76 (362)
T d1q8ya_ 2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-----YTEAAEDEIKLLQRVNDADNTKEDS 76 (362)
T ss_dssp CCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-----HHHHHHHHHHHHHHHHHTCCSHHHH
T ss_pred CCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-----chHHHHHHHHHHHHhcchhhhhhhh
Confidence 3445566554 579999999999999999999999999999999875432 1235678888887764
Q ss_pred --CCCcceeeeEEEcCCCceEEEEEeccc--CCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-CCcccCCCCCCC
Q psy787 97 --HRNVIGLVDVFVNDKKQKMYLIMEYCV--GGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS-QGIIHKDIKPGN 171 (235)
Q Consensus 97 --h~~i~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~n 171 (235)
|+||+++++++........+.++.++. ++............+++..+..++.|++.||+|||+ .||+||||||+|
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N 156 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence 578999998885555555666666654 345555555555789999999999999999999998 899999999999
Q ss_pred eEEccCCc------EEEeeeccccccCccccCCcccccCCCCcccCccccCCCCCCCCCcccEEEeeeeC
Q psy787 172 LLLTLDGT------LKISDFGVAESLDMFLHDDTITTSQGSPVFQAPEIANGLPEISGYKVDIWSSGVTL 235 (235)
Q Consensus 172 ili~~~~~------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 235 (235)
|+++.++. ++++|||.+..... ......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il 219 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLG--APWGCGADIWSTACLI 219 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHH
T ss_pred eeeeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccc--cCCCccccccchHHHH
Confidence 99987653 99999999875432 2234568899999999887 4589999999999974
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=4.1e-25 Score=161.38 Aligned_cols=137 Identities=20% Similarity=0.194 Sum_probs=104.3
Q ss_pred EEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCC--------------ccccHHHHHHHHHhcCCCCcceee
Q psy787 39 YVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPN--------------GEINVDREIRLLKMLQHRNVIGLV 104 (235)
Q Consensus 39 y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~ 104 (235)
+.+.++||+|+||+||+|.+. +|+.||+|+++......... .......|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999874 68899999886543221100 012234677888899999998887
Q ss_pred eEEEcCCCceEEEEEecccCCHHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHhCCcccCCCCCCCeEEccCCcEEEee
Q psy787 105 DVFVNDKKQKMYLIMEYCVGGLQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHSQGIIHKDIKPGNLLLTLDGTLKISD 184 (235)
Q Consensus 105 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~nili~~~~~~~l~d 184 (235)
+.. .. +++||++++.... .++...+..++.|++.++.+||+.|++||||||+||++++ +.++|+|
T Consensus 81 ~~~--~~----~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~~~~liD 145 (191)
T d1zara2 81 AWE--GN----AVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIID 145 (191)
T ss_dssp EEE--TT----EEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-TEEEECC
T ss_pred Eec--CC----EEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-CCEEEEE
Confidence 664 22 7999999875321 2344566789999999999999999999999999999985 4589999
Q ss_pred ecccccc
Q psy787 185 FGVAESL 191 (235)
Q Consensus 185 fg~~~~~ 191 (235)
||.+...
T Consensus 146 FG~a~~~ 152 (191)
T d1zara2 146 FPQSVEV 152 (191)
T ss_dssp CTTCEET
T ss_pred CCCcccC
Confidence 9998744
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.68 E-value=3.1e-07 Score=68.43 Aligned_cols=138 Identities=15% Similarity=0.122 Sum_probs=86.3
Q ss_pred ceEEeeeeeccccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCCceE
Q psy787 37 GKYVMGDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 37 ~~y~i~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 115 (235)
..|++++..+-++.+.||++.. .++.+++|....... .....+.+|...+..+. +-.+++++... ...+..
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~----~~~~~~~~E~~~l~~l~~~vpvP~vl~~~--~~~~~~ 85 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFE--RHDGWS 85 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEE--EETTEE
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcc----cchhhHHHHHHHHHHHhccCCCCcEEEEE--ecCCce
Confidence 4667777655455678998753 445667776654432 22335778988888774 33456777666 445678
Q ss_pred EEEEecccCC-HHHHhhcCCCCCCCHHhHHHHHHHHHHHHHHHHh-----------------------------------
Q psy787 116 YLIMEYCVGG-LQDMLDSTPYKKFPIWQAHGYFLQLLDGLEYLHS----------------------------------- 159 (235)
Q Consensus 116 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~----------------------------------- 159 (235)
++||++.+|. +.+..... .....++.++...++.||+
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999885 43322111 1122233344444444442
Q ss_pred ------------------C------CcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 160 ------------------Q------GIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 160 ------------------~------~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
. .++|+|+.|.||++++++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 26899999999999866556799999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.35 E-value=5.8e-06 Score=65.23 Aligned_cols=79 Identities=16% Similarity=-0.007 Sum_probs=47.3
Q ss_pred eeeeccccceEEEEeeccchhhheeeeeeeecccc---CCCCccccHHHHHHHHHhcC-C--CCcceeeeEEEcCCCceE
Q psy787 42 GDLLGEGSYGKVKEMLDSETLCRRAVKIFKKKKLQ---RIPNGEINVDREIRLLKMLQ-H--RNVIGLVDVFVNDKKQKM 115 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~~ 115 (235)
.+.||.|....||++.+..+++.+++|.-.+.... .+.....+...|...+..+. + ..+++++.+. +.. .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~--~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEM--A 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTT--T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCC--C
Confidence 35689899999999988777888888855432111 11223334566888887663 2 3455555443 443 3
Q ss_pred EEEEecccC
Q psy787 116 YLIMEYCVG 124 (235)
Q Consensus 116 ~lv~e~~~~ 124 (235)
+++||++++
T Consensus 107 ~lvmE~L~~ 115 (392)
T d2pula1 107 VTVMEDLSH 115 (392)
T ss_dssp EEEECCCTT
T ss_pred EEEEeccCC
Confidence 789999976
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=1.7e-05 Score=58.38 Aligned_cols=71 Identities=15% Similarity=0.070 Sum_probs=45.7
Q ss_pred ecccc-ceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCC--CcceeeeEEEcCCCceEEEEEec
Q psy787 45 LGEGS-YGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHR--NVIGLVDVFVNDKKQKMYLIMEY 121 (235)
Q Consensus 45 ig~g~-~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~~~lv~e~ 121 (235)
+..|. .+.||++.. ..+..+++|...... ...+..|...++.+... .+++++... .+.+..+++|++
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~--~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDWLLLGE 87 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEEEEEEC
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeec--ccccceEEEEEe
Confidence 34444 367898765 356667788654332 22477888888877433 356666665 445577899999
Q ss_pred ccCC
Q psy787 122 CVGG 125 (235)
Q Consensus 122 ~~~~ 125 (235)
++|.
T Consensus 88 i~G~ 91 (255)
T d1nd4a_ 88 VPGQ 91 (255)
T ss_dssp CSSE
T ss_pred eecc
Confidence 9773
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.43 E-value=0.00047 Score=54.01 Aligned_cols=71 Identities=14% Similarity=0.079 Sum_probs=45.9
Q ss_pred eeeeccccceEEEEeeccc-------hhhheeeeeeeeccccCCCCccccHHHHHHHHHhcC-CCCcceeeeEEEcCCCc
Q psy787 42 GDLLGEGSYGKVKEMLDSE-------TLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQ-HRNVIGLVDVFVNDKKQ 113 (235)
Q Consensus 42 ~~~ig~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 113 (235)
++.|+-|-.-.+|++.... ..+.+++|+.... .......+|..+++.+. +.-.+++++.+ ++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~------~~~idr~~E~~i~~~ls~~gl~Pkll~~~--~~-- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP------ETESHLVAESVIFTLLSERHLGPKLYGIF--SG-- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC------CCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT--
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc------chhhHHHHHHHHHHHHHhCCCCCeEEEEc--CC--
Confidence 3567778889999987542 2345667765421 12234567888888774 44455777776 43
Q ss_pred eEEEEEecccC
Q psy787 114 KMYLIMEYCVG 124 (235)
Q Consensus 114 ~~~lv~e~~~~ 124 (235)
.+|++|++|
T Consensus 117 --g~I~efi~g 125 (395)
T d1nw1a_ 117 --GRLEEYIPS 125 (395)
T ss_dssp --EEEECCCCE
T ss_pred --ceEEEEecc
Confidence 678999876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.31 E-value=0.0002 Score=54.33 Aligned_cols=29 Identities=31% Similarity=0.402 Sum_probs=25.9
Q ss_pred CcccCCCCCCCeEEccCCcEEEeeecccc
Q psy787 161 GIIHKDIKPGNLLLTLDGTLKISDFGVAE 189 (235)
Q Consensus 161 ~i~H~dl~p~nili~~~~~~~l~dfg~~~ 189 (235)
|++|+|+.++|++++.+...-++||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 69999999999999977767899999774
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.27 E-value=0.00029 Score=53.74 Aligned_cols=71 Identities=15% Similarity=0.137 Sum_probs=43.0
Q ss_pred ccceEEEEeeccchhhheeeeeeeeccccCCCCccccHHHHHHHHHhcCCCCcceeeeEEE-----cCCCceEEEEEecc
Q psy787 48 GSYGKVKEMLDSETLCRRAVKIFKKKKLQRIPNGEINVDREIRLLKMLQHRNVIGLVDVFV-----NDKKQKMYLIMEYC 122 (235)
Q Consensus 48 g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~~lv~e~~ 122 (235)
+..-.||++.. .+|+.+++|+.++... ....+..|...+..+...+++-...... ....+..+.++++.
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~-----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERW-----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCCC-----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeec
Confidence 44568999876 4788899999865532 2234677888777775333321111111 02334678899998
Q ss_pred cC
Q psy787 123 VG 124 (235)
Q Consensus 123 ~~ 124 (235)
+|
T Consensus 107 ~G 108 (325)
T d1zyla1 107 GG 108 (325)
T ss_dssp CC
T ss_pred CC
Confidence 76
|